Utilization Report

Transcription

Utilization Report

Utilization Report
3/15/2004
Listing by PDL Category and Drug
This listing is a reference guide only and may be subject to change.
* Market Share is based on scripts per PDL category.
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
5-HT3 RECEPTOR ANTAGONISTS/SUBSTANCE P NEUROKININ
00004023709
KYTRIL
SOL 2MG/10ML
00004023909
KYTRIL
INJ 1MG/ML
00004024126
KYTRIL
TAB 1MG
00004024133
KYTRIL
TAB 1MG
00006386203
EMEND
00029414901
0
$0.00
0.00%
10
$11,469.55
1.32%
7
$2,384.18
0.92%
29
$18,613.01
3.82%
CAP 80-125MG
0
$0.00
KYTRIL
INJ 1MG/ML
1
00029415105
KYTRIL
TAB 1MG
00051002121
MARINOL
CAP 2.5MG
00051002211
MARINOL
CAP 5MG
00051002321
MARINOL
00054260111
00054260125
$248.95
0.13%
0
$0.00
0.00%
15
$13,597.25
2.01%
16
$6,991.20
2.14%
0.00%
7
$1,426.26
0.94%
$605.16
0.13%
0
$0.00
0.00%
0
$0.00
0.00%
2
$738.39
0.27%
65
$17,347.60
8.55%
84
$20,920.94
11.26%
48
$24,799.46
6.32%
78
$56,855.64
10.46%
CAP 10MG
14
$12,413.20
1.84%
13
$13,427.31
1.74%
MARINOL
CAP 2.5MG
3
$592.29
0.39%
0
$0.00
0.00%
MARINOL
CAP 2.5MG
1
$90.82
0.13%
0
$0.00
0.00%
00054260211
MARINOL
CAP 5MG
4
$2,233.43
0.53%
0
$0.00
0.00%
00054260225
MARINOL
CAP 5MG
3
$2,423.82
0.39%
0
$0.00
0.00%
00088120305
ANZEMET
1
$331.99
0.13%
3
$1,859.76
0.40%
00173044200
ZOFRAN
INJ 2MG/ML
17
$6,215.99
2.24%
11
$4,037.77
1.47%
00173044202
ZOFRAN
INJ 2MG/ML
24
$1,338.42
3.16%
22
$975.09
2.95%
00173044600
ZOFRAN
TAB 4MG
166
$80,868.00
21.84%
167
$62,839.29
22.39%
00173044604
ZOFRAN
TAB 4MG
22
$13,440.81
2.89%
16
$4,973.01
2.14%
TAB 100MG
Copyright GHS Data Management, 2003
1
Page 1 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
- Category Continued -
5-HT3 RECEPTOR ANTAGONISTS/SUBSTANCE P NEUROKININ
00173044700
ZOFRAN
TAB 8MG
242
$208,338.17
31.84%
206
$165,333.16
27.61%
00173044704
ZOFRAN
TAB 8MG
29
$21,985.21
3.82%
17
$12,680.66
2.28%
00173048900
ZOFRAN
SOL 4MG/5ML
24
$7,342.79
3.16%
17
$2,454.52
2.28%
00173056900
ZOFRAN ODT TAB 4MG
20
$5,249.25
2.63%
25
$8,295.50
3.35%
00173057000
ZOFRAN ODT TAB 8MG
18
$8,698.99
2.37%
34
$12,792.77
4.56%
00173057004
ZOFRAN ODT TAB 8MG
12
$6,966.15
1.58%
12
$4,043.52
1.61%
9
$696.87
100.00%
4
$379.25
100.00%
1
$27.65
0.05%
0
$0.00
0.00%
5-Lipoxygenase Inhibitors
00074803622
ZYFLO
TAB 600MG
ACE AND THIAZIDE COMBOS
00003038450
CAPOZIDE
00006014031
PRINZIDE
TAB 20-12.5
1
$36.52
0.05%
0
$0.00
0.00%
00006014058
PRINZIDE
TAB 20-12.5
7
$252.41
0.34%
1
$36.02
0.04%
00006014258
PRINZIDE
TAB 20-25MG
6
$221.70
0.29%
0
$0.00
0.00%
00006014531
PRINZIDE
TAB 10/12.5
2
$71.66
0.10%
0
$0.00
0.00%
00006017368
VASERETIC
TAB 5-12.5MG
2
$67.92
0.10%
0
$0.00
0.00%
00006072068
VASERETIC
TAB 10-25MG
28
$1,243.08
1.37%
0
$0.00
0.00%
00071022006
ACCURETIC
TAB 20/12.5
26
$969.68
1.27%
0
$0.00
0.00%
00071022023
ACCURETIC
TAB 20/12.5
14
$513.99
0.68%
17
$632.88
0.66%
00071022206
ACCURETIC
TAB 10/12.5
3
$93.93
0.15%
0
$0.00
0.00%
00071022223
ACCURETIC
TAB 10/12.5
4
$116.19
0.20%
5
$139.99
0.19%
00071022306
ACCURETIC
TAB 20/25MG
7
$249.86
0.34%
0
$0.00
0.00%
00071022323
ACCURETIC
TAB 20/25MG
1
$29.37
0.05%
3
$133.91
0.12%
00083005730
LOTENSIN HCT TAB 5-6.25MG
7
$196.80
0.34%
1
$31.33
0.04%
00083007230
LOTENSIN HCT TAB 10-12.5
100
$2,891.00
4.88%
30
$898.08
1.16%
00083007430
LOTENSIN HCT TAB 20-12.5
136
$3,958.18
6.64%
51
$1,511.51
1.98%
TAB 50/15MG
Page 2 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00083007530
LOTENSIN HCT TAB 20-25MG
52
$1,517.61
2.54%
23
$635.45
0.89%
00087149201
MONOPRIL HCT TAB 10/12.5
32
$1,221.71
1.56%
9
$355.17
0.35%
00087149301
MONOPRIL HCT TAB 20/12.5
12
$401.00
0.59%
3
$106.05
0.12%
00091371201
UNIRETIC
TAB 7.5/12.5
17
$457.82
0.83%
30
$906.80
1.16%
00091372001
UNIRETIC
TAB 15-12.5
16
$430.90
0.78%
36
$1,064.16
1.39%
00091372501
UNIRETIC
TAB 15/25MG
70
$1,929.65
3.42%
98
$2,933.45
3.80%
00093017601
CAPTOPR/HCTZ TAB 25-15MG
0
$0.00
0.00%
2
$24.50
0.08%
00093017701
0
$0.00
0.00%
1
$7.45
0.04%
00093103501
LISINOP-HCTZ TAB 10-12.5
0
$0.00
0.00%
14
$196.80
0.54%
00093103601
8
$233.80
0.39%
29
$512.27
1.12%
00093103701
LISINOP-HCTZ TAB 20-25MG
5
$165.91
0.24%
31
$454.15
1.20%
00093105201
ENALAPR/HCTZ TAB 10-25MG
8
$369.11
0.39%
10
$166.60
0.39%
00143126401
0
$0.00
0.00%
4
$88.70
0.15%
00172503260
97
$3,689.52
4.74%
39
$631.23
1.51%
00172503270
1
$28.34
0.05%
1
$28.45
0.04%
00172503360
77
$2,118.94
3.76%
73
$955.72
2.83%
00172503370
0
$0.00
0.00%
16
$235.54
0.62%
00172503460
76
$2,556.05
3.71%
68
$1,100.19
2.63%
00172503470
0
$0.00
0.00%
38
$620.66
1.47%
00185015101
ENALAPR/HCTZ TAB 5-12.5MG
2
$52.78
0.10%
1
$9.55
0.04%
00185015201
112
$4,296.66
5.47%
215
$3,712.67
8.33%
00185017201
3
$185.97
0.15%
3
$65.85
0.12%
00185017301
148
$5,890.15
7.23%
234
$4,107.17
9.06%
00185710001
92
$2,940.27
4.49%
140
$1,881.69
5.42%
00228270611
13
$452.39
0.63%
3
$39.25
0.12%
00228270711
16
$723.27
0.78%
2
$53.30
0.08%
00228270811
4
$105.93
0.20%
5
$87.05
0.19%
Page 3 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00310014110
ZESTORETIC TAB 10/12.5
30
$1,007.90
1.46%
1
$15.28
0.04%
00310014210
ZESTORETIC TAB 20-12.5
26
$1,090.34
1.27%
2
$76.40
0.08%
00310014510
ZESTORETIC TAB 20-25MG
32
$1,288.53
1.56%
2
$77.28
0.08%
00378008101
2
$40.90
0.10%
12
$91.90
0.46%
00378008301
0
$0.00
0.00%
3
$28.95
0.12%
00378071201
15
$412.55
0.73%
21
$183.45
0.81%
00378072301
76
$3,350.16
3.71%
96
$1,286.93
3.72%
00378101201
102
$2,221.46
4.98%
235
$3,314.45
9.10%
00378201201
199
$5,827.01
9.72%
345
$6,041.79
13.36%
00378202501
149
$3,912.06
7.28%
337
$6,126.07
13.05%
00591086001
0
$0.00
0.00%
23
$479.15
0.89%
00591086101
0
$0.00
0.00%
28
$760.95
1.08%
00591086201
0
$0.00
0.00%
27
$610.35
1.05%
00781117601
20
$806.73
0.98%
30
$536.61
1.16%
00781117801
18
$726.19
0.88%
25
$402.65
0.97%
00781184801
18
$573.10
0.88%
33
$438.63
1.28%
49884068701
0
$0.00
0.00%
5
$92.95
0.19%
51672404501
18
$464.88
0.88%
23
$223.13
0.89%
51672404601
42
$1,384.66
2.05%
45
$612.24
1.74%
59772516005
4
$49.80
0.20%
3
$36.75
0.12%
59772516205
4
$88.40
0.20%
7
$119.35
0.27%
59772516305
6
$88.10
0.29%
5
$114.25
0.19%
60951073370
2
$27.50
0.10%
0
$0.00
0.00%
63304053601
30
$874.10
1.46%
14
$219.60
0.54%
63304053701
25
$963.24
1.22%
13
$237.35
0.50%
63304053801
24
$882.15
1.17%
9
$129.12
0.35%
64455014601
VASERETIC
0
$0.00
0.00%
2
$74.34
0.08%
TAB 10-25MG
Page 4 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
00003045054
CAPOTEN
TAB 12.5MG
00003045250
CAPOTEN
00003048250
3
$132.36
0.01%
0
$0.00
0.00%
TAB 25MG
13
$777.11
0.05%
0
$0.00
0.00%
CAPOTEN
TAB 50MG
9
$1,641.63
0.03%
0
$0.00
0.00%
00003048550
CAPOTEN
TAB 100MG
3
$634.56
0.01%
0
$0.00
0.00%
00006001468
VASOTEC
TAB 2.5MG
20
$535.84
0.07%
0
$0.00
0.00%
00006001531
PRINIVIL
TAB 2.5MG
2
$43.30
0.01%
0
$0.00
0.00%
00006001558
PRINIVIL
TAB 2.5MG
15
$182.09
0.05%
0
$0.00
0.00%
00006001928
PRINIVIL
TAB 5MG
29
$495.97
0.10%
0
$0.00
0.00%
00006001954
PRINIVIL
TAB 5MG
0
$0.00
0.00%
6
$258.90
0.02%
00006001958
PRINIVIL
TAB 5MG
61
$1,773.99
0.22%
2
$58.10
0.01%
00006010628
PRINIVIL
TAB 10MG
7
$297.65
0.02%
0
$0.00
0.00%
00006010654
PRINIVIL
TAB 10MG
0
$0.00
0.00%
2
$34.70
0.01%
00006010658
PRINIVIL
TAB 10MG
134
$3,729.99
0.48%
1
$29.97
0.00%
00006010682
PRINIVIL
TAB 10MG
38
$853.70
0.14%
1
$32.20
0.00%
00006020731
PRINIVIL
TAB 20MG
2
$65.04
0.01%
0
$0.00
0.00%
00006020754
PRINIVIL
TAB 20MG
0
$0.00
0.00%
3
$111.68
0.01%
00006020758
PRINIVIL
TAB 20MG
97
$3,212.56
0.35%
5
$191.32
0.01%
00006020782
PRINIVIL
TAB 20MG
7
$332.18
0.02%
0
$0.00
0.00%
00006023758
PRINIVIL
TAB 40MG
73
$3,262.06
0.26%
7
$370.68
0.02%
00006071268
VASOTEC
TAB 5MG
32
$1,412.15
0.11%
0
$0.00
0.00%
00006071368
VASOTEC
TAB 10MG
33
$1,378.58
0.12%
0
$0.00
0.00%
00006071382
VASOTEC
TAB 10MG
2
$58.12
0.01%
0
$0.00
0.00%
00006071468
VASOTEC
TAB 20MG
48
$3,405.05
0.17%
0
$0.00
0.00%
00006071482
VASOTEC
TAB 20MG
1
$93.16
0.00%
0
$0.00
0.00%
00032110101
ACEON
TAB 2MG
0
$0.00
0.00%
3
$56.03
0.01%
00032110201
ACEON
TAB 4MG
36
$1,154.99
0.13%
10
$344.89
0.03%
Page 5 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
00032110301
ACEON
TAB 8MG
00039010410
ALTACE
00039010510
ALTACE
00048580501
12
$680.30
0.04%
9
$618.02
0.03%
CAP 2.5MG
2
$48.30
0.01%
0
$0.00
0.00%
CAP 5MG
2
$59.56
0.01%
0
$0.00
0.00%
MAVIK
TAB 1MG
77
$2,042.38
0.27%
0
$0.00
0.00%
00048580601
MAVIK
TAB 2MG
136
$3,471.57
0.48%
6
$112.10
0.02%
00048580701
MAVIK
TAB 4MG
168
$5,156.39
0.60%
5
$173.14
0.01%
00071052723
ACCUPRIL
TAB 5MG
133
$4,085.90
0.47%
41
$1,209.85
0.12%
00071053023
ACCUPRIL
TAB 10MG
452
$14,033.17
1.61%
118
$3,425.13
0.34%
00071053223
ACCUPRIL
TAB 20MG
536
$16,905.06
1.91%
140
$4,173.58
0.40%
00071053523
ACCUPRIL
TAB 40MG
597
$22,010.80
2.12%
199
$6,992.74
0.57%
00074227813
MAVIK
TAB 1MG
0
$0.00
0.00%
14
$349.35
0.04%
00074227913
MAVIK
TAB 2MG
0
$0.00
0.00%
28
$703.63
0.08%
00074228011
MAVIK
TAB 4MG
0
$0.00
0.00%
1
$52.27
0.00%
00074228013
MAVIK
TAB 4MG
0
$0.00
0.00%
28
$803.33
0.08%
00083005930
LOTENSIN
TAB 5MG
141
$3,773.16
0.50%
54
$1,354.13
0.15%
00083005990
LOTENSIN
TAB 5MG
3
$47.04
0.01%
0
$0.00
0.00%
00083006330
LOTENSIN
TAB 10MG
542
$15,295.47
1.93%
163
$4,865.06
0.46%
00083006390
LOTENSIN
TAB 10MG
17
$507.00
0.06%
7
$201.65
0.02%
00083007930
LOTENSIN
TAB 20MG
653
$18,652.64
2.32%
272
$8,290.01
0.77%
00083007932
LOTENSIN
TAB 20MG
3
$80.01
0.01%
0
$0.00
0.00%
00083007990
LOTENSIN
TAB 20MG
14
$401.16
0.05%
8
$226.72
0.02%
00083009430
LOTENSIN
TAB 40MG
451
$14,148.07
1.61%
156
$5,300.02
0.44%
00083009490
LOTENSIN
TAB 40MG
15
$564.84
0.05%
6
$197.49
0.02%
00087015846
MONOPRIL
TAB 10MG
511
$16,935.54
1.82%
172
$5,658.31
0.49%
00087060942
MONOPRIL
TAB 20MG
411
$14,736.46
1.46%
138
$5,213.94
0.39%
00087120213
MONOPRIL
TAB 40MG
224
$8,514.40
0.80%
91
$3,268.20
0.26%
00091370701
UNIVASC
TAB 7.5MG
179
$4,421.64
0.64%
307
$9,027.19
0.87%
Page 6 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
00091370709
UNIVASC
TAB 7.5MG
0
$0.00
0.00%
3
$85.64
0.01%
00091371501
UNIVASC
TAB 15MG
196
$5,687.64
0.70%
335
$11,574.79
0.95%
00091371509
UNIVASC
TAB 15MG
4
$91.16
0.01%
9
$418.27
0.03%
00093001701
MOEXIPRIL
TAB 7.5MG
0
$0.00
0.00%
30
$621.73
0.09%
00093002601
ENALAPRIL
TAB 2.5MG
39
$491.99
0.14%
39
$512.08
0.11%
00093002701
ENALAPRIL
TAB 5MG
69
$651.28
0.25%
119
$976.36
0.34%
00093002710
ENALAPRIL
TAB 5MG
2
$28.50
0.01%
2
$24.50
0.01%
00093002801
ENALAPRIL
TAB 10MG
99
$1,043.17
0.35%
168
$1,615.59
0.48%
00093002901
ENALAPRIL
TAB 20MG
138
$2,034.09
0.49%
198
$2,644.21
0.56%
00093002910
ENALAPRIL
TAB 20MG
4
$90.40
0.01%
0
$0.00
0.00%
00093009101
CAPTOPRIL
TAB 12.5MG
53
$268.10
0.19%
77
$224.09
0.22%
00093009201
CAPTOPRIL
TAB 25MG
85
$511.98
0.30%
85
$343.52
0.24%
00093009701
CAPTOPRIL
TAB 50MG
56
$505.04
0.20%
66
$474.30
0.19%
00093009801
CAPTOPRIL
TAB 100MG
13
$215.68
0.05%
13
$142.95
0.04%
00093111101
LISINOPRIL TAB 2.5MG
11
$213.99
0.04%
11
$58.65
0.03%
00093111201
LISINOPRIL TAB 5MG
38
$1,198.78
0.14%
7
$35.35
0.02%
00093111210
LISINOPRIL TAB 5MG
0
$0.00
0.00%
143
$858.96
0.41%
00093111301
LISINOPRIL TAB 10MG
33
$1,008.62
0.12%
42
$330.30
0.12%
00093111310
LISINOPRIL TAB 10MG
0
$0.00
0.00%
443
$3,282.95
1.26%
00093111401
LISINOPRIL TAB 20MG
55
$1,600.06
0.20%
77
$699.63
0.22%
00093111410
LISINOPRIL TAB 20MG
0
$0.00
0.00%
390
$3,914.65
1.11%
00093111501
LISINOPRIL TAB 40MG
12
$474.78
0.04%
150
$1,969.98
0.43%
00093515001
MOEXIPRIL
TAB 15MG
0
$0.00
0.00%
28
$634.25
0.08%
00093515701
LISINOPRIL TAB 30MG
3
$200.80
0.01%
13
$216.25
0.04%
00093722298
FOSINOPRIL TAB 10MG
0
$0.00
0.00%
2
$21.52
0.01%
00093813201
CAPTOPRIL
TAB 12.5MG
0
$0.00
0.00%
3
$13.89
0.01%
00093813301
CAPTOPRIL
TAB 25MG
0
$0.00
0.00%
22
$88.27
0.06%
Page 7 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
00093813401
CAPTOPRIL
TAB 50MG
0
$0.00
0.00%
00093813501
CAPTOPRIL
TAB 100MG
0
$0.00
0.00%
00143117101
CAPTOPRIL
TAB 12.5MG
0
$0.00
0.00%
00143117110
CAPTOPRIL
TAB 12.5MG
16
$77.31
0.06%
00143117201
CAPTOPRIL
TAB 25MG
2
$12.54
00143117210
CAPTOPRIL
TAB 25MG
23
00143117301
CAPTOPRIL
TAB 50MG
14
00143117310
CAPTOPRIL
TAB 50MG
00143117401
CAPTOPRIL
TAB 100MG
00143126601
LISINOPRIL TAB 5MG
00143126701
LISINOPRIL TAB 10MG
00143126801
LISINOPRIL TAB 20MG
00143127001
LISINOPRIL TAB 40MG
00172375760
00172375770
00172375810
LISINOPRIL TAB 5MG
00172375860
$86.02
0.02%
1
$20.15
0.00%
46
$155.40
0.13%
38
$129.37
0.11%
0.01%
28
$151.16
0.08%
$132.39
0.08%
50
$216.40
0.14%
$123.38
0.05%
22
$164.12
0.06%
15
$143.95
0.05%
18
$129.16
0.05%
0
$0.00
0.00%
8
$100.95
0.02%
2
$54.92
0.01%
0
$0.00
0.00%
10
$267.08
0.04%
14
$103.40
0.04%
7
$181.36
0.02%
9
$82.65
0.03%
0
$0.00
0.00%
15
$193.65
0.04%
42
$633.89
0.15%
196
$1,138.67
0.56%
141
$2,571.35
0.50%
183
$1,225.34
0.52%
0
$0.00
0.00%
6
$52.40
0.02%
LISINOPRIL TAB 5MG
343
$8,460.39
1.22%
461
$2,879.18
1.31%
00172375870
LISINOPRIL TAB 5MG
167
$4,263.87
0.59%
630
$4,453.31
1.79%
00172375960
LISINOPRIL TAB 10MG
152
$3,388.38
0.54%
552
$3,979.05
1.57%
00172375970
LISINOPRIL TAB 10MG
373
$10,102.14
1.33%
840
$6,420.86
2.39%
00172376060
LISINOPRIL TAB 20MG
93
$2,215.85
0.33%
370
$3,758.63
1.05%
00172376070
LISINOPRIL TAB 20MG
265
$7,743.60
0.94%
628
$6,527.94
1.78%
00172376110
LISINOPRIL TAB 40MG
2
$54.84
0.01%
7
$77.35
0.02%
00172376160
LISINOPRIL TAB 40MG
59
$1,726.52
0.21%
180
$2,300.24
0.51%
00172376170
LISINOPRIL TAB 40MG
109
$3,919.60
0.39%
226
$2,913.97
0.64%
00172376260
LISINOPRIL TAB 30MG
8
$181.78
0.03%
25
$281.88
0.07%
00172376270
LISINOPRIL TAB 30MG
0
$0.00
0.00%
18
$236.62
0.05%
8
Page 8 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
00172419560
ENALAPRIL
TAB 2.5MG
7
$92.45
0.02%
58
$595.93
0.16%
00172419580
ENALAPRIL
TAB 2.5MG
14
$164.05
0.05%
11
$112.50
0.03%
00172419660
ENALAPRIL
TAB 5MG
4
$50.38
0.01%
27
$228.04
0.08%
00172419680
ENALAPRIL
TAB 5MG
50
$472.81
0.18%
201
$1,810.07
0.57%
00172419760
ENALAPRIL
TAB 10MG
2
$34.70
0.01%
53
$546.65
0.15%
00172419780
ENALAPRIL
TAB 10MG
37
$347.15
0.13%
135
$1,201.20
0.38%
00172419785
ENALAPRIL
TAB 10MG
4
$37.40
0.01%
4
$37.40
0.01%
00172419860
ENALAPRIL
TAB 20MG
24
$388.45
0.09%
63
$871.03
0.18%
00172419864
ENALAPRIL
TAB 20MG
0
$0.00
0.00%
5
$88.25
0.01%
00172419870
ENALAPRIL
TAB 20MG
1
$29.35
0.00%
0
$0.00
0.00%
00172419880
ENALAPRIL
TAB 20MG
21
$304.28
0.07%
32
$456.46
0.09%
00185002501
96
$1,680.99
0.34%
60
$344.75
0.17%
00185010101
LISINOPRIL TAB 10MG
331
$8,736.86
1.18%
373
$2,667.04
1.06%
00185010233
LISINOPRIL TAB 20MG
0
$0.00
0.00%
23
$227.05
0.07%
00185012701
ENALAPRIL
TAB 5MG
0
$0.00
0.00%
7
$63.35
0.02%
00185014701
ENALAPRIL
TAB 10MG
0
$0.00
0.00%
10
$93.50
0.03%
00185021401
ENALAPRIL
TAB 20MG
0
$0.00
0.00%
3
$35.25
0.01%
00185021410
ENALAPRIL
TAB 20MG
0
$0.00
0.00%
2
$102.50
0.01%
00185021450
ENALAPRIL
TAB 20MG
0
$0.00
0.00%
27
$367.35
0.08%
00185540001
LISINOPRIL TAB 5MG
268
$6,855.15
0.95%
118
$666.62
0.34%
00228266011
ENALAPRIL
1
$8.85
0.00%
0
$0.00
0.00%
00310013010
ZESTRIL
TAB 5MG
59
$1,679.45
0.21%
4
$115.69
0.01%
00310013034
ZESTRIL
TAB 5MG
8
$251.16
0.03%
1
$30.48
0.00%
00310013110
ZESTRIL
TAB 10MG
72
$2,298.86
0.26%
2
$63.54
0.01%
00310013134
ZESTRIL
TAB 10MG
39
$1,029.34
0.14%
0
$0.00
0.00%
00310013210
ZESTRIL
TAB 20MG
99
$3,103.80
0.35%
18
$781.13
0.05%
00310013234
ZESTRIL
TAB 20MG
5
$92.78
0.02%
0
$0.00
0.00%
TAB 10MG
Page 9 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
00310013273
ZESTRIL
TAB 20MG
2
$67.24
0.01%
0
00310013310
ZESTRIL
TAB 30MG
24
$1,032.94
0.09%
00310013410
ZESTRIL
TAB 40MG
44
$2,203.71
0.16%
00310013510
ZESTRIL
TAB 2.5MG
23
$455.13
00364269801
ENALAPRIL
TAB 2.5MG
23
00364269802
ENALAPRIL
TAB 2.5MG
00364270101
ENALAPRIL
TAB 5MG
00364270102
ENALAPRIL
00364272701
$0.00
0.00%
1
$47.71
0.00%
6
$343.90
0.02%
0.08%
1
$20.82
0.00%
$229.15
0.08%
26
$262.25
0.07%
5
$51.10
0.02%
0
$0.00
0.00%
6
$81.70
0.02%
2
$24.50
0.01%
TAB 5MG
2
$28.00
0.01%
0
$0.00
0.00%
ENALAPRIL
TAB 10MG
27
$259.52
0.10%
2
$19.70
0.01%
00364272702
ENALAPRIL
TAB 10MG
16
$170.60
0.06%
0
$0.00
0.00%
00364273401
ENALAPRIL
TAB 20MG
11
$167.65
0.04%
2
$35.30
0.01%
00364273402
ENALAPRIL
TAB 20MG
1
$1.68
0.00%
0
$0.00
0.00%
00378105101
ENALAPRIL
TAB 2.5MG
48
$674.12
0.17%
59
$816.97
0.17%
00378105201
ENALAPRIL
TAB 5MG
93
$904.50
0.33%
124
$1,158.96
0.35%
00378105210
ENALAPRIL
TAB 5MG
0
$0.00
0.00%
12
$86.10
0.03%
00378105301
ENALAPRIL
TAB 10MG
120
$1,236.40
0.43%
195
$1,733.25
0.55%
00378105401
ENALAPRIL
TAB 20MG
97
$1,611.79
0.35%
130
$2,145.71
0.37%
00378105405
ENALAPRIL
TAB 20MG
2
$13.54
0.01%
0
$0.00
0.00%
00378207201
183
$2,942.41
0.65%
406
$2,221.97
1.15%
00378207301
LISINOPRIL TAB 5MG
835
$17,776.21
2.97%
1,322
$7,998.77
3.76%
00378207310
LISINOPRIL TAB 5MG
40
$870.80
0.14%
166
$983.32
0.47%
00378207401
LISINOPRIL TAB 10MG
1,556
$35,816.55
5.54%
2,571
$17,973.78
7.31%
00378207410
LISINOPRIL TAB 10MG
97
$2,830.47
0.35%
639
$4,431.81
1.82%
00378207501
LISINOPRIL TAB 20MG
1,271
$32,252.66
4.52%
2,160
$21,229.37
6.14%
00378207510
LISINOPRIL TAB 20MG
64
$2,119.62
0.23%
369
$3,691.10
1.05%
00378207601
LISINOPRIL TAB 40MG
695
$22,268.23
2.47%
1,391
$18,628.47
3.95%
00378207701
LISINOPRIL TAB 30MG
73
$2,080.33
0.26%
129
$1,713.01
0.37%
Page 10 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
00378300701
CAPTOPRIL
TAB 12.5MG
38
$175.23
0.14%
50
$217.31
0.14%
00378300710
CAPTOPRIL
TAB 12.5MG
73
$352.56
0.26%
118
$578.54
0.34%
00378301201
CAPTOPRIL
TAB 25MG
27
$171.30
0.10%
103
$448.10
0.29%
00378301210
CAPTOPRIL
TAB 25MG
48
$302.94
0.17%
84
$477.33
0.24%
00378301701
CAPTOPRIL
TAB 50MG
32
$269.54
0.11%
72
$543.07
0.20%
00378301710
CAPTOPRIL
TAB 50MG
6
$52.74
0.02%
36
$300.08
0.10%
00378302201
CAPTOPRIL
TAB 100MG
5
$82.96
0.02%
8
$120.05
0.02%
00591040501
143
$2,830.70
0.51%
190
$967.76
0.54%
00591040601
LISINOPRIL TAB 5MG
559
$15,815.41
1.99%
834
$4,805.12
2.37%
00591040701
LISINOPRIL TAB 10MG
1,032
$30,216.69
3.67%
1,859
$12,997.48
5.28%
00591040801
LISINOPRIL TAB 20MG
847
$26,467.66
3.01%
1,623
$15,472.41
4.61%
00591040901
LISINOPRIL TAB 40MG
474
$21,446.24
1.69%
938
$12,206.56
2.67%
00591066801
ENALAPRIL
TAB 2.5MG
136
$1,556.74
0.48%
69
$867.59
0.20%
00591066805
ENALAPRIL
TAB 2.5MG
3
$36.15
0.01%
11
$155.85
0.03%
00591066901
ENALAPRIL
TAB 5MG
130
$1,141.37
0.46%
130
$1,075.13
0.37%
00591066905
ENALAPRIL
TAB 5MG
49
$382.26
0.17%
4
$30.69
0.01%
00591067001
ENALAPRIL
TAB 10MG
107
$961.55
0.38%
122
$1,116.20
0.35%
00591067005
ENALAPRIL
TAB 10MG
28
$288.30
0.10%
5
$30.05
0.01%
00591067101
ENALAPRIL
TAB 20MG
186
$2,915.98
0.66%
77
$1,199.78
0.22%
00591088501
LISINOPRIL TAB 30MG
55
$2,519.97
0.20%
94
$1,283.26
0.27%
00615451953
CAPTOPRIL
TAB 12.5MG
14
$63.27
0.05%
0
$0.00
0.00%
00615451963
CAPTOPRIL
TAB 12.5MG
44
$203.63
0.16%
0
$0.00
0.00%
00615452053
CAPTOPRIL
TAB 25MG
9
$56.91
0.03%
0
$0.00
0.00%
00615452063
CAPTOPRIL
TAB 25MG
18
$92.02
0.06%
0
$0.00
0.00%
00615452153
CAPTOPRIL
TAB 50MG
11
$73.07
0.04%
0
$0.00
0.00%
00615452163
CAPTOPRIL
TAB 50MG
11
$85.26
0.04%
0
$0.00
0.00%
00615459053
ENALAPRIL MA TAB 5MG
13
$90.46
0.05%
0
$0.00
0.00%
Page 11 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
00615459063
38
$346.25
0.14%
0
$0.00
0.00%
00615459153
12
$108.54
0.04%
0
$0.00
0.00%
00615459163
65
$595.49
0.23%
0
$0.00
0.00%
00781122901
ENALAPRIL
TAB 2.5MG
112
$1,605.25
0.40%
148
$2,039.80
0.42%
00781122910
ENALAPRIL
TAB 2.5MG
13
$178.55
0.05%
6
$69.10
0.02%
00781123101
ENALAPRIL
TAB 5MG
323
$3,122.75
1.15%
462
$3,774.58
1.31%
00781123110
ENALAPRIL
TAB 5MG
19
$206.60
0.07%
10
$118.60
0.03%
00781123201
ENALAPRIL
TAB 10MG
351
$3,786.90
1.25%
479
$4,521.30
1.36%
00781123210
ENALAPRIL
TAB 10MG
14
$177.90
0.05%
19
$162.85
0.05%
00781123301
ENALAPRIL
TAB 20MG
304
$4,969.28
1.08%
471
$6,951.59
1.34%
00781123310
ENALAPRIL
TAB 20MG
6
$97.10
0.02%
12
$130.30
0.03%
00781166501
LISINOPRIL TAB 5MG
140
$3,804.03
0.50%
186
$1,128.92
0.53%
00781166601
LISINOPRIL TAB 10MG
286
$7,870.06
1.02%
447
$3,103.61
1.27%
00781166701
LISINOPRIL TAB 20MG
147
$4,669.94
0.52%
321
$3,153.24
0.91%
00781166801
LISINOPRIL TAB 40MG
135
$6,394.76
0.48%
213
$2,845.33
0.61%
00781166901
34
$595.83
0.12%
58
$278.60
0.16%
00781167301
LISINOPRIL TAB 30MG
2
$81.40
0.01%
22
$272.76
0.06%
00781508392
FOSINOPRIL TAB 10MG
0
$0.00
0.00%
1
$15.00
0.00%
00781508492
FOSINOPRIL TAB 20MG
0
$0.00
0.00%
1
$34.40
0.00%
00904504560
CAPTOPRIL
TAB 12.5MG
8
$28.47
0.03%
0
$0.00
0.00%
00904504660
CAPTOPRIL
TAB 25MG
3
$18.81
0.01%
0
$0.00
0.00%
00904504680
CAPTOPRIL
TAB 25MG
2
$10.26
0.01%
4
$7.96
0.01%
00904504780
CAPTOPRIL
TAB 50MG
3
$22.99
0.01%
0
$0.00
0.00%
00904550280
ENALAPRIL
TAB 5MG
0
$0.00
0.00%
6
$50.70
0.02%
00904550460
ENALAPRIL
TAB 20MG
2
$22.94
0.01%
0
$0.00
0.00%
00904550480
ENALAPRIL
TAB 20MG
0
$0.00
0.00%
4
$62.20
0.01%
49884055701
LISINOPRIL TAB 5MG
9
$207.31
0.03%
0
$0.00
0.00%
Page 12 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
49884055801
LISINOPRIL TAB 10MG
9
$338.38
0.03%
1
$5.95
0.00%
49884055901
LISINOPRIL TAB 20MG
9
$261.91
0.03%
0
$0.00
0.00%
49884056001
LISINOPRIL TAB 40MG
7
$184.56
0.02%
0
$0.00
0.00%
49884059101
ENALAPRIL
TAB 2.5MG
22
$289.00
0.08%
36
$471.53
0.10%
49884059110
ENALAPRIL
TAB 2.5MG
14
$158.90
0.05%
12
$176.70
0.03%
49884059201
ENALAPRIL
TAB 5MG
45
$452.65
0.16%
72
$626.26
0.20%
49884059210
ENALAPRIL
TAB 5MG
70
$692.83
0.25%
143
$1,300.86
0.41%
49884059301
ENALAPRIL
TAB 10MG
84
$901.20
0.30%
55
$499.69
0.16%
49884059310
ENALAPRIL
TAB 10MG
87
$919.45
0.31%
246
$2,146.55
0.70%
49884059401
ENALAPRIL
TAB 20MG
96
$1,473.75
0.34%
148
$2,111.66
0.42%
49884059410
ENALAPRIL
TAB 20MG
65
$926.73
0.23%
174
$2,104.05
0.49%
49884061901
CAPTOPRIL
TAB 12.5MG
37
$201.11
0.13%
2
$8.25
0.01%
49884061910
CAPTOPRIL
TAB 12.5MG
9
$44.28
0.03%
9
$27.97
0.03%
49884062001
CAPTOPRIL
TAB 25MG
90
$569.90
0.32%
14
$68.42
0.04%
49884062010
CAPTOPRIL
TAB 25MG
13
$80.59
0.05%
11
$56.75
0.03%
49884062101
CAPTOPRIL
TAB 50MG
45
$407.15
0.16%
1
$12.37
0.00%
49884062110
CAPTOPRIL
TAB 50MG
4
$38.78
0.01%
11
$77.13
0.03%
49884062201
CAPTOPRIL
TAB 100MG
5
$87.89
0.02%
1
$19.89
0.00%
51079095120
ENALAPRIL
TAB 5MG
6
$53.16
0.02%
2
$16.01
0.01%
51079095220
ENALAPRIL
TAB 10MG
5
$46.55
0.02%
13
$77.75
0.04%
51079095320
ENALAPRIL
TAB 20MG
10
$132.62
0.04%
3
$19.01
0.01%
51672403701
ENALAPRIL
TAB 2.5MG
1
$12.35
0.00%
5
$47.65
0.01%
51672403801
ENALAPRIL
TAB 5MG
0
$0.00
0.00%
34
$244.96
0.10%
51672403901
ENALAPRIL
TAB 10MG
4
$37.40
0.01%
26
$211.90
0.07%
51672404001
ENALAPRIL
TAB 20MG
7
$95.05
0.02%
73
$1,158.17
0.21%
52544068901
CAPTOPRIL
TAB 25MG
0
$0.00
0.00%
1
$3.13
0.00%
52544068910
CAPTOPRIL
TAB 25MG
2
$13.04
0.01%
0
$0.00
0.00%
Page 13 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
55370014507
CAPTOPRIL
TAB 100MG
3
55370016409
CAPTOPRIL
TAB 12.5MG
55370092307
ENALAPRIL
TAB 5MG
55370092309
ENALAPRIL
55370092407
$35.43
0.01%
2
$23.62
0.01%
0
$0.00
0.00%
3
$17.34
0.01%
2
$18.10
0.01%
2
$18.10
0.01%
TAB 5MG
3
$25.65
0.01%
1
$6.55
0.00%
ENALAPRIL
TAB 10MG
11
$114.35
0.04%
0
$0.00
0.00%
55370092409
ENALAPRIL
TAB 10MG
10
$105.62
0.04%
0
$0.00
0.00%
55370092507
ENALAPRIL
TAB 20MG
2
$70.90
0.01%
0
$0.00
0.00%
59772704501
CAPTOPRIL
TAB 12.5MG
53
$243.16
0.19%
66
$220.89
0.19%
59772704503
CAPTOPRIL
TAB 12.5MG
62
$257.10
0.22%
46
$177.18
0.13%
59772704505
CAPTOPRIL
TAB 12.5MG
0
$0.00
0.00%
2
$9.94
0.01%
59772704601
CAPTOPRIL
TAB 25MG
64
$382.23
0.23%
93
$396.93
0.26%
59772704603
CAPTOPRIL
TAB 25MG
74
$433.07
0.26%
70
$347.31
0.20%
59772704701
CAPTOPRIL
TAB 50MG
58
$445.11
0.21%
64
$463.45
0.18%
59772704703
CAPTOPRIL
TAB 50MG
23
$218.73
0.08%
12
$95.66
0.03%
59772704801
CAPTOPRIL
TAB 100MG
9
$85.54
0.03%
16
$178.11
0.05%
60505018400
0
$0.00
0.00%
1
$4.45
0.00%
60505018500
LISINOPRIL TAB 5MG
0
$0.00
0.00%
7
$45.35
0.02%
60505018700
LISINOPRIL TAB 20MG
47
$1,351.58
0.17%
215
$2,163.22
0.61%
60505018701
LISINOPRIL TAB 20MG
21
$601.40
0.07%
138
$1,317.55
0.39%
60505018800
LISINOPRIL TAB 30MG
0
$0.00
0.00%
10
$159.20
0.03%
60505018900
LISINOPRIL TAB 40MG
20
$875.49
0.07%
95
$1,153.94
0.27%
61570011001
ALTACE
CAP 1.25MG
13
$317.70
0.05%
1
$29.90
0.00%
61570011101
ALTACE
CAP 2.5MG
446
$14,985.87
1.59%
230
$7,488.04
0.65%
61570011105
ALTACE
CAP 2.5MG
3
$99.07
0.01%
0
$0.00
0.00%
61570011201
ALTACE
CAP 5MG
622
$22,822.14
2.21%
267
$9,602.73
0.76%
61570011256
ALTACE
CAP 5MG
1
$37.24
0.00%
0
$0.00
0.00%
61570012001
ALTACE
CAP 10MG
553
$29,424.99
1.97%
243
$13,099.06
0.69%
Page 14 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
63304052201
ENALAPRIL
TAB 2.5MG
12
$138.80
0.04%
4
$39.40
0.01%
63304052210
ENALAPRIL
TAB 2.5MG
4
$62.40
0.01%
0
$0.00
0.00%
63304052301
ENALAPRIL
TAB 5MG
2
$18.10
0.01%
0
$0.00
0.00%
63304052310
ENALAPRIL
TAB 5MG
0
$0.00
0.00%
3
$53.85
0.01%
63304052401
ENALAPRIL
TAB 10MG
0
$0.00
0.00%
6
$65.10
0.02%
63304052410
ENALAPRIL
TAB 10MG
4
$59.40
0.01%
1
$6.85
0.00%
63304052501
ENALAPRIL
TAB 20MG
2
$21.50
0.01%
1
$17.65
0.00%
63304052510
ENALAPRIL
TAB 20MG
10
$157.90
0.04%
2
$68.90
0.01%
63304053101
40
$753.99
0.14%
16
$91.25
0.05%
63304053201
LISINOPRIL TAB 5MG
42
$1,081.68
0.15%
10
$50.32
0.03%
63304053210
LISINOPRIL TAB 5MG
38
$985.62
0.14%
121
$779.63
0.34%
63304053301
LISINOPRIL TAB 10MG
54
$1,644.38
0.19%
28
$179.80
0.08%
63304053310
LISINOPRIL TAB 10MG
97
$2,681.39
0.35%
51
$346.50
0.14%
63304053401
LISINOPRIL TAB 20MG
187
$5,176.84
0.67%
35
$271.55
0.10%
63304053410
LISINOPRIL TAB 20MG
57
$1,798.49
0.20%
10
$140.75
0.03%
63304053501
LISINOPRIL TAB 40MG
104
$4,198.31
0.37%
52
$639.40
0.15%
63304053510
LISINOPRIL TAB 40MG
16
$617.58
0.06%
30
$414.26
0.09%
63304083401
ENALAPRIL
TAB 2.5MG
0
$0.00
0.00%
2
$22.20
0.01%
63304083410
ENALAPRIL
TAB 2.5MG
0
$0.00
0.00%
5
$58.40
0.01%
63304083501
ENALAPRIL
TAB 5MG
0
$0.00
0.00%
11
$83.45
0.03%
63304083510
ENALAPRIL
TAB 5MG
21
$191.45
0.07%
75
$615.85
0.21%
63304083601
ENALAPRIL
TAB 10MG
0
$0.00
0.00%
14
$137.90
0.04%
63304083610
ENALAPRIL
TAB 10MG
17
$167.95
0.06%
56
$563.45
0.16%
63304083701
ENALAPRIL
TAB 20MG
0
$0.00
0.00%
7
$64.75
0.02%
63304083710
ENALAPRIL
TAB 20MG
1
$26.55
0.00%
49
$925.97
0.14%
64455014090
VASOTEC
TAB 2.5MG
0
$0.00
0.00%
8
$390.66
0.02%
64455014190
VASOTEC
TAB 5MG
0
$0.00
0.00%
6
$379.02
0.02%
Page 15 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
64455014290
VASOTEC
TAB 10MG
5
$264.63
0.02%
64455014390
VASOTEC
TAB 20MG
11
$570.66
0.04%
66685030100
ENALAPRIL
TAB 2.5MG
74
$799.21
0.26%
66685030102
ENALAPRIL
TAB 2.5MG
20
$279.00
0.07%
66685030200
ENALAPRIL
TAB 5MG
194
$1,841.64
66685030202
ENALAPRIL
TAB 5MG
120
66685030300
ENALAPRIL
TAB 10MG
229
66685030302
ENALAPRIL
TAB 10MG
66685030400
ENALAPRIL
66685030402
ENALAPRIL
66685070101
66685070201
11
$475.75
0.03%
8
$424.41
0.02%
119
$1,162.86
0.34%
43
$467.73
0.12%
0.69%
312
$2,673.00
0.89%
$1,258.80
0.43%
106
$913.45
0.30%
$2,396.10
0.82%
317
$2,774.32
0.90%
122
$1,067.62
0.43%
135
$958.63
0.38%
TAB 20MG
269
$4,284.04
0.96%
378
$5,549.53
1.07%
TAB 20MG
158
$2,350.53
0.56%
84
$1,252.29
0.24%
123
$2,168.82
0.44%
120
$661.19
0.34%
LISINOPRIL TAB 5MG
413
$10,785.40
1.47%
179
$1,059.20
0.51%
66685070202
LISINOPRIL TAB 5MG
6
$160.70
0.02%
12
$74.02
0.03%
66685070301
LISINOPRIL TAB 10MG
599
$16,366.54
2.13%
252
$1,720.21
0.72%
66685070302
LISINOPRIL TAB 10MG
52
$1,489.46
0.19%
15
$130.77
0.04%
66685070401
LISINOPRIL TAB 20MG
508
$15,350.91
1.81%
228
$2,194.67
0.65%
66685070402
LISINOPRIL TAB 20MG
30
$929.08
0.11%
13
$139.80
0.04%
66685070501
LISINOPRIL TAB 30MG
34
$1,253.45
0.12%
26
$356.30
0.07%
66685070601
LISINOPRIL TAB 40MG
221
$10,158.92
0.79%
237
$3,050.94
0.67%
66685070602
LISINOPRIL TAB 40MG
32
$1,444.99
0.11%
0
$0.00
0.00%
66685070603
LISINOPRIL TAB 40MG
0
$0.00
0.00%
10
$167.40
0.03%
ACE INHIBITORS AND CA CHANNEL BLOCKERS
00048592180
TARKA
TAB 2-180 CR
2
$103.14
0.22%
0
$0.00
0.00%
00048592240
TARKA
TAB 2-240 CR
4
$210.09
0.44%
0
$0.00
0.00%
00048594240
TARKA
TAB 4-240 CR
9
$448.02
1.00%
1
$91.88
0.26%
00074328713
TARKA
TAB 2-180 CR
4
$229.36
0.44%
2
$119.44
0.53%
Page 16 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS AND CA CHANNEL BLOCKERS
00074328813
TARKA
TAB 1-240 CR
1
$51.57
0.11%
0
$0.00
0.00%
00074328913
TARKA
TAB 2-240 CR
3
$205.93
0.33%
2
$111.22
0.53%
00074329013
TARKA
TAB 4-240 CR
5
$278.34
0.55%
8
$441.91
2.11%
00078036405
LOTREL
CAP 10-20MG
37
$2,653.74
4.11%
48
$2,736.70
12.63%
00083225530
LOTREL
CAP 2.5-10MG
49
$2,656.27
5.44%
18
$814.84
4.74%
00083226030
LOTREL
CAP 5-10MG
249
$14,501.81
27.64%
103
$6,040.41
27.11%
00083226530
LOTREL
CAP 5-20MG
507
$31,845.96
56.27%
191
$11,033.18
50.26%
00186000131
LEXXEL
TAB 5-5MG
20
$1,130.24
2.22%
5
$261.23
1.32%
00186000168
LEXXEL
TAB 5-5MG
11
$754.36
1.22%
2
$169.30
0.53%
ACNE PREPARATIONS
00004015549
ACCUTANE
CAP 10MG
9
$2,082.02
0.25%
4
$752.73
0.10%
00004015649
ACCUTANE
CAP 40MG
10
$4,244.10
0.27%
5
$2,118.70
0.12%
00004016949
ACCUTANE
CAP 20MG
10
$5,587.49
0.27%
11
$6,344.92
0.27%
00009311601
CLEOCIN-T
SOL 1%
0
$0.00
0.00%
26
$676.64
0.65%
00009311602
CLEOCIN-T
SOL 1%
2
$36.00
0.05%
122
$5,360.18
3.03%
00009311614
CLEOCIN-T
PAD 1%
9
$314.73
0.25%
29
$1,591.81
0.72%
00009332901
CLEOCIN-T
LOT 1%
13
$582.95
0.35%
42
$2,323.22
1.04%
00009333101
CLEOCIN-T
GEL 1%
4
$112.02
0.11%
84
$5,776.66
2.09%
00009333102
CLEOCIN-T
GEL 1%
3
$87.05
0.08%
55
$2,513.83
1.37%
00023431230
ERYGEL
GEL 2%
1
$35.29
0.03%
0
$0.00
0.00%
00023869430
AZELEX
CRE 20%
59
$2,883.87
1.61%
64
$2,922.25
1.59%
00023869450
AZELEX
CRE 20%
2
$154.40
0.05%
14
$1,008.30
0.35%
00062007507
RETIN-A
LIQ 0.05%
7
$362.74
0.19%
4
$284.34
0.10%
00062016501
RETIN-A
CRE 0.025%
3
$86.85
0.08%
17
$725.93
0.42%
00062016502
RETIN-A
CRE 0.025%
2
$112.00
0.05%
17
$1,266.19
0.42%
00062017512
RETIN-A
CRE 0.05%
4
$128.25
0.11%
19
$875.23
0.47%
Page 17 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
RETIN-A
00062019002
00062019003
$
Market Share*
ACNE PREPARATIONS
00062017513
# of Scripts
CRE 0.05%
0
$0.00
0.00%
12
$1,033.87
0.30%
RETIN-A MICR GEL 0.1%
63
$2,617.90
1.72%
42
$1,885.36
1.04%
78
$5,357.10
2.13%
47
$3,266.07
1.17%
00062020402
2
$77.38
0.05%
8
$388.34
0.20%
00062020403
9
$591.06
0.25%
12
$838.91
0.30%
00062027501
RETIN-A
CRE 0.1%
2
$157.47
0.05%
12
$1,207.39
0.30%
00062027523
RETIN-A
CRE 0.1%
1
$33.95
0.03%
7
$436.69
0.17%
00062047542
RETIN-A
GEL 0.025%
1
$19.90
0.03%
14
$551.08
0.35%
00062047545
RETIN-A
GEL 0.025%
3
$200.60
0.08%
4
$257.81
0.10%
00062057544
RETIN-A
GEL 0.01%
12
$391.75
0.33%
7
$309.24
0.17%
00062057546
RETIN-A
GEL 0.01%
2
$149.42
0.05%
23
$1,791.33
0.57%
00062118501
ERYCETTE
3
$90.18
0.08%
0
$0.00
0.00%
00064300025
AKNE-MYCIN OIN 2%
1
$37.93
0.03%
13
$524.36
0.32%
00066002825
SULFACET-R LOT
9
$417.19
0.25%
1
$45.20
0.02%
00066043015
BENZAGEL-5 GEL 5%
0
$0.00
0.00%
1
$25.53
0.02%
00066043115
BENZAGEL-10 GEL 10%
4
$110.46
0.11%
3
$87.77
0.07%
00066049425
BENZACLIN GEL 1-5%
334
$17,306.04
9.10%
154
$8,713.19
3.83%
00066049450
BENZACLIN GEL 1-5%
56
$5,285.74
1.53%
69
$6,099.88
1.71%
00066051023
BENZAMYCIN GEL
141
$8,509.54
3.84%
0
$0.00
0.00%
00066051046
BENZAMYCIN GEL
239
$25,435.13
6.51%
42
$4,466.47
1.04%
00066057760
BENZAMYCIN GEL PAK
9
$589.29
0.25%
17
$935.76
0.42%
00066750002
KLARON
LOT 10%
34
$1,592.65
0.93%
2
$116.52
0.05%
00066750004
KLARON
LOT 10%
0
$0.00
0.00%
7
$554.98
0.17%
00066902825
SULFACET-R LOT TINT-FRE
0
$0.00
0.00%
1
$46.11
0.02%
00066985030
NORITATE
15
$765.58
0.41%
18
$824.27
0.45%
00072200004
DESQUAM-X
BAR 10%
1
$5.87
0.03%
1
$5.87
0.02%
00072600345
DESQUAM-E
GEL 2.5%
4
$59.16
0.11%
0
$0.00
0.00%
PAD 2% PKT
CRE 1%
Page 18 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ACNE PREPARATIONS
00072610345
DESQUAM-E
GEL 5%
15
00072620345
DESQUAM-E
GEL 10%
00072662101
DESQUAM-X
GEL 5%
00072672101
DESQUAM-X
00072690505
$114.78
0.41%
2
$41.69
0.05%
0
$0.00
0.00%
1
$15.33
0.02%
1
$12.27
0.03%
0
$0.00
0.00%
GEL 10%
1
$13.21
0.03%
1
$12.44
0.02%
DESQUAM-X
LIQ WASH 5%
3
$56.95
0.08%
0
$0.00
0.00%
00072700005
DESQUAM-X
LIQ WASH 10%
0
$0.00
0.00%
2
$36.10
0.05%
00072830360
T-STAT
0
$0.00
0.00%
1
$25.39
0.02%
00074269802
ERYDERM
1
$6.97
0.03%
0
$0.00
0.00%
00145231005
BREVOXYL
1
$47.44
0.03%
1
$17.50
0.02%
00145237105
DUAC
1
$89.26
0.03%
26
$1,842.86
0.65%
00145237406
BREVOXYL
GEL 4%
2
$70.78
0.05%
1
$69.44
0.02%
00145237408
BREVOXYL
GEL 4%
0
$0.00
0.00%
2
$66.10
0.05%
00145238408
BREVOXYL
GEL 8%
1
$65.29
0.03%
3
$202.37
0.07%
00145247280
CLINDETS
4
$135.57
0.11%
1
$31.25
0.02%
00145247406
BREVOXYL-4 LIQ CREM WSH
7
$235.71
0.19%
5
$152.82
0.12%
00145248406
BREVOXYL-8 LIQ CREM WSH
3
$114.27
0.08%
1
$38.23
0.02%
00168020130
CLINDAMYCIN SOL 1%
1
$7.38
0.03%
3
$24.18
0.07%
00168020160
CLINDAMYCIN SOL 1%
5
$62.85
0.14%
7
$79.39
0.17%
00168020230
CLINDAMYCIN GEL 1%
74
$1,683.25
2.02%
63
$1,439.83
1.56%
00168020260
CLINDAMYCIN GEL 1%
94
$3,831.13
2.56%
84
$2,910.72
2.09%
00168020360
CLINDAMYCIN LOT 1%
69
$2,646.78
1.88%
45
$1,900.12
1.12%
00168021560
ERYTHROMYCIN SOL 2%
15
$109.55
0.41%
22
$151.94
0.55%
00168021630
ERYTHROMYCIN GEL 2%
23
$741.62
0.63%
32
$518.72
0.79%
00168021660
ERYTHROMYCIN GEL 2%
15
$526.10
0.41%
30
$723.05
0.75%
00172362149
ERYTHROMYCIN PAD 2%
0
$0.00
0.00%
1
$21.88
0.02%
00173044001
EMGEL
GEL 2%
1
$22.29
0.03%
0
$0.00
0.00%
00173044002
EMGEL
GEL 2%
2
$86.48
0.05%
3
$70.05
0.07%
PAD 2%
SOL 2%
LOT 4%
GEL 1-5%
PAD 1%
Page 19 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
ALTINAC
00299359060
00299360001
$
Market Share*
ACNE PREPARATIONS
00245904522
# of Scripts
CRE 0.025%
1
BENZAC W
GEL 2.5%
BENZAC W
GEL 5%
00299361001
BENZAC W
00299362060
$26.75
0.03%
0
$0.00
0.00%
0
$0.00
0.00%
1
$21.67
0.02%
4
$38.60
0.11%
0
$0.00
0.00%
GEL 10%
3
$63.35
0.08%
0
$0.00
0.00%
BENZAC AC
GEL 2.5%
5
$90.87
0.14%
0
$0.00
0.00%
00299362090
BENZAC AC
GEL 2.5%
3
$70.08
0.08%
0
$0.00
0.00%
00299362560
BENZAC AC
GEL 5%
7
$67.05
0.19%
1
$22.54
0.02%
00299363060
BENZAC AC
GEL 10%
1
$21.88
0.03%
1
$18.81
0.02%
00299363508
BENZAC AC
LIQ WASH2.5%
4
$75.76
0.11%
1
$29.28
0.02%
00299364008
BENZAC AC
LIQ WASH 5%
6
$186.82
0.16%
2
$65.35
0.05%
00299364508
BENZAC AC
LIQ WASH 10%
2
$64.95
0.05%
3
$109.21
0.07%
00299367008
BENZAC W
LIQ 5% WASH
3
$79.75
0.08%
0
$0.00
0.00%
00299367208
BENZAC W
LIQ 10% WASH
4
$88.80
0.11%
4
$130.28
0.10%
00299383528
METROGEL
GEL 0.75%
27
$1,035.93
0.74%
6
$322.17
0.15%
00299383545
METROGEL
GEL 0.75%
208
$10,424.34
5.67%
290
$17,513.00
7.20%
00299383645
METROCREAM CRE 0.75%
73
$3,689.69
1.99%
95
$6,534.08
2.36%
00299383802
METROLOTION LOT 0.75%
33
$1,763.44
0.90%
29
$2,050.55
0.72%
00299383906
ROSANIL
0
$0.00
0.00%
13
$425.18
0.32%
00299450042
CLINDAGEL
GEL 1%
4
$95.05
0.11%
3
$130.78
0.07%
00299450075
CLINDAGEL
GEL 1%
0
$0.00
0.00%
1
$86.49
0.02%
00299450077
CLINDAGEL
GEL 1%
1
$53.40
0.03%
1
$83.99
0.02%
00299590516
DIFFERIN
PAD 0.1%
8
$547.36
0.22%
4
$290.94
0.10%
00299590530
DIFFERIN
SOL 0.1%
7
$609.09
0.19%
5
$425.98
0.12%
00299591015
DIFFERIN
GEL 0.1%
71
$2,921.81
1.93%
19
$1,115.69
0.47%
00299591045
DIFFERIN
GEL 0.1%
176
$12,696.91
4.80%
322
$25,544.15
8.00%
00299591515
DIFFERIN
CRE 0.1%
33
$1,589.42
0.90%
7
$277.30
0.17%
00299591545
DIFFERIN
CRE 0.1%
92
$6,284.69
2.51%
106
$8,344.73
2.63%
EMU CLEANSER
Page 20 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ACNE PREPARATIONS
00472011720
TRETINOIN
CRE 0.025%
18
$547.70
0.49%
9
$190.75
0.22%
00472011745
TRETINOIN
CRE 0.025%
20
$1,094.17
0.54%
14
$730.50
0.35%
00472098792
CLINDAMYCIN SOL 1%
10
$116.58
0.27%
3
$38.31
0.07%
00472124492
ERYTHROMYCIN SOL 2%
26
$190.59
0.71%
7
$38.89
0.17%
00496085745
CLINAC BPO GEL 7%
1
$27.99
0.03%
0
$0.00
0.00%
00603770982
BENZOYL PER GEL 5%
0
$0.00
0.00%
4
$31.24
0.10%
00603771482
BENZOYL PER GEL 5%
6
$52.20
0.16%
16
$122.97
0.40%
00603771582
BENZOYL PER GEL 10%
0
$0.00
0.00%
1
$1.00
0.02%
00603773752
ERYTHROMYCIN SOL 2%
3
$20.99
0.08%
2
$14.94
0.05%
00781704519
TRETINOIN
CRE 0.025%
7
$334.66
0.19%
2
$112.00
0.05%
00781704522
TRETINOIN
CRE 0.025%
9
$172.38
0.25%
0
$0.00
0.00%
00781704719
TRETINOIN
CRE 0.05%
10
$561.40
0.27%
4
$244.90
0.10%
00781704722
TRETINOIN
CRE 0.05%
14
$467.90
0.38%
1
$29.35
0.02%
00781704919
TRETINOIN
CRE 0.1%
2
$127.18
0.05%
1
$72.20
0.02%
00781704922
TRETINOIN
CRE 0.1%
7
$268.74
0.19%
1
$33.95
0.02%
00781706119
TRETINOIN
GEL 0.025%
6
$290.98
0.16%
1
$56.00
0.02%
00781706127
TRETINOIN
GEL 0.025%
10
$335.99
0.27%
1
$20.90
0.02%
00904284503
ERYTHROMYCIN SOL 2%
1
$7.47
0.03%
0
$0.00
0.00%
24208042160
ERYTHROMYCIN SOL 2%
88
$714.93
2.40%
30
$209.29
0.75%
45802003846
ERYTHROMYCIN SOL 2%
0
$0.00
0.00%
13
$84.40
0.32%
45802008302
ERYTHROMYCIN GEL BENZOYL
0
$0.00
0.00%
49
$3,030.59
1.22%
45802008386
ERYTHROMYCIN GEL BENZOYL
0
$0.00
0.00%
150
$14,248.31
3.73%
45802026337
CLINDAMYCIN PAD 1%
19
$566.00
0.52%
19
$469.20
0.47%
45802026393
CLINDAMYCIN PAD 1%
0
$0.00
0.00%
1
$35.44
0.02%
50419082001
FINEVIN
CRE 20%
30
$1,071.29
0.82%
2
$74.56
0.05%
50419082002
FINEVIN
CRE 20%
1
$30.00
0.03%
0
$0.00
0.00%
50419082501
FINACEA
0
$0.00
0.00%
5
$169.24
0.12%
GEL 15%
Page 21 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ACNE PREPARATIONS
51479044001
EMGEL
GEL 2%
11
$279.07
0.30%
0
$0.00
0.00%
51479044002
EMGEL
GEL 2%
1
$36.92
0.03%
0
$0.00
0.00%
51552003825
METRONIDAZOL POW
2
$43.24
0.05%
0
$0.00
0.00%
59366246203
ERYTHROMYCIN GEL 2%
22
$423.87
0.60%
55
$880.99
1.37%
59366246205
ERYTHROMYCIN GEL 2%
13
$428.02
0.35%
34
$860.51
0.84%
59366273103
SOD SUL/SULF LOT 10%-5%
28
$1,283.35
0.76%
40
$1,638.41
0.99%
59366273608
BENZOYL PER LIQ WASH 2.5
9
$126.31
0.25%
18
$342.40
0.45%
59366273904
BENZOYL PER LIQ WASH 5%
2
$39.14
0.05%
9
$170.24
0.22%
59366273905
15
$262.28
0.41%
29
$442.13
0.72%
59366273908
54
$1,484.82
1.47%
90
$2,302.94
2.24%
59366274003
0
$0.00
0.00%
7
$192.45
0.17%
59366274105
18
$294.11
0.49%
13
$224.23
0.32%
59366274108
55
$1,702.47
1.50%
82
$2,503.59
2.04%
59366274201
BENZOYL PER GEL 2.5%
34
$614.23
0.93%
37
$762.53
0.92%
59366274301
BENZOYL PER GEL 5%
52
$463.74
1.42%
144
$1,358.32
3.58%
59366274303
BENZOYL PER GEL 5%
17
$215.60
0.46%
37
$470.05
0.92%
59366274401
BENZOYL PER GEL 10%
27
$477.50
0.74%
55
$1,041.51
1.37%
59366274403
BENZOYL PER GEL 10%
20
$433.44
0.54%
12
$269.80
0.30%
59366274501
BENZOYL PER GEL 5%
4
$33.34
0.11%
11
$118.75
0.27%
59366274601
BENZOYL PER GEL 10%
1
$20.27
0.03%
8
$161.07
0.20%
59366276205
2
$76.13
0.05%
9
$322.90
0.22%
59366276207
2
$122.39
0.05%
0
$0.00
0.00%
59366277605
ZETACET
1
$44.82
0.03%
0
$0.00
0.00%
59366283806
ERYTHROMYCIN PAD 2%
2
$44.71
0.05%
0
$0.00
0.00%
59366285206
CLINDAMYCIN PAD 1%
29
$827.00
0.79%
14
$372.75
0.35%
59366287806
ERYTHROMYCIN PAD 2%
139
$3,365.52
3.79%
153
$3,698.58
3.80%
59762372801
CLINDAMYCIN SOL 1%
27
$220.76
0.74%
18
$147.00
0.45%
SUS
Page 22 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ACNE PREPARATIONS
59762372802
CLINDAMYCIN SOL 1%
59762372803
CLINDAMYCIN PAD 1%
59762374301
CLINDAMYCIN GEL 1%
59762374302
CLINDAMYCIN GEL 1%
60267011930
60432067160
ERYTHROMYCIN SOL 2%
60432069330
CLINDAMYCIN SOL 1%
60432069360
CLINDAMYCIN SOL 1%
62794014103
AVITA
62794061193
AMNESTEEM
62794061293
AMNESTEEM
62794061488
$605.21
1.29%
2
$62.50
0.05%
15
$266.32
0.37%
10
$418.50
0.25%
0.19%
5
$54.66
0.12%
$322.41
1.23%
137
$926.68
3.40%
$44.40
0.16%
1
$12.77
0.02%
71
$857.55
1.93%
33
$375.65
0.82%
1
$53.00
0.03%
0
$0.00
0.00%
CAP 10MG
0
$0.00
0.00%
1
$382.65
0.02%
CAP 20MG
0
$0.00
0.00%
6
$1,517.46
0.15%
AMNESTEEM
CAP 40MG
0
$0.00
0.00%
3
$770.38
0.07%
62794061493
AMNESTEEM
CAP 40MG
0
$0.00
0.00%
17
$4,876.85
0.42%
65880000245
AVAR
GEL GREEN
0
$0.00
0.00%
1
$46.87
0.02%
65880020008
AVAR
EMU CLEANSER
0
$0.00
0.00%
1
$37.24
0.02%
66530024120
TRETINOIN
CRE 0.1%
7
$237.65
0.19%
10
$304.06
0.25%
66530024145
TRETINOIN
CRE 0.1%
12
$821.74
0.33%
9
$576.03
0.22%
66530024220
TRETINOIN
CRE 0.05%
12
$342.20
0.33%
12
$394.20
0.30%
66530024245
TRETINOIN
CRE 0.05%
15
$819.71
0.41%
25
$1,359.65
0.62%
66530024320
TRETINOIN
CRE 0.025%
25
$557.00
0.68%
24
$516.86
0.60%
66530024345
TRETINOIN
CRE 0.025%
35
$1,895.66
0.95%
42
$2,157.75
1.04%
66530024415
TRETINOIN
GEL 0.025%
11
$226.90
0.30%
5
$99.50
0.12%
66530024445
TRETINOIN
GEL 0.025%
15
$832.00
0.41%
14
$721.50
0.35%
66530024515
TRETINOIN
GEL 0.01%
15
$475.99
0.41%
5
$208.71
0.12%
66530024545
TRETINOIN
GEL 0.01%
6
$398.67
0.16%
20
$1,129.08
0.50%
99207005101
TRIAZ
11
$318.95
0.30%
5
$413.20
0.12%
99207010602
TRIAZ CLEANS LOT 10%
9
$208.51
0.25%
0
$0.00
0.00%
CRE 0.025%
GEL 6%
77
$939.09
2.10%
0
$0.00
0.00%
27
$577.56
0.74%
12
$537.20
0.33%
7
$161.50
45
6
52
Page 23 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ACNE PREPARATIONS
99207010609
1
99207010612
99207011609
TRIAZ CLEANS LOT 6%
99207011612
$5.17
0.03%
0
$0.00
0.00%
4
$96.86
0.11%
7
$274.10
0.19%
1
$25.79
0.02%
7
$316.51
0.17%
TRIAZ CLEANS LOT 6%
28
$675.33
0.76%
21
$554.85
0.52%
99207020609
TRIAZ CLEANS LOT 3%
3
$127.29
0.08%
3
$143.26
0.07%
99207020612
TRIAZ CLEANS LOT 3%
99207020701
TRIAZ
9
$252.47
0.25%
4
$139.43
0.10%
4
$126.92
0.11%
1
$35.22
0.02%
99207020809
TRIAZ CLEANS LOT 9%
0
$0.00
0.00%
7
$225.14
0.17%
99207020812
TRIAZ CLEANS LOT 9%
1
$26.32
0.03%
1
$30.19
0.02%
99207020901
TRIAZ
GEL 3%
12
$350.32
0.33%
6
$195.65
0.15%
99207021001
TRIAZ
GEL 10%
4
$121.67
0.11%
0
$0.00
0.00%
99207022230
TRIAZ
PAD 6%
0
$0.00
0.00%
7
$513.05
0.17%
99207074106
PLEXION
EMU
4
$150.51
0.11%
8
$268.87
0.20%
99207074112
PLEXION
EMU
4
$251.06
0.11%
2
$146.58
0.05%
99207074330
PLEXION TS SUS 10-5%
19
$876.17
0.52%
10
$544.70
0.25%
99207074404
PLEXION SCT CRE 10-5%
0
$0.00
0.00%
1
$46.14
0.02%
2
$124.84
7.41%
3
$188.76
14.29%
GEL 9%
ADRENERGIC AGENTS
00023920815
PROPINE
SOL 0.1% OP
11980005815
EPIFRIN
SOL 2% OP
1
$50.64
3.70%
0
$0.00
0.00%
11980012215
EPIFRIN
SOL 1% OP
0
$0.00
0.00%
1
$44.08
4.76%
24208054005
DIPIVEFRIN SOL 0.1% OP
4
$29.80
14.81%
5
$31.00
23.81%
24208054010
5
$56.25
18.52%
5
$50.25
23.81%
24208054015
0
$0.00
0.00%
1
$16.40
4.76%
61314023505
11
$102.10
40.74%
3
$17.50
14.29%
61314023510
2
$24.10
7.41%
3
$36.15
14.29%
61314023515
2
$31.80
7.41%
0
$0.00
0.00%
Page 24 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ADRENERGIC COMBINATIONS
00173069500
ADVAIR DISKU MIS 100/50
1,896
$187,275.81
15.55%
2,903
$302,734.23
17.15%
00173069502
5
$482.52
0.04%
2
$316.14
0.01%
00173069600
2,531
$321,271.13
20.75%
4,262
$566,561.71
25.18%
00173069700
1,268
$220,926.62
10.40%
2,186
$401,795.19
12.91%
00173069702
14
$2,023.51
0.11%
2
$538.76
0.01%
00597001314
COMBIVENT
5,558
$272,426.36
45.58%
7,123
$399,842.18
42.08%
49502067230
DUONEB
SOL
740
$64,664.93
6.07%
309
$28,047.01
1.83%
49502067260
DUONEB
SOL
183
$24,879.85
1.50%
141
$18,339.51
0.83%
7
$237.26
9.46%
5
$118.40
4.31%
67
$2,724.28
90.54%
111
$4,051.04
95.69%
13
$60,169.80
100.00%
23
$128,794.00
100.00%
24
$17,541.77
100.00%
17
$13,738.03
100.00%
2
$19.50
2.90%
0
$0.00
0.00%
AER
ALCOHOL DETERRENTS
50111033101
DISULFIRAM TAB 250MG
65473070601
ANTABUSE
TAB 250MG
ALPHA-PROTEINASE INHIBITOR
00026060135
PROLASTIN
INJ 1000MG
ALS DRUG
00075770060
RILUTEK
TAB 50MG
ALTERNATIVE MEDICINES
00182404426
COQ10
CAP 30MG
00182404826
GLUCOSAMINE CAP 500MG
0
$0.00
0.00%
8
$91.81
8.16%
00536641208
MELATONIN TAB 3MG
3
$26.94
4.35%
2
$63.02
2.04%
00573014440
FLEXAGEN
TAB
2
$51.08
2.90%
0
$0.00
0.00%
00677165206
GLUCOSAMINE/ CAP CHONDRTN
1
$38.50
1.45%
6
$439.85
6.12%
00677165267
GLUCOSAMINE/ CAP CHONDRTN
7
$268.35
10.14%
24
$1,249.62
24.49%
Page 25 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ALTERNATIVE MEDICINES
00904501546
COENZYME Q10 CAP 30MG
4
$318.83
5.80%
6
$786.28
6.12%
00904548152
GLUCOSAMINE/ CAP CHONDROI
0
$0.00
0.00%
2
$158.20
2.04%
00904559489
GLUC/CHONDR TAB 750-600M
0
$0.00
0.00%
2
$32.06
2.04%
24385038141
GLUC/CHONDR TAB 750-600M
2
$39.49
2.90%
3
$55.90
3.06%
49348032644
COENZYME Q10 CAP 50MG
4
$269.02
5.80%
5
$167.67
5.10%
51991002206
DHEA
2
$118.64
2.90%
0
$0.00
0.00%
52297089771
HM GINKGO
3
$23.16
4.35%
2
$11.44
2.04%
54022205501
COENZYME Q10 TAB 25MG
5
$943.98
7.25%
3
$617.46
3.06%
54022208001
22
$2,149.47
31.88%
27
$2,737.78
27.55%
54022208101
3
$93.42
4.35%
0
$0.00
0.00%
54022208501
COENZYME Q10 CHW 60MG
2
$79.78
2.90%
0
$0.00
0.00%
54022209001
CO-ENZYME
5
$500.98
7.25%
2
$126.76
2.04%
54022800201
0
$0.00
0.00%
6
$436.42
6.12%
59879060906
ARTHX DS
2
$62.45
2.90%
0
$0.00
0.00%
TAB 25MG
TAB 120MG
WAF Q10/E
CAP
AMINO GLYCOSIDES
00002738125
TOBRAMYCIN INJ 40MG/ML
0
$0.00
0.00%
1
$66.72
0.68%
00003272510
1
$6.68
0.85%
2
$379.30
1.36%
00054860025
NEOMYCIN
1
$4.84
0.85%
0
$0.00
0.00%
00074120703
GENTAMICIN INJ 40MG/ML
0
$0.00
0.00%
1
$8.23
0.68%
00074357801
2
$545.36
1.69%
2
$549.36
1.36%
00074788423
GENTAM/NACL INJ 80MG PB
00093117701
NEOMYCIN
00641039525
53905006501
TOBI
57664017508
63323001002
TAB 500MG
1
$73.63
0.85%
0
$0.00
0.00%
58
$2,988.89
49.15%
73
$4,800.20
49.66%
1
$31.06
0.85%
0
$0.00
0.00%
33
$55,190.57
27.97%
55
$108,528.45
37.41%
PAROMOMYCIN CAP 250MG
0
$0.00
0.00%
1
$96.21
0.68%
12
$211.59
10.17%
4
$146.72
2.72%
TAB 500MG
NEB 300/5ML
Page 26 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
AMINO GLYCOSIDES
63323001020
1
$6.39
0.85%
0
$0.00
0.00%
63430006501
TOBI
8
$18,359.44
6.78%
8
$8,948.02
5.44%
NEB 300/5ML
AMLODIPINES
00069152068
NORVASC
TAB 2.5MG
717
$27,393.99
8.23%
720
$29,581.86
7.94%
00069153041
NORVASC
TAB 5MG
9
$332.22
0.10%
6
$240.14
0.07%
00069153068
NORVASC
TAB 5MG
3,661
$143,562.16
42.01%
3,627
$153,282.55
39.99%
00069153072
NORVASC
TAB 5MG
804
$30,734.76
9.23%
869
$35,753.35
9.58%
00069154041
NORVASC
TAB 10MG
6
$341.55
0.07%
8
$284.13
0.09%
00069154068
NORVASC
TAB 10MG
3,517
$204,044.63
40.36%
3,839
$225,479.12
42.33%
ANAPHYLAXIS THERAPY
49502050001
EPIPEN
INJ 0.3MG
214
$12,182.57
68.81%
279
$17,852.25
61.45%
49502050002
EPIPEN
INJ 0.3MG
24
$1,788.53
7.72%
75
$6,319.96
16.52%
49502050101
EPIPEN-JR
INJ 0.15MG
64
$4,595.11
20.58%
61
$4,265.84
13.44%
49502050102
EPIPEN-JR
INJ 0.15MG
9
$820.78
2.89%
39
$3,322.71
8.59%
ANDROGENS / ANABOLICS
00009001401
HALOTESTIN TAB 2MG
0
$0.00
0.00%
1
$65.48
0.24%
00009001906
HALOTESTIN TAB 5MG
1
$128.46
0.33%
0
$0.00
0.00%
00009003604
HALOTESTIN TAB 10MG
2
$226.32
0.66%
0
$0.00
0.00%
00009034702
DEPO-TESTOST INJ 100MG/ML
6
$354.59
1.99%
11
$540.83
2.64%
00009041701
17
$261.82
5.65%
37
$1,023.86
8.89%
00009041702
20
$1,642.54
6.64%
43
$3,929.48
10.34%
00024030506
DANOCRINE
0
$0.00
0.00%
1
$360.22
0.24%
00024225304
WINSTROL
1
$24.86
0.33%
2
$32.76
0.48%
00051842530
ANDROGEL
9
$1,258.54
2.99%
14
$2,034.65
3.37%
CAP 200MG
TAB 2MG
GEL 1%(25MG)
Page 27 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANDROGENS / ANABOLICS
00051845030
ANDROGEL
GEL 1%(50MG)
00115703701
METHITEST
00187090101
TESTRED
CAP 10MG
00187090201
ANDROID
CAP 10MG
00555063302
DANAZOL
00555063402
00555063502
$15,876.87
27.91%
$12,186.10
15.87%
0
$0.00
0.00%
12
$950.47
3.99%
4
$358.73
0.96%
15
$1,142.85
3.61%
6
$732.80
1.99%
14
$2,159.06
3.37%
CAP 50MG
0
$0.00
0.00%
5
$217.86
1.20%
DANAZOL
CAP 100MG
2
$237.06
0.66%
DANAZOL
CAP 200MG
4
$631.80
1.33%
3
$377.71
0.72%
12
$1,475.16
2.88%
00555063509
DANAZOL
CAP 200MG
0
$0.00
0.00%
5
$579.97
1.20%
00574046025
TESTOSTERONE POW
0
$0.00
0.00%
1
$40.75
0.24%
00574046105
TESTOST PROP POW
3
00832008600
FLUOXYMESTER TAB 10MG
1
$298.78
1.00%
2
$25.94
0.48%
$150.76
0.33%
8
$887.39
1.92%
17314283603
TESTODERM
DIS 6MG/24HR
0
$0.00
0.00%
11
$1,278.19
2.64%
17314460803
TESTODERM
DIS 4MG/24HR
1
$102.39
0.33%
12
$1,393.48
2.88%
17314460903
17314471703
TESTODERM
DIS 6MG/24HR
2
$204.78
0.66%
6
$691.74
1.44%
TESTODERM
DIS TTS
1
$111.38
0.33%
0
$0.00
0.00%
52544046960
ANDRODERM
DIS 2.5MG/24
17
$1,583.29
5.65%
15
$1,624.86
3.61%
52544047030
ANDRODERM
DIS 5MG/24HR
50
$7,452.59
16.61%
54
$8,442.35
12.98%
54396011060
OXANDRIN
TAB 10MG
0
$0.00
0.00%
3
$2,059.75
0.72%
54396011111
OXANDRIN
TAB 2.5MG
43
$8,919.63
14.29%
53
$15,948.94
12.74%
54396032840
DELATESTRYL INJ 200MG/ML
19
$1,565.21
6.31%
18
$1,489.52
4.33%
TAB 10MG
84
66
ANGIOTENSIN RECEPTOR BLOCKER
00006095128
COZAAR
TAB 25MG
3
$122.64
0.05%
5
$219.17
0.07%
00006095154
COZAAR
TAB 25MG
161
$6,846.12
2.73%
265
$11,367.34
3.79%
00006095158
COZAAR
TAB 25MG
175
$6,836.51
2.97%
262
$10,470.87
3.75%
00006095228
COZAAR
TAB 50MG
0
$0.00
0.00%
2
$69.29
0.03%
00006095231
COZAAR
TAB 50MG
109
$4,562.75
1.85%
132
$5,674.16
1.89%
Page 28 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00006095254
COZAAR
TAB 50MG
537
$22,537.06
9.11%
665
$28,484.05
9.51%
00006095258
COZAAR
TAB 50MG
691
$28,357.20
11.73%
1,111
$47,050.37
15.89%
00006095282
COZAAR
TAB 50MG
0
$0.00
0.00%
3
$128.70
0.04%
00006096028
COZAAR
TAB 100MG
68
$3,503.01
1.15%
54
$3,230.31
0.77%
00006096031
COZAAR
TAB 100MG
228
$12,996.89
3.87%
335
$19,614.50
4.79%
00006096054
COZAAR
TAB 100MG
0
$0.00
0.00%
63
$3,732.86
0.90%
00006096058
COZAAR
TAB 100MG
516
$28,755.06
8.76%
912
$52,323.61
13.04%
00051504401
TEVETEN
TAB 400MG
10
$260.77
0.17%
11
$283.66
0.16%
00051504601
TEVETEN
TAB 600MG
18
$635.50
0.31%
29
$1,025.72
0.41%
00078035805
DIOVAN
TAB 80MG
1,027
$43,584.67
17.43%
552
$23,296.92
7.89%
00078035806
DIOVAN
TAB 80MG
19
$789.58
0.32%
1
$85.05
0.01%
00078035905
DIOVAN
TAB 160MG
886
$43,226.90
15.03%
452
$20,710.60
6.46%
00078035906
DIOVAN
TAB 160MG
3
$133.20
0.05%
0
$0.00
0.00%
00078036005
DIOVAN
TAB 320MG
61
$3,474.86
1.04%
78
$4,114.59
1.12%
00078037606
DIOVAN
TAB 40MG
0
$0.00
0.00%
1
$37.16
0.01%
00078037615
DIOVAN
TAB 40MG
11
$328.90
0.19%
13
$478.33
0.19%
00083400001
DIOVAN
CAP 80MG
6
$229.44
0.10%
3
$111.96
0.04%
00083400101
DIOVAN
CAP 160MG
8
$344.08
0.14%
1
$40.44
0.01%
00087277131
AVAPRO
TAB 75MG
7
$261.64
0.12%
1
$42.09
0.01%
00087277132
AVAPRO
TAB 75MG
19
$793.95
0.32%
10
$421.32
0.14%
00087277215
AVAPRO
TAB 150MG
0
$0.00
0.00%
2
$88.52
0.03%
00087277231
AVAPRO
TAB 150MG
124
$5,108.07
2.10%
33
$1,154.38
0.47%
00087277232
AVAPRO
TAB 150MG
169
$6,743.04
2.87%
107
$4,099.09
1.53%
00087277331
AVAPRO
TAB 300MG
53
$2,686.51
0.90%
17
$876.73
0.24%
00087277332
AVAPRO
TAB 300MG
94
$4,663.42
1.60%
52
$2,425.12
0.74%
00186000431
ATACAND
TAB 4MG
22
$774.28
0.37%
9
$243.96
0.13%
00186000831
ATACAND
TAB 8MG
66
$2,514.92
1.12%
31
$1,195.84
0.44%
Page 29 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00186001628
ATACAND
TAB 16MG
26
$1,035.48
0.44%
0
$0.00
0.00%
00186001631
ATACAND
TAB 16MG
260
$10,191.52
4.41%
108
$3,766.74
1.54%
00186001654
ATACAND
TAB 16MG
16
$608.59
0.27%
5
$246.04
0.07%
00186003228
ATACAND
TAB 32MG
22
$1,144.27
0.37%
0
$0.00
0.00%
00186003231
ATACAND
TAB 32MG
197
$10,401.89
3.34%
102
$5,322.03
1.46%
00186003254
ATACAND
TAB 32MG
23
$1,201.70
0.39%
14
$712.64
0.20%
00597003928
MICARDIS
TAB 20MG
0
$0.00
0.00%
25
$1,040.24
0.36%
00597004028
MICARDIS
TAB 40MG
74
$2,841.83
1.26%
183
$7,579.64
2.62%
00597004128
MICARDIS
TAB 80MG
66
$3,033.22
1.12%
151
$6,958.37
2.16%
64455013001
TEVETEN
TAB 400MG
0
$0.00
0.00%
41
$1,239.03
0.59%
64455013101
TEVETEN
TAB 600MG
5
$256.11
0.08%
165
$6,186.79
2.36%
65597010130
BENICAR
TAB 5MG
3
$88.85
0.05%
19
$832.40
0.27%
65597010310
BENICAR
TAB 20MG
12
$378.02
0.20%
56
$2,499.14
0.80%
65597010330
BENICAR
TAB 20MG
50
$1,794.13
0.85%
421
$15,623.86
6.02%
65597010390
BENICAR
TAB 20MG
15
$534.15
0.25%
117
$4,401.58
1.67%
65597010410
BENICAR
TAB 40MG
12
$421.24
0.20%
14
$491.56
0.20%
65597010430
BENICAR
TAB 40MG
19
$676.59
0.32%
293
$10,929.49
4.19%
65597010490
BENICAR
TAB 40MG
2
$71.22
0.03%
67
$2,556.54
0.96%
$1,851.99
30.17%
61
$1,936.82
20.89%
ANTHELMINTICS
00006003220
STROMECTOL TAB 3MG
70
00006013910
STROMECTOL TAB 6MG
0
$0.00
0.00%
2
$73.61
0.68%
00007550040
ALBENZA
TAB 200MG
5
$70.69
2.16%
12
$186.91
4.11%
00026252106
BILTRICIDE TAB 600MG
3
$121.95
1.29%
2
$32.76
0.68%
00093910729
MEBENDAZOLE CHW 100MG
138
$1,882.19
59.48%
214
$1,826.69
73.29%
38245010708
MEBENDAZOLE CHW 100MG
3
$21.43
1.29%
0
$0.00
0.00%
50580007012
VERMOX
13
$209.32
5.60%
1
$13.64
0.34%
CHW 100MG
Page 30 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANTI-ALLERGICS
00023642210
OPTICROM
SOL 4% OP
00023884205
ALOCRIL
00065027105
PATANOL
SOL 0.1% OP
00065032505
EMADINE
00065034510
ALOMIDE
00093138943
CROMOLYN SOD SOL 4% OP
00451702506
OPTIVAR
00451702530
OPTIVAR
17478029111
24208030010
CROLOM
SOL 4% OP
58768010205
ZADITOR
58768061005
1
$35.10
0.16%
3
$151.19
0.38%
17
$912.64
2.80%
42
$2,713.73
5.28%
463
$28,034.30
76.28%
586
$38,443.46
73.62%
SOL 0.05% OP
5
$233.03
0.82%
17
$944.95
2.14%
SOL 0.1% OP
6
$338.06
0.99%
26
$1,639.85
3.27%
0
$0.00
0.00%
8
$267.28
1.01%
DRO 0.05%
21
$1,051.00
3.46%
8
$394.39
1.01%
DRO 0.05%
4
$139.67
0.66%
2
$58.15
0.25%
7
$245.70
1.15%
0
$0.00
0.00%
2
$72.20
0.33%
1
$34.60
0.13%
SOL .025% OP
42
$1,911.90
6.92%
29
$1,390.33
3.64%
LIVOSTIN
SUS 0.05% OP
6
$264.91
0.99%
27
$1,372.39
3.39%
58768061010
LIVOSTIN
SUS 0.05% OP
9
$584.20
1.48%
7
$454.97
0.88%
60505081102
9
$215.44
1.48%
0
$0.00
0.00%
61314023710
15
$503.15
2.47%
20
$673.51
2.51%
65086071110
ALAMAST
0
$0.00
0.00%
20
$1,087.42
2.51%
140
$1,474.62
2.63%
121
$1,133.81
1.92%
18
$329.14
0.34%
2
$27.40
0.03%
SOL 2%
DRO 0.1%
ANTI-CHOLINERGIC / DOPAMINERGIC
00008001901
PHENERGAN
TAB 12.5MG
00008002702
PHENERGAN
TAB 25MG
00008006301
PHENERGAN
INJ 25MG/ML
9
$544.36
0.17%
1
$70.76
0.02%
00008021201
PHENERGAN
SUP 25MG
284
$13,312.19
5.33%
287
$16,364.20
4.55%
00008022901
PHENERGAN
SUP 50MG
4
$230.57
0.08%
8
$587.98
0.13%
00008023101
PHENER FORT SYP 25MG/5ML
3
$120.24
0.06%
0
$0.00
0.00%
00008049801
PHENERGAN
274
$8,169.82
5.14%
108
$4,261.30
1.71%
00049211066
ANTIVERT
1
$20.46
0.02%
0
$0.00
0.00%
SUP 12.5MG
TAB 25MG
Page 31 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
TORECAN
00067434504
00067434624
TAB 10MG
$
Market Share*
00054474825
# of Scripts
9
$211.99
0.17%
1
$41.21
0.02%
TRANSDERM-SC DIS 1.5MG
126
$3,797.93
2.36%
190
$5,615.64
3.01%
TRANSDERM-SC DIS 1.5MG
0
$0.00
0.00%
5
$244.68
0.08%
00364022201
PROMETHAZINE TAB 25MG
1
$3.49
0.02%
3
$8.74
0.05%
00364022202
2
$8.50
0.04%
2
$2.68
0.03%
00472009612
PROMETHAZINE SUP 25MG
0
$0.00
0.00%
48
$2,348.21
0.76%
00472150404
PROMETHAZINE SYP 6.25/5ML
4
$29.90
0.08%
2
$14.37
0.03%
00472150416
9
$60.94
0.17%
0
$0.00
0.00%
00472150428
2
$36.38
0.04%
0
$0.00
0.00%
00536398501
MECLIZINE
0
$0.00
0.00%
1
$2.27
0.02%
00574083625
PROMETHAZINE INJ 25MG/ML
0
$0.00
0.00%
6
$278.51
0.10%
00574723412
PHENADOZ
SUP 25MG
0
$0.00
0.00%
24
$1,092.36
0.38%
00574723612
PHENADOZ
SUP 12.5MG
0
$0.00
0.00%
2
$115.11
0.03%
00591080301
MECLIZINE
TAB 25MG
0
$0.00
0.00%
1
$3.00
0.02%
00591080310
MECLIZINE
TAB 25MG
1
$4.49
0.02%
0
$0.00
0.00%
00591530701
453
$6,304.88
8.50%
1,189
$17,585.86
18.86%
00591530710
0
$0.00
0.00%
424
$6,546.81
6.73%
00591531901
0
$0.00
0.00%
5
$68.85
0.08%
00615155353
MECLIZINE
TAB 12.5MG
46
$253.09
0.86%
0
$0.00
0.00%
00615155453
MECLIZINE
TAB 25MG
15
$104.54
0.28%
0
$0.00
0.00%
00615155463
MECLIZINE
TAB 25MG
37
$278.34
0.69%
0
$0.00
0.00%
00641092825
0
$0.00
0.00%
3
$123.69
0.05%
00641092925
0
$0.00
0.00%
2
$330.24
0.03%
00641094935
0
$0.00
0.00%
2
$134.62
0.03%
00641149535
112
$1,786.66
2.10%
83
$1,956.07
1.32%
00641149635
10
$315.15
0.19%
2
$11.92
0.03%
00713013212
PROMETHEGAN SUP 50MG
7
$709.68
0.13%
6
$466.09
0.10%
TAB 12.5MG
Page 32 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
PROMETHEGAN SUP 25MG
00713053612
PROMETHEGAN SUP 12.5MG
00781134501
MECLIZINE
TAB 12.5MG
00781134510
MECLIZINE
00781137501
$
Market Share*
00713052612
# of Scripts
$19,247.09
9.61%
198
$7,702.79
3.14%
0
$0.00
0.00%
31
$667.80
0.49%
5
$40.51
0.09%
5
$13.24
0.08%
TAB 12.5MG
4
$33.77
0.08%
2
$10.34
0.03%
MECLIZINE
TAB 25MG
0
$0.00
0.00%
8
$62.00
0.13%
00781137510
MECLIZINE
TAB 25MG
3
$15.00
0.06%
4
$24.90
0.06%
00781154201
MECLIZINE
TAB 12.5MG
143
$876.27
2.68%
150
$776.59
2.38%
00781154210
MECLIZINE
TAB 12.5MG
0
$0.00
0.00%
18
$98.77
0.29%
00781154401
MECLIZINE
TAB 25MG
348
$2,327.19
6.53%
416
$2,103.48
6.60%
00781154410
MECLIZINE
TAB 25MG
9
$65.74
0.17%
2
$9.58
0.03%
00781183001
1,016
$12,956.75
19.06%
703
$10,489.04
11.15%
00781183010
245
$3,213.28
4.60%
148
$2,969.89
2.35%
00781183201
8
$285.09
0.15%
4
$30.60
0.06%
00904129012
0
$0.00
0.00%
1
$45.40
0.02%
45802075830
PROMETHAZINE SUP 12.5MG
0
$0.00
0.00%
8
$174.68
0.13%
45802075930
0
$0.00
0.00%
24
$1,428.79
0.38%
49884003401
MECLIZINE
TAB 12.5MG
105
$588.48
1.97%
105
$533.34
1.67%
49884003410
MECLIZINE
TAB 12.5MG
328
$2,126.53
6.15%
315
$1,649.68
5.00%
49884003501
MECLIZINE
TAB 25MG
150
$1,000.31
2.81%
207
$1,108.51
3.28%
49884003510
MECLIZINE
TAB 25MG
770
$5,264.63
14.45%
969
$5,437.45
15.37%
52152011702
MECLIZINE
TAB 25MG
3
$14.00
0.06%
7
$27.11
0.11%
52152018502
TRIMETHOBENZ CAP 300MG
0
$0.00
0.00%
2
$36.97
0.03%
52544080301
MECLIZINE
TAB 25MG
3
$22.97
0.06%
0
$0.00
0.00%
52544080310
MECLIZINE
TAB 25MG
1
$4.49
0.02%
0
$0.00
0.00%
53265076212
PROMETHAZINE SUP 12.5MG
0
$0.00
0.00%
89
$2,539.85
1.41%
53265076312
0
$0.00
0.00%
244
$11,180.10
3.87%
53265076412
0
$0.00
0.00%
4
$194.57
0.06%
512
Page 33 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
53489037601
TRIMETHOBENZ CAP 300MG
0
$0.00
0.00%
2
$55.81
0.03%
54092054002
TIGAN
1
$19.18
0.02%
0
$0.00
0.00%
59911581803
6
$25.06
0.11%
0
$0.00
0.00%
59911587101
PROMETHAZINE TAB 12.5MG
5
$16.49
0.09%
1
$6.57
0.02%
59911587201
26
$108.88
0.49%
0
$0.00
0.00%
60432060804
20
$131.82
0.38%
25
$210.68
0.40%
60432060816
42
$309.30
0.79%
69
$478.60
1.09%
61570007901
TIGAN
CAP 300MG
4
$138.12
0.08%
6
$195.18
0.10%
61570018701
TIGAN
CAP 250MG
0
$0.00
0.00%
1
$23.63
0.02%
61570050310
TIGAN
SUP 100MG
0
$0.00
0.00%
3
$116.52
0.05%
61570050410
TIGAN
SUP 200MG
2
$22.20
0.04%
3
$78.03
0.05%
61570054002
TIGAN
INJ 100MG/ML
4
$72.78
0.08%
1
$24.79
0.02%
SUP 3GM
0
$0.00
0.00%
1
$4.48
0.02%
TAB 10MG
4
$353.74
0.09%
1
$105.55
0.02%
1
$7.00
0.02%
1
$24.10
0.02%
INJ 100MG/ML
ANTI-FLATULENTS / GI STIMULANTS
00003087823
GLYCERIN
00031670163
REGLAN
00043001336
GAS-X
00054348663
LACTULOSE
SYP 10GM/15
1
$13.86
0.02%
4
$83.11
0.06%
00054348668
LACTULOSE
SYP 10GM/15
1
$23.06
0.02%
0
$0.00
0.00%
00054356363
METOCLOPRAM SYP 5MG/5ML
3
$39.13
0.07%
5
$44.50
0.08%
00068041316
CEPHULAC
2
$91.46
0.05%
0
$0.00
0.00%
00074341401
METOCLOPRAM INJ 5MG/ML
2
$45.69
0.05%
5
$122.53
0.08%
00091440123
COLYTE
2
$41.50
0.05%
0
$0.00
0.00%
00091440305
COLYTE-FLAV SOL
2
$40.08
0.05%
1
$2.99
0.02%
00091440313
COLYTE-FLAV SOL
1
$16.60
0.02%
0
$0.00
0.00%
00091703623
COLYTE/FLAVR SOL PACKS
8
$166.35
0.18%
21
$653.50
0.32%
00093220301
METOCLOPRAM TAB 10MG
97
$934.90
2.23%
140
$1,057.15
2.14%
CHW 80MG
SYP 10GM/15
SOL
Page 34 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00093220305
126
00093220310
00093220401
METOCLOPRAM TAB 5MG
00093220405
METOCLOPRAM TAB 5MG
00121057616
00121057716
LACTULOSE
00132007924
GLYCERIN
SUP 3GM
00132008112
GLYCERIN
00132018001
FLEET
00182146001
GENASYME
00182178989
00182219166
GENASYME
00182607240
$1,032.29
1.88%
11
$95.25
0.17%
93
$1,476.45
1.42%
3.55%
303
$4,490.27
4.64%
$363.67
1.22%
33
$229.61
0.51%
0
$0.00
0.00%
1
$161.03
0.02%
1
$4.57
0.02%
1
$5.07
0.02%
SUP 1.5GM
2
$7.78
0.05%
1
$1.96
0.02%
ENE BABYLAX
0
$0.00
0.00%
1
$4.69
0.02%
0
$0.00
0.00%
1
$4.80
0.02%
3
$23.55
0.07%
0
$0.00
0.00%
DRO 40/0.6ML
0
$0.00
0.00%
18
$85.62
0.28%
LACTULOSE
SYP 10GM/15
3
$44.84
0.07%
5
$239.91
0.08%
00182607558
LACTULOSE
SYP 10GM/15
0
$0.00
0.00%
1
$24.50
0.02%
00182864389
SIMETHICONE CHW 80MG
0
$0.00
0.00%
1
$20.25
0.02%
00228226910
19
$180.53
0.44%
74
$627.26
1.13%
00228226950
93
$933.94
2.14%
158
$1,493.40
2.42%
00364234716
LACTULOSE
SYP 10GM/15
56
$956.77
1.29%
54
$765.64
0.83%
00364234764
LACTULOSE
SYP 10GM/15
9
$203.98
0.21%
3
$91.64
0.05%
00364251932
LACTULOSE
SYP 10GM/15
10
$383.69
0.23%
3
$254.85
0.05%
00364251976
LACTULOSE
SYP 10GM/15
6
$53.69
0.14%
0
$0.00
0.00%
00378333174
LACTULOSE
SYP 10GM/15
0
$0.00
0.00%
3
$37.44
0.05%
00472020816
LACTULOSE
SYP 10GM/15
00472045416
00472135832
CONSTULOSE SYP 10GM/15
00472136016
ENULOSE
00536453301
SYP 10GM/15
CHW 80MG
SYP 10GM/15
$1,311.95
2.90%
123
30
$298.25
0.69%
57
$1,035.06
1.31%
154
$2,690.97
53
1
$13.71
0.02%
0
$0.00
0.00%
48
$398.06
1.11%
31
$285.05
0.47%
5
$121.41
0.12%
1
$27.34
0.02%
51
$1,346.70
1.17%
473
$10,562.26
7.24%
2
$16.66
0.05%
8
$51.86
0.12%
Page 35 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00591234716
LACTULOSE
SYP 10GM/15
73
$1,252.99
1.68%
140
$2,349.70
2.14%
00591234764
LACTULOSE
SYP 10GM/15
0
$0.00
0.00%
7
$116.08
0.11%
00591251938
LACTULOSE
SYP 10GM/15
0
$0.00
0.00%
2
$13.93
0.03%
00591251965
LACTULOSE
SYP 10GM/15
27
$674.19
0.62%
111
$2,617.02
1.70%
00603137856
LACTULOSE
SYP 10GM/15
1
$8.11
0.02%
6
$51.66
0.09%
00603137858
LACTULOSE
SYP 10GM/15
68
$1,081.97
1.57%
129
$2,405.38
1.98%
00603137859
LACTULOSE
SYP 10GM/15
2
$25.42
0.05%
3
$108.94
0.05%
00603143558
6
$69.25
0.14%
13
$94.02
0.20%
00603461621
METOCLOPRAM TAB 5MG
3
$43.20
0.07%
2
$24.70
0.03%
00615253653
52
$511.26
1.20%
0
$0.00
0.00%
00615253663
80
$754.97
1.84%
0
$0.00
0.00%
00615354653
METOCLOPRAM TAB 5MG
108
$2,185.41
2.49%
0
$0.00
0.00%
00615354663
METOCLOPRAM TAB 5MG
8
$181.34
0.18%
0
$0.00
0.00%
00677103901
5
$56.75
0.12%
5
$40.25
0.08%
00677103905
23
$216.05
0.53%
28
$239.46
0.43%
00677109833
ENULOSE
4
$41.44
0.09%
0
$0.00
0.00%
00677132301
METOCLOPRAM TAB 5MG
47
$863.65
1.08%
29
$393.15
0.44%
00713010102
GLYCERIN
SUP 3GM
0
$0.00
0.00%
2
$16.36
0.03%
00713010151
GLYCERIN
SUP 3GM
0
$0.00
0.00%
1
$36.17
0.02%
00781503001
METOCLOPRAM TAB 5MG
61
$1,214.33
1.41%
33
$467.71
0.51%
00781503005
METOCLOPRAM TAB 5MG
0
$0.00
0.00%
4
$80.90
0.06%
00781630116
1
$10.79
0.02%
1
$8.29
0.02%
00781640516
LACTULOSE
SYP 10GM/15
12
$388.60
0.28%
15
$312.00
0.23%
00904106940
METOCLOPRAM TAB 5MG
0
$0.00
0.00%
59
$1,063.05
0.90%
00904106960
METOCLOPRAM TAB 5MG
0
$0.00
0.00%
3
$47.55
0.05%
00904107040
1
$7.35
0.02%
0
$0.00
0.00%
00904107080
2
$40.70
0.05%
42
$439.74
0.64%
SYP 10GM/15
Page 36 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00904107316
0
00904211516
CALULOSE
SYP 10GM/15
00904211769
CALULOSE
SYP 10GM/15
00904506730
GAS RELIEF DRO 40/0.6ML
10019045002
$0.00
0.00%
1
$5.21
0.02%
3
$63.86
0.07%
3
$130.20
0.07%
2
$56.61
0.03%
2
$100.26
0.03%
14
$138.18
0.32%
0
$0.00
0.00%
METOCLOPRAM INJ 5MG/ML
0
$0.00
0.00%
2
$44.78
0.03%
17236044301
30142031763
GLYCERIN
0
$0.00
0.00%
1
$3.75
0.02%
1
$3.95
0.02%
0
$0.00
0.00%
37205011910
SIMETHICONE DRO 40/0.6ML
1
$11.14
0.02%
3
$29.53
0.05%
37205031763
GLYCERIN
SUP 1.5GM
1
$4.05
0.02%
0
$0.00
0.00%
37205032063
GLYCERIN
SUP 3GM
2
$8.50
0.05%
4
$23.28
0.06%
50111043001
122
$1,227.39
2.81%
167
$1,449.67
2.56%
50111043002
613
$5,645.03
14.12%
887
$7,215.16
13.59%
50111043003
473
$4,424.73
10.90%
608
$4,992.20
9.31%
50111051701
METOCLOPRAM TAB 5MG
230
$4,346.78
5.30%
221
$3,381.06
3.38%
50111051702
METOCLOPRAM TAB 5MG
119
$2,455.45
2.74%
201
$3,024.28
3.08%
50383077908
LACTULOSE
SYP 10GM/15
7
$335.72
0.16%
34
$795.84
0.52%
50383077932
LACTULOSE
SYP 10GM/15
9
$576.17
0.21%
22
$751.13
0.34%
50383079516
LACTULOSE
SYP 10GM/15
33
$755.83
0.76%
173
$4,211.83
2.65%
51285058502
METOCLOPRAM TAB 5MG
13
$248.83
0.30%
4
$85.40
0.06%
51285058504
METOCLOPRAM TAB 5MG
8
$126.89
0.18%
1
$14.35
0.02%
52268010001
GOLYTELY
SOL
4
$72.66
0.09%
21
$599.40
0.32%
52268010101
GOLYTELY
SOL PINEAPPL
1
$19.15
0.02%
2
$36.95
0.03%
52268030001
NULYTELY
SOL
2
$42.18
0.05%
6
$127.15
0.09%
52268030101
NULYTELY
SOL CHERRY
2
$42.31
0.05%
7
$156.28
0.11%
52268030201
NULYTELY
SOL LMN/LIME
2
$40.72
0.05%
3
$69.39
0.05%
52268030301
NULYTELY
SOL ORANGE
2
$35.04
0.05%
16
$366.95
0.25%
52268070001
GOLYTELY
SOL
1
$11.05
0.02%
0
$0.00
0.00%
SUP 1.5GM
Page 37 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
52268080002
MIRALAX
POW 3350 NF
319
$7,692.51
7.35%
413
$9,946.41
6.33%
52268080003
MIRALAX
POW 3350 NF
270
$10,263.20
6.22%
588
$24,058.90
9.01%
52268080005
MIRALAX
PKG 3350
2
$46.24
0.05%
11
$376.84
0.17%
52735050506
GLYCERIN
SUP 3GM
0
$0.00
0.00%
1
$2.19
0.02%
53014067870
GASTROCROM CON 100/5ML
28
$5,441.73
0.65%
26
$4,655.27
0.40%
53489038401
METOCLOPRAM TAB 5MG
45
$799.85
1.04%
146
$2,220.38
2.24%
53489038405
METOCLOPRAM TAB 5MG
5
$104.98
0.12%
21
$398.35
0.32%
59911581501
0
$0.00
0.00%
1
$7.60
0.02%
59911581502
5
$34.70
0.12%
1
$9.85
0.02%
60432003708
LACTULOSE
SYP 10GM/15
4
$62.60
0.09%
2
$13.06
0.03%
60432003732
LACTULOSE
SYP 10GM/15
19
$617.83
0.44%
14
$469.45
0.21%
60432003816
GENERLAC
SYP 10GM/15
45
$977.09
1.04%
68
$1,525.06
1.04%
60432062216
354
$2,863.34
8.15%
429
$3,275.17
6.57%
60505036001
LACTULOSE
SOL 10GM/15
28
$579.72
0.65%
85
$1,557.17
1.30%
60505036002
LACTULOSE
SOL 10GM/15
10
$281.22
0.23%
25
$584.89
0.38%
62175044601
PEG 3350
SOL ELECTROL
40
$628.44
0.92%
61
$974.90
0.93%
62269026324
METOCLOPRAM TAB 5MG
22
$430.96
0.51%
0
$0.00
0.00%
62269026329
METOCLOPRAM TAB 5MG
19
$380.32
0.44%
0
$0.00
0.00%
62794050117
KRISTALOSE PAK 10GM
3
$146.90
0.07%
8
$268.84
0.12%
62794050193
KRISTALOSE PAK 10GM
6
$130.88
0.14%
11
$434.90
0.17%
62794050217
KRISTALOSE PAK 20GM
1
$31.08
0.02%
0
$0.00
0.00%
62794050293
KRISTALOSE PAK 20GM
13
$923.90
0.30%
15
$962.10
0.23%
1
$3,004.85
1.04%
1
$3,197.25
0.66%
ANTI-HEMOPHILIC AGENTS
00053762010
HUMATE-P
00053813001
HELIXATE FS SOL 250IU
0
$0.00
0.00%
1
$2,368.74
0.66%
00053813002
0
$0.00
0.00%
3
$16,925.14
1.97%
INJ 1000IU
Page 38 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANTI-HEMOPHILIC AGENTS
00053813004
2
$31,937.53
2.08%
6
$55,231.23
00169706001
NOVOSEVEN INJ 1200MCG
4
$53,506.05
4.17%
13
$236,276.42
8.55%
00169706101
NOVOSEVEN INJ 2400MCG
0
$0.00
0.00%
25
$145,325.03
16.45%
00944293801
RECOMBINATE INJ 220-400
1
$65,927.01
1.04%
2
$10,799.86
1.32%
00944293802
7
$15,325.16
7.29%
5
$28,085.15
3.29%
00944293803
55
$639,391.88
57.29%
49
$689,331.93
32.24%
00944294001
ADVATE
KIT 250IU
0
$0.00
0.00%
5
$33,472.95
3.29%
58394000101
BENEFIX
INJ 1000IU
24
$298,997.70
25.00%
37
$262,071.01
24.34%
58394000201
BENEFIX
INJ 500IU
2
$4,985.71
2.08%
5
$9,426.67
3.29%
3.95%
ANTI-INFLAMMATORY / STEROIDS OPHTH.
00023006604
PRED-G S.O.P OIN OP
4
$107.53
0.28%
0
$0.00
0.00%
00023010605
PRED-G
1
$29.09
0.07%
2
$53.18
0.15%
00023031304
BLEPHAMIDE OIN S.O.P.
33
$1,079.27
2.29%
15
$529.94
1.13%
00023031604
FML S.O.P. OIN 0.1% OP
20
$640.58
1.39%
26
$764.02
1.96%
00065009605
FLAREX
SUS 0.1% OP
3
$75.11
0.21%
16
$451.18
1.21%
00065009610
FLAREX
SUS 0.1% OP
1
$45.76
0.07%
0
$0.00
0.00%
00065062703
VEXOL
SUS 1% OP
5
$179.53
0.35%
3
$141.65
0.23%
00065062707
VEXOL
SUS 1% OP
16
$453.87
1.11%
13
$341.41
0.98%
00065063136
MAXITROL
OIN 0.1% OP
1
$51.53
0.07%
0
$0.00
0.00%
00065064705
TOBRADEX
SUS OP
327
$15,773.10
22.65%
256
$13,550.67
19.29%
00065064710
TOBRADEX
SUS OP
68
$5,548.67
4.71%
55
$5,278.18
4.14%
00065064725
TOBRADEX
SUS OP
11
$428.82
0.76%
7
$205.31
0.53%
00065064835
TOBRADEX
OIN OP
121
$5,824.94
8.38%
148
$7,993.49
11.15%
00168002938
BAC/POLY/NEO OIN /HC OP
19
$200.53
1.32%
13
$122.72
0.98%
00998061505
MAXIDEX
0
$0.00
0.00%
3
$98.07
0.23%
00998063505
ECONOPRED SUS 0.125%OP
9
$225.95
0.62%
0
$0.00
0.00%
SUS OP
SUS 0.1% OP
Page 39 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00998063510
ECONOPRED SUS 0.125%OP
2
$69.70
0.14%
1
$36.85
0.08%
00998063705
ECONOPRED PL SUS 1% OP
4
$85.39
0.28%
1
$61.74
0.08%
00998063710
ECONOPRED PL SUS 1% OP
1
$19.30
0.07%
2
$92.30
0.15%
11980002205
BLEPHAMIDE SUS OP
31
$1,093.26
2.15%
27
$1,182.13
2.03%
11980002210
BLEPHAMIDE SUS OP
5
$253.20
0.35%
13
$712.52
0.98%
11980017405
PRED MILD
SUS 0.12% OP
13
$308.02
0.90%
14
$364.23
1.06%
11980017410
PRED MILD
SUS 0.12% OP
4
$135.16
0.28%
10
$342.90
0.75%
11980018001
PRED FORTE SUS 1% OP
0
$0.00
0.00%
1
$72.60
0.08%
11980018005
14
$345.50
0.97%
19
$634.80
1.43%
11980018010
50
$2,211.74
3.46%
56
$2,456.35
4.22%
11980018015
27
$1,703.22
1.87%
15
$938.47
1.13%
11980021105
FML LIQUIFLM SUS 0.1% OP
2
$22.30
0.14%
7
$194.40
0.53%
11980021110
FML LIQUIFLM SUS 0.1% OP
2
$86.30
0.14%
1
$42.65
0.08%
11980042205
FML-S
SUS LIQUIFLM
3
$76.93
0.21%
3
$76.92
0.23%
11980042210
FML-S
SUS LIQUIFLM
2
$67.84
0.14%
2
$67.84
0.15%
17478023235
AK-SPORE HC OIN OP
3
$22.92
0.21%
1
$8.83
0.08%
17478023910
AK-TROL
1
$9.75
0.07%
0
$0.00
0.00%
24208028805
FLUOROMETHOL SUS 0.1% OP
5
$71.83
0.35%
3
$29.95
0.23%
24208028810
7
$132.58
0.48%
2
$37.38
0.15%
24208028815
1
$28.24
0.07%
0
$0.00
0.00%
24208029905
LOTEMAX
SUS 0.5%
30
$807.51
2.08%
42
$1,209.25
3.17%
24208029910
LOTEMAX
SUS 0.5%
3
$122.40
0.21%
6
$263.52
0.45%
24208029915
LOTEMAX
SUS 0.5%
3
$183.54
0.21%
1
$67.92
0.08%
24208031705
SULF/PRED NA SOL OP
13
$213.48
0.90%
14
$198.02
1.06%
24208031710
SULF/PRED NA SOL OP
0
$0.00
0.00%
2
$31.03
0.15%
24208035305
ALREX
SUS 0.2%
13
$455.95
0.90%
12
$449.66
0.90%
24208035310
ALREX
SUS 0.2%
2
$111.99
0.14%
2
$123.56
0.15%
SUS 0.1% OP
Page 40 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
24208071502
PRED SOD PHO SOL 1% OP
8
$151.86
0.55%
8
$173.52
0.60%
24208071506
3
$90.42
0.21%
4
$121.06
0.30%
24208071510
2
$32.30
0.14%
0
$0.00
0.00%
24208072002
DEXAMETH PHO SOL 0.1% OP
7
$121.87
0.48%
14
$358.79
1.06%
24208078555
NEO/POLY/BAC OIN /HC OP
5
$78.46
0.35%
0
$0.00
0.00%
24208079535
NEO-POLY-DEX OIN 0.1% OP
2
$13.70
0.14%
0
$0.00
0.00%
24208083060
DEX/NEO/POLY SUS 0.1% OP
3
$28.19
0.21%
4
$36.24
0.30%
58768010705
EFLONE
SUS 0.1% OP
2
$31.76
0.14%
0
$0.00
0.00%
58768010710
EFLONE
SUS 0.1% OP
4
$91.92
0.28%
3
$67.19
0.23%
58768035805
FLUOR-OP
1
$11.65
0.07%
1
$9.15
0.08%
58768087505
INFLAM MILD SOL .125% OP
1
$18.50
0.07%
0
$0.00
0.00%
58768087710
INFLAMASE
SOL FORTE 1%
1
$16.15
0.07%
0
$0.00
0.00%
58768088705
VASOCIDIN
SOL OP
2
$38.33
0.14%
1
$33.74
0.08%
60758011905
PREDNISOLONE SUS 1% OP
57
$701.39
3.95%
62
$619.13
4.67%
60758011910
42
$782.74
2.91%
66
$1,262.86
4.97%
60758011915
11
$285.80
0.76%
30
$738.58
2.26%
60758088005
9
$103.36
0.62%
5
$48.25
0.38%
60758088010
2
$33.52
0.14%
2
$33.47
0.15%
61314032805
7
$79.55
0.48%
9
$94.85
0.68%
61314032810
2
$38.88
0.14%
1
$17.44
0.08%
61314063006
NEO/POLY/DEX SUS 0.1% OP
12
$119.83
0.83%
6
$56.32
0.45%
61314063136
NEO/POLY/DEX OIN 0.1% OP
14
$94.40
0.97%
7
$39.38
0.53%
61314063705
155
$1,678.87
10.73%
140
$1,508.51
10.55%
61314063710
114
$2,274.54
7.89%
72
$1,353.41
5.43%
61314063715
62
$1,695.25
4.29%
42
$1,113.59
3.17%
61314064175
NEO/POLY/HC SUS OP
0
$0.00
0.00%
18
$812.44
1.36%
61570003535
CORTISPORIN OIN OP
0
$0.00
0.00%
2
$75.42
0.15%
SUS 0.1% OP
Page 41 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
CORTISPORIN SUS OP
$
Market Share*
61570003675
# of Scripts
36
$1,818.58
2.49%
16
$804.82
1.21%
ANTI-INFLAMMATORY AGENTS
00054816721
CROMOLYN SOD NEB 20MG/2ML
6
$187.65
1.71%
9
$241.35
3.96%
00054816723
9
$375.75
2.57%
1
$60.95
0.44%
00070999612
7
$359.45
2.00%
0
$0.00
0.00%
00172640649
3
$86.85
0.86%
0
$0.00
0.00%
00172640659
3
$108.45
0.86%
3
$89.25
1.32%
00585067501
INTAL INH
AER 800MCG
214
$15,741.03
61.14%
116
$9,207.09
51.10%
00585067502
INTAL INH
AER 800MCG
34
$1,885.10
9.71%
48
$2,912.41
21.15%
00585068502
TILADE
6
$234.88
1.71%
9
$521.85
3.96%
49502068902
42
$1,179.87
12.00%
16
$479.95
7.05%
49502068912
26
$896.75
7.43%
20
$591.40
8.81%
50242004062
XOLAIR
0
$0.00
0.00%
5
$14,138.40
2.20%
5
$453.93
0.18%
3
$271.21
0.09%
AER 1.75/ACT
SOL 150MG
ANTI-MALARIAL AGENTS
00004017202
LARIAM
TAB 250MG
00024008401
ARALEN
TAB 500MG
00024156210
PLAQUENIL
00093977401
1
$20.66
0.04%
0
$0.00
0.00%
60
$4,204.92
2.22%
39
$3,187.55
1.19%
HYDROXYCHLOR TAB 200MG
40
$1,922.32
1.48%
10
$245.55
0.30%
00093977405
7
$393.53
0.26%
12
$337.04
0.37%
00115705606
CHLOROQUINE TAB 250MG
9
$291.98
0.33%
0
$0.00
0.00%
00143212522
CHLOROQUINE TAB 500MG
7
$244.47
0.26%
5
$265.43
0.15%
00172300160
QUININE SULF TAB 260MG
195
$2,187.58
7.21%
198
$5,020.82
6.03%
00172300170
94
$1,009.29
3.47%
55
$1,014.35
1.68%
00172417160
QUININE SULF CAP 200MG
39
$379.01
1.44%
47
$985.23
1.43%
00172417260
49
$615.37
1.81%
50
$1,465.62
1.52%
TAB 200MG
Page 42 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00172417280
13
$108.10
0.48%
3
00173020155
DARAPRIM
12
$314.88
0.44%
00173067501
MALARONE
TAB 250-100
1
$130.21
0.04%
00173067502
MALARONE
TAB 250-100
0
$0.00
00182861589
1
00378037301
00591069801
00591069805
00591071501
$32.40
0.09%
10
$294.38
0.30%
7
$1,575.16
0.21%
0.00%
2
$297.50
0.06%
$5.91
0.04%
0
$0.00
0.00%
61
$3,010.38
2.25%
162
$4,188.96
4.94%
96
$4,056.42
3.55%
138
$3,545.48
4.21%
15
$1,145.26
0.55%
54
$1,155.78
1.65%
238
$3,325.97
8.80%
110
$2,877.19
3.35%
00591071505
90
$1,261.58
3.33%
76
$2,007.74
2.32%
00591071510
42
$709.97
1.55%
9
$356.85
0.27%
00591071601
373
$4,161.44
13.78%
226
$5,731.82
6.89%
00591071610
104
$1,102.21
3.84%
54
$1,543.77
1.65%
00603561821
0
$0.00
0.00%
131
$2,427.77
3.99%
00603561828
0
$0.00
0.00%
22
$509.70
0.67%
00603561832
0
$0.00
0.00%
6
$169.06
0.18%
00603562121
QUININE SULF CAP 5GR
2
$29.26
0.07%
8
$259.99
0.24%
00603562221
0
$0.00
0.00%
382
$8,374.22
11.64%
00603562228
0
$0.00
0.00%
3
$112.05
0.09%
00603562232
0
$0.00
0.00%
38
$1,062.07
1.16%
00615157953
10
$75.21
0.37%
0
$0.00
0.00%
00615157963
36
$299.05
1.33%
0
$0.00
0.00%
00677164701
18
$169.35
0.67%
10
$331.05
0.30%
00677164705
8
$68.80
0.30%
10
$200.00
0.30%
00677164707
8
$80.90
0.30%
2
$89.30
0.06%
00677164710
3
$19.05
0.11%
13
$494.87
0.40%
00781140701
452
$22,833.05
16.70%
487
$12,058.15
14.84%
TAB 25MG
Page 43 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00781140705
5
$179.21
0.18%
00781507686
MEFLOQUINE TAB 250MG
2
$98.82
00904056460
0
$0.00
00904564860
0
10267023101
0
10267023104
38245077410
51552035899
1
$21.25
0.03%
0.07%
7
$672.57
0.21%
0.00%
20
$486.94
0.61%
$0.00
0.00%
3
$18.47
0.09%
$0.00
0.00%
6
$72.32
0.18%
0
$0.00
0.00%
17
$249.86
0.52%
2
$109.12
0.07%
0
$0.00
0.00%
QUINACRINE POW
1
$62.83
0.04%
0
$0.00
0.00%
52544069801
8
$420.03
0.30%
5
$146.20
0.15%
52544069805
1
$54.56
0.04%
0
$0.00
0.00%
52544071501
17
$224.55
0.63%
2
$50.54
0.06%
52544071505
27
$273.47
1.00%
2
$43.16
0.06%
52544071510
2
$54.13
0.07%
0
$0.00
0.00%
52544071601
34
$364.38
1.26%
22
$537.40
0.67%
52544071610
62
$628.17
2.29%
9
$107.20
0.27%
53489022101
284
$3,180.27
10.50%
149
$2,925.55
4.54%
53489022105
26
$220.48
0.96%
41
$870.77
1.25%
53489022107
7
$88.15
0.26%
0
$0.00
0.00%
53489022110
110
$1,087.99
4.07%
113
$2,629.75
3.44%
62269025024
29
$1,190.86
1.07%
0
$0.00
0.00%
62584074000
0
$0.00
0.00%
8
$131.26
0.24%
64125012001
0
$0.00
0.00%
228
$6,230.72
6.95%
64125012010
0
$0.00
0.00%
81
$2,520.79
2.47%
64125012101
0
$0.00
0.00%
155
$4,230.39
4.72%
64125012105
0
$0.00
0.00%
30
$725.71
0.91%
ANTI-MYCOBACTERIALS / ANTI-TUBERCULOSIS
Page 44 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANTI-MYCOBACTERIALS / ANTI-TUBERCULOSIS
00013530117
MYCOBUTIN CAP 150MG
5
$802.63
9.09%
2
$183.07
1.59%
00068050861
RIFADIN
0
$0.00
0.00%
2
$160.01
1.59%
00143126101
ISONIAZID
TAB 300MG
0
$0.00
0.00%
3
$18.06
2.38%
00185079901
RIFAMPIN
CAP 300MG
7
$372.32
12.73%
21
$1,264.98
16.67%
00185079905
RIFAMPIN
CAP 300MG
0
$0.00
0.00%
2
$82.11
1.59%
00185079930
RIFAMPIN
CAP 300MG
16
$763.08
29.09%
22
$1,258.07
17.46%
00185079960
RIFAMPIN
CAP 300MG
2
$73.77
3.64%
8
$733.24
6.35%
00185080101
RIFAMPIN
CAP 150MG
1
$14.68
1.82%
2
$39.41
1.59%
00185435001
ISONIAZID
TAB 300MG
0
$0.00
0.00%
7
$33.94
5.56%
00555007102
ISONIAZID
TAB 300MG
0
$0.00
0.00%
22
$96.29
17.46%
00555092302
ETHAMBUTOL TAB 400MG
2
$127.28
3.64%
10
$963.60
7.94%
00781201801
RIMACTANE
4
$118.43
7.27%
2
$33.60
1.59%
00781207701
RIFAMPIN
CAP 300MG
0
$0.00
0.00%
1
$26.90
0.79%
00781207731
RIFAMPIN
CAP 300MG
0
$0.00
0.00%
9
$383.22
7.14%
17236018230
ISONIAZID
TAB 300MG
0
$0.00
0.00%
4
$23.55
3.17%
51479004601
MYAMBUTOL
TAB 100MG
2
$99.60
3.64%
0
$0.00
0.00%
51479004701
MYAMBUTOL
TAB 400MG
4
$623.08
7.27%
4
$852.27
3.17%
55390012301
RIFAMPIN
10
$4,396.17
18.18%
0
$0.00
0.00%
61748001101
0
$0.00
0.00%
1
$22.48
0.79%
61748001401
2
$188.44
3.64%
3
$343.32
2.38%
61748001801
RIFAMPIN
0
$0.00
0.00%
1
$64.87
0.79%
CAP 300MG
CAP 300MG
INJ 600 MG
CAP 300MG
ANTI-NEOPLASTICS
00023081230
FLUOROPLEX CRE 1%
6
$403.42
10.71%
7
$483.91
20.59%
00066715030
CARAC
CRE 0.5%
4
$270.00
7.14%
3
$265.39
8.82%
00187320210
EFUDEX
SOL 2%
0
$0.00
0.00%
1
$64.86
2.94%
00187320426
EFUDEX
CRE 5%
44
$4,017.70
78.57%
21
$1,947.26
61.76%
Page 45 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANTI-NEOPLASTICS
62436000350
SOLARAZE
GEL 3% W/W
1
$47.33
1.79%
2
$187.62
5.88%
62436003050
SOLARAZE
GEL 3% W/W
1
$78.65
1.79%
0
$0.00
0.00%
ANTI-PERISTALTIC AGENTS
00025006131
LOMOTIL
0
$0.00
0.00%
2
$106.69
0.12%
00045029506
IMODIUM A-D TAB 2MG
TAB 2.5MG
1
$37.40
0.06%
0
$0.00
0.00%
00054319446
DIPHEN/ATROP LIQ 2.5/5
1
$14.27
0.06%
2
$29.00
0.12%
00054353550
LOPERAMIDE LIQ 1MG/5ML
3
$24.07
0.17%
4
$110.12
0.23%
00093031101
LOPERAMIDE CAP 2MG
314
$8,644.82
18.05%
276
$2,227.25
16.04%
00093031105
LOPERAMIDE CAP 2MG
41
$1,127.05
2.36%
43
$326.02
2.50%
00172396660
DIPHEN/ATROP TAB 2.5MG
13
$324.11
0.75%
34
$303.82
1.98%
00172396680
44
$1,318.40
2.53%
96
$1,116.09
5.58%
00182108211
ANTI-DIARRHE TAB 2MG
12
$79.01
0.69%
10
$59.82
0.58%
00185002401
9
$104.49
0.52%
0
$0.00
0.00%
00185002405
21
$1,095.49
1.21%
31
$440.86
1.80%
00185002410
5
$46.82
0.29%
11
$102.85
0.64%
00378041501
102
$2,032.64
5.86%
122
$1,389.85
7.09%
00378041510
84
$2,021.14
4.83%
109
$1,093.42
6.33%
00378210001
LOPERAMIDE CAP 2MG
183
$6,123.64
10.52%
239
$2,596.12
13.89%
00378210005
LOPERAMIDE CAP 2MG
129
$2,717.74
7.41%
196
$1,687.96
11.39%
00406046301
24
$456.43
1.38%
18
$216.26
1.05%
00406046310
55
$1,501.60
3.16%
37
$509.23
2.15%
00472080216
PAREGORIC
56
$811.26
3.22%
18
$2,009.98
1.05%
00527117010
LOFENE
20
$628.53
1.15%
9
$63.55
0.52%
00603336032
2
$29.16
0.11%
0
$0.00
0.00%
00615036253
LOPERAMIDE CAP 2MG
5
$47.32
0.29%
0
$0.00
0.00%
00615036263
LOPERAMIDE CAP 2MG
35
$428.26
2.01%
0
$0.00
0.00%
TIN 2MG/5ML
TAB 2.5MG
Page 46 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00781126201
LONOX
TAB 2.5MG
00781126205
LONOX
TAB 2.5MG
1
$68.72
0.06%
00781126210
LONOX
TAB 2.5MG
301
$7,810.27
17.30%
00781613016
PAREGORIC
5
$39.70
0.29%
00904003620
7
$57.82
00904080216
PAREGORIC
0
00904772512
3
10135015801
LOPERAMIDE TAB 2MG
0
15127033866
SB ANTI-DIAR TAB 2MG
37205037053
37205037726
$81.13
0.52%
2
$10.95
0.12%
111
$888.75
6.45%
0
$0.00
0.00%
0.40%
9
$74.34
0.52%
$0.00
0.00%
1
$13.03
0.06%
$28.53
0.17%
1
$10.29
0.06%
$0.00
0.00%
1
$3.19
0.06%
1
$11.01
0.06%
0
$0.00
0.00%
2
$16.71
0.11%
3
$45.93
0.17%
1
$8.01
0.06%
0
$0.00
0.00%
49348052902
ANIT-DIARRHE TAB 2MG
0
$0.00
0.00%
2
$16.35
0.12%
49884077101
35
$1,067.89
2.01%
45
$462.99
2.61%
49884077110
167
$4,085.98
9.60%
178
$1,951.94
10.34%
50580029512
IMODIUM A-D TAB 2MG
0
$0.00
0.00%
1
$9.36
0.06%
50580029514
IMODIUM A-D TAB 2MG
0
$0.00
0.00%
1
$9.21
0.06%
50580029524
IMODIUM A-D TAB 2MG
0
$0.00
0.00%
1
$27.78
0.06%
51079006720
0
$0.00
0.00%
2
$29.70
0.12%
51079069020
LOPERAMIDE CAP 2MG
0
$0.00
0.00%
1
$4.45
0.06%
52735054417
0
$0.00
0.00%
1
$6.08
0.06%
53265023710
0
$0.00
0.00%
1
$2.25
0.06%
53265023711
0
$0.00
0.00%
21
$305.25
1.22%
55953002040
LOPERAMIDE CAP 2MG
6
$112.80
0.34%
0
$0.00
0.00%
60432045716
PAREGORIC
4
$906.37
0.23%
12
$1,270.42
0.70%
63304020301
OPIUM
TIN 10%
16
$524.59
0.92%
15
$426.89
0.87%
63304020302
OPIUM
TIN 10%
2
$29.40
0.11%
3
$42.14
0.17%
65162030110
0
$0.00
0.00%
12
$161.60
0.70%
TIN 2MG/5ML
TIN 2MG/5ML
TIN 2MG/5ML
16
$463.35
0.92%
9
Page 47 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
65234007410
MOTOFEN
TAB
$
Market Share*
65162030111
# of Scripts
2
$27.16
0.11%
16
$224.32
0.93%
12
$643.70
0.69%
15
$886.35
0.87%
ANTI-PRURITICS
00064360045
PRUDOXIN
CRE 5%
1
$43.28
3.13%
4
$179.74
8.00%
62436052330
ZONALON
CRE 5%
23
$841.48
71.88%
40
$2,104.51
80.00%
62436052345
ZONALON
CRE 5%
8
$408.82
25.00%
6
$327.56
12.00%
ANTI-PSORIATICS
00004021357
SORIATANE
CAP 10MG
4
$817.35
0.87%
1
$235.62
0.18%
00004021457
SORIATANE
CAP 25MG
5
$2,129.75
1.08%
0
$0.00
0.00%
00004028857
SORIATANE
CAP 10MG
1
$270.11
0.22%
5
$2,128.74
0.90%
00004028957
SORIATANE
CAP 25MG
23
$11,589.35
4.98%
27
$10,133.34
4.85%
00023004203
TAZORAC
GEL 0.1%
15
$1,040.81
3.25%
18
$1,401.24
3.23%
00023004210
TAZORAC
GEL 0.1%
2
$457.24
0.43%
1
$248.04
0.18%
00023833503
TAZORAC
GEL 0.05%
6
$462.31
1.30%
5
$365.75
0.90%
00023915515
TAZORAC
CRE 0.05%
0
$0.00
0.00%
1
$73.14
0.18%
00023915530
TAZORAC
CRE 0.05%
15
$1,044.86
3.25%
17
$1,242.70
3.05%
00023915560
TAZORAC
CRE 0.05%
3
$385.23
0.65%
7
$993.08
1.26%
00023915615
TAZORAC
CRE 0.1%
0
$0.00
0.00%
1
$40.45
0.18%
00023915630
TAZORAC
CRE 0.1%
16
$1,152.58
3.46%
25
$1,896.51
4.49%
00023915660
TAZORAC
CRE 0.1%
5
$691.05
1.08%
4
$596.67
0.72%
00072026003
DOVONEX
CRE 0.005%
0
$0.00
0.00%
1
$88.72
0.18%
00072026006
DOVONEX
CRE 0.005%
127
$15,034.53
27.49%
137
$17,363.23
24.60%
00072026010
DOVONEX
CRE 0.005%
2
$593.11
0.43%
0
$0.00
0.00%
00072026012
DOVONEX
CRE 0.005%
8
$1,889.20
1.73%
32
$7,090.81
5.75%
00072116006
DOVONEX
SOL 0.005%
49
$4,503.10
10.61%
52
$5,082.04
9.34%
Page 48 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANTI-PSORIATICS
00072254003
DOVONEX
OIN 0.005%
10
$887.20
2.16%
1
$88.72
0.18%
00072254006
DOVONEX
OIN 0.005%
100
$11,399.40
21.65%
133
$16,589.60
23.88%
00072254010
DOVONEX
OIN 0.005%
1
$141.40
0.22%
0
$0.00
0.00%
00072254012
DOVONEX
OIN 0.005%
58
$12,850.89
12.55%
75
$19,520.19
13.46%
00187065042
OXSORALEN-UL CAP 10MG
3
$479.90
0.65%
9
$2,288.73
1.62%
64980031250
ANTHRALIN
0
$0.00
0.00%
2
$155.42
0.36%
65880041550
PSORIATEC
9
$524.52
1.95%
3
$196.33
0.54%
CRE 1%
CRE 1%
ANTI-PSYCHOTICS ATYPICALS
00002411204
ZYPREXA
TAB 2.5MG
143
$19,189.66
0.41%
251
$31,431.82
0.59%
00002411233
ZYPREXA
TAB 2.5MG
0
$0.00
0.00%
6
$862.60
0.01%
00002411260
ZYPREXA
TAB 2.5MG
1,609
$202,592.82
4.59%
1,419
$181,386.77
3.33%
00002411504
ZYPREXA
TAB 5MG
146
$22,969.84
0.42%
240
$37,558.89
0.56%
00002411533
ZYPREXA
TAB 5MG
7
$1,131.52
0.02%
0
$0.00
0.00%
00002411560
ZYPREXA
TAB 5MG
2,192
$343,408.41
6.25%
2,016
$332,567.98
4.73%
00002411633
ZYPREXA
TAB 7.5MG
2
$359.32
0.01%
4
$438.05
0.01%
00002411660
ZYPREXA
TAB 7.5MG
564
$106,161.34
1.61%
514
$104,866.96
1.21%
00002411704
ZYPREXA
TAB 10MG
78
$18,363.67
0.22%
222
$52,371.08
0.52%
00002411733
ZYPREXA
TAB 10MG
10
$2,719.42
0.03%
2
$546.60
0.00%
00002411760
ZYPREXA
TAB 10MG
2,073
$501,699.65
5.91%
1,921
$492,479.99
4.51%
00002441530
ZYPREXA
TAB 15MG
84
$31,975.90
0.24%
0
$0.00
0.00%
00002441533
ZYPREXA
TAB 15MG
25
$11,842.95
0.07%
1
$378.18
0.00%
00002441560
ZYPREXA
TAB 15MG
834
$348,812.74
2.38%
1,058
$456,498.81
2.48%
00002442033
ZYPREXA
TAB 20MG
38
$18,181.93
0.11%
17
$7,674.98
0.04%
00002442060
ZYPREXA
TAB 20MG
1,168
$574,947.33
3.33%
1,540
$827,887.44
3.61%
00002445301
ZYPREXA ZYDI TAB 5MG
3
$588.03
0.01%
2
$300.97
0.00%
00002445385
126
$23,135.51
0.36%
101
$18,233.29
0.24%
Page 49 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00002445401
1
$285.49
0.00%
1
$285.49
0.00%
00002445485
102
$33,435.88
0.29%
67
$21,370.03
0.16%
00002445501
0
$0.00
0.00%
2
$1,638.48
0.00%
00002445585
19
$8,840.99
0.05%
23
$9,322.79
0.05%
00002445601
1
$533.31
0.00%
2
$1,067.62
0.00%
00002445685
24
$14,747.27
0.07%
30
$16,315.57
0.07%
00049392083
GEODON
INJ 20MG
3
$314.56
0.01%
1
$2,287.10
0.00%
00049396041
GEODON
CAP 20MG
4
$720.62
0.01%
0
$0.00
0.00%
00049396060
GEODON
CAP 20MG
407
$100,095.61
1.16%
394
$79,786.47
0.92%
00049397041
GEODON
CAP 40MG
1
$112.21
0.00%
6
$950.96
0.01%
00049397060
GEODON
CAP 40MG
408
$80,210.58
1.16%
459
$88,169.36
1.08%
00049398041
GEODON
CAP 60MG
3
$672.24
0.01%
0
$0.00
0.00%
00049398060
GEODON
CAP 60MG
200
$37,298.22
0.57%
283
$60,637.22
0.66%
00049399041
GEODON
CAP 80MG
2
$454.16
0.01%
6
$1,148.58
0.01%
00049399060
GEODON
CAP 80MG
347
$62,446.71
0.99%
445
$94,118.94
1.04%
00310027110
SEROQUEL
TAB 100MG
3,353
$471,970.30
9.57%
3,718
$536,569.15
8.72%
00310027139
SEROQUEL
TAB 100MG
5
$450.21
0.01%
8
$945.27
0.02%
00310027210
SEROQUEL
TAB 200MG
1,871
$490,922.24
5.34%
2,480
$715,324.04
5.82%
00310027239
SEROQUEL
TAB 200MG
22
$8,216.57
0.06%
27
$7,463.90
0.06%
00310027439
SEROQUEL
TAB 300MG
118
$29,816.06
0.34%
75
$19,315.17
0.18%
00310027460
SEROQUEL
TAB 300MG
569
$147,509.80
1.62%
1,203
$308,584.89
2.82%
00310027510
SEROQUEL
TAB 25MG
4,196
$444,917.42
11.97%
4,973
$529,366.71
11.67%
00310027534
SEROQUEL
TAB 25MG
0
$0.00
0.00%
1
$90.13
0.00%
00310027539
SEROQUEL
TAB 25MG
35
$3,626.84
0.10%
20
$2,295.92
0.05%
50458030001
RISPERDAL
TAB 1MG
8
$1,021.11
0.02%
14
$816.21
0.03%
50458030006
RISPERDAL
TAB 1MG
2,871
$235,134.28
8.19%
3,841
$362,348.90
9.01%
50458030050
RISPERDAL
TAB 1MG
887
$70,020.55
2.53%
1,058
$93,310.57
2.48%
Page 50 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
RISPERDAL
TAB 0.25MG
50458030150
RISPERDAL
TAB 0.25MG
50458030206
RISPERDAL
TAB 0.5MG
50458030250
RISPERDAL
TAB 0.5MG
50458030503
RISPERDAL
SOL 1MG/ML
50458030611
RISPERDAL
50458031528
RISPERDAL
50458031530
$
Market Share*
50458030104
# of Scripts
$58,586.26
2.11%
$67,677.87
1.99%
205
$15,616.65
0.58%
2,178
$173,246.25
6.21%
296
$22,949.96
0.69%
2,567
$219,737.31
6.02%
668
$50,499.19
1.91%
801
$64,747.05
1.88%
855
$119,441.63
2.44%
852
$136,495.57
2.00%
INJ 25MG/2ML
0
$0.00
0.00%
TAB M-TAB 1M
0
$0.00
0.00%
1
$32.07
0.00%
24
$4,333.39
0.06%
RISPERDAL
TAB M-TAB 1M
0
$0.00
0.00%
8
$863.50
0.02%
50458032001
RISPERDAL
TAB 2MG
0
$0.00
0.00%
2
$291.22
0.00%
50458032006
RISPERDAL
TAB 2MG
2,293
50458032050
RISPERDAL
TAB 2MG
338
$305,109.27
6.54%
2,960
$424,824.78
6.95%
$45,668.01
0.96%
506
$73,217.13
1.19%
50458032528
RISPERDAL
TAB M-TAB 2M
0
$0.00
0.00%
15
$3,866.03
0.04%
50458033001
RISPERDAL
TAB 3MG
2
$314.04
0.01%
0
$0.00
0.00%
50458033006
50458033050
RISPERDAL
TAB 3MG
1,521
$341,227.30
4.34%
1,738
$434,274.44
4.08%
RISPERDAL
TAB 3MG
209
$47,911.95
0.60%
267
$62,447.28
0.63%
50458035001
RISPERDAL
TAB 4MG
7
$1,455.77
0.02%
0
$0.00
0.00%
50458035006
RISPERDAL
TAB 4MG
1,438
$349,101.58
4.10%
1,818
$501,338.01
4.27%
50458039528
RISPERDAL
TAB M-TAB .5
0
$0.00
0.00%
38
$3,923.29
0.09%
50458039530
RISPERDAL
TAB M-TAB .5
0
$0.00
0.00%
7
$879.14
0.02%
59148000713
ABILIFY
TAB 5MG
0
$0.00
0.00%
36
$8,347.38
0.08%
59148000735
ABILIFY
TAB 5MG
0
$0.00
0.00%
1
$146.57
0.00%
59148000813
ABILIFY
TAB 10MG
6
$1,288.38
0.02%
413
$100,142.53
0.97%
59148000835
ABILIFY
TAB 10MG
0
$0.00
0.00%
2
$859.30
0.00%
59148000913
ABILIFY
TAB 15MG
32
$7,846.69
0.09%
541
$150,299.05
1.27%
59148000935
ABILIFY
TAB 15MG
0
$0.00
0.00%
3
$859.29
0.01%
59148001013
ABILIFY
TAB 20MG
0
$0.00
0.00%
151
$60,622.14
0.35%
59148001113
ABILIFY
TAB 30MG
0
$0.00
0.00%
270
$94,796.59
0.63%
741
847
Page 51 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
ABILIFY
TAB 30MG
$
Market Share*
59148001135
# of Scripts
0
$0.00
0.00%
1
$405.92
0.00%
14
$1,553.86
0.17%
10
$1,012.13
0.12%
ANTI-PSYCHOTICS TYPICAL
00003056915
PROLIXIN-DEC INJ 25MG/ML
00003082030
PROLIXIN
ELX 2.5/5ML
0
$0.00
0.00%
1
$119.52
0.01%
00003086350
PROLIXIN
TAB 1MG
1
$46.93
0.01%
0
$0.00
0.00%
00003087750
PROLIXIN
TAB 5MG
5
$760.03
0.06%
8
$674.89
0.10%
00003095650
PROLIXIN
TAB 10MG
6
$858.09
0.07%
2
$471.10
0.02%
00007334301
COMPAZINE
INJ 5MG/ML
2
$60.71
0.02%
0
$0.00
0.00%
00007334615
COMPAZINE
CAP 15MG CR
1
$36.24
0.01%
0
$0.00
0.00%
00007335216
COMPAZINE
INJ 5MG/ML
2
$19.27
0.02%
1
$8.36
0.01%
00007336003
COMPAZINE
SUP 2.5MG
3
$75.06
0.04%
1
$25.16
0.01%
00007336103
COMPAZINE
SUP 5MG
17
$531.56
0.21%
5
$178.95
0.06%
00007336203
COMPAZINE
SUP 25MG
7
$193.92
0.09%
0
$0.00
0.00%
00007336620
COMPAZINE
TAB 5MG
1
$6.45
0.01%
0
$0.00
0.00%
00007507244
THORAZINE
SYP 10MG/5ML
4
$189.89
0.05%
0
$0.00
0.00%
00007507620
THORAZINE
TAB 50MG
0
$0.00
0.00%
1
$48.03
0.01%
00045025301
HALDOL DECAN INJ 50MG/ML
9
$407.39
0.11%
6
$114.86
0.07%
00045025303
3
$215.80
0.04%
1
$116.22
0.01%
00045025346
12
$2,074.20
0.15%
5
$965.85
0.06%
00045025414
33
$4,112.36
0.40%
7
$1,212.95
0.09%
00045025446
25
$7,943.96
0.30%
14
$4,943.82
0.17%
00045025501
HALDOL
INJ 5MG/ML
45
$1,768.77
0.55%
36
$1,953.08
0.44%
00049571066
NAVANE
CAP 1MG
1
$14.56
0.01%
0
$0.00
0.00%
00049572066
NAVANE
CAP 2MG
7
$157.37
0.09%
0
$0.00
0.00%
00049573066
NAVANE
CAP 5MG
2
$54.22
0.02%
0
$0.00
0.00%
00049574066
NAVANE
CAP 10MG
10
$1,296.75
0.12%
6
$459.75
0.07%
Page 52 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
NAVANE
00054314450
00054314658
CAP 20MG
$
Market Share*
00049577066
# of Scripts
10
$1,086.59
0.12%
9
$972.09
0.11%
CHLORPROMAZ CON 30MG/ML
5
$50.93
0.06%
5
$45.88
0.06%
1
$5.17
0.01%
2
$21.54
0.02%
00054386050
THIORIDAZINE CON 30MG/ML
5
$62.90
0.06%
0
$0.00
0.00%
00054386150
2
$70.88
0.02%
0
$0.00
0.00%
00074188022
PROCHLORPER INJ 5MG/ML
00078000131
MELLARIL
CON 30MG/ML
1
$6.06
0.01%
0
$0.00
0.00%
1
$42.52
0.01%
0
$0.00
0.00%
00078000205
MELLARIL
TAB 10MG
4
$56.49
0.05%
0
$0.00
0.00%
00078000405
MELLARIL
TAB 50MG
0
$0.00
0.00%
1
$41.76
0.01%
00078000505
MELLARIL
TAB 100MG
10
$817.44
0.12%
0
$0.00
0.00%
00093960412
HALOPERIDOL CON 2MG/ML
55
$1,684.09
0.67%
52
$1,776.45
0.64%
00093960423
13
$74.95
0.16%
11
$124.60
0.14%
00093963012
FLUPHENAZINE CON 5MG/ML
5
$532.80
0.06%
2
$452.90
0.02%
00093964301
PROCHLORPER TAB 5MG
23
$233.34
0.28%
8
$105.46
0.10%
00093965201
PROCHLORPER TAB 10MG
67
$1,351.59
0.81%
47
$1,949.58
0.58%
00108490620
STELAZINE
2
$162.20
0.02%
2
$133.59
0.02%
00121058104
5
$86.40
0.06%
5
$252.00
0.06%
00121065304
FLUPHENAZINE CON 5MG/ML
0
$0.00
0.00%
4
$487.47
0.05%
00121067304
PERPHENAZINE CON 16MG/5ML
2
$66.30
0.02%
0
$0.00
0.00%
00172366760
PERPHENAZINE TAB 2MG
1
$19.16
0.01%
2
$18.50
0.02%
00172366860
8
$175.96
0.10%
3
$95.64
0.04%
00172366960
0
$0.00
0.00%
3
$158.29
0.04%
00172367060
0
$0.00
0.00%
1
$41.61
0.01%
00172369060
PROCHLORPER TAB 5MG
27
$450.83
0.33%
19
$169.30
0.23%
00172369160
21
$427.49
0.26%
15
$152.20
0.18%
00182605971
0
$0.00
0.00%
2
$22.35
0.02%
00182709611
PROCHLORPER SUP 25MG
0
$0.00
0.00%
46
$1,502.69
0.56%
TAB 5MG
Page 53 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00182821189
2
$119.02
0.02%
0
$0.00
0.00%
00254494128
2
$30.14
0.02%
0
$0.00
0.00%
00364216701
THIOTHIXENE CAP 2MG
5
$55.81
0.06%
0
$0.00
0.00%
00364216801
THIOTHIXENE CAP 5MG
10
$94.00
0.12%
1
$5.05
0.01%
00364216802
THIOTHIXENE CAP 5MG
0
$0.00
0.00%
1
$11.75
0.01%
00364216901
THIOTHIXENE CAP 10MG
5
$199.70
0.06%
0
$0.00
0.00%
00364216902
0
$0.00
0.00%
1
$39.94
0.01%
00378021401
HALOPERIDOL TAB 2MG
228
$1,303.61
2.77%
209
$2,983.20
2.57%
00378021410
HALOPERIDOL TAB 2MG
42
$242.85
0.51%
115
$1,525.96
1.41%
00378025701
HALOPERIDOL TAB 1MG
149
$733.09
1.81%
102
$426.74
1.25%
00378025710
HALOPERIDOL TAB 1MG
72
$374.67
0.88%
170
$794.71
2.09%
00378032701
HALOPERIDOL TAB 5MG
284
$1,620.07
3.45%
253
$3,588.22
3.11%
00378032710
HALOPERIDOL TAB 5MG
92
$570.02
1.12%
133
$1,984.73
1.63%
00378035101
HALOPERIDOL TAB 0.5MG
108
$528.40
1.31%
85
$359.11
1.04%
00378035110
133
$608.33
1.62%
261
$1,115.05
3.20%
00378061201
THIORIDAZINE TAB 10MG
54
$648.20
0.66%
68
$1,385.64
0.83%
00378061210
12
$117.15
0.15%
17
$601.73
0.21%
00378061401
87
$829.74
1.06%
69
$1,130.95
0.85%
00378061410
24
$206.45
0.29%
27
$392.69
0.33%
00378061601
116
$2,180.81
1.41%
84
$2,052.16
1.03%
00378061610
0
$0.00
0.00%
3
$79.98
0.04%
00378061801
92
$1,373.31
1.12%
91
$2,123.12
1.12%
00378100101
THIOTHIXENE CAP 1MG
29
$213.54
0.35%
11
$205.24
0.14%
00378200201
THIOTHIXENE CAP 2MG
43
$692.72
0.52%
21
$381.31
0.26%
00378200210
THIOTHIXENE CAP 2MG
11
$62.86
0.13%
0
$0.00
0.00%
00378240101
TRIFLUOPERAZ TAB 1MG
14
$150.75
0.17%
8
$100.94
0.10%
00378240201
73
$1,158.91
0.89%
60
$954.43
0.74%
Page 54 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00378240501
78
$2,177.61
0.95%
63
$1,684.05
0.77%
00378241001
38
$1,174.61
0.46%
44
$1,569.60
0.54%
00378300501
THIOTHIXENE CAP 5MG
79
$914.09
0.96%
68
$610.50
0.83%
00378300510
THIOTHIXENE CAP 5MG
7
$78.05
0.09%
1
$5.05
0.01%
00378501001
48
$1,414.44
0.58%
63
$1,953.02
0.77%
00378510501
PROCHLORPER TAB 5MG
25
$299.46
0.30%
31
$347.88
0.38%
00378511001
70
$1,543.30
0.85%
78
$1,309.34
0.96%
00378600401
FLUPHENAZINE TAB 1MG
25
$448.72
0.30%
27
$481.52
0.33%
00378600405
13
$393.61
0.16%
5
$153.12
0.06%
00378600901
FLUPHENAZINE TAB 2.5MG
13
$212.81
0.16%
15
$347.63
0.18%
00378600905
0
$0.00
0.00%
3
$50.84
0.04%
00378607401
53
$1,131.31
0.64%
67
$1,471.71
0.82%
00378607405
39
$839.28
0.47%
33
$654.84
0.41%
00378609701
57
$1,600.39
0.69%
65
$2,227.75
0.80%
00378609705
19
$642.96
0.23%
24
$791.86
0.29%
00472074298
4
$154.94
0.05%
8
$135.55
0.10%
00472145194
1
$42.09
0.01%
0
$0.00
0.00%
00555052102
PROCHLORPER TAB 5MG
0
$0.00
0.00%
8
$96.41
0.10%
00555052202
30
$602.21
0.36%
56
$1,190.01
0.69%
00574722612
COMPRO
SUP 25MG
133
$3,469.32
1.62%
55
$2,477.20
0.68%
00591036901
LOXAPINE
CAP 5MG
0
$0.00
0.00%
3
$80.31
0.04%
00591037001
LOXAPINE
CAP 10MG
29
$1,558.45
0.35%
39
$2,412.23
0.48%
00591037101
LOXAPINE
CAP 25MG
18
$1,622.50
0.22%
41
$4,101.92
0.50%
00591037201
LOXAPINE
CAP 50MG
9
$823.02
0.11%
27
$2,669.74
0.33%
00597002001
SERENTIL
TAB 10MG
19
$760.87
0.23%
7
$233.97
0.09%
00597002101
SERENTIL
TAB 25MG
56
$5,290.43
0.68%
53
$4,902.96
0.65%
00597002301
SERENTIL
TAB 100MG
29
$3,234.78
0.35%
29
$3,303.86
0.36%
Page 55 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00597002504
SERENTIL
CON 25MG/ML
5
$329.45
0.06%
3
$210.84
0.04%
00603280821
CHLORPROMAZ TAB 10MG
6
$48.80
0.07%
0
$0.00
0.00%
00603281021
0
$0.00
0.00%
2
$8.87
0.02%
00603281121
3
$68.80
0.04%
0
$0.00
0.00%
00603509021
0
$0.00
0.00%
34
$793.37
0.42%
00603509121
7
$270.37
0.09%
73
$2,031.29
0.90%
00603509221
22
$1,270.26
0.27%
113
$5,660.32
1.39%
00603509228
0
$0.00
0.00%
7
$416.10
0.09%
00603509321
0
$0.00
0.00%
31
$1,274.80
0.38%
00603599321
2
$19.65
0.02%
0
$0.00
0.00%
00615250453
21
$202.90
0.26%
0
$0.00
0.00%
00615250653
11
$70.19
0.13%
0
$0.00
0.00%
00615250753
10
$134.92
0.12%
0
$0.00
0.00%
00615259453
19
$83.84
0.23%
0
$0.00
0.00%
00615259463
81
$382.80
0.98%
0
$0.00
0.00%
00615259553
HALOPERIDOL TAB 1MG
20
$93.62
0.24%
0
$0.00
0.00%
00615259563
HALOPERIDOL TAB 1MG
49
$220.88
0.60%
0
$0.00
0.00%
00615259653
HALOPERIDOL TAB 2MG
28
$165.94
0.34%
0
$0.00
0.00%
00615259663
HALOPERIDOL TAB 2MG
21
$123.55
0.26%
0
$0.00
0.00%
00615259753
HALOPERIDOL TAB 5MG
14
$80.61
0.17%
0
$0.00
0.00%
00615259763
HALOPERIDOL TAB 5MG
19
$119.07
0.23%
0
$0.00
0.00%
00641049125
PROCHLORPER INJ 5MG/ML
3
$29.24
0.04%
1
$19.99
0.01%
00641139735
CHLORPROMAZ INJ 25MG/ML
0
$0.00
0.00%
2
$79.36
0.02%
00641139835
CHLORPROMAZ INJ 25MG/ML
2
$209.14
0.02%
4
$2,126.96
0.05%
00677082301
5
$69.59
0.06%
9
$233.78
0.11%
00677082406
1
$8.63
0.01%
0
$0.00
0.00%
00677083201
2
$16.90
0.02%
0
$0.00
0.00%
Page 56 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
00703500301
FLUPHENAZ DE INJ 25MG/ML
00703701103
HALOPER DEC INJ 50MG/ML
00703701301
$
Market Share*
00677083206
# of Scripts
0
$0.00
0.00%
2
$61.60
0.02%
145
$3,608.79
1.76%
167
$4,000.50
2.05%
2
$85.67
0.02%
4
$113.64
0.05%
13
$935.57
0.16%
14
$838.12
0.17%
00703702103
0
$0.00
0.00%
1
$103.57
0.01%
00703702301
37
$4,712.19
0.45%
57
$7,259.41
0.70%
00703704501
HALOPER LAC INJ 5MG/ML
1
$65.03
0.01%
0
$0.00
0.00%
00713013512
168
$5,646.60
2.04%
97
$3,782.48
1.19%
00781103001
2
$16.41
0.02%
2
$20.50
0.02%
00781103201
46
$642.17
0.56%
57
$939.55
0.70%
00781103210
4
$95.96
0.05%
6
$106.50
0.07%
00781103401
87
$2,093.12
1.06%
96
$2,239.24
1.18%
00781103410
22
$355.19
0.27%
11
$190.45
0.14%
00781103601
167
$3,926.64
2.03%
54
$2,244.95
0.66%
00781103610
1
$22.70
0.01%
8
$329.95
0.10%
00781103613
3
$83.45
0.04%
0
$0.00
0.00%
00781104601
98
$2,216.93
1.19%
43
$854.25
0.53%
00781104610
4
$44.20
0.05%
0
$0.00
0.00%
00781104701
179
$4,109.70
2.18%
146
$3,149.61
1.79%
00781104710
8
$227.07
0.10%
0
$0.00
0.00%
00781104713
5
$161.90
0.06%
3
$95.64
0.04%
00781104801
153
$7,986.60
1.86%
63
$3,133.09
0.77%
00781104810
5
$206.90
0.06%
0
$0.00
0.00%
00781104901
59
$2,657.85
0.72%
35
$1,605.65
0.43%
00781139101
37
$190.38
0.45%
41
$199.80
0.50%
00781139110
1
$5.45
0.01%
2
$8.07
0.02%
00781139201
HALOPERIDOL TAB 1MG
20
$91.09
0.24%
44
$222.58
0.54%
Page 57 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00781139210
HALOPERIDOL TAB 1MG
6
$33.00
0.07%
11
$50.25
0.14%
00781139301
HALOPERIDOL TAB 2MG
30
$149.40
0.36%
68
$886.78
0.83%
00781139310
HALOPERIDOL TAB 2MG
7
$35.70
0.09%
11
$146.10
0.14%
00781139601
HALOPERIDOL TAB 5MG
77
$512.31
0.94%
131
$2,396.35
1.61%
00781139610
HALOPERIDOL TAB 5MG
3
$12.87
0.04%
0
$0.00
0.00%
00781139613
HALOPERIDOL TAB 5MG
3
$9.93
0.04%
0
$0.00
0.00%
00781139701
HALOPERIDOL TAB 10MG
214
$3,330.99
2.60%
245
$14,353.35
3.01%
00781139710
24
$434.43
0.29%
4
$123.83
0.05%
00781139801
3
$552.96
0.04%
8
$2,201.96
0.10%
00781143601
54
$923.54
0.66%
56
$1,169.83
0.69%
00781143650
1
$51.08
0.01%
3
$153.24
0.04%
00781143701
41
$714.41
0.50%
41
$708.81
0.50%
00781143801
137
$2,963.80
1.67%
161
$3,399.12
1.98%
00781143805
6
$170.67
0.07%
1
$35.26
0.01%
00781143901
175
$3,464.85
2.13%
217
$3,882.86
2.66%
00781143905
0
$0.00
0.00%
8
$259.02
0.10%
00781160401
35
$579.97
0.43%
54
$2,156.60
0.66%
00781160410
41
$448.49
0.50%
6
$125.53
0.07%
00781161401
12
$276.42
0.15%
9
$192.92
0.11%
00781162401
59
$459.56
0.72%
49
$673.57
0.60%
00781162410
64
$560.45
0.78%
33
$503.66
0.41%
00781163401
53
$954.16
0.64%
62
$1,619.95
0.76%
00781163410
69
$1,251.80
0.84%
23
$742.61
0.28%
00781164401
37
$647.35
0.45%
49
$1,214.41
0.60%
00781166401
17
$721.55
0.21%
23
$1,181.69
0.28%
00781167401
11
$312.37
0.13%
6
$199.50
0.07%
00781171501
21
$347.87
0.26%
16
$293.36
0.20%
Page 58 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00781171513
1
$18.85
0.01%
0
$0.00
0.00%
00781171601
110
$1,347.79
1.34%
62
$703.17
0.76%
00781171610
19
$183.93
0.23%
13
$120.03
0.16%
00781171613
1
$1.00
0.01%
0
$0.00
0.00%
00781171701
97
$1,267.36
1.18%
65
$1,301.16
0.80%
00781171710
75
$1,184.93
0.91%
57
$965.68
0.70%
00781171801
154
$2,654.58
1.87%
86
$1,426.97
1.06%
00781171810
15
$266.11
0.18%
7
$188.95
0.09%
00781171813
0
$0.00
0.00%
2
$60.70
0.02%
00781171901
47
$1,095.45
0.57%
15
$229.55
0.18%
00781222601
THIOTHIXENE CAP 1MG
29
$425.94
0.35%
41
$578.08
0.50%
00781222701
THIOTHIXENE CAP 2MG
39
$429.41
0.47%
62
$630.81
0.76%
00781222710
THIOTHIXENE CAP 2MG
0
$0.00
0.00%
4
$25.15
0.05%
00781222801
THIOTHIXENE CAP 5MG
114
$1,199.46
1.39%
132
$1,226.49
1.62%
00781222810
THIOTHIXENE CAP 5MG
1
$28.55
0.01%
15
$142.51
0.18%
00781222901
96
$2,703.42
1.17%
113
$3,108.91
1.39%
00781502001
PROCHLORPER TAB 5MG
57
$771.07
0.69%
122
$1,293.11
1.50%
00781502101
270
$5,276.47
3.28%
392
$7,559.63
4.81%
00832030000
7
$102.25
0.09%
17
$229.61
0.21%
00832030100
65
$953.78
0.79%
132
$1,571.72
1.62%
00832030110
16
$232.84
0.19%
3
$44.44
0.04%
00832030200
112
$1,692.97
1.36%
119
$2,799.85
1.46%
00832030210
3
$27.69
0.04%
22
$666.48
0.27%
00832030300
171
$1,788.29
2.08%
270
$3,327.46
3.31%
00832030310
9
$111.00
0.11%
25
$381.60
0.31%
00832030400
8
$117.80
0.10%
42
$1,280.20
0.52%
00904289060
THIOTHIXENE CAP 1MG
3
$117.69
0.04%
0
$0.00
0.00%
Page 59 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
38245065210
4
49884006101
49884006201
49884006401
$32.20
0.05%
4
$95.24
0.05%
8
$176.97
0.10%
19
$1,063.31
0.23%
49884006405
6
$298.74
49884007601
10
49884007605
6
49884022301
49884022410
HALOPERIDOL TAB 1MG
49884022501
HALOPERIDOL TAB 2MG
49884055001
51079013020
51079051920
$0.00
0.00%
5
$44.07
0.06%
11
$295.78
0.14%
13
$406.67
0.16%
0.07%
3
$142.72
0.04%
$185.43
0.12%
6
$207.21
0.07%
$176.67
0.07%
9
$341.93
0.11%
7
$33.95
0.09%
0
$0.00
0.00%
5
$27.05
0.06%
0
$0.00
0.00%
1
$4.64
0.01%
0
$0.00
0.00%
20
$475.71
0.24%
0
$0.00
0.00%
0
$0.00
0.00%
1
$17.76
0.01%
0
$0.00
0.00%
1
$5.62
0.01%
51079054220
0
$0.00
0.00%
2
$8.24
0.02%
51079058720
THIOTHIXENE CAP 2MG
1
$12.28
0.01%
3
$25.68
0.04%
51079090020
LOXAPINE
0
$0.00
0.00%
1
$18.25
0.01%
51285052102
PROCHLORPER TAB 5MG
2
$8.92
0.02%
3
$27.35
0.04%
51285052202
10
$278.99
0.12%
8
$172.23
0.10%
51991019601
PROCHLORPER TAB 5MG
0
$0.00
0.00%
3
$18.55
0.04%
51991019701
0
$0.00
0.00%
14
$237.80
0.17%
52544036901
LOXAPINE
CAP 5MG
2
$47.20
0.02%
0
$0.00
0.00%
52544037001
LOXAPINE
CAP 10MG
19
$1,168.55
0.23%
6
$228.10
0.07%
52544037101
LOXAPINE
CAP 25MG
25
$1,410.85
0.30%
8
$387.11
0.10%
52544037201
LOXAPINE
CAP 50MG
20
$1,500.76
0.24%
7
$601.25
0.09%
52544049401
LOXITANE
CAP 5MG
1
$107.75
0.01%
0
$0.00
0.00%
52544049501
LOXITANE
CAP 10MG
8
$1,076.10
0.10%
3
$514.86
0.04%
52544049601
LOXITANE
CAP 25MG
1
$193.86
0.01%
0
$0.00
0.00%
CAP 5MG
0
Page 60 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
52544049701
LOXITANE
CAP 50MG
6
$736.96
0.07%
0
$0.00
0.00%
52544081301
LOXITANE
CAP 25MG
2
$109.00
0.02%
0
$0.00
0.00%
52544081534
LOXITANE-C CON 25MG/ML
2
$522.12
0.02%
0
$0.00
0.00%
53265024312
PROCHLORPER SUP 2.5MG
0
$0.00
0.00%
1
$5.30
0.01%
53265024412
PROCHLORPER SUP 5MG
1
$17.01
0.01%
9
$210.23
0.11%
53265024512
85
$3,002.66
1.03%
102
$2,958.28
1.25%
53489014801
5
$118.10
0.06%
4
$83.53
0.05%
53489014810
3
$18.70
0.04%
0
$0.00
0.00%
53489014901
15
$140.80
0.18%
39
$770.29
0.48%
53489014910
12
$136.60
0.15%
16
$288.10
0.20%
53489015001
18
$367.18
0.22%
31
$1,113.82
0.38%
53489015010
4
$320.93
0.05%
9
$190.47
0.11%
53489050001
8
$110.50
0.10%
26
$694.17
0.32%
55390014701
1
$65.88
0.01%
0
$0.00
0.00%
55390014710
7
$349.14
0.09%
7
$140.47
0.09%
55390041201
2
$32.80
0.02%
0
$0.00
0.00%
55390041205
3
$201.80
0.04%
2
$132.20
0.02%
55390041305
6
$799.10
0.07%
9
$1,199.65
0.11%
55390046505
41
$1,224.00
0.50%
66
$1,855.10
0.81%
59746011506
0
$0.00
0.00%
6
$96.98
0.07%
59930160301
3
$128.19
0.04%
0
$0.00
0.00%
59930160501
1
$22.71
0.01%
0
$0.00
0.00%
60505066402
9
$229.65
0.11%
11
$272.85
0.14%
60505070201
10
$1,598.90
0.12%
5
$678.08
0.06%
60505070301
20
$4,479.84
0.24%
33
$7,649.06
0.41%
62269027524
PROCHLORPER TAB 5MG
113
$1,197.84
1.37%
0
$0.00
0.00%
62269027624
108
$2,058.00
1.31%
8
$197.48
0.10%
Page 61 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
62269027824
8
62269027924
62269028024
62269028124
63323027205
$138.74
0.10%
17
$271.92
0.21%
1
$9.55
0.01%
0
$0.00
0.00%
2
$60.30
0.02%
0
$0.00
0.00%
2
$7.56
0.02%
0
$0.00
0.00%
36
$2,749.36
0.44%
8
$556.91
0.10%
63323046901
0
$0.00
0.00%
1
$24.34
0.01%
63323046905
0
$0.00
0.00%
1
$118.30
0.01%
63323047101
4
$179.68
0.05%
14
$1,235.28
0.17%
63323047105
4
$874.72
0.05%
4
$1,085.04
0.05%
63323047401
21
$796.78
0.26%
30
$946.23
0.37%
63481007270
MOBAN
TAB 5MG
37
$1,478.73
0.45%
13
$770.80
0.16%
63481007370
MOBAN
TAB 10MG
28
$4,135.92
0.34%
19
$3,055.92
0.23%
63481007470
MOBAN
TAB 25MG
12
$2,068.22
0.15%
9
$2,219.22
0.11%
63481007670
MOBAN
TAB 50MG
6
$623.32
0.07%
6
$457.65
0.07%
63481007770
MOBAN
TAB 100MG
4
$516.60
0.05%
0
$0.00
0.00%
66993080502
PROCHLORPER TAB 5MG
0
$0.00
0.00%
16
$138.70
0.20%
66993081002
0
$0.00
0.00%
129
$2,650.27
1.58%
ANTI-RETROVIRALS
00003196401
ZERIT
CAP 15MG
0
$0.00
0.00%
2
$560.18
0.08%
00003196501
ZERIT
CAP 20MG
10
$2,520.59
0.57%
12
$2,650.17
0.48%
00003196601
ZERIT
CAP 30MG
23
$6,851.45
1.32%
20
$6,181.81
0.79%
00003196701
ZERIT
CAP 40MG
200
$56,453.51
11.47%
153
$45,534.72
6.07%
00003196801
ZERIT
SOL 1MG/ML
10
$3,456.82
0.57%
6
$1,985.64
0.24%
00003362312
REYATAZ
CAP 100MG
0
$0.00
0.00%
2
$727.06
0.08%
00003362412
REYATAZ
CAP 150MG
0
$0.00
0.00%
33
$21,617.15
1.31%
00003363112
REYATAZ
CAP 200MG
0
$0.00
0.00%
20
$13,019.48
0.79%
Page 62 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANTI-RETROVIRALS
00004022101
HIVID
TAB 0.75MG
00004024515
INVIRASE
00004024648
FORTOVASE
00004038039
FUZEON
00006057143
CRIXIVAN
CAP 200MG
00006057354
CRIXIVAN
CAP 400MG
00006057362
CRIXIVAN
CAP 400MG
00006057465
CRIXIVAN
CAP 333MG
00054464721
VIRAMUNE
00054464725
VIRAMUNE
00056047330
SUSTIVA
CAP 100MG
00056047492
SUSTIVA
00056051030
CAP 200MG
2
$446.10
0.11%
2
$447.12
0.08%
8
$1,038.68
0.46%
10
$5,099.61
0.40%
16
$5,289.40
0.92%
16
$5,202.87
0.63%
0
$0.00
0.00%
21
$38,011.24
0.83%
4
$1,079.86
0.23%
3
$1,435.98
0.12%
8
$3,626.08
0.46%
8
$3,727.84
0.32%
24
$11,065.69
1.38%
30
$14,208.20
1.19%
2
$382.42
0.11%
3
$1,760.76
0.12%
TAB 200MG
8
$2,215.00
0.46%
0
$0.00
0.00%
TAB 200MG
1
$270.76
0.06%
0
$0.00
0.00%
2
$131.88
0.11%
2
$141.02
0.08%
CAP 200MG
136
$48,810.03
7.80%
105
$39,105.76
4.16%
SUSTIVA
TAB 600MG
33
$12,894.52
1.89%
182
$71,959.83
7.22%
00074194063
NORVIR
SOL 80MG/ML
4
$1,892.74
0.23%
5
$1,935.24
0.20%
00074395646
KALETRA
SOL
0
$0.00
0.00%
6
$3,687.28
0.24%
00074395977
KALETRA
CAP
154
$95,669.15
8.84%
224
$137,397.38
8.88%
00074663322
NORVIR
27
$6,101.43
1.55%
52
$14,054.52
2.06%
00087663341
VIDEX
4
$394.70
0.23%
3
$717.02
0.12%
00087665201
VIDEX BUFFER CHW 100MG
5
$1,001.99
0.29%
4
$785.26
0.16%
00087666515
VIDEX BUFFER CHW 200MG
1
$240.64
0.06%
1
$248.36
0.04%
00087667217
VIDEX EC
CAP 200MG
15
$3,917.34
0.86%
19
$3,922.86
0.75%
00087667317
VIDEX EC
CAP 250MG
15
$2,564.55
0.86%
40
$7,136.10
1.59%
00087667417
VIDEX EC
CAP 400MG
92
$22,315.67
5.28%
90
$22,594.61
3.57%
00173010855
RETROVIR
CAP 100MG
13
$3,391.51
0.75%
16
$3,645.69
0.63%
00173011318
RETROVIR
SYP 10MG/ML
0
$0.00
0.00%
1
$29.04
0.04%
00173047001
EPIVIR
TAB 150MG
223
$58,234.35
12.79%
284
$73,942.67
11.26%
00173047100
EPIVIR
SOL 10MG/ML
7
$1,340.22
0.40%
4
$599.96
0.16%
CAP 200MG
KIT
CAP 100MG SG
SOL 4GM
Page 63 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANTI-RETROVIRALS
00173050100
RETROVIR
TAB 300MG
00173059500
COMBIVIR
00173066100
ZIAGEN
TAB 300MG
00173066101
ZIAGEN
TAB 300MG
00173066200
4
$1,286.44
0.23%
10
$3,060.47
0.40%
158
$89,775.22
9.06%
243
$143,934.58
9.64%
7
$2,556.06
0.40%
9
$3,332.89
0.36%
104
$36,988.01
5.97%
141
$50,471.86
5.59%
EPIVIR HBV TAB 100MG
13
$1,825.27
0.75%
26
$4,221.26
1.03%
00173067200
AGENERASE
18
$6,740.13
1.03%
21
$7,281.54
0.83%
00173069100
TRIZIVIR
48
$45,162.99
2.75%
52
$46,312.48
2.06%
00173071400
EPIVIR
0
$0.00
0.00%
31
$8,227.85
1.23%
00597004601
VIRAMUNE
TAB 200MG
40
$11,823.47
2.29%
20
$6,518.07
0.79%
00597004660
VIRAMUNE
TAB 200MG
73
$22,762.18
4.19%
123
$43,030.20
4.88%
00597004661
VIRAMUNE
TAB 200MG
3
$957.99
0.17%
0
$0.00
0.00%
00597004724
VIRAMUNE
SUS 50MG/5ML
0
$0.00
0.00%
1
$79.68
0.04%
61958040101
VIREAD
123
$44,776.71
7.06%
336
$126,281.41
13.32%
61958060101
EMTRIVA
CAP 200MG
0
$0.00
0.00%
5
$1,321.55
0.20%
63010001030
VIRACEPT
TAB 250MG
99
$62,671.33
5.68%
106
$64,903.85
4.20%
63010002036
RESCRIPTOR TAB 100 MG
1
$268.57
0.06%
0
$0.00
0.00%
63010002118
RESCRIPTOR TAB 200MG
5
$1,370.85
0.29%
2
$1,095.08
0.08%
63304063728
GANCICLOVIR CAP 500MG
0
$0.00
0.00%
17
$21,657.52
0.67%
AER 10%
0
$0.00
0.00%
1
$37.30
0.51%
SHA 2%
TAB
CAP 150MG
TAB
TAB 300MG
TAB 300MG
ANTI-SEBORRHEICS
00064410050
OVACE
00072685004
CAPITROL
9
$192.76
4.86%
6
$98.77
3.08%
00074662030
SELSUN BLUE SHA 1%
1
$8.20
0.54%
0
$0.00
0.00%
00145098605
ZNP
2
$33.01
1.08%
0
$0.00
0.00%
00182608837
SELENIUM SUL SHA 2.5%
15
$128.03
8.11%
8
$78.49
4.10%
00472153304
41
$381.44
22.16%
12
$110.60
6.15%
00677055241
7
$51.01
3.78%
3
$23.96
1.54%
BAR
Page 64 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANTI-SEBORRHEICS
00904153320
0
$0.00
0.00%
8
$107.80
4.10%
45802004064
SELENIUM SUL LOT 2.5%
34
$310.11
18.38%
84
$921.63
43.08%
60432052804
76
$647.16
41.08%
73
$723.40
37.44%
ANTI-SPASMODICS
00007529020
URISPAS
TAB 100MG
1
$104.45
0.04%
0
$0.00
0.00%
00009454101
DETROL
TAB 1MG
4
$577.04
0.15%
0
$0.00
0.00%
00009454102
DETROL
TAB 1MG
189
$13,876.93
7.19%
36
$2,008.87
1.80%
00009454103
DETROL
TAB 1MG
41
$3,555.99
1.56%
5
$259.14
0.25%
00009454401
DETROL
TAB 2MG
12
$866.18
0.46%
1
$97.63
0.05%
00009454402
DETROL
TAB 2MG
1,098
$85,861.85
41.78%
112
$7,096.96
5.61%
00009454403
DETROL
TAB 2MG
134
$10,562.73
5.10%
27
$1,191.97
1.35%
00115181101
FLAVOXATE
0
$0.00
0.00%
3
$155.31
0.15%
00182128901
OXYBUTYNIN TAB 5MG
13
$117.15
0.49%
19
$192.30
0.95%
00182128905
OXYBUTYNIN TAB 5MG
38
$445.49
1.45%
0
$0.00
0.00%
00182128989
OXYBUTYNIN TAB 5MG
0
$0.00
0.00%
4
$28.80
0.20%
00364041001
BETHANECHOL TAB 25MG
0
$0.00
0.00%
1
$49.55
0.05%
00536567201
OXYBUTYNIN TAB 5MG
3
$32.40
0.11%
0
$0.00
0.00%
00591077901
OXYBUTYNIN TAB 5MG
15
$119.45
0.57%
100
$1,016.88
5.01%
00591077905
OXYBUTYNIN TAB 5MG
20
$130.90
0.76%
92
$692.84
4.61%
00603149058
OXYBUTYNIN SYP 5MG/5ML
9
$240.35
0.34%
13
$353.83
0.65%
00603497521
OXYBUTYNIN TAB 5MG
23
$268.65
0.88%
39
$391.45
1.95%
00603497528
OXYBUTYNIN TAB 5MG
8
$85.00
0.30%
8
$82.90
0.40%
00603497532
OXYBUTYNIN TAB 5MG
22
$240.30
0.84%
16
$169.60
0.80%
00615351253
OXYBUTYNIN TAB 5MG
21
$161.87
0.80%
0
$0.00
0.00%
00615351263
OXYBUTYNIN TAB 5MG
95
$861.66
3.61%
0
$0.00
0.00%
00677175901
OXYBUTYNIN TAB 5MG
0
$0.00
0.00%
2
$18.60
0.10%
TAB 100MG
Page 65 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANTI-SPASMODICS
00677175905
OXYBUTYNIN TAB 5MG
00832003800
OXYBUTYNIN TAB 5MG
00832003810
OXYBUTYNIN TAB 5MG
00904282180
OXYBUTYNIN TAB 5MG
17314920001
DITROPAN
17314920104
DITROPAN
17314922001
URISPAS
TAB 100MG
17314922002
URISPAS
TAB 100MG
38779038406
OXYBUTININ POW CHLORIDE
50111045601
50111045602
$43.60
0.30%
0
$0.00
0.00%
6
$38.80
0.30%
0.11%
0
$0.00
0.00%
$465.99
0.27%
1
$54.54
0.05%
11
$500.28
0.42%
2
$88.69
0.10%
44
$4,324.53
1.67%
62
$6,644.45
3.10%
6
$521.22
0.23%
0
$0.00
0.00%
5
$115.30
0.19%
1
$18.69
0.05%
OXYBUTYNIN TAB 5MG
350
$4,064.59
13.32%
666
$6,670.78
33.35%
OXYBUTYNIN TAB 5MG
57
$637.65
2.17%
145
$1,358.57
7.26%
50111045603
OXYBUTYNIN TAB 5MG
192
$2,044.55
7.31%
488
$4,923.98
24.44%
51991013501
HYOSPAZ
TAB 0.15MG
0
$0.00
0.00%
2
$10.94
0.10%
52544077901
OXYBUTYNIN TAB 5MG
60
$744.79
2.28%
14
$126.00
0.70%
52544077905
OXYBUTYNIN TAB 5MG
46
$296.97
1.75%
1
$33.25
0.05%
52544092008
OXYTROL
0
$0.00
0.00%
46
$3,182.81
2.30%
60258007116
15
$456.57
0.57%
3
$56.05
0.15%
60432009216
32
$803.96
1.22%
33
$914.61
1.65%
60505600809
23
$597.99
0.88%
41
$1,317.34
2.05%
61451222501
CYSTOSPAZ
2
$45.56
0.08%
0
$0.00
0.00%
63304099401
BETHANECHOL TAB 10MG
0
$0.00
0.00%
1
$70.71
0.05%
66993040202
HYOSCYAMINE TAB 0.15MG
0
$0.00
0.00%
1
$9.29
0.05%
TAB 5MG
SYP 5MG/5ML
DIS 3.9MG/24
TAB 0.15MG
10
$89.40
0.38%
6
4
$40.54
0.15%
15
$131.65
0.57%
3
$32.15
7
ANTI-SPASMODICS - LONG ACTING
00009519001
DETROL LA
CAP 2MG
184
$14,024.77
4.68%
454
$36,231.89
8.24%
00009519002
DETROL LA
CAP 2MG
42
$3,050.22
1.07%
340
$26,018.37
6.17%
00009519004
DETROL LA
CAP 2MG
6
$474.54
0.15%
1
$27.21
0.02%
Page 66 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANTI-SPASMODICS - LONG ACTING
00009519101
DETROL LA
CAP 4MG
1,355
$106,764.76
34.49%
2,742
$228,227.58
49.79%
00009519102
DETROL LA
CAP 4MG
408
$32,737.40
10.38%
1,060
$87,870.28
19.25%
00009519103
DETROL LA
CAP 4MG
0
$0.00
0.00%
8
$659.36
0.15%
00009519104
DETROL LA
CAP 4MG
10
$777.20
0.25%
2
$158.41
0.04%
17314850001
DITROPAN XL TAB 5MG
650
$44,799.84
16.54%
240
$16,962.00
4.36%
17314850101
DITROPAN XL TAB 10MG
1,007
$84,585.52
25.63%
436
$36,605.34
7.92%
17314850201
DITROPAN XL TAB 15MG
267
$23,857.61
6.80%
224
$20,446.61
4.07%
ANTI-THYROID THERAPIES
00005460923
PROPYLTHIOUR TAB 50MG
4
$90.61
1.07%
1
$2.39
0.22%
00143148001
70
$1,107.84
18.72%
50
$943.67
11.01%
00143148010
17
$174.35
4.55%
25
$152.02
5.51%
00185020501
METHIMAZOLE TAB 5MG
56
$1,523.30
14.97%
40
$508.25
8.81%
00185020510
METHIMAZOLE TAB 5MG
4
$104.34
1.07%
1
$23.35
0.22%
00185021001
METHIMAZOLE TAB 10MG
34
$1,913.69
9.09%
47
$1,104.95
10.35%
00185021010
2
$124.52
0.53%
0
$0.00
0.00%
00228234810
52
$1,047.77
13.90%
112
$2,087.29
24.67%
49884064001
METHIMAZOLE TAB 5MG
47
$923.59
12.57%
112
$1,430.45
24.67%
49884064074
METHIMAZOLE TAB 5MG
2
$16.53
0.53%
4
$17.40
0.88%
49884064101
35
$1,844.82
9.36%
49
$1,177.45
10.79%
49884064174
5
$114.89
1.34%
8
$201.70
1.76%
52604109401
TAPAZOLE
TAB 5MG
26
$417.17
6.95%
1
$14.77
0.22%
52604109501
TAPAZOLE
TAB 10MG
20
$781.26
5.35%
4
$128.64
0.88%
ANTI-VIRALS
00067602415
DENAVIR
CRE 1%
0
$0.00
0.00%
188
$4,674.92
26.40%
00078036964
DENAVIR
CRE 1%
346
$8,460.87
49.86%
158
$4,123.60
22.19%
Page 67 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANTI-VIRALS
00135031551
DENAVIR
CRE 1%
6
00135031552
DENAVIR
CRE 1%
30
00173099341
ZOVIRAX
OIN 5%
87
00173099394
ZOVIRAX
OIN 5%
218
64455099394
ZOVIRAX
OIN 5%
64455099442
ZOVIRAX
64455099445
ZOVIRAX
$125.73
0.86%
0
$0.00
0.00%
$710.72
4.32%
$2,515.96
12.54%
10
$217.24
1.40%
57
$1,602.39
8.01%
$16,706.42
31.41%
93
$7,564.34
13.06%
7
$441.62
1.01%
177
$13,813.25
24.86%
CRE 5%
CRE 5%
0
$0.00
0.00%
20
$928.86
2.81%
0
$0.00
0.00%
9
$766.02
1.26%
ANTIARRHYTHMICS
00008418804
CORDARONE
TAB 200MG
8
$947.85
0.85%
13
$1,262.80
1.21%
00025273231
NORPACE
CAP 100MG CR
4
$292.27
0.43%
10
$874.19
0.93%
00025274231
NORPACE
CAP 150MG CR
27
$2,972.78
2.87%
9
$756.39
0.84%
00025275231
NORPACE
CAP 100MG
4
$290.44
0.43%
1
$13.50
0.09%
00025276231
NORPACE
CAP 150MG
1
$91.25
0.11%
1
$32.52
0.09%
00031664963
QUINIDEX EXT TAB 300MG CR
0
$0.00
0.00%
2
$181.21
0.19%
00044502202
RYTHMOL
9
$1,139.84
0.96%
6
$1,306.86
0.56%
00054261625
MEXILETINE CAP 150MG
4
$203.40
0.43%
5
$418.38
0.47%
00054261725
12
$967.45
1.28%
0
$0.00
0.00%
00069582060
TIKOSYN
CAP 500MCG
0
$0.00
0.00%
4
$275.76
0.37%
00074162814
RYTHMOL
TAB 150MG
0
$0.00
0.00%
35
$6,750.15
3.26%
00074173214
RYTHMOL
TAB 225MG
0
$0.00
0.00%
8
$1,658.63
0.74%
00089030510
TAMBOCOR
TAB 50MG
17
$2,185.85
1.81%
27
$3,518.15
2.51%
00089030710
TAMBOCOR
TAB 100MG
17
$2,558.04
1.81%
65
$10,501.82
6.05%
00089031410
TAMBOCOR
TAB 150MG
0
$0.00
0.00%
9
$2,129.42
0.84%
00093312901
DISOPYRAMIDE CAP 150MG
2
$70.30
0.21%
0
$0.00
0.00%
00093873901
7
$580.15
0.74%
7
$571.95
0.65%
00093874001
2
$119.70
0.21%
7
$420.45
0.65%
TAB 150MG
Page 68 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANTIARRHYTHMICS
00093911401
PROCAINAMIDE TAB 750MG ER
00093911701
PROCAINAMIDE TAB 1000 ER
0
$0.00
0.00%
00093913306
AMIODARONE TAB 200MG
138
$5,724.92
14.68%
00093913352
10
$399.50
1.06%
00093917501
QUINIDINE SU TAB 300MG ER
4
$53.17
00093917552
3
00093918801
PROCAINAMIDE TAB 500MG CR
2
00172234560
PROCAINAMIDE CAP 250MG
00172234760
PROCAINAMIDE CAP 500MG
00185014405
10
$425.90
00185014460
162
$8,192.30
00185434610
QUINIDINE SU TAB 200MG
3
$136.07
00245014530
PACERONE
TAB 400MG
2
00245014715
PACERONE
TAB 200MG
00245014760
PACERONE
TAB 200MG
00364022901
00364058201
$0.00
0.00%
2
$186.12
0.19%
89
$1,597.26
8.29%
8
$229.40
0.74%
0.43%
1
$16.13
0.09%
$217.89
0.32%
3
$64.47
0.28%
$159.78
0.21%
0
$0.00
0.00%
1
$9.18
0.11%
2
$103.70
0.19%
0
$0.00
0.00%
4
$337.41
0.37%
1.06%
69
$1,538.49
6.42%
17.23%
205
$5,042.50
19.09%
0.32%
0
$0.00
0.00%
$369.32
0.21%
0
$0.00
0.00%
2
$74.70
0.21%
0
$0.00
0.00%
62
$3,947.72
6.60%
16
$376.50
1.49%
4
$81.32
0.43%
0
$0.00
0.00%
3
$70.62
0.32%
0
$0.00
0.00%
00364060401
QUINIDINE GL TAB 324MG ER
3
$99.56
0.32%
0
$0.00
0.00%
00364060404
1
$130.32
0.11%
0
$0.00
0.00%
00364060405
3
$121.35
0.32%
1
$24.49
0.09%
00364073901
0
$0.00
0.00%
3
$143.70
0.28%
00378850501
FLECAINIDE TAB 50MG
6
$643.70
0.64%
5
$138.15
0.47%
00378851001
FLECAINIDE TAB 100MG
29
$4,932.99
3.09%
5
$274.57
0.47%
00378851501
4
$789.32
0.43%
0
$0.00
0.00%
00555091704
1
$217.35
0.11%
0
$0.00
0.00%
00555091709
0
$0.00
0.00%
6
$147.90
0.56%
00591058201
PROPAFENONE TAB 150MG
9
$1,091.20
0.96%
3
$306.42
0.28%
1
$81.11
0.11%
0
Page 69 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANTIARRHYTHMICS
00591058301
1
00591543801
00591545401
00591553801
$176.54
0.11%
0
$0.00
0.00%
3
$60.10
0.32%
10
$274.21
0.93%
5
$172.28
0.53%
3
$103.50
0.28%
QUINIDINE GL TAB 324MG SA
10
$513.71
1.06%
6
$142.84
0.56%
00591553805
3
$247.05
0.32%
0
$0.00
0.00%
00591553825
19
$436.30
2.02%
0
$0.00
0.00%
00591556001
12
$629.05
1.28%
15
$755.40
1.40%
00591556101
9
$582.36
0.96%
24
$2,212.22
2.23%
00597006601
MEXITIL
3
$289.38
0.32%
0
$0.00
0.00%
00677012201
1
$36.31
0.11%
0
$0.00
0.00%
00677067501
QUINIDINE GL TAB 324MG CR
3
$114.12
0.32%
3
$83.55
0.28%
00677067503
0
$0.00
0.00%
15
$422.65
1.40%
00677067505
4
$113.40
0.43%
7
$128.05
0.65%
00781120305
35
$1,525.00
3.72%
95
$1,776.59
8.85%
00781120360
38
$1,653.97
4.04%
66
$945.72
6.15%
00904220240
3
$98.97
0.32%
0
$0.00
0.00%
49884045802
57
$2,932.55
6.06%
40
$879.50
3.72%
49884045805
0
$0.00
0.00%
7
$126.04
0.65%
49884069401
FLECAINIDE TAB 50MG
1
$48.78
0.11%
0
$0.00
0.00%
49884069501
3
$433.66
0.32%
3
$92.75
0.28%
49884069601
0
$0.00
0.00%
1
$197.02
0.09%
51672402504
54
$3,036.50
5.74%
54
$1,490.70
5.03%
53489014101
24
$1,011.56
2.55%
34
$1,761.61
3.17%
53489014103
0
$0.00
0.00%
2
$143.20
0.19%
53489014105
0
$0.00
0.00%
4
$172.69
0.37%
53489055101
6
$699.87
0.64%
1
$128.93
0.09%
58177000204
DISOPYRAMIDE CAP 150MG ER
27
$2,729.70
2.87%
35
$1,897.41
3.26%
CAP 150MG
Page 70 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANTIARRHYTHMICS
58177033104
6
$846.75
0.64%
2
$155.07
0.19%
58177033204
6
$874.80
0.64%
1
$147.49
0.09%
59911589501
6
$161.85
0.64%
0
$0.00
0.00%
61570006960
PROCANBID TAB 500MG CR
11
$1,103.37
1.17%
8
$831.93
0.74%
61570007101
PROCANBID TAB 1000 MG
0
$0.00
0.00%
4
$748.82
0.37%
61570007160
13
$1,533.85
1.38%
1
$90.57
0.09%
61570007170
0
$0.00
0.00%
2
$197.68
0.19%
ANTIASTHMATIC - ANTI-CHOLINERGICS
00054840211
IPRATROPIUM SOL INHAL
206
$12,878.13
6.07%
39
$1,241.82
0.91%
00054840213
11
$749.06
0.32%
0
$0.00
0.00%
00054840221
1
$1.00
0.03%
0
$0.00
0.00%
00172640744
143
$7,502.67
4.21%
415
$15,061.98
9.69%
00172640749
124
$7,778.26
3.65%
53
$1,936.15
1.24%
00472075123
268
$9,094.25
7.89%
547
$12,339.42
12.78%
00472075130
6
$277.98
0.18%
3
$45.53
0.07%
00472075160
41
$1,379.88
1.21%
88
$3,487.92
2.06%
00472075360
0
$0.00
0.00%
3
$152.93
0.07%
00487980101
3
$163.48
0.09%
0
$0.00
0.00%
00487980130
0
$0.00
0.00%
12
$562.48
0.28%
00487980160
0
$0.00
0.00%
11
$397.96
0.26%
00597008062
ATROVENT
2
$69.18
0.06%
0
$0.00
0.00%
00597008214
ATROVENT INH AER 18MCG/AC
1,715
$86,241.92
50.50%
1,678
$95,955.76
39.20%
00597008218
ATROVENT REF AER 18MCG/AC
6
$216.30
0.18%
0
$0.00
0.00%
49502068503
720
$29,312.49
21.20%
1,055
$23,823.86
24.64%
49502068533
35
$1,864.05
1.03%
4
$75.47
0.09%
49502068560
107
$7,131.92
3.15%
167
$7,330.81
3.90%
SOL INHAL
Page 71 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANTIASTHMATIC - ANTI-CHOLINERGICS
60505080601
3
$63.27
0.09%
16
$445.53
0.37%
65271000125
5
$378.29
0.15%
36
$1,402.31
0.84%
65271000160
0
$0.00
0.00%
16
$573.81
0.37%
66794000225
0
$0.00
0.00%
125
$4,638.00
2.92%
66794000260
0
$0.00
0.00%
13
$963.70
0.30%
ANTIBIOTIC TOPICALS
00029152544
BACTROBAN
OIN 2%
537
$23,407.70
37.24%
602
$27,136.78
36.68%
00029152722
BACTROBAN
CRE 2%
424
$14,378.12
29.40%
381
$12,980.63
23.22%
00029152725
BACTROBAN
CRE 2%
350
$17,118.56
24.27%
439
$22,721.77
26.75%
00062161001
CENTANY
OIN 2%
0
$0.00
0.00%
9
$231.16
0.55%
00062161003
CENTANY
OIN 2%
0
$0.00
0.00%
3
$149.92
0.18%
00093101042
MUPIROCIN OIN 2%
0
$0.00
0.00%
51
$1,954.47
3.11%
00168001131
BACITR ZINC OIN 500U/GM
0
$0.00
0.00%
5
$24.26
0.30%
00168001231
BAC/NEO/POLY OIN
1
$2.25
0.07%
6
$44.58
0.37%
00168007115
GENTAMICIN CRE 0.1%
14
$77.43
0.97%
26
$101.10
1.58%
00168007815
GENTAMICIN OIN 0.1%
32
$220.43
2.22%
26
$156.95
1.58%
00182020830
BACITRACIN OIN 500U/GM
1
$6.40
0.07%
0
$0.00
0.00%
00182020833
0
$0.00
0.00%
2
$8.11
0.12%
00182512234
TRIPLE ANTIB OIN
0
$0.00
0.00%
1
$5.84
0.06%
00472017934
TRIPLE ANTIB OIN
0
$0.00
0.00%
1
$2.99
0.06%
00472017956
TRIPLE ANTIB OIN
3
$8.97
0.21%
10
$85.13
0.61%
00536110095
TRIPLE ANTIB OIN
1
$5.98
0.07%
1
$7.66
0.06%
00603044150
3
$11.75
0.21%
2
$12.96
0.12%
00677070330
1
$5.66
0.07%
0
$0.00
0.00%
00677075237
TRIPLE ANTIB OIN
3
$17.64
0.21%
1
$5.25
0.06%
00713028031
3
$13.23
0.21%
1
$1.08
0.06%
Page 72 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANTIBIOTIC TOPICALS
00781701424
1
24385006103
TRIPLE ANTIB OIN
37205027310
TRIPLE ANTIB OIN
37205027510
45802004611
$5.05
0.07%
0
$0.00
0.00%
9
$42.90
0.62%
13
$63.34
0.90%
GENTAMICIN OIN 0.1%
3
$22.83
45802004635
GENTAMICIN OIN 0.1%
7
45802005611
GENTAMICIN CRE 0.1%
4
45802005635
GENTAMICIN CRE 0.1%
45802006001
0
$0.00
0.00%
1
$7.65
0.06%
18
$83.91
1.10%
18
$92.13
1.10%
0.21%
1
$5.98
0.06%
$38.72
0.49%
7
$37.05
0.43%
$31.98
0.28%
0
$0.00
0.00%
19
$109.25
1.32%
9
$35.65
0.55%
0
$0.00
0.00%
1
$1.72
0.06%
45802006003
0
$0.00
0.00%
1
$5.49
0.06%
45802006010
1
$4.54
0.07%
0
$0.00
0.00%
45802006070
0
$0.00
0.00%
1
$3.84
0.06%
45802011222
MUPIROCIN OIN 2%
0
$0.00
0.00%
2
$78.50
0.12%
49158019168
GENTAMICIN OIN 0.1%
1
$7.16
0.07%
0
$0.00
0.00%
49348002972
SM TRIPLE
OIN ANTIBIOT
0
$0.00
0.00%
1
$6.54
0.06%
50428219634
0
$0.00
0.00%
1
$3.99
0.06%
51672201602
TRPL ANTIBIO OIN
0
$0.00
0.00%
1
$6.18
0.06%
55045142206
0
$0.00
0.00%
1
$5.29
0.06%
59390002617
1
$2.59
0.07%
0
$0.00
0.00%
61570003150
CORTISPORIN OIN
8
$354.72
0.55%
11
$526.21
0.67%
61570003275
CORTISPORIN CRE
2
$65.18
0.14%
0
$0.00
0.00%
ANTICOAGULANTS
00009026801
HEPARIN SOD INJ 1000U/ML
6
$108.45
0.06%
0
$0.00
0.00%
00009026802
0
$0.00
0.00%
2
$56.82
0.02%
00013240691
FRAGMIN
INJ 2500/0.2
1
$144.73
0.01%
2
$151.42
0.02%
00013242601
FRAGMIN
INJ 7500/0.3
0
$0.00
0.00%
1
$2,065.36
0.01%
Page 73 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANTICOAGULANTS
00013242691
FRAGMIN
INJ 5000/0.2
15
$6,230.22
0.14%
59
$49,123.78
0.45%
00013243606
FRAGMIN
INJ 10000/ML
47
$30,955.54
0.44%
31
$14,821.03
0.24%
00013519001
FRAGMIN
INJ 10000/ML
1
$278.63
0.01%
3
$2,233.98
0.02%
00056016870
COUMADIN
TAB 4MG
39
$820.50
0.37%
31
$928.21
0.24%
00056016875
COUMADIN
TAB 4MG
201
$1,829.76
1.88%
33
$419.57
0.25%
00056016890
COUMADIN
TAB 4MG
4
$54.08
0.04%
5
$122.95
0.04%
00056016970
COUMADIN
TAB 1MG
106
$3,549.32
0.99%
93
$3,351.94
0.71%
00056016975
COUMADIN
TAB 1MG
289
$1,863.15
2.71%
60
$472.25
0.46%
00056016990
COUMADIN
TAB 1MG
5
$87.41
0.05%
2
$10.62
0.02%
00056017070
COUMADIN
TAB 2MG
102
$2,918.55
0.96%
63
$1,923.75
0.48%
00056017075
COUMADIN
TAB 2MG
259
$2,278.00
2.43%
33
$385.30
0.25%
00056017090
COUMADIN
TAB 2MG
3
$29.12
0.03%
6
$68.90
0.05%
00056017270
COUMADIN
TAB 5MG
188
$5,881.65
1.76%
145
$5,021.04
1.10%
00056017275
COUMADIN
TAB 5MG
251
$2,109.99
2.35%
46
$516.35
0.35%
00056017290
COUMADIN
TAB 5MG
42
$1,307.38
0.39%
19
$848.67
0.14%
00056017370
COUMADIN
TAB 7.5MG
28
$694.39
0.26%
13
$382.55
0.10%
00056017375
COUMADIN
TAB 7.5MG
50
$759.58
0.47%
9
$128.00
0.07%
00056017470
COUMADIN
TAB 10MG
17
$655.66
0.16%
18
$630.44
0.14%
00056017475
COUMADIN
TAB 10MG
12
$273.69
0.11%
0
$0.00
0.00%
00056017670
COUMADIN
TAB 2.5MG
79
$2,379.68
0.74%
53
$1,788.43
0.40%
00056017675
COUMADIN
TAB 2.5MG
208
$1,742.70
1.95%
46
$666.02
0.35%
00056017690
COUMADIN
TAB 2.5MG
7
$52.33
0.07%
4
$82.29
0.03%
00056018870
COUMADIN
TAB 3MG
25
$740.15
0.23%
37
$917.65
0.28%
00056018875
COUMADIN
TAB 3MG
284
$2,413.30
2.66%
46
$656.97
0.35%
00056018890
COUMADIN
TAB 3MG
2
$9.74
0.02%
0
$0.00
0.00%
00056018970
COUMADIN
TAB 6MG
7
$211.83
0.07%
7
$189.83
0.05%
00056018975
COUMADIN
TAB 6MG
43
$897.87
0.40%
10
$139.53
0.08%
Page 74 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANTICOAGULANTS
00074115170
HEPARIN LOCK INJ 10U/ML
4
$53.78
0.04%
4
$53.22
0.03%
00074115178
9
$50.54
0.08%
1
$4.78
0.01%
00074115212
4
$51.75
0.04%
0
$0.00
0.00%
00074115270
33
$607.02
0.31%
17
$394.79
0.13%
00074115278
56
$249.05
0.53%
1
$14.33
0.01%
00074128101
2
$137.54
0.02%
0
$0.00
0.00%
00074128135
2
$8.92
0.02%
3
$14.49
0.02%
00074131613
HEPARIN SOD INJ 10000/ML
15
$253.16
0.14%
0
$0.00
0.00%
00074131614
0
$0.00
0.00%
2
$79.81
0.02%
00074140201
0
$0.00
0.00%
1
$12.59
0.01%
00074140231
0
$0.00
0.00%
6
$255.22
0.05%
00075062040
LOVENOX
INJ 40/0.4ML
62
$16,201.12
0.58%
81
$20,803.89
0.62%
00075062160
LOVENOX
INJ 60/0.6ML
30
$12,191.59
0.28%
39
$19,484.85
0.30%
00075062280
LOVENOX
INJ 80/0.8ML
45
$40,105.08
0.42%
41
$25,325.18
0.31%
00075062300
LOVENOX
INJ 100/1ML
40
$35,369.10
0.38%
64
$73,825.85
0.49%
00075062403
LOVENOX
INJ 30/0.3ML
0
$0.00
0.00%
1
$19.31
0.01%
00075062430
LOVENOX
INJ 30/0.3ML
53
$7,529.12
0.50%
39
$8,725.29
0.30%
00075062603
LOVENOX
INJ 300MG/3M
0
$0.00
0.00%
3
$532.98
0.02%
00075291201
LOVENOX
INJ 120/.8ML
4
$1,426.98
0.04%
17
$21,753.10
0.13%
00075291501
LOVENOX
INJ 150/1ML
6
$1,838.61
0.06%
8
$12,377.84
0.06%
00182267201
WARFARIN
TAB 2MG
12
$133.20
0.11%
0
$0.00
0.00%
00182267401
WARFARIN
TAB 3MG
1
$13.25
0.01%
0
$0.00
0.00%
00182267501
WARFARIN
TAB 4MG
2
$24.50
0.02%
0
$0.00
0.00%
00182267601
WARFARIN
TAB 5MG
6
$96.94
0.06%
0
$0.00
0.00%
00555083102
WARFARIN
TAB 1MG
625
$8,974.60
5.86%
833
$11,990.00
6.33%
00555083105
WARFARIN
TAB 1MG
173
$1,626.43
1.62%
524
$5,337.55
3.98%
00555083202
WARFARIN
TAB 2.5MG
382
$4,680.60
3.58%
691
$6,992.96
5.25%
Page 75 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANTICOAGULANTS
00555083205
WARFARIN
TAB 2.5MG
211
$1,786.04
1.98%
393
$3,711.39
2.99%
00555083302
WARFARIN
TAB 5MG
985
$15,196.34
9.24%
1,339
$18,657.84
10.18%
00555083305
WARFARIN
TAB 5MG
329
$3,476.55
3.08%
781
$8,642.45
5.94%
00555083402
WARFARIN
TAB 7.5MG
159
$2,432.62
1.49%
283
$3,282.37
2.15%
00555083502
WARFARIN
TAB 10MG
95
$2,163.07
0.89%
153
$2,512.18
1.16%
00555086902
WARFARIN
TAB 2MG
586
$7,994.66
5.49%
768
$9,009.84
5.84%
00555086905
WARFARIN
TAB 2MG
211
$1,956.12
1.98%
431
$4,266.08
3.28%
00555087402
WARFARIN
TAB 4MG
311
$2,638.13
2.92%
617
$5,743.35
4.69%
00555087405
WARFARIN
TAB 4MG
175
$1,665.70
1.64%
272
$2,500.32
2.07%
00555092502
WARFARIN SOD TAB 3MG
659
$6,672.16
6.18%
1,161
$10,957.24
8.82%
00555092602
WARFARIN SOD TAB 6MG
140
$2,104.41
1.31%
287
$3,589.29
2.18%
00641038725
HEP-LOCK
INJ 100U/ML
1
$6.16
0.01%
2
$33.20
0.02%
00641038925
HEP-LOCK
INJ 100U/ML
1
$13.78
0.01%
0
$0.00
0.00%
00641040025
28
$297.37
0.26%
27
$366.17
0.21%
00641041025
0
$0.00
0.00%
2
$92.27
0.02%
00641243641
HEP-LOCK
INJ 100U/ML
1
$4.00
0.01%
0
$0.00
0.00%
00641243645
HEP-LOCK
INJ 100U/ML
1
$4.98
0.01%
0
$0.00
0.00%
00641243841
HEP-LOCK
INJ 10U/ML
4
$15.30
0.04%
1
$3.95
0.01%
00641243845
HEP-LOCK
INJ 10U/ML
1
$17.30
0.01%
1
$21.02
0.01%
00641244045
1
$6.33
0.01%
1
$12.81
0.01%
00641244241
HEP-LOCK
INJ 10U/ML
12
$102.10
0.11%
6
$51.60
0.05%
00641244341
HEP-LOCK
INJ 100U/ML
6
$33.68
0.06%
22
$158.48
0.17%
00641246045
3
$25.23
0.03%
1
$7.19
0.01%
00641247045
2
$47.06
0.02%
1
$120.21
0.01%
00781035207
WARFARIN
TAB 1MG
186
$4,252.11
1.74%
66
$1,236.29
0.50%
00781036307
WARFARIN
TAB 2MG
149
$3,137.84
1.40%
86
$1,662.05
0.65%
00781036407
WARFARIN
TAB 2.5MG
118
$2,254.42
1.11%
65
$1,090.85
0.49%
Page 76 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANTICOAGULANTS
00781036607
WARFARIN
TAB 3MG
0
$0.00
0.00%
00781036907
WARFARIN
TAB 4MG
103
$1,512.32
0.97%
00781037707
WARFARIN
TAB 5MG
456
$8,165.71
4.28%
00781038107
WARFARIN
TAB 6MG
0
$0.00
0.00%
00781038607
WARFARIN
TAB 7.5MG
15
$511.27
00781038707
WARFARIN
TAB 10MG
8
08290036003
4
08290036005
08290039003
$443.71
0.24%
61
$769.29
0.46%
131
$2,427.46
1.00%
1
$17.49
0.01%
0.14%
19
$362.65
0.14%
$488.92
0.08%
24
$438.00
0.18%
$243.33
0.04%
0
$0.00
0.00%
3
$176.51
0.03%
47
$4,087.89
0.36%
2
$29.36
0.02%
2
$11.30
0.02%
08290039005
66
$3,397.56
0.62%
326
$18,150.90
2.48%
50862036001
HEP SOD/NACL INJ 10U/ML
6
$520.71
0.06%
0
$0.00
0.00%
50862039001
59
$2,420.05
0.55%
0
$0.00
0.00%
51672402701
WARFARIN
TAB 1MG
230
$4,099.50
2.16%
387
$7,130.07
2.94%
51672402703
WARFARIN
TAB 1MG
6
$79.20
0.06%
5
$55.75
0.04%
51672402801
WARFARIN
TAB 2MG
264
$3,880.08
2.48%
387
$5,745.93
2.94%
51672402803
WARFARIN
TAB 2MG
7
$160.15
0.07%
0
$0.00
0.00%
51672402901
WARFARIN
TAB 2.5MG
173
$2,606.25
1.62%
140
$2,476.74
1.06%
51672402903
WARFARIN
TAB 2.5MG
8
$89.05
0.08%
8
$124.60
0.06%
51672403001
WARFARIN
TAB 3MG
154
$2,000.81
1.44%
249
$2,692.54
1.89%
51672403003
WARFARIN
TAB 3MG
0
$0.00
0.00%
1
$10.75
0.01%
51672403101
WARFARIN
TAB 4MG
121
$1,459.25
1.13%
231
$2,508.39
1.76%
51672403201
WARFARIN
TAB 5MG
191
$2,644.70
1.79%
677
$11,669.69
5.15%
51672403203
WARFARIN
TAB 5MG
207
$3,364.98
1.94%
74
$1,092.88
0.56%
51672403301
WARFARIN
TAB 6MG
14
$333.01
0.13%
18
$301.44
0.14%
51672403401
WARFARIN
TAB 7.5MG
14
$256.49
0.13%
35
$549.60
0.27%
51672403501
WARFARIN
TAB 10MG
14
$337.30
0.13%
20
$536.50
0.15%
53303001101
CARRINGTON SOL
2
$51.22
0.02%
0
$0.00
0.00%
32
Page 77 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANTICOAGULANTS
59772035207
WARFARIN
TAB 1MG
23
$302.16
0.22%
4
$96.40
0.03%
59772036307
WARFARIN
TAB 2MG
16
$392.10
0.15%
7
$161.05
0.05%
59772036407
WARFARIN
TAB 2.5MG
10
$198.25
0.09%
0
$0.00
0.00%
59772036907
WARFARIN
TAB 4MG
15
$227.01
0.14%
1
$10.75
0.01%
59772037707
WARFARIN
TAB 5MG
46
$924.44
0.43%
10
$134.85
0.08%
59772038607
WARFARIN
TAB 7.5MG
2
$51.48
0.02%
0
$0.00
0.00%
59772038707
WARFARIN
TAB 10MG
12
$432.39
0.11%
0
$0.00
0.00%
63323004710
9
$140.96
0.08%
0
$0.00
0.00%
63323026201
30
$778.95
0.28%
37
$1,107.49
0.28%
63323054001
1
$25.80
0.01%
0
$0.00
0.00%
63323054201
0
$0.00
0.00%
11
$421.59
0.08%
63323054505
0
$0.00
0.00%
6
$77.65
0.05%
63323091501
1
$1.00
0.01%
3
$336.46
0.02%
64054100302
0
$0.00
0.00%
1
$10.00
0.01%
64253022223
0
$0.00
0.00%
24
$581.82
0.18%
64253022233
12
$627.01
0.11%
21
$300.58
0.16%
64253022235
14
$521.80
0.13%
7
$243.30
0.05%
64253033333
2
$519.83
0.02%
53
$2,240.21
0.40%
64253033335
83
$5,393.02
0.78%
75
$2,685.68
0.57%
66203230001
ARIXTRA
0
$0.00
0.00%
2
$1,136.35
0.02%
SOL 2.5MG/.5
ANTIHYPERTENSIVE COMBOS
00378071101
METHYLD/HCTZ TAB 250/25
4
$133.23
36.36%
0
$0.00
0.00%
62794000101
CLORPRES
TAB 0.1-15MG
5
$129.22
45.45%
1
$27.01
100.00%
62794002701
CLORPRES
TAB 0.2-15MG
2
$70.38
18.18%
0
$0.00
0.00%
ANTILEPROTIC
Page 78 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ANTILEPROTIC
59572010511
THALOMID
CAP 50MG
59572010592
THALOMID
CAP 50MG
59572010593
THALOMID
CAP 50MG
59572020514
THALOMID
CAP 50MG
59572020594
THALOMID
59572021015
59572021095
0
$0.00
0.00%
1
$401.05
3.03%
6
$4,369.62
35.29%
11
$17,149.71
64.71%
1
$797.77
3.03%
3
$1,762.82
9.09%
0
$0.00
0.00%
2
$4,814.98
6.06%
CAP 50MG
0
$0.00
0.00%
21
$24,612.67
63.64%
THALOMID
CAP 100MG
THALOMID
CAP 100MG
0
$0.00
0.00%
1
$2,005.33
3.03%
0
$0.00
0.00%
4
$2,607.60
12.12%
ANTIPARKINSONIAN - ANTI-CHOLINERGICS
00006327516
COGENTIN
INJ 1MG/ML
3
$53.17
0.07%
1
$3.80
0.02%
00006327538
COGENTIN
INJ 1MG/ML
1
$10.50
0.02%
0
$0.00
0.00%
00121065816
TRIHEXYPHEN ELX 0.4MG/ML
12
$164.88
0.28%
7
$137.55
0.16%
00143176301
TRIHEXYPHEN TAB 5MG
13
$274.45
0.30%
15
$291.39
0.35%
00143176310
TRIHEXYPHEN TAB 5MG
0
$0.00
0.00%
7
$69.53
0.16%
00143176401
TRIHEXYPHEN TAB 2MG
32
$224.16
0.75%
39
$426.42
0.91%
00143176410
TRIHEXYPHEN TAB 2MG
63
$633.14
1.48%
75
$769.13
1.75%
00182129989
BENZTROPINE TAB 0.5MG
0
$0.00
0.00%
2
$3.55
0.05%
00182170001
BENZTROPINE TAB 1MG
1
$7.17
0.02%
0
$0.00
0.00%
00182170089
BENZTROPINE TAB 1MG
1
$2.88
0.02%
3
$8.64
0.07%
00182170189
BENZTROPINE TAB 2MG
6
$55.42
0.14%
6
$50.16
0.14%
00364040801
TRIHEXYPHEN TAB 2MG
78
$758.90
1.83%
39
$369.83
0.91%
00364040802
TRIHEXYPHEN TAB 2MG
4
$16.96
0.09%
2
$8.48
0.05%
00364040901
TRIHEXYPHEN TAB 5MG
26
$429.35
0.61%
4
$58.48
0.09%
00364040902
TRIHEXYPHEN TAB 5MG
30
$314.00
0.70%
6
$65.82
0.14%
00364040990
TRIHEXYPHEN TAB 5MG
6
$132.60
0.14%
6
$132.60
0.14%
00364083401
1
$4.20
0.02%
0
$0.00
0.00%
00591533501
TRIHEXYPHEN TAB 2MG
255
$2,746.31
5.97%
251
$2,487.27
5.86%
Page 79 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00591533510
TRIHEXYPHEN TAB 2MG
242
$2,685.10
5.67%
317
$3,118.39
7.40%
00591533701
TRIHEXYPHEN TAB 5MG
242
$2,274.45
5.67%
214
$2,183.92
5.00%
00591533710
TRIHEXYPHEN TAB 5MG
20
$350.70
0.47%
20
$280.50
0.47%
00603243121
BENZTROPINE TAB 1MG
2
$9.05
0.05%
0
$0.00
0.00%
00603624021
TRIHEXYPHEN TAB 2MG
3
$20.04
0.07%
24
$198.77
0.56%
00603624032
TRIHEXYPHEN TAB 2MG
10
$105.53
0.23%
0
$0.00
0.00%
00603624121
TRIHEXYPHEN TAB 5MG
2
$27.45
0.05%
5
$73.56
0.12%
00615067553
TRIHEXYPHEN TAB 2MG
62
$630.83
1.45%
0
$0.00
0.00%
00615067563
TRIHEXYPHEN TAB 2MG
32
$259.62
0.75%
0
$0.00
0.00%
00615254753
27
$147.75
0.63%
0
$0.00
0.00%
00615254763
83
$468.22
1.94%
0
$0.00
0.00%
00615254863
BENZTROPINE TAB 1MG
114
$679.64
2.67%
0
$0.00
0.00%
00615254953
BENZTROPINE TAB 2MG
23
$175.99
0.54%
0
$0.00
0.00%
00615254963
BENZTROPINE TAB 2MG
2
$11.24
0.05%
0
$0.00
0.00%
00677175101
TRIHEXYPHEN TAB 2MG
1
$6.68
0.02%
0
$0.00
0.00%
00832108000
9
$34.30
0.21%
58
$284.10
1.35%
00832108100
BENZTROPINE TAB 1MG
27
$123.63
0.63%
111
$453.03
2.59%
00832108110
BENZTROPINE TAB 1MG
28
$172.36
0.66%
109
$542.08
2.55%
00832108200
BENZTROPINE TAB 2MG
13
$42.89
0.30%
30
$306.56
0.70%
00832108210
BENZTROPINE TAB 2MG
4
$27.14
0.09%
3
$16.95
0.07%
00904105560
0
$0.00
0.00%
32
$145.47
0.75%
00904105561
0
$0.00
0.00%
1
$2.70
0.02%
00904105660
BENZTROPINE TAB 1MG
6
$34.97
0.14%
7
$40.39
0.16%
00904105680
BENZTROPINE TAB 1MG
3
$12.87
0.07%
5
$30.85
0.12%
00904105760
BENZTROPINE TAB 2MG
0
$0.00
0.00%
6
$67.60
0.14%
00904105780
BENZTROPINE TAB 2MG
11
$82.53
0.26%
6
$92.10
0.14%
49884016401
354
$1,925.16
8.29%
418
$2,100.38
9.76%
Page 80 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
49884016501
BENZTROPINE TAB 1MG
283
$1,613.44
6.63%
348
$1,597.61
8.13%
49884016510
BENZTROPINE TAB 1MG
445
$2,511.26
10.42%
456
$2,482.24
10.65%
49884016601
BENZTROPINE TAB 2MG
126
$1,025.39
2.95%
121
$1,164.61
2.83%
49884016610
BENZTROPINE TAB 2MG
150
$1,150.29
3.51%
188
$1,851.31
4.39%
49884069301
AKINETON
82
$1,949.43
1.92%
70
$1,931.24
1.64%
50111039301
268
$1,462.88
6.27%
244
$1,030.05
5.70%
50111039401
BENZTROPINE TAB 1MG
538
$2,891.10
12.60%
578
$2,354.53
13.50%
50111039403
BENZTROPINE TAB 1MG
132
$765.67
3.09%
94
$529.95
2.20%
50111039501
BENZTROPINE TAB 2MG
186
$1,837.52
4.35%
168
$1,846.68
3.92%
50111039503
BENZTROPINE TAB 2MG
53
$458.19
1.24%
78
$684.14
1.82%
52544057501
TRIHEXYPHEN TAB 2MG
1
$11.00
0.02%
2
$17.00
0.05%
52544057601
TRIHEXYPHEN TAB 5MG
4
$69.40
0.09%
0
$0.00
0.00%
61570005901
KEMADRIN
6
$155.22
0.14%
13
$464.32
0.30%
62269020824
15
$78.80
0.35%
0
$0.00
0.00%
62269020924
BENZTROPINE TAB 1MG
25
$135.09
0.59%
0
$0.00
0.00%
62269020930
BENZTROPINE TAB 1MG
68
$354.06
1.59%
0
$0.00
0.00%
62269021024
BENZTROPINE TAB 2MG
13
$126.45
0.30%
0
$0.00
0.00%
62269021030
BENZTROPINE TAB 2MG
24
$165.04
0.56%
0
$0.00
0.00%
64980011101
0
$0.00
0.00%
3
$4.05
0.07%
64980011210
BENZTROPINE TAB 1MG
0
$0.00
0.00%
89
$438.14
2.08%
TAB 2MG
TAB 5MG
ANTISEPTICS / DISINFECTANTS
00024153502
PHISOHEX
LIQ 3%
41
$762.75
48.24%
44
$797.72
39.29%
00024153506
PHISOHEX
LIQ 3%
33
$924.23
38.82%
44
$1,425.14
39.29%
00024153508
PHISOHEX
LIQ 3%
0
$0.00
0.00%
1
$8.02
0.89%
00034213580
BETADINE
MIS SWAB AID
0
$0.00
0.00%
1
$4.29
0.89%
00034234010
BETADINE
OIN 10%
3
$82.23
3.53%
0
$0.00
0.00%
Page 81 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
Market Share*
ANTISEPTICS / DISINFECTANTS
00310057516
HIBICLENS
LIQ 4%
1
$5.02
1.18%
0
00310057591
HIBICLENS
LIQ 4%
1
$39.69
1.18%
00884398603
LAZERFORMALY SOL 10%
2
$48.19
2.35%
00884478902
FORMALYDE-10 AER 10% SPRA
1
$13.35
08213010040
IODOSORB
0
45802005207
POVIDONE-IOD SOL 10%
GEL
$
$0.00
0.00%
0
$0.00
0.00%
5
$117.28
4.46%
1.18%
2
$52.92
1.79%
$0.00
0.00%
12
$520.98
10.71%
3
$18.48
3.53%
3
$12.48
2.68%
9
$50.36
0.03%
0
$0.00
0.00%
ANXIOLYTIC - BENZODIAZEPINES
00005312831
DIAZEPAM
TAB 2MG
00008005202
SERAX
CAP 30MG
1
$138.85
0.00%
0
$0.00
0.00%
00008006402
ATIVAN
TAB 1MG
15
$1,363.13
0.05%
11
$899.08
0.03%
00008006502
ATIVAN
TAB 2MG
2
$87.58
0.01%
2
$94.36
0.01%
00008008102
ATIVAN
TAB 0.5MG
7
$357.52
0.02%
9
$389.97
0.02%
00008031701
SERAX
4
$39.00
0.01%
0
$0.00
0.00%
00008057015
ATIVAN
INJ 4MG/ML
1
$30.07
0.00%
0
$0.00
0.00%
00008058104
ATIVAN
INJ 2MG/ML
9
$125.09
0.03%
1
$77.85
0.00%
00008058115
ATIVAN
INJ 2MG/ML
44
$1,678.39
0.15%
10
$261.46
0.03%
00009002901
XANAX
TAB 0.25MG
9
$952.21
0.03%
8
$676.72
0.02%
00009005501
XANAX
TAB 0.5MG
15
$1,594.67
0.05%
8
$841.41
0.02%
00009005503
XANAX
TAB 0.5MG
6
$692.28
0.02%
4
$475.34
0.01%
00009009001
XANAX
TAB 1MG
18
$3,196.39
0.06%
9
$1,984.29
0.02%
00009009401
XANAX
TAB 2MG
9
$2,014.83
0.03%
2
$159.48
0.01%
00054318544
DIAZEPAM
CON 5MG/ML
7
$330.36
0.02%
3
$81.21
0.01%
00054318863
DIAZEPAM
SOL 1MG/ML
38
$788.90
0.13%
34
$758.63
0.09%
00054353244
LORAZEPAM
62
$2,539.23
0.20%
109
$5,272.68
0.29%
00054820716
DIAZEPAM
SOL 1MG/ML
0
$0.00
0.00%
1
$1.90
0.00%
00074127302
DIAZEPAM
INJ 5MG/ML
4
$27.32
0.01%
14
$110.07
0.04%
TAB 15MG
CON 2MG/ML
Page 82 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00074127322
DIAZEPAM
INJ 5MG/ML
1
$9.46
0.00%
0
$0.00
0.00%
00074127332
DIAZEPAM
INJ 5MG/ML
3
$63.03
0.01%
14
$469.27
0.04%
00074198501
LORAZEPAM
INJ 2MG/ML
3
$25.89
0.01%
4
$81.37
0.01%
00074198510
LORAZEPAM
INJ 2MG/ML
0
$0.00
0.00%
7
$222.95
0.02%
00074198511
LORAZEPAM
INJ 2MG/ML
2
$61.20
0.01%
0
$0.00
0.00%
00074198530
LORAZEPAM
INJ 2MG/ML
1
$25.10
0.00%
0
$0.00
0.00%
00074198531
LORAZEPAM
INJ 2MG/ML
8
$70.97
0.03%
12
$177.11
0.03%
00074269913
TRANXENE-SD TAB 11.25MG
11
$2,448.13
0.04%
8
$2,227.10
0.02%
00074299713
TRANXENE-SD TAB 22.5MG
8
$1,223.46
0.03%
4
$1,430.72
0.01%
00074321032
DIAZEPAM
INJ 5MG/ML
1
$1.67
0.00%
0
$0.00
0.00%
00074321302
DIAZEPAM
INJ 5MG/ML
3
$8.11
0.01%
2
$9.59
0.01%
00074438913
TRANXENE T TAB 3.75MG
4
$491.12
0.01%
4
$489.36
0.01%
00074439013
TRANXENE T TAB 7.5MG
1
$328.14
0.00%
0
$0.00
0.00%
00074677801
LORAZEPAM
INJ 2MG/ML
1
$5.94
0.00%
1
$5.94
0.00%
00074677802
LORAZEPAM
INJ 2MG/ML
7
$99.54
0.02%
89
$1,663.22
0.24%
00172392560
DIAZEPAM
TAB 2MG
14
$71.03
0.05%
7
$22.42
0.02%
00172392570
DIAZEPAM
TAB 2MG
230
$1,202.91
0.76%
343
$1,269.49
0.93%
00172392580
DIAZEPAM
TAB 2MG
21
$130.91
0.07%
0
$0.00
0.00%
00172392660
DIAZEPAM
TAB 5MG
16
$87.35
0.05%
39
$311.94
0.11%
00172392670
DIAZEPAM
TAB 5MG
955
$6,219.19
3.15%
1,983
$9,953.39
5.36%
00172392680
DIAZEPAM
TAB 5MG
247
$1,746.87
0.82%
56
$267.33
0.15%
00172392760
DIAZEPAM
TAB 10MG
89
$897.42
0.29%
73
$754.86
0.20%
00172392770
DIAZEPAM
TAB 10MG
512
$5,917.53
1.69%
1,043
$10,547.60
2.82%
00172392780
DIAZEPAM
TAB 10MG
32
$389.87
0.11%
10
$127.80
0.03%
00172480460
OXAZEPAM
CAP 10MG
61
$1,192.87
0.20%
35
$476.61
0.09%
00172480470
OXAZEPAM
CAP 10MG
2
$25.47
0.01%
12
$142.45
0.03%
00172480560
OXAZEPAM
CAP 15MG
24
$431.20
0.08%
15
$472.55
0.04%
Page 83 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00172480570
OXAZEPAM
CAP 15MG
6
$200.90
0.02%
5
$234.35
0.01%
00172480660
OXAZEPAM
CAP 30MG
16
$754.04
0.05%
33
$756.14
0.09%
00228202710
ALPRAZOLAM TAB 0.25MG
0
$0.00
0.00%
6
$30.57
0.02%
00228202750
0
$0.00
0.00%
86
$360.78
0.23%
00228202796
127
$624.79
0.42%
499
$2,242.11
1.35%
00228202910
3
$16.00
0.01%
10
$54.78
0.03%
00228202950
1
$7.78
0.00%
121
$579.51
0.33%
00228202996
52
$288.55
0.17%
369
$1,865.41
1.00%
00228203110
ALPRAZOLAM TAB 1MG
0
$0.00
0.00%
38
$230.48
0.10%
00228203150
ALPRAZOLAM TAB 1MG
0
$0.00
0.00%
177
$1,021.57
0.48%
00228203196
ALPRAZOLAM TAB 1MG
18
$108.00
0.06%
311
$1,857.35
0.84%
00228203910
ALPRAZOLAM TAB 2MG
0
$0.00
0.00%
17
$210.52
0.05%
00228203950
ALPRAZOLAM TAB 2MG
3
$58.80
0.01%
16
$180.53
0.04%
00228205110
DIAZEPAM
TAB 2MG
5
$25.98
0.02%
9
$49.24
0.02%
00228205150
DIAZEPAM
TAB 2MG
105
$593.76
0.35%
145
$776.95
0.39%
00228205210
DIAZEPAM
TAB 5MG
7
$49.03
0.02%
9
$51.15
0.02%
00228205250
DIAZEPAM
TAB 5MG
643
$4,030.94
2.12%
198
$1,218.98
0.54%
00228205310
DIAZEPAM
TAB 10MG
18
$243.74
0.06%
26
$276.06
0.07%
00228205350
DIAZEPAM
TAB 10MG
194
$2,308.67
0.64%
79
$779.76
0.21%
00228205710
LORAZEPAM
TAB 0.5MG
7
$33.46
0.02%
207
$1,116.28
0.56%
00228205750
LORAZEPAM
TAB 0.5MG
3
$39.45
0.01%
5
$27.35
0.01%
00228205910
LORAZEPAM
TAB 1MG
3
$36.00
0.01%
0
$0.00
0.00%
00228205950
LORAZEPAM
TAB 1MG
10
$189.30
0.03%
8
$106.60
0.02%
00228206310
LORAZEPAM
TAB 2MG
0
$0.00
0.00%
3
$4.50
0.01%
00228206350
LORAZEPAM
TAB 2MG
4
$11.35
0.01%
3
$10.80
0.01%
00228206710
OXAZEPAM
CAP 10MG
103
$3,099.35
0.34%
136
$2,761.20
0.37%
00228206750
OXAZEPAM
CAP 10MG
49
$1,192.09
0.16%
36
$591.00
0.10%
Page 84 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00228206910
OXAZEPAM
CAP 15MG
131
00228206950
OXAZEPAM
CAP 15MG
00228207310
OXAZEPAM
CAP 30MG
00364077401
DIAZEPAM
00364077402
$3,199.33
0.43%
241
$6,676.45
0.65%
36
$820.23
92
$3,643.88
0.12%
87
$1,574.51
0.24%
0.30%
110
$4,289.00
0.30%
TAB 2MG
3
$11.94
0.01%
7
$13.19
0.02%
DIAZEPAM
TAB 2MG
7
$51.12
0.02%
4
$19.15
0.01%
00364077405
DIAZEPAM
00364077501
DIAZEPAM
TAB 2MG
1
$3.48
0.00%
2
$16.86
0.01%
TAB 5MG
1
$3.93
0.00%
2
$7.44
0.01%
00364077502
DIAZEPAM
TAB 5MG
8
$64.37
0.03%
10
$66.66
0.03%
00364077505
DIAZEPAM
TAB 5MG
0
$0.00
0.00%
1
$7.31
0.00%
00364077602
DIAZEPAM
TAB 10MG
1
$3.92
0.00%
0
$0.00
0.00%
00364077605
DIAZEPAM
TAB 10MG
5
$67.25
0.02%
3
$48.30
0.01%
00378003001
CLORAZ DIPOT TAB 3.75MG
28
$646.65
0.09%
38
$465.65
0.10%
00378003005
26
$492.30
0.09%
25
$364.95
0.07%
00378004001
124
$3,234.41
0.41%
104
$2,028.85
0.28%
00378004005
27
$843.45
0.09%
21
$382.85
0.06%
00378007001
CLORAZ DIPOT TAB 15MG
23
$715.55
0.08%
29
$758.15
0.08%
00378027101
DIAZEPAM
TAB 2MG
83
$415.41
0.27%
92
$342.71
0.25%
00378027105
DIAZEPAM
TAB 2MG
160
$787.73
0.53%
152
$662.70
0.41%
00378032101
LORAZEPAM
TAB 0.5MG
708
$8,505.47
2.34%
849
$6,063.68
2.30%
00378032105
LORAZEPAM
TAB 0.5MG
1,004
$12,166.90
3.31%
1,383
$10,189.76
3.74%
00378034501
DIAZEPAM
TAB 5MG
327
$2,211.21
1.08%
434
$2,321.39
1.17%
00378034505
DIAZEPAM
TAB 5MG
590
$4,134.47
1.95%
609
$3,467.96
1.65%
00378045701
LORAZEPAM
TAB 1MG
472
$6,889.32
1.56%
613
$4,990.87
1.66%
00378045705
LORAZEPAM
TAB 1MG
921
$12,303.74
3.04%
1,218
$9,654.18
3.29%
00378045710
LORAZEPAM
TAB 1MG
125
$1,656.21
0.41%
165
$1,295.18
0.45%
00378047701
DIAZEPAM
TAB 10MG
144
$1,686.24
0.48%
244
$2,581.17
0.66%
00378047705
DIAZEPAM
TAB 10MG
341
$3,907.66
1.13%
476
$4,702.13
1.29%
Page 85 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00378077701
LORAZEPAM
TAB 2MG
262
$4,939.42
0.86%
340
$5,989.30
0.92%
00378077705
LORAZEPAM
TAB 2MG
73
$1,470.62
0.24%
43
$847.11
0.12%
00378400101
2
$8.49
0.01%
24
$112.59
0.06%
00378400105
449
$2,347.99
1.48%
872
$3,168.90
2.36%
00378400301
18
$106.29
0.06%
9
$58.64
0.02%
00378400305
692
$4,195.09
2.28%
1,416
$6,659.58
3.83%
00378400501
ALPRAZOLAM TAB 1MG
451
$3,596.84
1.49%
944
$5,429.63
2.55%
00378400505
ALPRAZOLAM TAB 1MG
21
$147.65
0.07%
126
$771.06
0.34%
00378400701
ALPRAZOLAM TAB 2MG
79
$848.10
0.26%
120
$1,077.15
0.32%
00555003302
CHLORDIAZEP CAP 10MG
65
$445.94
0.21%
106
$535.11
0.29%
00555003305
77
$586.13
0.25%
61
$314.37
0.16%
00555015802
CHLORDIAZEP CAP 5MG
54
$455.54
0.18%
73
$495.57
0.20%
00555015804
CHLORDIAZEP CAP 5MG
7
$47.92
0.02%
3
$18.57
0.01%
00555015902
128
$1,031.87
0.42%
173
$940.43
0.47%
00555015904
17
$134.15
0.06%
12
$76.84
0.03%
00555016302
DIAZEPAM
TAB 2MG
12
$55.77
0.04%
7
$20.12
0.02%
00555016305
DIAZEPAM
TAB 2MG
17
$95.02
0.06%
31
$114.31
0.08%
00555016402
DIAZEPAM
TAB 10MG
22
$241.50
0.07%
26
$259.60
0.07%
00555016405
DIAZEPAM
TAB 10MG
75
$967.54
0.25%
86
$1,020.20
0.23%
00555036302
DIAZEPAM
TAB 5MG
95
$596.86
0.31%
69
$340.75
0.19%
00555036305
DIAZEPAM
TAB 5MG
114
$769.49
0.38%
120
$699.12
0.32%
00591024001
LORAZEPAM
TAB 0.5MG
54
$796.37
0.18%
45
$364.75
0.12%
00591024005
LORAZEPAM
TAB 0.5MG
576
$6,022.25
1.90%
748
$4,779.66
2.02%
00591024010
LORAZEPAM
TAB 0.5MG
1,480
$18,155.67
4.88%
1,857
$12,823.88
5.02%
00591024101
LORAZEPAM
TAB 1MG
101
$1,018.18
0.33%
74
$462.82
0.20%
00591024105
LORAZEPAM
TAB 1MG
49
$709.85
0.16%
81
$766.34
0.22%
00591024110
LORAZEPAM
TAB 1MG
1,788
$24,104.12
5.90%
2,335
$17,945.25
6.31%
Page 86 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00591024201
LORAZEPAM
TAB 2MG
354
$5,380.05
1.17%
331
$5,301.14
0.89%
00591024205
LORAZEPAM
TAB 2MG
40
$725.60
0.13%
92
$1,254.60
0.25%
00591024210
LORAZEPAM
TAB 2MG
0
$0.00
0.00%
8
$101.80
0.02%
00591078501
CHLORDIAZEP CAP 5MG
7
$51.31
0.02%
2
$17.38
0.01%
00591078601
2
$16.20
0.01%
17
$113.21
0.05%
00591078605
6
$41.18
0.02%
17
$86.34
0.05%
00591078610
4
$35.00
0.01%
9
$83.25
0.02%
00591078701
37
$282.22
0.12%
47
$284.07
0.13%
00591078705
9
$64.30
0.03%
13
$59.97
0.04%
00591561901
DIAZEPAM
TAB 5MG
58
$411.59
0.19%
28
$159.73
0.08%
00591561905
DIAZEPAM
TAB 5MG
6
$36.27
0.02%
24
$118.30
0.06%
00591561910
DIAZEPAM
TAB 5MG
135
$875.95
0.45%
345
$1,861.18
0.93%
00591562001
DIAZEPAM
TAB 10MG
63
$745.60
0.21%
57
$608.70
0.15%
00591562005
DIAZEPAM
TAB 10MG
2
$14.77
0.01%
2
$18.49
0.01%
00591562010
DIAZEPAM
TAB 10MG
44
$640.26
0.15%
48
$538.83
0.13%
00591562101
DIAZEPAM
TAB 2MG
8
$44.85
0.03%
13
$88.38
0.04%
00591562105
DIAZEPAM
TAB 2MG
17
$121.08
0.06%
33
$177.90
0.09%
00591562110
DIAZEPAM
TAB 2MG
17
$54.55
0.06%
27
$94.96
0.07%
00615040153
37
$228.41
0.12%
0
$0.00
0.00%
00615040163
31
$170.94
0.10%
0
$0.00
0.00%
00615042653
61
$310.63
0.20%
0
$0.00
0.00%
00615042663
156
$733.68
0.51%
0
$0.00
0.00%
00615045053
LORAZEPAM
TAB 0.5MG
167
$1,589.94
0.55%
0
$0.00
0.00%
00615045063
LORAZEPAM
TAB 0.5MG
644
$6,253.88
2.13%
0
$0.00
0.00%
00615045153
LORAZEPAM
TAB 1MG
72
$896.30
0.24%
0
$0.00
0.00%
00615045163
LORAZEPAM
TAB 1MG
230
$2,661.50
0.76%
0
$0.00
0.00%
00615153253
DIAZEPAM
34
$204.26
0.11%
0
$0.00
0.00%
TAB 2MG
Page 87 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00615153263
DIAZEPAM
TAB 2MG
37
00615153353
DIAZEPAM
TAB 5MG
00615153363
DIAZEPAM
TAB 5MG
00641037125
DIAZEPAM
00641140835
DIAZEPAM
00677105605
00677105701
00781106101
$172.37
0.12%
0
$0.00
0.00%
10
$57.79
0.03%
0
$0.00
0.00%
43
$280.78
0.14%
0
$0.00
0.00%
INJ 5MG/ML
4
$29.63
0.01%
3
$24.09
0.01%
INJ 5MG/ML
1
$4.46
0.00%
0
$0.00
0.00%
LORAZEPAM
TAB 0.5MG
19
$262.01
0.06%
7
$52.27
0.02%
LORAZEPAM
TAB 1MG
1
$21.35
0.00%
0
$0.00
0.00%
16
$80.83
0.05%
60
$216.58
0.16%
00781106105
225
$1,134.97
0.74%
508
$1,911.04
1.37%
00781106110
196
$1,042.17
0.65%
137
$573.54
0.37%
00781107701
76
$475.93
0.25%
24
$117.34
0.06%
00781107705
219
$1,216.04
0.72%
468
$2,200.01
1.27%
00781107710
392
$2,441.31
1.29%
152
$812.82
0.41%
00781107901
ALPRAZOLAM TAB 1MG
154
$1,163.58
0.51%
249
$1,406.60
0.67%
00781107905
ALPRAZOLAM TAB 1MG
95
$712.65
0.31%
656
$3,972.45
1.77%
00781107910
ALPRAZOLAM TAB 1MG
148
$1,084.80
0.49%
90
$550.10
0.24%
00781108901
ALPRAZOLAM TAB 2MG
55
$597.40
0.18%
65
$706.60
0.18%
00781108905
ALPRAZOLAM TAB 2MG
18
$238.85
0.06%
12
$132.80
0.03%
00781132601
3
$15.48
0.01%
0
$0.00
0.00%
00781140301
LORAZEPAM
TAB 0.5MG
280
$2,678.29
0.92%
69
$470.04
0.19%
00781140305
LORAZEPAM
TAB 0.5MG
763
$7,857.68
2.52%
1,491
$10,516.94
4.03%
00781140401
LORAZEPAM
TAB 1MG
97
$1,288.70
0.32%
93
$635.12
0.25%
00781140405
LORAZEPAM
TAB 1MG
206
$2,838.56
0.68%
536
$4,732.57
1.45%
00781140410
LORAZEPAM
TAB 1MG
365
$4,328.04
1.20%
68
$531.43
0.18%
00781140501
LORAZEPAM
TAB 2MG
72
$1,140.11
0.24%
80
$1,071.63
0.22%
00781140505
LORAZEPAM
TAB 2MG
96
$1,361.05
0.32%
92
$1,165.42
0.25%
00781280901
OXAZEPAM
CAP 10MG
16
$512.98
0.05%
33
$592.39
0.09%
Page 88 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
OXAZEPAM
CAP 15MG
00781281005
OXAZEPAM
CAP 15MG
00781281101
OXAZEPAM
CAP 30MG
00904009160
00904009260
$
Market Share*
00781281001
# of Scripts
$1,019.05
0.13%
69
$2,389.32
0.19%
1
$25.35
10
$607.50
0.00%
3
$145.65
0.01%
0.03%
14
$448.90
0.04%
0
$0.00
0.00%
1
$3.77
0.00%
0
$0.00
0.00%
1
$8.15
0.00%
00904150040
LORAZEPAM
10019010201
ATIVAN
INJ 2MG/ML
0
$0.00
0.00%
3
$28.95
0.01%
5
$139.36
0.02%
1
$27.27
0.00%
10019010210
ATIVAN
INJ 2MG/ML
5
$244.55
0.02%
0
$0.00
0.00%
51079014120
1
$3.33
0.00%
1
$10.45
0.00%
51079038620
LORAZEPAM
TAB 1MG
1
$4.55
0.00%
0
$0.00
0.00%
51079041720
LORAZEPAM
TAB 0.5MG
0
$0.00
0.00%
5
$21.63
0.01%
51079041721
LORAZEPAM
TAB 0.5MG
11
$11.80
0.04%
0
$0.00
0.00%
51079078820
1
$0.04
0.00%
1
$3.39
0.00%
51672404201
59
$1,402.20
0.19%
60
$971.70
0.16%
51672404301
119
$3,617.65
0.39%
145
$2,589.00
0.39%
51672404302
2
$74.70
0.01%
3
$70.05
0.01%
51672404401
21
$723.35
0.07%
17
$343.05
0.05%
52544024001
LORAZEPAM
TAB 0.5MG
19
$201.95
0.06%
0
$0.00
0.00%
52544024005
LORAZEPAM
TAB 0.5MG
32
$333.21
0.11%
0
$0.00
0.00%
52544024010
LORAZEPAM
TAB 0.5MG
27
$285.45
0.09%
0
$0.00
0.00%
52544024101
LORAZEPAM
TAB 1MG
25
$214.05
0.08%
0
$0.00
0.00%
52544024105
LORAZEPAM
TAB 1MG
33
$369.14
0.11%
16
$90.05
0.04%
52544024110
LORAZEPAM
TAB 1MG
44
$629.88
0.15%
0
$0.00
0.00%
52544024201
LORAZEPAM
TAB 2MG
4
$71.82
0.01%
1
$30.85
0.00%
52544024205
LORAZEPAM
TAB 2MG
5
$102.25
0.02%
3
$84.69
0.01%
52544024210
LORAZEPAM
TAB 2MG
7
$121.95
0.02%
0
$0.00
0.00%
52544036401
1
$25.35
0.00%
0
$0.00
0.00%
TAB 0.5MG
39
Page 89 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
52544036405
3
$76.05
0.01%
0
$0.00
0.00%
52544068205
3
$12.39
0.01%
0
$0.00
0.00%
52544068310
6
$37.56
0.02%
0
$0.00
0.00%
52544068405
ALPRAZOLAM TAB 1MG
14
$92.20
0.05%
7
$30.75
0.02%
52544078501
CHLORDIAZEP CAP 5MG
7
$85.47
0.02%
0
$0.00
0.00%
52544078601
31
$185.63
0.10%
11
$64.67
0.03%
52544078605
4
$27.36
0.01%
0
$0.00
0.00%
52544078610
6
$55.50
0.02%
0
$0.00
0.00%
52544078701
7
$38.39
0.02%
0
$0.00
0.00%
52544083501
60
$1,757.80
0.20%
35
$536.80
0.09%
52544083505
6
$135.75
0.02%
6
$107.31
0.02%
52544083601
40
$1,207.61
0.13%
56
$1,027.10
0.15%
52544083605
11
$417.85
0.04%
14
$194.40
0.04%
52544083701
14
$505.50
0.05%
16
$269.10
0.04%
53265004810
3
$41.55
0.01%
3
$40.35
0.01%
53265004850
0
$0.00
0.00%
3
$42.87
0.01%
53265004910
2
$54.70
0.01%
11
$201.85
0.03%
53265004950
53489035705
LORAZEPAM
TAB 0.5MG
53489035801
LORAZEPAM
53489035810
0
$0.00
0.00%
2
$54.20
0.01%
74
$1,010.77
0.24%
18
$99.58
0.05%
TAB 1MG
3
$67.05
0.01%
0
$0.00
0.00%
LORAZEPAM
TAB 1MG
37
$513.65
0.12%
18
$133.18
0.05%
53489035901
LORAZEPAM
TAB 2MG
9
$164.65
0.03%
3
$35.05
0.01%
53489035905
LORAZEPAM
TAB 2MG
0
$0.00
0.00%
14
$228.65
0.04%
59762371901
97
$508.34
0.32%
658
$2,408.82
1.78%
59762371903
1,228
$6,537.74
4.05%
172
$575.87
0.47%
59762371904
438
$2,387.80
1.45%
185
$843.74
0.50%
59762372001
259
$1,544.03
0.85%
1,602
$7,859.25
4.33%
Page 90 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
59762372003
1,640
$10,001.85
5.41%
385
$1,892.79
1.04%
59762372004
739
$4,628.85
2.44%
559
$2,892.40
1.51%
59762372101
ALPRAZOLAM TAB 1MG
313
$2,296.68
1.03%
61
$309.99
0.16%
59762372103
ALPRAZOLAM TAB 1MG
977
$7,200.93
3.22%
613
$3,649.26
1.66%
59762372104
ALPRAZOLAM TAB 1MG
438
$3,285.05
1.45%
297
$1,842.09
0.80%
59762372201
ALPRAZOLAM TAB 2MG
303
$3,174.64
1.00%
371
$3,769.96
1.00%
59762372203
ALPRAZOLAM TAB 2MG
71
$824.35
0.23%
115
$1,013.81
0.31%
59911581101
LORAZEPAM
TAB 0.5MG
1
$8.25
0.00%
0
$0.00
0.00%
59911581301
LORAZEPAM
TAB 2MG
3
$11.05
0.01%
0
$0.00
0.00%
59911587601
OXAZEPAM
CAP 10MG
7
$78.16
0.02%
0
$0.00
0.00%
59911587701
OXAZEPAM
CAP 15MG
3
$60.56
0.01%
3
$28.93
0.01%
59911587801
OXAZEPAM
CAP 30MG
4
$67.20
0.01%
0
$0.00
0.00%
63304077201
LORAZEPAM
TAB 0.5MG
15
$133.61
0.05%
23
$142.71
0.06%
63304077205
LORAZEPAM
TAB 0.5MG
523
$6,401.52
1.73%
922
$6,789.81
2.49%
63304077301
LORAZEPAM
TAB 1MG
43
$626.40
0.14%
100
$793.48
0.27%
63304077305
LORAZEPAM
TAB 1MG
180
$3,067.90
0.59%
282
$2,514.55
0.76%
63304077310
LORAZEPAM
TAB 1MG
236
$3,348.36
0.78%
667
$5,731.15
1.80%
63304077401
LORAZEPAM
TAB 2MG
42
$841.92
0.14%
79
$1,097.92
0.21%
63304077405
LORAZEPAM
TAB 2MG
17
$220.45
0.06%
70
$1,261.75
0.19%
63857032910
SERAX
1
$52.29
0.00%
0
$0.00
0.00%
CAP 30MG
ARBS AND DIURETICS
00006071731
HYZAAR
TAB 50-12.5
189
$7,712.52
12.05%
167
$6,792.98
10.83%
00006071754
HYZAAR
TAB 50-12.5
51
$2,059.36
3.25%
61
$2,500.23
3.96%
00006071758
HYZAAR
TAB 50-12.5
130
$5,101.43
8.29%
106
$4,353.23
6.87%
00006074728
HYZAAR
TAB 100-25
9
$509.25
0.57%
1
$57.22
0.06%
00006074731
HYZAAR
TAB 100-25
156
$8,540.05
9.95%
231
$12,640.97
14.98%
Page 91 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ARBS AND DIURETICS
00006074758
HYZAAR
TAB 100-25
00078031405
DIOVAN HCT TAB 80/12.5
00078031505
00078031506
105
$5,808.51
6.70%
150
$8,422.18
9.73%
217
$9,586.68
13.84%
122
$5,435.01
7.91%
468
$23,506.44
29.85%
200
$10,652.97
12.97%
10
$474.16
0.64%
2
$103.26
0.13%
00078038305
DIOVAN HCT TAB 160-25MG
13
$723.97
0.83%
56
$2,986.78
3.63%
00087277531
AVALIDE
TAB 150-12.5
44
$2,599.92
2.81%
20
$1,249.02
1.30%
00087277532
AVALIDE
TAB 150-12.5
10
$526.88
0.64%
5
$286.53
0.32%
00087277631
AVALIDE
TAB 300-12.5
36
$1,928.64
2.30%
24
$1,366.86
1.56%
00087277632
AVALIDE
TAB 300-12.5
13
$690.95
0.83%
3
$119.71
0.19%
00186016228
ATACAND HCT TAB 16-12.5
0
$0.00
0.00%
2
$109.38
0.13%
00186016254
21
$1,013.42
1.34%
12
$591.09
0.78%
00186032228
5
$257.85
0.32%
4
$224.44
0.26%
00186032254
68
$3,597.65
4.34%
40
$2,034.02
2.59%
00597004328
MICARDIS HCT TAB 40/12.5
3
$123.72
0.19%
39
$1,889.45
2.53%
00597004428
MICARDIS HCT TAB 80/12.5
20
$974.15
1.28%
40
$2,070.74
2.59%
64455013201
TEVETEN HCT TAB 600-12.5
0
$0.00
0.00%
46
$1,712.68
2.98%
64455013301
TEVETEN HCT TAB 600-25MG
0
$0.00
0.00%
13
$442.01
0.84%
65597010530
BENICAR HCT TAB 20-12.5
0
$0.00
0.00%
65
$2,858.90
4.22%
65597010590
0
$0.00
0.00%
9
$406.60
0.58%
65597010630
0
$0.00
0.00%
85
$3,766.01
5.51%
65597010690
0
$0.00
0.00%
17
$858.88
1.10%
65597010730
BENICAR HCT TAB 40-25MG
0
$0.00
0.00%
19
$833.57
1.23%
65597010790
BENICAR HCT TAB 40-25MG
0
$0.00
0.00%
3
$115.17
0.19%
4
$29.16
14.29%
3
$17.62
8.11%
18
$2,311.58
64.29%
12
$1,028.78
32.43%
ARTIFICIAL SALIVA/STIMULANTS
00054376950
SALIVA SUBST SOL
58063070510
SALAGEN
TAB 5MG
Page 92 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
EVOXAC
CAP 30MG
$
Market Share*
ARTIFICIAL SALIVA/STIMULANTS
63395020113
# of Scripts
6
$399.93
21.43%
22
$2,292.19
59.46%
1
$9.42
0.04%
1
$42.78
0.04%
ARTIFICIAL TEARS AND LUBRICANTS
00023024001
LACRI-LUB NP OIN OP
00023031204
LACRI-LUBE OIN S.O.P.
123
$1,358.08
4.42%
98
$1,150.76
3.78%
00023031207
LACRI-LUBE OIN S.O.P.
37
$743.86
1.33%
25
$393.99
0.96%
00023040330
REFRESH PLUS SOL 0.5% OP
83
$962.28
2.98%
63
$731.51
2.43%
00023040350
37
$512.18
1.33%
43
$751.08
1.66%
00023050601
REFRESH
SOL OP
111
$1,540.35
3.99%
108
$1,249.48
4.17%
00023050650
REFRESH
SOL OP
43
$690.80
1.55%
47
$705.85
1.81%
00023066704
REFRESH-PM OIN OP
86
$1,192.85
3.09%
96
$1,243.19
3.70%
00023079815
REFRESH TEAR SOL 0.5% OP
136
$1,285.16
4.89%
76
$653.81
2.93%
00023079830
REFRESH TEAR SOL 0.5% OP
34
$385.43
1.22%
22
$225.96
0.85%
00023455430
CELLUVISC
149
$2,178.26
5.36%
152
$2,348.20
5.86%
00023548730
89
$930.31
3.20%
104
$1,085.46
4.01%
00023548750
7
$84.70
0.25%
3
$50.93
0.12%
00023920515
REFRESH
15
$163.71
0.54%
35
$343.24
1.35%
00023923520
REFRESH ENDU DRO 1-1%
0
$0.00
0.00%
14
$283.22
0.54%
00065041435
DURATEARS
1
$14.55
0.04%
0
$0.00
0.00%
00065041625
TEARS NATURA SOL FREE OP
41
$457.33
1.47%
26
$327.87
1.00%
00065041815
TEARS NATURA SOL II OP
31
$284.96
1.11%
34
$298.62
1.31%
00065041830
TEARS NATURA SOL II OP
14
$165.63
0.50%
16
$174.73
0.62%
00065041928
BION TEARS SOL OP
58
$802.79
2.09%
54
$796.06
2.08%
00065042005
TEARS NATURA OIN PM
1
$9.20
0.04%
1
$7.70
0.04%
00065042615
TEARS NATURA SOL FORTE
2
$20.40
0.07%
2
$18.08
0.08%
00065042630
TEARS NATURA SOL FORTE
3
$35.71
0.11%
1
$5.49
0.04%
00065042915
SYSTANE
0
$0.00
0.00%
11
$100.84
0.42%
SOL 1% OP
SOL 1%
OIN OP
SOL
Page 93 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
SYSTANE
SOL
00074557405
MURINE
00168015038
PURALUBE
OIN OP
00168017715
PURALUBE
SOL TEARS OP
00182154364
TEARGEN
00182505631
EYE LUBRICAN OIN OP
00364242772
ARTIFIC TEAR SOL OP
00536197072
ARTIFI TEARS SOL OP
00536623772
NATURE'S
00536655091
ARTIFI TEARS OIN OP
00677098530
ARTIFICIAL SOL TEARS OP
00904165335
SOL OP
SOL OP
SOL TEARS
$
Market Share*
00065042930
# of Scripts
0
$0.00
0.00%
2
$24.88
0.08%
3
$18.42
0.11%
77
$484.33
2.77%
1
$4.14
0.04%
62
$347.38
2.39%
85
$564.32
3.06%
15
$88.99
0.58%
4
$29.96
0.14%
0
$0.00
0.00%
1
$6.70
0.04%
2
$13.40
0.08%
158
$819.52
5.68%
412
$1,935.50
15.90%
1
$8.49
0.04%
15
$77.28
0.58%
48
$340.33
1.73%
5
$26.37
0.19%
4
$23.03
0.14%
0
$0.00
0.00%
114
$652.03
4.10%
58
$291.53
2.24%
MAJOR TEARS SOL OP
1
$6.31
0.04%
0
$0.00
0.00%
00904501735
LIQUITEARS SOL
1
$6.65
0.04%
0
$0.00
0.00%
00904501835
NATURAL
0
$0.00
0.00%
29
$169.99
1.12%
00904516838
LUBRIFRESH OIN P.M.
18
$152.85
0.65%
1
$5.99
0.04%
00998040815
ISOPTO TEARS SOL 0.5% OP
13
$219.46
0.47%
2
$79.30
0.08%
00998041315
TEARS NATURA SOL OP
14
$140.32
0.50%
8
$66.12
0.31%
00998041330
TEARS NATURA SOL OP
4
$43.35
0.14%
1
$9.82
0.04%
17478006012
AKWA TEARS SOL OP
154
$989.27
5.54%
19
$108.97
0.73%
17478006235
AKWA TEARS OIN OP
51
$327.05
1.83%
49
$307.65
1.89%
17478006335
TEARS RENEW OIN OP
7
$61.64
0.25%
6
$47.24
0.23%
24208028015
MUROCEL
10
$135.37
0.36%
7
$151.35
0.27%
24385000601
2
$12.50
0.07%
6
$37.49
0.23%
37205013479
DRY EYES
6
$25.32
0.22%
0
$0.00
0.00%
37205013705
ARTIFICIAL SOL TEARS
67
$334.46
2.41%
83
$433.72
3.20%
37205060305
TEARS PURE SOL
5
$29.84
0.18%
12
$73.40
0.46%
49348069929
SM ARTIFICIA SOL TEARS
7
$54.78
0.25%
9
$60.80
0.35%
SOL BALANCE
SOL 1% OP
OIN OP
Page 94 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
58768013015
HYPOTEARS
58768013030
HYPOTEARS
58768013136
HYPOTEARS
$
Market Share*
50383002615
# of Scripts
0
$0.00
0.00%
1
$2.04
0.04%
SOL OP
86
$978.61
3.09%
15
$199.03
0.58%
SOL OP
72
$966.29
2.59%
18
$231.39
0.69%
OIN OP
15
$184.72
0.54%
19
$198.81
0.73%
58768013230
HYPO TEARS SOL PF
11
$215.18
0.40%
0
$0.00
0.00%
58768013425
HYPOTEARS
2
$23.84
0.07%
0
$0.00
0.00%
58768072515
TEARISOL
SOL
7
$77.64
0.25%
2
$21.48
0.08%
58768078815
GENTEAL
SOL OPTH
327
$3,333.22
11.76%
402
$3,996.60
15.51%
58768078825
GENTEAL
SOL OPTH
97
$1,134.60
3.49%
122
$1,335.50
4.71%
58768079035
GENTEAL
GEL
0
$0.00
0.00%
5
$27.05
0.19%
58768079036
GENTEAL
GEL
137
$1,328.65
4.93%
141
$1,350.58
5.44%
58768079115
GENTEAL MILD DRO 0.2%
0
$0.00
0.00%
22
$199.57
0.85%
58768079125
GENTEAL MILD DRO 0.2%
0
$0.00
0.00%
1
$12.92
0.04%
58790000032
THERATEARS SOL OP
54
$745.79
1.94%
3
$68.02
0.12%
58790000115
THERATEARS SOL OP
16
$157.91
0.58%
5
$47.35
0.19%
SOL SELECT
ASSORTED ANTI-FUNGALS
00049318030
VFEND
1
$1,631.60
0.03%
4
$3,382.10
0.08%
00049341030
DIFLUCAN
TAB 200MG
TAB 50MG
14
$727.16
0.35%
13
$360.39
0.26%
00049342030
DIFLUCAN
TAB 100MG
379
$32,515.31
9.54%
506
$45,099.16
10.24%
00049343030
DIFLUCAN
TAB 200MG
175
$16,552.11
4.40%
226
$26,579.47
4.57%
00049343526
DIFLUCAN/
INJ NACL 200
0
$0.00
0.00%
2
$1,864.04
0.04%
00049343626
DIFLUCAN/
INJ NACL 400
0
$0.00
0.00%
5
$1,783.48
0.10%
00049343726
DIFLUCAN/DEX INJ 2MG/ML
1
$16.08
0.03%
0
$0.00
0.00%
00049344019
DIFLUCAN
SUS 10MG/ML
84
$3,388.63
2.11%
91
$3,684.89
1.84%
00049345019
DIFLUCAN
SUS 40MG/ML
31
$4,329.07
0.78%
39
$5,459.07
0.79%
00049350079
DIFLUCAN
TAB 150MG
2,917
$60,925.18
73.40%
3,595
$70,491.18
72.76%
Page 95 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00062020604
GRIFULVIN V SUS 125/5ML
25
$2,075.29
0.63%
30
$2,679.70
0.61%
00062021460
GRIFULVIN V TAB MICR 500
28
$1,474.04
0.70%
41
$2,544.25
0.83%
00078017905
LAMISIL
TAB 250MG
9
$1,850.58
0.23%
7
$1,591.58
0.14%
00078017915
LAMISIL
TAB 250MG
128
$27,398.98
3.22%
144
$33,604.23
2.91%
00093090001
KETOCONAZOLE TAB 200MG
52
$538.00
1.31%
76
$724.05
1.54%
00093098301
NYSTATIN
TAB 500000U
16
$788.12
0.40%
10
$480.41
0.20%
00187355510
ANCOBON
CAP 500MG
1
$98.16
0.03%
0
$0.00
0.00%
00378026101
3
$36.05
0.08%
2
$16.80
0.04%
00574040405
NYSTATIN
POW
7
$220.77
0.18%
3
$86.38
0.06%
00574040415
NYSTATIN
POW
2
$99.62
0.05%
0
$0.00
0.00%
00677061301
NYSTATIN
TAB 500000U
2
$73.76
0.05%
0
$0.00
0.00%
00677170001
2
$16.70
0.05%
6
$45.75
0.12%
00677170007
1
$1.00
0.03%
0
$0.00
0.00%
00884076304
GRIS-PEG
TAB 125MG
0
$0.00
0.00%
2
$76.34
0.04%
00884077304
GRIS-PEG
TAB 250MG
1
$33.98
0.03%
16
$815.43
0.32%
00884077350
GRIS-PEG
TAB 250MG
5
$140.16
0.13%
3
$120.94
0.06%
50111062101
3
$40.55
0.08%
4
$23.00
0.08%
50458029004
SPORANOX
CAP 100MG
28
$8,127.17
0.70%
39
$10,928.90
0.79%
50458029028
SPORANOX
CAP PULSEPAK
8
$1,089.75
0.20%
7
$1,564.72
0.14%
50458029515
SPORANOX
SOL 10MG/ML
3
$412.39
0.08%
8
$772.56
0.16%
51672402601
12
$111.70
0.30%
25
$161.50
0.51%
51672402606
12
$89.50
0.30%
12
$93.05
0.24%
53489040001
NYSTATIN
0
$0.00
0.00%
2
$131.78
0.04%
53489055401
6
$121.10
0.15%
2
$31.20
0.04%
53489055407
14
$103.05
0.35%
17
$173.80
0.34%
55370055807
0
$0.00
0.00%
2
$6.20
0.04%
55953082740
1
$4.35
0.03%
0
$0.00
0.00%
TAB 500000U
Page 96 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
59930162001
GRISEOFULVIN TAB ULTR 125
2
$32.80
0.05%
0
59930162101
GRISEOFULVIN TAB ULTR 250
1
$20.30
0.03%
60505009200
0
$0.00
0.00%
3
$27.95
$0.00
0.00%
0
$0.00
0.00%
2
$14.30
0.04%
3.61%
0
$0.00
0.00%
ASTRINGENTS / PROTECTANTS
00064030004
PROSHIELD
CRE PLUS
00096070735
DRYSOL
SOL 20%
28
$258.90
33.73%
29
$232.82
25.66%
00096070737
DRYSOL
SOL 20%
11
$94.66
13.25%
15
$127.57
13.27%
00096070760
DRYSOL
SOL 20%
11
$122.57
13.25%
10
$108.80
8.85%
00096070935
XERAC-AC
SOL 6.25%
2
$16.62
2.41%
2
$17.62
1.77%
00096070960
XERAC-AC
SOL 6.25%
4
$41.12
4.82%
5
$46.81
4.42%
00182507945
MOISTURIN
CRE DRY SKIN
1
$15.20
1.20%
1
$13.53
0.88%
00904775127
DRY SKIN
0
$0.00
0.00%
1
$9.91
0.88%
53303001030
CARRASYN
0
$0.00
0.00%
2
$38.48
1.77%
59366271003
ALUMINUM CL SOL 20%
17
$142.25
20.48%
30
$239.98
26.55%
59366271004
ALUMINUM CL SOL 20%
3
$25.45
3.61%
6
$39.26
5.31%
59366271006
ALUMINUM CL SOL 20%
3
$31.77
3.61%
12
$116.77
10.62%
CRE
GEL DRESSING
BARBITURATE
00024123105
MEBARAL
TAB 32MG
24
$522.31
1.10%
9
$320.38
0.41%
00024123205
MEBARAL
TAB 50MG
20
$857.72
0.92%
32
$1,909.67
1.45%
00024123305
MEBARAL
TAB 100MG
16
$561.62
0.73%
19
$1,041.65
0.86%
00037011360
BUTISOL SOD TAB 30MG
0
$0.00
0.00%
2
$32.40
0.09%
00037011460
BUTISOL SOD TAB 50MG
0
$0.00
0.00%
1
$43.29
0.05%
00074234931
LUMINAL
2
$225.80
0.09%
4
$361.08
0.18%
00121053105
PHENOBARB
ELX 20MG/5ML
0
$0.00
0.00%
1
$3.71
0.05%
00121053107
PHENOBARB
ELX 20MG/5ML
0
$0.00
0.00%
1
$6.05
0.05%
INJ 130MG/ML
Page 97 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
BARBITURATE
00121053204
CHLORAL HYDR SYP 500/5ML
00121053205
00143144510
PHENOBARB
TAB 15MG
00143145010
PHENOBARB
TAB 30MG
00143145510
PHENOBARB
TAB 60MG
00143145801
PHENOBARBITA TAB 100MG
00182031440
PHENOBARB
ELX 20MG/5ML
00228202696
PHENOBARB
TAB 15MG
00228202896
PHENOBARB
TAB 30MG
00254501138
PHENOBARB
TAB 16.2MG
00254501238
PHENOBARB
TAB 32.4MG
00254501328
PHENOBARB
00254501338
1
$2.16
0.05%
0
$0.00
0.00%
44
$147.69
2.02%
242
$836.42
11.12%
161
$550.42
0
12
38
161
1
$3.85
0.05%
1
$11.11
0.05%
66
$187.32
2.99%
282
$685.18
12.77%
7.40%
124
$316.60
5.61%
$0.00
0.00%
1
$4.58
0.05%
$73.10
0.55%
2
$9.45
0.09%
$131.77
1.75%
57
$190.96
2.58%
$590.19
7.40%
186
$673.56
8.42%
13
$31.54
0.60%
5
$16.31
0.23%
29
$109.23
1.33%
3
$10.04
0.14%
TAB 64.8MG
11
$31.27
0.51%
1
$0.42
0.05%
PHENOBARB
TAB 64.8MG
38
$130.08
1.75%
16
$53.66
0.72%
00254501428
PHENOBARB
TAB 97.2MG
2
$12.38
0.09%
3
$7.56
0.14%
00254906858
1
$3.47
0.05%
2
$7.04
0.09%
00254935558
PHENOBARB
ELX 20MG/5ML
1
$5.15
0.05%
0
$0.00
0.00%
00472101516
PHENOBARB
ELX 20MG/5ML
119
$714.44
5.47%
117
$618.69
5.30%
00603108858
00603150858
PHENOBARB
ELX 20MG/5ML
00603516521
PHENOBARB
00603516532
9
$35.13
0.41%
17
$66.97
0.77%
151
$897.68
6.94%
254
$1,411.80
11.50%
TAB 16.2MG
28
$102.44
1.29%
11
$29.67
0.50%
PHENOBARB
TAB 16.2MG
26
$93.46
1.19%
17
$48.47
0.77%
00603516621
PHENOBARB
TAB 32.4MG
47
$164.66
2.16%
12
$23.18
0.54%
00603516632
PHENOBARB
TAB 32.4MG
196
$691.00
9.00%
264
$565.45
11.95%
00603516721
PHENOBARB
TAB 64.8MG
92
$322.57
4.23%
100
$196.63
4.53%
00603516732
PHENOBARB
TAB 64.8MG
103
$367.47
4.73%
97
$306.61
4.39%
00603516821
PHENOBARB
TAB 97.2MG
60
$339.93
2.76%
45
$219.01
2.04%
00603516832
PHENOBARB
TAB 97.2MG
6
$29.92
0.28%
9
$42.21
0.41%
Page 98 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
BARBITURATE
00615046353
PHENOBARB
TAB 32.4MG
21
$79.76
0.96%
0
00615046363
PHENOBARB
TAB 32.4MG
37
$137.14
1.70%
00641047625
PHENOBARB
INJ 65MG/ML
0
$0.00
0.00%
00641047725
PHENOBARB
INJ 130MG/ML
1
$45.38
00677166610
PHENOBARB
TAB 30MG
54
00677166710
PHENOBARB
TAB 15MG
00677166810
PHENOBARB
TAB 64.8MG
00677169810
PHENOBARB
00677169910
$0.00
0.00%
0
$0.00
0.00%
2
$12.62
0.09%
0.05%
0
$0.00
0.00%
$190.91
2.48%
1
$3.85
0.05%
17
$50.86
0.78%
0
$0.00
0.00%
2
$7.82
0.09%
0
$0.00
0.00%
TAB 64.8MG
31
$108.70
1.42%
27
$70.30
1.22%
PHENOBARB
TAB 97.2MG
3
$11.22
0.14%
6
$10.44
0.27%
00677173210
PHENOBARB
TAB 30MG
4
$12.56
0.18%
16
$33.91
0.72%
00781109110
PHENOBARB
TAB 15MG
2
$7.07
0.09%
2
$2.38
0.09%
00781111010
PHENOBARB
TAB 30MG
1
$3.68
0.05%
0
$0.00
0.00%
00781660516
25
$114.80
1.15%
1
$3.56
0.05%
00904130016
9
$48.21
0.41%
12
$41.77
0.54%
00904381580
PHENOBARB
TAB 15MG
3
$9.57
0.14%
4
$7.60
0.18%
51660078510
PHENOBARB
TAB 30MG
2
$6.36
0.09%
0
$0.00
0.00%
51660078610
PHENOBARB
TAB 60MG
1
$5.37
0.05%
5
$13.33
0.23%
51991008051
SOMNOTE
CAP 500MG
21
$526.90
0.96%
29
$1,350.73
1.31%
51991008052
SOMNOTE
CAP 500MG
9
$297.28
0.41%
9
$390.68
0.41%
60432053316
121
$577.84
5.56%
154
$729.00
6.97%
63304067901
SECONAL
1
$6.06
0.05%
1
$11.26
0.05%
63304074101
PHENOBARB
TAB 15MG
14
$45.08
0.64%
6
$14.01
0.27%
63304074201
PHENOBARB
TAB 30MG
16
$56.88
0.73%
6
$13.97
0.27%
63304074210
PHENOBARB
TAB 30MG
6
$24.34
0.28%
8
$29.91
0.36%
63304074301
PHENOBARB
TAB 60MG
9
$32.42
0.41%
11
$35.23
0.50%
63304074310
PHENOBARB
TAB 60MG
27
$99.81
1.24%
19
$59.97
0.86%
63304074401
PHENOBARB
TAB 100MG
28
$170.23
1.29%
28
$166.00
1.27%
CAP 100MG
Page 99 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
BARBITURATE
64125090110
PHENOBARB
TAB 30MG
29
$35.21
1.33%
47
$107.09
2.13%
64125090210
PHENOBARB
TAB 60MG
13
$19.19
0.60%
31
$52.78
1.40%
64125090301
PHENOBARB
TAB 100MG
2
$5.44
0.09%
11
$45.47
0.50%
64125091510
PHENOBARB
TAB 15MG
15
$29.49
0.69%
11
$35.28
0.50%
TAB 200MG
3
$296.13
100.00%
0
$0.00
0.00%
BEPRIDIL
00045068233
VASCOR
BETA - ADRENERGICS
00028007201
BRETHINE
TAB 2.5MG
12
$342.11
0.04%
13
$271.06
0.04%
00028010501
BRETHINE
TAB 5MG
12
$389.98
0.04%
4
$84.68
0.01%
00028750723
BRETHINE
INJ 1MG/ML
1
$136.01
0.00%
0
$0.00
0.00%
00054806311
ALBUTEROL
NEB 0.083%
20
$298.14
0.07%
6
$70.20
0.02%
00083016702
FORADIL
CAP AEROLIZE
0
$0.00
0.00%
4
$461.88
0.01%
00083016711
FORADIL
CAP AEROLIZE
2
$50.82
0.01%
0
$0.00
0.00%
00083016774
FORADIL
CAP AEROLIZE
169
$10,878.97
0.58%
236
$18,067.18
0.68%
00085020802
PROVENTIL
NEB 0.5%
3
$294.69
0.01%
0
$0.00
0.00%
00085061402
PROVENTIL
AER 90MCG
00085113201
PROVENTIL
AER HFA
00085140101
FORADIL
00089081521
92
$4,096.45
0.32%
27
$1,456.11
0.08%
649
$25,683.57
2.24%
278
$12,033.01
0.81%
0
$0.00
0.00%
224
$16,831.18
0.65%
MAXAIR AUTOH AER 200MCG
377
$22,737.97
1.30%
394
$27,916.85
1.14%
00093066116
ALBUTEROL
349
$3,566.12
1.20%
308
$3,760.20
0.89%
00115261101
TERBUTALINE TAB 2.5MG
25
$607.87
0.09%
51
$1,371.26
0.15%
00115262201
TERBUTALINE TAB 5MG
47
$1,514.15
0.16%
52
$1,820.29
0.15%
00172439018
ALBUTEROL
AER 90MCG
2,901
$43,780.50
10.01%
2,545
$28,796.85
7.38%
00172439019
ALBUTEROL
AER 90MCG RF
10
$139.90
0.03%
0
$0.00
0.00%
00172640544
ALBUTEROL
NEB 0.083%
730
$13,468.22
2.52%
1,153
$16,428.22
3.34%
CAP AEROLIZE
SYP 2MG/5ML
Page 100 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
BETA - ADRENERGICS
00172640549
ALBUTEROL
NEB 0.083%
00173032188
VENTOLIN
AER 90MCG
00173032198
VENTOLIN
AER 90MCG RF
00173046400
SEREVENT
00173046500
84
$2,129.72
0.29%
70
$1,321.60
0.20%
138
$5,340.09
0.48%
10
$485.58
0.03%
11
$322.25
0.04%
0
$0.00
0.00%
AER 21MCG/AC
3,068
$225,980.13
10.58%
42
$3,343.05
0.12%
SEREVENT
AER RF 21MCG
83
$5,836.68
0.29%
0
$0.00
0.00%
00173046700
SEREVENT
AER INS21MCG
1
$90.95
0.00%
0
$0.00
0.00%
00173052000
SEREVENT DIS AER 50MCG
0
$0.00
0.00%
1
$109.54
0.00%
00173052100
SEREVENT DIS AER 50MCG
236
$17,944.17
0.81%
2,621
$212,371.99
7.60%
00173068200
VENTOLIN HFA AER
21
$777.90
0.07%
10
$348.40
0.03%
00182601465
ALBUTEROL
NEB 0.5%
0
$0.00
0.00%
7
$108.35
0.02%
00378025501
ALBUTEROL
TAB 2MG
25
$230.70
0.09%
29
$589.35
0.08%
00378025505
ALBUTEROL
TAB 2MG
18
$172.92
0.06%
19
$455.74
0.06%
00378057201
ALBUTEROL
TAB 4MG
53
$265.83
0.18%
68
$851.14
0.20%
00378057205
ALBUTEROL
TAB 4MG
16
$85.10
0.06%
17
$173.08
0.05%
00378340172
ALBUTEROL
SYP 2MG/5ML
12
$118.34
0.04%
0
$0.00
0.00%
00451039850
VOLMAX
TAB 4MG ER
163
$8,661.85
0.56%
60
$2,976.88
0.17%
00451039860
VOLMAX
TAB 4MG ER
1
$47.63
0.00%
0
$0.00
0.00%
00451039950
VOLMAX
TAB 8 MG
58
$6,238.21
0.20%
16
$2,048.74
0.05%
00472082516
ALBUTEROL
SYP 2MG/5ML
60
$1,359.78
0.21%
82
$1,251.12
0.24%
00472083123
ALBUTEROL
NEB 0.083%
43
$1,076.16
0.15%
11
$326.85
0.03%
00472083160
ALBUTEROL
NEB 0.083%
70
$1,843.56
0.24%
26
$604.90
0.08%
00487950125
ALBUTEROL
NEB 0.083%
1
$37.85
0.00%
15
$326.25
0.04%
00487950160
ALBUTEROL
NEB 0.083%
00597007017
ALUPENT INH AER .65/ACT
00603100540
ALBUTEROL
00603142258
00677135901
0
$0.00
0.00%
83
$1,670.57
0.24%
39
$1,444.30
0.13%
22
$772.31
0.06%
2
$23.96
0.01%
0
$0.00
0.00%
METAPROTEREN SYP 10MG/5ML
1
$10.27
0.00%
1
$7.68
0.00%
ALBUTEROL
5
$43.71
0.02%
4
$70.18
0.01%
NEB 0.083%
TAB 2MG
Page 101 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
BETA - ADRENERGICS
00677136001
ALBUTEROL
TAB 4MG
11
$55.23
0.04%
13
$150.15
0.04%
00904765855
ALBUTEROL
NEB 0.5%
0
$0.00
0.00%
2
$15.90
0.01%
00904768116
ALBUTEROL
SYP 2MG/5ML
1
$5.25
0.00%
0
$0.00
0.00%
00904773117
ALBUTEROL
NEB 0.083%
1
$44.48
0.00%
0
$0.00
0.00%
24208034720
ALBUTEROL
NEB 0.5%
62
$730.72
0.21%
29
$361.41
0.08%
49502010501
ALBUTEROL
NEB 0.5%
95
$787.37
0.33%
386
$3,158.20
1.12%
49502033317
ALBUTEROL
AER 90MCG
166
$2,543.62
0.57%
50
$598.13
0.14%
49502067603
METAPROTEREN NEB 0.6%
3
$46.43
0.01%
2
$31.14
0.01%
49502067803
METAPROTEREN NEB 0.4%
1
$13.16
0.00%
1
$13.16
0.00%
49502069203
ACCUNEB
NEB .63MG/3M
21
$1,115.78
0.07%
21
$1,031.75
0.06%
49502069303
ACCUNEB
NEB 1.25MG/3
14
$666.93
0.05%
31
$1,837.89
0.09%
49502069703
ALBUTEROL
NEB 0.083%
1,211
$22,201.58
4.18%
1,688
$20,925.14
4.89%
49502069733
ALBUTEROL
NEB 0.083%
77
$866.37
0.27%
34
$345.11
0.10%
49502069760
ALBUTEROL
NEB 0.083%
557
$13,700.12
1.92%
616
$10,612.84
1.79%
49884025801
METAPROTEREN TAB 10MG
1
$38.58
0.00%
0
$0.00
0.00%
49884025901
METAPROTEREN TAB 20MG
1
$44.13
0.00%
2
$80.12
0.01%
50111080131
ALBUTEROL
AER 90MCG
195
$2,806.98
0.67%
604
$6,980.71
1.75%
50111080132
ALBUTEROL
AER 90MCG RF
0
$0.00
0.00%
1
$10.00
0.00%
50383074016
ALBUTEROL
SYP 2MG/5ML
219
$2,466.69
0.76%
278
$3,759.48
0.81%
50383074120
ALBUTEROL
NEB 0.5%
168
$1,732.17
0.58%
242
$2,391.09
0.70%
52555059417
ALBUTEROL
AER 90MCG
146
$2,181.95
0.50%
11
$113.48
0.03%
53489017601
ALBUTEROL
TAB 2MG
24
$180.19
0.08%
28
$552.24
0.08%
53489017605
ALBUTEROL
TAB 2MG
4
$21.41
0.01%
3
$50.82
0.01%
53489017701
ALBUTEROL
TAB 4MG
26
$111.34
0.09%
49
$584.43
0.14%
53489017705
ALBUTEROL
TAB 4MG
3
$15.03
0.01%
0
$0.00
0.00%
55953049940
ALBUTEROL
TAB 4MG
3
$13.83
0.01%
0
$0.00
0.00%
55953049970
ALBUTEROL
TAB 4MG
2
$8.58
0.01%
0
$0.00
0.00%
Page 102 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
BETA - ADRENERGICS
59930150006
ALBUTEROL
NEB 0.083%
134
$2,872.49
0.46%
65
$986.20
0.19%
59930150008
ALBUTEROL
NEB 0.083%
1,365
$25,369.23
4.71%
121
$1,747.97
0.35%
59930151005
ALBUTEROL
SYP 2MG/5ML
19
$262.36
0.07%
0
$0.00
0.00%
59930151504
ALBUTEROL
NEB 0.5%
367
$3,396.51
1.27%
112
$1,146.46
0.32%
59930151701
ALBUTEROL
NEB 0.083%
264
$4,295.97
0.91%
1,774
$23,512.13
5.14%
59930151702
ALBUTEROL
NEB 0.083%
0
$0.00
0.00%
90
$1,768.37
0.26%
59930153001
ALBUTEROL
TAB 4MG
3
$11.86
0.01%
0
$0.00
0.00%
59930156001
ALBUTEROL
AER 90MCG
11,342
$170,207.40
39.13%
14,220
$158,182.53
41.23%
59930156002
ALBUTEROL
AER 90MCG RF
18
$246.20
0.06%
9
$99.24
0.03%
59930164702
ALBUTEROL
NEB 0.5%
26
$203.21
0.09%
231
$1,965.89
0.67%
60432067630
METAPROTEREN NEB 5%
1
$40.57
0.00%
0
$0.00
0.00%
60505580209
METAPROTEREN SYP 10MG/5ML
1
$7.50
0.00%
0
$0.00
0.00%
62037079444
ALBUTEROL
2,146
$31,825.12
7.40%
4,336
$48,011.37
12.57%
63402051124
XOPENEX
NEB 0.31MG
26
$1,680.58
0.09%
21
$2,498.45
0.06%
63402051224
XOPENEX
NEB 0.63MG
445
$34,476.90
1.54%
271
$22,397.04
0.79%
63402051324
XOPENEX
NEB 1.25MG
206
$17,249.93
0.71%
164
$19,430.11
0.48%
65473075401
VOSPIRE ER TAB 4MG
4
$180.68
0.01%
13
$531.47
0.04%
65473075801
VOSPIRE ER TAB 8MG
1
$90.99
0.00%
3
$328.21
0.01%
66794000125
ALBUTEROL
NEB 0.083%
1
$11.98
0.00%
460
$6,724.32
1.33%
66794000130
ALBUTEROL
NEB 0.083%
0
$0.00
0.00%
2
$30.50
0.01%
66794000160
ALBUTEROL
NEB 0.083%
0
$0.00
0.00%
1
$12.95
0.00%
56
$1,917.65
3.49%
19
$625.07
1.10%
AER 90MCG
BETA - BLOCKERS - OPHTHALMIC
00006355803
TIMOPTIC-XE SOL 0.5% OP
00006889535
TIMOPTIC
SOL 0.25% OP
5
$114.25
0.31%
1
$17.10
0.06%
00006889635
TIMOPTIC
SOL 0.5% OP
9
$374.81
0.56%
2
$40.16
0.12%
00006889636
TIMOPTIC
SOL 0.5% OP
26
$962.54
1.62%
5
$190.80
0.29%
Page 103 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
TIMOPTIC
SOL 0.5% OP
00023438505
BETAGAN
SOL 0.5% OP
00023438510
BETAGAN
SOL 0.5% OP
00023438515
BETAGAN
SOL 0.5% OP
00065024605
$
Market Share*
00006969060
# of Scripts
$0.00
0.00%
2
$65.82
0.12%
2
$35.19
0.12%
0
$0.00
0.00%
8
$430.68
0.50%
0
$0.00
0.00%
5
$312.04
0.31%
2
$156.52
0.12%
BETOPTIC-S SUS 0.25% OP
210
$7,027.61
13.08%
262
$9,729.32
15.10%
00065024610
123
$7,214.60
7.66%
133
$8,376.08
7.67%
00065024615
76
$6,481.43
4.73%
66
$6,359.77
3.80%
00065024620
0
$0.00
0.00%
2
$81.56
0.12%
00364303954
LEVOBUNOLOL SOL 0.5% OP
6
$58.25
0.37%
3
$31.55
0.17%
00364307753
TIMOLOL MAL SOL 0.25% OP
0
$0.00
0.00%
3
$19.80
0.17%
00904524805
0
$0.00
0.00%
1
$5.35
0.06%
00904524810
1
$11.35
0.06%
0
$0.00
0.00%
00904524835
5
$84.25
0.31%
6
$49.60
0.35%
17478028812
0
$0.00
0.00%
1
$9.35
0.06%
24208027509
OPTIPRANOLOL SOL 0.3% OP
2
$58.78
0.12%
0
$0.00
0.00%
24208032405
73
$573.75
4.55%
25
$96.05
1.44%
24208032410
28
$333.80
1.74%
45
$271.25
2.59%
24208032415
23
$371.55
1.43%
18
$135.80
1.04%
24208033005
10
$68.75
0.62%
12
$52.45
0.69%
24208033010
9
$86.15
0.56%
10
$76.00
0.58%
24208033015
0
$0.00
0.00%
1
$10.60
0.06%
24208036705
CARTEOLOL
SOL OPHTH 1%
20
$341.00
1.25%
7
$101.35
0.40%
24208036710
CARTEOLOL
SOL OPHTH 1%
9
$265.65
0.56%
6
$172.60
0.35%
24208036715
CARTEOLOL
SOL OPHTH 1%
0
$0.00
0.00%
1
$42.10
0.06%
24208050505
24
$246.32
1.49%
31
$221.85
1.79%
24208050510
16
$220.65
1.00%
22
$206.85
1.27%
24208050515
17
$307.90
1.06%
23
$308.05
1.33%
0
Page 104 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
24208054510
58768000101
OCUPRESS
SOL 1% OP
58768000102
OCUPRESS
SOL 1% OP
60505055104
$
Market Share*
24208054505
# of Scripts
$8.05
0.06%
0
$0.00
0.00%
0
$0.00
0.00%
2
$25.50
0.12%
18
$301.30
1.12%
0
$0.00
0.00%
14
$507.11
0.87%
8
$435.47
0.46%
1
$15.85
0.06%
0
$0.00
0.00%
60505055302
4
$53.00
0.25%
0
$0.00
0.00%
60505055303
5
$93.50
0.31%
1
$1.00
0.06%
60758006005
2
$16.60
0.12%
2
$9.70
0.12%
60758006010
4
$53.00
0.25%
4
$37.90
0.23%
60758006015
3
$56.10
0.19%
8
$102.80
0.46%
60758080105
2
$24.70
0.12%
0
$0.00
0.00%
60758080110
5
$82.25
0.31%
4
$33.90
0.23%
60758080115
2
$31.70
0.12%
1
$6.85
0.06%
61314022405
TIMOLOL GEL SOL 0.25% OP
36
$811.99
2.24%
25
$488.14
1.44%
61314022505
463
$13,862.48
28.83%
521
$13,535.98
30.03%
61314022525
9
$182.89
0.56%
3
$87.42
0.17%
61314022605
4
$18.70
0.25%
35
$228.99
2.02%
61314022610
8
$76.95
0.50%
10
$74.50
0.58%
61314022615
1
$12.10
0.06%
1
$13.10
0.06%
61314022705
66
$460.10
4.11%
165
$775.05
9.51%
61314022710
54
$655.61
3.36%
62
$401.20
3.57%
61314022715
16
$275.10
1.00%
25
$180.90
1.44%
61314022905
10
$69.90
0.62%
8
$35.25
0.46%
61314022910
8
$110.00
0.50%
21
$230.85
1.21%
61314022915
2
$38.40
0.12%
4
$56.40
0.23%
61314023805
CARTEOLOL
SOL OPHTH 1%
17
$279.02
1.06%
40
$575.49
2.31%
61314023810
CARTEOLOL
SOL OPHTH 1%
13
$381.05
0.81%
14
$404.40
0.81%
1
Page 105 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
61314023815
CARTEOLOL
SOL OPHTH 1%
2
$61.70
0.12%
1
$30.85
0.06%
61314024501
BETAXOLOL
SOL 0.5% OP
7
$162.73
0.44%
1
$23.39
0.06%
61314024502
BETAXOLOL
SOL 0.5% OP
1
$53.07
0.06%
0
$0.00
0.00%
61314024503
BETAXOLOL
SOL 0.5% OP
3
$120.36
0.19%
1
$33.35
0.06%
65086052205
BETIMOL
SOL 0.25%
6
$79.93
0.37%
4
$74.64
0.23%
65086052210
BETIMOL
SOL 0.25%
16
$411.74
1.00%
11
$311.20
0.63%
65086052215
BETIMOL
SOL 0.25%
1
$39.85
0.06%
3
$136.05
0.17%
65086052505
BETIMOL
SOL 0.5%
15
$301.70
0.93%
15
$334.38
0.86%
65086052510
BETIMOL
SOL 0.5%
14
$490.18
0.87%
15
$548.85
0.86%
65086052515
BETIMOL
SOL 0.5%
10
$478.30
0.62%
11
$586.89
0.63%
53
$770.22
10.66%
68
$619.44
10.01%
BETA BLOCKERS - ALPHA / BETA
00172436460
LABETALOL
TAB 100MG
00172436470
LABETALOL
TAB 100MG
8
$104.80
1.61%
0
$0.00
0.00%
00172436560
LABETALOL
TAB 200MG
49
$1,239.04
9.86%
49
$968.53
7.22%
00172436570
LABETALOL
TAB 200MG
13
$249.15
2.62%
24
$566.62
3.53%
00172436660
LABETALOL
TAB 300MG
16
$400.64
3.22%
23
$346.35
3.39%
00185001001
LABETALOL
TAB 100MG
34
$556.10
6.84%
111
$1,317.21
16.35%
00185001005
LABETALOL
TAB 100MG
3
$37.55
0.60%
7
$60.62
1.03%
00185011701
LABETALOL
TAB 200MG
72
$1,874.63
14.49%
180
$4,128.47
26.51%
00185011705
LABETALOL
TAB 200MG
12
$215.05
2.41%
34
$781.06
5.01%
00185011801
LABETALOL
TAB 300MG
28
$796.94
5.63%
51
$1,151.30
7.51%
00185011805
LABETALOL
TAB 300MG
3
$66.45
0.60%
3
$47.55
0.44%
00591060501
LABETALOL
TAB 100MG
22
$301.00
4.43%
23
$270.65
3.39%
00591060505
LABETALOL
TAB 100MG
5
$93.75
1.01%
5
$70.05
0.74%
00591060601
LABETALOL
TAB 200MG
38
$1,158.98
7.65%
28
$889.66
4.12%
00591060605
LABETALOL
TAB 200MG
11
$366.90
2.21%
1
$47.42
0.15%
Page 106 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
BETA BLOCKERS - ALPHA / BETA
00591060701
LABETALOL
TAB 300MG
18
$583.35
3.62%
6
00677170101
LABETALOL
TAB 100MG
2
$30.70
0.40%
00677170301
LABETALOL
TAB 300MG
0
$0.00
0.00%
52544060501
LABETALOL
TAB 100MG
27
$376.55
52544060601
LABETALOL
TAB 200MG
20
52544060605
LABETALOL
TAB 200MG
52544060701
LABETALOL
TAB 300MG
53489035401
LABETALOL
53489035405
$140.10
0.88%
0
$0.00
0.00%
2
$76.70
0.29%
5.43%
14
$132.08
2.06%
$393.20
4.02%
11
$221.17
1.62%
2
$2.00
0.40%
3
$79.89
0.44%
9
$175.99
1.81%
0
$0.00
0.00%
TAB 100MG
10
$146.00
2.01%
5
$59.20
0.74%
LABETALOL
TAB 100MG
0
$0.00
0.00%
7
$116.35
1.03%
53489035501
LABETALOL
TAB 200MG
25
$659.90
5.03%
3
$149.76
0.44%
53489035505
LABETALOL
TAB 200MG
1
$6.99
0.20%
6
$110.72
0.88%
53489035601
LABETALOL
TAB 300MG
5
$167.15
1.01%
0
$0.00
0.00%
53489035605
LABETALOL
TAB 300MG
0
$0.00
0.00%
6
$105.10
0.88%
59930163601
LABETALOL
TAB 200MG
8
$136.55
1.61%
7
$122.09
1.03%
59930165301
LABETALOL
TAB 300MG
0
$0.00
0.00%
1
$18.35
0.15%
60976034843
TRANDATE
TAB 300MG
1
$69.83
0.20%
0
$0.00
0.00%
65483039210
TRANDATE
TAB 200MG
0
$0.00
0.00%
1
$1.00
0.15%
65483039310
TRANDATE
TAB 300MG
2
$139.66
0.40%
0
$0.00
0.00%
BETA BLOCKERS - CARDIO SELECTIVE
00005321834
ATENOLOL
TAB 25MG
4
$18.00
0.02%
1
$1.33
0.00%
00005321843
ATENOLOL
TAB 25MG
2
$9.38
0.01%
1
$2.91
0.00%
00005322034
ATENOLOL
TAB 100MG
1
$5.10
0.00%
0
$0.00
0.00%
00005381638
ZEBETA
TAB 5MG
17
$768.97
0.07%
2
$57.42
0.01%
00005381738
ZEBETA
TAB 10MG
4
$240.86
0.02%
0
$0.00
0.00%
00025510131
KERLONE
7
$192.57
0.03%
0
$0.00
0.00%
00028005101
LOPRESSOR
67
$3,408.85
0.26%
28
$1,802.52
0.08%
TAB 10MG
TAB 50MG
Page 107 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00028005110
LOPRESSOR
TAB 50MG
10
$179.55
0.04%
1
$27.03
0.00%
00028007101
LOPRESSOR
TAB 100MG
15
$918.13
0.06%
7
$562.36
0.02%
00028007110
LOPRESSOR
TAB 100MG
4
$243.34
0.02%
0
$0.00
0.00%
00093073301
METOPROLOL TAB 50MG
216
$972.32
0.84%
1
$3.55
0.00%
00093073310
METOPROLOL TAB 50MG
2,739
$14,015.22
10.59%
3,566
$12,834.92
10.55%
00093073401
METOPROLOL TAB 100MG
218
$1,590.19
0.84%
297
$1,714.12
0.88%
00093073410
504
$3,949.85
1.95%
616
$3,586.83
1.82%
00093075210
ATENOLOL
10
$45.18
0.04%
18
$82.99
0.05%
00185077101
BISOPROL FUM TAB 5MG
2
$38.54
0.01%
5
$76.25
0.01%
00185077130
47
$1,546.30
0.18%
34
$584.25
0.10%
00185077401
BISOPRO FUM TAB 10MG
0
$0.00
0.00%
1
$28.99
0.00%
00185077430
BISOPRO FUM TAB 10MG
3
$99.54
0.01%
2
$57.98
0.01%
00186108805
TOPROL XL
TAB 25MG
365
$7,482.40
1.41%
905
$18,321.82
2.68%
00186108839
TOPROL XL
TAB 25MG
7
$143.45
0.03%
8
$104.91
0.02%
00186109005
TOPROL XL
TAB 50MG
1,019
$21,893.16
3.94%
1,741
$37,427.63
5.15%
00186109039
TOPROL XL
TAB 50MG
1
$1.00
0.00%
3
$6.27
0.01%
00186109205
TOPROL XL
TAB 100MG
542
$17,458.03
2.10%
1,004
$35,300.00
2.97%
00186109239
TOPROL XL
TAB 100MG
0
$0.00
0.00%
2
$68.65
0.01%
00186109405
TOPROL XL
TAB 200MG
183
$10,245.86
0.71%
310
$16,756.73
0.92%
00310010110
TENORMIN
TAB 100MG
15
$1,450.03
0.06%
3
$232.72
0.01%
00310010510
TENORMIN
TAB 50MG
33
$1,970.20
0.13%
6
$224.78
0.02%
00310010710
TENORMIN
TAB 25MG
13
$419.05
0.05%
5
$175.15
0.01%
00364251301
ATENOLOL
TAB 50MG
5
$26.77
0.02%
0
$0.00
0.00%
00364251302
ATENOLOL
TAB 50MG
39
$195.22
0.15%
6
$30.90
0.02%
00364251401
ATENOLOL
TAB 100MG
37
$209.68
0.14%
11
$73.70
0.03%
00378003201
METOPROLOL TAB 50MG
506
$2,780.45
1.96%
654
$2,457.43
1.93%
00378003210
METOPROLOL TAB 50MG
1,273
$6,386.48
4.92%
3,161
$14,456.64
9.35%
TAB 50MG
Page 108 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00378004701
195
$1,485.59
0.75%
234
$1,458.75
0.69%
00378004710
233
$1,728.59
0.90%
392
$2,615.51
1.16%
00378021801
ATENOLOL
TAB 25MG
540
$3,313.56
2.09%
725
$5,454.44
2.14%
00378021810
ATENOLOL
TAB 25MG
736
$4,500.91
2.85%
137
$1,104.74
0.41%
00378023101
ATENOLOL
TAB 50MG
433
$2,173.27
1.67%
578
$2,727.82
1.71%
00378023110
ATENOLOL
TAB 50MG
969
$4,716.51
3.75%
1,330
$6,931.31
3.93%
00378075701
ATENOLOL
TAB 100MG
408
$2,683.87
1.58%
603
$4,813.66
1.78%
00378120001
ACEBUTOLOL CAP 200MG
29
$622.75
0.11%
33
$503.00
0.10%
00378140001
17
$449.75
0.07%
11
$249.05
0.03%
00591046201
METOPROLOL TAB 50MG
0
$0.00
0.00%
4
$13.30
0.01%
00591046210
METOPROLOL TAB 50MG
11
$55.15
0.04%
20
$81.40
0.06%
00591046301
3
$21.15
0.01%
1
$5.05
0.00%
00591577701
ATENOLOL
TAB 50MG
33
$167.88
0.13%
27
$122.95
0.08%
00591577710
ATENOLOL
TAB 50MG
992
$4,974.08
3.84%
377
$1,882.77
1.12%
00591577801
ATENOLOL
TAB 100MG
271
$1,766.09
1.05%
459
$3,610.13
1.36%
00615353253
ATENOLOL
TAB 50MG
258
$1,197.49
1.00%
0
$0.00
0.00%
00615353263
ATENOLOL
TAB 50MG
32
$159.69
0.12%
0
$0.00
0.00%
00615354453
ATENOLOL
TAB 25MG
77
$484.85
0.30%
0
$0.00
0.00%
00615354463
ATENOLOL
TAB 25MG
403
$2,206.43
1.56%
0
$0.00
0.00%
00615355253
METOPROLOL TAB 50MG
501
$2,626.59
1.94%
0
$0.00
0.00%
00615355263
METOPROLOL TAB 50MG
278
$1,338.53
1.07%
0
$0.00
0.00%
00615355353
11
$66.94
0.04%
0
$0.00
0.00%
00615355363
14
$122.50
0.05%
0
$0.00
0.00%
00677147810
ATENOLOL
TAB 50MG
1
$4.24
0.00%
2
$11.24
0.01%
00677147901
ATENOLOL
TAB 100MG
6
$33.60
0.02%
4
$33.20
0.01%
00677148210
METOPROLOL TAB 50MG
16
$95.53
0.06%
29
$107.65
0.09%
00781107801
ATENOLOL
1,381
$8,753.19
5.34%
1,847
$14,339.66
5.46%
TAB 25MG
Page 109 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
$
Market Share*
TAB 25MG
# of Scripts
00781107810
ATENOLOL
00781122301
METOPROLOL TAB 50MG
00781122310
METOPROLOL TAB 50MG
00781122801
00781122810
00781150601
ATENOLOL
TAB 50MG
114
$536.53
0.44%
120
$550.44
0.35%
00781150610
ATENOLOL
TAB 50MG
2,987
$14,767.98
11.55%
3,502
$15,958.41
10.36%
00781150613
ATENOLOL
TAB 50MG
4
$16.97
0.02%
0
$0.00
0.00%
00781150701
ATENOLOL
TAB 100MG
916
$6,417.58
3.54%
990
$7,759.27
2.93%
00781150710
ATENOLOL
TAB 100MG
226
$1,411.21
0.87%
400
$3,383.22
1.18%
00904539280
ATENOLOL
TAB 25MG
0
$0.00
0.00%
4
$19.27
0.01%
00904794660
METOPROLOL TAB 50MG
0
$0.00
0.00%
3
$14.30
0.01%
00904794680
METOPROLOL TAB 50MG
5
$33.15
0.02%
229
$845.62
0.68%
00904794780
0
$0.00
0.00%
11
$81.70
0.03%
49884058701
3
$57.45
0.01%
6
$105.90
0.02%
49884058801
2
$32.50
0.01%
6
$82.50
0.02%
51079068420
ATENOLOL
6
$12.52
0.02%
1
$1.40
0.00%
51079080120
METOPROLOL TAB 50MG
52152017902
BETAXOLOL
52544046210
TAB 50MG
1,719
$10,236.87
6.65%
2,249
$17,252.75
6.65%
0
$0.00
0.00%
36
$215.51
0.14%
1
$3.21
0.00%
4
$23.45
0.01%
1
$7.05
0.00%
14
$93.03
0.04%
18
$124.60
0.07%
6
$45.30
0.02%
3
$12.31
0.01%
14
$60.92
0.04%
10
$352.36
0.04%
12
$525.09
0.04%
METOPROLOL TAB 50MG
3
$13.60
0.01%
0
$0.00
0.00%
52544046301
13
$110.75
0.05%
8
$67.70
0.02%
53489036601
METOPROLOL TAB 50MG
4
$28.95
0.02%
7
$24.85
0.02%
53489036610
METOPROLOL TAB 50MG
159
$853.12
0.61%
173
$692.02
0.51%
53489036701
21
$168.05
0.08%
8
$48.04
0.02%
53489036710
28
$192.54
0.11%
47
$259.31
0.14%
53489052901
ATENOLOL
TAB 50MG
0
$0.00
0.00%
105
$503.74
0.31%
53489052910
ATENOLOL
TAB 50MG
3
$14.83
0.01%
1,442
$6,662.71
4.27%
TAB 10MG
Page 110 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
53489053001
ATENOLOL
TAB 100MG
0
53489053010
ATENOLOL
TAB 100MG
53489053601
ATENOLOL
TAB 25MG
53489053610
ATENOLOL
$0.00
0.00%
0
$0.00
0.00%
5
$46.93
0.02%
TAB 25MG
22
$130.58
0.09%
53489055501
BISOPROLOL TAB 5MG
0
$0.00
53489055507
BISOPROLOL TAB 5MG
0
53489055601
BISOPROLOL TAB 10MG
0
55953072740
METOPROLOL TAB 50MG
55953072780
METOPROLOL TAB 50MG
57664016608
METOPROLOL TAB 50MG
124
$643.24
0.48%
57664016618
METOPROLOL TAB 50MG
2,936
$15,491.86
11.35%
57664016708
110
$793.41
0.43%
57664016718
518
$4,057.93
59772369205
METOPROLOL TAB 50MG
72
59772369302
6
59911706001
62269025630
ATENOLOL
62269025724
62269025930
13
$90.25
0.04%
2
$11.60
0.01%
151
$1,031.26
0.45%
817
$5,857.68
2.42%
0.00%
10
$195.55
0.03%
$0.00
0.00%
4
$55.00
0.01%
$0.00
0.00%
3
$193.89
0.01%
6
$18.63
0.02%
0
$0.00
0.00%
2
$11.10
0.01%
0
$0.00
0.00%
61
$215.05
0.18%
3,223
$12,205.98
9.53%
94
$674.39
0.28%
2.00%
823
$4,875.48
2.43%
$383.19
0.28%
19
$89.35
0.06%
$43.80
0.02%
3
$15.15
0.01%
7
$179.21
0.03%
0
$0.00
0.00%
TAB 50MG
6
$29.61
0.02%
3
$10.89
0.01%
ATENOLOL
TAB 100MG
1
$9.10
0.00%
2
$10.70
0.01%
ATENOLOL
TAB 25MG
8
$40.86
0.03%
3
$21.09
0.01%
63739002801
ATENOLOL
TAB 50MG
0
$0.00
0.00%
2
$5.62
0.01%
63739017301
METOPROLOL TAB 50MG
6
$9.45
0.02%
0
$0.00
0.00%
BETA BLOCKERS - NON SELECTIVE
00003020750
CORGARD
TAB 40MG
8
$478.14
0.15%
3
$129.88
0.05%
00003024150
CORGARD
TAB 80MG
3
$412.62
0.05%
0
$0.00
0.00%
00007413920
COREG
TAB 3.125MG
231
$18,647.58
4.22%
254
$21,737.85
3.88%
00007413955
COREG
TAB 3.125MG
4
$361.56
0.07%
0
$0.00
0.00%
Page 111 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
COREG
TAB 6.25MG
00007414055
COREG
TAB 6.25MG
00007414120
COREG
TAB 12.5MG
00007414220
COREG
TAB 25MG
00046042181
INDERAL
00046042281
00046042481
$
Market Share*
00007414020
# of Scripts
$24,175.75
5.09%
$27,637.38
4.77%
0
$0.00
0.00%
208
$17,567.19
3.80%
1
$90.89
0.02%
189
$16,254.76
2.89%
138
$12,854.12
2.52%
147
$12,291.46
2.25%
TAB 10MG
4
$145.64
0.07%
0
$0.00
0.00%
INDERAL
TAB 20MG
7
INDERAL
TAB 40MG
8
$439.86
0.13%
1
$68.71
0.02%
$434.62
0.15%
6
$445.56
0.09%
00046042681
INDERAL
TAB 60MG
1
$6.00
0.02%
1
$31.31
0.02%
00046047081
INDERAL LA CAP 60MG
332
$11,657.24
6.06%
408
$14,291.67
6.23%
00046047181
INDERAL LA CAP 80MG
461
$19,838.76
8.42%
660
$29,261.25
10.08%
00046047381
INDERAL LA CAP 120MG
248
$13,338.89
4.53%
333
$19,694.79
5.09%
00046047981
INDERAL LA CAP 160MG
144
$10,033.16
2.63%
189
$13,645.17
2.89%
00054372763
PROPRANOLOL SOL 20MG/5ML
13
$157.93
0.24%
22
$261.97
0.34%
00054373063
PROPRANOLOL SOL 40MG/5ML
1
$6.53
0.02%
0
$0.00
0.00%
00093106001
SOTALOL HCL TAB 120MG
65
$8,417.62
1.19%
73
$2,037.15
1.12%
00093106101
162
$15,640.60
2.96%
192
$3,826.08
2.93%
00093106201
14
$2,191.48
0.26%
22
$878.80
0.34%
00093106301
3
$801.06
0.05%
3
$117.75
0.05%
00115271101
7
$782.89
0.13%
4
$140.30
0.06%
00172421760
PINDOLOL
TAB 5MG
8
$92.56
0.15%
13
$116.58
0.20%
00172421860
PINDOLOL
TAB 10MG
18
$229.78
0.33%
20
$328.93
0.31%
00172423560
NADOLOL
TAB 20MG
46
$871.37
0.84%
15
$130.89
0.23%
00172423570
NADOLOL
TAB 20MG
1
$9.20
0.02%
13
$101.25
0.20%
00172423660
NADOLOL
TAB 40MG
53
$1,275.20
0.97%
26
$200.10
0.40%
00172423760
NADOLOL
TAB 80MG
10
$181.75
0.18%
5
$48.75
0.08%
00172423860
NADOLOL
TAB 120MG
3
$71.55
0.05%
3
$33.15
0.05%
00172423960
NADOLOL
TAB 160MG
0
$0.00
0.00%
1
$26.15
0.02%
279
312
Page 112 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00182181389
PROPRANOLOL TAB 20MG
1
$4.97
0.02%
0
00185017001
21
$3,703.87
0.38%
00185017101
65
$5,542.34
1.19%
00185017105
0
$0.00
00185017701
6
00228232996
00364075601
00364075602
00364075701
$0.00
0.00%
22
$637.40
0.34%
54
$1,002.18
0.82%
0.00%
4
$82.70
0.06%
$582.55
0.11%
0
$0.00
0.00%
2
$14.16
0.04%
0
$0.00
0.00%
35
$253.98
0.64%
4
$32.72
0.06%
9
$66.74
0.16%
1
$5.11
0.02%
0
$0.00
0.00%
1
$7.20
0.02%
00364075702
30
$261.35
0.55%
20
$122.15
0.31%
00364075801
6
$51.45
0.11%
0
$0.00
0.00%
00364075802
35
$261.89
0.64%
20
$149.58
0.31%
00364076001
14
$126.44
0.26%
1
$23.65
0.02%
00364076005
3
$36.41
0.05%
0
$0.00
0.00%
00378002801
NADOLOL
TAB 20MG
82
$1,427.86
1.50%
125
$1,108.32
1.91%
00378005201
PINDOLOL
TAB 5MG
31
$428.71
0.57%
31
$300.77
0.47%
00378005501
TIMOLOL MAL TAB 5MG
15
$225.76
0.27%
16
$217.76
0.24%
00378012701
PINDOLOL
19
$266.99
0.35%
21
$281.52
0.32%
00378018201
4
$15.04
0.07%
0
$0.00
0.00%
00378018210
79
$565.03
1.44%
141
$911.44
2.15%
00378018301
2
$15.16
0.04%
2
$18.62
0.03%
00378018310
72
$629.82
1.31%
162
$1,227.20
2.47%
00378018401
0
$0.00
0.00%
4
$26.88
0.06%
00378018410
43
$385.78
0.79%
91
$701.53
1.39%
00378018501
3
$18.81
0.05%
8
$80.62
0.12%
00378018505
20
$271.46
0.37%
18
$230.02
0.27%
00378022101
TIMOLOL MAL TAB 10MG
15
$386.87
0.27%
22
$450.59
0.34%
TAB 10MG
Page 113 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
00378031001
00378071501
00378113201
NADOLOL
00378117101
$
Market Share*
00378030501
# of Scripts
39
$3,857.98
0.71%
20
$474.36
0.31%
SOTALOL HCL TAB 120 MG
8
$1,198.62
0.15%
11
$276.85
0.17%
TIMOLOL MAL TAB 20MG
0
$0.00
0.00%
2
$83.60
0.03%
TAB 80MG
21
$343.82
0.38%
55
$544.84
0.84%
NADOLOL
TAB 40MG
46
$1,069.10
0.84%
109
$1,182.94
1.67%
00378117110
NADOLOL
TAB 40MG
2
$30.44
0.04%
2
$13.70
0.03%
00591555401
90
$696.74
1.64%
79
$428.24
1.21%
00591555410
50
$342.31
0.91%
58
$329.09
0.89%
00591555501
64
$590.62
1.17%
82
$523.06
1.25%
00591555510
131
$1,120.05
2.39%
91
$689.25
1.39%
00591555601
56
$505.06
1.02%
57
$435.27
0.87%
00591555610
63
$530.31
1.15%
29
$207.22
0.44%
00591555701
8
$85.28
0.15%
19
$150.19
0.29%
00591555705
10
$93.48
0.18%
12
$105.26
0.18%
00603549132
4
$42.47
0.07%
3
$30.49
0.05%
00603549221
1
$9.15
0.02%
0
$0.00
0.00%
00615256153
44
$320.60
0.80%
0
$0.00
0.00%
00615256163
3
$30.57
0.05%
0
$0.00
0.00%
00615256253
33
$244.84
0.60%
0
$0.00
0.00%
00615256263
26
$228.51
0.47%
0
$0.00
0.00%
00615256353
8
$53.10
0.15%
0
$0.00
0.00%
00615256363
15
$154.34
0.27%
0
$0.00
0.00%
00677145701
PINDOLOL
TAB 5MG
1
$8.75
0.02%
0
$0.00
0.00%
00677145801
PINDOLOL
TAB 10MG
0
$0.00
0.00%
1
$7.61
0.02%
00677170901
8
$1,834.63
0.15%
10
$215.08
0.15%
00781116901
PINDOLOL
3
$46.80
0.05%
0
$0.00
0.00%
00781138405
0
$0.00
0.00%
4
$19.32
0.06%
TAB 10MG
Page 114 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
00904041480
49884058201
49884058210
49884058301
49884058401
50111046701
$
Market Share*
00904041280
# of Scripts
$7.08
0.02%
$14.40
0.03%
2
$15.88
0.04%
48
$4,872.77
0.88%
0
$0.00
0.00%
39
$751.37
0.60%
0
$0.00
0.00%
36
$664.36
0.55%
10
$1,410.91
0.18%
46
$1,111.40
0.70%
2
$207.06
0.04%
17
$115.85
0.31%
0
$0.00
0.00%
42
$283.21
0.64%
50111046703
257
$2,010.30
4.69%
343
$2,124.64
5.24%
50111046801
11
$74.23
0.20%
30
$185.69
0.46%
50111046803
366
50111046901
17
$2,908.07
6.68%
492
$3,371.98
7.52%
$147.07
0.31%
19
$150.66
0.29%
50111046903
263
$2,243.67
4.80%
462
$3,341.77
7.06%
50111047001
85
$735.42
1.55%
87
$669.95
1.33%
50111047101
50
$593.06
0.91%
61
$650.92
0.93%
50111047102
29
$253.20
0.53%
30
$239.47
0.46%
50419010510
BETAPACE
TAB 80MG
5
$727.34
0.09%
3
$363.90
0.05%
50419010910
BETAPACE
TAB 120MG
6
$1,588.56
0.11%
9
$2,013.39
0.14%
50419011506
BETAPACE AF TAB 80MG
37
$4,107.63
0.68%
8
$1,000.68
0.12%
50419011511
4
$284.56
0.07%
0
$0.00
0.00%
50419011606
3
$681.70
0.05%
4
$1,022.16
0.06%
50419011906
0
$0.00
0.00%
4
$817.92
0.06%
52544030801
2
$18.88
0.04%
0
$0.00
0.00%
52544035201
1
$9.35
0.02%
0
$0.00
0.00%
55953008840
PINDOLOL
TAB 5MG
1
$11.57
0.02%
0
$0.00
0.00%
55953008870
PINDOLOL
TAB 5MG
3
$27.66
0.05%
0
$0.00
0.00%
59772246101
NADOLOL
TAB 20MG
131
$2,556.32
2.39%
177
$1,354.32
2.70%
59772246201
NADOLOL
TAB 40MG
175
$3,246.45
3.20%
162
$1,409.40
2.47%
1
2
Page 115 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
59772246203
NADOLOL
TAB 40MG
6
$126.90
0.11%
6
$65.10
0.09%
59772246301
NADOLOL
TAB 80MG
75
$1,603.45
1.37%
74
$872.35
1.13%
59772246303
NADOLOL
TAB 80MG
0
$0.00
0.00%
2
$23.50
0.03%
59772246401
NADOLOL
TAB 120MG
17
$667.95
0.31%
18
$304.30
0.27%
59772246501
NADOLOL
TAB 160MG
2
$96.94
0.04%
6
$179.14
0.09%
59911547001
PROPRANOLOL CAP 60MG LA
4
$97.50
0.07%
1
$19.44
0.02%
59911547101
5
$171.90
0.09%
1
$33.88
0.02%
59911547301
9
$358.82
0.16%
1
$41.79
0.02%
59911547901
6
$544.10
0.11%
1
$42.85
0.02%
60505008000
0
$0.00
0.00%
27
$595.11
0.41%
60505008100
0
$0.00
0.00%
2
$60.50
0.03%
60505015900
0
$0.00
0.00%
9
$251.94
0.14%
60505022201
SOTALOL AF TAB 80MG
0
$0.00
0.00%
3
$414.60
0.05%
60505022301
SOTALOL AF TAB 120MG
0
$0.00
0.00%
1
$208.53
0.02%
61570020001
CORGARD
TAB 20MG
1
$39.99
0.02%
0
$0.00
0.00%
61570020101
CORGARD
TAB 40MG
0
$0.00
0.00%
1
$61.96
0.02%
65726025010
INNOPRAN XL CAP 80MG
0
$0.00
0.00%
8
$198.50
0.12%
65726025025
INNOPRAN XL CAP 80MG
0
$0.00
0.00%
1
$31.84
0.02%
TAB 40/5
6
$218.04
0.90%
0
$0.00
0.00%
BETA BLOCKERS AND DIURETIC COMBOS
00003028350
CORZIDE
00005323423
ZIAC
TAB 5/6.25MG
5
$185.70
0.75%
1
$38.01
0.14%
00005323538
ZIAC
TAB 10/6.25
5
$101.37
0.75%
3
$86.75
0.41%
00005323823
ZIAC
TAB 2.5/6.25
7
$360.35
1.05%
0
$0.00
0.00%
00006006768
TIMOLIDE
4
$95.99
0.60%
3
$74.61
0.41%
00028003501
LOPRESS HCT TAB 50/25MG
6
$182.32
0.90%
2
$36.10
0.27%
00028005301
8
$383.38
1.20%
3
$144.84
0.41%
TAB 10/25
Page 116 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
00185070101
00185070105
$
Market Share*
00028007301
# of Scripts
8
$362.96
1.20%
1
$51.15
0.14%
BISOPRL/HCTZ TAB 2.5/6.25
19
$158.80
2.85%
39
$301.60
5.34%
0
$0.00
0.00%
1
$17.95
0.14%
00185070130
5
$42.75
0.75%
7
$45.85
0.96%
00185070401
BISOPRL/HCTZ TAB 5/6.25MG
35
$350.05
5.25%
71
$535.73
9.73%
00185070405
3
$25.65
0.45%
0
$0.00
0.00%
00185070430
2
$17.10
0.30%
0
$0.00
0.00%
00185070701
BISOPRL/HCTZ TAB 10/6.25
14
$131.10
2.10%
42
$401.35
5.75%
00185070730
9
$69.40
1.35%
8
$52.40
1.10%
00228265010
2
$17.10
0.30%
0
$0.00
0.00%
00310011510
TENORETIC
TAB -50
3
$196.11
0.45%
1
$40.67
0.14%
00310011710
TENORETIC
TAB -100
3
$162.09
0.45%
0
$0.00
0.00%
00364252701
ATENOL/CHLOR TAB 50-25MG
3
$24.42
0.45%
0
$0.00
0.00%
00378034701
PROPRAN/HCTZ TAB 80/25
4
$34.97
0.60%
5
$28.82
0.68%
00378050101
34
$362.80
5.10%
50
$375.50
6.85%
00378050301
60
$579.85
9.00%
70
$600.35
9.59%
00378050501
47
$452.00
7.05%
54
$467.79
7.40%
00378073101
PROPRAN/HCTZ TAB 40/25
1
$5.16
0.15%
4
$12.64
0.55%
00378206301
34
$347.88
5.10%
68
$519.04
9.32%
00378206401
5
$63.60
0.75%
12
$123.76
1.64%
00591084101
15
$139.15
2.25%
12
$105.94
1.64%
00591084105
2
$28.00
0.30%
4
$26.20
0.55%
00591084201
26
$226.80
3.90%
24
$233.76
3.29%
00591084205
2
$17.10
0.30%
3
$19.65
0.41%
00591084330
23
$232.98
3.45%
11
$78.41
1.51%
00591578201
34
$303.95
5.10%
46
$365.43
6.30%
00591578301
21
$233.45
3.15%
29
$292.33
3.97%
Page 117 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
00677148101
00781182401
00781183301
00781184101
00904788160
51285004702
52544084101
$
Market Share*
00677148001
# of Scripts
$147.26
2.40%
4
$42.63
0.55%
3
$75.42
0.45%
6
$104.49
0.82%
36
$302.95
5.40%
8
$39.77
1.10%
32
$310.25
4.80%
14
$118.63
1.92%
23
$216.10
3.45%
5
$45.25
0.68%
0
$0.00
0.00%
6
$36.84
0.82%
ZIAC
0
$0.00
0.00%
4
$132.22
0.55%
23
$186.17
3.45%
0
$0.00
0.00%
52544084105
3
$25.65
0.45%
0
$0.00
0.00%
52544084201
11
$130.10
1.65%
0
$0.00
0.00%
52544084330
10
$87.50
1.50%
0
$0.00
0.00%
53489053101
34
$348.89
5.10%
84
$612.77
11.51%
53489053201
21
$238.58
3.15%
24
$221.79
3.29%
61570017501
CORZIDE
0
$0.00
0.00%
1
$51.01
0.14%
55
$274.20
0.23%
82
$361.97
0.28%
TAB 2.5/6.25
TAB 40/5
16
BETA-LACTAMS / CLAVULANATE COMBOS
00003010120
TRIMOX
CAP 250MG
00003010150
TRIMOX
CAP 250MG
22
$117.96
0.09%
8
$37.58
0.03%
00003010160
TRIMOX
CAP 250MG
499
$2,532.58
2.05%
606
$2,640.61
2.07%
00003010920
TRIMOX
CAP 500MG
295
$1,907.72
1.21%
384
$2,114.51
1.31%
00003010955
TRIMOX
CAP 500MG
35
$218.97
0.14%
10
$51.94
0.03%
00003010960
TRIMOX
CAP 500MG
1,834
$11,883.72
7.54%
2,374
$12,443.36
8.10%
00003011550
VEETIDS
TAB 250MG
11
$67.33
0.05%
1
$9.01
0.00%
00003011575
VEETIDS
TAB 250MG
217
$1,489.68
0.89%
72
$561.72
0.25%
00003011650
VEETIDS
TAB 500MG
37
$182.12
0.15%
8
$75.99
0.03%
00003011675
VEETIDS
TAB 500MG
142
$709.25
0.58%
35
$328.39
0.12%
00003012250
PRINCIPEN CAP 250MG
48
$375.15
0.20%
23
$214.42
0.08%
Page 118 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00003012260
PRINCIPEN CAP 250MG
4
$27.13
0.02%
3
$15.45
0.01%
00003013450
PRINCIPEN CAP 500MG
81
$498.38
0.33%
53
$489.54
0.18%
00003013460
PRINCIPEN CAP 500MG
9
$54.32
0.04%
2
$16.00
0.01%
00003068144
VEETIDS
SOL 125/5ML
7
$48.31
0.03%
3
$22.95
0.01%
00003068154
VEETIDS
SOL 125/5ML
34
$223.38
0.14%
25
$164.24
0.09%
00003068244
VEETIDS
SOL 250/5ML
79
$476.76
0.32%
90
$534.37
0.31%
00003068254
VEETIDS
SOL 250/5ML
201
$1,357.48
0.83%
225
$1,521.16
0.77%
00003097252
PRINCIPEN SUS 250/5ML
1
$5.30
0.00%
0
$0.00
0.00%
00003097261
PRINCIPEN SUS 250/5ML
1
$6.75
0.00%
0
$0.00
0.00%
00003173730
TRIMOX
SUS 125/5ML
40
$218.79
0.16%
51
$276.45
0.17%
00003173740
TRIMOX
SUS 125/5ML
62
$362.69
0.25%
76
$441.02
0.26%
00003173745
TRIMOX
SUS 125/5ML
344
$2,210.51
1.41%
365
$2,352.51
1.25%
00003173830
TRIMOX
SUS 250/5ML
201
$1,950.26
0.83%
230
$2,344.78
0.78%
00003173840
TRIMOX
SUS 250/5ML
489
$5,430.03
2.01%
711
$7,945.80
2.43%
00003173845
TRIMOX
SUS 250/5ML
1,658
$16,991.32
6.82%
1,969
$20,285.50
6.72%
00008002135
BICILLIN L-A INJ 1200000U
2
$36.46
0.01%
0
$0.00
0.00%
00015710328
OXACILLIN INJ 10GM
1
$172.67
0.00%
0
$0.00
0.00%
00015722620
NAFCILLIN
INJ 2GM
0
$0.00
0.00%
1
$12.94
0.00%
00015740420
AMPICILLIN INJ 1GM
1
$22.88
0.00%
0
$0.00
0.00%
00015785640
DYNAPEN
4
$83.27
0.02%
3
$159.14
0.01%
00015797018
OXACILLIN INJ 2GM
5
$910.72
0.02%
0
$0.00
0.00%
00015798120
OXACILLIN INJ 1GM
0
$0.00
0.00%
1
$15.01
0.00%
00029600630
AMOXIL
CAP 250MG
17
$86.08
0.07%
6
$37.40
0.02%
00029600632
AMOXIL
CAP 250MG
11
$55.50
0.05%
21
$86.79
0.07%
00029600730
AMOXIL
CAP 500MG
1
$7.94
0.00%
0
$0.00
0.00%
00029600732
AMOXIL
CAP 500MG
128
$780.82
0.53%
135
$732.79
0.46%
00029600821
AMOXIL
SUS 125/5ML
3
$16.49
0.01%
0
$0.00
0.00%
SUS 62.5/5ML
Page 119 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
AMOXIL
SUS 125/5ML
00029600921
AMOXIL
SUS 250/5ML
00029600922
AMOXIL
SUS 250/5ML
00029600923
AMOXIL
SUS 250/5ML
00029603520
AMOXIL
00029603839
00029604412
$
Market Share*
00029600822
# of Scripts
$1,326.82
0.92%
$1,172.28
0.62%
3
$20.20
0.01%
773
$6,763.74
3.18%
2
$12.40
0.01%
906
$8,284.44
3.09%
263
$2,366.94
1.08%
302
$3,034.93
1.03%
DRO 50MG/ML
3
$20.31
0.01%
6
$34.21
0.02%
AMOXIL
DRO 50MG/ML
13
AMOXIL
CHW 200MG
2
$91.55
0.05%
12
$85.20
0.04%
$25.20
0.01%
0
$0.00
0.00%
00029604512
AMOXIL
CHW 400MG
7
$114.30
0.03%
3
$45.31
0.01%
00029604520
AMOXIL
CHW 400MG
5
$90.55
0.02%
1
$10.55
0.00%
00029604712
00029604720
AMOXIL
TAB 875MG
1
$15.80
0.00%
0
$0.00
0.00%
AMOXIL
TAB 875MG
3
$56.10
0.01%
10
$175.92
0.03%
00029604854
AMOXIL
SUS 200/5ML
5
$56.86
0.02%
1
$7.79
0.00%
00029604855
AMOXIL
SUS 200/5ML
4
$70.39
0.02%
7
$115.98
0.02%
00029604859
AMOXIL
SUS 200/5ML
169
$2,273.75
0.69%
79
$1,050.82
0.27%
00029604954
AMOXIL
SUS 400/5ML
85
$1,166.91
0.35%
51
$645.62
0.17%
00029604955
AMOXIL
SUS 400/5ML
70
$1,031.70
0.29%
39
$613.20
0.13%
00029604959
AMOXIL
SUS 400/5ML
1,098
$16,739.22
4.52%
418
$6,788.45
1.43%
00029607112
AUGMENTIN
CHW 200MG
4
$187.38
0.02%
4
$128.25
0.01%
00029607212
AUGMENTIN
CHW 400MG
79
$6,059.83
0.32%
72
$5,733.12
0.25%
00029607347
AUGMENTIN
CHW 125MG
0
$0.00
0.00%
2
$48.41
0.01%
00029607447
AUGMENTIN
CHW 250MG
29
$2,205.51
0.12%
21
$1,768.86
0.07%
00029607527
AUGMENTIN
TAB 250MG
117
$7,355.58
0.48%
109
$6,537.33
0.37%
00029607531
AUGMENTIN
TAB 250MG
12
$138.14
0.05%
12
$103.80
0.04%
00029608012
AUGMENTIN
TAB 500MG
396
$28,377.53
1.63%
540
$45,687.80
1.84%
00029608031
AUGMENTIN
TAB 500MG
10
$80.66
0.04%
14
$354.02
0.05%
00029608522
AUGMENTIN
SUS 125/5ML
35
$1,327.56
0.14%
36
$1,545.76
0.12%
00029608523
AUGMENTIN
SUS 125/5ML
5
$139.57
0.02%
3
$86.67
0.01%
224
182
Page 120 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
AUGMENTIN
SUS 125/5ML
00029608612
AUGMENTIN
00029608621
AUGMENTIN
00029608729
$
Market Share*
00029608539
# of Scripts
1
$58.68
0.00%
5
$148.53
0.02%
TAB 875MG
861
$79,402.14
3.54%
1,278
$129,399.14
4.36%
TAB 875MG
0
$0.00
0.00%
4
$398.94
0.01%
AUGMENTIN
SUS 200/5ML
10
$309.98
0.04%
6
$205.67
0.02%
00029608739
AUGMENTIN
SUS 200/5ML
6
$168.92
0.02%
2
$56.22
0.01%
00029608751
AUGMENTIN
SUS 200/5ML
90
$3,453.28
0.37%
49
$2,037.18
0.17%
00029609022
AUGMENTIN
SUS 250/5ML
179
$13,916.55
0.74%
155
$12,527.12
0.53%
00029609023
AUGMENTIN
SUS 250/5ML
67
$4,541.42
0.28%
74
$5,420.09
0.25%
00029609039
AUGMENTIN
SUS 250/5ML
42
$1,993.63
0.17%
44
$2,307.38
0.15%
00029609229
AUGMENTIN
SUS 400/5ML
56
$2,716.83
0.23%
33
$1,768.56
0.11%
00029609239
AUGMENTIN
SUS 400/5ML
69
$4,346.80
0.28%
32
$2,131.11
0.11%
00029609251
AUGMENTIN
SUS 400/5ML
287
$22,405.78
1.18%
192
$16,755.40
0.66%
00029609422
AUGMENTIN
SUS ES-600
131
$9,077.37
0.54%
12
$1,050.59
0.04%
00029609424
AUGMENTIN
SUS ES-600
0
$0.00
0.00%
191
$16,928.51
0.65%
00029609429
AUGMENTIN
SUS ES-600
100
$5,253.48
0.41%
6
$493.19
0.02%
00029609439
AUGMENTIN
SUS ES-600
135
$5,772.17
0.56%
400
$19,114.29
1.36%
00029609445
AUGMENTIN
SUS ES-600
0
$0.00
0.00%
667
$40,377.48
2.28%
00029609451
AUGMENTIN
SUS ES-600
601
$31,623.78
2.47%
35
$2,109.95
0.12%
00029609628
AUGMENTIN XR TAB SR 12HR
4
$271.62
0.02%
63
$5,565.59
0.21%
00029609640
36
$3,161.47
0.15%
274
$23,662.20
0.93%
00029609648
0
$0.00
0.00%
31
$2,445.14
0.11%
00029609660
0
$0.00
0.00%
333
$29,055.58
1.14%
00029615033
BEEPEN-VK
TAB 250MG
10
$48.26
0.04%
0
$0.00
0.00%
00029616032
BEEPEN-VK
TAB 500MG
2
$9.60
0.01%
0
$0.00
0.00%
00029655226
TICAR
1
$97.07
0.00%
0
$0.00
0.00%
00029657126
TIMENTIN
2
$607.70
0.01%
0
$0.00
0.00%
00047040424
AMPICILLIN CAP 500MG
1
$5.58
0.00%
0
$0.00
0.00%
INJ 3GM
INJ 3.1GM
Page 121 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00047064824
PENICILLN VK TAB 250MG
3
$17.67
0.01%
0
$0.00
0.00%
00049003183
UNASYN
INJ 1.5GM
1
$158.04
0.00%
0
$0.00
0.00%
00049003283
UNASYN
INJ 3GM
2
$722.62
0.01%
0
$0.00
0.00%
00093117101
7
$29.27
0.03%
0
$0.00
0.00%
00093117110
40
$174.88
0.16%
11
$36.86
0.04%
00093117201
12
$42.67
0.05%
0
$0.00
0.00%
00093117210
25
$88.37
0.10%
2
$6.53
0.01%
00093117301
27
$136.27
0.11%
5
$22.70
0.02%
00093117310
28
$139.32
0.12%
12
$51.13
0.04%
00093117410
11
$59.86
0.05%
0
$0.00
0.00%
00093226301
AMOXICILLIN TAB 500
4
$42.41
0.02%
1
$10.45
0.00%
00093226401
AMOXICILLIN TAB 875MG
500
$8,763.81
2.06%
712
$13,008.05
2.43%
00093226701
AMOXICILLIN CHW 125MG
2
$14.80
0.01%
4
$23.20
0.01%
00093226801
390
$3,072.65
1.60%
239
$2,127.76
0.82%
00093226805
32
$255.46
0.13%
33
$294.59
0.11%
00093227434
AMOX/K CLAV TAB 500MG
127
$8,635.79
0.52%
164
$11,800.15
0.56%
00093227534
369
$31,985.57
1.52%
364
$28,826.92
1.24%
00093310701
AMOXICILLIN CAP 250MG
7
$35.18
0.03%
27
$116.70
0.09%
00093310705
284
$1,309.64
1.17%
248
$983.14
0.85%
00093310905
524
$3,158.80
2.15%
653
$3,349.46
2.23%
00093310953
25
$157.99
0.10%
24
$132.47
0.08%
00093312301
DICLOXACILL CAP 250MG
18
$185.58
0.07%
16
$249.21
0.05%
00093312501
20
$192.38
0.08%
27
$603.61
0.09%
00093412574
PENICILLN VK SOL 125/5ML
1
$6.25
0.00%
0
$0.00
0.00%
00093412773
8
$40.34
0.03%
2
$16.60
0.01%
00093412774
5
$34.90
0.02%
0
$0.00
0.00%
00093415073
AMOXICILLIN SUS 125/5ML
12
$68.34
0.05%
17
$98.95
0.06%
Page 122 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00093415079
7
$36.33
0.03%
00093415080
64
$403.79
0.26%
00093415573
65
$712.97
0.27%
00093415579
43
$383.19
0.18%
00093415580
277
$2,857.63
1.14%
00093416073
0
$0.00
00093416173
0
$0.00
00093416176
0
00093416178
0
00093514501
00093514505
00093514601
00093514605
00093519401
00093519410
00093519501
00093519505
00093519874
00093519973
00093519974
00206845406
ZOSYN
00206882102
$30.17
0.02%
46
$299.24
0.16%
149
$1,573.81
0.51%
65
$631.03
0.22%
412
$4,189.25
1.41%
0.00%
93
$1,106.35
0.32%
0.00%
655
$9,907.91
2.23%
$0.00
0.00%
5
$76.44
0.02%
$0.00
0.00%
19
$261.31
0.06%
2
$12.87
0.01%
25
$141.75
0.09%
19
$105.44
0.08%
29
$129.98
0.10%
15
$95.35
0.06%
35
$377.37
0.12%
5
$27.39
0.02%
18
$231.69
0.06%
13
$73.63
0.05%
115
$795.83
0.39%
123
$654.29
0.51%
196
$1,654.41
0.67%
118
$598.00
0.49%
100
$1,043.93
0.34%
1,002
$4,731.24
4.12%
1,422
$14,009.26
4.85%
1
$6.25
0.00%
2
$13.03
0.01%
18
$95.57
0.07%
24
$157.99
0.08%
113
$730.37
0.46%
143
$959.46
0.49%
INJ 3GM/.37G
1
$45.66
0.00%
0
$0.00
0.00%
ZOSYN
SOL 3GM/.375
4
$668.38
0.02%
8
$3,006.52
0.03%
00206882202
ZOSYN
SOL 4GM/.50G
1
$222.88
0.00%
0
$0.00
0.00%
00781120501
32
$234.73
0.13%
75
$677.64
0.26%
00781120510
224
$1,734.28
0.92%
376
$3,578.20
1.28%
00781161966
AMOX/K CLAV CHW 200MG
4
$129.84
0.02%
4
$116.03
0.01%
00781164366
AMOX/K CLAV CHW 400MG
74
$5,272.76
0.30%
55
$4,073.38
0.19%
5
Page 123 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00781165501
1,339
00781165510
00781183120
00781185220
$6,760.43
5.51%
1,796
$18,414.37
6.13%
467
$2,329.95
1.92%
614
$5,702.86
2.09%
389
$28,249.06
1.60%
87
$4,609.69
0.30%
968
$87,825.24
3.98%
132
$9,652.74
0.45%
00781202005
20
$101.39
0.08%
1
$2.76
0.00%
00781261305
7
$43.08
0.03%
1
$4.67
0.00%
00781610246
AMOX/K CLAV SUS 200/5ML
128
$4,474.91
0.53%
55
$2,205.96
0.19%
00781610446
301
$19,771.96
1.24%
170
$12,093.37
0.58%
49884057810
2
$9.96
0.01%
0
$0.00
0.00%
51079061520
0
$0.00
0.00%
1
$7.73
0.00%
51079061620
1
$2.60
0.00%
0
$0.00
0.00%
55370088007
2
$19.75
0.01%
10
$86.22
0.03%
55370088008
1
$4.60
0.00%
2
$20.93
0.01%
55370088107
9
$55.55
0.04%
19
$198.85
0.06%
55370088313
AMPICILLIN SUS 250/5ML
0
$0.00
0.00%
1
$9.20
0.00%
55370088340
AMPICILLIN SUS 250/5ML
2
$2.00
0.01%
0
$0.00
0.00%
55370088407
0
$0.00
0.00%
4
$12.97
0.01%
55370088408
108
$537.92
0.44%
271
$1,163.47
0.92%
55370088507
1
$6.78
0.00%
0
$0.00
0.00%
55370088508
873
$5,598.26
3.59%
1,283
$7,250.61
4.38%
55370088613
2
$10.72
0.01%
2
$14.74
0.01%
55370088614
88
$566.52
0.36%
42
$270.55
0.14%
55370088680
6
$29.40
0.02%
2
$9.92
0.01%
55370088713
47
$480.16
0.19%
34
$347.83
0.12%
55370088714
240
$2,390.16
0.99%
136
$1,338.60
0.46%
55370088780
13
$139.00
0.05%
12
$109.62
0.04%
55370089207
2
$20.45
0.01%
0
$0.00
0.00%
Page 124 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
55953067347
55953071670
$
Market Share*
55370089208
# of Scripts
1
$8.95
0.00%
0
$0.00
0.00%
2
$17.58
0.01%
0
$0.00
0.00%
16
$94.79
0.07%
0
$0.00
0.00%
59772604801
58
$542.56
0.24%
97
$1,546.60
0.33%
59772605801
100
$1,030.11
0.41%
153
$3,612.19
0.52%
61570014710
BICILLIN L-A INJ 600000U
0
$0.00
0.00%
2
$582.16
0.01%
63304050901
0
$0.00
0.00%
53
$4,486.53
0.18%
63304050920
0
$0.00
0.00%
53
$4,376.76
0.18%
63304051401
0
$0.00
0.00%
1
$10.55
0.00%
63304051501
433
$3,397.51
1.78%
552
$5,094.55
1.88%
63304051504
22
$170.27
0.09%
37
$341.03
0.13%
63304065401
43
$186.91
0.18%
26
$100.76
0.09%
63304065405
182
$886.77
0.75%
172
$693.58
0.59%
63304065501
84
$500.79
0.35%
62
$309.31
0.21%
63304065505
621
$3,995.54
2.55%
396
$2,033.96
1.35%
63304071320
0
$0.00
0.00%
24
$1,827.69
0.08%
63304076020
3
$50.68
0.01%
0
$0.00
0.00%
63304076101
76
$989.26
0.31%
125
$923.01
0.43%
63304076120
128
$1,868.18
0.53%
213
$1,641.18
0.73%
63304076301
91
$1,743.50
0.37%
135
$2,395.88
0.46%
63304076305
0
$0.00
0.00%
2
$30.64
0.01%
63304076320
48
$996.75
0.20%
64
$1,011.01
0.22%
63304096901
0
$0.00
0.00%
4
$60.99
0.01%
63304096903
0
$0.00
0.00%
1
$11.34
0.00%
63304096904
0
$0.00
0.00%
45
$566.48
0.15%
63304097001
AMOXICILLIN SUS 400MG/5M
0
$0.00
0.00%
42
$578.70
0.14%
63304097003
0
$0.00
0.00%
30
$380.90
0.10%
Page 125 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
63304097004
0
$0.00
0.00%
379
$5,181.40
1.29%
63304097704
0
$0.00
0.00%
3
$104.46
0.01%
63304097901
0
$0.00
0.00%
1
$44.08
0.00%
63304097903
0
$0.00
0.00%
1
$95.09
0.00%
63304097904
0
$0.00
0.00%
15
$886.50
0.05%
66685100100
0
$0.00
0.00%
422
$34,502.63
1.44%
66685100200
0
$0.00
0.00%
186
$15,309.98
0.63%
66685101100
0
$0.00
0.00%
8
$226.05
0.03%
66685101101
0
$0.00
0.00%
12
$389.97
0.04%
66685101102
0
$0.00
0.00%
44
$1,444.58
0.15%
66685101200
0
$0.00
0.00%
21
$963.73
0.07%
66685101201
0
$0.00
0.00%
50
$2,717.36
0.17%
66685101202
0
$0.00
0.00%
106
$6,935.72
0.36%
67253020010
0
$0.00
0.00%
3
$29.61
0.01%
67253020011
0
$0.00
0.00%
5
$40.71
0.02%
67253020110
0
$0.00
0.00%
45
$447.12
0.15%
67253020150
0
$0.00
0.00%
118
$1,202.59
0.40%
4
$120.92
23.53%
11
$469.06
61.11%
TAB 10/11-28
13
$321.32
76.47%
7
$133.97
38.89%
BI-PHASIC COMBINATIONS
00062177115
ORTHO-NOVUM TAB 10/11-28
52544055428
NECON
BPH
00006007231
PROSCAR
TAB 5MG
89
$5,970.16
1.94%
63
$4,515.10
1.21%
00006007258
PROSCAR
TAB 5MG
354
$23,987.53
7.74%
287
$19,178.73
5.50%
00024420010
UROXATRAL
0
$0.00
0.00%
3
$153.38
0.06%
00049276066
CARDURA
14
$467.43
0.31%
1
$47.42
0.02%
TAB 10MG
TAB 2MG
Page 126 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
BPH
00049277066
CARDURA
TAB 4MG
22
$632.49
0.48%
3
$102.82
0.06%
00049278066
CARDURA
00074380513
HYTRIN
CAP 1MG
TAB 8MG
4
$133.56
0.09%
1
$35.07
0.02%
0
$0.00
0.00%
1
$57.16
0.02%
00074380613
HYTRIN
CAP 2MG
10
$758.68
0.22%
3
$156.47
0.06%
00074380711
HYTRIN
CAP 5MG
0
$0.00
0.00%
1
$60.61
0.02%
00074380713
HYTRIN
CAP 5MG
12
$652.94
0.26%
4
$154.66
0.08%
00074380813
HYTRIN
CAP 10MG
15
$816.68
0.33%
3
$171.48
0.06%
00083010330
ISMELIN
TAB 25MG
2
$51.48
0.04%
0
$0.00
0.00%
00093076001
TERAZOSIN
CAP 1MG
0
$0.00
0.00%
14
$155.20
0.27%
00093076101
TERAZOSIN
CAP 2MG
29
$434.15
0.63%
50
$515.80
0.96%
00093076201
TERAZOSIN
CAP 5MG
56
$850.60
1.22%
58
$649.30
1.11%
00093076301
TERAZOSIN
CAP 10MG
31
$452.85
0.68%
16
$201.10
0.31%
00093812001
DOXAZOSIN TAB 1MG
3
$24.75
0.07%
10
$75.80
0.19%
00093812101
DOXAZOSIN TAB 2MG
10
$92.80
0.22%
17
$117.93
0.33%
00093812201
DOXAZOSIN TAB 4MG
13
$110.88
0.28%
23
$209.45
0.44%
00093812301
DOXAZOSIN TAB 8MG
5
$41.25
0.11%
10
$73.50
0.19%
00172368560
DOXAZOSIN TAB 1MG
17
$168.37
0.37%
61
$495.47
1.17%
00172368570
DOXAZOSIN TAB 1MG
18
$174.60
0.39%
0
$0.00
0.00%
00172368660
DOXAZOSIN TAB 2MG
58
$536.92
1.27%
70
$563.24
1.34%
00172368670
DOXAZOSIN TAB 2MG
23
$190.54
0.50%
46
$420.78
0.88%
00172368760
DOXAZOSIN TAB 4MG
94
$974.40
2.05%
61
$527.98
1.17%
00172368770
DOXAZOSIN TAB 4MG
18
$168.60
0.39%
44
$428.22
0.84%
00172368780
DOXAZOSIN TAB 4MG
2
$28.00
0.04%
0
$0.00
0.00%
00172368860
DOXAZOSIN TAB 8MG
67
$706.05
1.46%
37
$346.05
0.71%
00172368870
DOXAZOSIN TAB 8MG
0
$0.00
0.00%
10
$91.70
0.19%
00172433660
TERAZOSIN
CAP 1MG
4
$48.40
0.09%
0
$0.00
0.00%
00172433760
TERAZOSIN
CAP 2MG
6
$68.10
0.13%
0
$0.00
0.00%
Page 127 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
BPH
00172433860
TERAZOSIN
CAP 5MG
3
$34.05
0.07%
0
$0.00
0.00%
00173071200
AVODART
CAP 0.5MG
0
$0.00
0.00%
11
$733.93
0.21%
00173071201
AVODART
CAP 0.5MG
0
$0.00
0.00%
1
$36.60
0.02%
00228264211
DOXAZOSIN TAB 1MG
3
$28.93
0.07%
5
$31.25
0.10%
00228264311
DOXAZOSIN TAB 2MG
7
$56.84
0.15%
8
$68.26
0.15%
00228264411
DOXAZOSIN TAB 4MG
17
$168.09
0.37%
1
$20.45
0.02%
00228264511
DOXAZOSIN TAB 8MG
2
$17.70
0.04%
0
$0.00
0.00%
00378157001
TERAZOSIN
CAP 10MG
32
$387.80
0.70%
68
$823.30
1.30%
00378226001
TERAZOSIN
CAP 1MG
10
$100.15
0.22%
21
$204.25
0.40%
00378226401
TERAZOSIN
CAP 2MG
42
$694.90
0.92%
130
$1,737.43
2.49%
00378226801
TERAZOSIN
CAP 5MG
28
$295.56
0.61%
121
$1,512.90
2.32%
00378402101
DOXAZOSIN TAB 1MG
0
$0.00
0.00%
1
$6.25
0.02%
00378402201
DOXAZOSIN TAB 2MG
5
$60.35
0.11%
2
$17.90
0.04%
00378402401
DOXAZOSIN TAB 4MG
0
$0.00
0.00%
18
$150.35
0.34%
00591064001
DOXAZOSIN TAB 2MG
9
$74.25
0.20%
0
$0.00
0.00%
00591064101
DOXAZOSIN TAB 4MG
14
$141.00
0.31%
0
$0.00
0.00%
00597005801
FLOMAX
CAP 0.4MG
1,676
$92,416.62
36.63%
1,028
$55,508.30
19.69%
00615133853
TERAZOSIN
CAP 2MG
24
$351.00
0.52%
0
$0.00
0.00%
00615133863
TERAZOSIN
CAP 2MG
11
$108.35
0.24%
0
$0.00
0.00%
00781205101
TERAZOSIN
CAP 1MG
146
$1,709.90
3.19%
258
$2,832.22
4.94%
00781205105
TERAZOSIN
CAP 1MG
2
$27.70
0.04%
0
$0.00
0.00%
00781205201
TERAZOSIN
CAP 2MG
270
$4,154.80
5.90%
560
$7,452.51
10.73%
00781205205
TERAZOSIN
CAP 2MG
0
$0.00
0.00%
1
$9.85
0.02%
00781205301
TERAZOSIN
CAP 5MG
343
$4,205.00
7.50%
332
$3,873.04
6.36%
00781205401
TERAZOSIN
CAP 10MG
155
$1,932.80
3.39%
130
$1,632.45
2.49%
00781500101
DOXAZOSIN TAB 1MG
4
$33.00
0.09%
0
$0.00
0.00%
00781500201
DOXAZOSIN TAB 2MG
27
$239.95
0.59%
34
$283.12
0.65%
Page 128 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
BPH
00781500301
DOXAZOSIN TAB 4MG
43
$436.70
0.94%
30
$294.18
0.57%
00781500401
DOXAZOSIN TAB 8MG
30
$332.00
0.66%
7
$66.75
0.13%
00904552260
DOXAZOSIN TAB 1MG
0
$0.00
0.00%
6
$43.62
0.11%
00904552360
DOXAZOSIN TAB 2MG
0
$0.00
0.00%
11
$79.15
0.21%
00904552460
DOXAZOSIN TAB 4MG
0
$0.00
0.00%
18
$181.35
0.34%
00904552560
DOXAZOSIN TAB 8MG
0
$0.00
0.00%
13
$136.75
0.25%
49884055201
DOXAZOSIN TAB 1MG
1
$18.55
0.02%
19
$125.20
0.36%
49884055301
DOXAZOSIN TAB 2MG
21
$233.65
0.46%
45
$361.07
0.86%
49884055401
DOXAZOSIN TAB 4MG
38
$430.93
0.83%
62
$626.04
1.19%
49884055501
DOXAZOSIN TAB 8MG
8
$87.80
0.17%
9
$70.65
0.17%
50111065101
DOXAZOSIN TAB 1MG
0
$0.00
0.00%
22
$120.78
0.42%
50111065201
DOXAZOSIN TAB 2MG
0
$0.00
0.00%
62
$437.74
1.19%
50111065301
DOXAZOSIN TAB 4MG
0
$0.00
0.00%
97
$826.07
1.86%
50111065401
DOXAZOSIN TAB 8MG
0
$0.00
0.00%
38
$322.10
0.73%
52544063901
DOXAZOSIN TAB 1MG
16
$131.50
0.35%
0
$0.00
0.00%
52544064001
DOXAZOSIN TAB 2MG
19
$176.85
0.42%
0
$0.00
0.00%
52544064101
DOXAZOSIN TAB 4MG
39
$385.65
0.85%
0
$0.00
0.00%
52544064201
DOXAZOSIN TAB 8MG
20
$232.00
0.44%
0
$0.00
0.00%
58177026604
DOXAZOSIN TAB 1MG
29
$293.41
0.63%
94
$770.02
1.80%
58177026704
DOXAZOSIN TAB 2MG
84
$802.41
1.84%
186
$1,388.28
3.56%
58177026722
DOXAZOSIN TAB 2MG
0
$0.00
0.00%
3
$42.45
0.06%
58177026804
DOXAZOSIN TAB 4MG
95
$940.11
2.08%
232
$1,988.30
4.44%
58177026904
DOXAZOSIN TAB 8MG
78
$853.27
1.70%
120
$1,094.90
2.30%
60505009300
DOXAZOSIN TAB 1MG
48
$371.83
1.05%
72
$552.37
1.38%
60505009400
DOXAZOSIN TAB 2MG
98
$808.95
2.14%
107
$821.82
2.05%
60505009401
DOXAZOSIN TAB 2MG
0
$0.00
0.00%
5
$41.25
0.10%
60505009500
DOXAZOSIN TAB 4MG
77
$745.05
1.68%
72
$714.04
1.38%
Page 129 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
BPH
60505009501
DOXAZOSIN TAB 4MG
0
$0.00
0.00%
5
$44.15
0.10%
60505009600
DOXAZOSIN TAB 8MG
26
$249.60
0.57%
25
$278.25
0.48%
60505011500
TERAZOSIN
CAP 1MG
0
$0.00
0.00%
13
$189.29
0.25%
60505011600
TERAZOSIN
CAP 2MG
0
$0.00
0.00%
46
$628.80
0.88%
60505011700
TERAZOSIN
CAP 5MG
0
$0.00
0.00%
46
$620.60
0.88%
60505011800
TERAZOSIN
CAP 10MG
0
$0.00
0.00%
12
$152.70
0.23%
63304066201
TERAZOSIN
CAP 1MG
0
$0.00
0.00%
36
$393.62
0.69%
63304066301
TERAZOSIN
CAP 2MG
0
$0.00
0.00%
26
$432.30
0.50%
63304066305
TERAZOSIN
CAP 2MG
0
$0.00
0.00%
2
$22.20
0.04%
63304066401
TERAZOSIN
CAP 5MG
0
$0.00
0.00%
40
$481.80
0.77%
63304066501
TERAZOSIN
CAP 10MG
0
$0.00
0.00%
12
$138.50
0.23%
BURN PRODUCTS
00088105085
SILVADENE
1
$18.74
0.27%
0
$0.00
0.00%
00591081046
SILVER SULFA CRE 1%
11
$181.01
3.01%
7
$144.27
1.83%
00591081055
SILVER SULFA CRE 1%
96
$1,003.02
26.23%
95
$1,208.57
24.80%
00591081083
SILVER SULFA CRE 1%
13
$110.06
3.55%
8
$48.78
2.09%
08880950550
THERMAZENE CRE 1%
0
$0.00
0.00%
2
$8.36
0.52%
08880950585
THERMAZENE CRE 1%
1
$9.10
0.27%
0
$0.00
0.00%
49884060036
SSD
CRE 1%
72
$572.72
19.67%
82
$594.57
21.41%
49884060040
SSD
CRE 1%
21
$489.92
5.74%
44
$1,049.80
11.49%
49884060057
SSD
CRE 1%
24
$157.17
6.56%
25
$165.46
6.53%
49884060058
SSD
CRE 1%
40
$314.70
10.93%
46
$352.16
12.01%
49884060085
SSD
CRE 1%
53
$622.13
14.48%
62
$809.28
16.19%
49884060136
SSD AF
CRE 1%
13
$123.65
3.55%
5
$40.45
1.31%
49884060140
SSD AF
CRE 1%
1
$27.51
0.27%
3
$83.53
0.78%
52544081046
SILVER SULFA CRE 1%
1
$11.51
0.27%
0
$0.00
0.00%
CRE 1%
Page 130 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
BURN PRODUCTS
52544081052
SILVER SULFA CRE 1%
6
$41.56
1.64%
0
52544081055
SILVER SULFA CRE 1%
3
$24.00
0.82%
52544081085
SILVER SULFA CRE 1%
0
$0.00
0.00%
61570013120
SILVADENE
CRE 1%
2
$116.49
61570013140
SILVADENE
CRE 1%
1
61570013150
SILVADENE
CRE 1%
$0.00
0.00%
0
$0.00
0.00%
2
$25.54
0.52%
0.55%
2
$13.00
0.52%
$40.27
0.27%
0
$0.00
0.00%
7
$81.76
1.91%
0
$0.00
0.00%
7
$2,035.39
87.50%
2
$219.10
100.00%
1
$1,263.17
12.50%
0
$0.00
0.00%
CARBAPENEMS
00006384371
INVANZ
00310032130
MERREM
INJ 1GM
INJ 1GM
CARBONIC ANHYDRASE INHIBITORS/COMBO
00006351903
TRUSOPT
SOL 2% OP
15
$473.94
1.38%
16
$530.30
1.33%
00006351910
TRUSOPT
SOL 2% OP
61
$2,636.72
5.62%
32
$1,515.96
2.67%
00006351935
TRUSOPT
SOL
87
$2,282.62
8.02%
92
$2,736.49
7.67%
00006351936
TRUSOPT
SOL
165
$8,036.67
15.21%
195
$10,028.77
16.26%
00006362803
COSOPT
SOL 2-.5% OP
123
$5,462.10
11.34%
58
$2,738.22
4.84%
00006362810
COSOPT
SOL 2-.5% OP
46
$3,527.01
4.24%
39
$2,674.48
3.25%
00006362835
COSOPT
SOL
208
$9,270.91
19.17%
272
$12,678.00
22.69%
00006362836
COSOPT
SOL
189
$15,225.29
17.42%
283
$23,815.21
23.60%
00065027505
AZOPT
SUS 1% OP
95
$2,850.37
8.76%
100
$3,149.14
8.34%
00065027510
AZOPT
SUS 1% OP
69
$3,615.12
6.36%
90
$5,127.69
7.51%
00065027515
AZOPT
SUS 1% OP
27
$2,151.26
2.49%
22
$1,762.86
1.83%
CARBOXYLIC ACID DERIVATIVES
00074382611
DEPAKOTE ER TAB 250 MG
0
$0.00
0.00%
2
$52.89
0.06%
00074382613
DEPAKOTE ER TAB 250 MG
5
$264.66
0.30%
518
$24,417.22
14.38%
Page 131 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
CARBOXYLIC ACID DERIVATIVES
00074712611
DEPAKOTE ER TAB 500MG
3
$245.96
0.18%
0
$0.00
0.00%
00074712613
1,674
$185,208.49
99.52%
3,072
$392,722.31
85.29%
00074712653
0
$0.00
0.00%
10
$1,054.63
0.28%
44
$580.84
0.72%
35
$556.63
0.58%
CARDIAC GLYCOSIDES
00054319246
DIGOXIN PED DRO 0.05/ML
00173024255
LANOXIN
TAB 0.125MG
147
$1,306.18
2.40%
98
$732.31
1.63%
00173024256
LANOXIN
TAB 0.125MG
7
$61.02
0.11%
12
$70.84
0.20%
00173024275
LANOXIN
TAB 0.125MG
945
$6,619.63
15.43%
854
$5,481.99
14.17%
00173024955
LANOXIN
TAB 0.25MG
143
$1,326.53
2.33%
80
$601.28
1.33%
00173024975
LANOXIN
TAB 0.25MG
545
$3,905.67
8.90%
437
$2,760.43
7.25%
00173024980
LANOXIN
TAB 0.25MG
54
$369.37
0.88%
32
$204.06
0.53%
00173026427
LANOXIN PED ELX 0.05/ML
53
$2,058.98
0.87%
36
$1,302.74
0.60%
00173027255
LANOXICAPS CAP 0.1MG
32
$348.20
0.52%
27
$265.23
0.45%
00173027455
LANOXICAPS CAP 0.2MG
20
$219.73
0.33%
11
$84.72
0.18%
00527132401
DIGOXIN
TAB 0.125MG
0
$0.00
0.00%
66
$540.92
1.10%
00527132410
DIGOXIN
TAB 0.125MG
11
$81.40
0.18%
153
$1,129.77
2.54%
00527132501
DIGOXIN
TAB 0.25MG
0
$0.00
0.00%
42
$310.90
0.70%
00527132510
DIGOXIN
TAB 0.25MG
7
$53.68
0.11%
136
$1,014.84
2.26%
00615456653
DIGITEK
TAB 0.125MG
168
$1,534.59
2.74%
0
$0.00
0.00%
00615456663
DIGITEK
TAB 0.125MG
466
$4,074.87
7.61%
0
$0.00
0.00%
00615456753
DIGITEK
TAB 0.25MG
56
$557.18
0.91%
0
$0.00
0.00%
00615456763
DIGITEK
TAB 0.25MG
112
$1,010.43
1.83%
0
$0.00
0.00%
51285091502
DIGOXIN
TAB 0.25MG
11
$94.43
0.18%
1
$17.19
0.02%
51285091505
DIGOXIN
TAB 0.25MG
151
$1,210.14
2.46%
77
$474.77
1.28%
51285091602
DIGOXIN
TAB 0.125MG
38
$334.62
0.62%
4
$40.69
0.07%
51285091605
DIGOXIN
TAB 0.125MG
179
$1,396.02
2.92%
119
$820.33
1.97%
Page 132 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
CARDIAC GLYCOSIDES
57664043718
DIGOXIN
TAB 0.125MG
0
$0.00
0.00%
5
$41.24
0.08%
57664043788
DIGOXIN
TAB 0.125MG
0
$0.00
0.00%
2
$11.64
0.03%
57664044118
DIGOXIN
TAB 0.25MG
0
$0.00
0.00%
3
$17.47
0.05%
62794014501
DIGITEK
TAB 0.125MG
971
$8,045.17
15.85%
1,085
$8,284.61
18.00%
62794014510
DIGITEK
TAB 0.125MG
793
$5,454.67
12.94%
678
$4,950.15
11.25%
62794014556
DIGITEK
TAB 0.125MG
7
$51.88
0.11%
606
$3,890.67
10.05%
62794014601
DIGITEK
TAB 0.25MG
785
$6,838.66
12.81%
882
$6,999.07
14.63%
62794014610
DIGITEK
TAB 0.25MG
316
$2,102.67
5.16%
324
$2,123.40
5.38%
62794014656
DIGITEK
TAB 0.25MG
65
$423.34
1.06%
222
$1,424.74
3.68%
CENTRALLY ACTING
00005356223
METHOCARBAM TAB 500MG
1
$6.35
0.01%
0
$0.00
0.00%
00005356323
1
$11.24
0.01%
0
$0.00
0.00%
00006093168
FLEXERIL
TAB 10MG
3
$98.10
0.02%
0
$0.00
0.00%
00028002301
LIORESAL
TAB 10MG
1
$10.37
0.01%
0
$0.00
0.00%
00031744963
ROBAXIN-750 TAB 750MG
2
$187.60
0.01%
1
$94.30
0.01%
00037200101
SOMA
13
$4,393.45
0.10%
2
$827.57
0.01%
00045032560
PARAFON FORT TAB DSC
0
$0.00
0.00%
1
$67.93
0.01%
00086006210
SKELAXIN
TAB 400MG
713
$46,579.50
5.30%
352
$24,141.69
2.08%
00086006250
SKELAXIN
TAB 400MG
0
$0.00
0.00%
2
$60.83
0.01%
00089022110
NORFLEX
TAB 100MG CR
2
$483.02
0.01%
2
$271.00
0.01%
00093054201
CHLORZOXAZON TAB 500MG
32
$236.19
0.24%
114
$1,030.88
0.67%
00093516051
TIZANIDINE TAB 4MG
138
$15,931.34
1.03%
71
$4,981.00
0.42%
00093516351
TIZANIDINE TAB 2MG
51
$3,381.48
0.38%
21
$875.12
0.12%
00115201101
ORPHENADRINE TAB 100MG ER
8
$228.80
0.06%
30
$675.40
0.18%
00115201102
3
$112.05
0.02%
0
$0.00
0.00%
00143117601
CARISOPRODOL TAB 350MG
44
$759.00
0.33%
19
$260.05
0.11%
TAB 350MG
Page 133 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
CENTRALLY ACTING
00143117605
4
$40.90
0.03%
20
$215.50
0.12%
00143117610
150
$2,510.35
1.11%
128
$1,473.19
0.75%
00143129001
13
$144.33
0.10%
40
$532.02
0.24%
00143129005
0
$0.00
0.00%
5
$89.01
0.03%
00143129201
21
$709.92
0.16%
116
$2,420.89
0.68%
00143129205
16
$659.27
0.12%
31
$626.49
0.18%
00149003005
DANTRIUM
CAP 25MG
57
$3,500.23
0.42%
43
$2,824.89
0.25%
00149003066
DANTRIUM
CAP 25MG
4
$433.53
0.03%
0
$0.00
0.00%
00149003077
DANTRIUM
CAP 25MG
2
$641.06
0.01%
0
$0.00
0.00%
00149003105
DANTRIUM
CAP 50MG
53
$7,273.87
0.39%
43
$5,350.01
0.25%
00149003305
DANTRIUM
CAP 100MG
18
$2,939.88
0.13%
16
$2,193.01
0.09%
00172409660
BACLOFEN
TAB 10MG
283
$4,913.02
2.10%
471
$13,094.88
2.78%
00172409680
BACLOFEN
TAB 10MG
101
$1,722.45
0.75%
186
$6,563.17
1.10%
00172409760
BACLOFEN
TAB 20MG
133
$4,486.37
0.99%
202
$13,585.68
1.19%
00185002201
51
$1,476.95
0.38%
6
$101.78
0.04%
00185440051
TIZANIDINE TAB 4MG
141
$12,995.78
1.05%
85
$6,356.54
0.50%
00228274115
TIZANIDINE TAB 4MG
135
$16,336.95
1.00%
38
$2,575.91
0.22%
00228274150
TIZANIDINE TAB 4MG
0
$0.00
0.00%
1
$71.05
0.01%
00228274215
TIZANIDINE TAB 2MG
60
$4,307.19
0.45%
34
$2,521.10
0.20%
00364034601
10
$141.83
0.07%
3
$62.45
0.02%
00364034701
3
$75.18
0.02%
0
$0.00
0.00%
00364047501
19
$328.05
0.14%
9
$123.65
0.05%
00364047505
3
$62.55
0.02%
1
$3.85
0.01%
00364231201
BACLOFEN
TAB 10MG
50
$1,127.15
0.37%
40
$1,194.22
0.24%
00364231301
BACLOFEN
TAB 20MG
38
$1,533.82
0.28%
6
$138.53
0.04%
00364234801
CYCLOBENZAPR TAB 10MG
3
$14.31
0.02%
0
$0.00
0.00%
00364234802
6
$54.58
0.04%
4
$39.08
0.02%
Page 134 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
CENTRALLY ACTING
00364234805
00364283001
00378075101
00378075110
00378335801
$109.03
0.11%
$46.30
0.02%
23
$743.05
0.17%
530
$3,058.91
3.94%
1
$33.85
0.01%
1,013
$9,420.99
5.97%
11
$68.33
0.08%
689
$7,810.16
4.06%
341
$9,375.29
2.53%
139
$3,154.60
0.82%
00378335805
12
$494.80
0.09%
00555058502
42
$370.10
0.31%
1
$33.85
0.01%
214
$1,916.73
1.26%
00555058504
1
$17.00
0.01%
25
$256.50
0.15%
00591283001
ORPHENADRINE TAB 100MG CR
26
$729.00
0.19%
1
$33.85
0.01%
00591538101
22
00591538105
9
$441.03
0.16%
63
$855.13
0.37%
$102.76
0.07%
10
$187.40
0.06%
00591538201
62
$1,663.76
0.46%
78
$1,376.94
0.46%
00591538205
32
$1,504.24
0.24%
12
$315.08
0.07%
00591551301
403
$6,477.77
2.99%
221
$2,353.53
1.30%
00591551305
117
$2,134.81
0.87%
64
$706.81
0.38%
00591551310
52
$891.40
0.39%
28
$403.90
0.17%
00591565801
3,516
$19,741.27
26.13%
246
$2,838.17
1.45%
00591565805
221
$1,337.87
1.64%
161
$1,865.55
0.95%
00591565810
1,745
$10,181.52
12.97%
1,684
$19,679.88
9.93%
00591573001
BACLOFEN
TAB 10MG
345
$5,770.28
2.56%
449
$12,681.84
2.65%
00591573005
BACLOFEN
TAB 10MG
89
$1,574.67
0.66%
16
$582.84
0.09%
00591573101
BACLOFEN
TAB 20MG
196
$5,627.89
1.46%
198
$11,075.36
1.17%
00591573105
BACLOFEN
TAB 20MG
22
$474.06
0.16%
8
$621.12
0.05%
00603240821
BACLOFEN
TAB 10MG
79
$1,649.35
0.59%
36
$1,079.58
0.21%
00603240828
BACLOFEN
TAB 10MG
1
$6.86
0.01%
4
$134.60
0.02%
00603240832
BACLOFEN
TAB 10MG
2
$24.84
0.01%
9
$225.65
0.05%
00603240921
BACLOFEN
TAB 20MG
6
$320.93
0.04%
10
$506.89
0.06%
15
4
Page 135 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
CENTRALLY ACTING
00603240928
BACLOFEN
TAB 20MG
00603258221
00603258228
00603258232
00603448521
4
$49.03
0.03%
0
$0.00
0.00%
8
$84.00
0.06%
10
$79.65
0.06%
12
$250.49
0.09%
1
$5.35
0.01%
13
$192.95
0.10%
15
$145.65
0.09%
0
$0.00
0.00%
286
$3,318.66
1.69%
00603448528
0
$0.00
0.00%
36
$543.74
0.21%
00603448621
0
$0.00
0.00%
199
$3,875.28
1.17%
00603448628
0
$0.00
0.00%
21
$418.85
0.12%
00603448721
1
$11.32
0.01%
6
$77.90
0.04%
00603448821
1
$11.49
0.01%
3
$40.60
0.02%
00615352063
51
$266.37
0.38%
0
$0.00
0.00%
00615354153
BACLOFEN
TAB 10MG
44
$684.75
0.33%
0
$0.00
0.00%
00615354163
BACLOFEN
TAB 10MG
26
$135.28
0.19%
0
$0.00
0.00%
00615354253
BACLOFEN
TAB 20MG
45
$785.20
0.33%
0
$0.00
0.00%
00615354263
BACLOFEN
TAB 20MG
7
$116.66
0.05%
0
$0.00
0.00%
00677043001
0
$0.00
0.00%
3
$38.65
0.02%
00677043101
1
$11.76
0.01%
5
$55.00
0.03%
00677058901
57
$799.80
0.42%
3
$31.05
0.02%
00677058905
8
$167.30
0.06%
0
$0.00
0.00%
00677058910
1
$6.85
0.01%
0
$0.00
0.00%
00781105005
9
$151.65
0.07%
2
$28.70
0.01%
00781105010
17
$194.45
0.13%
8
$74.30
0.05%
00781132405
00781164901
00781175001
2
$9.54
0.01%
0
$0.00
0.00%
51
$1,105.79
0.38%
62
$1,084.65
0.37%
138
$4,760.11
1.03%
83
$1,504.13
0.49%
00781175005
5
$120.63
0.04%
2
$41.60
0.01%
00781176001
120
$2,113.22
0.89%
86
$1,201.80
0.51%
Page 136 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
CENTRALLY ACTING
00781176005
2
$27.28
0.01%
0
$0.00
0.00%
00781500501
1
$20.35
0.01%
0
$0.00
0.00%
00781500510
0
$0.00
0.00%
1
$6.95
0.01%
00832102400
BACLOFEN
TAB 10MG
130
$2,486.80
0.97%
833
$21,981.05
4.91%
00832102450
BACLOFEN
TAB 10MG
9
$113.55
0.07%
51
$1,324.37
0.30%
00832102500
BACLOFEN
TAB 20MG
41
$1,231.64
0.30%
301
$19,254.78
1.78%
00832102550
BACLOFEN
TAB 20MG
4
$104.33
0.03%
1
$19.39
0.01%
00904035560
1
$14.35
0.01%
0
$0.00
0.00%
00904565460
0
$0.00
0.00%
3
$57.52
0.02%
00904780940
0
$0.00
0.00%
1
$21.85
0.01%
00904780960
0
$0.00
0.00%
14
$129.93
0.08%
00904780980
0
$0.00
0.00%
4
$36.16
0.02%
17314870001
FLEXERIL
10
$859.41
0.07%
0
$0.00
0.00%
49884078230
TIZANIDINE TAB 2MG
1
$32.92
0.01%
0
$0.00
0.00%
49884078253
TIZANIDINE TAB 2MG
172
$13,397.26
1.28%
120
$6,016.19
0.71%
49884078353
TIZANIDINE TAB 4MG
368
$37,103.81
2.73%
294
$21,384.62
1.73%
50111056301
36
$229.35
0.27%
5,026
$54,825.35
29.64%
50111056302
0
$0.00
0.00%
28
$286.79
0.17%
50111056303
151
$923.78
1.12%
800
$8,854.34
4.72%
50580028010
FLEXERIL
TAB 5MG
0
$0.00
0.00%
242
$9,749.78
1.43%
50580087411
FLEXERIL
TAB 10MG
10
$869.36
0.07%
5
$414.37
0.03%
51079064420
0
$0.00
0.00%
2
$26.90
0.01%
51285087405
84
$1,487.50
0.62%
0
$0.00
0.00%
52152005302
0
$0.00
0.00%
2
$10.34
0.01%
52152013602
19
$359.15
0.14%
0
$0.00
0.00%
52152013604
15
$290.25
0.11%
1
$9.85
0.01%
52152013605
27
$506.45
0.20%
7
$86.60
0.04%
TAB 10MG
Page 137 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
CENTRALLY ACTING
52544041801
2
$16.08
0.01%
0
52544041810
18
$134.78
0.13%
52544068601
BACLOFEN
TAB 10MG
5
$70.02
0.04%
52544068701
BACLOFEN
TAB 20MG
6
$30.17
52544068705
BACLOFEN
TAB 20MG
1
52544069301
52544078401
52544078410
$0.00
0.00%
0
$0.00
0.00%
5
$140.40
0.03%
0.04%
0
$0.00
0.00%
$37.35
0.01%
0
$0.00
0.00%
13
$137.29
0.10%
4
$43.34
0.02%
2
$98.70
0.01%
0
$0.00
0.00%
2
$17.70
0.01%
0
$0.00
0.00%
52555069501
BACLOFEN
TAB 10MG
0
$0.00
0.00%
4
$66.20
0.02%
52555069505
BACLOFEN
TAB 10MG
1
$29.43
0.01%
3
$358.95
0.02%
53265026610
256
$3,967.03
1.90%
196
$1,819.59
1.16%
53265026611
45
$795.53
0.33%
48
$566.55
0.28%
53265026650
20
$400.70
0.15%
14
$234.05
0.08%
53489011001
673
$10,633.22
5.00%
348
$3,694.21
2.05%
53489011005
9
$137.35
0.07%
3
$40.65
0.02%
53489011010
161
$2,923.25
1.20%
60
$765.15
0.35%
58281056001
LIORESAL INT INJ 10/20ML
2
$428.74
0.01%
0
$0.00
0.00%
58281056104
LIORESAL INT INJ 10MG/5ML
10
$7,909.70
0.07%
2
$1,583.14
0.01%
59075006810
SKELAXIN
TAB 800MG
6
$561.10
0.04%
83
$6,237.64
0.49%
59075059215
ZANAFLEX
TAB 2MG
48
$3,211.98
0.36%
2
$46.86
0.01%
59075059415
ZANAFLEX
TAB 4MG
169
$18,710.13
1.26%
10
$1,239.43
0.06%
65162010615
TIZANIDINE TAB 2MG
0
$0.00
0.00%
8
$177.33
0.05%
65162013815
TIZANIDINE TAB 4MG
0
$0.00
0.00%
73
$2,891.85
0.43%
1
$17.65
0.01%
0
$0.00
0.00%
1
$7.35
0.01%
4
$28.70
0.04%
CEPHALOSPORINS
00002306102
CECLOR
00003087460
CEPHALEXIN CAP 500MG
CAP 250MG
Page 138 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
CEPHALOSPORINS
00003220140
CEPHALEXIN SUS 125/5ML
1
00003220230
00003773299
MAXIPIME
INJ 1GM
00004196202
ROCEPHIN
00004196301
$14.09
0.01%
0
$0.00
0.00%
2
$31.67
0.02%
1
$38.79
0.01%
1
$100.42
0.01%
0
$0.00
0.00%
INJ 250MG
2
$51.97
0.02%
6
$112.68
0.06%
ROCEPHIN
INJ 500MG
6
$793.04
0.07%
6
$1,026.91
0.06%
00004196302
ROCEPHIN
INJ 500MG
4
$139.37
0.05%
0
$0.00
0.00%
00004196401
ROCEPHIN
INJ 1GM
168
$25,953.81
2.01%
234
$26,932.28
2.42%
00004196404
ROCEPHIN
INJ 1GM
132
$15,526.96
1.58%
122
$13,992.08
1.26%
00004196405
ROCEPHIN
INJ 1GM
3
$1,144.73
0.04%
4
$472.47
0.04%
00004196501
ROCEPHIN
INJ 2GM
4
$1,880.05
0.05%
11
$4,132.37
0.11%
00004196505
ROCEPHIN
INJ 2GM
0
$0.00
0.00%
3
$2,546.08
0.03%
00004197101
ROCEPHIN
INJ 10GM
2
$1,303.46
0.02%
0
$0.00
0.00%
00004200278
ROCEPHIN/DEX INJ 1GM
7
$964.25
0.08%
5
$791.81
0.05%
00004200378
ROCEPHIN/DEX INJ 2GM
5
$2,893.33
0.06%
6
$1,315.29
0.06%
00005389718
SUPRAX
TAB 400MG
31
$2,257.62
0.37%
6
$382.43
0.06%
00005389723
SUPRAX
TAB 400MG
3
$190.33
0.04%
0
$0.00
0.00%
00005389794
SUPRAX
TAB 400MG
3
$240.45
0.04%
0
$0.00
0.00%
00005389840
SUPRAX
SUS 100/5ML
160
$6,770.40
1.92%
5
$248.43
0.05%
00005389842
SUPRAX
SUS 100/5ML
63
$3,711.57
0.75%
4
$200.31
0.04%
00005389846
SUPRAX
SUS 100/5ML
77
$6,343.93
0.92%
5
$409.82
0.05%
00005389923
SUPRAX
TAB 200MG
1
$71.45
0.01%
0
$0.00
0.00%
00007508216
TAZICEF
INJ 1GM
1
$15.91
0.01%
0
$0.00
0.00%
00009353101
VANTIN
SUS 50MG/5ML
6
$290.23
0.07%
1
$45.38
0.01%
00009353103
VANTIN
SUS 50MG/5ML
2
$47.26
0.02%
0
$0.00
0.00%
00009361501
VANTIN
SUS 100/5ML
35
$3,133.71
0.42%
35
$3,000.19
0.36%
00009361502
VANTIN
SUS 100/5ML
3
$131.10
0.04%
1
$61.10
0.01%
00009361503
VANTIN
SUS 100/5ML
8
$444.37
0.10%
8
$459.72
0.08%
Page 139 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
CEPHALOSPORINS
00009361701
VANTIN
TAB 100MG
00009361702
VANTIN
TAB 100MG
00009361801
VANTIN
TAB 200MG
00009361802
VANTIN
TAB 200MG
00015733999
CEFAZOLIN
00074376910
00074376930
$294.48
0.06%
$648.85
0.12%
3
$381.45
0.04%
83
$8,010.97
0.99%
3
$207.40
0.03%
132
$12,442.78
1.36%
38
$2,455.70
0.45%
51
$4,550.24
0.53%
INJ 1GM
0
$0.00
0.00%
1
$33.80
0.01%
OMNICEF
CAP 300MG
2
OMNICEF
CAP 300MG
2
$72.39
0.02%
0
$0.00
0.00%
$154.32
0.02%
5
$330.15
0.05%
00074376960
OMNICEF
CAP 300MG
80
$5,271.52
0.96%
70
$5,362.47
0.72%
00074377113
OMNICEF
SUS 125MG/5
177
$11,845.85
2.12%
261
$18,562.48
2.70%
00074377160
OMNICEF
SUS 125MG/5
00074508216
TAZICEF
INJ 1GM
148
$8,122.14
1.77%
185
$9,231.83
1.91%
1
$41.03
0.01%
0
$0.00
0.00%
00074509216
TAZICEF
INJ 1GM
0
$0.00
0.00%
1
$210.85
0.01%
00087078241
DURICEF
SUS 250/5ML
40
$1,839.01
0.48%
27
$1,194.05
0.28%
00087078242
00087078305
DURICEF
SUS 250/5ML
4
$152.04
0.05%
5
$143.65
0.05%
DURICEF
SUS 500/5ML
1
$39.85
0.01%
3
$206.37
0.03%
00087078341
DURICEF
SUS 500/5ML
38
$2,096.33
0.45%
11
$501.64
0.11%
00087078342
DURICEF
SUS 500/5ML
1
$55.77
0.01%
0
$0.00
0.00%
00087078446
DURICEF
CAP 500MG
0
$0.00
0.00%
1
$75.16
0.01%
00087078542
DURICEF
TAB 1GM
1
$16.48
0.01%
0
$0.00
0.00%
00087771840
CEFZIL
SUS 125/5ML
5
$155.49
0.06%
10
$370.68
0.10%
00087771862
CEFZIL
SUS 125/5ML
1
$29.65
0.01%
11
$564.20
0.11%
00087771864
CEFZIL
SUS 125/5ML
55
$2,157.78
0.66%
69
$2,798.37
0.71%
00087771940
CEFZIL
SUS 250/5ML
32
$2,056.67
0.38%
59
$3,271.79
0.61%
00087771962
CEFZIL
SUS 250/5ML
32
$2,124.27
0.38%
57
$4,264.76
0.59%
00087771964
CEFZIL
SUS 250/5ML
248
$17,245.94
2.97%
371
$27,451.85
3.84%
00087772060
CEFZIL
TAB 250MG FC
85
$6,919.75
1.02%
141
$12,399.80
1.46%
00087772150
CEFZIL
TAB 500MG FC
25
$3,193.73
0.30%
30
$5,424.67
0.31%
5
12
Page 140 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
CEFZIL
00093108701
00093121501
$
Market Share*
CEPHALOSPORINS
00087772160
# of Scripts
TAB 500MG FC
46
$5,926.72
0.55%
48
$7,634.91
0.50%
CEFACLOR ER TAB
0
$0.00
0.00%
1
$66.85
0.01%
CEFACLOR ER TAB
0
$0.00
0.00%
1
$69.35
0.01%
00093223801
CEPHALEXIN TAB 250MG
0
$0.00
0.00%
2
$66.46
0.02%
00093224001
CEPHALEXIN TAB 500MG
4
$206.11
0.05%
1
$53.71
0.01%
00093314501
416
$4,005.73
4.98%
359
$3,430.97
3.71%
00093314505
336
$2,548.91
4.02%
301
$1,898.29
3.11%
00093314701
1,477
$17,439.13
17.68%
1,855
$20,588.56
19.18%
00093314705
817
$9,726.12
9.78%
153
$1,738.50
1.58%
00093417573
18
$229.15
0.22%
16
$201.05
0.17%
00093417574
26
$437.24
0.31%
17
$284.83
0.18%
00093417773
116
$3,198.91
1.39%
118
$2,253.69
1.22%
00093417774
309
$9,590.91
3.70%
316
$9,380.96
3.27%
00172405843
CEFADROXIL CAP 500MG
1
$12.15
0.01%
4
$103.70
0.04%
00172405848
12
$164.00
0.14%
112
$3,094.52
1.16%
00172405860
89
$1,257.09
1.07%
100
$3,390.41
1.03%
00172405948
CEFADROXIL TAB 1000MG
0
$0.00
0.00%
4
$167.20
0.04%
00172407360
135
$1,402.02
1.62%
183
$1,676.72
1.89%
00172407370
30
$297.90
0.36%
66
$526.90
0.68%
00172407460
506
$6,085.57
6.06%
711
$7,497.51
7.35%
00172407470
115
$1,250.61
1.38%
272
$3,054.62
2.81%
00172419460
CEFACLOR ER TAB 500MG
8
$496.00
0.10%
0
$0.00
0.00%
00172477060
CEFACLOR
CAP 250MG
10
$164.20
0.12%
3
$55.88
0.03%
00172477160
CEFACLOR
CAP 500MG
9
$271.20
0.11%
3
$77.07
0.03%
00172477223
CEFACLOR
SUS 125/5ML
4
$77.29
0.05%
0
$0.00
0.00%
00172477321
CEFACLOR
SUS 187/5ML
0
$0.00
0.00%
1
$15.35
0.01%
00172477422
CEFACLOR
SUS 250/5ML
1
$14.98
0.01%
2
$23.20
0.02%
Page 141 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
CEPHALOSPORINS
00172477423
CEFACLOR
SUS 250/5ML
12
00172477521
CEFACLOR
00173037835
FORTAZ
INJ 1GM
SUS 375/5ML
00173038237
FORTAZ
INJ 6GM
00173038700
CEFTIN
00173038742
00173039400
$319.20
0.14%
10
$196.00
0.10%
10
$163.58
0.12%
5
$1,194.45
0.06%
6
$44.20
0.06%
5
$511.85
0.05%
0
$0.00
0.00%
1
$144.42
0.01%
TAB 250MG
8
$722.63
0.10%
7
$657.04
0.07%
CEFTIN
TAB 250MG
CEFTIN
TAB 500MG
57
$4,873.33
0.68%
5
$529.40
0.05%
17
$2,538.24
0.20%
1
$174.04
0.01%
00173039401
CEFTIN
TAB 500MG
1
$158.39
0.01%
0
$0.00
0.00%
00173039442
CEFTIN
TAB 500MG
38
$5,368.65
0.45%
4
$250.54
0.04%
00173040600
CEFTIN
SUS 125/5ML
35
$1,812.13
0.42%
24
$1,234.91
0.25%
00173041200
FORTAZ
INJ 1GM
3
$378.20
0.04%
4
$543.50
0.04%
00173041300
FORTAZ
INJ 2GM
1
$135.85
0.01%
2
$949.20
0.02%
00173043400
FORTAZ
INJ 1GM
3
$409.44
0.04%
2
$224.22
0.02%
00173055400
CEFTIN
SUS 250/5ML
24
$1,429.48
0.29%
22
$931.45
0.23%
00173055500
CEFTIN
SUS 250/5ML
98
$6,685.55
1.17%
123
$9,427.77
1.27%
00182268915
CEFUROXIME TAB 250MG
0
$0.00
0.00%
3
$385.89
0.03%
00182268926
0
$0.00
0.00%
64
$3,578.76
0.66%
00182269015
0
$0.00
0.00%
4
$424.40
0.04%
00182269026
0
$0.00
0.00%
25
$2,481.36
0.26%
00300753560
SPECTRACEF TAB 200MG
1
$21.50
0.01%
0
$0.00
0.00%
00338350341
CEFAZOLIN
INJ 1GM/50ML
0
$0.00
0.00%
4
$115.78
0.04%
00364246534
CEFAZOLIN
INJ 1GM
2
$86.16
0.02%
0
$0.00
0.00%
00364246693
CEFAZOLIN
INJ 10GM
3
$353.13
0.04%
0
$0.00
0.00%
00378725001
CEFACLOR
CAP 250MG
31
$507.97
0.37%
9
$148.07
0.09%
00378750001
CEFACLOR
CAP 500MG
11
$278.93
0.13%
2
$36.72
0.02%
00378760206
CEFACLOR
SUS 125/5ML
3
$59.88
0.04%
0
$0.00
0.00%
00378761006
CEFACLOR
SUS 250/5ML
8
$193.86
0.10%
3
$59.55
0.03%
Page 142 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
CEFACLOR
00430278217
DURICEF
00430278317
DURICEF
00555058202
$
Market Share*
CEPHALOSPORINS
00378761209
# of Scripts
SUS 375/5ML
3
$57.90
0.04%
0
$0.00
0.00%
SUS 250/5ML
0
$0.00
0.00%
21
$1,003.10
0.22%
SUS 500/5ML
0
$0.00
0.00%
16
$876.58
0.17%
6
$64.65
0.07%
21
$565.05
0.22%
00555058210
9
$90.60
0.11%
14
$358.10
0.14%
00591236668
CEFAZOLIN
0
$0.00
0.00%
1
$148.31
0.01%
00591322415
0
$0.00
0.00%
150
$11,235.71
1.55%
00591322515
0
$0.00
0.00%
80
$10,539.69
0.83%
00777086902
KEFLEX
CAP 250MG
1
$3.60
0.01%
0
$0.00
0.00%
00777087102
KEFLEX
CAP 500MG
2
$169.68
0.02%
2
$170.68
0.02%
00777087120
KEFLEX
CAP 500MG
0
$0.00
0.00%
1
$60.04
0.01%
51079060420
10
$24.71
0.12%
4
$12.55
0.04%
51079060520
1
$9.28
0.01%
0
$0.00
0.00%
51479003560
CECLOR CD
TAB 500MG
6
$370.14
0.07%
0
$0.00
0.00%
51479005430
MAXIPIME
INJ 1GM
1
$19.08
0.01%
0
$0.00
0.00%
51479005530
MAXIPIME
INJ 2GM
0
$0.00
0.00%
1
$376.16
0.01%
55370090108
0
$0.00
0.00%
19
$205.34
0.20%
55953008401
4
$13.99
0.05%
0
$0.00
0.00%
55953008440
5
$52.08
0.06%
0
$0.00
0.00%
55953008470
5
$57.36
0.06%
0
$0.00
0.00%
55953011470
34
$419.17
0.41%
0
$0.00
0.00%
59772727103
6
$87.85
0.07%
24
$862.10
0.25%
59772727104
153
$2,218.11
1.83%
97
$2,941.03
1.00%
59772749104
CEFACLOR
CAP 250MG
5
$104.43
0.06%
0
$0.00
0.00%
59772749204
CEFACLOR
SUS 250/5ML
6
$159.60
0.07%
0
$0.00
0.00%
59772749303
CEFACLOR
SUS 375/5ML
1
$26.45
0.01%
0
$0.00
0.00%
59772749404
CEFACLOR
CAP 500MG
2
$8.18
0.02%
0
$0.00
0.00%
INJ 10GM
Page 143 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
CEFOXITIN
60505120100
60505120103
$
Market Share*
CEPHALOSPORINS
59911596302
# of Scripts
INJ 1GM
0
$0.00
0.00%
3
$3,189.88
0.03%
0
$0.00
0.00%
39
$4,380.55
0.40%
0
$0.00
0.00%
19
$1,683.45
0.20%
60505120200
0
$0.00
0.00%
87
$5,361.24
0.90%
60505120203
0
$0.00
0.00%
15
$934.65
0.16%
63304058201
21
$384.90
0.25%
5
$268.86
0.05%
63304058250
5
$65.05
0.06%
0
$0.00
0.00%
63304065601
11
$119.31
0.13%
55
$516.55
0.57%
63304065605
54
$585.27
0.65%
121
$1,202.14
1.25%
63304065701
22
$235.44
0.26%
81
$962.34
0.84%
63304065705
308
$3,427.93
3.69%
714
$7,719.68
7.38%
63304065801
CEFACLOR
CAP 250MG
67
$1,329.50
0.80%
46
$760.87
0.48%
63304065901
CEFACLOR
CAP 500MG
32
$905.79
0.38%
21
$430.48
0.22%
63304075120
476
$34,276.79
5.70%
176
$11,376.45
1.82%
63304075220
206
$27,624.44
2.47%
130
$13,930.95
1.34%
63304095401
CEFACLOR
SUS 125/5ML
0
$0.00
0.00%
1
$8.96
0.01%
63304095402
CEFACLOR
SUS 125/5ML
8
$159.68
0.10%
2
$33.70
0.02%
63304095503
CEFACLOR
SUS 187/5ML
0
$0.00
0.00%
1
$27.35
0.01%
63304095504
CEFACLOR
SUS 187/5ML
0
$0.00
0.00%
1
$15.35
0.01%
63304095601
CEFACLOR
SUS 250/5ML
14
$254.21
0.17%
4
$46.40
0.04%
63304095602
CEFACLOR
SUS 250/5ML
59
$1,510.03
0.71%
59
$1,233.12
0.61%
63304095703
CEFACLOR
SUS 375/5ML
2
$45.99
0.02%
2
$31.35
0.02%
63304095704
CEFACLOR
SUS 375/5ML
16
$421.20
0.19%
12
$251.20
0.12%
63304095801
2
$29.98
0.02%
11
$91.17
0.11%
63304095802
0
$0.00
0.00%
7
$117.75
0.07%
63304095901
1
$19.79
0.01%
46
$781.68
0.48%
63304095902
24
$746.22
0.29%
66
$1,843.28
0.68%
Page 144 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
CEPHALOSPORINS
63323023710
CEFAZOLIN
64455069101
CEDAX
64455077701
CEDAX
64455077702
INJ 1GM
1
$37.21
0.01%
0
$0.00
0.00%
CAP 400MG
3
$138.56
0.04%
8
$746.96
0.08%
SUS 90MG/5ML
2
$82.04
0.02%
3
$168.29
0.03%
CEDAX
SUS 90MG/5ML
0
$0.00
0.00%
1
$83.13
0.01%
64455077703
CEDAX
SUS 90MG/5ML
0
$0.00
0.00%
4
$60.68
0.04%
64860010407
0
$0.00
0.00%
13
$135.96
0.13%
64860010408
0
$0.00
0.00%
39
$388.83
0.40%
64860010507
0
$0.00
0.00%
22
$249.95
0.23%
64860010508
0
$0.00
0.00%
434
$5,040.94
4.49%
65939038700
CEFTIN
TAB 250MG
4
$27.46
0.05%
0
$0.00
0.00%
65939038742
CEFTIN
TAB 250MG
20
$458.36
0.24%
2
$87.35
0.02%
65939039400
CEFTIN
TAB 500MG
5
$371.73
0.06%
0
$0.00
0.00%
65939039442
CEFTIN
TAB 500MG
10
$1,339.67
0.12%
0
$0.00
0.00%
65939040600
CEFTIN
SUS 125/5ML
5
$173.70
0.06%
1
$34.74
0.01%
65939055500
CEFTIN
SUS 250/5ML
21
$1,255.33
0.25%
9
$644.83
0.09%
8
$549.35
72.73%
10
$895.28
100.00%
3
$654.39
27.27%
0
$0.00
0.00%
CHELATING AGENTS
00006060268
CUPRIMINE
00037440101
DEPEN TITRA TAB 250MG
CAP 250MG
CHOLESTEROL - BILE SEQUESTRANTS
00009026001
COLESTID
POW 5GM
28
$1,432.84
3.06%
52
$3,521.56
5.39%
00009026002
COLESTID
GRA 5GM
8
$787.43
0.88%
7
$481.89
0.73%
00009026004
COLESTID
POW 5GM
1
$148.05
0.11%
1
$97.32
0.10%
00009026017
COLESTID
GRA 5GM
2
$117.94
0.22%
4
$240.39
0.41%
00009037003
COLESTID FLA GRA 5/7.5GM
1
$108.57
0.11%
1
$232.01
0.10%
00009037005
COLESTID FLA GRA 5GM
2
$151.24
0.22%
7
$563.99
0.73%
Page 145 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
COLESTID
00015058011
QUESTRAN
00015944214
QUESTRAN
00087058005
TAB 1GM
$
Market Share*
00009045003
# of Scripts
205
$8,726.92
22.43%
272
$11,740.54
28.19%
POW 4GM
5
$298.51
0.55%
3
$296.58
0.31%
POW 4GM LITE
4
$496.94
0.44%
2
$294.68
0.21%
QUESTRAN
POW 4GM
9
$610.07
0.98%
3
$78.18
0.31%
00087058011
QUESTRAN
POW 4GM
1
$41.75
0.11%
0
$0.00
0.00%
00087944211
QUESTRAN
POW 4GM LITE
7
$322.07
0.77%
0
$0.00
0.00%
00093809667
CHOLESTYRAM POW 4GM
1
$6.93
0.11%
10
$291.74
1.04%
00093809682
CHOLESTYRAM POW 4GM
11
$467.55
1.20%
6
$230.02
0.62%
00093811167
CHOLESTYRAM POW 4GM LITE
1
$40.95
0.11%
0
$0.00
0.00%
00093811183
0
$0.00
0.00%
1
$21.64
0.10%
00185093997
42
$1,401.80
4.60%
48
$1,594.13
4.97%
00185093998
10
$589.45
1.09%
25
$1,922.87
2.59%
00185094097
CHOLESTYRAM POW 4GM
92
$4,422.09
10.07%
119
$4,217.24
12.33%
00185094098
CHOLESTYRAM POW 4GM
37
$1,148.49
4.05%
37
$2,006.03
3.83%
00245003623
PREVALITE
POW 4GM
5
$194.72
0.55%
2
$43.28
0.21%
00245003642
PREVALITE
POW 4GM
2
$35.06
0.22%
1
$68.75
0.10%
00245003660
PREVALITE
POW 4GM
6
$235.07
0.66%
7
$234.45
0.73%
00904523442
CHOLESTYRAM POW 4GM
1
$79.37
0.11%
0
$0.00
0.00%
00904523452
CHOLESTYRAM POW 4GM
7
$201.56
0.77%
0
$0.00
0.00%
00904523552
6
$251.70
0.66%
0
$0.00
0.00%
38245026679
CHOLESTYRAM POW 4GM
1
$33.18
0.11%
0
$0.00
0.00%
49884079165
QUESTRAN
POW 4GM
0
$0.00
0.00%
1
$7.00
0.10%
49884079166
QUESTRAN
POW 4GM
0
$0.00
0.00%
1
$64.65
0.10%
49884079289
QUESTRAN
POW 4GM LITE
0
$0.00
0.00%
5
$325.06
0.52%
55953009635
CHOLESTYRAM POW 4GM
4
$125.60
0.44%
0
$0.00
0.00%
55953009665
CHOLESTYRAM POW 4GM
5
$263.90
0.55%
0
$0.00
0.00%
59772558501
CHOLESTYRAM POW 4GM
73
$2,773.62
7.99%
90
$5,707.21
9.33%
Page 146 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
59772558502
CHOLESTYRAM POW 4GM
52
$2,177.38
5.69%
149
$5,459.50
15.44%
59772558901
21
$939.73
2.30%
35
$2,869.90
3.63%
59772558902
26
$788.88
2.84%
23
$652.19
2.38%
65597070118
WELCHOL
238
$27,556.33
26.04%
53
$5,806.52
5.49%
TAB 625MG
CHOLESTEROL - FIBRIC ACID DERIVATIVES
00047008420
GEMFIBROZIL TAB 600MG
7
$147.75
0.23%
0
$0.00
0.00%
00047008430
122
$1,905.36
3.97%
0
$0.00
0.00%
00071073720
LOPID
TAB 600MG
14
$1,043.02
0.46%
0
$0.00
0.00%
00074400990
TRICOR
TAB 54MG
276
$8,767.92
8.98%
452
$15,390.20
10.42%
00074401390
TRICOR
TAB 160MG
811
$56,419.59
26.38%
1,266
$105,254.66
29.20%
00074434290
TRICOR
CAP 67MG
5
$88.35
0.16%
0
$0.00
0.00%
00074641590
TRICOR
CAP 200MG
1
$13.35
0.03%
0
$0.00
0.00%
00093067005
1,069
$15,814.45
34.78%
1,482
$27,643.49
34.18%
00093067006
232
$3,584.87
7.55%
106
$1,992.15
2.44%
00182195689
10
$155.30
0.33%
0
$0.00
0.00%
00615355953
45
$606.50
1.46%
0
$0.00
0.00%
00615355963
17
$200.39
0.55%
0
$0.00
0.00%
00904537940
25
$396.80
0.81%
53
$1,012.12
1.22%
00904537952
0
$0.00
0.00%
13
$247.29
0.30%
00904537961
1
$23.35
0.03%
0
$0.00
0.00%
00904773240
0
$0.00
0.00%
1
$13.67
0.02%
51079078720
3
$37.80
0.10%
1
$54.33
0.02%
60505003404
58
$865.85
1.89%
116
$2,508.83
2.68%
60505003408
378
$5,975.96
12.30%
846
$16,720.96
19.51%
CHOLESTEROL - HGM COA + ABSORB INHIBITORS
Page 147 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00003515405
PRAVACHOL
TAB 10MG
76
$5,278.50
0.23%
43
$3,434.15
0.10%
00003517805
PRAVACHOL
TAB 20MG
386
$28,819.24
1.18%
150
$11,459.93
0.34%
00003517806
PRAVACHOL
TAB 20MG
1
$80.21
0.00%
0
$0.00
0.00%
00003517875
PRAVACHOL
TAB 20MG
1
$78.85
0.00%
0
$0.00
0.00%
00003519410
PRAVACHOL
TAB 40MG
330
$36,301.20
1.01%
145
$16,090.43
0.33%
00003519510
PRAVACHOL
TAB 80MG
18
$1,904.56
0.05%
27
$2,891.23
0.06%
00006054328
ZOCOR
TAB 80MG
0
$0.00
0.00%
15
$1,627.93
0.03%
00006054331
ZOCOR
TAB 80MG
227
$26,073.96
0.69%
572
$68,109.02
1.28%
00006054354
ZOCOR
TAB 80MG
163
$18,405.88
0.50%
445
$52,038.20
1.00%
00006054361
ZOCOR
TAB 80MG
146
$15,360.31
0.44%
1
$17.00
0.00%
00006072631
ZOCOR
TAB 5MG
43
$2,163.54
0.13%
62
$3,309.10
0.14%
00006072654
ZOCOR
TAB 5MG
110
$5,323.59
0.34%
129
$6,805.15
0.29%
00006072661
ZOCOR
TAB 5MG
25
$1,160.89
0.08%
27
$1,438.97
0.06%
00006073061
MEVACOR
TAB 10MG
36
$2,674.02
0.11%
0
$0.00
0.00%
00006073161
MEVACOR
TAB 20MG
4
$139.21
0.01%
0
$0.00
0.00%
00006073261
MEVACOR
TAB 40MG
2
$87.70
0.01%
0
$0.00
0.00%
00006073531
ZOCOR
TAB 10MG
649
$42,460.65
1.98%
898
$63,064.86
2.02%
00006073554
ZOCOR
TAB 10MG
686
$45,865.89
2.09%
877
$61,313.62
1.97%
00006073561
ZOCOR
TAB 10MG
143
$9,456.62
0.44%
162
$11,160.55
0.36%
00006073582
ZOCOR
TAB 10MG
11
$649.90
0.03%
2
$141.91
0.00%
00006074028
ZOCOR
TAB 20MG
12
$1,295.06
0.04%
0
$0.00
0.00%
00006074031
ZOCOR
TAB 20MG
1,643
$185,449.90
5.01%
2,797
$340,561.21
6.28%
00006074054
ZOCOR
TAB 20MG
1,192
$135,725.74
3.63%
2,036
$246,471.51
4.57%
00006074061
ZOCOR
TAB 20MG
634
$68,551.11
1.93%
914
$110,750.69
2.05%
00006074082
ZOCOR
TAB 20MG
15
$1,644.08
0.05%
47
$5,340.41
0.11%
00006074931
ZOCOR
TAB 40MG
988
$113,149.19
3.01%
1,827
$220,517.63
4.10%
00006074954
ZOCOR
TAB 40MG
500
$57,416.94
1.52%
1,141
$138,309.69
2.56%
Page 148 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
$
Market Share*
TAB 40MG
# of Scripts
00006074961
ZOCOR
00006074982
ZOCOR
TAB 40MG
3
$6.06
0.01%
3
$138.73
0.01%
00071015523
LIPITOR
TAB 10MG
11,614
$690,860.86
35.38%
13,315
$847,460.04
29.91%
00071015534
LIPITOR
TAB 10MG
1
$53.21
0.00%
24
$1,388.44
0.05%
00071015540
LIPITOR
TAB 10MG
0
$0.00
0.00%
33
$2,047.65
0.07%
00071015623
LIPITOR
TAB 20MG
6,833
$604,298.41
20.82%
8,198
$773,726.10
18.41%
00071015640
LIPITOR
TAB 20MG
3
$214.36
0.01%
0
$0.00
0.00%
00071015723
LIPITOR
TAB 40MG
2,713
$258,660.16
8.26%
3,587
$343,304.72
8.06%
00071015823
LIPITOR
TAB 80MG
774
$73,462.58
2.36%
1,153
$108,871.73
2.59%
00078017605
LESCOL
CAP 20MG
397
$17,650.02
1.21%
445
$21,796.85
1.00%
00078017615
LESCOL
CAP 20MG
30
$1,376.03
0.09%
34
$1,654.26
0.08%
00078023405
LESCOL
CAP 40MG
488
$22,920.73
1.49%
583
$31,958.84
1.31%
00078023415
LESCOL
CAP 40MG
25
$1,400.14
0.08%
25
$1,282.66
0.06%
00078035405
LESCOL XL
TAB 80MG
244
$13,174.20
0.74%
445
$27,555.07
1.00%
00078035415
LESCOL XL
TAB 80MG
48
$2,571.52
0.15%
53
$3,150.44
0.12%
00093057606
LOVASTATIN TAB 20MG
217
$6,356.15
0.66%
326
$8,285.27
0.73%
00093057610
LOVASTATIN TAB 20MG
0
$0.00
0.00%
13
$305.75
0.03%
00093092606
LOVASTATIN TAB 10MG
88
$2,135.67
0.27%
103
$1,646.61
0.23%
00093092806
LOVASTATIN TAB 40MG
111
$5,805.35
0.34%
207
$9,528.76
0.46%
00185007201
LOVASTATIN TAB 20MG
0
$0.00
0.00%
1
$25.25
0.00%
00185007210
LOVASTATIN TAB 20MG
1
$27.35
0.00%
0
$0.00
0.00%
00185007260
LOVASTATIN TAB 20MG
0
$0.00
0.00%
1
$25.25
0.00%
00185007401
LOVASTATIN TAB 40MG
2
$87.70
0.01%
1
$40.25
0.00%
00228263306
LOVASTATIN TAB 10MG
8
$229.70
0.02%
16
$256.85
0.04%
00228263406
LOVASTATIN TAB 20MG
34
$856.41
0.10%
106
$2,590.94
0.24%
00228263450
LOVASTATIN TAB 20MG
4
$96.00
0.01%
4
$98.50
0.01%
00228263506
LOVASTATIN TAB 40MG
4
$169.40
0.01%
28
$1,132.84
0.06%
497
$53,656.15
1.51%
614
$70,350.35
Page 149 of 522
1.38%
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00310075139
CRESTOR
TAB 10MG
0
$0.00
0.00%
14
$883.29
0.03%
00310075190
CRESTOR
TAB 10MG
0
$0.00
0.00%
499
$33,489.11
1.12%
00310075290
CRESTOR
TAB 20MG
0
$0.00
0.00%
98
$6,830.92
0.22%
00310075430
CRESTOR
TAB 40MG
0
$0.00
0.00%
60
$4,107.00
0.13%
00310075590
CRESTOR
TAB 5MG
0
$0.00
0.00%
15
$1,052.04
0.03%
00378651091
LOVASTATIN TAB 10MG
36
$922.53
0.11%
88
$1,592.84
0.20%
00378652005
LOVASTATIN TAB 20MG
3
$74.74
0.01%
29
$737.95
0.07%
00378652091
LOVASTATIN TAB 20MG
253
$6,949.66
0.77%
329
$8,029.66
0.74%
00378654005
LOVASTATIN TAB 40MG
0
$0.00
0.00%
4
$298.60
0.01%
00378654091
LOVASTATIN TAB 40MG
169
$9,032.34
0.51%
230
$10,764.50
0.52%
00781121060
LOVASTATIN TAB 20MG
56
$1,535.95
0.17%
105
$2,533.37
0.24%
00781121360
LOVASTATIN TAB 40MG
33
$1,388.70
0.10%
60
$2,605.89
0.13%
00781132360
LOVASTATIN TAB 10MG
20
$447.99
0.06%
28
$475.90
0.06%
00904558252
LOVASTATIN TAB 20MG
2
$50.70
0.01%
1
$25.25
0.00%
00904558352
LOVASTATIN TAB 40MG
0
$0.00
0.00%
1
$26.30
0.00%
49884075401
LOVASTATIN TAB 10MG
0
$0.00
0.00%
5
$77.25
0.01%
49884075410
LOVASTATIN TAB 10MG
1
$76.95
0.00%
0
$0.00
0.00%
49884075501
LOVASTATIN TAB 20MG
0
$0.00
0.00%
13
$298.25
0.03%
49884075510
LOVASTATIN TAB 20MG
0
$0.00
0.00%
17
$403.72
0.04%
49884075601
LOVASTATIN TAB 40MG
0
$0.00
0.00%
7
$237.49
0.02%
51079097520
LOVASTATIN TAB 20MG
0
$0.00
0.00%
3
$65.70
0.01%
60598000690
ADVICOR
TAB 500-20MG
17
$772.84
0.05%
42
$2,705.18
0.09%
60598000790
ADVICOR
TAB 750-20MG
7
$423.23
0.02%
6
$361.62
0.01%
60598000890
ADVICOR
TAB 1000-20
9
$651.81
0.03%
3
$375.21
0.01%
62022077030
ALTOCOR
TAB 20MG CR
0
$0.00
0.00%
19
$931.63
0.04%
62022078030
ALTOCOR
TAB 40MG CR
0
$0.00
0.00%
36
$2,026.63
0.08%
62022078130
ALTOCOR
TAB 60MG CR
0
$0.00
0.00%
39
$2,220.69
0.09%
Page 150 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
62037079101
LOVASTATIN TAB 10MG
0
$0.00
0.00%
7
$132.85
0.02%
62037079201
LOVASTATIN TAB 20MG
0
$0.00
0.00%
10
$251.68
0.02%
62037079301
LOVASTATIN TAB 40MG
0
$0.00
0.00%
15
$559.34
0.03%
66582041428
ZETIA
TAB 10MG
0
$0.00
0.00%
1
$63.82
0.00%
66582041431
ZETIA
TAB 10MG
40
$2,544.20
0.12%
887
$58,106.90
1.99%
66582041454
ZETIA
TAB 10MG
0
$0.00
0.00%
214
$13,787.63
0.48%
Cholinomimetics - ACHE Inhibitors
00078032306
EXELON
CAP 1.5MG
0
$0.00
0.00%
4
$543.60
0.11%
00078032344
EXELON
CAP 1.5MG
77
$11,507.70
2.88%
93
$11,687.18
2.48%
00078032444
EXELON
CAP 3MG
77
$8,674.10
2.88%
92
$11,066.47
2.46%
00078032506
EXELON
CAP 4.5MG
1
$129.65
0.04%
0
$0.00
0.00%
00078032544
EXELON
CAP 4.5MG
54
$6,525.12
2.02%
49
$6,014.14
1.31%
00078032644
EXELON
CAP 6MG
77
$9,498.22
2.88%
102
$12,057.33
2.72%
00078033931
EXELON
SOL 2MG/ML
4
$80.00
0.15%
5
$1,267.47
0.13%
50458039060
REMINYL
TAB 4MG
94
$11,741.81
3.52%
155
$19,576.58
4.14%
50458039160
REMINYL
TAB 8MG
77
$8,860.02
2.88%
136
$16,447.83
3.63%
50458039260
REMINYL
TAB 12MG
16
$1,802.42
0.60%
47
$5,097.42
1.25%
59630019012
COGNEX
CAP 10MG
20
$1,604.84
0.75%
1
$307.89
0.03%
62856024530
ARICEPT
TAB 5MG
649
$77,013.39
24.32%
780
$94,366.68
20.82%
62856024590
ARICEPT
TAB 5MG
204
$23,334.40
7.64%
328
$39,871.62
8.75%
62856024630
ARICEPT
TAB 10MG
889
$103,544.42
33.31%
1,144
$140,326.76
30.53%
62856024641
ARICEPT
TAB 10MG
2
$2.00
0.07%
3
$23.23
0.08%
62856024690
ARICEPT
TAB 10MG
428
$49,658.48
16.04%
808
$98,767.88
21.56%
4
$18.48
2.84%
6
$19.27
4.84%
COMBO PSYCHOTHERAPEUTICS
00378004201
PERPHEN/AMIT TAB 4-10MG
Page 151 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
COMBO PSYCHOTHERAPEUTICS
00378007301
3
$74.01
2.13%
1
$22.73
0.81%
00378021101
CDP/AMITRIP TAB 5-12.5MG
10
$578.30
7.09%
13
$759.45
10.48%
00378021105
CDP/AMITRIP TAB 5-12.5MG
2
$74.70
1.42%
0
$0.00
0.00%
00378027701
CDP/AMITRIP TAB 10-25MG
21
$549.72
14.89%
14
$665.81
11.29%
00378027705
CDP/AMITRIP TAB 10-25MG
0
$0.00
0.00%
4
$95.11
3.23%
00378033001
9
$66.27
6.38%
19
$87.38
15.32%
00378033005
0
$0.00
0.00%
1
$7.57
0.81%
00378044201
51
$384.09
36.17%
43
$281.51
34.68%
00378057401
13
$274.50
9.22%
12
$205.13
9.68%
00378057405
0
$0.00
0.00%
3
$77.37
2.42%
00781126501
3
$16.38
2.13%
0
$0.00
0.00%
00781127305
3
$24.18
2.13%
3
$18.18
2.42%
52544070601
13
$80.84
9.22%
5
$43.04
4.03%
52544070701
2
$16.12
1.42%
0
$0.00
0.00%
52544070801
3
$13.86
2.13%
0
$0.00
0.00%
52544070901
1
$10.94
0.71%
0
$0.00
0.00%
52544070905
3
$78.87
2.13%
0
$0.00
0.00%
COMT INHIBITORS
00004592001
TASMAR
TAB 100MG
11
$2,110.14
12.09%
3
$794.94
2.61%
00078032705
COMTAN
TAB 200MG
80
$11,399.39
87.91%
112
$14,836.88
97.39%
CONTRACEPTIVES
00062313301
DELFEN
AER STARTER
1
$10.47
50.00%
0
$0.00
0.00%
00062318501
GYNOL II
GEL 3% X-STR
1
$18.49
50.00%
2
$33.98
100.00%
COUGH/COLD
Page 152 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
COUGH/COLD
00009771601
PEDIACARE
00024086016
00031223022
00031228378
LIQ CGH/COLD
2
$16.93
0.03%
0
$0.00
0.00%
HISTUSSIN HC SYP
1
$21.71
0.02%
0
$0.00
0.00%
DIMETAPP
1
$4.99
0.02%
0
$0.00
0.00%
DIMETAPP PED DRO 7.5/.8ML
0
$0.00
0.00%
2
$14.92
0.09%
00031860246
ROBITUSSIN CAP COLD/FLU
1
$8.75
0.02%
0
$0.00
0.00%
00031860912
ROBITUSS PED LIQ CGH/COLD
2
$13.06
0.03%
0
$0.00
0.00%
00031862412
ROBITUSSIN SYP 100/5ML
4
$25.96
0.06%
0
$0.00
0.00%
00031862418
ROBITUSSIN SYP 100/5ML
9
$75.45
0.14%
0
$0.00
0.00%
00031867012
ROBITUSSIN SYP MAX-ST
2
$18.84
0.03%
0
$0.00
0.00%
00031867810
ROBITUSSIN LIQ CF
1
$7.29
0.02%
0
$0.00
0.00%
00031868512
ROBITUSSIN SYP DM
5
$29.43
0.08%
582
$3,595.53
27.48%
00031868518
ROBITUSSIN SYP DM
12
$105.74
0.19%
451
$3,811.95
21.29%
00031868522
ROBITUSSIN SYP DM
6
$65.75
0.10%
143
$1,407.92
6.75%
00031868525
ROBITUSSIN SYP DM
0
$0.00
0.00%
28
$223.29
1.32%
00031868612
ROBITUSSIN SYP SUGAR FR
3
$20.55
0.05%
206
$2,057.00
9.73%
00031869518
ROBITUSSIN SYP PE
4
$26.86
0.06%
0
$0.00
0.00%
00037064216
TUSSI-12
3
$114.57
0.05%
0
$0.00
0.00%
00037065504
RYNA-12 S
3
$171.93
0.05%
0
$0.00
0.00%
00037068204
TUSSI-12 S SUS 4-30MG/5
3
$94.90
0.05%
0
$0.00
0.00%
00037069304
TUSSI-12D S SUS
2
$77.39
0.03%
0
$0.00
0.00%
00037070710
RYNATAN
15
$802.84
0.24%
0
$0.00
0.00%
00037071416
RYNATAN PED SUS
19
$1,339.78
0.30%
0
$0.00
0.00%
00037071867
RYNATUSS PED SUS
19
$2,302.43
0.30%
0
$0.00
0.00%
00037071868
RYNATUSS PED SUS
4
$605.80
0.06%
0
$0.00
0.00%
00037471401
TUSSI-ORGANI LIQ DM-S NR
1
$50.49
0.02%
0
$0.00
0.00%
00037481410
TUSSI-ORGANI LIQ NR
1
$26.84
0.02%
0
$0.00
0.00%
00043014224
TAVIST SINUS TAB ND/MS
1
$3.19
0.02%
0
$0.00
0.00%
ELX 2-12.5/5
SUS
SUS
TAB 9-25MG
Page 153 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
COUGH/COLD
00054333750
GUAIFENESIN SYP 100/5ML
1
00054474325
PSEUDOEPHEDR TAB 30MG
00054474425
00067021704
$5.79
0.02%
0
$0.00
0.00%
11
$44.33
28
$135.15
0.17%
45
$204.99
2.12%
0.44%
131
$608.87
6.19%
TRIAMINIC CO SYP 15-5MG/5
1
$5.96
0.02%
0
$0.00
0.00%
00071255517
BENADRYL ALL LIQ SINUS
2
$14.02
0.03%
0
$0.00
0.00%
00081008220
ACTIFED PLUS TAB
00081067013
SUDAFED 12HR TAB 120MG CR
1
$6.99
0.02%
0
$0.00
0.00%
6
$109.75
0.10%
10
$157.53
0.47%
00085014701
DRIXORAL CLD TAB /ALLERGY
3
$76.71
0.05%
0
$0.00
0.00%
00085014702
DRIXORAL CLD TAB /ALLERGY
1
$20.15
0.02%
0
$0.00
0.00%
00085070304
TRINALIN REP TAB CR
17
$1,031.09
0.27%
0
$0.00
0.00%
00085078902
DRIXORAL SIN TAB 6-120 CR
3
$59.19
0.05%
0
$0.00
0.00%
00085090103
CHLOR-TRIMET TAB 4-60
2
$16.92
0.03%
0
$0.00
0.00%
00093006001
BENZONATATE CAP 100MG
4
$37.74
0.06%
0
$0.00
0.00%
00113031034
TUSSIN COUGH SYP 100/5ML
1
$2.98
0.02%
0
$0.00
0.00%
00121041904
6
$47.66
0.10%
0
$0.00
0.00%
00121042104
PSEUDOEPHEDR SYP 30MG/5ML
3
$23.91
0.05%
13
$70.22
0.61%
00121068304
GG/CODEINE SYP 100-10/5
1
$6.61
0.02%
0
$0.00
0.00%
00131513164
CODIMAL DM SYP
1
$13.31
0.02%
0
$0.00
0.00%
00131513170
CODIMAL DM SYP
1
$11.99
0.02%
0
$0.00
0.00%
00143148501
1
$4.99
0.02%
0
$0.00
0.00%
00182001737
GUIATUSS AC SYP 10-100/5
8
$48.28
0.13%
0
$0.00
0.00%
00182001740
1
$4.76
0.02%
0
$0.00
0.00%
00182025937
GUIATUSS
SYP 100/5ML
7
$29.57
0.11%
0
$0.00
0.00%
00182025940
GUIATUSS
SYP 100/5ML
4
$26.76
0.06%
0
$0.00
0.00%
00182108001
1
$5.70
0.02%
0
$0.00
0.00%
00182118801
GUAIFENESIN TAB 600MG ER
5
$267.43
0.08%
0
$0.00
0.00%
00182137840
GUIATUSS DAC SOL
2
$10.18
0.03%
0
$0.00
0.00%
Page 154 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
COUGH/COLD
00182145916
GENAPHED
00182602240
00182606440
TAB 30MG
2
$6.86
0.03%
4
$17.17
0.19%
BROMATANE DX SYP
5
$42.25
0.08%
0
$0.00
0.00%
GUIATUSS DM SYP 100-10/5
4
$25.10
0.06%
0
$0.00
0.00%
00185078401
GUIAPAX PSE TAB 120-600
2
$22.62
0.03%
0
$0.00
0.00%
00185130401
CPM/PSE
CAP 8-120 CR
9
$127.57
0.14%
0
$0.00
0.00%
00225042045
KWELCOF
SYP 5-100/5
4
$48.05
0.06%
0
$0.00
0.00%
00254531228
GUAIBID LA TAB 600MG
1
$13.89
0.02%
0
$0.00
0.00%
00254531235
GUAIBID LA TAB 600MG
21
$350.85
0.33%
0
$0.00
0.00%
00254906458
CHERATUSSIN SYP AC
3
$14.91
0.05%
0
$0.00
0.00%
00254918858
H-C TUSSIVE SYP
1
$8.74
0.02%
0
$0.00
0.00%
00256011101
EXTENDRYL SR CAP
4
$83.88
0.06%
0
$0.00
0.00%
00256012701
EXTENDRYL
SYP
4
$75.44
0.06%
0
$0.00
0.00%
00256013301
EXTENDRYL
CHW
12
$148.47
0.19%
0
$0.00
0.00%
00256017701
EXTENDRYL JR CAP TD
15
$273.87
0.24%
0
$0.00
0.00%
00258365401
109
$1,155.46
1.73%
1
$9.00
0.05%
00258365405
3
$32.89
0.05%
0
$0.00
0.00%
00258367801
60
$3,008.29
0.95%
0
$0.00
0.00%
00372000604
SCOT-TUSSIN LIQ EXPCT SF
1
$6.24
0.02%
0
$0.00
0.00%
00451400050
BROMFED
6
$429.26
0.10%
0
$0.00
0.00%
00451400250
GUAIFED
1
$26.09
0.02%
0
$0.00
0.00%
00451400350
GUAIFED-PD CAP 60-300CR
2
$178.24
0.03%
0
$0.00
0.00%
00451420116
BROMFED
SYP 2-30/5
1
$8.18
0.02%
0
$0.00
0.00%
00456069801
TESSALON
CAP 200MG
00472001116
GUIATUSS DAC SOL
00472001204
CAP 12-120CR
CAP CR
6
$443.85
0.10%
0
$0.00
0.00%
25
$214.79
0.40%
0
$0.00
0.00%
9
$59.35
0.14%
0
$0.00
0.00%
00472001216
138
$847.86
2.19%
0
$0.00
0.00%
00472041594
GUIATUSS
2
$8.78
0.03%
0
$0.00
0.00%
SYP CF
Page 155 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
COUGH/COLD
00472041904
GUIATUSS
SYP 100/5ML
8
$40.58
0.13%
0
$0.00
0.00%
00472041916
GUIATUSS
SYP 100/5ML
17
$99.19
0.27%
0
$0.00
0.00%
00472042194
GUIATUSS PE SYP 30-100/5
1
$5.71
0.02%
0
$0.00
0.00%
00472072716
CARDEC-S
1
$5.68
0.02%
0
$0.00
0.00%
00472073331
CARDEC DM
DRO
1
$8.53
0.02%
0
$0.00
0.00%
00472103016
HYDROMET
SYP 5-1.5/5
10
$54.82
0.16%
0
$0.00
0.00%
00472103104
2
$11.81
0.03%
0
$0.00
0.00%
00472103116
9
$65.64
0.14%
0
$0.00
0.00%
00472151704
DECOFED
SYP 30MG/5ML
0
$0.00
0.00%
1
$5.08
0.05%
00472151716
DECOFED
SYP 30MG/5ML
26
$98.36
0.41%
1
$2.28
0.05%
00472151794
DECOFED
SYP 30MG/5ML
1
$5.53
0.02%
1
$5.53
0.05%
00472162704
PROMETH/COD SYP 6.25-10
26
$279.73
0.41%
0
$0.00
0.00%
00472162716
249
$2,636.58
3.95%
0
$0.00
0.00%
00472162728
3
$28.36
0.05%
0
$0.00
0.00%
00472162804
PROMETH VC SYP 6.25-5/5
6
$90.09
0.10%
0
$0.00
0.00%
00472162816
PROMETH VC SYP 6.25-5/5
5
$81.42
0.08%
0
$0.00
0.00%
00472162904
PROMETH VC/ SYP CODEINE
6
$83.19
0.10%
0
$0.00
0.00%
00472162908
1
$10.31
0.02%
0
$0.00
0.00%
00472162916
65
$945.71
1.03%
0
$0.00
0.00%
00472163004
PROMETHAZINE SYP DM
1
$9.02
0.02%
0
$0.00
0.00%
00472163016
PROMETHAZINE SYP DM
1
$9.42
0.02%
0
$0.00
0.00%
00472163316
TRIACIN-C
2
$18.19
0.03%
0
$0.00
0.00%
00472163904
DIHISTINE DH LIQ
1
$11.87
0.02%
0
$0.00
0.00%
00472163916
DIHISTINE DH LIQ
4
$34.24
0.06%
0
$0.00
0.00%
00482018516
DECONAMINE SYP
1
$16.31
0.02%
0
$0.00
0.00%
00496043402
KRONOFED-A CAP JR
12
$468.90
0.19%
0
$0.00
0.00%
00501210004
BENYLIN ADLT SYP 15MG/5ML
4
$21.12
0.06%
0
$0.00
0.00%
SYP 4-60/5ML
SYP
Page 156 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
COUGH/COLD
00501276624
SUDAFED
00501278710
00501278720
TAB SINUS
1
$6.93
0.02%
0
$0.00
0.00%
0
$0.00
0.00%
11
$174.66
0.52%
0
$0.00
0.00%
65
$960.96
3.07%
00501286548
SUDAFED
0
$0.00
0.00%
1
$6.45
0.05%
00501288004
CHILD SUDAFE LIQ 15MG/5ML
1
$7.21
0.02%
1
$7.27
0.05%
00536082585
5
$29.48
0.08%
0
$0.00
0.00%
00536082597
4
$17.16
0.06%
0
$0.00
0.00%
00536097097
GG/DM
1
$4.56
0.02%
0
$0.00
0.00%
00536185085
11
$64.18
0.17%
21
$135.76
0.99%
00536185097
3
$18.22
0.05%
6
$36.49
0.28%
00536439101
0
$0.00
0.00%
3
$13.12
0.14%
00536439135
5
$27.00
0.08%
15
$84.58
0.71%
00536500575
NRS NASAL
1
$4.99
0.02%
0
$0.00
0.00%
00603024821
Q-FED
TAB 60MG
5
$41.44
0.08%
0
$0.00
0.00%
00603104458
BROMOPHED DX SYP
1
$10.91
0.02%
0
$0.00
0.00%
00603107554
CHERATUSSIN SYP AC
4
$25.67
0.06%
0
$0.00
0.00%
00603107558
CHERATUSSIN SYP AC
57
$287.82
0.90%
0
$0.00
0.00%
00603107560
CHERATUSSIN SYP AC
4
$23.00
0.06%
0
$0.00
0.00%
00603107858
CHERATUSSIN SOL DAC
2
$11.20
0.03%
0
$0.00
0.00%
00603111158
CODITUSS DH SYP
2
$17.40
0.03%
0
$0.00
0.00%
00603118258
DRITUSS HD ELX
31
$337.54
0.49%
0
$0.00
0.00%
00603128458
H-C TUSSIVE SYP
2
$15.18
0.03%
0
$0.00
0.00%
00603152058
PHENYLHIST LIQ DH
6
$55.13
0.10%
0
$0.00
0.00%
00603250621
BPM/PSE-PD CAP 6-60MGCR
2
$40.34
0.03%
0
$0.00
0.00%
00603314321
DECONGESTINE CAP 8-120 TR
1
$6.59
0.02%
0
$0.00
0.00%
00603350321
DRITUSS G
1
$26.86
0.02%
0
$0.00
0.00%
00603377321
GUAIFENESIN TAB 1200 ER
5
$80.27
0.08%
0
$0.00
0.00%
TAB 30MG
SYP 100-10/5
SPR 0.05%
TAB 1200MG
Page 157 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
COUGH/COLD
00603554221
Q-BID-DM
TAB 30-600CR
00603554321
Q-BID-LA
00603554328
Q-BID-LA
00603566821
2
$16.78
0.03%
0
$0.00
0.00%
TAB 600MG
69
$1,551.41
1.10%
TAB 600MG
1
$43.38
0.02%
0
$0.00
0.00%
2
$27.38
0.09%
GUAIFEN PSE TAB 600-120
4
$82.13
0.06%
0
$0.00
0.00%
00603566828
GUAIFEN PSE TAB 600-120
2
$22.79
0.03%
0
$0.00
0.00%
00615452453
GUAIFENESIN TAB 600MG LA
00615452463
26
$1,048.30
0.41%
0
$0.00
0.00%
13
$319.84
0.21%
0
$0.00
0.00%
00677083130
12 HR NASAL SPR 0.05%
1
$5.72
0.02%
0
$0.00
0.00%
00677147201
2
$14.93
0.03%
0
$0.00
0.00%
00677147501
31
$677.89
0.49%
0
$0.00
0.00%
00677147505
5
$143.54
0.08%
0
$0.00
0.00%
00677147601
GG/PSE CR
TAB 600-120
24
$275.89
0.38%
0
$0.00
0.00%
00677150201
GG/PSE CR
CAP 300-60MG
10
$212.06
0.16%
0
$0.00
0.00%
00677150301
GG/PSE CR
CAP 250-120
16
$270.27
0.25%
0
$0.00
0.00%
00677164301
GUAIFENESIN TAB 1200 LA
7
$77.62
0.11%
4
$109.56
0.19%
00677166101
GUAIFENESIN TAB 200MG
4
$61.64
0.06%
0
$0.00
0.00%
00677173333
3
$28.97
0.05%
0
$0.00
0.00%
00677174701
CPM/PSE
49
$425.89
0.78%
0
$0.00
0.00%
00677178501
GG/PSE
5
$80.07
0.08%
1
$12.02
0.05%
00677182633
PED TAN/CHLO SUS
1
$18.69
0.02%
0
$0.00
0.00%
00677182641
PED TAN/CHLO SUS
32
$1,009.57
0.51%
0
$0.00
0.00%
00677182833
7
$57.20
0.11%
0
$0.00
0.00%
00781153301
34
$147.78
0.54%
72
$411.06
3.40%
00781153501
30
$153.35
0.48%
102
$650.78
4.82%
00904005316
ROBAFEN DM SYP 100-10/5
1
$6.97
0.02%
0
$0.00
0.00%
00904005320
1
$2.49
0.02%
0
$0.00
0.00%
00904005328
3
$15.90
0.05%
0
$0.00
0.00%
CAP 8-120 SR
TAB 1200/120
Page 158 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
COUGH/COLD
00904006109
ROBAFEN
SYP 100/5ML
00904324860
RONDAMINE
00904326480
PPA/GG CR
00904505324
SUDOGEST
00904512559
SUDOGEST
00904536720
SUDOGEST
00904540460
GG/PSE CR
00904545360
4
$10.60
0.06%
0
$0.00
0.00%
TAB 4-60MG
2
$65.10
0.03%
0
$0.00
0.00%
TAB 75-400MG
1
$6.32
0.02%
0
$0.00
0.00%
TAB 30MG
0
$0.00
0.00%
7
$19.11
0.33%
TAB 60MG
1
$3.86
0.02%
6
$37.66
0.28%
LIQ 15MG/5ML
0
$0.00
0.00%
1
$4.20
0.05%
1
$32.62
0.02%
0
$0.00
0.00%
GUAIFENESIN TAB 1200 SA
3
$72.24
0.05%
0
$0.00
0.00%
00904556516
RONDAMINE DM SYP
1
$10.00
0.02%
0
$0.00
0.00%
00904765016
RHINATATE
4
$192.09
0.06%
0
$0.00
0.00%
00904775960
1
$14.01
0.02%
0
$0.00
0.00%
11822040230
RA SUPHEDRIN TAB 30MG
0
$0.00
0.00%
5
$44.68
0.24%
11822386780
RA SUPHEDRIN TAB 120MG CR
0
$0.00
0.00%
6
$85.74
0.28%
11845086101
PSEUDO
4
$11.26
0.06%
0
$0.00
0.00%
12333902901
SUPHEDRIN TAB 30MG
1
$5.28
0.02%
0
$0.00
0.00%
17236026324
0
$0.00
0.00%
1
$4.24
0.05%
17236026701
3
$12.85
0.05%
3
$2.72
0.14%
24385043262
SUPHEDRIN TAB 30MG
1
$3.75
0.02%
3
$16.67
0.14%
37205000105
PEDIA RELIEF DRO 7.5/.8ML
1
$6.50
0.02%
0
$0.00
0.00%
37205021226
TUSSIN CF
LIQ
1
$11.35
0.02%
0
$0.00
0.00%
37205044426
CHILD PSEUPH LIQ 15MG/5ML
4
$20.30
0.06%
10
$53.66
0.47%
37205044562
16
$119.45
0.25%
24
$165.41
1.13%
37205044580
5
$32.95
0.08%
55
$410.81
2.60%
37205044652
PSEUDOEPHEDR CAP 120MG CR
0
$0.00
0.00%
53
$902.61
2.50%
37205071226
TUSSIN DM
5
$41.60
0.08%
0
$0.00
0.00%
37205096026
TUSSIN
SYP 100/5ML
36
$269.14
0.57%
0
$0.00
0.00%
37205096034
TUSSIN
SYP 100/5ML
22
$124.60
0.35%
0
$0.00
0.00%
TAB 600-120
SUS PED
TAB 30MG
LIQ CLEAR
Page 159 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
COUGH/COLD
37205096226
HONEY TUSSIN SYP 10MG/5ML
2
$12.10
0.03%
0
$0.00
0.00%
37205097026
TUSSIN DM
SYP 100-10/5
4
$33.47
0.06%
0
$0.00
0.00%
37205097034
TUSSIN DM
SYP 100-10/5
8
$59.70
0.13%
0
$0.00
0.00%
37205097526
TUSSIN PE
7
$51.80
0.11%
0
$0.00
0.00%
49348019727
SM NOSE DROP SOL 1%
0
$0.00
0.00%
1
$4.32
0.05%
49348027834
EXPECTORANT SYP 100/5ML
1
$7.50
0.02%
0
$0.00
0.00%
50111038501
PPA/GG CR
TAB 75-400MG
8
$62.18
0.13%
0
$0.00
0.00%
50111052201
PPA/GG CR
TAB 75-400MG
1
$7.74
0.02%
0
$0.00
0.00%
50111085101
292
$2,688.69
4.64%
2
$14.06
0.09%
50313011742
PRO-TANNATE SUS PEDI
1
$23.56
0.02%
0
$0.00
0.00%
50383006104
DIABET EXPEC SYP 100/5ML
2
$4.98
0.03%
0
$0.00
0.00%
50383009804
GUAIATUSSIN SYP DM
1
$5.95
0.02%
0
$0.00
0.00%
50383009816
GUAIATUSSIN SYP DM
2
$11.65
0.03%
0
$0.00
0.00%
50383013516
HT-TUSS DM ELX 200-20/5
11
$131.44
0.17%
0
$0.00
0.00%
50383059316
BROMETANE DX SYP
8
$150.90
0.13%
0
$0.00
0.00%
50383080416
105
$1,276.40
1.67%
0
$0.00
0.00%
50383080816
TRI-TANNATE SUS PED
4
$305.62
0.06%
0
$0.00
0.00%
50383084216
PHENYL CHLOR SUS TAN
1
$18.49
0.02%
0
$0.00
0.00%
50428125740
DECONGESTANT TAB 30MG
0
$0.00
0.00%
2
$25.73
0.09%
50428144665
12HR DECONGE TAB 120MG CR
0
$0.00
0.00%
4
$63.92
0.19%
50428382283
NASAL DECONG TAB 30MG
1
$5.49
0.02%
0
$0.00
0.00%
50474061016
DURATUSS HD ELX
10
$208.67
0.16%
0
$0.00
0.00%
50474061201
DURATUSS
5
$68.65
0.08%
0
$0.00
0.00%
50474062001
DURATUSS G TAB 1200 CR
3
$51.92
0.05%
0
$0.00
0.00%
50474063016
DURATUSS DM ELX 200-20/5
4
$42.86
0.06%
0
$0.00
0.00%
50474064001
DURATUSS GP TAB 120/1200
10
$265.50
0.16%
0
$0.00
0.00%
50474065040
DURATUSS
18
$620.09
0.29%
0
$0.00
0.00%
SYP 30-100/5
TAB 120-600
TAB AM/PM
Page 160 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
COUGH/COLD
50580019304
SIMPLY STUFF LIQ 15MG/5ML
1
50580043224
TYLENOL
TAB SINUS MS
51285040102
PSE/GG CR
TAB 120-600
51285040202
$7.13
0.02%
0
$0.00
0.00%
3
$21.61
0.05%
0
$0.00
0.00%
7
$158.44
0.11%
0
$0.00
0.00%
PSEUDO/GG ER TAB 120-600
3
$69.60
0.05%
0
$0.00
0.00%
51285041702
GUAIFENESIN TAB 600MG CR
7
$155.24
0.11%
0
$0.00
0.00%
51285042002
GG/DM SR
8
$308.30
0.13%
0
$0.00
0.00%
51285071757
TRIOTANN-S SUS PED
5
$318.83
0.08%
0
$0.00
0.00%
51285071957
MEDTUSS HD ELX
1
$9.24
0.02%
0
$0.00
0.00%
51285072255
R-TANNA 12 SUS
2
$55.98
0.03%
0
$0.00
0.00%
51285085702
GUAIFENESIN TAB 1200 CR
11
$263.58
0.17%
0
$0.00
0.00%
51285087902
GUAIFENESIN TAB 1200 SA
15
$300.83
0.24%
0
$0.00
0.00%
51285089402
PSE/GG TR
CAP 120-250
3
$54.81
0.05%
0
$0.00
0.00%
51285089502
PSE/GG TR
CAP 60-300MG
3
$29.21
0.05%
0
$0.00
0.00%
51285089802
PSEUDO/GG SR TAB 120-600
1
$36.76
0.02%
0
$0.00
0.00%
51479003201
ENTEX PSE
3
$79.76
0.05%
0
$0.00
0.00%
51672203003
NASAL DECONG SPR 0.05%
1
$4.99
0.02%
0
$0.00
0.00%
51991001616
DURADRYL
1
$8.80
0.02%
0
$0.00
0.00%
51991021701
DYNAHIST ER CAP 4-60MG
3
$32.10
0.05%
0
$0.00
0.00%
51991023601
CRANTEX LA TAB 30-600MG
3
$72.89
0.05%
0
$0.00
0.00%
51991070001
DURADRYL JR CAP CR
1
$5.71
0.02%
0
$0.00
0.00%
51991081516
QUAD TANN
1
$27.62
0.02%
0
$0.00
0.00%
52152005802
AMI-TEX LA TAB 75-400MG
2
$13.06
0.03%
0
$0.00
0.00%
52152005804
52152010604
AMIBID LA
52152013002
TAB 600-30MG
TAB 120-600
SYP
SUS
1
$6.61
0.02%
0
$0.00
0.00%
34
$707.46
0.54%
0
$0.00
0.00%
AMITEX PSE TAB 120-600
7
$101.76
0.11%
0
$0.00
0.00%
52152013004
AMITEX PSE TAB 120-600
3
$63.52
0.05%
0
$0.00
0.00%
52152013902
AMIBID DM
3
$81.81
0.05%
0
$0.00
0.00%
TAB 600MG CR
TAB 30-600CR
Page 161 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
COUGH/COLD
52152014002
HYDROCODONE/ TAB HOMATROP
6
$137.65
0.10%
0
$0.00
0.00%
52152017202
CODEINE/GG TAB 10-300
7
$126.71
0.11%
0
$0.00
0.00%
52152024502
GUAIFENESIN TAB ER 1200M
4
$51.90
0.06%
0
$0.00
0.00%
52152024702
GG/PSE
4
$58.49
0.06%
0
$0.00
0.00%
52152025302
12
$247.15
0.19%
0
$0.00
0.00%
52544048916
HALOTUSSN-AC LIQ 100-10/5
8
$88.60
0.13%
0
$0.00
0.00%
52735041944
TUSSIN DM
1
$4.25
0.02%
0
$0.00
0.00%
52735063641
PSEUDOEPHEDR LIQ 15MG/5ML
0
$0.00
0.00%
1
$6.28
0.05%
52959026104
CHILD'S PSEU LIQ 30MG/5ML
1
$15.73
0.02%
1
$7.41
0.05%
53014040210
HUMIBID
CAP PEDIATRI
11
$752.52
0.17%
0
$0.00
0.00%
53014040410
SEMPREX-D
CAP 8-60MG
38
$1,802.53
0.60%
0
$0.00
0.00%
53014054867
TUSSIONEX
SUS EXT-REL
1,239
$46,918.16
19.67%
0
$0.00
0.00%
53014084261
DELSYM
LIQ 30MG/5ML
30
$312.77
0.48%
0
$0.00
0.00%
53489042401
GG/PSE CR
TAB 600-120
78
$1,036.91
1.24%
0
$0.00
0.00%
53807015304
RI-TUSSIN
SYP 100/5ML
14
$77.43
0.22%
0
$0.00
0.00%
54838011780
SILTUSSIN SA SYP 100/5ML
5
$33.44
0.08%
0
$0.00
0.00%
54838012480
GG/DM NR
4
$92.78
0.06%
0
$0.00
0.00%
57664015208
23
$499.67
0.37%
0
$0.00
0.00%
57664015213
54
$818.17
0.86%
3
$18.42
0.14%
57664022208
MIRAPHEN PSE TAB 120-600
2
$14.90
0.03%
0
$0.00
0.00%
57664022213
MIRAPHEN PSE TAB 120-600
1
$23.27
0.02%
0
$0.00
0.00%
57664035508
GG/DM CR
3
$178.85
0.05%
0
$0.00
0.00%
58177001904
BROMFENEX
19
$365.09
0.30%
0
$0.00
0.00%
58177002004
BROMFENEX PD CAP 6-60MGCR
12
$291.89
0.19%
0
$0.00
0.00%
58177004504
PSEUDOVENT CAP CR
18
$365.88
0.29%
0
$0.00
0.00%
58177004604
PSEUDOVENT CAP PED CR
21
$426.92
0.33%
0
$0.00
0.00%
58177020504
GUAIFENEX LA TAB 600MG
347
$6,151.83
5.51%
1
$10.90
0.05%
TAB 1200/120
SYP 100-10/5
LIQ 100-10/5
TAB 600-30MG
CAP 12-120CR
Page 162 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
COUGH/COLD
58177020508
GUAIFENEX LA TAB 600MG
141
$2,933.72
2.24%
0
$0.00
0.00%
58177020804
GUAIFENEX
138
$1,788.23
2.19%
0
$0.00
0.00%
58177021304
GUAIFENEX DM TAB 30-600CR
64
$1,222.00
1.02%
0
$0.00
0.00%
58177021404
GUAIFENEX
TAB PSE 60
7
$128.27
0.11%
0
$0.00
0.00%
58177022304
CODEINE/GG TAB 10-300
15
$307.37
0.24%
0
$0.00
0.00%
58177022704
HISTA-VENT TAB DA
6
$140.10
0.10%
0
$0.00
0.00%
58177030804
GUAIFENEX G TAB 1200 CR
82
$1,282.76
1.30%
0
$0.00
0.00%
58177037304
GUAIFENEX GP TAB 120/1200
16
$271.59
0.25%
0
$0.00
0.00%
58177087707
HISTINEX HC SYP
61
$558.10
0.97%
0
$0.00
0.00%
58177087712
HISTINEX HC SYP
58177088107
HYDROCOD/GG SYP 5-100/5
58177089007
TAB PSE 120
4
$50.92
0.06%
0
$0.00
0.00%
93
$1,160.42
1.48%
0
$0.00
0.00%
HYDRO-TUSSIN SOL HD
9
$81.03
0.14%
0
$0.00
0.00%
59196000201
OMNIHIST LA TAB
3
$73.43
0.05%
0
$0.00
0.00%
59196000301
AH-CHEW
7
$294.97
0.11%
0
$0.00
0.00%
59390003613
12 HR NASAL SPR 0.05%
0
$0.00
0.00%
2
$7.51
0.09%
59630010004
PROTUSS
SYP 5-300/5M
1
$26.53
0.02%
0
$0.00
0.00%
59630010016
PROTUSS
SYP 5-300/5M
2
$127.28
0.03%
0
$0.00
0.00%
59630012004
TANAFED
SUS
13
$513.97
0.21%
0
$0.00
0.00%
59630012016
TANAFED
SUS
50
$2,239.68
0.79%
0
$0.00
0.00%
59630012504
TANAFED DM SUS
14
$470.39
0.22%
0
$0.00
0.00%
59630012516
TANAFED DM SUS
28
$826.88
0.44%
0
$0.00
0.00%
59630015010
MESCOLOR
8
$271.26
0.13%
0
$0.00
0.00%
59630046516
TANAFED DP SUS
59630047016
TANAFED DMX SUS
59741011216
CHW
TAB
1
$39.44
0.02%
0
$0.00
0.00%
10
$281.79
0.16%
0
$0.00
0.00%
6
$28.06
0.10%
0
$0.00
0.00%
59743001901
GG 200 NR
2
$54.74
0.03%
0
$0.00
0.00%
59743005301
D-AMINE-SR CAP 8-120 CR
1
$7.61
0.02%
0
$0.00
0.00%
TAB 200MG
Page 163 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
COUGH/COLD
59743005401
AQUABID-DM TAB 30-600CR
2
59743005616
TUSSADUR-HD SOL
59911581903
59911582203
$22.56
0.03%
0
$0.00
0.00%
1
$7.49
0.02%
0
$0.00
0.00%
3
$12.54
0.05%
0
$0.00
0.00%
PROMETHAZINE SYP DM
1
$4.11
0.02%
0
$0.00
0.00%
60242050101
4
$15.76
0.06%
4
$8.42
0.19%
60258022016
DEHISTINE
1
$17.26
0.02%
0
$0.00
0.00%
60258024516
SU-TUSS DM ELX 200-20/5
2
$18.99
0.03%
0
$0.00
0.00%
60258025801
GUAIFENESIN TAB 1200MG
22
$523.51
0.35%
0
$0.00
0.00%
60258026116
GANI-TUSS NR LIQ 10-100/5
3
$33.48
0.05%
0
$0.00
0.00%
60258026216
GANI-TUSS DM LIQ 100-10/5
3
$38.88
0.05%
0
$0.00
0.00%
60258026601
GFN/PSE
8
$93.70
0.13%
0
$0.00
0.00%
60258030204
TANNIC-12 S SUS 4-30MG/5
2
$24.77
0.03%
0
$0.00
0.00%
60258043530
ANDEHIST NR DRO 1-15/ML
3
$93.90
0.05%
0
$0.00
0.00%
60258044416
ANDEHIST DM SYP NR
6
$44.51
0.10%
0
$0.00
0.00%
60258044530
ANDEHIST DM DRO NR
10
$385.95
0.16%
0
$0.00
0.00%
60258071516
SU-TUSS HD ELX
9
$75.29
0.14%
0
$0.00
0.00%
60258077016
CODAL-DH
2
$14.62
0.03%
0
$0.00
0.00%
60432004504
MYTUSSIN AC SYP 10-100/5
71
$507.22
1.13%
0
$0.00
0.00%
60432004516
256
$1,474.34
4.06%
0
$0.00
0.00%
60432004528
32
$132.10
0.51%
0
$0.00
0.00%
60432004816
GUAIFENESIN LIQ DM
10
$195.55
0.16%
0
$0.00
0.00%
60432007916
GUAIFENESIN LIQ 100/5ML
1
$33.46
0.02%
0
$0.00
0.00%
60432008816
GUAIFENESIN LIQ AC
291
$4,412.91
4.62%
0
$0.00
0.00%
60432010130
CARBINOXAMIN DRO 2-25/ML
3
$35.43
0.05%
0
$0.00
0.00%
60432010216
CARBINOXAMIN SYP 4-60/5ML
2
$11.05
0.03%
0
$0.00
0.00%
60432011604
TRI TANNATE SUS PED
4
$123.02
0.06%
0
$0.00
0.00%
60432011616
TRI TANNATE SUS PED
8
$276.89
0.13%
0
$0.00
0.00%
SYP
TAB 1200/120
SYP
Page 164 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
COUGH/COLD
60432011708
TETRA TANN SUS PED
20
$1,834.94
0.32%
0
$0.00
0.00%
60432011716
TETRA TANN SUS PED
18
$1,537.59
0.29%
0
$0.00
0.00%
60432018316
TANNIHIST-12 SUS
5
$154.12
0.08%
0
$0.00
0.00%
60432019104
PYRILAFEN TA SUS 30-5MG/5
5
$157.08
0.08%
0
$0.00
0.00%
60432019604
C-PHED TANNA SUS 4.5-75/5
20
$849.19
0.32%
0
$0.00
0.00%
60432019616
C-PHED TANNA SUS 4.5-75/5
20
$797.63
0.32%
0
$0.00
0.00%
60432020204
CARBINOXAMIN SYP CPD
1
$4.22
0.02%
0
$0.00
0.00%
60432020216
CARBINOXAMIN SYP CPD
13
$61.85
0.21%
0
$0.00
0.00%
60432022604
C-PHED DM
SUS TANNATE
1
$21.97
0.02%
0
$0.00
0.00%
60432022616
C-PHED DM
SUS TANNATE
2
$20.00
0.03%
0
$0.00
0.00%
60432023604
BROMAXEFED SYP DM RF
19
$424.23
0.30%
0
$0.00
0.00%
60432023730
CARBAXEFED D DRO RF
20
$427.46
0.32%
0
$0.00
0.00%
60432034504
PHENCLOR TAN SUS PEDI
5
$179.66
0.08%
0
$0.00
0.00%
60432034516
PHENCLOR TAN SUS PEDI
37
$1,986.71
0.59%
0
$0.00
0.00%
60432045516
HYDROCOD/HOM SYP 5-1.5/5
29
$157.24
0.46%
0
$0.00
0.00%
60432054104
MYTUSSIN DAC SOL
1
$9.95
0.02%
0
$0.00
0.00%
60432054116
MYTUSSIN DAC SOL
14
$120.21
0.22%
0
$0.00
0.00%
60432060404
PROMETHAZINE SYP DM
3
$22.08
0.05%
0
$0.00
0.00%
60432060416
PROMETHAZINE SYP DM
1
$9.57
0.02%
0
$0.00
0.00%
60432060604
3
$40.56
0.05%
0
$0.00
0.00%
60432060616
1
$14.19
0.02%
0
$0.00
0.00%
60432095130
CARBINOXAMIN DRO CPD
18
$158.96
0.29%
0
$0.00
0.00%
60569006104
DIABTC TUSSN SYP 100/5ML
1
$6.39
0.02%
0
$0.00
0.00%
61073002404
2
$15.93
0.03%
0
$0.00
0.00%
61646017201
GUAIFENESIN TAB 1200 TR
1
$19.97
0.02%
0
$0.00
0.00%
61787006304
DIABETIC TUS LIQ EX
24
$188.15
0.38%
0
$0.00
0.00%
62022003201
ENTEX PSE
3
$77.65
0.05%
0
$0.00
0.00%
TAB 120-600
Page 165 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
COUGH/COLD
62022030516
ENTEX
62022033001
ENTEX LA
62022094116
ENTEX HC
63481004270
HYCODAN
63481023516
LIQ 7.5-100
2
$29.52
0.03%
0
$0.00
0.00%
TAB 30-600MG
2
$93.62
0.03%
0
$0.00
0.00%
LIQ
2
$84.68
0.03%
0
$0.00
0.00%
1
$18.10
0.02%
0
$0.00
0.00%
HYCOTUSS EXP SYP 5-100/5
8
$248.53
0.13%
0
$0.00
0.00%
63824004710
AQUATAB D
2
$36.62
0.03%
0
$0.00
0.00%
63824017016
ALLERX
SUS
3
$101.08
0.05%
0
$0.00
0.00%
64376050501
BOCA-TEX PSE TAB 120-600
1
$8.93
0.02%
0
$0.00
0.00%
64455001301
D.A. CHEWABL CHW
1
$42.45
0.02%
0
$0.00
0.00%
64455002501
RONDEC-TR
TAB 8-120
5
$422.05
0.08%
0
$0.00
0.00%
64455007003
RONDEC DM
DRO
9
$417.42
0.14%
0
$0.00
0.00%
64455007112
RONDEC DM
SYP
2
$49.33
0.03%
0
$0.00
0.00%
64455008003
RONDEC
DRO 1-15/ML
2
$67.24
0.03%
0
$0.00
0.00%
64455008112
RONDEC
SYP 4-45MG/5
2
$96.63
0.03%
0
$0.00
0.00%
64455008148
RONDEC
SYP 4-45MG/5
2
$42.37
0.03%
0
$0.00
0.00%
64543008901
RESCON MX
TAB
1
$14.14
0.02%
0
$0.00
0.00%
65430010101
DEXALONE
CAP 30MG
4
$92.11
0.06%
0
$0.00
0.00%
65772646301
2
$24.36
0.03%
0
$0.00
0.00%
66993054257
T-TANNA DM SUS
1
$46.15
0.02%
0
$0.00
0.00%
TAB 5MG
TAB 60-1200M
COX 2 INHIBITORS
00006007428
VIOXX
TAB 12.5MG
18
$1,144.07
0.13%
21
$1,435.05
0.14%
00006007431
VIOXX
TAB 12.5MG
97
$7,289.46
0.71%
73
$5,420.40
0.49%
00006007468
VIOXX
TAB 12.5MG
661
$51,538.72
4.82%
665
$51,939.06
4.44%
00006011028
VIOXX
TAB 25MG
29
$2,185.74
0.21%
12
$1,047.66
0.08%
00006011031
VIOXX
TAB 25MG
36
$2,428.03
0.26%
31
$1,945.26
0.21%
00006011068
VIOXX
TAB 25MG
3,355
$248,266.20
24.46%
3,789
$297,846.21
25.32%
Page 166 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
COX 2 INHIBITORS
00006011082
VIOXX
TAB 25MG
9
$616.39
0.07%
3
$238.73
0.02%
00006011428
VIOXX
TAB 50MG
18
$1,823.36
0.13%
1
$115.72
0.01%
00006011431
VIOXX
TAB 50MG
9
$998.30
0.07%
8
$873.33
0.05%
00006011468
VIOXX
TAB 50MG
678
$69,100.83
4.94%
900
$95,344.39
6.01%
00006378464
VIOXX
SUS 12.5MG
23
$2,276.54
0.17%
7
$1,043.97
0.05%
00006378564
VIOXX
SUS 25MG
9
$1,145.43
0.07%
16
$1,214.88
0.11%
00025152031
CELEBREX
CAP 100MG
548
$29,386.02
4.00%
453
$25,446.82
3.03%
00025152051
CELEBREX
CAP 100MG
110
$5,283.83
0.80%
97
$4,746.72
0.65%
00025152531
CELEBREX
CAP 200MG
6,034
$590,928.32
44.00%
5,927
$598,050.36
39.61%
00025152534
CELEBREX
CAP 200MG
3
$164.51
0.02%
0
$0.00
0.00%
00025152551
CELEBREX
CAP 200MG
879
$78,847.12
6.41%
899
$86,107.75
6.01%
00025153001
CELEBREX
CAP 400MG
0
$0.00
0.00%
5
$834.22
0.03%
00025153002
CELEBREX
CAP 400MG
1
$116.08
0.01%
27
$4,851.44
0.18%
00025197531
BEXTRA
TAB 10MG
603
$49,644.51
4.40%
775
$66,345.34
5.18%
00025198031
BEXTRA
TAB 20MG
594
$46,380.50
4.33%
1,256
$104,799.54
8.39%
CYCLOPLEGICS
00065035905
CYCLOMYDRIL SOL OP
0
$0.00
0.00%
1
$22.22
0.56%
00065039605
CYCLOGYL
SOL 1% OP
5
$109.49
3.52%
4
$89.52
2.23%
00065039615
CYCLOGYL
SOL 1% OP
2
$70.38
1.41%
2
$60.87
1.12%
00065039705
CYCLOGYL
SOL 2% OP
0
$0.00
0.00%
1
$27.54
0.56%
00168006538
ATROPINE SUL OIN 1% OP
1
$2.28
0.70%
3
$16.32
1.68%
00168017215
ATROPINE SUL SOL 1% OP
1
$5.75
0.70%
4
$23.00
2.23%
00998030305
ISO ATROPINE SOL 1% OP
1
$3.65
0.70%
1
$19.88
0.56%
00998030315
ISO ATROPINE SOL 1% OP
1
$5.25
0.70%
0
$0.00
0.00%
00998031505
ISO HOMATROP SOL 5% OP
5
$113.05
3.52%
5
$115.65
2.79%
00998031515
ISO HOMATROP SOL 5% OP
2
$53.93
1.41%
1
$28.37
0.56%
Page 167 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
CYCLOPLEGICS
00998033105
ISO HYOSCINE SOL 0.25% OP
18
00998033115
ISO HYOSCINE SOL 0.25% OP
17478010012
AK-PENTOLATE SOL 1% OP
17478010020
$386.96
12.68%
20
$370.62
11.17%
0
$0.00
0.00%
1
$28.36
0.56%
3
$35.52
2.11%
0
$0.00
0.00%
AK-PENTOLATE SOL 1% OP
5
$46.18
3.52%
1
$8.70
0.56%
24208027805
MUROCOLL-2 SOL OP
1
$9.24
0.70%
0
$0.00
0.00%
24208058559
TROPICAMIDE SOL 1% OP
0
$0.00
0.00%
1
$4.75
0.56%
24208073501
CYCLOPENTOL SOL 1% OP
4
$35.26
2.82%
2
$24.10
1.12%
24208073506
4
$37.04
2.82%
3
$26.53
1.68%
24208075006
25
$130.62
17.61%
40
$201.10
22.35%
24208075060
36
$130.51
25.35%
26
$100.40
14.53%
24208082555
4
$22.52
2.82%
12
$65.40
6.70%
58768046705
HOMATROPINE SOL 5% OP
13
$187.18
9.15%
27
$363.72
15.08%
59390018650
0
$0.00
0.00%
1
$5.06
0.56%
61314030301
9
$34.20
6.34%
19
$69.11
10.61%
61314030302
0
$0.00
0.00%
1
$5.75
0.56%
61314039603
2
$19.22
1.41%
3
$17.09
1.68%
23
$27,376.55
63.89%
15
$21,249.43
78.95%
CYTO-MEGALOVIRUS AGENTS
00004003822
VALCYTE
TAB 450MG
00004026948
CYTOVENE
CAP 250MG
4
$1,533.54
11.11%
1
$7.42
5.26%
00004027848
CYTOVENE
CAP 500MG
9
$9,078.96
25.00%
0
$0.00
0.00%
66019010001
FLUMIST NASA LIQ 2003-04
0
$0.00
0.00%
3
$160.14
15.79%
DE-PIGMENTING AGENTS
00187038231
ELDOQUIN
CRE 2%
1
$23.43
2.38%
0
$0.00
0.00%
00187039431
ELDOQUIN
CRE 4% FORTE
1
$43.84
2.38%
0
$0.00
0.00%
00187039631
SOLAQUIN FOR CRE 4%
2
$87.82
4.76%
0
$0.00
0.00%
Page 168 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
DE-PIGMENTING AGENTS
00187042046
GLYQUIN
CRE 4% W/SUN
00299595030
TRI-LUMA
CRE
58177080102
HYDROQUINONE CRE 4%
59366278303
HYDROQUINONE GEL 4%/SUNS
59366278503
HYDROQUINONE CRE 4%
59366278703
HYDROQUINONE CRE 4%/SUNS
99207025110
ALUSTRA
CRE
4
$190.35
9.52%
1
$53.38
11.11%
14
$984.60
33.33%
4
$325.28
44.44%
1
$36.16
2.38%
0
$0.00
0.00%
2
$73.38
4.76%
0
$0.00
0.00%
12
$935.54
28.57%
2
$78.65
22.22%
3
$82.46
7.14%
1
$71.49
11.11%
2
$134.34
4.76%
1
$68.78
11.11%
DENTAL PRODUCTS
00126008802
PREVIDENT
GEL 1.1% MIN
56
$625.15
9.29%
80
$880.40
10.83%
00126013066
PHOS-FLUR
GEL 1.1%
1
$10.42
0.17%
1
$8.92
0.14%
00126013166
PHOS-FLUR
GEL 1.1%
1
$10.42
0.17%
3
$28.59
0.41%
00126014446
PHOS FLUR
SOL 0.044%
1
$11.80
0.17%
1
$11.80
0.14%
00126017916
PREVIDENT
SOL RINSE
0
$0.00
0.00%
17
$182.64
2.30%
00126017999
PREVIDENT
SOL RINSE
47
$406.50
7.79%
17
$149.15
2.30%
00126019293
GEL-KAM
0
$0.00
0.00%
2
$19.30
0.27%
00126019654
THERA-FLUR-N DRO 1.1%
2
$15.48
0.33%
0
$0.00
0.00%
00126028733
PREVIDENT
CRE 5000 PLS
16
$266.30
2.65%
29
$490.19
3.92%
00126028766
PREVIDENT
CRE 5000 PLS
119
$1,328.71
19.73%
197
$2,173.27
26.66%
00126028802
PREVIDENT
GEL 1.1% BER
11
$127.20
1.82%
17
$182.69
2.30%
00126028866
PREVIDENT
CRE 5000 PLS
32
$373.93
5.31%
55
$637.99
7.44%
00126029002
PREVIDENT
GEL 1.1% CHR
3
$29.58
0.50%
3
$29.75
0.41%
00126231068
GEL-KAM
1
$16.87
0.17%
1
$17.87
0.14%
58177083537
ETHEDENT
16
$153.49
2.65%
84
$881.19
11.37%
60258015001
SF 5000 PLUS CRE 1.1%
214
$2,266.78
35.49%
105
$1,032.17
14.21%
60258015101
SF
73
$789.70
12.11%
127
$1,299.06
17.19%
60258015301
APF
5
$40.83
0.83%
0
$0.00
0.00%
GEL 0.4%
CON 0.63%
CRE DENTAL
GEL 1.1%
GEL 1.1%
Page 169 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
DENTAL PRODUCTS
60258015401
APF
GEL 1.1%
3
$28.44
0.50%
0
$0.00
0.00%
60258015910
STAN FLUORID CON 0.63%
1
$15.34
0.17%
0
$0.00
0.00%
64980030760
DENTAGEL
1
$7.99
0.17%
0
$0.00
0.00%
GEL 1.1%
Diabetic - Alpha-Glucosidase Inhibitors
00009501201
GLYSET
TAB 25MG
38
$2,058.99
15.26%
81
$4,105.70
39.13%
00009501301
GLYSET
TAB 50MG
29
$1,996.48
11.65%
52
$3,306.95
25.12%
00009501401
GLYSET
TAB 100MG
15
$984.34
6.02%
18
$1,216.65
8.70%
00026286151
PRECOSE
TAB 50MG
89
$4,756.30
35.74%
34
$1,897.26
16.43%
00026286251
PRECOSE
TAB 100MG
20
$1,135.16
8.03%
4
$173.66
1.93%
00026286351
PRECOSE
TAB 25MG
58
$2,545.21
23.29%
18
$813.74
8.70%
Diabetic - Biguanides
00087606005
GLUCOPHAGE TAB 500MG
94
$5,184.37
0.84%
70
$4,900.75
0.49%
00087606010
25
$1,127.11
0.22%
9
$641.62
0.06%
00087606313
GLUCOPHAGE TAB XR 500MG
1,037
$49,537.30
9.32%
410
$21,355.75
2.88%
00087606314
1
$18.58
0.01%
0
$0.00
0.00%
00087606413
0
$0.00
0.00%
12
$551.77
0.08%
00087607005
19
$1,617.21
0.17%
12
$1,064.39
0.08%
00087607111
66
$5,222.44
0.59%
26
$2,123.44
0.18%
00093104801
METFORMIN
TAB 500MG
22
$432.20
0.20%
66
$934.51
0.46%
00093104805
METFORMIN
TAB 500MG
22
$486.35
0.20%
44
$681.20
0.31%
00093104901
METFORMIN
TAB 850MG
0
$0.00
0.00%
11
$160.55
0.08%
00093104905
METFORMIN
TAB 850MG
0
$0.00
0.00%
3
$59.25
0.02%
00093721401
METFORMIN
TAB 1000MG
0
$0.00
0.00%
167
$11,388.58
1.17%
00172433060
METFORMIN
TAB 850MG
218
$4,881.76
1.96%
222
$3,406.01
1.56%
00172433160
METFORMIN
TAB 500MG
1,655
$36,931.01
14.88%
2,269
$33,607.23
15.91%
Page 170 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00172433170
METFORMIN
TAB 500MG
12
$279.65
0.11%
4
$61.20
0.03%
00172443260
METFORMIN
TAB 1000MG
580
$11,647.23
5.21%
574
$10,865.75
4.03%
00172443560
METFORMIN
TAB 500MG ER
0
$0.00
0.00%
5
$198.32
0.04%
00185021301
METFORMIN
TAB 500MG
8
$144.80
0.07%
9
$126.65
0.06%
00185021305
METFORMIN
TAB 500MG
1
$43.85
0.01%
0
$0.00
0.00%
00185021501
METFORMIN
TAB 850MG
4
$99.00
0.04%
4
$72.70
0.03%
00185022101
METFORMIN
TAB 1000MG
5
$95.75
0.04%
19
$392.09
0.13%
00185022105
METFORMIN
TAB 1000MG
0
$0.00
0.00%
5
$88.25
0.04%
00228265711
METFORMIN
TAB 500MG
1,597
$36,308.46
14.35%
134
$2,122.71
0.94%
00228265750
METFORMIN
TAB 500MG
15
$308.25
0.13%
47
$656.60
0.33%
00228271511
METFORMIN
TAB 850MG
186
$3,989.56
1.67%
36
$615.48
0.25%
00228271550
METFORMIN
TAB 850MG
5
$92.75
0.04%
20
$266.40
0.14%
00228271811
METFORMIN
TAB 1000MG
447
$8,964.92
4.02%
26
$552.82
0.18%
00228271850
METFORMIN
TAB 1000MG
25
$481.75
0.22%
0
$0.00
0.00%
00378023401
METFORMIN
TAB 500MG
519
$11,107.26
4.66%
557
$8,610.00
3.91%
00378024001
METFORMIN
TAB 850MG
58
$1,278.50
0.52%
66
$1,116.70
0.46%
00378024401
METFORMIN
TAB 1000MG
268
$5,201.26
2.41%
218
$3,988.68
1.53%
00555038502
METFORMIN
TAB 500MG
72
$1,410.95
0.65%
6
$40.95
0.04%
00555038504
METFORMIN
TAB 500MG
1
$9.85
0.01%
0
$0.00
0.00%
00555038602
METFORMIN
TAB 850MG
17
$364.55
0.15%
0
$0.00
0.00%
00555038702
METFORMIN
TAB 1000MG
17
$329.55
0.15%
1
$20.15
0.01%
00591245501
METFORMIN
TAB 1000MG
470
$8,865.95
4.22%
186
$3,316.61
1.30%
00591245505
METFORMIN
TAB 1000MG
18
$309.38
0.16%
0
$0.00
0.00%
00591271301
METFORMIN
TAB 500MG
804
$16,825.11
7.23%
414
$6,215.33
2.90%
00591271305
METFORMIN
TAB 500MG
123
$1,927.11
1.11%
0
$0.00
0.00%
00591277501
METFORMIN
TAB 850MG
167
$3,288.85
1.50%
83
$1,367.27
0.58%
00591277525
METFORMIN
TAB 850MG
2
$35.82
0.02%
3
$42.39
0.02%
Page 171 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00615458053
METFORMIN
TAB 500MG
00615458063
METFORMIN
TAB 500MG
00781505001
METFORMIN
TAB 500MG
00781505101
METFORMIN
TAB 850MG
00781505201
METFORMIN
49884073601
49884073605
$4,036.08
2.39%
16
$172.31
0.14%
0
$0.00
0.00%
903
$18,174.40
8.12%
1,615
$21,803.81
11.33%
74
$1,598.71
0.67%
149
$2,379.32
1.05%
TAB 1000MG
307
$5,768.25
2.76%
608
$10,569.71
4.26%
METFORMIN
TAB 500MG
51
$1,141.41
0.46%
35
$542.05
0.25%
METFORMIN
TAB 500MG
4
$96.40
0.04%
0
$0.00
0.00%
49884073801
METFORMIN
TAB 1000MG
10
$192.50
0.09%
11
$261.03
0.08%
49884073805
METFORMIN
TAB 1000MG
2
$38.30
0.02%
0
$0.00
0.00%
49884074001
METFORMIN
TAB 850MG
2
$72.90
0.02%
14
$241.61
0.10%
49884074005
METFORMIN
TAB 850MG
3
$55.85
0.03%
0
$0.00
0.00%
49884074101
METFORMIN
TAB 1000MG
0
$0.00
0.00%
15
$162.90
0.11%
49884074105
METFORMIN
TAB 1000MG
0
$0.00
0.00%
7
$76.40
0.05%
51079097220
METFORMIN
TAB 500MG
12
$331.45
0.11%
0
$0.00
0.00%
53489046701
METFORMIN
TAB 500MG
0
$0.00
0.00%
430
$6,158.45
3.02%
53489046705
METFORMIN
TAB 500MG
92
$2,265.70
0.83%
661
$8,772.06
4.64%
53489046710
METFORMIN
TAB 500MG
33
$748.30
0.30%
308
$4,842.74
2.16%
53489046801
METFORMIN
TAB 850MG
3
$60.65
0.03%
198
$3,235.80
1.39%
53489046805
METFORMIN
TAB 850MG
17
$325.55
0.15%
70
$978.57
0.49%
53489046810
METFORMIN
TAB 850MG
0
$0.00
0.00%
1
$15.95
0.01%
53489046901
METFORMIN
TAB 1000MG
94
$1,779.91
0.84%
477
$8,794.00
3.35%
53489046905
METFORMIN
TAB 1000MG
17
$276.65
0.15%
177
$3,391.61
1.24%
53489046910
METFORMIN
TAB 1000MG
0
$0.00
0.00%
16
$319.90
0.11%
57664039713
METFORMIN
TAB 500MG
3
$133.55
0.03%
44
$701.73
0.31%
57664039718
METFORMIN
TAB 500MG
3
$50.65
0.03%
9
$165.75
0.06%
57664039788
METFORMIN
TAB 500MG
28
$529.40
0.25%
72
$862.15
0.51%
57664043588
METFORMIN
TAB 850MG
0
$0.00
0.00%
2
$39.50
0.01%
266
0
$0.00
Page 172 of 522
0.00%
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
57664047418
METFORMIN
TAB 1000MG
0
57664047488
METFORMIN
TAB 1000MG
60505019000
METFORMIN
TAB 500MG
60505019001
METFORMIN
60505019100
$0.00
0.00%
23
$390.71
0.16%
10
$196.50
0.09%
44
$878.94
0.31%
62
$1,347.95
0.56%
2
$27.20
0.01%
TAB 500MG
0
$0.00
0.00%
589
$9,397.45
4.13%
METFORMIN
TAB 850MG
0
$0.00
0.00%
53
$933.20
0.37%
60505019101
METFORMIN
TAB 850MG
0
$0.00
0.00%
3
$40.35
0.02%
60505019200
METFORMIN
TAB 1000MG
4
$121.80
0.04%
190
$3,711.92
1.33%
62037067401
METFORMIN
TAB 500MG
358
$7,091.01
3.22%
1,839
$27,665.72
12.90%
62037067410
METFORMIN
TAB 500MG
6
$204.10
0.05%
121
$1,753.78
0.85%
62037067501
METFORMIN
TAB 850MG
38
$698.92
0.34%
48
$792.00
0.34%
62037067510
METFORMIN
TAB 850MG
0
$0.00
0.00%
9
$126.05
0.06%
62037067601
METFORMIN
TAB 1000MG
128
$2,592.73
1.15%
661
$12,712.74
4.64%
62037067610
METFORMIN
TAB 1000MG
0
$0.00
0.00%
18
$212.75
0.13%
Diabetic - Insulin
00002751001
HUMALOG
INJ 100U/ML
1,382
$106,431.42
13.14%
1,377
$137,704.56
10.36%
00002751101
HUMALOG MIX SUS 75/25
281
$21,079.25
2.67%
286
$27,947.03
2.15%
00002821101
ILETIN II RG INJ U100PORK
00002821501
HUMULIN R
00002831101
ILETIN II
00002831501
HUMULIN N
00002841101
ILETIN II
00002841501
HUMULIN L
INJ U-100
00002850101
HUMULIN R
INJ U-500
00002861501
HUMULIN U
INJ U-100
00002871501
HUMULIN
00002951501
HUMULIN
6
$388.77
0.06%
3
$255.50
0.02%
938
$32,113.83
8.92%
781
$29,939.77
5.88%
38
$2,323.88
0.36%
28
$1,893.60
0.21%
2,226
$96,383.40
21.17%
1,714
$83,390.57
12.90%
3
$251.49
0.03%
0
$0.00
0.00%
113
$4,294.43
1.07%
95
$3,619.78
0.72%
0
$0.00
0.00%
5
$1,340.76
0.04%
30
$1,024.27
0.29%
16
$683.93
0.12%
INJ 70/30
1,040
$50,502.99
9.89%
863
$47,917.79
6.50%
INJ 50/50
23
$615.42
0.22%
16
$422.83
0.12%
INJ U-100
INJ NPH PORK
INJ U-100
INJ LENTE PK
Page 173 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
Diabetic - Insulin
00088222033
LANTUS
INJ 100U/ML
00169007011
VELOSULIN BR INJ 100U/ML
00169183311
NOVOLIN R
00169183318
RELION R
00169183411
NOVOLIN N INJ U-100
00169183418
RELION N
00169183511
NOVOLIN L
00169183711
NOVOLIN
00169183718
RELION 70/30 INJ 70/30
00169368512
NOVOLOG MIX SUS 70/30
00169750111
NOVOLOG
59060183302
RELION R
59060183402
RELION N
59060183702
RELION 70/30 INJ 100U/ML
INJ U-100
INJ U-100
INJ U-100
INJ U-100
INJ 70/30
2,314
$131,550.22
22.00%
4,130
$286,834.60
31.09%
4
$450.63
0.04%
2
$266.36
0.02%
416
$11,044.00
3.96%
669
$21,069.39
5.04%
23
$462.38
0.22%
40
$930.42
0.30%
846
$24,264.75
8.04%
1,203
$50,024.64
9.05%
79
$2,044.51
0.75%
15
$382.36
0.11%
35
$1,022.00
0.33%
18
$737.71
0.14%
552
$19,034.31
5.25%
856
$41,277.29
6.44%
37
$1,213.44
0.35%
38
$1,228.65
0.29%
0
$0.00
0.00%
45
$4,822.99
0.34%
130
$10,122.06
1.24%
981
$91,522.21
7.38%
INJ 100U/ML
0
$0.00
0.00%
4
$63.78
0.03%
INJ 100U/ML
0
$0.00
0.00%
86
$1,973.08
0.65%
0
$0.00
0.00%
15
$626.83
0.11%
54
$3,665.56
23.89%
24
$1,896.73
21.05%
INJ 100U/ML
Diabetic - Meglitinides
00169008181
PRANDIN
TAB 0.5MG
00169008281
PRANDIN
TAB 1MG
45
$3,454.09
19.91%
26
$1,340.49
22.81%
00169008481
PRANDIN
TAB 2MG
127
$11,330.37
56.19%
64
$7,007.48
56.14%
Diabetic - Penfills
00002751559
HUMALOG
INJ 100U/ML
63
$4,411.92
4.63%
23
$2,251.53
2.36%
00002751659
HUMALOG
INJ 100U/ML
13
$2,347.28
0.96%
11
$2,597.63
1.13%
00002872559
HUMALOG PEN INJ 100U/ML
409
$45,434.90
30.07%
264
$32,499.45
27.13%
00002873059
HUMULIN N PN INJ U-100
179
$16,744.31
13.16%
88
$9,289.16
9.04%
00002877059
HUMULIN PEN INJ 70/30
108
$13,132.01
7.94%
46
$4,503.99
4.73%
00002879459
HUMALOG PEN INJ 75/25
252
$31,281.60
18.53%
126
$21,825.06
12.95%
Page 174 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
Diabetic - Penfills
00169001771
NOVOLIN
00169004471
NOVOLIN R
00169004571
00169183317
NOVOLIN R
INJ 70/30
21
$1,472.38
1.54%
3
$104.98
0.31%
INJ U-100
11
$430.70
0.81%
NOVOLIN N INJ U-100
20
$835.60
1.47%
0
$0.00
0.00%
3
$273.36
0.31%
INJ U-100
15
$764.65
1.10%
0
$0.00
0.00%
00169183417
NOVOLIN N INJ U-100
18
$1,280.73
1.32%
4
$265.43
0.41%
00169183717
NOVOLIN
00169231321
NOVOLIN R
INJ INNOLET
5
$301.30
0.37%
1
$24.71
0.10%
0
$0.00
0.00%
3
$156.85
0.31%
00169231421
NOVOLIN N INJ INNOLET
14
$665.70
1.03%
20
$1,307.95
2.06%
00169231721
NOVOLIN 70/ INJ 30 INNLT
15
$854.82
1.10%
24
$1,527.77
2.47%
00169330312
NOVOLOG
INJ PENFILL
97
$9,014.02
7.13%
127
$14,260.06
13.05%
00169347318
NOVOLIN R
INJ PENFILL
10
$803.38
0.74%
14
$1,542.94
1.44%
00169347418
NOVOLIN N INJ PENFILL
46
$3,991.72
3.38%
56
$6,996.63
5.76%
00169347718
NOVOLIN 70/ INJ 30 PNFIL
62
$5,946.60
4.56%
49
$5,959.28
5.04%
00169368213
NOVOLOG MIX INJ CARTRIDG
0
$0.00
0.00%
7
$990.31
0.72%
00169369619
NOVOLOG MIX INJ SYRINGE
2
$193.10
0.15%
22
$3,001.94
2.26%
00169633910
NOVOLOG
0
$0.00
0.00%
82
$11,503.84
8.43%
INJ 70/30
INJ FLEXPEN
Diabetic - Sulfonylurea-Biguanide Combinations
00087607211
GLUCOVANCE TAB 1.25/250
61
$2,610.18
11.32%
22
$937.45
14.67%
00087607311
GLUCOVANCE TAB 2.5/500
182
$11,132.60
33.77%
35
$2,242.92
23.33%
00087607411
GLUCOVANCE TAB 5/500MG
286
$19,605.09
53.06%
88
$6,439.72
58.67%
00087607731
METAGLIP
TAB 2.5-500M
6
$272.54
1.11%
2
$64.87
1.33%
00087607831
METAGLIP
TAB 5-500MG
4
$257.05
0.74%
3
$139.41
2.00%
8
$142.30
0.07%
0
$0.00
0.00%
13
$889.57
0.11%
5
$350.96
0.04%
Diabetic - Sulfonylureas
00009014101
MICRONASE
TAB 2.5MG
00009017105
MICRONASE
TAB 5MG
Page 175 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00009017107
MICRONASE
00009017112
MICRONASE
00009034101
GLYNASE
00009035201
GLYNASE
00009344901
TAB 5MG
0
TAB 5MG
TAB 1.5MG
$0.00
0.00%
1
$25.23
0.01%
0
$0.00
0.00%
1
$56.00
0.01%
3
$177.78
0.03%
0
$0.00
0.00%
TAB 3MG
2
$85.58
0.02%
2
$104.36
0.01%
GLYNASE
TAB 6MG
4
$197.09
0.03%
0
$0.00
0.00%
00039005210
DIABETA
TAB 5MG
12
$862.65
0.10%
5
$234.92
0.04%
00039005305
DIABETA
TAB 1.25MG
2
$15.30
0.02%
3
$23.32
0.02%
00039022110
AMARYL
TAB 1MG
79
$848.18
0.67%
59
$586.39
0.42%
00039022210
AMARYL
TAB 2MG
342
$5,073.60
2.91%
137
$2,225.95
0.98%
00039022310
AMARYL
TAB 4MG
808
$30,128.75
6.87%
347
$13,609.90
2.48%
00049155066
GLUCOTROL XL TAB 5MG
1,293
$22,035.45
10.99%
403
$7,131.00
2.88%
00049155073
110
$1,801.67
0.93%
45
$774.78
0.32%
00049156066
1,481
$49,718.64
12.58%
558
$19,609.57
3.99%
00049156073
151
$5,387.44
1.28%
71
$2,157.09
0.51%
00049162030
GLUCOTROL XL TAB 2.5MG
299
$4,240.53
2.54%
130
$1,657.78
0.93%
00049411066
GLUCOTROL
TAB 5MG
10
$396.05
0.08%
1
$37.32
0.01%
00049411073
GLUCOTROL
TAB 5MG
0
$0.00
0.00%
1
$14.90
0.01%
00078035105
STARLIX
TAB 60MG
19
$1,372.10
0.16%
25
$2,100.07
0.18%
00078035205
STARLIX
TAB 120MG
111
$7,995.20
0.94%
161
$13,053.24
1.15%
00093803401
GLYBURID MCR TAB 1.5MG
3
$32.00
0.03%
3
$19.05
0.02%
00093803501
GLYBURID MCR TAB 3MG
35
$429.55
0.30%
30
$307.21
0.21%
00093803510
3
$32.25
0.03%
0
$0.00
0.00%
00093803601
13
$312.70
0.11%
12
$106.10
0.09%
00093834201
GLYBURIDE
TAB 1.25MG
140
$1,325.67
1.19%
262
$2,226.41
1.87%
00093834301
GLYBURIDE
TAB 2.5MG
332
$3,887.35
2.82%
587
$5,727.26
4.20%
00093834305
GLYBURIDE
TAB 2.5MG
56
$616.30
0.48%
83
$641.06
0.59%
00093834310
GLYBURIDE
TAB 2.5MG
183
$1,807.91
1.56%
316
$3,083.34
2.26%
Page 176 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00093834401
GLYBURIDE
TAB 5MG
00093834405
GLYBURIDE
TAB 5MG
33
$727.35
0.28%
231
$3,835.68
1.65%
00093834410
GLYBURIDE
TAB 5MG
1,354
$26,552.50
11.51%
1,943
$34,773.65
13.90%
00093936401
GLYBURIDE
TAB 5MG
72
$1,665.13
0.61%
128
$2,433.81
0.92%
00093936405
GLYBURIDE
TAB 5MG
46
$1,173.54
0.39%
67
$1,285.45
0.48%
00093936410
GLYBURIDE
TAB 5MG
142
$2,945.29
1.21%
211
$3,975.43
1.51%
00093943301
GLYBURIDE
TAB 2.5MG
76
$717.16
0.65%
60
$490.32
0.43%
00093943305
GLYBURIDE
TAB 2.5MG
38
$261.22
0.32%
56
$520.51
0.40%
00093947753
GLYBURIDE
TAB 1.25MG
23
$208.22
0.20%
35
$227.07
0.25%
00172297860
TOLAZAMIDE TAB 100MG
5
$74.30
0.04%
5
$51.11
0.04%
00172297960
8
$73.34
0.07%
11
$134.98
0.08%
00172364960
GLIPIZIDE
TAB 5MG
6
$26.10
0.05%
477
$1,527.14
3.41%
00172364970
GLIPIZIDE
TAB 5MG
126
$703.88
1.07%
8
$32.98
0.06%
00172365060
GLIPIZIDE
TAB 10MG
4
$36.50
0.03%
362
$1,908.54
2.59%
00172365070
GLIPIZIDE
TAB 10MG
110
$817.48
0.93%
9
$65.55
0.06%
00378019701
CHLORPROPAM TAB 100MG
6
$16.65
0.05%
2
$11.50
0.01%
00378021001
9
$133.26
0.08%
12
$173.34
0.09%
00378021501
TOLBUTAMIDE TAB 500MG
22
$426.77
0.19%
29
$477.37
0.21%
00378021505
TOLBUTAMIDE TAB 500MG
12
$233.92
0.10%
15
$295.85
0.11%
00378021701
6
$97.59
0.05%
2
$35.26
0.01%
00378055101
3
$43.85
0.03%
0
$0.00
0.00%
00378110501
GLIPIZIDE
TAB 5MG
159
$902.45
1.35%
627
$2,106.81
4.49%
00378110505
GLIPIZIDE
TAB 5MG
75
$364.50
0.64%
418
$1,866.41
2.99%
00378111001
GLIPIZIDE
TAB 10MG
106
$846.29
0.90%
426
$2,382.37
3.05%
00378111005
GLIPIZIDE
TAB 10MG
55
$418.35
0.47%
255
$1,602.39
1.82%
00378111301
12
$142.62
0.10%
30
$150.43
0.21%
00378112501
19
$208.15
0.16%
53
$396.85
0.38%
282
$5,953.50
2.40%
483
$8,449.25
Page 177 of 522
3.46%
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00378112510
16
$137.16
0.14%
23
$148.67
0.16%
00378114201
14
$539.90
0.12%
21
$234.15
0.15%
00591046001
GLIPIZIDE
TAB 5MG
13
$89.35
0.11%
88
$308.35
0.63%
00591046005
GLIPIZIDE
TAB 5MG
4
$18.60
0.03%
0
$0.00
0.00%
00591046010
GLIPIZIDE
TAB 5MG
27
$146.24
0.23%
69
$278.65
0.49%
00591046101
GLIPIZIDE
TAB 10MG
3
$25.85
0.03%
84
$435.12
0.60%
00591046105
GLIPIZIDE
TAB 10MG
2
$21.50
0.02%
21
$101.09
0.15%
00591046110
GLIPIZIDE
TAB 10MG
16
$126.60
0.14%
68
$379.69
0.49%
00591084401
GLIPIZIDE ER TAB 5MG
0
$0.00
0.00%
6
$141.07
0.04%
00591084501
0
$0.00
0.00%
4
$111.00
0.03%
00615359553
GLIPIZIDE
TAB 5MG
66
$317.94
0.56%
0
$0.00
0.00%
00615359563
GLIPIZIDE
TAB 5MG
28
$127.58
0.24%
0
$0.00
0.00%
00615359653
GLIPIZIDE
TAB 10MG
36
$241.93
0.31%
0
$0.00
0.00%
00615359663
GLIPIZIDE
TAB 10MG
16
$87.01
0.14%
0
$0.00
0.00%
00781113801
GLYBURIDE
TAB 1.25MG
0
$0.00
0.00%
14
$89.09
0.10%
00781114601
GLYBURIDE
TAB 2.5MG
0
$0.00
0.00%
23
$235.06
0.16%
00781119110
GLYBURIDE
TAB 5MG
0
$0.00
0.00%
87
$1,659.03
0.62%
00781145201
GLIPIZIDE
TAB 5MG
205
$1,051.95
1.74%
524
$1,860.88
3.75%
00781145210
GLIPIZIDE
TAB 5MG
32
$160.78
0.27%
86
$335.09
0.62%
00781145301
GLIPIZIDE
TAB 10MG
126
$931.44
1.07%
339
$1,944.92
2.43%
00781145310
GLIPIZIDE
TAB 10MG
18
$140.63
0.15%
13
$89.95
0.09%
00904792460
GLIPIZIDE
TAB 5MG
0
$0.00
0.00%
8
$19.65
0.06%
00904792560
GLIPIZIDE
TAB 10MG
5
$25.30
0.04%
4
$16.00
0.03%
00904792580
GLIPIZIDE
TAB 10MG
0
$0.00
0.00%
11
$79.20
0.08%
38245036450
GLYBURIDE
2
$31.90
0.02%
0
$0.00
0.00%
38245038120
16
$187.90
0.14%
0
$0.00
0.00%
38245038150
2
$21.50
0.02%
0
$0.00
0.00%
TAB 5MG
Page 178 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
38245043350
GLYBURIDE
TAB 2.5MG
50111037201
50111037301
50111037303
51285059802
GLIPIZIDE
51285059804
51285059805
$26.25
0.03%
$0.00
0.00%
9
$69.55
0.08%
9
$270.57
0.08%
5
$54.82
0.04%
21
$455.25
0.15%
15
$253.75
0.13%
1
$13.55
0.01%
TAB 5MG
1
$6.45
0.01%
2
$7.80
0.01%
GLIPIZIDE
TAB 5MG
3
GLIPIZIDE
TAB 5MG
3
$14.35
0.03%
0
$0.00
0.00%
$14.55
0.03%
0
$0.00
0.00%
51285059902
GLIPIZIDE
TAB 10MG
2
$9.90
0.02%
0
$0.00
0.00%
52544046001
GLIPIZIDE
TAB 5MG
1
$9.55
0.01%
0
$0.00
0.00%
52544046005
GLIPIZIDE
TAB 5MG
52544046010
GLIPIZIDE
TAB 5MG
2
$8.02
0.02%
0
$0.00
0.00%
31
$141.35
0.26%
0
$0.00
0.00%
52544046101
GLIPIZIDE
TAB 10MG
15
$109.15
0.13%
0
$0.00
0.00%
52544046110
GLIPIZIDE
TAB 10MG
1
$4.95
0.01%
2
$10.10
0.01%
55370014607
55370014608
20
$239.31
0.17%
12
$67.70
0.09%
1
$11.00
0.01%
1
$9.35
0.01%
55370014609
1
$7.17
0.01%
0
$0.00
0.00%
55370014707
89
$1,052.80
0.76%
100
$930.45
0.72%
55370014708
19
$199.45
0.16%
22
$230.90
0.16%
55370014709
5
$70.55
0.04%
0
$0.00
0.00%
55370050607
74
$3,210.90
0.63%
88
$1,030.50
0.63%
55370050608
0
$0.00
0.00%
12
$85.20
0.09%
55953003540
2
$21.50
0.02%
0
$0.00
0.00%
55953034470
GLYBURIDE
TAB 5MG
1
$9.65
0.01%
0
$0.00
0.00%
55953034480
GLYBURIDE
TAB 5MG
11
$179.45
0.09%
0
$0.00
0.00%
59762372501
GLYBURIDE
TAB 1.25MG
121
$1,006.24
1.03%
150
$1,294.13
1.07%
59762372603
GLYBURIDE
TAB 2.5MG
440
$4,468.49
3.74%
459
$4,537.71
3.28%
59762372704
GLYBURIDE
TAB 5MG
215
$4,137.78
1.83%
55
$1,070.95
0.39%
3
0
Page 179 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
59762372706
GLYBURIDE
TAB 5MG
309
$5,490.26
2.63%
156
$2,507.64
1.12%
59762372707
GLYBURIDE
TAB 5MG
1,142
$23,939.35
9.70%
1,776
$33,336.39
12.70%
59762378101
15
$150.09
0.13%
24
$142.64
0.17%
59762378201
79
$1,010.55
0.67%
47
$428.20
0.34%
59762378203
11
$294.85
0.09%
11
$121.85
0.08%
59762378301
104
$3,893.92
0.88%
106
$994.10
0.76%
59762378302
29
$957.45
0.25%
15
$109.75
0.11%
59762378303
8
$489.60
0.07%
24
$249.90
0.17%
60505014100
GLIPIZIDE
TAB 5MG
0
$0.00
0.00%
58
$255.22
0.41%
60505014101
GLIPIZIDE
TAB 5MG
0
$0.00
0.00%
13
$88.91
0.09%
60505014200
GLIPIZIDE
TAB 10MG
2
$21.50
0.02%
28
$126.36
0.20%
60505014201
GLIPIZIDE
TAB 10MG
0
$0.00
0.00%
25
$153.79
0.18%
60951071470
GLIPIZIDE
TAB 10MG
7
$51.85
0.06%
3
$18.05
0.02%
62037087130
GLIPIZIDE ER TAB 2.5MG
0
$0.00
0.00%
7
$84.88
0.05%
62037087201
0
$0.00
0.00%
25
$363.96
0.18%
62037087205
0
$0.00
0.00%
1
$11.47
0.01%
62037087301
0
$0.00
0.00%
28
$832.12
0.20%
62037087305
0
$0.00
0.00%
6
$205.07
0.04%
$0.00
0.00%
6
$681.92
1.62%
Diabetic - Thiazol/Biquanide combo
00007316318
AVANDAMET
TAB 2-1000MG
0
00007316418
AVANDAMET
TAB 4-1000MG
0
$0.00
0.00%
16
$2,702.22
4.32%
00007316618
AVANDAMET
TAB 1-500MG
4
$480.16
22.22%
13
$1,178.97
3.51%
00007316620
AVANDAMET
TAB 1-500MG
0
$0.00
0.00%
7
$438.46
1.89%
00007316718
AVANDAMET
TAB 2-500MG
6
$451.48
33.33%
164
$18,869.41
44.32%
00007316720
AVANDAMET
TAB 2-500MG
2
$213.40
11.11%
32
$3,449.24
8.65%
00007316818
AVANDAMET
TAB 4-500MG
3
$288.16
16.67%
100
$11,505.46
27.03%
Page 180 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
AVANDAMET
TAB 4-500MG
$
Market Share*
Diabetic - Thiazol/Biquanide combo
00007316820
# of Scripts
3
$431.70
16.67%
32
$4,505.93
8.65%
Diabetic - Thiazolidinediones
00029315818
AVANDIA
TAB 2MG
131
$6,980.55
1.97%
322
$17,547.43
3.98%
00029315913
AVANDIA
TAB 4MG
217
$15,765.02
3.27%
418
$31,663.06
5.16%
00029315918
AVANDIA
TAB 4MG
118
$8,505.59
1.78%
187
$14,099.52
2.31%
00029315920
AVANDIA
TAB 4MG
999
$73,495.87
15.05%
2,166
$168,165.66
26.75%
00029316013
AVANDIA
TAB 8MG
1,095
$145,991.13
16.50%
2,021
$283,511.75
24.96%
00029316020
AVANDIA
TAB 8MG
336
$45,744.12
5.06%
903
$127,032.33
11.15%
64764015104
ACTOS
TAB 15MG
2,397
$421,865.42
36.12%
969
$141,631.16
11.97%
64764015105
ACTOS
TAB 15MG
1,117
$190,668.16
16.83%
681
$99,073.61
8.41%
64764015106
ACTOS
TAB 15MG
40
$7,706.79
0.60%
40
$3,947.67
0.49%
64764030114
ACTOS
TAB 30MG
51
$5,755.98
0.77%
117
$14,889.07
1.45%
64764030115
ACTOS
TAB 30MG
24
$2,336.37
0.36%
89
$8,263.67
1.10%
64764045124
ACTOS
TAB 45MG
81
$10,674.56
1.22%
114
$15,144.32
1.41%
64764045125
ACTOS
TAB 45MG
30
$2,748.32
0.45%
69
$9,787.24
0.85%
DIGESTIVE ENZYMES
00032120501
CREON 5
CAP
8
$560.70
1.45%
11
$527.31
2.01%
00032120507
CREON 5
CAP
5
$325.84
0.91%
3
$323.59
0.55%
00032121001
CREON 10
CAP EC
42
$7,644.36
7.61%
53
$14,631.64
9.69%
00032121007
CREON 10
CAP EC
8
$1,450.75
1.45%
10
$1,089.76
1.83%
00032122001
CREON 20
CAP
34
$14,682.44
6.16%
45
$19,198.22
8.23%
00032122007
CREON 20
CAP
24
$14,346.24
4.35%
16
$9,169.45
2.93%
00045008002
LACTAID
TAB 3000U
0
$0.00
0.00%
1
$14.01
0.18%
00045009560
PANCREASE
CAP EC
14
$809.23
2.54%
20
$2,304.89
3.66%
00045009569
PANCREASE
CAP EC
24
$3,279.98
4.35%
22
$4,546.63
4.02%
Page 181 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
DIGESTIVE ENZYMES
00045034160
PANCREASE MT CAP 4
14
$527.63
2.54%
7
$471.55
1.28%
00045034260
PANCREASE MT CAP 10
15
$2,970.17
2.72%
20
$3,643.11
3.66%
00045034360
PANCREASE MT CAP 16
7
$1,093.04
1.27%
5
$1,213.25
0.91%
00045034660
PANCREASE MT CAP 20
21
$7,464.20
3.80%
14
$7,255.30
2.56%
00045090012
LACTAID ULTR TAB 9000U
0
$0.00
0.00%
2
$68.40
0.37%
00045090060
5
$154.67
0.91%
12
$204.24
2.19%
00045090090
0
$0.00
0.00%
1
$17.53
0.18%
00045090512
LACTAID ULTR CHW 9000U
0
$0.00
0.00%
1
$23.83
0.18%
00045090532
LACTAID ULTR CHW 9000U
2
$142.90
0.36%
8
$163.43
1.46%
00091350501
LACTRASE
3
$164.55
0.54%
15
$697.11
2.74%
00091412201
KU-ZYME
CAP
2
$176.53
0.36%
1
$101.61
0.18%
00091417501
KUTRASE
CAP
2
$150.70
0.36%
1
$64.19
0.18%
00115700301
LIPRAM 10000 CAP EC
1
$98.55
0.18%
0
$0.00
0.00%
00115702301
LIPRAM-PN16 CAP
6
$632.10
1.09%
2
$316.20
0.37%
00115702401
LIPRAM-CR20 CAP
9
$1,661.53
1.63%
9
$1,513.57
1.65%
00115702405
LIPRAM-CR20 CAP
11
$1,800.14
1.99%
4
$1,148.15
0.73%
00115702901
PANCRELIPASE TAB
6
$165.90
1.09%
9
$656.53
1.65%
00115702902
PANCRELIPASE TAB
10
$929.70
1.81%
7
$479.57
1.28%
00115703501
LIPRAM 4500 CAP
61
$2,398.20
11.05%
68
$2,531.70
12.43%
00115703505
LIPRAM 4500 CAP
34
$1,357.01
6.16%
22
$457.72
4.02%
00115703601
LIPRAM 10000 CAP CR
31
$1,089.00
5.62%
17
$629.55
3.11%
00115703605
LIPRAM 10000 CAP CR
3
$335.45
0.54%
4
$270.97
0.73%
00115704001
LIPRAM-PN10 CAP
4
$221.40
0.72%
5
$207.65
0.91%
00115704301
LIPRAM-UL20 CAP
0
$0.00
0.00%
3
$178.05
0.55%
00115704302
LIPRAM-UL20 CAP
1
$651.35
0.18%
3
$1,302.70
0.55%
00115705501
LIPRAM-PN20 CAP
1
$224.55
0.18%
2
$336.50
0.37%
00115705701
LIPRAM-CR5 CAP
5
$184.29
0.91%
2
$67.99
0.37%
CAP 250MG
Page 182 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
DIGESTIVE ENZYMES
00115705801
PANCRELIPASE TAB 16000 U
0
00536781106
LAC-DOSE
00904347240
PANCRELIPASE TAB
00904347260
$0.00
0.00%
1
$133.99
0.18%
0
$0.00
0.00%
1
$9.30
0.18%
1
$34.35
0.18%
0
$0.00
0.00%
PANCRELIPASE TAB
5
$116.75
0.91%
2
$41.30
0.37%
00904541360
PANCRELIPASE CAP 4500U
0
$0.00
0.00%
2
$59.35
0.37%
00904541370
PANCRELIPASE CAP 4500U
0
$0.00
0.00%
1
$71.05
0.18%
37205011472
DAIRY DIGEST TAB ULTRA
0
$0.00
0.00%
1
$37.25
0.18%
51991065501
PANOKASE
TAB
10
$275.65
1.81%
1
$42.95
0.18%
51991065505
PANOKASE
TAB
2
$116.70
0.36%
0
$0.00
0.00%
58177002804
PANGES MT 16 CAP
1
$50.15
0.18%
2
$100.30
0.37%
58177002904
PANGES CN 10 CAP
2
$197.10
0.36%
2
$163.70
0.37%
58177003004
PANGES CN 20 CAP
0
$0.00
0.00%
5
$846.99
0.91%
58177003104
PANGESTYM EC CAP
7
$202.65
1.27%
16
$605.57
2.93%
58177003106
PANGESTYM EC CAP
26
$768.20
4.71%
12
$576.07
2.19%
58177004804
PANGES UL 12 CAP
0
$0.00
0.00%
2
$138.02
0.37%
58177004904
PANGES UL 18 CAP
0
$0.00
0.00%
1
$217.46
0.18%
58177005004
PANGES UL 20 CAP
0
$0.00
0.00%
1
$293.35
0.18%
58177041604
PLARETASE
0
$0.00
0.00%
8
$817.70
1.46%
58914000210
ULTRASE MT12 CAP
12
$4,630.87
2.17%
10
$2,953.20
1.83%
58914000410
ULTRASE MT20 CAP
22
$7,198.20
3.99%
15
$10,150.81
2.74%
58914000450
ULTRASE MT20 CAP
4
$2,183.75
0.72%
7
$5,310.45
1.28%
58914001810
ULTRASE MT18 CAP
16
$7,488.15
2.90%
11
$5,493.87
2.01%
58914004510
ULTRASE
CAP
9
$627.74
1.63%
2
$747.70
0.37%
58914011110
VIOKASE 8
TAB
9
$395.33
1.63%
2
$76.08
0.37%
58914011150
VIOKASE 8
TAB
4
$458.49
0.72%
5
$259.52
0.91%
58914011508
VIOKASE
POW
1
$149.92
0.18%
0
$0.00
0.00%
58914011610
VIOKASE 16 TAB
5
$851.96
0.91%
6
$938.83
1.10%
TAB 3000U
TAB 8000
Page 183 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
DIGESTIVE ENZYMES
59767000101
PANCRECARB CAP MS-8
2
59767000102
PANCRECARB CAP MS-8
59879012201
PANCRELIPASE CAP MST-16
00005333443
DILTIAZEM
00088177147
$351.96
0.36%
4
$621.66
0.73%
0
$0.00
0.00%
2
$82.16
0.37%
1
$105.35
0.18%
0
$0.00
0.00%
TAB 60MG
1
$10.45
0.02%
0
$0.00
0.00%
CARDIZEM
TAB 30MG
6
$272.05
0.11%
2
$94.86
0.03%
00088177247
CARDIZEM
TAB 60MG
7
$414.69
0.13%
1
$147.03
0.01%
00088177747
CARDIZEM
CAP 60MG SR
6
$319.65
0.11%
4
$331.31
0.06%
00088177847
CARDIZEM
CAP 90MG SR
0
$0.00
0.00%
2
$102.18
0.03%
00088177947
CARDIZEM
CAP 120MG SR
0
$0.00
0.00%
1
$86.00
0.01%
00088179530
CARDIZEM CD CAP 120MG/24
7
$278.67
0.13%
7
$273.13
0.10%
00088179542
14
$468.80
0.26%
5
$194.95
0.07%
00088179630
15
$710.45
0.28%
13
$589.75
0.19%
00088179642
9
$459.12
0.17%
7
$414.74
0.10%
00088179730
10
$761.85
0.19%
3
$196.08
0.04%
00088179742
27
$1,823.88
0.50%
17
$1,370.15
0.25%
00088179830
0
$0.00
0.00%
1
$61.80
0.01%
00088179842
8
$664.20
0.15%
3
$255.96
0.04%
00088179942
19
$1,617.06
0.35%
16
$1,319.13
0.24%
00093002201
DILTIAZEM
CAP 90MG ER
2
$42.70
0.04%
0
$0.00
0.00%
00093002301
DILTIAZEM
CAP 120MG ER
4
$117.90
0.07%
0
$0.00
0.00%
00093031801
DILTIAZEM
TAB 30MG
17
$132.15
0.32%
14
$83.02
0.21%
00093031805
DILTIAZEM
TAB 30MG
5
$33.75
0.09%
6
$36.60
0.09%
00093031901
DILTIAZEM
TAB 60MG
28
$350.40
0.52%
25
$224.50
0.37%
00093031905
DILTIAZEM
TAB 60MG
2
$22.70
0.04%
1
$8.95
0.01%
00093032001
DILTIAZEM
TAB 90MG
9
$110.18
0.17%
2
$11.56
0.03%
DILTIAZEMS
Page 184 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
DILTIAZEMS
00093032101
DILTIAZEM
00093511298
00093511798
TAB 120MG
19
$360.95
0.35%
6
$101.76
0.09%
DILTIAZEM ER CAP 120MG/24
27
$614.29
0.50%
28
$713.58
0.41%
18
$548.70
0.33%
30
$916.67
0.44%
00093511898
14
$541.98
0.26%
30
$1,170.44
0.44%
00093511998
13
$497.42
0.24%
81
$3,808.28
1.20%
00228257709
DILTIAZEM CD CAP 180MG/24
39
$1,194.60
0.72%
40
$1,027.53
0.59%
00228257750
0
$0.00
0.00%
12
$298.42
0.18%
00228257809
50
$1,984.76
0.93%
62
$2,205.80
0.92%
00228257850
15
$537.05
0.28%
25
$646.51
0.37%
00228257903
0
$0.00
0.00%
1
$50.45
0.01%
00228257909
7
$435.35
0.13%
68
$3,144.83
1.01%
00228257950
2
$75.78
0.04%
9
$413.23
0.13%
00228258803
0
$0.00
0.00%
1
$23.65
0.01%
00228258809
42
$1,030.48
0.78%
52
$1,218.15
0.77%
00228258850
20
$359.85
0.37%
19
$317.25
0.28%
00258368790
DILTIAZEM
CAP 120MG
0
$0.00
0.00%
87
$2,258.11
1.29%
00258368890
DILTIAZEM
CAP 180MG
0
$0.00
0.00%
146
$4,659.15
2.16%
00258368990
DILTIAZEM
CAP 240MG
0
$0.00
0.00%
163
$7,039.82
2.41%
00258369090
DILTIAZEM
CAP 300MG
0
$0.00
0.00%
193
$11,635.32
2.85%
00258369190
DILTIAZEM
CAP 360MG
0
$0.00
0.00%
345
$21,601.65
5.10%
00378002301
DILTIAZEM
TAB 30MG
18
$129.80
0.33%
18
$94.86
0.27%
00378002305
DILTIAZEM
TAB 30MG
34
$240.50
0.63%
31
$205.18
0.46%
00378004501
DILTIAZEM
TAB 60MG
21
$172.80
0.39%
26
$206.59
0.38%
00378004505
DILTIAZEM
TAB 60MG
15
$151.85
0.28%
35
$296.97
0.52%
00378013501
DILTIAZEM
TAB 90MG
14
$215.69
0.26%
5
$64.45
0.07%
00378013505
DILTIAZEM
TAB 90MG
7
$82.10
0.13%
9
$108.30
0.13%
00378052501
DILTIAZEM
TAB 120MG
12
$148.10
0.22%
3
$43.05
0.04%
Page 185 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
DILTIAZEMS
00378522001
6
$75.90
0.11%
00378522005
3
$57.45
00378528001
3
$73.95
00378528005
1
00378534001
2
00378534005
00378606001
DILTIAZEM
CAP 60MG ER
00378609001
DILTIAZEM
CAP 90MG ER
00378612001
DILTIAZEM
CAP 120MG ER
00456261230
TIAZAC
00456261290
TIAZAC
00456261330
242
$4,361.80
3.58%
0.06%
74
$1,374.98
1.09%
0.06%
216
$4,986.05
3.19%
$23.65
0.02%
8
$165.87
0.12%
$52.30
0.04%
254
$5,910.50
3.76%
1
$2.93
0.02%
43
$1,056.63
0.64%
52
$2,218.67
0.97%
23
$762.87
0.34%
19
$650.65
0.35%
24
$602.00
0.35%
32
$1,612.20
0.59%
15
$499.25
0.22%
CAP 120MG/24
456
$15,279.09
8.48%
36
$1,281.66
0.53%
CAP 120MG/24
469
$14,374.47
8.72%
102
$3,042.32
1.51%
TIAZAC
CAP 180MG/24
479
$19,095.81
8.90%
15
$656.69
0.22%
00456261363
TIAZAC
CAP 180MG/24
0
$0.00
0.00%
1
$39.22
0.01%
00456261390
TIAZAC
CAP 180MG/24
667
$24,060.04
12.40%
125
$4,398.91
1.85%
00456261430
TIAZAC
CAP 240MG/24
577
$32,028.55
10.72%
25
$1,269.79
0.37%
00456261490
TIAZAC
CAP 240MG/24
867
$44,096.00
16.12%
166
$8,889.12
2.46%
00456261530
TIAZAC
CAP 300MG/24
223
$15,929.50
4.14%
14
$1,225.38
0.21%
00456261563
TIAZAC
CAP 300MG/24
1
$73.63
0.02%
0
$0.00
0.00%
00456261590
TIAZAC
CAP 300MG/24
195
$12,275.97
3.62%
40
$2,384.73
0.59%
00456261630
TIAZAC
CAP 360MG/24
210
$15,119.19
3.90%
16
$1,227.54
0.24%
00456261690
TIAZAC
CAP 360MG/24
225
$15,005.02
4.18%
37
$2,224.29
0.55%
00456261730
TIAZAC
CAP 420MG/24
28
$2,129.12
0.52%
14
$1,048.26
0.21%
00456261790
TIAZAC
CAP 420MG/24
23
$1,608.29
0.43%
10
$738.10
0.15%
00615134153
DILTIAZEM XR CAP 180MG
5
$15.22
0.09%
0
$0.00
0.00%
00615134163
5
$65.50
0.09%
0
$0.00
0.00%
00615134253
12
$208.06
0.22%
0
$0.00
0.00%
00615134263
1
$20.63
0.02%
0
$0.00
0.00%
Page 186 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
DILTIAZEMS
00615354853
DILTIAZEM
TAB 30MG
10
$75.35
0.19%
0
$0.00
0.00%
00615354863
DILTIAZEM
TAB 30MG
8
$59.35
0.15%
0
$0.00
0.00%
00615354953
DILTIAZEM
TAB 60MG
3
$16.92
0.06%
0
$0.00
0.00%
00615354963
DILTIAZEM
TAB 60MG
13
$123.53
0.24%
0
$0.00
0.00%
00904538260
0
$0.00
0.00%
20
$475.50
0.30%
51079092420
DILTIAZEM
CAP 60MG ER
3
$78.09
0.06%
5
$115.86
0.07%
51079092520
DILTIAZEM
CAP 90MG ER
0
$0.00
0.00%
4
$85.10
0.06%
51079092620
DILTIAZEM
CAP 120MG ER
0
$0.00
0.00%
2
$91.70
0.03%
51079094708
0
$0.00
0.00%
1
$7.17
0.01%
52544048201
DILACOR XR CAP 120MG/24
0
$0.00
0.00%
1
$44.07
0.01%
52544066301
DILTIAZEM XR CAP 180MG/24
2
$47.30
0.04%
0
$0.00
0.00%
52544077501
DILTIAZEM
TAB 30MG
6
$42.60
0.11%
3
$21.65
0.04%
52544077505
DILTIAZEM
TAB 30MG
4
$29.40
0.07%
1
$5.35
0.01%
52544077601
DILTIAZEM
TAB 60MG
5
$38.14
0.09%
2
$18.58
0.03%
52544077701
DILTIAZEM
TAB 90MG
0
$0.00
0.00%
1
$6.80
0.01%
60505001406
DILTIAZEM ER CAP 120MG
0
$0.00
0.00%
66
$1,202.94
0.98%
60505001506
DILTIAZEM ER CAP 180MG
0
$0.00
0.00%
56
$1,188.38
0.83%
60505001606
0
$0.00
0.00%
77
$1,837.07
1.14%
60505001608
3
$72.45
0.06%
0
$0.00
0.00%
62037054801
DILTIA XT
CAP 120MG/24
14
$308.30
0.26%
387
$7,034.92
5.72%
62037054901
DILTIA XT
CAP 180MG/24
23
$467.82
0.43%
507
$11,600.30
7.50%
62037054910
DILTIA XT
CAP 180MG/24
0
$0.00
0.00%
3
$73.95
0.04%
62037055001
DILTIA XT
CAP 240MG/24
7
$222.25
0.13%
526
$12,788.09
7.78%
62037059790
CARTIA XT
CAP 120/24HR
50
$1,060.51
0.93%
34
$731.33
0.50%
62037059890
CARTIA XT
CAP 180/24HR
26
$739.68
0.48%
20
$579.40
0.30%
62037059990
CARTIA XT
CAP 240/24HR
43
$1,677.68
0.80%
38
$1,579.15
0.56%
62037060090
CARTIA XT
CAP 300/24HR
15
$433.08
0.28%
8
$301.96
0.12%
Page 187 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
DILTIAZEMS
62037069630
TAZTIA XT
CAP 120MG/24
0
$0.00
0.00%
62037069690
TAZTIA XT
CAP 120MG/24
0
$0.00
62037069730
TAZTIA XT
CAP 180MG/24
0
$0.00
62037069790
TAZTIA XT
CAP 180MG/24
0
62037069830
TAZTIA XT
CAP 240MG/24
62037069890
TAZTIA XT
62037069930
TAZTIA XT
62037069990
12
$347.86
0.18%
0.00%
7
$112.40
0.10%
0.00%
13
$485.09
0.19%
$0.00
0.00%
9
$278.96
0.13%
0
$0.00
0.00%
24
$1,248.37
0.35%
CAP 240MG/24
0
$0.00
0.00%
6
$285.64
0.09%
CAP 300MG/24
0
$0.00
0.00%
10
$603.52
0.15%
TAZTIA XT
CAP 300MG/24
0
$0.00
0.00%
1
$1.00
0.01%
62037070030
TAZTIA XT
CAP 360MG/24
0
$0.00
0.00%
6
$353.78
0.09%
62037070090
TAZTIA XT
CAP 360MG/24
0
$0.00
0.00%
3
$186.58
0.04%
62584097490
0
$0.00
0.00%
2
$47.30
0.03%
62584097630
0
$0.00
0.00%
1
$40.55
0.01%
62584097730
0
$0.00
0.00%
10
$359.49
0.15%
62584097790
0
$0.00
0.00%
3
$143.85
0.04%
64455010030
CARDIZEM LA TAB 120MG
0
$0.00
0.00%
298
$10,336.40
4.41%
64455010090
0
$0.00
0.00%
2
$72.06
0.03%
64455010110
0
$0.00
0.00%
3
$113.16
0.04%
64455010130
0
$0.00
0.00%
593
$23,173.57
8.77%
64455010230
0
$0.00
0.00%
612
$25,633.31
9.05%
64455010290
0
$0.00
0.00%
1
$40.65
0.01%
64455010330
0
$0.00
0.00%
2
$113.82
0.03%
64455010390
0
$0.00
0.00%
5
$288.30
0.07%
64455010430
0
$0.00
0.00%
185
$11,352.39
2.74%
64455010490
0
$0.00
0.00%
2
$123.06
0.03%
64455010530
0
$0.00
0.00%
33
$2,288.88
0.49%
64455010590
0
$0.00
0.00%
1
$69.36
0.01%
Page 188 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
DIURETICS
00003060650
NATURETIN TAB 5MG
1
$33.82
0.00%
2
$38.50
0.00%
00004012101
BUMEX
TAB 1MG
3
$52.65
0.01%
0
$0.00
0.00%
00004012501
BUMEX
TAB 0.5MG
1
$3.51
0.00%
0
$0.00
0.00%
00004016201
BUMEX
TAB 2MG
6
$236.37
0.02%
6
$257.19
0.01%
00004026201
DEMADEX
TAB 5MG
8
$138.55
0.02%
0
$0.00
0.00%
00004026301
DEMADEX
TAB 10MG
8
$310.74
0.02%
0
$0.00
0.00%
00004026401
DEMADEX
TAB 20MG
85
$3,197.56
0.24%
5
$151.65
0.01%
00004026449
DEMADEX
TAB 20MG
3
$63.41
0.01%
1
$27.33
0.00%
00004026501
DEMADEX
TAB 100MG
18
$2,226.57
0.05%
2
$233.41
0.00%
00005075323
DIAMOX
CAP 500MG CR
47
$2,458.69
0.13%
13
$1,067.14
0.03%
00005351923
METHAZOLAMID TAB 25MG
1
$21.25
0.00%
0
$0.00
0.00%
00005352023
2
$95.70
0.01%
0
$0.00
0.00%
00005375234
HYDROCHLOROT TAB 25MG
67
$238.11
0.19%
41
$88.11
0.09%
00005375334
00005446923
DIAMOX
00006009268
MIDAMOR
00006021468
DIURIL
00006043268
DIURIL
00006091768
MODURETIC
00006323966
DIURIL
00007365022
34
$147.07
0.10%
19
$64.98
0.04%
TAB 250MG
4
$209.80
0.01%
0
$0.00
0.00%
TAB 5MG
9
$165.60
0.03%
0
$0.00
0.00%
TAB 250MG
4
$26.61
0.01%
0
$0.00
0.00%
TAB 500MG
3
$48.84
0.01%
0
$0.00
0.00%
TAB 5-50
1
$19.45
0.00%
1
$17.95
0.00%
SUS 250/5ML
18
$152.97
0.05%
15
$128.07
0.03%
DYAZIDE
CAP 37.5-25
37
$672.35
0.11%
18
$318.39
0.04%
00007365030
DYAZIDE
CAP 37.5-25
24
$462.38
0.07%
0
$0.00
0.00%
00025100131
ALDACTONE
TAB 25MG
3
$56.10
0.01%
1
$5.60
0.00%
00025102131
ALDACTAZIDE TAB 50/50
14
$478.99
0.04%
0
$0.00
0.00%
00025103131
ALDACTONE
TAB 100MG
12
$744.57
0.03%
0
$0.00
0.00%
00025104131
ALDACTONE
TAB 50MG
9
$386.68
0.03%
0
$0.00
0.00%
00039006011
LASIX
2
$41.12
0.01%
0
$0.00
0.00%
TAB 40MG
Page 189 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
DIURETICS
00039006013
LASIX
TAB 40MG
67
00039006050
LASIX
TAB 40MG
00039006070
LASIX
TAB 40MG
00039006605
LASIX
00039006710
$771.67
0.19%
3
$44.83
0.01%
5
$48.35
0.01%
8
$126.37
0.02%
0
$0.00
0.00%
3
$27.06
0.01%
TAB 80MG
7
$130.52
0.02%
0
$0.00
0.00%
LASIX
TAB 20MG
8
$61.00
0.02%
3
$26.36
0.01%
00039006750
LASIX
TAB 20MG
00054329446
FUROSEMIDE SOL 10MG/ML
11
$74.51
0.03%
1
$9.25
0.00%
9
$74.80
0.03%
13
$121.40
0.03%
00054329450
4
$43.40
0.01%
10
$104.70
0.02%
00054329863
4
$43.46
0.01%
3
$20.59
0.01%
00054338363
HYDROCHLOROT SOL 50MG/5ML
1
$8.14
0.00%
0
$0.00
0.00%
00054429725
FUROSEMIDE TAB 20MG
60
$275.15
0.17%
9
$16.29
0.02%
00054429731
FUROSEMIDE TAB 20MG
665
$2,933.44
1.89%
739
$2,508.42
1.69%
00054429925
FUROSEMIDE TAB 40MG
3
$12.87
0.01%
1
$7.25
0.00%
00054429931
FUROSEMIDE TAB 40MG
447
$2,015.65
1.27%
620
$1,892.60
1.42%
00054430125
FUROSEMIDE TAB 80MG
102
$780.84
0.29%
1
$10.00
0.00%
00054430129
FUROSEMIDE TAB 80MG
172
$1,274.85
0.49%
84
$548.46
0.19%
00054829925
FUROSEMIDE TAB 40MG
2
$9.54
0.01%
0
$0.00
0.00%
00070077799
INDAPAMIDE TAB 1.25MG
3
$26.03
0.01%
0
$0.00
0.00%
00070300000
5
$25.96
0.01%
2
$10.96
0.00%
00074610104
FUROSEMIDE INJ 10MG/ML
2
$9.47
0.01%
5
$25.05
0.01%
00074610110
1
$3.57
0.00%
0
$0.00
0.00%
00074610202
15
$42.52
0.04%
18
$64.85
0.04%
00074610204
64
$297.34
0.18%
33
$191.48
0.08%
00074610210
1
$3.77
0.00%
2
$6.29
0.00%
00074681201
ENDURON
1
$23.30
0.00%
0
$0.00
0.00%
00075008200
LOZOL
TAB 2.5MG
3
$100.08
0.01%
0
$0.00
0.00%
00085054703
NAQUA
TAB 4MG
2
$33.30
0.01%
0
$0.00
0.00%
TAB 5MG
Page 190 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
DIURETICS
00093712701
TORSEMIDE
TAB 5MG
00093712801
TORSEMIDE
TAB 10MG
00093712901
TORSEMIDE
TAB 20MG
00093713001
TORSEMIDE
TAB 100MG
00093941101
$0.00
0.00%
$34.80
0.00%
22
$571.39
0.06%
242
$7,985.72
0.69%
14
$274.10
0.03%
226
$7,085.19
0.52%
29
$3,620.54
0.08%
16
$1,848.13
0.04%
8
$182.45
0.02%
3
$82.30
0.01%
00093942401
6
00143121001
CHLOROTHIAZ TAB 500MG
4
$139.51
0.02%
9
$387.09
0.02%
$37.79
0.01%
4
$32.24
0.01%
00172208360
59
$245.71
0.17%
75
$253.17
0.17%
00172208380
5,265
$23,418.99
14.95%
6,684
$20,869.45
15.31%
00172208960
00172208980
26
$132.96
0.07%
32
$142.84
0.07%
851
$4,647.63
2.42%
777
$3,020.97
1.78%
00172208985
3
$15.63
0.01%
2
$5.42
0.00%
00172290770
FUROSEMIDE TAB 40MG
0
$0.00
0.00%
1
$1.81
0.00%
00172290780
FUROSEMIDE TAB 40MG
1,406
$6,166.94
3.99%
2,828
$11,616.94
6.48%
00172290860
FUROSEMIDE TAB 20MG
86
$384.64
0.24%
0
$0.00
0.00%
00172290870
FUROSEMIDE TAB 20MG
1
$4.31
0.00%
1
$1.33
0.00%
00172290880
FUROSEMIDE TAB 20MG
1,543
$6,737.98
4.38%
2,883
$11,619.17
6.60%
00172295060
TRIAMT/HCTZ CAP 50-25MG
1
$10.90
0.00%
6
$116.40
0.01%
00172295080
149
$1,068.35
0.42%
78
$1,596.16
0.18%
00172423260
BUMETANIDE TAB 0.5MG
23
$170.41
0.07%
12
$93.95
0.03%
00172423280
0
$0.00
0.00%
2
$13.70
0.00%
00172423360
BUMETANIDE TAB 1MG
48
$513.42
0.14%
49
$465.44
0.11%
00172423370
BUMETANIDE TAB 1MG
2
$42.85
0.01%
3
$48.55
0.01%
00172423380
BUMETANIDE TAB 1MG
14
$159.50
0.04%
78
$683.60
0.18%
00172423460
BUMETANIDE TAB 2MG
48
$775.97
0.14%
54
$982.49
0.12%
00172423470
BUMETANIDE TAB 2MG
1
$11.90
0.00%
0
$0.00
0.00%
00172423480
BUMETANIDE TAB 2MG
8
$116.58
0.02%
41
$795.87
0.09%
0
2
Page 191 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
DIURETICS
00172425960
6
$53.58
0.02%
14
$86.20
0.03%
00172425980
3
$18.69
0.01%
3
$22.80
0.01%
00172426260
3
$16.47
0.01%
7
$34.99
0.02%
00172426280
3
$16.47
0.01%
0
$0.00
0.00%
00182055689
0
$0.00
0.00%
1
$2.21
0.00%
00182116189
FUROSEMIDE TAB 40MG
3
$13.35
0.01%
3
$7.35
0.01%
00182117089
FUROSEMIDE TAB 20MG
1
$3.81
0.00%
3
$5.43
0.01%
00185012801
33
$238.19
0.09%
12
$62.70
0.03%
00185012901
BUMETANIDE TAB 1MG
101
$1,160.73
0.29%
117
$1,175.18
0.27%
00185012905
BUMETANIDE TAB 1MG
4
$36.50
0.01%
0
$0.00
0.00%
00185013001
BUMETANIDE TAB 2MG
142
$2,692.18
0.40%
111
$2,196.28
0.25%
00185013005
BUMETANIDE TAB 2MG
1
$10.90
0.00%
0
$0.00
0.00%
00228222196
425
$1,990.80
1.21%
40
$131.36
0.09%
00228222296
108
$583.43
0.31%
19
$72.53
0.04%
00228257111
23
$174.01
0.07%
32
$168.48
0.07%
00228257196
0
$0.00
0.00%
2
$20.20
0.00%
00228259711
14
$105.54
0.04%
21
$114.97
0.05%
00228267211
SPIRONOLACT TAB 50MG
213
$8,710.43
0.60%
235
$9,230.87
0.54%
00228267250
50
$1,297.63
0.14%
108
$2,466.15
0.25%
00228267311
66
$4,269.22
0.19%
118
$8,016.10
0.27%
00228267350
5
$293.79
0.01%
3
$144.10
0.01%
00364040001
ACETAZOLAMID TAB 250MG
25
$269.85
0.07%
0
$0.00
0.00%
00364224205
TRIAMT/HCTZ TAB 75-50MG
0
$0.00
0.00%
2
$9.62
0.00%
00378006901
70
$404.69
0.20%
74
$309.63
0.17%
00378008001
45
$358.85
0.13%
41
$227.09
0.09%
00378014101
SPIRONO/HCTZ TAB 25/25
80
$860.54
0.23%
88
$919.14
0.20%
00378014105
65
$873.19
0.18%
73
$798.81
0.17%
Page 192 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
DIURETICS
00378015001
14
$158.15
0.04%
21
$189.96
0.05%
00378016001
METHYCLOTHIA TAB 5MG
49
$1,039.54
0.14%
45
$688.65
0.10%
00378016201
47
$366.01
0.13%
22
$190.25
0.05%
00378016210
1
$15.85
0.00%
0
$0.00
0.00%
00378020801
FUROSEMIDE TAB 20MG
305
$1,361.70
0.87%
416
$1,121.71
0.95%
00378020810
FUROSEMIDE TAB 20MG
1,786
$7,325.72
5.07%
2,715
$7,825.44
6.22%
00378021301
CHLORTHALID TAB 50MG
3
$17.47
0.01%
16
$52.27
0.04%
00378021601
FUROSEMIDE TAB 40MG
74
$331.95
0.21%
103
$290.07
0.24%
00378021610
FUROSEMIDE TAB 40MG
2,399
$10,455.22
6.81%
3,835
$12,124.21
8.78%
00378022201
28
$141.54
0.08%
61
$179.15
0.14%
00378022210
2
$6.90
0.01%
13
$40.01
0.03%
00378023201
FUROSEMIDE TAB 80MG
584
$4,666.27
1.66%
758
$4,748.99
1.74%
00378023205
FUROSEMIDE TAB 80MG
613
$4,474.49
1.74%
1,155
$7,334.22
2.64%
00378024301
46
$1,347.86
0.13%
44
$1,848.52
0.10%
00378024501
40
$304.11
0.11%
40
$326.70
0.09%
00378037001
BUMETANIDE TAB 1MG
121
$1,307.43
0.34%
149
$1,341.75
0.34%
00378041701
BUMETANIDE TAB 2MG
132
$2,405.42
0.37%
117
$2,335.55
0.27%
00378043701
3
$83.20
0.01%
4
$351.50
0.01%
00378057701
AMILOR/HCTZ TAB 5-50
76
$414.79
0.22%
104
$436.51
0.24%
00378057705
5
$31.65
0.01%
4
$22.77
0.01%
00378081001
HYDROCHLOROT CAP 12.5MG
233
$3,583.24
0.66%
576
$7,999.77
1.32%
00378135201
TRIAMT/HCTZ TAB 37.5-25
41
$396.33
0.12%
124
$944.03
0.28%
00378135205
6
$56.68
0.02%
39
$323.76
0.09%
00378135501
59
$262.58
0.17%
83
$241.36
0.19%
00378135505
35
$171.98
0.10%
21
$58.78
0.05%
00378214601
346
$5,024.86
0.98%
611
$7,572.06
1.40%
00378214605
412
$4,917.36
1.17%
750
$8,926.98
1.72%
Page 193 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
DIURETICS
00378253701
TRIAM/HCTZ CAP 37.5-25
176
$2,210.01
0.50%
233
$2,505.71
0.53%
00378253710
295
$3,579.00
0.84%
609
$6,806.56
1.39%
00517570225
15
$104.41
0.04%
22
$92.43
0.05%
00517570425
27
$266.29
0.08%
9
$62.90
0.02%
00517571025
2
$13.66
0.01%
5
$191.44
0.01%
00527105001
1
$3.61
0.00%
61
$645.70
0.14%
00555044402
13
$49.35
0.04%
9
$26.30
0.02%
00555044404
1
$4.81
0.00%
6
$21.36
0.01%
00555048302
53
$282.09
0.15%
48
$181.87
0.11%
00555048802
TRIAM/HCTZ CAP 37.5-25M
19
$258.97
0.05%
14
$171.55
0.03%
00555048805
TRIAM/HCTZ CAP 37.5-25M
23
$234.58
0.07%
89
$796.70
0.20%
00555064304
0
$0.00
0.00%
3
$19.95
0.01%
00555087505
24
$344.50
0.07%
0
$0.00
0.00%
00591034701
155
$2,283.58
0.44%
415
$5,567.07
0.95%
00591034801
28
$137.05
0.08%
29
$93.26
0.07%
00591034805
8
$34.83
0.02%
28
$117.26
0.06%
00591042401
67
$665.22
0.19%
76
$630.98
0.17%
00591042405
1
$21.67
0.00%
3
$39.25
0.01%
00591543001
32
$284.39
0.09%
54
$490.95
0.12%
00603125052
9
$78.15
0.03%
9
$114.15
0.02%
00603385521
0
$0.00
0.00%
50
$715.39
0.11%
00603385525
0
$0.00
0.00%
16
$222.34
0.04%
00603385621
1
$2.40
0.00%
11
$47.78
0.03%
00603385632
549
$2,493.81
1.56%
3,565
$10,177.82
8.16%
00603385721
4
$18.84
0.01%
16
$48.36
0.04%
00603385732
21
$124.86
0.06%
509
$1,865.67
1.17%
00603447021
2
$25.60
0.01%
0
$0.00
0.00%
Page 194 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
DIURETICS
00603447121
00615044653
FUROSEMIDE TAB 40MG
00615044663
FUROSEMIDE TAB 40MG
00615133353
00615133363
$0.00
0.00%
3
$139.80
0.01%
63
$273.27
0.18%
0
$0.00
0.00%
1,162
$5,013.46
3.30%
0
$0.00
0.00%
120
$1,219.60
0.34%
0
$0.00
0.00%
18
$158.39
0.05%
0
$0.00
0.00%
00615153553
231
$2,560.69
0.66%
0
$0.00
0.00%
00615153563
7
$103.95
0.02%
0
$0.00
0.00%
00615156153
92
$399.30
0.26%
0
$0.00
0.00%
00615156163
309
$1,321.47
0.88%
0
$0.00
0.00%
00615156953
FUROSEMIDE TAB 20MG
74
$319.39
0.21%
0
$0.00
0.00%
00615156963
FUROSEMIDE TAB 20MG
1,145
$4,764.30
3.25%
0
$0.00
0.00%
00615157153
FUROSEMIDE TAB 80MG
63
$436.92
0.18%
0
$0.00
0.00%
00615157163
FUROSEMIDE TAB 80MG
276
$1,884.30
0.78%
0
$0.00
0.00%
00615453653
BUMETANIDE TAB 1MG
12
$99.85
0.03%
0
$0.00
0.00%
00615453663
BUMETANIDE TAB 1MG
42
$344.42
0.12%
0
$0.00
0.00%
00615454153
3
$19.56
0.01%
0
$0.00
0.00%
00615454163
6
$41.99
0.02%
0
$0.00
0.00%
00677062401
6
$63.63
0.02%
6
$62.70
0.01%
00677062405
3
$50.25
0.01%
0
$0.00
0.00%
00677062410
3
$27.24
0.01%
0
$0.00
0.00%
00677062501
4
$46.18
0.01%
17
$286.95
0.04%
00677062510
64
$726.03
0.18%
43
$554.05
0.10%
00677124801
8
$54.65
0.02%
8
$59.14
0.02%
00677170701
24
$1,053.40
0.07%
8
$633.70
0.02%
00677170706
3
$64.65
0.01%
4
$80.20
0.01%
00677170801
5
$268.19
0.01%
4
$416.87
0.01%
00677170806
1
$231.28
0.00%
0
$0.00
0.00%
0
Page 195 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
DIURETICS
00781100801
29
00781100805
00781107101
00781107201
00781112301
$134.35
0.08%
18
$58.08
0.04%
6
$36.12
0.02%
9
$462.89
0.03%
5
$17.41
0.01%
5
$278.95
0.01%
6
$130.50
0.02%
7
$138.80
0.02%
178
$1,660.52
0.51%
159
$1,214.71
0.36%
00781112305
00781144601
FUROSEMIDE TAB 80MG
74
$693.44
0.21%
57
$477.38
0.13%
41
$324.82
0.12%
40
$278.83
0.09%
00781144605
FUROSEMIDE TAB 80MG
86
$638.00
0.24%
164
$1,110.45
0.38%
00781159901
78
$1,365.05
0.22%
49
$989.75
0.11%
00781159910
95
$1,351.69
0.27%
36
$448.80
0.08%
00781181801
FUROSEMIDE TAB 20MG
54
$243.71
0.15%
37
$138.95
0.08%
00781181810
FUROSEMIDE TAB 20MG
1,775
$7,680.52
5.04%
1,884
$5,665.46
4.31%
00781196601
FUROSEMIDE TAB 40MG
65
$307.09
0.18%
75
$256.94
0.17%
00781196610
FUROSEMIDE TAB 40MG
3,204
$14,471.48
9.10%
2,650
$8,271.20
6.07%
00781207401
520
$6,722.59
1.48%
557
$6,433.58
1.28%
00781207410
517
$6,139.93
1.47%
498
$5,394.85
1.14%
00781254001
8
$39.55
0.02%
0
$0.00
0.00%
00781254010
4
$33.20
0.01%
1
$25.06
0.00%
00781271501
76
$556.77
0.22%
165
$3,029.13
0.38%
00781271510
78
$519.66
0.22%
37
$474.78
0.08%
00904034380
0
$0.00
0.00%
1
$8.35
0.00%
00904034440
1
$14.99
0.00%
0
$0.00
0.00%
00904208380
50
$225.66
0.14%
109
$311.82
0.25%
00904208980
11
$53.59
0.03%
20
$63.21
0.05%
00904787340
3
$27.45
0.01%
0
$0.00
0.00%
10019050610
BUMETANIDE INJ 0.25/ML
1
$12.68
0.00%
0
$0.00
0.00%
49884011701
AMILORIDE
42
$841.18
0.12%
49
$1,003.54
0.11%
TAB 5MG
Page 196 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
DIURETICS
49884058901
10
$65.68
0.03%
5
$38.89
0.01%
49884059001
30
$227.00
0.09%
27
$149.56
0.06%
49884059010
0
$0.00
0.00%
4
$16.92
0.01%
49884065201
TORSEMIDE
TAB 10MG
0
$0.00
0.00%
5
$132.95
0.01%
49884065301
TORSEMIDE
TAB 20MG
0
$0.00
0.00%
22
$786.46
0.05%
49884065401
TORSEMIDE
TAB 100MG
0
$0.00
0.00%
19
$2,612.91
0.04%
50111036201
8
$33.17
0.02%
29
$76.46
0.07%
50111036301
9
$44.03
0.03%
4
$16.78
0.01%
50111050501
14
$66.86
0.04%
6
$16.36
0.01%
50111050502
0
$0.00
0.00%
5
$14.48
0.01%
50111053401
1
$8.65
0.00%
3
$27.13
0.01%
51079007220
FUROSEMIDE TAB 20MG
7
$26.32
0.02%
16
$59.68
0.04%
51079007320
FUROSEMIDE TAB 40MG
10
$39.08
0.03%
8
$31.53
0.02%
51079052720
FUROSEMIDE TAB 80MG
0
$0.00
0.00%
1
$5.55
0.00%
51079089220
BUMETANIDE TAB 1MG
3
$21.60
0.01%
0
$0.00
0.00%
51285048805
8
$127.10
0.02%
7
$108.45
0.02%
51285075402
DIAMOX
0
$0.00
0.00%
11
$611.08
0.03%
51672402201
20
$130.37
0.06%
16
$109.71
0.04%
51672402301
125
$1,183.84
0.35%
130
$1,281.16
0.30%
52544030110
FUROSEMIDE TAB 40MG
15
$78.45
0.04%
18
$58.83
0.04%
52544030205
FUROSEMIDE TAB 80MG
11
$95.86
0.03%
3
$13.54
0.01%
52544031110
FUROSEMIDE TAB 20MG
23
$100.63
0.07%
10
$32.90
0.02%
52544034701
4
$74.88
0.01%
1
$34.09
0.00%
52544034801
6
$35.15
0.02%
0
$0.00
0.00%
52544034805
2
$8.62
0.01%
0
$0.00
0.00%
52544042401
2
$12.26
0.01%
0
$0.00
0.00%
52544050401
3
$18.69
0.01%
0
$0.00
0.00%
CAP 500MG CR
Page 197 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
DIURETICS
52544062201
MICROZIDE
52544068501
52544068510
CAP
7
$126.07
0.02%
0
$0.00
0.00%
3
$11.52
0.01%
1
$7.44
0.00%
4
$19.83
0.01%
0
$0.00
0.00%
52555057710
4
$14.00
0.01%
0
$0.00
0.00%
53014083571
ZAROXOLYN
TAB 10MG
18
$929.68
0.05%
28
$1,346.03
0.06%
53014085071
ZAROXOLYN
TAB 5MG
246
$7,446.80
0.70%
283
$11,795.00
0.65%
53014085072
ZAROXOLYN
TAB 5MG
1
$37.17
0.00%
0
$0.00
0.00%
53014097571
ZAROXOLYN
TAB 2.5MG
303
$6,769.82
0.86%
322
$9,832.58
0.74%
53489014301
23
$355.69
0.07%
29
$469.65
0.07%
53489014305
7
$185.95
0.02%
3
$40.05
0.01%
53489014310
267
$3,864.04
0.76%
265
$3,461.72
0.61%
53489014401
12
$152.82
0.03%
8
$76.40
0.02%
53489014410
8
$76.40
0.02%
16
$136.30
0.04%
53489016601
3
$17.51
0.01%
2
$11.74
0.00%
53489032801
98
$2,921.39
0.28%
59
$2,279.33
0.14%
53489032805
1
$116.55
0.00%
3
$67.55
0.01%
53489032901
13
$1,360.36
0.04%
19
$1,331.81
0.04%
55390050010
0
$0.00
0.00%
4
$297.57
0.01%
55390050110
0
$0.00
0.00%
1
$79.47
0.00%
57706075323
DIAMOX SEQUE CAP 500MG CR
3
$189.54
0.01%
0
$0.00
0.00%
59762501101
311
$4,614.00
0.88%
499
$6,527.83
1.14%
59762501102
175
$2,261.03
0.50%
166
$1,975.37
0.38%
59762501201
49
$2,314.97
0.14%
171
$6,977.30
0.39%
59762501301
4
$265.72
0.01%
7
$457.22
0.02%
59762501401
31
$404.89
0.09%
66
$739.84
0.15%
60432061304
45
$621.14
0.13%
47
$614.32
0.11%
60432061360
100
$934.77
0.28%
79
$743.75
0.18%
Page 198 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
DIURETICS
62269024724
0
$0.00
0.00%
2
$8.46
0.00%
62794046001
MAXZIDE
1
$35.73
0.00%
0
$0.00
0.00%
62794046401
MAXZIDE-25 TAB
5
$73.70
0.01%
0
$0.00
0.00%
63323028002
0
$0.00
0.00%
2
$12.05
0.00%
63323028004
3
$183.27
0.01%
1
$4.54
0.00%
65580064371
METOLAZONE TAB 2.5MG
0
$0.00
0.00%
71
$2,179.76
0.16%
65580064471
METOLAZONE TAB 5MG
0
$0.00
0.00%
54
$2,797.03
0.12%
65580064571
METOLAZONE TAB 10MG
0
$0.00
0.00%
1
$92.41
0.00%
87
$2,195.52
124
$2,893.63
100.00%
TAB 75-50
EMERGENCY CONTRACEPTIVE
63955001001
PREVEN EMERG KIT CONTRCPT
100.00%
EMOLLIENTS
00062018503
RENOVA
CRE 0.05%
3
$223.77
0.59%
0
$0.00
0.00%
00062018505
RENOVA
CRE 0.05%
11
$653.63
2.16%
3
$210.31
0.58%
00062018702
RENOVA
CRE 0.02%
1
$59.83
0.20%
0
$0.00
0.00%
00066060303
VANAMIDE
CRE 40%
0
$0.00
0.00%
13
$534.65
2.52%
00066060307
VANAMIDE
CRE 40%
0
$0.00
0.00%
4
$309.62
0.78%
00072571208
LAC-HYDRIN LOT 12%
99
$3,831.26
19.45%
81
$3,237.65
15.70%
00072571214
LAC-HYDRIN LOT 12%
52
$3,345.89
10.22%
77
$4,533.80
14.92%
00072573028
LAC-HYDRIN CRE 12%
162
$5,349.23
31.83%
148
$5,110.80
28.68%
00072573038
LAC-HYDRIN CRE 12%
33
$1,735.50
6.48%
33
$1,678.75
6.40%
00085141002
A/D ZINC OXI CRE
2
$31.56
0.39%
4
$57.12
0.78%
00245002322
AMLACTIN
LOT 12%
0
$0.00
0.00%
1
$10.28
0.19%
00245002414
AMLACTIN
CRE 12%
0
$0.00
0.00%
4
$35.25
0.78%
00259030320
MEDERMA
GEL
1
$37.37
0.20%
1
$36.87
0.19%
00299391816
CETAPHIL
0
$0.00
0.00%
1
$8.97
0.19%
LOT MOISTURE
Page 199 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
EMOLLIENTS
00299392116
CETAPHIL
LOT CLEANSER
00299392140
CETAPHIL
LOT CLEANSER
00574202108
LACLOTION LOT 12%
00574202116
LACLOTION LOT 12%
00884044904
$0.00
0.00%
1
$5.84
0.20%
47
$1,648.09
9.23%
45
$2,318.45
8.84%
UREACIN-20 CRE 20%
2
$21.12
00884499004
LACTINOL-E CRE
0
00884529212
LACTINOL
5
45802049326
AMMONIUM LAC CRE 12%
0
45802049383
50383066308
UREA
51672130104
LOT 10%
LOT 40%
0
1
$8.96
0.19%
0
$0.00
0.00%
33
$1,173.31
6.40%
25
$1,298.07
4.84%
0.39%
5
$57.71
0.97%
$0.00
0.00%
4
$101.98
0.78%
$150.43
0.98%
0
$0.00
0.00%
$0.00
0.00%
14
$571.56
2.71%
45
$1,267.43
8.84%
62
$1,654.45
12.02%
0
$0.00
0.00%
1
$69.55
0.19%
0
$0.00
0.00%
1
$34.67
0.19%
ENZYMES / KERATOLYTICS / UREA
00044527003
SANTYL
OIN 250U/GM
00064341030
PANAFIL
OIN
00064390060
XENADERM
00574060115
PODOCON
00603127054
GRANUL-DERM AER
2
$33.76
0.99%
10337065219
CARMOL 40
CRE 40%
21
$919.93
10.34%
10337065249
CARMOL 40
CRE 40%
11
$803.16
5.42%
10337065252
CARMOL 40
CRE 40%
10
$425.54
10337065651
CARMOL 40
0
50484052715
SANTYL
OIN 250U/GM
15
50484052730
SANTYL
OIN 250U/GM
69
53706100101
TBC
AER
58980076511
ZIOX
OIN
60258003130
PAPA-UREA-CH OIN
OIN
SOL 25%
LOT
4
$163.67
1.97%
0
$0.00
0.00%
33
$2,392.05
16.26%
89
$6,693.94
22.25%
20
$900.24
9.85%
261
$12,333.30
65.25%
0
$0.00
0.00%
1
$47.59
0.25%
1
$15.44
0.25%
13
$543.54
3.25%
9
$600.86
2.25%
4.93%
4
$110.78
1.00%
$0.00
0.00%
2
$147.73
0.50%
$462.26
7.39%
2
$58.18
0.50%
$3,968.99
33.99%
7
$354.40
1.75%
2
$30.16
0.99%
2
$34.31
0.50%
1
$63.31
0.49%
5
$364.55
1.25%
1
$93.84
0.49%
0
$0.00
0.00%
Page 200 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ENZYMES / KERATOLYTICS / UREA
62794000250
GRANULEX
AER
1
$15.07
0.49%
0
$0.00
0.00%
62794000251
GRANULEX
AER
13
$254.96
6.40%
4
$75.44
1.00%
ERGOTAMINE DERIVATIVES
00078004101
D.H.E. 45
INJ 1MG/ML
5
$2,102.30
31.25%
0
$0.00
0.00%
00078005805
SANSERT
TAB 2MG
3
$1,112.62
18.75%
0
$0.00
0.00%
00078024598
MIGRANAL
8
$1,077.50
50.00%
1
$110.28
16.67%
66490004101
D.H.E. 45
0
$0.00
0.00%
3
$2,831.65
50.00%
66490024598
MIGRANAL
SPR 4MG/ML
0
$0.00
0.00%
2
$131.82
33.33%
$560.31
2.12%
SPR 4MG/ML
INJ 1MG/ML
ERYTHROPOEITINS
55513001004
ARANESP
INJ 25MCG/ML
15
$4,688.17
2.95%
12
55513001101
ARANESP
INJ 40MCG/ML
4
$2,778.44
0.79%
0
$0.00
0.00%
55513001104
ARANESP
INJ 40MCG/ML
2
$1,392.22
0.39%
3
$1,296.95
0.53%
55513001204
ARANESP
SOL 60MCG/ML
0
$0.00
0.00%
2
$1,043.24
0.35%
55513001301
ARANESP
SOL 100MCG
0
$0.00
0.00%
2
$2,176.26
0.35%
55513001304
ARANESP
SOL 100MCG
12
$11,285.98
2.36%
3
$937.73
0.53%
55513001401
ARANESP
INJ 200MCG
0
$0.00
0.00%
1
$1,736.50
0.18%
55513001404
ARANESP
INJ 200MCG
1
$1,714.45
0.20%
0
$0.00
0.00%
55513012610
EPOGEN
INJ 2000U/ML
2
$491.56
0.39%
0
$0.00
0.00%
55513014401
EPOGEN
INJ 10000/ML
10
$3,692.74
1.97%
0
$0.00
0.00%
55513014410
EPOGEN
INJ 10000/ML
27
$22,972.24
5.31%
6
$4,159.87
1.06%
55513014810
EPOGEN
INJ 4000U/ML
17
$4,607.07
3.35%
0
$0.00
0.00%
55513026701
EPOGEN
INJ 3000U/ML
1
$442.46
0.20%
0
$0.00
0.00%
55513026710
EPOGEN
INJ 3000U/ML
6
$1,553.97
1.18%
0
$0.00
0.00%
55513028301
EPOGEN
INJ 10000/ML
2
$1,958.28
0.39%
0
$0.00
0.00%
55513028310
EPOGEN
INJ 10000/ML
6
$5,582.43
1.18%
3
$1,705.17
0.53%
Page 201 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ERYTHROPOEITINS
55513047801
EPOGEN
INJ 20000/ML
1
$1,052.67
0.20%
0
$0.00
0.00%
55513047810
EPOGEN
INJ 20000/ML
9
$12,603.84
1.77%
3
$3,155.47
0.53%
55513082301
EPOGEN
INJ 40000/ML
2
$4,124.66
0.39%
0
$0.00
0.00%
55513082310
EPOGEN
INJ 40000/ML
40
$65,727.44
7.87%
6
$12,363.98
1.06%
59676030201
PROCRIT
INJ 2000U/ML
4
$513.96
0.79%
8
$1,367.18
1.41%
59676030202
PROCRIT
INJ 2000U/ML
3
$567.80
0.59%
2
$143.64
0.35%
59676030301
PROCRIT
INJ 3000U/ML
20
$3,115.26
3.94%
15
$5,443.27
2.65%
59676030302
PROCRIT
INJ 3000U/ML
5
$1,271.68
0.98%
15
$2,863.81
2.65%
59676030401
PROCRIT
INJ 4000U/ML
30
$8,312.73
5.91%
38
$13,327.97
6.71%
59676030402
PROCRIT
INJ 4000U/ML
7
$1,734.28
1.38%
24
$3,991.30
4.24%
59676031001
PROCRIT
INJ 10000/ML
81
$27,939.12
15.94%
107
$40,610.10
18.90%
59676031002
PROCRIT
INJ 10000/ML
12
$5,152.86
2.36%
43
$23,072.99
7.60%
59676031201
PROCRIT
INJ 10000/ML
26
$10,506.91
5.12%
42
$23,942.25
7.42%
59676032001
PROCRIT
INJ 20000/ML
73
$72,782.90
14.37%
129
$108,274.38
22.79%
59676034001
PROCRIT
INJ 40000/ML
90
$132,960.90
17.72%
102
$172,541.78
18.02%
ESTROGEN COMBOS
00009517401
ACTIVELLA
TAB 1-0.5MG
79
$2,006.85
2.89%
58
$1,560.68
3.12%
00009517402
ACTIVELLA
TAB 1-0.5MG
57
$1,418.18
2.08%
55
$1,488.24
2.96%
00032102301
ESTRATEST HS TAB
174
$6,943.31
6.36%
113
$4,444.84
6.08%
00032102601
ESTRATEST
330
$15,821.00
12.07%
186
$9,249.72
10.01%
00046087501
PREMPRO
TAB .625-2.5
0
$0.00
0.00%
11
$226.29
0.59%
00046087505
PREMPRO
TAB .625-2.5
210
$6,818.24
7.68%
116
$3,951.36
6.24%
00046087506
PREMPRO
TAB .625-2.5
1,105
$36,829.02
40.40%
639
$22,684.29
34.39%
00046093708
PREMPRO
TAB 0.45-1.5
0
$0.00
0.00%
9
$318.77
0.48%
00046093709
PREMPRO
TAB 0.45-1.5
0
$0.00
0.00%
69
$2,465.21
3.71%
00046097505
PREMPRO
TAB 0.625-5
18
$589.66
0.66%
18
$617.42
0.97%
TAB
Page 202 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ESTROGEN COMBOS
00046097506
PREMPRO
TAB 0.625-5
00046257305
PREMPHASE
TAB
00046257306
PREMPHASE
TAB
00062184001
ORTHO-PREFES TAB
00062184015
ORTHO-PREFES TAB
00071014423
00071014445
00075051408
259
$8,599.34
9.47%
160
$5,635.98
8.61%
15
$414.03
0.55%
138
$4,199.01
5.05%
14
$312.29
0.75%
79
$2,731.95
4.25%
5
$117.35
0.18%
0
$0.00
0.00%
60
$1,718.34
2.19%
60
$1,816.59
3.23%
FEMHRT 1/5 TAB
FEMHRT 1/5 TAB
42
$1,039.41
1.54%
16
$469.14
0.86%
191
$4,610.08
6.98%
176
$4,574.92
9.47%
COMBIPATCH DIS .05/.14
2
$61.16
0.07%
0
$0.00
0.00%
00078037742
3
$91.74
0.11%
2
$75.83
0.11%
00078037745
35
$1,170.45
1.28%
31
$1,088.52
1.67%
00078037842
3
$93.93
0.11%
4
$144.96
0.22%
00078037845
9
$302.58
0.33%
12
$434.88
0.65%
00430054423
FEMHRT 1/5 TAB
0
$0.00
0.00%
5
$149.73
0.27%
66576023001
SYNTEST H.S. TAB
0
$0.00
0.00%
9
$367.70
0.48%
66576023101
SYNTEST D.S. TAB
0
$0.00
0.00%
16
$706.83
0.86%
ESTROGENS - PATCHES
00078034342
VIVELLE-DOT DIS 0.0375MG
1
$29.20
0.14%
3
$82.40
0.49%
00078034345
1
$29.20
0.14%
10
$300.80
1.62%
00078034442
1
$29.72
0.14%
6
$190.62
0.97%
00078034445
32
$933.60
4.46%
24
$806.17
3.88%
00078034542
4
$121.28
0.56%
2
$64.86
0.32%
00078034545
18
$545.76
2.51%
18
$583.74
2.91%
00078034642
5
$150.77
0.70%
2
$66.18
0.32%
00078034645
28
$882.49
3.91%
32
$1,121.26
5.18%
00078034862
VIVELLE
0
$0.00
0.00%
1
$23.02
0.16%
00078036545
0
$0.00
0.00%
2
$61.92
0.32%
DIS 0.025MG
Page 203 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ESTROGENS - PATCHES
00083231008
ESTRADERM
DIS 0.05MG
16
$427.30
2.23%
19
$487.18
3.07%
00083231062
ESTRADERM
DIS 0.05MG
99
$3,058.26
13.81%
71
$2,296.98
11.49%
00083232008
ESTRADERM
DIS 0.1MG
11
$326.22
1.53%
3
$98.11
0.49%
00083232062
ESTRADERM
DIS 0.1MG
54
$1,624.85
7.53%
42
$1,432.11
6.80%
00083232508
VIVELLE
DIS 0.0375MG
3
$70.26
0.42%
11
$343.20
1.78%
00083232562
VIVELLE
DIS 0.0375MG
7
$204.40
0.98%
2
$57.40
0.32%
00083232608
VIVELLE
DIS 0.05MG
15
$408.82
2.09%
17
$534.79
2.75%
00083232662
VIVELLE
DIS 0.05MG
13
$367.62
1.81%
3
$45.80
0.49%
00083232708
VIVELLE
DIS 0.075MG
0
$0.00
0.00%
3
$99.79
0.49%
00083232801
VIVELLE
DIS 0.1MG
0
$0.00
0.00%
3
$96.71
0.49%
00083232808
VIVELLE
DIS 0.1MG
0
$0.00
0.00%
10
$330.90
1.62%
00083232862
VIVELLE
DIS 0.1MG
20
$672.90
2.79%
8
$361.76
1.29%
00378335099
ESTRADIOL
DIS .05MG/24
91
$2,450.87
12.69%
73
$1,545.94
11.81%
00378335299
ESTRADIOL
DIS 0.1MG/24
32
$842.40
4.46%
39
$843.27
6.31%
50419045104
CLIMARA
DIS 0.05MG
97
$2,648.62
13.53%
56
$1,742.74
9.06%
50419045204
CLIMARA
DIS 0.1MG
86
$2,549.73
11.99%
74
$3,043.70
11.97%
50419045304
CLIMARA
DIS 0.075MG
29
$796.81
4.04%
28
$910.25
4.53%
50419045404
CLIMARA
DIS 0.025MG
34
$1,044.25
4.74%
27
$692.70
4.37%
50419045604
CLIMARA
DIS 0.0375MG
0
$0.00
0.00%
2
$65.20
0.32%
52544047108
ALORA
DIS 0.05MG
10
$287.91
1.39%
9
$285.57
1.46%
52544047123
ALORA
DIS 0.05MG
1
$28.87
0.14%
0
$0.00
0.00%
52544047208
ALORA
DIS 0.075MG
3
$90.96
0.42%
8
$263.26
1.29%
52544047308
ALORA
DIS 0.1MG
2
$57.98
0.28%
0
$0.00
0.00%
64248031001
ESCLIM
DIS 0.025MG
1
$25.73
0.14%
5
$138.35
0.81%
64248032001
ESCLIM
DIS 0.0375MG
1
$27.97
0.14%
0
$0.00
0.00%
64248033001
ESCLIM
DIS 0.05MG
2
$55.00
0.28%
2
$58.00
0.32%
64248035001
ESCLIM
DIS 0.1MG
0
$0.00
0.00%
3
$86.88
0.49%
Page 204 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ESTROGENS - TABS
00003025150
DELESTROGEN INJ 40MG/ML
3
$362.51
0.04%
1
$123.74
0.01%
00003033050
1
$49.94
0.01%
0
$0.00
0.00%
00009377201
OGEN
TAB 0.625
10
$290.09
0.12%
3
$89.35
0.04%
00009377301
OGEN
TAB 1.25
10
$362.19
0.12%
2
$67.82
0.03%
00009377401
OGEN
TAB 2.5
8
$500.78
0.10%
4
$255.50
0.05%
00032101401
ESTRATAB
TAB 0.3MG
1
$14.32
0.01%
0
$0.00
0.00%
00046086481
PREMARIN
TAB 0.9MG
497
$13,327.94
6.16%
477
$15,216.84
6.18%
00046086581
PREMARIN
TAB 2.5MG
9
$495.11
0.11%
0
$0.00
0.00%
00046086681
PREMARIN
TAB 1.25MG
798
$27,538.58
9.90%
854
$34,155.64
11.06%
00046086691
PREMARIN
TAB 1.25MG
61
$2,020.25
0.76%
55
$2,142.16
0.71%
00046086781
PREMARIN
TAB 0.625MG
2,621
$66,724.43
32.51%
2,165
$59,214.05
28.04%
00046086791
PREMARIN
TAB 0.625MG
1,785
$42,584.88
22.14%
1,469
$39,628.66
19.02%
00046086795
PREMARIN
TAB 0.625MG
7
$177.81
0.09%
3
$63.06
0.04%
00046086799
PREMARIN
TAB 0.625MG
7
$152.24
0.09%
16
$435.81
0.21%
00046086881
PREMARIN
TAB 0.3MG
595
$11,429.56
7.38%
691
$15,957.27
8.95%
00046086891
PREMARIN
TAB 0.3MG
23
$437.54
0.29%
30
$748.12
0.39%
00046093681
PREMARIN
TAB 0.45MG
0
$0.00
0.00%
18
$487.78
0.23%
00046386781
PREMARIN
TAB 0.625MG
7
$90.27
0.09%
2
$54.42
0.03%
00087002141
ESTRACE
TAB 0.5MG
8
$146.34
0.10%
2
$26.78
0.03%
00087075501
ESTRACE
TAB 1MG
25
$460.62
0.31%
8
$144.48
0.10%
00087075601
ESTRACE
TAB 2MG
11
$299.50
0.14%
1
$27.33
0.01%
00378145201
ESTRADIOL
TAB 0.5MG
29
$205.88
0.36%
52
$342.92
0.67%
00378145205
ESTRADIOL
TAB 0.5MG
8
$82.74
0.10%
16
$131.04
0.21%
00378145401
ESTRADIOL
TAB 1MG
10
$84.05
0.12%
43
$379.50
0.56%
00378145405
ESTRADIOL
TAB 1MG
5
$58.65
0.06%
22
$199.68
0.28%
00378145801
ESTRADIOL
TAB 2MG
13
$151.98
0.16%
85
$596.00
1.10%
Page 205 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
ESTRADIOL
00378455101
00378455301
$
Market Share*
ESTROGENS - TABS
00378145805
# of Scripts
TAB 2MG
6
$74.36
0.07%
25
$136.33
0.32%
ESTROPIPATE TAB 0.75MG
11
$131.33
0.14%
26
$131.90
0.34%
10
$148.90
0.12%
1
$7.75
0.01%
00555072702
61
$648.09
0.76%
63
$342.01
0.82%
00555072802
43
$523.08
0.53%
45
$455.21
0.58%
00555072902
ESTROPIPATE TAB 3MG
3
$68.25
0.04%
5
$23.75
0.06%
00555088602
ESTRADIOL
TAB 1MG
247
$2,582.06
3.06%
303
$2,742.34
3.92%
00555088604
ESTRADIOL
TAB 1MG
6
$54.80
0.07%
28
$250.85
0.36%
00555088702
ESTRADIOL
TAB 2MG
45
$584.04
0.56%
88
$569.78
1.14%
00555088704
ESTRADIOL
TAB 2MG
00555089902
ESTRADIOL
TAB 0.5MG
00591041401
0
$0.00
0.00%
4
$30.95
0.05%
95
$830.77
1.18%
140
$974.42
1.81%
81
$963.77
1.00%
66
$378.44
0.85%
00591041501
28
$399.40
0.35%
41
$369.03
0.53%
00591041601
ESTROPIPATE TAB 3MG
23
$710.01
0.29%
36
$218.54
0.47%
00591048701
ESTRADIOL
TAB 1MG
179
$1,937.24
2.22%
215
$1,903.73
2.78%
00591048705
ESTRADIOL
TAB 1MG
6
$50.40
0.07%
4
$25.60
0.05%
00591048801
ESTRADIOL
TAB 2MG
85
$974.73
1.05%
111
$749.10
1.44%
00591048805
ESTRADIOL
TAB 2MG
00591052801
ESTRADIOL
TAB 0.5MG
51285001002
0
$0.00
0.00%
2
$11.60
0.03%
40
$324.01
0.50%
50
$367.83
0.65%
2
$18.60
0.02%
0
$0.00
0.00%
51285044102
CENESTIN
TAB 0.3MG
2
$35.77
0.02%
23
$475.76
0.30%
51285044202
CENESTIN
TAB 0.625MG
67
$1,445.14
0.83%
123
$3,176.25
1.59%
51285044302
CENESTIN
TAB 0.9MG
36
$872.47
0.45%
59
$1,699.80
0.76%
51285044402
CENESTIN
TAB 1.25MG
47
$1,495.22
0.58%
76
$2,515.47
0.98%
51285050102
ESTRADIOL
TAB 0.5MG
5
$39.59
0.06%
0
$0.00
0.00%
51285050202
ESTRADIOL
TAB 1MG
0
$0.00
0.00%
1
$8.90
0.01%
51285050204
ESTRADIOL
TAB 1MG
1
$8.40
0.01%
0
$0.00
0.00%
Page 206 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ESTROGENS - TABS
51552038105
ESTRIOL
POW MICRONIZ
51552038405
ESTRADIOL
52544041401
52544041501
52544041601
ESTROPIPATE TAB 3MG
52544048701
ESTRADIOL
52544048705
ESTRADIOL
52544048801
0
$0.00
0.00%
1
$41.65
0.01%
3
$71.55
0.04%
1
$23.35
0.01%
6
$64.48
0.07%
1
$4.45
0.01%
12
$140.17
0.15%
6
$62.60
0.08%
4
$131.80
0.05%
0
$0.00
0.00%
TAB 1MG
29
$287.28
0.36%
7
$51.19
0.09%
TAB 1MG
8
$77.80
0.10%
3
$19.20
0.04%
ESTRADIOL
TAB 2MG
3
$50.08
0.04%
0
$0.00
0.00%
52544052801
ESTRADIOL
TAB 0.5MG
4
$33.51
0.05%
0
$0.00
0.00%
59772002503
ESTRADIOL
TAB 0.5MG
35
$269.34
0.43%
10
$49.87
0.13%
59772002603
ESTRADIOL
TAB 1MG
59
$580.14
0.73%
16
$112.40
0.21%
59772002604
ESTRADIOL
TAB 1MG
42
$422.95
0.52%
23
$180.50
0.30%
59772002703
ESTRADIOL
TAB 2MG
72
$769.34
0.89%
24
$135.70
0.31%
59772002704
ESTRADIOL
TAB 2MG
19
$264.61
0.24%
3
$30.05
0.04%
61570007201
MENEST
TAB 0.3MG
9
$93.95
0.11%
10
$115.10
0.13%
61570007301
MENEST
TAB 0.625MG
38
$544.54
0.47%
35
$571.25
0.45%
61570007401
MENEST
TAB 1.25MG
29
$650.57
0.36%
22
$598.53
0.28%
61570007550
MENEST
TAB 2.5MG
0
$0.00
0.00%
3
$115.70
0.04%
61570018101
0
$0.00
0.00%
1
$74.92
0.01%
61570018201
0
$0.00
0.00%
1
$136.03
0.01%
64248010101
ORTHO-EST
TAB 0.625
9
$174.36
0.11%
1
$24.32
0.01%
64248010201
ORTHO-EST
TAB 1.25
1
$11.15
0.01%
0
$0.00
0.00%
POW
FELODIPINES
00186045031
PLENDIL
TAB 2.5MG CR
11
$358.66
3.87%
2
$26.84
4.65%
00186045058
PLENDIL
TAB 2.5MG CR
14
$499.05
4.93%
3
$204.78
6.98%
00186045131
PLENDIL
TAB 5MG CR
19
$621.87
6.69%
3
$97.95
6.98%
Page 207 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
FELODIPINES
00186045158
PLENDIL
TAB 5MG CR
130
00186045231
PLENDIL
TAB 10MG CR
15
$851.22
5.28%
1
$57.96
2.33%
00186045258
PLENDIL
TAB 10MG CR
95
$5,848.06
33.45%
10
$563.30
23.26%
0
$0.00
0.00%
1
$44.17
3.85%
$4,399.71
45.77%
24
$802.16
55.81%
FERTILITY REGULATORS
00052031510
PREGNYL
INJ 10000U
00093004103
CLOMIPHENE TAB 50MG
0
$0.00
0.00%
4
$64.40
15.38%
00093004156
CLOMIPHENE TAB 50MG
1
$3.54
50.00%
2
$39.95
7.69%
00591078130
CLOMIPHENE TAB 50MG
0
$0.00
0.00%
7
$91.48
26.92%
44087025001
OVIDREL
0
$0.00
0.00%
1
$64.49
3.85%
49884070155
CLOMIPHENE TAB 50MG
1
$22.75
50.00%
11
$133.76
42.31%
INJ 250MCG
FLUOROQUINOLONES
00006070520
NOROXIN
TAB 400MG
10
$804.81
0.14%
15
$1,022.41
0.17%
00006070568
NOROXIN
TAB 400MG
23
$1,645.34
0.32%
24
$1,925.86
0.27%
00015111750
TEQUIN
TAB 200MG
87
$4,828.64
1.19%
48
$2,986.77
0.54%
00015111780
TEQUIN
TAB 200MG
2
$87.39
0.03%
0
$0.00
0.00%
00015117719
TEQUIN
TAB 400MG
26
$1,523.01
0.36%
4
$202.06
0.05%
00015117721
TEQUIN
TAB 400MG
0
$0.00
0.00%
1
$52.43
0.01%
00015117760
TEQUIN
TAB 400MG
452
$29,413.81
6.20%
279
$18,770.47
3.16%
00015118080
TEQUIN
INJ 2MG/ML
0
$0.00
0.00%
1
$47.33
0.01%
00015118180
TEQUIN
INJ 2MG/ML
1
$132.73
0.01%
0
$0.00
0.00%
00026851106
CIPRO CYSTIT TAB 100MG
15
$1,113.97
0.21%
22
$1,005.35
0.25%
00026851248
CIPRO
TAB 250MG
42
$609.63
0.58%
95
$1,150.03
1.07%
00026851251
CIPRO
TAB 250MG
1,258
$61,233.54
17.27%
1,199
$56,569.03
13.56%
00026851348
CIPRO
TAB 500MG
3
$293.52
0.04%
94
$6,851.92
1.06%
00026851351
CIPRO
TAB 500MG
2,035
$159,791.99
27.93%
1,201
$104,297.92
13.58%
Page 208 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
FLUOROQUINOLONES
00026851448
CIPRO
TAB 750MG
1
$103.51
0.01%
2
$198.12
0.02%
00026851450
CIPRO
TAB 750MG
122
$13,244.58
1.67%
76
$9,516.09
0.86%
00026855136
CIPRO
SUS 5G/100ML
22
$1,880.08
0.30%
16
$1,635.12
0.18%
00026855236
CIPRO I.V. SOL 200MG
0
$0.00
0.00%
1
$57.63
0.01%
00026855336
CIPRO
30
$2,593.52
0.41%
30
$4,005.33
0.34%
00026855463
CIPRO I.V. SOL 400MG
1
$55.55
0.01%
7
$1,169.37
0.08%
00026856464
CIPRO I.V. INJ 400/1%
2
$48.41
0.03%
0
$0.00
0.00%
00026858141
AVELOX ABC TAB 400MG
25
$1,278.88
0.34%
24
$1,628.68
0.27%
00026858169
AVELOX
276
$19,811.06
3.79%
1,086
$86,422.07
12.28%
00026858231
AVELOX
INJ
0
$0.00
0.00%
2
$458.30
0.02%
00026888950
CIPRO XR
TAB 500MG
0
$0.00
0.00%
167
$9,901.07
1.89%
00026888951
CIPRO XR
TAB 500MG
0
$0.00
0.00%
18
$1,062.24
0.20%
00026889750
CIPRO XR
TAB 1000MG
0
$0.00
0.00%
35
$3,198.19
0.40%
00026889751
CIPRO XR
TAB 1000MG
0
$0.00
0.00%
2
$87.50
0.02%
00045006701
LEVAQUIN/D5W INJ 250/50ML
1
$2.72
0.01%
0
$0.00
0.00%
00045006801
LEVAQUIN/D5W INJ 500/100
18
$3,593.65
0.25%
6
$1,012.85
0.07%
00045006951
LEVAQUIN
INJ 25MG/ML
0
$0.00
0.00%
1
$270.92
0.01%
00045152010
LEVAQUIN
TAB 250MG
39
$773.89
0.54%
30
$542.25
0.34%
00045152050
LEVAQUIN
TAB 250MG
799
$39,462.16
10.97%
566
$35,229.19
6.40%
00045152510
LEVAQUIN
TAB 500MG
32
$2,245.08
0.44%
8
$613.78
0.09%
00045152550
LEVAQUIN
TAB 500MG
1,868
$136,909.71
25.64%
1,459
$113,218.65
16.50%
00045153010
LEVAQUIN
TAB 750MG
2
$248.21
0.03%
0
$0.00
0.00%
00045153050
LEVAQUIN
9
$1,652.26
0.12%
20
$3,619.15
0.23%
00062154002
FLOXIN
TAB 200MG
25
$1,838.97
0.34%
14
$1,591.02
0.16%
00062154102
FLOXIN
TAB 300MG
20
$2,032.91
0.27%
13
$1,383.42
0.15%
00062154201
FLOXIN
TAB 400MG
38
$4,572.28
0.52%
37
$5,093.44
0.42%
00555037987
CIPROFLOXACI SUS 5%
0
$0.00
0.00%
3
$466.64
0.03%
SUS 10GM/100
TAB 400MG
TAB 750MG
Page 209 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
FLUOROQUINOLONES
00555038087
CIPROFLOXACI SUS 10%
0
$0.00
0.00%
00555081402
CIPROFLOXACI TAB 250MG
0
$0.00
0.00%
588
$36,867.94
6.65%
00555081502
0
$0.00
0.00%
1,579
$134,753.83
17.86%
00555081610
0
$0.00
0.00%
48
$5,421.35
0.54%
49884068401
OFLOXACIN
0
$0.00
0.00%
7
$499.19
0.08%
54092009720
NOROXIN
1
$24.88
0.01%
0
$0.00
0.00%
63304071650
OFLOXACIN
TAB 200MG
0
$0.00
0.00%
1
$25.82
0.01%
63304071701
OFLOXACIN
TAB 400MG
0
$0.00
0.00%
2
$299.20
0.02%
55513019001
NEULASTA
INJ 6MG/0.6M
0
$0.00
0.00%
5
$8,479.27
9.26%
55513020901
NEUPOGEN
INJ
0
$0.00
0.00%
1
$3,473.72
1.85%
55513020910
NEUPOGEN
INJ
0
$0.00
0.00%
2
$9,781.70
3.70%
55513053001
NEUPOGEN
INJ 300/ML
0
$0.00
0.00%
4
$4,157.98
7.41%
55513053010
NEUPOGEN
INJ 300/ML
38
$54,622.50
66.67%
25
$33,559.18
46.30%
55513054601
NEUPOGEN
INJ 480/1.6
0
$0.00
0.00%
2
$5,759.66
3.70%
55513054610
NEUPOGEN
INJ 480/1.6
6
$11,795.49
10.53%
1
$2,304.50
1.85%
55513092401
NEUPOGEN
INJ
8
$15,059.69
14.04%
0
$0.00
0.00%
55513092410
NEUPOGEN
INJ
5
$8,133.14
8.77%
13
$20,215.53
24.07%
58406005014
LEUKINE
0
$0.00
0.00%
1
$3,729.21
1.85%
193
$23,863.91
91.47%
268
$39,927.84
92.10%
TAB 400MG
TAB 400MG
10
$1,415.84
0.11%
G/M CSF
SOL 500MCG
GENITAL WARTS
00089061012
ALDARA
00574061105
PODOFILOX SOL 0.5%
3
$266.31
1.42%
8
$764.52
2.75%
55515010101
CONDYLOX
SOL 0.5%
9
$892.24
4.27%
8
$847.96
2.75%
55515010201
CONDYLOX
GEL 0.5%
6
$646.97
2.84%
7
$957.00
2.41%
CRE 5%
Page 210 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
GLUCOCORTICOIDS / MINERALOCORTICOIDS
00003029305
KENALOG-40 INJ 40MG/ML
00003029320
00003042950
FLORINEF
00003049420
0
$0.00
0.00%
1
$24.55
0.01%
1
$30.74
0.01%
0
$0.00
0.00%
166
$4,488.86
1.53%
14
$272.41
0.11%
1
$20.34
0.01%
1
$37.45
0.01%
00006006312
DECADRON
1
$17.12
0.01%
0
$0.00
0.00%
00006061968
HYDROCORTONE TAB 10MG
71
$1,456.54
0.65%
55
$1,163.79
0.42%
00009001201
CORTEF
58
$1,324.02
0.53%
92
$1,964.51
0.70%
00009002201
MEDROL
TAB 8MG
2
$24.08
0.02%
1
$11.40
0.01%
00009003101
CORTEF
TAB 10MG
35
$831.84
0.32%
29
$844.04
0.22%
00009003201
DELTASONE
105
$569.17
0.97%
9
$45.73
0.07%
00009004401
CORTEF
3
$92.07
0.03%
2
$60.38
0.02%
00009004501
DELTASONE
TAB 5MG
30
$133.54
0.28%
3
$5.86
0.02%
00009004502
DELTASONE
TAB 5MG
293
$1,067.45
2.70%
21
$72.28
0.16%
00009004516
DELTASONE
TAB 5MG
17
$69.31
0.16%
1
$1.43
0.01%
00009004902
MEDROL
TAB 2MG
0
$0.00
0.00%
1
$50.51
0.01%
00009005604
MEDROL
PAK 4MG
2
$32.58
0.02%
1
$19.91
0.01%
00009007301
MEDROL
TAB 16MG
3
$29.49
0.03%
8
$166.98
0.06%
00009011312
SOLU-MEDROL INJ 40MG
0
$0.00
0.00%
4
$42.48
0.03%
00009016501
DELTASONE
TAB 20MG
246
$991.17
2.27%
82
$278.16
0.62%
00009016502
DELTASONE
TAB 20MG
331
$1,114.16
3.05%
7
$15.39
0.05%
00009017601
MEDROL
6
$47.16
0.06%
9
$70.88
0.07%
00009019009
6
$34.45
0.06%
1
$2.44
0.01%
00009019301
DELTASONE
TAB 10MG
207
$942.45
1.91%
123
$489.98
0.93%
00009019302
DELTASONE
TAB 10MG
486
$1,797.89
4.48%
168
$602.80
1.27%
00009028002
DEPO-MEDROL INJ 40MG/ML
2
$50.00
0.02%
0
$0.00
0.00%
00009030602
2
$48.65
0.02%
0
$0.00
0.00%
00009038801
DELTASONE
60
$235.15
0.55%
35
$110.33
0.26%
TAB 0.1MG
PAK 0.75MG
TAB 5MG
TAB 2.5MG
TAB 20MG
TAB 32MG
TAB 50MG
Page 211 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00009069801
0
00009082501
SOLU-CORTEF INJ 100MG
00009090013
00009090020
$0.00
0.00%
1
$31.36
0.01%
1
$9.04
0.01%
8
$53.13
0.07%
1
$2.75
0.01%
9
$30.06
0.07%
0
$0.00
0.00%
3
$20.46
0.02%
00009307301
0
$0.00
0.00%
4
$55.12
0.03%
00009338901
00009347501
3
$55.59
0.03%
0
$0.00
0.00%
2
$79.57
0.02%
2
$29.90
0.02%
00054317644
DEXAMETHASON CON 1MG/ML
9
$306.64
0.08%
9
$128.73
0.07%
00054317763
DEXAMETHASON SOL 0.5/5ML
0
$0.00
0.00%
1
$6.72
0.01%
00054372144
PREDNISONE CON 5MG/ML
1
$110.67
0.01%
0
$0.00
0.00%
00054372250
PREDNISONE SOL 5MG/5ML
4
$115.26
0.04%
4
$213.07
0.03%
00054372263
PREDNISONE SOL 5MG/5ML
18
$709.38
0.17%
13
$403.84
0.10%
00054417925
DEXAMETHASON TAB 0.5MG
12
$55.48
0.11%
10
$32.94
0.08%
00054418125
DEXAMETHASON TAB 1MG
49
$615.65
0.45%
51
$739.57
0.39%
00054418325
26
$600.16
0.24%
54
$1,684.86
0.41%
00054418425
61
$607.95
0.56%
164
$1,360.79
1.24%
00054418625
1
$8.82
0.01%
0
$0.00
0.00%
00054472825
PREDNISONE TAB 5MG
6
$28.02
0.06%
0
$0.00
0.00%
00054472831
PREDNISONE TAB 5MG
32
$125.43
0.29%
355
$1,028.94
2.69%
00054472925
PREDNISONE TAB 20MG
14
$55.22
0.13%
1,136
$3,095.54
8.60%
00054472929
PREDNISONE TAB 20MG
0
$0.00
0.00%
48
$153.54
0.36%
00054473025
PREDNISONE TAB 10MG
9
$41.13
0.08%
898
$3,224.00
6.80%
00054473029
PREDNISONE TAB 10MG
8
$35.61
0.07%
56
$226.29
0.42%
00054473325
PREDNISONE TAB 50MG
47
$210.39
0.43%
82
$326.87
0.62%
00054474125
PREDNISONE TAB 1MG
198
$3,221.43
1.82%
239
$4,419.17
1.81%
00054474131
PREDNISONE TAB 1MG
118
$1,630.30
1.09%
158
$2,579.11
1.20%
00054474225
PREDNISONE TAB 2.5MG
149
$707.04
1.37%
147
$762.38
1.11%
Page 212 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00054817425
2
$13.62
0.02%
1
$1.15
0.01%
00054817525
0
$0.00
0.00%
9
$40.10
0.07%
00054817625
1
$6.42
0.01%
0
$0.00
0.00%
00054817925
0
$0.00
0.00%
2
$7.09
0.02%
00054872925
PREDNISONE TAB 50MG
1
$3.66
0.01%
2
$4.38
0.02%
00054873925
PREDNISONE TAB 1MG
13
$173.75
0.12%
8
$131.06
0.06%
00054874025
PREDNISONE TAB 2.5MG
3
$29.28
0.03%
0
$0.00
0.00%
00093611816
PREDNISOLONE SYP 15MG/5ML
132
$1,794.57
1.22%
71
$1,136.38
0.54%
00093611887
142
$1,901.51
1.31%
82
$1,087.91
0.62%
00115703301
FLUDROCORT TAB 0.1MG
148
$3,900.27
1.36%
227
$6,439.34
1.72%
00143120201
CORTISONE AC TAB 25MG
7
$90.41
0.06%
4
$149.40
0.03%
00143125401
HYDROCORT
TAB 20MG
47
$394.98
0.43%
74
$550.41
0.56%
00143147301
PREDNISONE TAB 10MG
4
$19.46
0.04%
9
$25.05
0.07%
00143147310
PREDNISONE TAB 10MG
78
$389.20
0.72%
77
$245.23
0.58%
00143147510
PREDNISONE TAB 5MG
64
$269.65
0.59%
101
$296.02
0.76%
00143147701
PREDNISONE TAB 20MG
26
$97.81
0.24%
17
$52.86
0.13%
00143147705
PREDNISONE TAB 20MG
13
$53.83
0.12%
7
$26.68
0.05%
00143147710
PREDNISONE TAB 20MG
21
$95.28
0.19%
23
$78.73
0.17%
00182108610
PREDNISONE TAB 20MG
1
$4.22
0.01%
0
$0.00
0.00%
00186070210
ENTOCORT EC CAP 3MG/24HR
39
$6,335.17
0.36%
67
$9,329.57
0.51%
00254421628
METHYLPRED TAB 4MG
0
$0.00
0.00%
1
$5.41
0.01%
00259039021
STERAPRED
1
$4.05
0.01%
1
$9.99
0.01%
00364021701
PREDNISOLONE TAB 5MG
2
$14.79
0.02%
2
$30.96
0.02%
00364021801
PREDNISONE TAB 5MG
8
$31.16
0.07%
0
$0.00
0.00%
00364021802
PREDNISONE TAB 5MG
23
$93.14
0.21%
1
$3.38
0.01%
00364044201
PREDNISONE TAB 20MG
2
$7.72
0.02%
0
$0.00
0.00%
00364044202
PREDNISONE TAB 20MG
13
$58.75
0.12%
9
$20.99
0.07%
PAK 5MG
Page 213 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00364044205
PREDNISONE TAB 20MG
5
$19.10
0.05%
0
$0.00
0.00%
00364046101
PREDNISONE TAB 10MG
2
$16.11
0.02%
0
$0.00
0.00%
00364046102
PREDNISONE TAB 10MG
7
$42.80
0.06%
0
$0.00
0.00%
00364046105
PREDNISONE TAB 10MG
3
$13.33
0.03%
0
$0.00
0.00%
00378342524
1
$7.51
0.01%
0
$0.00
0.00%
00451150008
PRELONE
SYP 15MG/5ML
21
$332.29
0.19%
4
$59.40
0.03%
00451150016
PRELONE
SYP 15MG/5ML
4
$57.17
0.04%
2
$33.39
0.02%
00451220104
PRELONE
SYP 5MG/5ML
18
$260.39
0.17%
6
$57.93
0.05%
00472021208
60
$904.31
0.55%
5
$67.72
0.04%
00472021216
58
$752.88
0.53%
1
$25.20
0.01%
00472025008
0
$0.00
0.00%
17
$215.91
0.13%
00472025016
0
$0.00
0.00%
6
$62.85
0.05%
00472097208
DEXAMETHASON ELX 0.5/5ML
6
$42.86
0.06%
7
$57.01
0.05%
00472097233
4
$26.66
0.04%
0
$0.00
0.00%
00517490125
DEXAMETH PHO INJ 4MG/ML
9
$147.44
0.08%
2
$9.77
0.02%
00517490525
6
$68.76
0.06%
4
$29.85
0.03%
00517493025
2
$19.34
0.02%
7
$57.88
0.05%
00527129607
METHYLPRED PAK 4MG
4
$44.27
0.04%
0
$0.00
0.00%
00555030102
METHYLPRED TAB 4MG
20
$494.91
0.18%
25
$365.59
0.19%
00555030138
METHYLPRED PAK 4MG
327
$3,825.60
3.01%
301
$2,193.98
2.28%
00555099702
FLUDROCORT TAB 0.1MG
0
$0.00
0.00%
43
$1,315.60
0.33%
00574040810
DEXAMETH SOD POW PHOSPHAT
1
$14.99
0.01%
0
$0.00
0.00%
00591052038
0
$0.00
0.00%
11
$152.35
0.08%
00591505201
PREDNISONE TAB 5MG
67
$303.13
0.62%
69
$229.92
0.52%
00591505210
PREDNISONE TAB 5MG
689
$2,983.56
6.35%
1,199
$4,314.06
9.08%
00591505901
PREDNISOLONE TAB 5MG
0
$0.00
0.00%
5
$31.38
0.04%
00591544201
PREDNISONE TAB 10MG
231
$1,190.48
2.13%
296
$1,089.53
2.24%
Page 214 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00591544205
PREDNISONE TAB 10MG
368
$1,700.43
3.39%
536
$1,956.54
4.06%
00591544210
PREDNISONE TAB 10MG
481
$2,384.97
4.43%
843
$3,329.37
6.38%
00591544301
PREDNISONE TAB 20MG
632
$2,583.19
5.82%
783
$2,220.36
5.93%
00591544305
PREDNISONE TAB 20MG
195
$861.64
1.80%
319
$1,136.88
2.42%
00591544310
PREDNISONE TAB 20MG
172
$745.83
1.59%
327
$1,010.96
2.48%
00603459315
METHYLPRED PAK 4MG
0
$0.00
0.00%
240
$1,770.56
1.82%
00603459321
METHYLPRED TAB 4MG
0
$0.00
0.00%
24
$270.38
0.18%
00603533215
PREDNISONE PAK 5MG
2
$12.68
0.02%
1
$24.34
0.01%
00603533221
PREDNISONE TAB 5MG
4
$17.76
0.04%
0
$0.00
0.00%
00603533232
PREDNISONE TAB 5MG
18
$84.68
0.17%
0
$0.00
0.00%
00603533315
PREDNISONE PAK 10MG
1
$3.95
0.01%
0
$0.00
0.00%
00603533331
PREDNISONE PAK 10MG
5
$37.51
0.05%
0
$0.00
0.00%
00603533332
PREDNISONE TAB 10MG
4
$26.20
0.04%
0
$0.00
0.00%
00603533721
PREDNISONE TAB 5MG
0
$0.00
0.00%
6
$35.36
0.05%
00603533732
PREDNISONE TAB 5MG
0
$0.00
0.00%
3
$4.28
0.02%
00603533815
PREDNISONE PAK 10MG
0
$0.00
0.00%
1
$19.01
0.01%
00615053653
PREDNISONE TAB 5MG
9
$39.33
0.08%
0
$0.00
0.00%
00615053663
PREDNISONE TAB 5MG
104
$427.84
0.96%
0
$0.00
0.00%
00615359353
PREDNISONE TAB 10MG
228
$1,041.64
2.10%
0
$0.00
0.00%
00615359363
PREDNISONE TAB 10MG
4
$19.48
0.04%
0
$0.00
0.00%
00677007601
HYDROCORT
10
$68.12
0.09%
5
$42.83
0.04%
00677011701
PREDNISONE TAB 5MG
36
$167.08
0.33%
34
$134.02
0.26%
00677011710
PREDNISONE TAB 5MG
32
$146.30
0.29%
17
$48.03
0.13%
00677042701
PREDNISONE TAB 20MG
11
$38.95
0.10%
9
$28.95
0.07%
00677042705
PREDNISONE TAB 20MG
14
$53.78
0.13%
0
$0.00
0.00%
00677042710
PREDNISONE TAB 20MG
13
$70.74
0.12%
0
$0.00
0.00%
00677056501
METHYLPRED TAB 4MG
2
$60.11
0.02%
0
$0.00
0.00%
TAB 20MG
Page 215 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00677056513
METHYLPRED PAK 4MG
3
$28.44
0.03%
0
$0.00
0.00%
00677069801
PREDNISONE TAB 10MG
13
$57.27
0.12%
17
$56.03
0.13%
00677069805
PREDNISONE TAB 10MG
2
$12.33
0.02%
7
$29.45
0.05%
00677069810
PREDNISONE TAB 10MG
50
$261.63
0.46%
38
$128.33
0.29%
00677084901
13
$103.73
0.12%
4
$29.90
0.03%
00677183101
METHYLPRED TAB 4MG
0
$0.00
0.00%
6
$60.05
0.05%
00781502201
METHYLPRED TAB 4MG
0
$0.00
0.00%
5
$149.42
0.04%
00781502207
METHYLPRED PAK 4MG
0
$0.00
0.00%
60
$413.10
0.45%
00904217519
METHYLPRED PAK 4MG
1
$12.72
0.01%
24
$164.23
0.18%
00904267460
HYDROCORT
1
$4.33
0.01%
0
$0.00
0.00%
49884008301
4
$17.02
0.04%
3
$8.69
0.02%
49884008401
9
$42.05
0.08%
11
$39.52
0.08%
49884008501
7
$34.28
0.06%
7
$28.35
0.05%
49884008701
151
$1,338.20
1.39%
108
$649.76
0.82%
49884008703
17
$104.27
0.16%
6
$31.12
0.05%
49884012901
0
$0.00
0.00%
1
$97.77
0.01%
50383004248
0
$0.00
0.00%
26
$228.98
0.20%
51285030102
METHYLPRED TAB 4MG
15
$233.46
0.14%
0
$0.00
0.00%
51285030121
METHYLPRED PAK 4MG
101
$1,145.77
0.93%
53
$377.20
0.40%
51552002525
DEXAMETH SOD POW PHOSPHAT
2
$24.20
0.02%
0
$0.00
0.00%
51991018821
METHYLPRED PAK 4MG
0
$0.00
0.00%
1
$9.33
0.01%
52544052016
15
$182.25
0.14%
21
$406.50
0.16%
52544052038
11
$134.32
0.10%
2
$15.98
0.02%
52544079021
METHYLPRED PAK 4MG
2
$25.44
0.02%
3
$27.99
0.02%
53014025001
PEDIAPRED
50
$1,127.52
0.46%
19
$377.69
0.14%
53489013801
PREDNISONE TAB 5MG
3
$8.70
0.03%
292
$929.16
2.21%
53489013810
PREDNISONE TAB 5MG
349
$1,675.73
3.22%
22
$77.91
0.17%
TAB 20MG
LIQ 6.7/5ML
Page 216 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
53489013901
PREDNISONE TAB 10MG
690
$3,486.12
6.36%
465
$1,654.22
3.52%
53489013905
PREDNISONE TAB 10MG
49
$261.50
0.45%
61
$212.66
0.46%
53489013910
PREDNISONE TAB 10MG
50
$264.35
0.46%
22
$75.56
0.17%
53489014001
PREDNISONE TAB 20MG
808
$3,367.46
7.45%
642
$1,829.05
4.86%
53489014005
PREDNISONE TAB 20MG
2
$6.81
0.02%
1
$3.74
0.01%
53489014010
PREDNISONE TAB 20MG
32
$148.73
0.29%
7
$16.61
0.05%
58177091005
69
$994.20
0.64%
215
$2,898.30
1.63%
58177091007
40
$500.72
0.37%
107
$1,128.11
0.81%
58177091203
6
$80.52
0.06%
18
$181.11
0.14%
59196001024
11
$186.73
0.10%
6
$113.75
0.05%
59196001048
16
$207.45
0.15%
11
$163.08
0.08%
59196001224
PREDNISOLONE SOL SOD PHOS
6
$63.72
0.06%
0
$0.00
0.00%
59439045502
ORAPRED
367
$7,596.74
3.38%
602
$15,219.33
4.56%
59746000103
METHYLPRED PAK 4MG
16
$191.09
0.15%
14
$94.26
0.11%
59746000106
METHYLPRED PAK 4MG
0
$0.00
0.00%
1
$10.30
0.01%
59762332701
METHYLPRED PAK 4MG
83
$969.11
0.76%
80
$571.68
0.61%
59762332702
METHYLPRED TAB 4MG
19
$616.69
0.18%
20
$322.65
0.15%
60432008904
PRED SOD PHO LIQ 6.7/5ML
2
$23.54
0.02%
67
$1,213.71
0.51%
60432046608
20
$128.03
0.18%
13
$85.70
0.10%
62269035121
METHYLPRED PAK 4MG
46
$536.57
0.42%
6
$43.36
0.05%
62269035124
METHYLPRED TAB 4MG
7
$156.81
0.06%
4
$36.11
0.03%
63304059122
METHYLPRED PAK 4MG
7
$82.34
0.06%
0
$0.00
0.00%
63323016501
0
$0.00
0.00%
1
$3.92
0.01%
63323016530
3
$33.15
0.03%
2
$19.10
0.02%
65580025101
PRED SOD PHO LIQ 6.7/5ML
91
$1,565.28
0.84%
40
$723.13
0.30%
66440015008
PRELONE
0
$0.00
0.00%
2
$46.92
0.02%
SOL 15MG/5ML
SYP 15MG/5ML
Page 217 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
GOUT
00074007402
COLCHICINE TAB 0.5MG
00074378101
00143120101
00143120110
00172219060
PROBENECID TAB 500MG
00172219360
PROBEN/COLCH TAB 500/.5MG
00364007401
00364007402
00364031501
00364063201
ALLOPURINOL TAB 100MG
00364063202
00364063301
00364063305
00378013701
00378013710
00378015601
$0.00
0.00%
6
$64.15
0.21%
64
$409.53
2.19%
0
$0.00
0.00%
0.16%
7
$290.91
0.24%
$42.99
0.04%
1
$44.85
0.03%
$269.64
1.58%
9
$68.17
0.31%
$14.20
0.08%
0
$0.00
0.00%
$165.84
0.28%
0
$0.00
0.00%
1
$9.41
0.04%
0
$0.00
0.00%
17
$102.64
0.69%
15
$95.26
0.51%
5
$24.26
0.20%
0
$0.00
0.00%
7
$33.60
0.28%
0
$0.00
0.00%
46
$307.57
1.87%
231
$1,260.76
7.90%
142
$956.85
5.77%
249
$1,519.43
8.52%
8
$179.57
0.32%
11
$503.35
0.38%
00378018101
56
$300.03
2.27%
204
$1,542.04
6.98%
00378018105
71
$359.02
2.88%
110
$859.56
3.76%
00555027102
SULFINPYRAZ TAB 100MG
2
$21.40
0.08%
2
$200.98
0.07%
00591094401
58
$450.04
2.35%
91
$642.35
3.11%
00591094410
81
$646.33
3.29%
64
$411.22
2.19%
00591532501
42
$1,336.00
1.71%
45
$1,435.08
1.54%
00591534701
63
$2,153.30
2.56%
71
$2,124.20
2.43%
00591534710
0
$0.00
0.00%
6
$160.50
0.21%
00591554301
203
$1,390.13
8.24%
123
$706.92
4.21%
00591554310
45
$265.99
1.83%
99
$514.02
3.39%
00591554401
174
$970.82
7.06%
45
$333.33
1.54%
2
$18.77
0.08%
1
$5.23
0.04%
60
$511.14
2.44%
6
$51.30
0.24%
4
$184.20
1
39
2
7
0
Page 218 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
GOUT
00591554405
176
$943.34
7.15%
112
00603211521
0
$0.00
0.00%
00603211621
0
$0.00
0.00%
00603211732
2
$25.87
00603211828
0
00603305221
00603305232
00615159253
$853.86
3.83%
172
$877.09
5.88%
173
$1,361.57
5.92%
0.08%
0
$0.00
0.00%
$0.00
0.00%
2
$11.72
0.07%
150
$1,182.33
6.09%
162
$1,033.97
5.54%
18
$175.82
0.73%
39
$275.40
1.33%
110
$669.35
4.47%
0
$0.00
0.00%
00615159263
13
$72.09
0.53%
0
$0.00
0.00%
00615159353
21
$110.07
0.85%
0
$0.00
0.00%
00615159363
21
$108.24
0.85%
0
$0.00
0.00%
00677087001
8
$58.57
0.32%
13
$70.18
0.44%
00677087101
5
$34.23
0.20%
5
$56.88
0.17%
00677087105
11
$53.80
0.45%
10
$60.22
0.34%
00677168301
7
$62.21
0.28%
5
$30.50
0.17%
00677168310
14
$123.40
0.57%
12
$93.95
0.41%
00904204780
6
$42.85
0.24%
0
$0.00
0.00%
00904261360
7
$69.33
0.28%
19
$91.24
0.65%
00904261380
0
$0.00
0.00%
8
$34.60
0.27%
00904261440
0
$0.00
0.00%
5
$46.83
0.17%
00904261480
19
$100.43
0.77%
32
$225.10
1.09%
49884010401
12
$73.04
0.49%
10
$51.87
0.34%
49884010410
36
$211.77
1.46%
7
$46.66
0.24%
49884010501
9
$56.85
0.37%
7
$49.56
0.24%
49884010505
2
$17.40
0.08%
1
$15.89
0.03%
49884010510
2
$9.13
0.08%
9
$50.54
0.31%
49884060201
38
$257.26
1.54%
42
$219.31
1.44%
Page 219 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
GOUT
49884060210
29
$185.12
1.18%
40
$182.85
1.37%
49884060301
31
$178.71
1.26%
26
$235.26
0.89%
49884060305
22
$119.86
0.89%
63
$514.69
2.15%
49884060310
36
$191.28
1.46%
40
$326.08
1.37%
51079020620
2
$3.90
0.08%
4
$20.04
0.14%
53489015601
196
$1,306.00
7.96%
67
$320.85
2.29%
53489015605
1
$5.20
0.04%
4
$22.51
0.14%
53489015610
72
$387.12
2.92%
83
$401.41
2.84%
53489015701
195
$1,123.79
7.92%
79
$610.20
2.70%
53489015705
12
$65.54
0.49%
48
$317.98
1.64%
53489015710
14
$51.16
0.57%
38
$232.42
1.30%
59743008501
2
$13.20
0.08%
0
$0.00
0.00%
59743008510
14
$112.74
0.57%
13
$116.45
0.44%
64125010401
0
$0.00
0.00%
41
$303.50
1.40%
64125010410
0
$0.00
0.00%
76
$523.09
2.60%
64731018701
1
$23.85
0.04%
0
$0.00
0.00%
64731018710
2
$9.08
0.08%
4
$20.90
0.14%
65483099110
ZYLOPRIM
TAB 100MG
4
$40.58
0.16%
0
$0.00
0.00%
$19,409.38
13.61%
13
$9,852.17
8.61%
GROWTH HORMONE
00002733516
HUMATROPE
INJ 5MG
23
00002808901
HUMATROPE
INJ 6MG
4
$953.84
2.37%
5
$828.71
3.31%
00002809001
HUMATROPE
INJ 12MG
3
$6,258.60
1.78%
2
$5,273.06
1.32%
00002809101
HUMATROPE
INJ 24MG
4
$16,355.92
2.37%
2
$8,635.90
1.32%
00013262681
GENOTROPIN INJ 5.8MG
17
$17,011.29
10.06%
16
$21,839.07
10.60%
00013264681
39
$54,906.82
23.08%
46
$109,302.80
30.46%
00013264902
0
$0.00
0.00%
4
$729.31
2.65%
Page 220 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
GROWTH HORMONE
00013265202
4
$3,751.98
2.37%
2
$162.10
1.32%
00013265302
GENOTROPIN INJ 1MG
3
$3,514.86
1.78%
4
$4,807.40
2.65%
00013265402
0
$0.00
0.00%
3
$4,220.63
1.99%
00013265602
0
$0.00
0.00%
3
$5,621.01
1.99%
00169776811
NORDITROPIN INJ 5MG/1.5M
0
$0.00
0.00%
2
$18.00
1.32%
00169777011
NORDITROPIN INJ 15MG/1.5
5
$7,860.74
2.96%
3
$2,113.58
1.99%
44087108801
SAIZEN
8
$12,807.64
4.73%
5
$7,024.27
3.31%
50242001821
NUTROPIN
20
$45,213.87
11.83%
13
$32,548.95
8.61%
50242002220
NUTROPIN AQ INJ 5MG/ML
15
$24,245.66
8.88%
12
$25,528.69
7.95%
50242003235
NUTROPIN
KIT DEPOT
5
$4,559.64
2.96%
0
$0.00
0.00%
50242003441
NUTROPIN
KIT DEPOT
5
$6,801.11
2.96%
3
$4,669.10
1.99%
50242003654
NUTROPIN
KIT DEPOT
4
$7,523.77
2.37%
2
$3,859.00
1.32%
50242004314
NUTROPIN AQ INJ 5MG/ML
5
$12,545.34
2.96%
8
$16,493.26
5.30%
50242007203
NUTROPIN
INJ 5MG
5
$1,947.33
2.96%
3
$2,511.44
1.99%
INJ 8.8MG
INJ 10MG
H2-ANTAGONISTS
00002314403
AXID
CAP 150MG
1
$83.20
0.01%
0
$0.00
0.00%
00002314460
AXID
CAP 150MG
12
$1,635.69
0.08%
0
$0.00
0.00%
00002314530
AXID
CAP 300MG
1
$156.89
0.01%
0
$0.00
0.00%
00006096328
PEPCID
TAB 20MG
0
$0.00
0.00%
1
$109.21
0.01%
00006096331
PEPCID
TAB 20MG
13
$723.94
0.09%
9
$546.95
0.06%
00006096358
PEPCID
TAB 20MG
38
$4,001.41
0.25%
18
$1,723.15
0.11%
00006096431
PEPCID
TAB 40MG
4
$615.22
0.03%
4
$826.84
0.03%
00006096458
PEPCID
TAB 40MG
14
$2,373.90
0.09%
10
$2,476.20
0.06%
00006353892
PEPCID
SUS 40MG/5ML
281
$31,429.68
1.87%
169
$16,240.52
1.06%
00006353904
PEPCID I.V. INJ 20MG/2ML
2
$247.80
0.01%
1
$124.40
0.01%
00093011101
CIMETIDINE TAB 200MG
2
$26.98
0.01%
5
$92.24
0.03%
Page 221 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
H2-ANTAGONISTS
00093011201
00093011205
00093011301
00093011305
00093012201
00093012256
00093050687
CIMETIDINE SOL 300/5ML
00093089601
FAMOTIDINE TAB 20MG
00093089701
FAMOTIDINE TAB 40MG
00093854401
RANITIDINE TAB 150MG
00093854405
00093854406
00093854410
$631.14
0.41%
0
$0.00
0.00%
6
$42.94
0.04%
0.15%
5
$54.96
0.03%
$582.46
0.25%
32
$535.09
0.20%
3
$46.90
0.02%
0
$0.00
0.00%
13
$310.47
0.09%
7
$100.90
0.04%
717
$9,032.26
4.77%
911
$8,693.79
5.72%
123
$1,595.55
0.82%
164
$1,842.14
1.03%
1
$14.35
0.01%
4
$23.90
0.03%
532
$7,435.83
3.54%
523
$4,634.70
3.28%
253
$3,658.35
1.68%
203
$1,657.37
1.28%
138
$1,951.74
0.92%
680
$5,950.68
4.27%
00093854701
37
$528.44
0.25%
5
$71.75
0.03%
00093854752
53
$888.55
0.35%
19
$200.30
0.12%
00093854756
99
$1,606.56
0.66%
159
$1,556.81
1.00%
00108501320
TAGAMET
TAB 300MG
14
$794.38
0.09%
11
$663.29
0.07%
00108501325
TAGAMET
TAB 300MG
0
$0.00
0.00%
1
$9.75
0.01%
00108502618
TAGAMET
TAB 400MG
17
$1,947.60
0.11%
7
$941.64
0.04%
00172562360
NIZATIDINE CAP 150MG
4
$293.28
0.03%
1
$109.84
0.01%
00172562460
1
$216.99
0.01%
0
$0.00
0.00%
00172572810
FAMOTIDINE TAB 20MG
0
$0.00
0.00%
2
$9.90
0.01%
00172572860
FAMOTIDINE TAB 20MG
53
$646.48
0.35%
189
$1,856.36
1.19%
00172572864
FAMOTIDINE TAB 20MG
2
$20.50
0.01%
0
$0.00
0.00%
00172572870
FAMOTIDINE TAB 20MG
26
$254.30
0.17%
200
$1,939.56
1.26%
00172572880
FAMOTIDINE TAB 20MG
4
$59.00
0.03%
84
$766.75
0.53%
00172572960
FAMOTIDINE TAB 40MG
27
$390.45
0.18%
50
$543.07
0.31%
66
$769.81
0.44%
66
3
$54.33
0.02%
106
$1,203.31
0.71%
23
$299.92
38
Page 222 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
H2-ANTAGONISTS
00172572970
FAMOTIDINE TAB 40MG
0
$0.00
0.00%
6
$56.90
0.04%
00172711760
10
$118.18
0.07%
18
$137.05
0.11%
00172711770
0
$0.00
0.00%
5
$46.15
0.03%
00172717149
3
$28.80
0.02%
5
$41.75
0.03%
00172717160
17
$193.06
0.11%
10
$122.67
0.06%
00172717170
13
$153.99
0.09%
41
$476.33
0.26%
00172771160
0
$0.00
0.00%
2
$35.00
0.01%
00173034414
ZANTAC
TAB 150MG
2
$28.70
0.01%
3
$286.85
0.02%
00173034417
ZANTAC
TAB 150MG
1
$107.70
0.01%
0
$0.00
0.00%
00173034442
ZANTAC
TAB 150MG
00173038354
ZANTAC
SYP 75MG/5ML
00173039340
ZANTAC
00173045101
ZANTAC
00182266115
00182266117
72
$7,420.42
0.48%
29
$3,402.81
0.18%
611
$46,486.17
4.07%
733
$45,941.86
4.60%
TAB 300MG
11
$1,657.24
0.07%
7
$1,042.79
0.04%
GRA 150MG
6
$500.77
0.04%
0
$0.00
0.00%
RANITIDINE TAB 75MG
9
$124.57
0.06%
7
$87.16
0.04%
RANITIDINE TAB 75MG
13
$124.10
0.09%
1
$12.73
0.01%
00182266126
RANITIDINE TAB 75MG
7
$49.62
0.05%
4
$35.76
0.03%
00182266217
FAMOTIDINE TAB 10MG
0
$0.00
0.00%
1
$2.98
0.01%
00185015060
1
$91.35
0.01%
1
$58.27
0.01%
00228264111
FAMOTIDINE TAB 40MG
3
$43.05
0.02%
0
$0.00
0.00%
00228264196
FAMOTIDINE TAB 40MG
2
$40.70
0.01%
0
$0.00
0.00%
00364263305
1
$9.55
0.01%
0
$0.00
0.00%
00378005301
1
$9.78
0.01%
10
$86.81
0.06%
00378031701
6
$105.71
0.04%
11
$118.91
0.07%
00378031705
26
$298.69
0.17%
15
$127.68
0.09%
00378037201
21
$246.87
0.14%
20
$198.69
0.13%
00378037205
50
$575.49
0.33%
37
$432.49
0.23%
00378054101
18
$241.62
0.12%
16
$221.23
0.10%
Page 223 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
H2-ANTAGONISTS
00378302001
FAMOTIDINE TAB 20MG
363
$4,451.36
2.42%
438
$4,437.73
2.75%
00378302005
FAMOTIDINE TAB 20MG
9
$121.95
0.06%
99
$1,010.08
0.62%
00378304001
FAMOTIDINE TAB 40MG
8
$135.40
0.05%
11
$103.79
0.07%
00378325205
3
$43.05
0.02%
1
$10.55
0.01%
00378325291
0
$0.00
0.00%
2
$30.50
0.01%
00378325405
2
$25.78
0.01%
0
$0.00
0.00%
00378325493
0
$0.00
0.00%
3
$38.55
0.02%
00378515091
23
$1,983.68
0.15%
22
$1,988.29
0.14%
00378530093
9
$1,782.32
0.06%
0
$0.00
0.00%
00472051408
8
$44.82
0.05%
19
$576.46
0.12%
00472051416
7
$165.08
0.05%
9
$233.42
0.06%
00501520030
ZANTAC 75
4
$66.46
0.03%
2
$17.48
0.01%
00573240040
AXID AR
2
$94.56
0.01%
0
$0.00
0.00%
00591076005
64
$861.98
0.43%
47
$384.02
0.30%
00591076060
1
$14.35
0.01%
0
$0.00
0.00%
00591312301
FAMOTIDINE TAB 20MG
40
$503.64
0.27%
0
$0.00
0.00%
00591312310
FAMOTIDINE TAB 20MG
13
$138.97
0.09%
0
$0.00
0.00%
00591312401
FAMOTIDINE TAB 40MG
8
$145.80
0.05%
3
$20.75
0.02%
00591312405
FAMOTIDINE TAB 40MG
4
$45.40
0.03%
0
$0.00
0.00%
00591313760
20
$2,165.86
0.13%
9
$714.87
0.06%
00591313830
2
$500.30
0.01%
0
$0.00
0.00%
00615451353
86
$1,040.21
0.57%
0
$0.00
0.00%
00615451363
852
$10,394.77
5.67%
0
$0.00
0.00%
00615458253
FAMOTIDINE TAB 20MG
101
$1,168.46
0.67%
0
$0.00
0.00%
00615458263
FAMOTIDINE TAB 20MG
46
$437.22
0.31%
0
$0.00
0.00%
00781173601
FAMOTIDINE TAB 20MG
40
$539.30
0.27%
20
$223.30
0.13%
00781174601
FAMOTIDINE TAB 40MG
10
$195.70
0.07%
12
$124.26
0.08%
TAB
TAB 75MG
Page 224 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
H2-ANTAGONISTS
00781174610
FAMOTIDINE TAB 40MG
00781188301
00781188305
00781188310
00781188313
$11.35
0.01%
$0.00
0.00%
14
$215.30
0.09%
345
$4,716.78
2.30%
0
$0.00
0.00%
170
$1,512.58
1.07%
327
$3,580.69
2.18%
227
$1,493.70
1.43%
0
$0.00
0.00%
3
$24.15
0.02%
00781188360
13
00781188410
5
$213.05
0.09%
12
$123.00
0.08%
$113.74
0.03%
0
$0.00
0.00%
00781188425
6
$128.60
0.04%
3
$29.55
0.02%
00781188431
31
$486.02
0.21%
9
$105.15
0.06%
00781285505
RANITIDINE CAP 150MG
1,004
$12,123.40
6.68%
1,121
$9,664.85
7.04%
00781285560
448
$6,237.00
2.98%
573
$4,765.66
3.60%
00781286505
73
$1,280.15
0.49%
8
$74.80
0.05%
00781286531
98
$1,836.83
0.65%
177
$1,679.65
1.11%
00904526140
8
$123.30
0.05%
388
$3,273.58
2.44%
00904526152
86
$1,208.40
0.57%
3
$24.15
0.02%
00904526247
0
$0.00
0.00%
1
$21.35
0.01%
00904526270
0
$0.00
0.00%
11
$94.85
0.07%
00904539946
RANITIDINE TAB 75MG
3
$31.84
0.02%
0
$0.00
0.00%
00904539952
RANITIDINE TAB 75MG
0
$0.00
0.00%
2
$30.18
0.01%
00904544540
0
$0.00
0.00%
1
$13.98
0.01%
00904544560
4
$56.68
0.03%
0
$0.00
0.00%
00904544660
6
$46.23
0.04%
0
$0.00
0.00%
00904544760
0
$0.00
0.00%
2
$46.10
0.01%
00904555346
FAMOTIDINE TAB 20MG
0
$0.00
0.00%
5
$28.57
0.03%
00904555360
FAMOTIDINE TAB 20MG
2
$17.70
0.01%
3
$29.05
0.02%
16837087230
PEPCID AC
TAB 10MG
3
$55.90
0.02%
2
$39.26
0.01%
16837087361
PEPCID AC
CHW 10MG
1
$15.24
0.01%
0
$0.00
0.00%
1
0
Page 225 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
H2-ANTAGONISTS
17236044760
0
$0.00
0.00%
2
24385029665
RANITIDINE TAB 75MG
1
$10.13
0.01%
37205052965
RANITIDINE TAB 75MG
8
$81.92
0.05%
37205052972
RANITIDINE TAB 75MG
1
$10.66
49348034312
ACID REDUCER TAB 75MG
3
49884054401
49884054402
49884054405
$25.14
0.01%
0
$0.00
0.00%
4
$34.29
0.03%
0.01%
2
$21.32
0.01%
$34.56
0.02%
1
$11.52
0.01%
29
$479.35
0.19%
79
$723.65
0.50%
39
$512.80
0.26%
100
$795.25
0.63%
16
$212.00
0.11%
83
$687.37
0.52%
49884054410
202
$2,150.94
1.34%
318
$2,362.17
2.00%
49884054501
27
$351.83
0.18%
49
$462.15
0.31%
49884054511
25
$313.70
0.17%
36
$314.73
0.23%
49884060801
FAMOTIDINE TAB 20MG
262
$3,099.19
1.74%
302
$2,919.48
1.90%
49884060810
FAMOTIDINE TAB 20MG
135
$1,449.63
0.90%
261
$2,270.52
1.64%
49884060811
FAMOTIDINE TAB 20MG
10
$135.10
0.07%
12
$111.40
0.08%
49884060901
FAMOTIDINE TAB 40MG
92
$1,249.03
0.61%
152
$1,680.71
0.95%
49884060910
FAMOTIDINE TAB 40MG
2
$22.70
0.01%
19
$221.05
0.12%
49884060911
FAMOTIDINE TAB 40MG
8
$90.00
0.05%
2
$12.15
0.01%
49884064702
1
$3.90
0.01%
0
$0.00
0.00%
49884064705
2
$23.20
0.01%
6
$49.70
0.04%
49884064801
0
$0.00
0.00%
4
$53.90
0.03%
49884076601
14
$1,430.06
0.09%
4
$578.32
0.03%
49884076701
1
$141.23
0.01%
1
$135.85
0.01%
50111055102
1
$11.57
0.01%
0
$0.00
0.00%
50111055103
1
$20.79
0.01%
0
$0.00
0.00%
50111055104
1
$9.81
0.01%
0
$0.00
0.00%
50383005008
0
$0.00
0.00%
1
$51.19
0.01%
50428536722
0
$0.00
0.00%
1
$5.80
0.01%
Page 226 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
H2-ANTAGONISTS
50428695189
CVS RANITID TAB 75MG
0
$0.00
0.00%
1
50428697847
CVS RANITID TAB 75MG
0
$0.00
0.00%
50962020360
RANITIDINE SYP 75MG/5ML
0
$0.00
0.00%
51079087920
12
$99.40
52544076005
86
52544076060
52544076101
52544076130
$13.63
0.01%
1
$15.85
0.01%
5
$149.11
0.03%
0.08%
2
$12.22
0.01%
$1,265.90
0.57%
0
$0.00
0.00%
12
$163.20
0.08%
0
$0.00
0.00%
6
$96.42
0.04%
0
$0.00
0.00%
2
$25.05
0.01%
0
$0.00
0.00%
55370013507
0
$0.00
0.00%
3
$49.83
0.02%
55370013508
0
$0.00
0.00%
5
$47.59
0.03%
55370013607
0
$0.00
0.00%
4
$46.25
0.03%
55370013608
16
$160.15
0.11%
0
$0.00
0.00%
55370013725
1
$29.10
0.01%
0
$0.00
0.00%
55390002910
FAMOTIDINE INJ 10MG/ML
0
$0.00
0.00%
1
$42.24
0.01%
55953019240
1
$10.23
0.01%
0
$0.00
0.00%
55953020440
11
$119.93
0.07%
0
$0.00
0.00%
55953030540
3
$32.04
0.02%
0
$0.00
0.00%
55953054435
2
$30.70
0.01%
0
$0.00
0.00%
55953054440
8
$117.80
0.05%
0
$0.00
0.00%
55953054480
17
$229.65
0.11%
0
$0.00
0.00%
55953054740
2
$20.51
0.01%
0
$0.00
0.00%
58437000218
175
$1,989.60
1.16%
161
$1,555.19
1.01%
59911595102
FAMOTIDINE INJ 10MG/ML
6
$217.53
0.04%
0
$0.00
0.00%
60432000708
7
$184.63
0.05%
17
$307.24
0.11%
60505001904
5
$51.15
0.03%
2
$27.96
0.01%
60505001906
6
$124.48
0.04%
7
$84.74
0.04%
60505002004
42
$553.68
0.28%
42
$512.07
0.26%
Page 227 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
H2-ANTAGONISTS
60505002006
11
$117.13
0.07%
15
$162.46
0.09%
60505002008
27
$338.55
0.18%
40
$461.08
0.25%
60505002103
8
$87.28
0.05%
15
$144.69
0.09%
60505002504
192
$2,571.48
1.28%
117
$1,023.15
0.73%
60505002506
5
$113.75
0.03%
13
$132.45
0.08%
60505002508
2,733
$38,736.33
18.19%
2,804
$24,167.52
17.61%
60505002602
232
$3,540.76
1.54%
236
$2,556.15
1.48%
60505002603
83
$1,400.97
0.55%
98
$1,010.66
0.62%
60505002607
142
$2,383.79
0.94%
173
$1,753.90
1.09%
60505016000
RANITIDINE TAB 75MG
1
$9.29
0.01%
1
$9.99
0.01%
60505035302
2
$51.13
0.01%
16
$526.32
0.10%
60951063070
3
$29.34
0.02%
3
$24.84
0.02%
60951063170
4
$45.26
0.03%
0
$0.00
0.00%
60951063270
28
$355.09
0.19%
1
$12.57
0.01%
60951063330
0
$0.00
0.00%
2
$35.01
0.01%
60951063535
8
$271.10
0.05%
6
$275.09
0.04%
62037095501
FAMOTIDINE TAB 20MG
45
$442.20
0.30%
70
$540.79
0.44%
62037095510
FAMOTIDINE TAB 20MG
68
$859.14
0.45%
93
$870.78
0.58%
62037095601
FAMOTIDINE TAB 40MG
12
$140.80
0.08%
25
$339.15
0.16%
62037095610
FAMOTIDINE TAB 40MG
2
$22.70
0.01%
2
$17.30
0.01%
63304074505
18
$243.45
0.12%
0
$0.00
0.00%
63304074560
35
$556.25
0.23%
12
$101.48
0.08%
63304074630
14
$236.70
0.09%
0
$0.00
0.00%
63304077001
4
$34.60
0.03%
3
$21.21
0.02%
63304077005
20
$243.90
0.13%
3
$32.75
0.02%
63304077060
25
$239.55
0.17%
4
$30.96
0.03%
63304077101
7
$77.51
0.05%
1
$6.00
0.01%
Page 228 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
H2-ANTAGONISTS
63304077104
3
$38.67
0.02%
63304077130
4
$54.97
0.03%
63304083805
5
$60.85
0.03%
63304083860
1,865
$26,754.27
12.41%
63304083930
224
$3,568.32
65726014415
AXID
CAP 150MG
27
65726014510
AXID
CAP 300MG
7
66685170200
66685170201
66685170301
66685170302
66685170303
66685170401
67253034110
0
$0.00
0.00%
0
$0.00
0.00%
47
$489.39
0.30%
2,030
$17,307.70
12.75%
1.49%
282
$2,917.73
1.77%
$4,486.70
0.18%
9
$1,290.34
0.06%
$2,054.98
0.05%
1
$313.93
0.01%
3
$46.44
0.02%
15
$225.71
0.09%
3
$46.44
0.02%
2
$21.40
0.01%
8
$82.04
0.05%
100
$1,020.89
0.63%
19
$213.26
0.13%
27
$335.50
0.17%
0
$0.00
0.00%
3
$30.21
0.02%
2
$38.00
0.01%
15
$300.81
0.09%
0
$0.00
0.00%
1
$14.68
0.01%
00517912005
AMINOCAPR AC INJ 250MG/ML
1
$15.04
14.29%
0
$0.00
0.00%
52604710201
THROMBIN-JMI SOL 5000U
0
$0.00
0.00%
1
$290.65
16.67%
58406061261
AMICAR
1
$751.87
14.29%
0
$0.00
0.00%
61748004416
AMINOCAPR AC SYP 25%
2
$613.51
28.57%
4
$1,562.40
66.67%
66479002182
AMICAR
TAB 500MG
1
$359.77
14.29%
0
$0.00
0.00%
66479002356
AMICAR
SYP 25%
2
$896.42
28.57%
1
$157.13
16.67%
HEPSERA
TAB 10MG
3
$1,379.13
100.00%
21
$9,806.55
100.00%
HEMOSTATIC
TAB 500MG
HEPATITIS B
61958050101
HEPATITIS C
Page 229 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
HEPATITIS C
00004008694
COPEGUS
TAB 200MG
0
$0.00
0.00%
12
$10,760.21
2.23%
00004035009
PEGASYS
INJ 180MCG/M
6
$7,597.20
1.11%
13
$14,331.82
2.41%
00004035039
PEGASYS
KIT 180MCG/M
0
$0.00
0.00%
41
$52,031.93
7.61%
00085119403
REBETOL
CAP 200MG
126
$182,935.29
23.25%
114
$150,709.41
21.15%
00085125801
REBETRON
KIT 1200/PEN
1
$773.57
0.18%
0
$0.00
0.00%
00085125802
REBETRON
KIT 1000/PEN
1
$2,099.63
0.18%
0
$0.00
0.00%
00085127901
PEG-INTRON KIT 150MCG
122
$152,427.99
22.51%
114
$152,376.30
21.15%
00085129101
28
$32,963.00
5.17%
39
$49,172.60
7.24%
00085130401
123
$142,881.10
22.69%
72
$96,470.36
13.36%
00085132704
REBETOL
CAP 200MG
7
$5,534.83
1.29%
8
$11,530.29
1.48%
00085135105
REBETOL
CAP 200MG
36
$47,238.54
6.64%
35
$51,781.21
6.49%
00085136801
10
$11,212.20
1.85%
6
$7,350.26
1.11%
00085138507
REBETOL
CAP 200MG
82
$105,320.46
15.13%
84
$108,492.29
15.58%
64116003106
INFERGEN
INJ 15MCG
0
$0.00
0.00%
1
$1,828.89
0.19%
$0.00
0.00%
HERPES AGENTS
00007411513
FAMVIR
TAB 125MG
11
$525.96
0.60%
0
00007411613
FAMVIR
TAB 250MG
6
$571.42
0.33%
0
$0.00
0.00%
00007411713
FAMVIR
TAB 500MG
7
$704.68
0.38%
2
$231.32
0.08%
00078036615
FAMVIR
TAB 125MG
40
$2,464.22
2.20%
23
$1,306.81
0.91%
00078036715
FAMVIR
TAB 250MG
82
$10,883.32
4.50%
47
$5,536.98
1.85%
00078036815
FAMVIR
TAB 500MG
136
$20,054.48
7.47%
98
$14,921.39
3.87%
00078036864
FAMVIR
TAB 500MG
1
$149.36
0.05%
0
$0.00
0.00%
00093894001
ACYCLOVIR
CAP 200MG
36
$357.77
1.98%
126
$1,094.62
4.97%
00093894301
ACYCLOVIR
TAB 400MG
61
$854.25
3.35%
227
$2,699.15
8.95%
00093894305
ACYCLOVIR
TAB 400MG
0
$0.00
0.00%
2
$48.20
0.08%
00093894701
ACYCLOVIR
TAB 800MG
30
$466.66
1.65%
56
$631.94
2.21%
Page 230 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
HERPES AGENTS
00172426660
ACYCLOVIR
CAP 200MG
00172426670
ACYCLOVIR
CAP 200MG
00172426760
ACYCLOVIR
TAB 400MG
00172426770
ACYCLOVIR
TAB 400MG
00172426860
ACYCLOVIR
TAB 800MG
00173056500
VALTREX
TAB 1GM
00173056502
VALTREX
TAB 1GM
00173093303
VALTREX
TAB 500MG
00173093308
VALTREX
00173093356
00173094955
$221.73
1.21%
0
$0.00
0.00%
39
$481.36
2.14%
7
$114.25
0.38%
17
$269.95
0.93%
22
$2,087.17
1.21%
2
$173.71
0.08%
162
$19,097.40
8.90%
429
$57,272.32
16.92%
654
$54,661.71
35.91%
177
$19,838.63
6.98%
TAB 500MG
0
$0.00
0.00%
879
$80,939.96
34.67%
VALTREX
TAB 500MG
2
$215.64
0.11%
12
$1,155.74
0.47%
ZOVIRAX
TAB 400MG
1
$39.74
0.05%
0
$0.00
0.00%
00173095396
ZOVIRAX
SUS 200/5ML
3
$108.27
0.16%
2
$51.27
0.08%
00173099155
ZOVIRAX
CAP 200MG
3
$376.03
0.16%
1
$167.03
0.04%
00228260511
ACYCLOVIR
CAP 200MG
74
$856.08
4.06%
7
$44.36
0.28%
00228260611
ACYCLOVIR
TAB 400MG
118
$1,643.57
6.48%
11
$81.52
0.43%
00228260711
ACYCLOVIR
TAB 800MG
15
$244.66
0.82%
5
$37.35
0.20%
00364269001
ACYCLOVIR
TAB 800MG
1
$1.00
0.05%
1
$11.47
0.04%
00364269201
ACYCLOVIR
CAP 200MG
17
$187.15
0.93%
2
$19.12
0.08%
00378025301
ACYCLOVIR
TAB 400MG
16
$182.84
0.88%
0
$0.00
0.00%
00378146801
ACYCLOVIR
TAB 800MG
4
$47.35
0.22%
0
$0.00
0.00%
00378220001
ACYCLOVIR
CAP 200MG
15
$139.25
0.82%
3
$42.56
0.12%
00472008216
ACYCLOVIR
SUS 200/5ML
53
$2,540.40
2.91%
36
$2,042.79
1.42%
00591033601
ACYCLOVIR
TAB 800MG
0
$0.00
0.00%
12
$409.21
0.47%
00591269201
ACYCLOVIR
CAP 200MG
0
$0.00
0.00%
28
$236.09
1.10%
49884056501
ACYCLOVIR
CAP 200MG
0
$0.00
0.00%
1
$4.55
0.04%
49884056701
ACYCLOVIR
TAB 800MG
0
$0.00
0.00%
5
$65.80
0.20%
51079087720
ACYCLOVIR
TAB 400MG
3
$39.60
0.16%
0
$0.00
0.00%
22
22
$134.17
0.87%
1
$10.74
0.04%
54
$687.98
2.13%
6
$81.70
0.24%
23
$297.03
0.91%
Page 231 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
HERPES AGENTS
52544033501
ACYCLOVIR
TAB 400MG
52544033601
ACYCLOVIR
55370055507
ACYCLOVIR
55370055607
37
$435.93
2.03%
37
$452.94
1.46%
TAB 800MG
5
$113.65
0.27%
TAB 400MG
17
$196.03
0.93%
3
$27.49
0.12%
8
$105.00
0.32%
ACYCLOVIR
TAB 800MG
2
$26.65
0.11%
5
$141.20
0.20%
55370055707
ACYCLOVIR
CAP 200MG
5
$60.80
0.27%
0
$0.00
0.00%
55390061210
ACYCLOVIR NA INJ 500MG
55953094340
ACYCLOVIR
TAB 400MG
1
$99.05
0.05%
0
$0.00
0.00%
5
$96.07
0.27%
0
$0.00
0.00%
63304050401
ACYCLOVIR
TAB 400MG
55
$734.16
3.02%
109
$1,222.76
4.30%
63304050501
ACYCLOVIR
TAB 800MG
0
$0.00
0.00%
5
$55.04
0.20%
63304065201
ACYCLOVIR
CAP 200MG
36
$440.29
1.98%
67
$594.57
2.64%
63323032510
ACYCLOVIR NA INJ 50MG/ML
0
$0.00
0.00%
1
$261.35
0.04%
HYDRO-LYTIC ENZYMES
50242010039
PULMOZYME
SOL 1MG/ML
1
$1,144.88
1.23%
0
$0.00
0.00%
50242010040
PULMOZYME
SOL 1MG/ML
80
$85,769.12
98.77%
95
$84,226.86
100.00%
IMMUNOMODULATORS
00078037540
ELIDEL
CRE 1%
177
$5,514.38
20.85%
97
$3,149.70
12.33%
00078037546
ELIDEL
CRE 1%
439
$22,378.74
51.71%
421
$22,492.10
53.49%
00078037549
ELIDEL
CRE 1%
0
$0.00
0.00%
52
$4,751.32
6.61%
00078037563
ELIDEL
CRE 1%
88
$14,382.15
10.37%
94
$11,674.09
11.94%
00469520130
PROTOPIC
OIN 0.03%
49
$2,933.22
5.77%
30
$1,952.13
3.81%
00469520160
PROTOPIC
OIN 0.03%
15
$1,710.81
1.77%
7
$604.62
0.89%
00469520211
PROTOPIC
OIN 0.1%
0
$0.00
0.00%
1
$26.00
0.13%
00469520230
PROTOPIC
OIN 0.1%
53
$3,680.17
6.24%
54
$4,326.18
6.86%
00469520260
PROTOPIC
OIN 0.1%
28
$3,369.86
3.30%
31
$4,042.68
3.94%
Page 232 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
IMMUNOSUPPRESSANTS
00004025901
CELLCEPT
CAP 250MG
00004025943
CELLCEPT
CAP 250MG
7
$1,157.09
00004026001
CELLCEPT
TAB 500MG
163
$86,731.56
00004026043
CELLCEPT
TAB 500MG
1
$613.13
00004026129
CELLCEPT
SUS 200MG/ML
11
00008103006
RAPAMUNE
SOL 1MG/ML
00008103007
RAPAMUNE
SOL 1MG/ML
00008103105
RAPAMUNE
00008103110
RAPAMUNE
00008103205
RAPAMUNE
TAB 2MG
00074646332
GENGRAF
CAP 25MG
00074647932
GENGRAF
CAP 100MG
00078010901
SANDIMMUNE INJ 50MG/ML
00078011022
SANDIMMUNE SOL 100MG/ML
00078024015
SANDIMMUNE CAP 25MG
00078024115
SANDIMMUNE CAP 100MG
00078024615
NEORAL
00078024815
00078027422
00185093230
35
$11,334.62
0.68%
33
$13,476.03
3.83%
15.72%
115
$59,603.22
13.34%
0.10%
47
$20,812.60
5.45%
$5,434.80
1.06%
8
$3,936.56
0.93%
2
$1,566.70
0.19%
0
$0.00
0.00%
2
$1,430.98
0.19%
0
$0.00
0.00%
TAB 1MG
49
$31,384.85
4.73%
20
$7,584.05
2.32%
TAB 1MG
0
$0.00
0.00%
11
$9,187.56
1.28%
0
$0.00
0.00%
16
$15,967.24
1.86%
10
$2,459.38
0.96%
19
$2,711.58
2.20%
11
$3,503.65
1.06%
20
$6,848.90
2.32%
2
$152.90
0.19%
0
$0.00
0.00%
4
$898.75
0.39%
1
$589.10
0.12%
18
$4,004.96
1.74%
26
$5,268.68
3.02%
20
$6,061.31
1.93%
26
$15,335.89
3.02%
CAP 25MG
202
$36,454.79
19.48%
136
$26,520.17
15.78%
NEORAL
CAP 100MG
192
$58,744.88
18.51%
146
$44,385.43
16.94%
NEORAL
SOL 100MG/ML
14
$3,808.77
1.35%
20
$5,292.82
2.32%
CYCLOSPORINE CAP MOD 25MG
17
$3,059.72
1.64%
10
$2,542.04
1.16%
00185093330
CYCLOSPORINE CAP MD 100MG
19
$6,859.08
1.83%
11
$2,592.43
1.28%
00469060767
PROGRAF
CAP 0.5MG
2
$89.60
0.19%
0
$0.00
0.00%
00469060773
PROGRAF
CAP 0.5MG
17
$1,610.89
1.64%
4
$420.68
0.46%
00469061710
PROGRAF
CAP 1MG
6
$844.28
0.58%
1
$260.47
0.12%
00469061711
PROGRAF
CAP 1MG
1
$577.29
0.10%
0
$0.00
0.00%
00469061771
PROGRAF
CAP 1MG
25
$10,901.42
2.41%
3
$1,283.13
0.35%
00469061773
PROGRAF
CAP 1MG
117
$48,142.24
11.28%
105
$45,362.86
12.18%
77
$33,450.75
7.43%
Page 233 of 522
4.06%
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
IMMUNOSUPPRESSANTS
00469065710
PROGRAF
CAP 5MG
00469065711
PROGRAF
CAP 5MG
00469065773
PROGRAF
CAP 5MG
50111088542
CYCLOSPORINE SOL MODIFIED
50111090943
3
$2,506.20
0.29%
0
$0.00
0.00%
34
$22,478.21
3.28%
1
$1,045.71
0.10%
CYCLOSPORINE CAP MOD 25MG
3
$400.90
50111092043
CYCLOSPORINE CAP MD 100MG
5
60505013300
CYCLOSPORINE CAP 25MG
1
60505013400
CYCLOSPORINE CAP 100MG
0
$0.00
0.00%
3
$2,701.23
0.35%
27
$17,165.85
3.13%
0
$0.00
0.00%
0.29%
6
$866.58
0.70%
$1,458.75
0.48%
10
$2,767.30
1.16%
$84.81
0.10%
2
$169.62
0.23%
1
$328.68
0.10%
1
$328.68
0.12%
IMPOTENCE AGENTS
00009370101
CAVERJECT
KIT 20MCG
9
$1,630.15
1.17%
0
$0.00
0.00%
00009377805
CAVERJECT
INJ 10MCG
4
$413.26
0.52%
0
$0.00
0.00%
00009377808
CAVERJECT
KIT 10MCG
2
$255.28
0.26%
0
$0.00
0.00%
00009377813
CAVERJECT
KIT 10MCG
0
$0.00
0.00%
1
$135.66
0.13%
00009518101
CAVERJECT
KIT 10MCG
0
$0.00
0.00%
5
$346.27
0.63%
00009518201
CAVERJECT
KIT 20MCG
0
$0.00
0.00%
10
$1,069.06
1.26%
00009768604
CAVERJECT
INJ 40MCG
4
$749.92
0.52%
3
$387.51
0.38%
00026872069
LEVITRA
TAB 5MG
0
$0.00
0.00%
2
$202.67
0.25%
00026873069
LEVITRA
TAB 10MG
0
$0.00
0.00%
23
$1,545.43
2.89%
00026874069
LEVITRA
TAB 20MG
0
$0.00
0.00%
6
$409.54
0.75%
00069420030
VIAGRA
TAB 25MG
9
$292.84
1.17%
3
$108.27
0.38%
00069421030
VIAGRA
TAB 50MG
272
$9,240.28
35.32%
253
$9,123.67
31.82%
00069421066
VIAGRA
TAB 50MG
3
$104.16
0.39%
2
$38.67
0.25%
00069422030
VIAGRA
TAB 100MG
442
$15,114.22
57.40%
477
$17,472.71
60.00%
00069422066
VIAGRA
TAB 100MG
6
$210.32
0.78%
2
$72.18
0.25%
00091111011
EDEX
KIT 10MCG SP
1
$38.04
0.13%
0
$0.00
0.00%
00091144044
EDEX
KIT 40MCG
0
$0.00
0.00%
1
$17.50
0.13%
Page 234 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
IMPOTENCE AGENTS
62541011001
MUSE
SUP 125MCG
1
$56.14
0.13%
0
62541011006
MUSE
SUP 125MCG
2
$223.86
0.26%
62541012006
MUSE
SUP 250MCG
0
$0.00
0.00%
62541013006
MUSE
SUP 500MCG
1
$125.30
62541014001
MUSE
SUP 1000MCG
2
62541014006
MUSE
SUP 1000MCG
$0.00
0.00%
1
$75.23
0.13%
2
$159.92
0.25%
0.13%
2
$209.95
0.25%
$270.16
0.26%
0
$0.00
0.00%
12
$1,576.19
1.56%
2
$181.36
0.25%
40
$2,109.26
3.89%
INFLAMMATORY BOWEL AGENTS
00013010201
AZULFIDINE TAB 500MG EN
23
$1,358.17
2.60%
00013010501
DIPENTUM
12
$1,367.77
1.36%
5
$753.10
0.49%
00032192482
ROWASA
37
$7,302.79
4.18%
27
$7,459.03
2.62%
00149075202
ASACOL
450
$67,683.88
50.85%
551
$95,402.47
53.55%
00591079601
SULFASALAZIN TAB 500MG
7
$173.56
0.79%
16
$287.75
1.55%
00591079605
32
$789.88
3.62%
43
$1,051.39
4.18%
00591079610
4
$116.05
0.45%
0
$0.00
0.00%
00603580228
2
$25.78
0.23%
0
$0.00
0.00%
00603580321
SULFAZINE EC TAB 500MG
18
$855.05
2.03%
3
$162.97
0.29%
00603580325
SULFAZINE EC TAB 500MG
0
$0.00
0.00%
1
$58.59
0.10%
00677048301
1
$64.60
0.11%
1
$57.19
0.10%
00677048305
3
$38.67
0.34%
6
$68.94
0.58%
52544079605
12
$354.38
1.36%
0
$0.00
0.00%
52544079610
2
$46.86
0.23%
3
$58.05
0.29%
53014072671
DIPENTUM
0
$0.00
0.00%
8
$1,256.53
0.78%
53489014701
13
$288.47
1.47%
4
$60.94
0.39%
53489014705
16
$421.78
1.81%
28
$549.98
2.72%
54092018980
PENTASA
CAP 250MG CR
4
$329.58
0.45%
2
$50.00
0.19%
54092018981
PENTASA
CAP 250MG CR
98
$14,370.67
11.07%
127
$18,967.45
12.34%
CAP 250MG
ENE 4GM
TAB 400MG EC
CAP 250MG
Page 235 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
CANASA
59762500001
59762500002
65649010102
SUP 500MG
$
Market Share*
INFLAMMATORY BOWEL AGENTS
58914050056
# of Scripts
22
$3,074.91
2.49%
34
$3,797.20
3.30%
65
$1,954.80
7.34%
68
$1,635.95
6.61%
49
$1,105.37
5.54%
33
$669.88
3.21%
COLAZAL
15
$1,235.89
1.69%
29
$4,985.07
2.82%
CAP 750MG
INFLUENZA AGENTS
00004080085
TAMIFLU
CAP 75MG
9
$580.23
32.14%
219
$12,975.48
29.40%
00004081095
TAMIFLU
SUS 12MG/ML
1
$33.67
3.57%
33
$1,310.78
4.43%
00115191101
RIMANTADINE TAB 100MG
0
$0.00
0.00%
34
$468.60
4.56%
00173068101
RELENZA
MIS DISKHALE
1
$47.05
3.57%
0
$0.00
0.00%
00258371101
0
$0.00
0.00%
253
$4,145.74
33.96%
00456052101
FLUMADINE
TAB 100MG
2
$49.64
7.14%
86
$2,178.24
11.54%
00456052708
FLUMADINE
SYP 50MG/5ML
0
$0.00
0.00%
3
$36.43
0.40%
00781502901
15
$329.10
53.57%
117
$1,826.54
15.70%
421
$21,794.18
31.46%
913
$49,025.50
52.90%
INJECTIBLES
00009074630
DEPO-PROVERA INJ 150MG/ML
00009074635
2
$104.32
0.15%
76
$4,055.07
4.40%
00009348404
LUNELLE
INJ
27
$746.84
2.02%
0
$0.00
0.00%
00009348406
LUNELLE
INJ
87
$2,505.08
6.50%
0
$0.00
0.00%
00009737601
699
$36,435.18
52.24%
127
$6,383.26
7.36%
00009737602
92
$4,852.59
6.88%
10
$521.60
0.58%
00009737603
10
$521.60
0.75%
3
$156.48
0.17%
00009737604
0
$0.00
0.00%
597
$32,244.64
34.59%
5
$569.00
13.16%
18
$1,523.38
9.68%
IRRITABLE BOWEL SYNDROME AGENTS
00078035580
ZELNORM
TAB 2MG
Page 236 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
ZELNORM
00173069005
LOTRONEX
TAB 6MG
TAB 1MG
$
Market Share*
IRRITABLE BOWEL SYNDROME AGENTS
00078035680
# of Scripts
32
$3,960.97
84.21%
164
$19,992.20
88.17%
1
$150.77
2.63%
4
$1,196.72
2.15%
ISOSORBIDE DI-NITRATE
00008415401
ISORDIL
TAB 20MG
2
$130.16
0.07%
0
$0.00
0.00%
00008419201
ISORDIL
TAB 40MG
21
$1,575.71
0.78%
2
$19.20
0.06%
00091092001
DILATRATE SR CAP 40MG
6
$269.13
0.22%
1
$14.66
0.03%
00143176510
ISOSORB DIN SUB 2.5MG
5
$17.68
0.19%
0
$0.00
0.00%
00143176701
ISOSORB DIN SUB 5MG
2
$7.12
0.07%
1
$4.81
0.03%
00143176901
ISOSORB DIN TAB 5MG
27
$115.97
1.00%
13
$31.10
0.42%
00143176910
ISOSORB DIN TAB 5MG
10
$40.79
0.37%
25
$84.21
0.80%
00143177101
ISOSORB DIN TAB 10MG
4
$16.90
0.15%
16
$45.74
0.51%
00143177110
113
$486.27
4.18%
158
$546.30
5.08%
00143177201
11
$53.90
0.41%
9
$35.51
0.29%
00143177210
178
$923.75
6.59%
203
$821.17
6.53%
00182268701
ISOSORB MONO TAB 60MG ER
0
$0.00
0.00%
26
$195.25
0.84%
00228271111
46
$509.21
1.70%
31
$240.14
1.00%
00228271150
139
$1,372.01
5.14%
295
$2,334.49
9.49%
00258361301
ISOSORB DIN TAB 40MG ER
319
$12,560.37
11.81%
302
$11,188.03
9.72%
00603411732
3
$12.87
0.11%
0
$0.00
0.00%
00603411832
1
$4.60
0.04%
0
$0.00
0.00%
00603412221
ISOSORB DIN SUB 2.5MG
3
$45.18
0.11%
0
$0.00
0.00%
00603412332
ISOSORB DIN SUB 5MG
1
$7.86
0.04%
0
$0.00
0.00%
00615156053
25
$116.69
0.93%
0
$0.00
0.00%
00615156063
18
$89.63
0.67%
0
$0.00
0.00%
00615156463
ISOSORB DIN TAB 5MG
2
$7.55
0.07%
0
$0.00
0.00%
00615157553
5
$24.93
0.19%
0
$0.00
0.00%
Page 237 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ISOSORBIDE DI-NITRATE
00615157563
43
$197.90
1.59%
0
$0.00
0.00%
00677068910
6
$29.64
0.22%
8
$34.52
0.26%
00781141710
ISOSORB DIN TAB 40MG TD
2
$10.52
0.07%
0
$0.00
0.00%
00781155601
18
$78.78
0.67%
15
$47.11
0.48%
00781155605
1
$5.73
0.04%
0
$0.00
0.00%
00781155610
18
$75.06
0.67%
11
$47.79
0.35%
00781163501
ISOSORB DIN TAB 5MG
6
$23.57
0.22%
4
$11.60
0.13%
00781169501
33
$163.42
1.22%
29
$100.68
0.93%
00781169510
29
$129.12
1.07%
23
$74.56
0.74%
00904214960
ISOSORB DIN TAB 40MG CR
1
$4.79
0.04%
0
$0.00
0.00%
00904215060
ISOSORB DIN TAB 5MG
0
$0.00
0.00%
1
$4.90
0.03%
00904215160
1
$4.31
0.04%
0
$0.00
0.00%
49884000901
26
$179.11
0.96%
39
$197.30
1.25%
49884000910
9
$53.15
0.33%
23
$180.05
0.74%
49884002001
ISOSORB DIN TAB 5MG
9
$38.35
0.33%
7
$17.90
0.23%
49884002101
12
$51.38
0.44%
11
$33.01
0.35%
49884002110
20
$89.50
0.74%
31
$80.94
1.00%
49884002201
10
$46.22
0.37%
4
$20.66
0.13%
49884002210
50
$248.01
1.85%
35
$132.25
1.13%
58177023804
368
$4,223.64
13.62%
479
$3,524.18
15.41%
59930154901
857
$9,432.56
31.72%
1,062
$7,731.74
34.17%
62175011937
242
$2,659.48
8.96%
244
$1,827.49
7.85%
17
$1,116.03
0.64%
0
$0.00
0.00%
ISOSORBIDE MONONITRATE
00008077101
ISMO
TAB 20MG
00085115303
IMDUR
TAB 120MG ER
16
$1,015.90
0.60%
3
$232.23
0.09%
00085330603
IMDUR
TAB 30MG ER
13
$546.49
0.49%
4
$204.48
0.13%
Page 238 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
IMDUR
TAB 60MG ER
00091362001
MONOKET
00093007601
ISOSORB MONO TAB 20MG
00093007605
$
Market Share*
ISOSORBIDE MONONITRATE
00085411003
# of Scripts
17
$1,012.53
0.64%
7
$376.57
0.22%
4
$132.20
0.15%
1
$15.70
0.03%
6
$190.30
0.22%
0
$0.00
0.00%
3
$51.60
0.11%
0
$0.00
0.00%
00172502660
0
$0.00
0.00%
9
$107.15
0.28%
00172502760
0
$0.00
0.00%
7
$281.38
0.22%
00182268789
0
$0.00
0.00%
1
$5.95
0.03%
00228262011
89
$3,229.11
3.33%
117
$4,288.06
3.69%
00228263111
1
$74.67
0.04%
2
$143.66
0.06%
00228271311
201
$2,847.78
7.51%
270
$3,378.05
8.51%
00228271350
178
$2,330.75
6.65%
417
$5,425.93
13.14%
00615454453
82
$776.91
3.07%
0
$0.00
0.00%
00615454463
71
$724.90
2.65%
0
$0.00
0.00%
00615454653
78
$1,120.58
2.92%
0
$0.00
0.00%
00615454663
145
$1,863.74
5.42%
0
$0.00
0.00%
58177020104
148
$4,053.30
5.53%
246
$6,249.14
7.75%
58177022204
131
$1,776.09
4.90%
187
$2,067.65
5.89%
58177022211
3
$3.00
0.11%
0
$0.00
0.00%
59930150201
748
$10,930.92
27.96%
973
$11,956.94
30.66%
59930158701
360
$9,839.49
13.46%
453
$11,316.08
14.28%
62175010601
5
$197.28
0.19%
8
$281.75
0.25%
62175010701
95
$3,478.93
3.55%
119
$4,148.49
3.75%
62175012837
182
$2,573.33
6.80%
278
$3,464.32
8.76%
62175012937
82
$2,249.53
3.07%
71
$2,013.25
2.24%
1
$51.99
2.04%
1
$51.99
0.40%
TAB 20MG
ISRADIPINES
00078022605
DYNACIRC
CAP 2.5MG
Page 239 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
ISRADIPINES
00078022644
DYNACIRC
CAP 2.5MG
00078022705
DYNACIRC
CAP 5MG
65726022615
DYNACIRC
CAP 2.5MG
65726022625
DYNACIRC
65726022715
2
$105.64
4.08%
0
$0.00
0.00%
11
$402.65
22.45%
3
$211.44
6.12%
0
$0.00
0.00%
1
$73.08
0.40%
CAP 2.5MG
8
$539.04
16.33%
1
$71.88
0.40%
DYNACIRC
CAP 5MG
0
$0.00
0.00%
9
$433.33
3.63%
65726022725
DYNACIRC
CAP 5MG
65726023510
DYNACIRC CR TAB 5MG
21
$1,737.53
42.86%
4
$212.74
1.61%
0
$0.00
0.00%
102
$5,512.90
41.13%
65726023525
DYNACIRC CR TAB 5MG
0
$0.00
0.00%
70
$3,598.97
28.23%
65726023610
DYNACIRC CR TAB 10MG
0
$0.00
0.00%
51
$4,145.01
20.56%
65726023625
DYNACIRC CR TAB 10MG
3
$350.94
6.12%
9
$650.91
3.63%
8
$1,421.07
4.68%
12
$1,804.55
7.55%
71
$2,327.32
41.52%
52
$2,112.82
32.70%
2
$329.15
1.17%
0
$0.00
0.00%
10
$218.11
5.85%
13
$969.08
8.18%
POW USP
1
$170.74
0.58%
2
$340.48
1.26%
K REMOVING RESINS
00024107501
KAYEXALATE POW
00054380563
SOD POLY SUL SUS 15GM/60
00054881501
SPS
00054881611
SOD POLY SUL SUS 15GM/60
00574200416
KIONEX
46287000601
SPS
SUS 15GM/60M
45
$1,448.17
26.32%
53
$1,436.85
33.33%
46287000660
SPS
SUS 15GM/60M
29
$1,367.29
16.96%
24
$414.50
15.09%
46287001216
SOD POLY SUL POW
5
$363.95
2.92%
3
$221.97
1.89%
SUS 30GM/120
LEUKOTRIENE RECEPTOR ANTAGONISTS
00006011728
SINGULAIR
TAB 10MG
42
$3,252.00
0.62%
28
$1,865.34
0.28%
00006011731
SINGULAIR
TAB 10MG
2,275
$170,555.58
33.36%
3,487
$280,599.72
35.26%
00006011754
SINGULAIR
TAB 10MG
1,359
$100,349.84
19.93%
2,484
$196,461.23
25.12%
00006027528
SINGULAIR
CHW 5MG
24
$1,439.25
0.35%
14
$1,362.45
0.14%
00006027531
SINGULAIR
CHW 5MG
1,276
$94,007.09
18.71%
1,958
$151,722.38
19.80%
Page 240 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
SINGULAIR
CHW 5MG
00006071128
SINGULAIR
CHW 4MG
00006071131
SINGULAIR
CHW 4MG
00006071154
SINGULAIR
CHW 4MG
00006384130
SINGULAIR
GRA 4MG
00310040160
ACCOLATE
00310040239
ACCOLATE
00310040260
ACCOLATE
$
Market Share*
LEUKOTRIENE RECEPTOR ANTAGONISTS
00006027554
# of Scripts
253
$17,903.72
3.71%
22
$1,752.64
0.32%
549
$41,625.86
8.05%
156
$11,148.95
2.29%
0
$0.00
TAB 10MG
22
TAB 20MG
2
TAB 20MG
357
$26,485.65
3.61%
3
$255.12
0.03%
917
$73,186.95
9.27%
215
$15,688.43
2.17%
0.00%
56
$4,323.24
0.57%
$1,305.56
0.32%
12
$808.64
0.12%
$132.22
0.03%
0
$0.00
0.00%
839
$53,238.94
12.30%
359
$22,242.69
3.63%
LINCOSAMIDES / OXAZOLIDINONES / LEPROSTATICS
00009033102
CLEOCIN
CAP 75MG
4
$225.99
0.28%
3
$114.31
0.15%
00009039514
CLEOCIN
CAP 300MG
6
$781.77
0.42%
2
$300.00
0.10%
00009076004
CLEOCIN PED SOL 75MG/5ML
38
$1,895.71
2.68%
46
$2,294.89
2.30%
00009337502
CLEOCIN
INJ 600MG
4
$455.35
0.28%
2
$333.58
0.10%
00009338202
CLEOCIN
INJ 900MG
0
$0.00
0.00%
1
$233.24
0.05%
00009513502
ZYVOX
TAB 600MG
12
$16,139.50
0.85%
27
$25,876.92
1.35%
00009513503
ZYVOX
TAB 600MG
2
$2,283.52
0.14%
7
$16,177.39
0.35%
00009513601
ZYVOX
SUS 100MG/5M
3
$6,201.49
0.21%
14
$7,439.29
0.70%
00009514001
ZYVOX
SOL 2MG/ML
0
$0.00
0.00%
1
$424.37
0.05%
00074405201
CLINDAMYCIN INJ 150MG/ML
0
$0.00
0.00%
7
$1,758.60
0.35%
00074962113
CLINDAMYCIN INJ IN D5W
0
$0.00
0.00%
2
$263.43
0.10%
00074962313
CLINDAMYCIN INJ IN D5W
0
$0.00
0.00%
1
$154.85
0.05%
00093317101
CLINDAMYCIN CAP 150MG
172
$3,241.58
12.13%
275
$5,334.79
13.74%
00364233701
2
$64.90
0.14%
3
$92.09
0.15%
00591312001
0
$0.00
0.00%
5
$582.46
0.25%
00591570801
80
$1,648.60
5.64%
107
$1,952.30
5.34%
49938010101
DAPSONE
71
$496.27
5.01%
84
$530.08
4.20%
TAB 100MG
Page 241 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
DAPSONE
59762332801
59762501001
TAB 25MG
$
Market Share*
LINCOSAMIDES / OXAZOLIDINONES / LEPROSTATICS
49938010201
# of Scripts
14
$201.15
0.99%
25
$293.41
1.25%
533
$9,969.42
37.59%
795
$13,160.87
39.71%
20
$1,958.92
1.41%
17
$1,571.16
0.85%
59762501002
9
$666.52
0.63%
5
$389.26
0.25%
63304069201
77
$1,317.74
5.43%
140
$2,117.47
6.99%
63304069301
120
$12,469.36
8.46%
127
$11,938.93
6.34%
63304069316
251
$27,471.83
17.70%
306
$33,203.27
15.28%
LITHIUM
00007400720
ESKALITH
00007401020
ESKALITH CR TAB 450MG
CAP 300MG
00032449201
LITHOBID
7
$176.97
0.17%
8
$192.65
0.17%
1,123
$35,565.13
27.18%
940
$31,863.46
19.65%
TAB 300MG SR
849
$29,342.23
20.55%
420
$17,033.07
8.78%
00054252625
LITHIUM CARB CAP 150MG
240
$2,287.70
5.81%
264
$2,403.97
5.52%
00054252725
226
$3,445.78
5.47%
223
$3,273.40
4.66%
00054252731
916
$14,108.09
22.17%
1,054
$14,473.97
22.04%
00054253125
19
$347.39
0.46%
28
$643.86
0.59%
00054352763
LITHIUM CITR SYP 8MEQ/5ML
10
$174.24
0.24%
11
$137.54
0.23%
00054452725
LITHIUM CARB TAB 300MG
52
$935.34
1.26%
55
$915.91
1.15%
00054452731
LITHIUM CARB TAB 300MG
31
$472.05
0.75%
31
$400.95
0.65%
00054852625
4
$33.47
0.10%
7
$55.85
0.15%
00054852725
10
$116.09
0.24%
0
$0.00
0.00%
00054853125
0
$0.00
0.00%
7
$182.45
0.15%
00143127701
LITHIUM CARB TAB 450MG ER
0
$0.00
0.00%
333
$9,707.18
6.96%
00143318801
0
$0.00
0.00%
5
$37.12
0.10%
00143318901
0
$0.00
0.00%
3
$37.39
0.06%
00555034502
LITHIUM CARB TAB 300MG ER
0
$0.00
0.00%
233
$7,606.07
4.87%
00781610016
3
$36.51
0.07%
3
$36.51
0.06%
Page 242 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
LITHIUM
00904556860
00904556880
53265027010
53265027011
53265028310
60432061616
0
$0.00
0.00%
0
$0.00
0.00%
182
$2,765.77
4.41%
430
$6,579.43
10.41%
LITHIUM CARB TAB 300MG CR
0
$0.00
29
3
$23.28
0.06%
34
$454.02
0.71%
229
$3,548.90
4.79%
403
$5,600.65
8.43%
0.00%
450
$16,091.50
9.41%
$503.28
0.70%
39
$601.63
0.82%
$475.14
1.25%
10
$128.38
1.02%
LOCAL ANESTHETICS
00054350547
LIDOCAINE
SOL 4%
14
00074156010
MARCAINE
INJ 0.5%
0
$0.00
0.00%
1
$2.28
0.10%
00074158750
MARCAINE
INJ 0.25%
2
$12.82
0.18%
2
$8.82
0.20%
00074186602
PONTOCAINE SOL 2%
1
$60.40
0.09%
0
$0.00
0.00%
00074317801
LIDO/EPI
0
$0.00
0.00%
1
$4.55
0.10%
00074427501
LIDOCAINE
INJ 0.5%
0
$0.00
0.00%
1
$1.96
0.10%
00074427601
LIDOCAINE
INJ 1%
2
$6.86
0.18%
11
$41.45
1.12%
00074427602
LIDOCAINE
INJ 1%
4
$14.53
0.36%
2
$8.20
0.20%
00074427701
LIDOCAINE
INJ 2%
4
$19.00
0.36%
1
$3.49
0.10%
00074428201
LIDOCAINE
INJ 2%
1
$1.59
0.09%
0
$0.00
0.00%
00074428301
LIDOCAINE
INJ 4%
2
$35.88
0.18%
0
$0.00
0.00%
00074471302
LIDOCAINE
INJ 1%
5
$28.93
0.45%
0
$0.00
0.00%
00074471332
LIDOCAINE
INJ 1%
8
$30.61
0.71%
59
$241.92
6.01%
00093920031
LIDOCAINE
GEL 2%
50
$925.94
4.45%
55
$878.78
5.61%
00168020437
LIDOCAINE
OIN 5%
37
$545.08
3.29%
52
$729.64
5.30%
00168035730
LIDOC/PRILOC CRE 2.5-2.5%
0
$0.00
0.00%
103
$4,145.32
10.50%
00186011001
XYLOCAINE
INJ 1%
5
$35.28
0.45%
5
$35.69
0.51%
00186014501
XYLOCAINE
INJ 1%
0
$0.00
0.00%
5
$46.15
0.51%
00186027512
XYLOCAINE
INJ 1%
28
$150.64
2.49%
18
$91.16
1.83%
INJ 1%
Page 243 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
LOCAL ANESTHETICS
00186027613
XYLOCAINE
INJ -MPF 1%
9
$62.48
0.80%
40
$426.93
4.08%
00186031521
XYLOCAINE
OIN 5%
2
$34.09
0.18%
9
$208.83
0.92%
00186032001
XYLOCAINE
SOL 4%
0
$0.00
0.00%
2
$59.90
0.20%
00186033001
XYLOCAINE
GEL 2%
56
$1,284.49
4.99%
46
$982.41
4.69%
00186033036
XYLOCAINE
GEL 2%
0
$0.00
0.00%
5
$234.17
0.51%
00186103001
SENSORCAINE INJ MPF .25%
2
$52.54
0.18%
0
$0.00
0.00%
00186151270
EMLA
PAD
1
$11.13
0.09%
0
$0.00
0.00%
00186151271
EMLA
PAD
3
$111.03
0.27%
0
$0.00
0.00%
00186151501
EMLA
KIT TEGADERM
143
$2,586.13
12.73%
5
$288.98
0.51%
00186151503
EMLA
KIT TEGADERM
00186151601
EMLA
CRE
00496082306
ELA-MAX
00496082308
44
$1,684.45
3.92%
3
$95.59
0.31%
278
$13,166.49
24.76%
110
$4,968.79
11.21%
CRE 4%
0
$0.00
0.00%
1
$50.26
0.10%
ELA-MAX
KIT 4%
1
$10.44
0.09%
4
$43.56
0.41%
00496082315
ELA-MAX
CRE 4%
0
$0.00
0.00%
2
$67.20
0.20%
00496082330
ELA-MAX
CRE 4%
2
$83.60
0.18%
11
$460.93
1.12%
00496088215
LMX 4
CRE 4%
0
$0.00
0.00%
3
$69.67
0.31%
00496088230
LMX 4
CRE 4%
0
$0.00
0.00%
5
$208.95
0.51%
00517062525
LIDOCAINE
INJ 1%
2
$8.60
0.18%
0
$0.00
0.00%
00536252525
CAPSAICIN
CRE 0.025%
8
$103.66
0.71%
5
$118.53
0.51%
00548301100
LIDOCAINE
GEL 2%
1
$33.98
0.09%
1
$33.48
0.10%
00548301200
LIDOCAINE
GEL 2%
0
$0.00
0.00%
1
$32.12
0.10%
00548301300
LIDOCAINE
GEL 2%
6
$1,526.59
0.53%
21
$2,928.05
2.14%
00548301500
LIDOCAINE
GEL 2%
6
$128.21
0.53%
6
$64.33
0.61%
00641239041
LIDOCAINE
INJ 1%
4
$17.70
0.36%
0
$0.00
0.00%
00781705803
LIDOC/PRILOC CRE 2.5-2.5%
0
$0.00
0.00%
5
$257.23
0.51%
10019001957
LIDOCAINE
1
$4.22
0.09%
0
$0.00
0.00%
10337070052
LIDAMANTLE CRE 3%
1
$24.29
0.09%
4
$179.60
0.41%
INJ 2%
Page 244 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
LIDOCAINE
45802032910
45802033023
$
Market Share*
LOCAL ANESTHETICS
17478071130
# of Scripts
GEL 2%
0
$0.00
0.00%
1
$14.34
0.10%
CAPSAICIN-HP CRE 0.075%
0
$0.00
0.00%
1
$12.74
0.10%
CAPSAICIN
CRE 0.025%
0
$0.00
0.00%
1
$7.80
0.10%
49158013019
LIDOCAINE
OIN 5%
1
$10.19
0.09%
18
$156.39
1.83%
60258004001
LIDOCAINE
CRE 3%
0
$0.00
0.00%
1
$56.46
0.10%
60432046550
LIDOCAINE
SOL 4%
1
$3.55
0.09%
1
$10.90
0.10%
62436060102
ZOSTRIX-HP CRE 0.075%
2
$34.04
0.18%
0
$0.00
0.00%
62436060202
ZOSTRIX
2
$26.32
0.18%
0
$0.00
0.00%
63323020102
LIDOCAINE
INJ 1%
94
$610.57
8.37%
62
$406.90
6.32%
63323020110
LIDOCAINE
INJ 1%
65
$288.32
5.79%
62
$313.34
6.32%
63323020202
LIDOCAINE
INJ 2%
2
$22.14
0.18%
1
$5.09
0.10%
63323020805
LIDOCAINE
INJ 2%
0
$0.00
0.00%
1
$16.98
0.10%
63481068706
LIDODERM
DIS 5%
223
$30,556.53
19.86%
217
$30,709.48
22.12%
CRE 0.025%
LONG ACTING ANXIOLYTICS
00009005707
XANAX XR
TAB 0.5MG
0
$0.00
0.00%
7
$330.52
20.59%
00009005907
XANAX XR
TAB 1MG
0
$0.00
0.00%
14
$758.86
41.18%
00009006607
XANAX XR
TAB 2MG
0
$0.00
0.00%
8
$793.81
23.53%
00009006807
XANAX XR
TAB 3MG
0
$0.00
0.00%
5
$1,018.23
14.71%
LONG ACTING NARCOTICS
00008065301
MORPHINE SUL INJ 4MG/ML
3
$35.28
0.02%
0
$0.00
0.00%
00008065601
6
$58.27
0.04%
0
$0.00
0.00%
00034051310
MS CONTIN TAB 200MG CR
6
$8,629.74
0.04%
4
$2,356.41
0.02%
00034051410
116
$4,526.95
0.78%
20
$416.63
0.12%
00034051490
2
$10.62
0.01%
0
$0.00
0.00%
00034051510
97
$9,601.51
0.65%
20
$976.71
0.12%
Page 245 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00034051512
0
00034051545
00034051550
00034051590
$0.00
0.00%
1
$37.50
0.01%
0
$0.00
0.00%
1
$19.32
0.01%
6
$526.47
0.04%
0
$0.00
0.00%
7
$256.55
0.05%
0
$0.00
0.00%
00034051610
36
$6,492.00
0.24%
27
$3,672.99
0.16%
00034051710
83
$39,233.13
0.56%
32
$15,577.64
0.19%
00054355344
METHADONE
CON 10MG/ML
0
$0.00
0.00%
1
$44.96
0.01%
00054355563
METHADONE
SOL 5MG/5ML
4
$59.64
0.03%
14
$333.59
0.08%
00054355663
METHADONE
SOL 10MG/5ML
8
$116.01
0.05%
11
$1,088.13
0.07%
00054378549
MORPHINE SUL SOL 10MG/5ML
1
$10.21
0.01%
1
$84.71
0.01%
00054378563
133
$1,871.34
0.90%
173
$2,828.30
1.03%
00054378649
0
$0.00
0.00%
1
$1.00
0.01%
00054378663
11
$160.37
0.07%
22
$569.38
0.13%
00054453825
METHADONE
TAB 40MG
53
$1,300.03
0.36%
12
$330.43
0.07%
00054454725
METHADONE
TAB 40MG
57
$1,618.75
0.38%
1
$29.16
0.01%
00054457025
METHADONE
TAB 5MG
178
$1,774.36
1.20%
391
$3,187.82
2.32%
00054457125
METHADONE
TAB 10MG
921
$18,708.84
6.21%
1,109
$22,368.24
6.58%
00054479025
ORAMORPH SR TAB 15MG
30
$1,390.30
0.20%
2
$36.82
0.01%
00054479225
10
$1,722.11
0.07%
1
$1.00
0.01%
00054479325
2
$500.84
0.01%
1
$229.49
0.01%
00054480525
12
$736.26
0.08%
2
$116.72
0.01%
00054855324
METHADONE
TAB 5MG
0
$0.00
0.00%
1
$40.81
0.01%
00054855424
METHADONE
TAB 10MG
1
$28.69
0.01%
1
$46.51
0.01%
00054858516
4
$25.27
0.03%
2
$8.70
0.01%
00074113403
0
$0.00
0.00%
5
$140.58
0.03%
00074113405
8
$505.36
0.05%
7
$619.77
0.04%
00074113422
0
$0.00
0.00%
1
$101.22
0.01%
Page 246 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00074125801
54
$478.61
0.36%
41
$317.37
0.24%
00074125802
0
$0.00
0.00%
15
$157.96
0.09%
00074125830
0
$0.00
0.00%
22
$237.76
0.13%
00074125831
5
$42.99
0.03%
1
$7.16
0.01%
00074125901
3
$28.95
0.02%
2
$14.89
0.01%
00074126031
1
$7.10
0.01%
0
$0.00
0.00%
00074126101
24
$128.39
0.16%
1
$7.39
0.01%
00074126102
54
$587.63
0.36%
52
$552.87
0.31%
00074126130
170
$1,657.20
1.15%
270
$2,516.44
1.60%
00074126131
19
$148.93
0.13%
19
$122.04
0.11%
00074126201
1
$17.60
0.01%
15
$285.38
0.09%
00074126301
10
$50.28
0.07%
100
$870.23
0.59%
00074126431
0
$0.00
0.00%
1
$12.38
0.01%
00074176201
39
$483.68
0.26%
13
$112.33
0.08%
00074176202
0
$0.00
0.00%
13
$150.69
0.08%
00074176231
3
$57.41
0.02%
0
$0.00
0.00%
00074602304
1
$25.21
0.01%
0
$0.00
0.00%
00245016012
RMS
SUP 5MG
67
$851.61
0.45%
45
$570.50
0.27%
00245016112
RMS
SUP 10MG
16
$227.40
0.11%
15
$254.84
0.09%
00245016212
RMS
SUP 20MG
0
$0.00
0.00%
1
$39.12
0.01%
00378326001
METHADONE
TAB 5MG
0
$0.00
0.00%
2
$15.08
0.01%
00378327201
METHADONE
TAB 10MG
0
$0.00
0.00%
3
$28.21
0.02%
00406054034
METHADOSE
TAB 40MG
61
$1,761.07
0.41%
317
$8,350.66
1.88%
00406345434
METHADOSE
TAB 10MG
720
$13,804.43
4.86%
1,949
$36,769.44
11.56%
00406697434
METHADOSE
TAB 5MG
167
$1,710.55
1.13%
340
$2,789.15
2.02%
00406831501
MORPHINE SUL TAB 15MG ER
0
$0.00
0.00%
1
$24.18
0.01%
00406833001
0
$0.00
0.00%
3
$244.07
0.02%
Page 247 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00406838001
00406839001
00574711212
MORPHINE SUL SUP 10MG
00574711412
00591061701
00591093201
OXYCODO-APAP TAB 10-325
00641017025
00641018025
00641019025
1
$173.84
0.01%
0.00%
7
$344.22
0.04%
0.26%
10
$234.30
0.06%
$22.14
0.01%
0
$0.00
0.00%
$770.70
0.02%
0
$0.00
0.00%
0
$0.00
0.00%
37
$3,429.13
0.22%
19
$171.73
0.13%
0
$0.00
0.00%
229
$1,993.33
1.54%
273
$2,251.59
1.62%
14
$454.85
0.09%
1
$8.08
0.01%
00641118035
31
$494.96
0.21%
0
$0.00
0.00%
00641234341
8
$126.18
0.05%
8
$111.47
0.05%
00641234541
10
$117.72
0.07%
9
$342.34
0.05%
10019017844
9
$66.39
0.06%
21
$144.05
0.12%
10019017862
13
$126.14
0.09%
9
$86.20
0.05%
10019017963
9
$602.07
0.06%
37
$905.01
0.22%
50458003305
DURAGESIC
DIS 25MCG/HR
1,219
$97,632.66
8.22%
635
$47,465.40
3.77%
50458003405
DURAGESIC
DIS 50MCG/HR
1,131
$183,232.20
7.63%
727
$108,139.98
4.31%
50458003505
DURAGESIC
DIS 75MCG/HR
662
$166,550.17
4.46%
400
$98,079.95
2.37%
50458003605
DURAGESIC
DIS 100MCG/H
766
$316,249.42
5.17%
531
$255,089.39
3.15%
59011010010
OXYCONTIN
TAB 10MG CR
1,131
$76,081.06
7.63%
438
$25,728.34
2.60%
59011010025
OXYCONTIN
TAB 10MG CR
6
$28.18
0.04%
0
$0.00
0.00%
59011010310
OXYCONTIN
TAB 20MG CR
2,126
$310,175.93
14.34%
771
$104,653.38
4.57%
59011010510
OXYCONTIN
TAB 40MG CR
1,978
$569,594.63
13.34%
692
$206,411.22
4.10%
59011010710
OXYCONTIN
TAB 80MG CR
789
$453,243.51
5.32%
494
$327,716.33
2.93%
60951065270
376
$18,551.77
2.54%
84
$2,140.94
0.50%
60951065285
8
$452.93
0.05%
0
$0.00
0.00%
60951065370
431
$33,055.16
2.91%
107
$6,224.76
0.63%
0
$0.00
0.00%
0
$0.00
39
$878.88
1
3
Page 248 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
60951065570
268
$47,264.49
1.81%
65
$11,175.23
0.39%
60951065870
53
$18,532.54
0.36%
24
$5,737.96
0.14%
60951065970
13
$8,302.05
0.09%
19
$2,606.00
0.11%
61703022521
12
$3,659.35
0.08%
4
$1,347.45
0.02%
61703022543
1
$1,548.20
0.01%
0
$0.00
0.00%
61703022672
3
$4,111.80
0.02%
1
$1.00
0.01%
61703022676
8
$14,852.80
0.05%
3
$10,176.70
0.02%
63857032206
KADIAN
CAP 20MG CR
111
$10,270.97
0.75%
1,563
$153,533.17
9.27%
63857032306
KADIAN
CAP 50MG CR
44
$5,408.51
0.30%
603
$111,857.74
3.58%
63857032406
KADIAN
CAP 100MG CR
31
$11,235.62
0.21%
678
$283,368.03
4.02%
63857032506
KADIAN
CAP 30MG CR
46
$3,555.51
0.31%
975
$93,559.11
5.78%
63857032606
KADIAN
CAP 60MG CR
18
$3,791.51
0.12%
711
$151,127.10
4.22%
64019053825
METHADONE
TAB 40MG
0
$0.00
0.00%
44
$1,290.96
0.26%
64019055467
METHADONE
CON 10MG/ML
0
$0.00
0.00%
1
$5.26
0.01%
64365050503
AVINZA
CAP 30MG CR
0
$0.00
0.00%
626
$40,599.02
3.71%
64365050603
AVINZA
CAP 60MG CR
0
$0.00
0.00%
543
$74,870.43
3.22%
64365050702
AVINZA
CAP 90MG CR
0
$0.00
0.00%
265
$57,487.79
1.57%
64365050802
AVINZA
CAP 120MG CR
1
$206.54
0.01%
309
$111,189.44
1.83%
66591069141
DARVOCET
TAB A500
0
$0.00
0.00%
9
$534.30
0.05%
66689089840
METHADONE
0
$0.00
0.00%
25
$625.76
0.15%
1
$9.05
0.01%
0
$0.00
0.00%
10
$346.24
0.07%
19
$526.04
0.10%
TAB 40MG
MACROLIDES / ERYTHROMYCINS
00044020805
E-MYCIN
00069305175
ZITHROMAX
POW 1GM PAK
00069306030
ZITHROMAX
TAB 250MG
1,520
$56,153.84
10.78%
2,231
$91,073.63
11.19%
00069306075
ZITHROMAX
TAB Z-PAK
5,504
$216,252.25
39.04%
8,775
$364,615.43
44.02%
00069306086
ZITHROMAX
TAB 250MG
104
$3,140.92
0.74%
98
$3,007.25
0.49%
TAB 333MG EC
Page 249 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
ZITHROMAX
TAB 500MG
00069307075
ZITHROMAX
TAB TRI-PAK
00069308030
ZITHROMAX
TAB 600MG
00069311019
ZITHROMAX
00069312019
$
Market Share*
00069307030
# of Scripts
1
$39.59
0.01%
125
$8,079.35
0.63%
275
$11,192.60
1.95%
543
$25,055.84
2.72%
23
$4,339.19
0.16%
39
$6,555.21
0.20%
SUS 100/5ML
897
$33,142.27
6.36%
1,140
$45,802.34
5.72%
ZITHROMAX
SUS 200/5ML
1,303
$45,748.30
9.24%
1,855
$64,134.81
9.31%
00069313019
ZITHROMAX
SUS 200/5ML
378
$13,120.40
2.68%
770
$27,528.40
3.86%
00069314019
ZITHROMAX
SUS 200/5ML
588
$18,651.02
4.17%
959
$32,634.31
4.81%
00074258611
BIAXIN
TAB 500MG
0
$0.00
0.00%
2
$173.02
0.01%
00074258660
BIAXIN
TAB 500MG
624
$48,943.37
4.43%
468
$37,574.55
2.35%
00074258913
ERYTHROM ETH TAB 400MG
78
$924.56
0.55%
109
$1,131.26
0.55%
00074316313
BIAXIN
SUS 125/5ML
54
$2,003.90
0.38%
38
$1,512.37
0.19%
00074316350
BIAXIN
SUS 125/5ML
10
$216.95
0.07%
2
$62.92
0.01%
00074316511
BIAXIN XL
TAB 500MG
0
$0.00
0.00%
5
$364.35
0.03%
00074316514
BIAXIN XL
TAB 500MG PK
30
$2,085.53
0.21%
10
$756.70
0.05%
00074316541
BIAXIN XL
TAB 500MG PK
124
$8,538.39
0.88%
62
$5,428.12
0.31%
00074316560
BIAXIN XL
TAB 500MG
453
$35,770.41
3.21%
289
$23,692.48
1.45%
00074318813
BIAXIN
SUS 250/5ML
106
$7,668.35
0.75%
69
$5,728.42
0.35%
00074318850
BIAXIN
SUS 250/5ML
11
$530.43
0.08%
9
$538.51
0.05%
00074336811
BIAXIN
TAB 250MG
3
$31.14
0.02%
2
$20.60
0.01%
00074336860
BIAXIN
TAB 250MG
184
$13,417.30
1.30%
119
$8,787.91
0.60%
00074338913
PCE
2
$79.95
0.01%
4
$163.98
0.02%
00074374716
ERYTHROM ETH SUS 200/5ML
45
$489.35
0.32%
117
$1,399.25
0.59%
00074374816
32
$508.17
0.23%
85
$1,236.38
0.43%
00074572913
E.E.S. 400 TAB 400MG
15
$179.29
0.11%
19
$192.07
0.10%
00074622713
ERYTHROMYCIN TAB BS 500MG
58
$578.82
0.41%
85
$743.51
0.43%
00074629060
PCE
TAB 333MG EC
4
$269.85
0.03%
4
$213.33
0.02%
00074630113
ERYTHROMYCIN CAP 250MG EC
12
$154.53
0.09%
21
$131.76
0.11%
TAB 500MG EC
Page 250 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
ERYPED 200 SUS 200/5ML
00074630253
00074630413
ERY-TAB
TAB 250MG EC
00074630453
ERY-TAB
TAB 250MG EC
00074630513
$
Market Share*
00074630213
# of Scripts
$23.18
0.01%
$120.45
0.06%
1
$15.75
0.01%
119
$1,541.61
0.84%
2
$31.48
0.01%
163
$1,869.73
0.82%
209
$2,392.32
1.48%
259
$2,805.73
1.30%
5
$110.27
0.04%
4
$106.92
0.02%
00074630553
4
00074630613
E.E.S. 200 SUS 200/5ML
0
$100.44
0.03%
5
$147.42
0.03%
$0.00
0.00%
1
$9.58
0.01%
00074630616
E.E.S. 200 SUS 200/5ML
0
$0.00
0.00%
10
$149.15
0.05%
00074631440
ERYPED
92
$2,629.54
0.65%
0
$0.00
0.00%
00074631613
ERYTHROCIN TAB 500MG
00074632013
ERY-TAB
TAB 333MG EC
3
$27.92
0.02%
3
$8.38
0.02%
240
$3,169.22
1.70%
352
$4,063.01
1.77%
00074632053
ERY-TAB
TAB 333MG EC
453
$5,693.63
3.21%
565
$6,093.94
2.83%
00074632113
ERY-TAB
TAB 500MG EC
174
$2,338.44
1.23%
259
$3,817.52
1.30%
00074632613
00074632653
ERYTHROMYCIN TAB 250MG
45
$409.78
0.32%
80
$644.86
0.40%
ERYTHROMYCIN TAB 250MG
7
$63.97
0.05%
4
$31.31
0.02%
00074634620
3
$36.75
0.02%
8
$70.39
0.04%
00074634653
1
$8.39
0.01%
0
$0.00
0.00%
00074636902
E.E.S. GRAN SUS 200/5ML
0
$0.00
0.00%
1
$17.95
0.01%
00074636910
E.E.S. GRAN SUS 200/5ML
1
$13.86
0.01%
2
$47.44
0.01%
00074637316
E.E.S. 400 SUS 400/5ML
0
$0.00
0.00%
2
$60.60
0.01%
00378010601
ERYTHROM ST TAB 250MG
3
$22.20
0.02%
1
$8.15
0.01%
00378010605
1
$7.83
0.01%
1
$21.14
0.01%
00378010701
3
$43.39
0.02%
1
$4.50
0.01%
00378640001
6
$89.80
0.04%
9
$102.92
0.05%
00378640005
3
$30.23
0.02%
2
$18.50
0.01%
00430069624
ERYC
0
$0.00
0.00%
1
$10.87
0.01%
00451049010
DYNABAC
46
$1,719.39
0.33%
0
$0.00
0.00%
CHW 200MG
CAP 250MG EC
TAB 250MG EC
2
11
Page 251 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
DYNABAC
00472097116
00472097416
TAB 250MG EC
$
Market Share*
00451049060
# of Scripts
74
$3,644.53
0.52%
6
$741.14
0.03%
31
$244.91
0.22%
29
$316.42
0.15%
40
$479.79
0.28%
8
$93.83
0.04%
00472097716
ERYTHROM EST SUS 125/5ML
6
$139.80
0.04%
11
$277.44
0.06%
00472097916
ERYTHROM EST SUS 250/5ML
43
$987.53
0.30%
32
$686.79
0.16%
00555021523
2
$26.84
0.01%
2
$32.62
0.01%
00555058402
18
$164.44
0.13%
13
$118.77
0.07%
00555058404
16
$174.90
0.11%
13
$144.70
0.07%
00904246216
0
$0.00
0.00%
1
$11.51
0.01%
21
$1,735.55
30.43%
21
$1,395.64
32.81%
MAO INHIBITORS
00007447120
PARNATE
TAB 10MG
00071027024
NARDIL
TAB 15MG
48
$2,151.23
69.57%
21
$1,003.93
32.81%
00071035024
NARDIL
TAB 15MG
0
$0.00
0.00%
22
$1,022.18
34.38%
3
$330.86
1.85%
19
$954.02
21.35%
MIGRAINE MISCELLANEOUS MIXTURE THERAPIES
00078003302
CAFERGOT
SUP 2/100
00078034905
CAFERGOT
48
$1,285.36
29.63%
63
$1,843.74
70.79%
00677177501
BEL-TABS
TAB
0
$0.00
0.00%
1
$42.56
1.12%
51991004501
SPASTRIN
TAB
1
$13.25
0.62%
6
$90.42
6.74%
51991039501
MIGRAZONE
CAP
98
$1,233.44
60.49%
0
$0.00
0.00%
51991039502
MIGRAZONE
CAP
5
$54.95
3.09%
0
$0.00
0.00%
53746014101
ISOMETH/APAP CAP DICHLOR
7
$92.77
4.32%
0
$0.00
0.00%
TAB 1-100MG
MIOTICS - DIRECT ACTING
00065021535
PILOPINE HS GEL 4% OP
19
$736.52
8.52%
16
$649.21
8.47%
00364713272
PILOCARPINE SOL 2% OP
0
$0.00
0.00%
1
$6.35
0.53%
Page 252 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MIOTICS - DIRECT ACTING
00603724741
0
$0.00
0.00%
1
00603724941
2
$12.70
0.90%
00603725341
2
$15.40
0.90%
00998020315
ISOPTO CARP SOL 1% OP
2
$11.50
00998022315
ISO CARBACHO SOL 1.5% OP
2
00998022515
ISO CARBACHO SOL 3% OP
00998022530
ISO CARBACHO SOL 3% OP
24208067615
$5.75
0.53%
0
$0.00
0.00%
5
$38.50
2.65%
0.90%
3
$72.18
1.59%
$61.36
0.90%
3
$94.78
1.59%
9
$371.49
4.04%
11
$494.95
5.82%
2
$92.89
0.90%
0
$0.00
0.00%
5
$26.25
2.24%
4
$15.50
2.12%
24208068115
19
$119.33
8.52%
16
$69.75
8.47%
24208068615
41
$321.62
18.39%
18
$115.39
9.52%
24208080615
PILOCARPINE SOL 0.5% OP
5
$31.50
2.24%
13
$72.00
6.88%
24208081115
1
$8.30
0.45%
0
$0.00
0.00%
52238075215
PILOPTIC-2 SOL 2% OP
0
$0.00
0.00%
2
$12.70
1.06%
52555099501
PILOCARPINE SOL 0.5% OP
1
$1.32
0.45%
0
$0.00
0.00%
58768051815
PILOCAR
0
$0.00
0.00%
1
$9.55
0.53%
61314020315
27
$152.08
12.11%
12
$50.65
6.35%
61314020415
44
$249.00
19.73%
35
$174.75
18.52%
61314020615
42
$317.73
18.83%
48
$336.41
25.40%
SOL 4% OP
MISC - ANTI-CONVULSANTS
00004005801
KLONOPIN
TAB 1MG
60
$3,587.75
0.10%
36
$3,279.13
0.05%
00004006801
KLONOPIN
TAB 0.5MG
25
$1,564.07
0.04%
27
$1,501.75
0.04%
00004009801
KLONOPIN
TAB 2MG
6
$606.57
0.01%
22
$994.52
0.03%
00004028122
KLONOPIN WAF TAB 0.5MG
0
$0.00
0.00%
1
$55.66
0.00%
00037043001
FELBATOL
TAB 400MG
44
$12,946.35
0.08%
51
$14,688.88
0.08%
00037043101
FELBATOL
TAB 600MG
158
$39,229.78
0.27%
149
$40,364.04
0.22%
00037044267
FELBATOL
SUS 600/5ML
32
$8,315.84
0.05%
23
$9,589.95
0.03%
Page 253 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00045063965
TOPAMAX
TAB 25MG
2,069
$237,300.19
3.54%
2,010
$256,827.35
3.00%
00045064165
TOPAMAX
TAB 100MG
1,774
$322,387.45
3.03%
2,332
$479,716.13
3.48%
00045064265
TOPAMAX
TAB 200MG
538
$104,519.68
0.92%
758
$171,432.69
1.13%
00045064565
TOPAMAX
CAP 25MG
35
$7,942.24
0.06%
45
$12,135.87
0.07%
00045064765
TOPAMAX
CAP 15MG
40
$3,621.28
0.07%
60
$5,745.22
0.09%
00071000724
DILANTIN
CHW 50MG
634
$12,304.28
1.08%
735
$16,082.40
1.10%
00071000740
DILANTIN
CHW 50MG
3
$30.87
0.01%
1
$8.38
0.00%
00071023724
ZARONTIN
66
$5,386.65
0.11%
58
$5,594.09
0.09%
00071036224
DILANTIN
CAP 100MG
1,278
$36,933.55
2.19%
1,234
$37,192.28
1.84%
00071036232
DILANTIN
CAP 100MG
592
$16,042.39
1.01%
744
$21,040.56
1.11%
00071036240
DILANTIN
CAP 100MG
43
$1,144.12
0.07%
16
$477.14
0.02%
00071036524
DILANTIN
CAP 30MG
253
$4,298.95
0.43%
326
$5,696.60
0.49%
00071041624
NEURONTIN
TAB 600MG
2,976
$393,445.70
5.09%
3,130
$460,946.09
4.68%
00071042624
NEURONTIN
TAB 800MG
1,500
$284,136.98
2.57%
1,817
$380,945.72
2.71%
00071052524
CELONTIN
CAP 300MG
6
$244.80
0.01%
6
$218.29
0.01%
00071053724
CELONTIN
CAP 150MG
5
$217.63
0.01%
9
$401.21
0.01%
00071080324
NEURONTIN
CAP 100MG
2,311
$98,874.40
3.95%
1,818
$83,157.16
2.72%
00071080340
NEURONTIN
CAP 100MG
5
$294.02
0.01%
0
$0.00
0.00%
00071080524
NEURONTIN
CAP 300MG
4,430
$348,372.62
7.58%
4,208
$352,474.86
6.29%
00071080540
NEURONTIN
CAP 300MG
1
$154.49
0.00%
2
$83.56
0.00%
00071080624
NEURONTIN
CAP 400MG
1,534
$214,018.87
2.62%
1,573
$222,663.15
2.35%
00071201223
NEURONTIN
SOL 250/5ML
57
$5,117.41
0.10%
39
$4,230.76
0.06%
00071221420
DILANTIN-125 SUS 125/5ML
136
$5,314.50
0.23%
110
$4,904.06
0.16%
00071241823
ZARONTIN
SYP 250/5ML
32
$1,784.80
0.05%
21
$1,111.86
0.03%
00071400705
CEREBYX
INJ 50MG/ML
0
$0.00
0.00%
3
$946.60
0.00%
00074390413
GABITRIL
TAB 4MG
7
$435.27
0.01%
0
$0.00
0.00%
00074391013
GABITRIL
TAB 12MG
2
$96.74
0.00%
0
$0.00
0.00%
CAP 250MG
Page 254 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
GABITRIL
00074568113
DEPAKENE
00074568216
DEPAKENE
00074611411
TAB 2MG
$
Market Share*
00074396313
# of Scripts
3
$143.77
0.01%
0
$0.00
0.00%
CAP 250MG
6
$1,515.24
SYP 250/5ML
34
$7,583.43
0.01%
4
$1,020.82
0.01%
0.06%
16
$6,179.45
0.02%
DEPAKOTE SPR CAP 125 MG
0
$0.00
0.00%
3
$206.40
0.00%
00074611413
DEPAKOTE SPR CAP 125 MG
950
$68,580.06
1.62%
1,047
$92,339.23
1.56%
00074621213
DEPAKOTE
00074621411
DEPAKOTE
TAB 125MG EC
612
$21,424.09
1.05%
607
$23,791.41
0.91%
TAB 250MG EC
14
$875.21
0.02%
1
$7.55
0.00%
00074621413
DEPAKOTE
TAB 250MG EC
2,280
$182,502.31
3.90%
2,045
$175,239.87
3.06%
00074621453
DEPAKOTE
TAB 250MG EC
908
$67,759.52
1.55%
1,138
$97,129.94
1.70%
00074621511
DEPAKOTE
TAB 500MG EC
5
$513.35
0.01%
0
$0.00
0.00%
00074621513
DEPAKOTE
TAB 500MG EC
2,790
$376,491.11
4.77%
2,569
$389,839.69
3.84%
00074621553
DEPAKOTE
TAB 500MG EC
751
$105,127.86
1.28%
982
$153,352.48
1.47%
00078033605
TRILEPTAL
TAB 150MG
440
$27,084.57
0.75%
413
$25,641.17
0.62%
00078033606
TRILEPTAL
TAB 150MG
6
$837.95
0.01%
6
$361.72
0.01%
00078033705
TRILEPTAL
TAB 300MG
939
$107,751.32
1.61%
1,080
$140,020.27
1.61%
00078033706
TRILEPTAL
TAB 300MG
3
$326.62
0.01%
3
$379.56
0.00%
00078033805
TRILEPTAL
TAB 600MG
293
$53,702.13
0.50%
679
$133,199.78
1.01%
00078033806
TRILEPTAL
TAB 600MG
00078035752
TRILEPTAL
SUS 300MG/5M
00083001976
TEGRETOL
00083002730
6
$1,532.67
0.01%
6
$1,207.00
0.01%
23
$2,179.04
0.04%
46
$5,445.68
0.07%
SUS 100/5ML
138
$7,189.29
0.24%
102
$7,542.85
0.15%
TEGRETOL
TAB 200MG
286
$17,723.07
0.49%
237
$14,795.74
0.35%
00083002740
TEGRETOL
TAB 200MG
87
$5,462.52
0.15%
95
$6,910.81
0.14%
00083005230
TEGRETOL
CHW 100MG
91
$3,473.74
0.16%
99
$4,506.31
0.15%
00083005232
TEGRETOL
CHW 100MG
4
$69.60
0.01%
2
$36.86
0.00%
00083006030
TEGRETOL XR TAB 400MG
365
$25,739.96
0.62%
430
$31,840.13
0.64%
00083006130
246
$6,470.63
0.42%
272
$6,945.26
0.41%
00083006230
535
$27,287.82
0.92%
560
$28,379.23
0.84%
Page 255 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
EPITOL
00093010901
00093010910
TAB 200MG
$
Market Share*
00093009001
# of Scripts
114
$1,564.93
0.19%
128
$1,756.61
0.19%
CARBAMAZEPIN TAB 200MG
973
$13,344.95
1.66%
795
$9,799.13
1.19%
94
$1,329.91
0.16%
127
$1,654.87
0.19%
00093077801
CARBAMAZEPIN CHW 100MG
618
$13,138.71
1.06%
702
$14,736.77
1.05%
00093083201
CLONAZEPAM TAB 0.5MG
3,091
$37,929.60
5.29%
3,610
$21,319.86
5.39%
00093083205
447
$5,329.01
0.76%
1,167
$7,235.62
1.74%
00093083210
416
$5,206.68
0.71%
346
$2,204.03
0.52%
00093083301
CLONAZEPAM TAB 1MG
3,650
$53,858.56
6.24%
4,413
$32,344.22
6.59%
00093083305
CLONAZEPAM TAB 1MG
498
$6,768.84
0.85%
1,095
$7,920.24
1.64%
00093083310
CLONAZEPAM TAB 1MG
268
$3,819.10
0.46%
469
$3,314.80
0.70%
00093083401
CLONAZEPAM TAB 2MG
779
$11,345.23
1.33%
1,165
$10,319.34
1.74%
00093083405
CLONAZEPAM TAB 2MG
37
$436.60
0.06%
62
$419.06
0.09%
00093963316
VALPROIC ACD SYP 250/5ML
111
$4,348.56
0.19%
57
$2,172.60
0.09%
00121067016
ETHOSUXIMIDE SYP 250/5ML
5
$149.85
0.01%
5
$281.13
0.01%
00121067516
21
$753.19
0.04%
59
$3,006.07
0.09%
00172205760
PHENY SOD
CAP PROMPT
9
$211.83
0.02%
7
$263.71
0.01%
00173052600
LAMICTAL
CHW 5MG
16
$3,188.09
0.03%
50
$10,124.80
0.07%
00173052700
LAMICTAL
CHW 25MG
75
$19,876.10
0.13%
132
$38,657.30
0.20%
00173063302
LAMICTAL
TAB 25MG
858
$179,210.86
1.47%
1,081
$226,240.44
1.62%
00173064255
LAMICTAL
TAB 100MG
746
$102,270.19
1.28%
1,178
$171,793.16
1.76%
00173064360
LAMICTAL
TAB 150MG
247
$36,494.22
0.42%
405
$70,610.58
0.61%
00173064460
LAMICTAL
TAB 200MG
607
$100,325.54
1.04%
837
$154,786.56
1.25%
00182123301
3
$61.05
0.01%
0
$0.00
0.00%
00182175401
VALPROIC ACD CAP 250MG
18
$580.50
0.03%
87
$4,136.14
0.13%
00185006301
1
$11.95
0.00%
36
$257.80
0.05%
00185006305
7
$133.85
0.01%
10
$50.75
0.01%
00185006310
99
$1,236.16
0.17%
26
$179.42
0.04%
Page 256 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
CLONAZEPAM TAB 1MG
00185006405
CLONAZEPAM TAB 1MG
00185006410
CLONAZEPAM TAB 1MG
00185006501
CLONAZEPAM TAB 2MG
00185006505
$
Market Share*
00185006401
# of Scripts
$0.00
0.00%
81
$451.75
0.12%
5
$82.45
0.01%
77
$600.42
0.12%
88
$1,377.72
0.15%
11
$80.50
0.02%
0
$0.00
0.00%
6
$46.10
0.01%
CLONAZEPAM TAB 2MG
21
$311.40
0.04%
4
$32.20
0.01%
00185006510
CLONAZEPAM TAB 2MG
0
$0.00
0.00%
31
$348.75
0.05%
00228214310
1
$25.35
0.00%
1
$6.85
0.00%
00228214350
3
$36.15
0.01%
32
$373.20
0.05%
00228214396
159
$1,971.35
0.27%
387
$5,170.22
0.58%
00228300311
131
$1,422.07
0.22%
146
$908.82
0.22%
00228300350
326
$3,689.90
0.56%
937
$6,017.68
1.40%
00228300411
CLONAZEPAM TAB 1MG
122
$1,768.74
0.21%
118
$965.14
0.18%
00228300450
CLONAZEPAM TAB 1MG
458
$6,140.18
0.78%
1,022
$7,737.62
1.53%
00228300511
CLONAZEPAM TAB 2MG
110
$1,740.90
0.19%
139
$1,321.87
0.21%
00228300550
CLONAZEPAM TAB 2MG
84
$1,119.24
0.14%
130
$1,169.95
0.19%
00258358701
1
$8.85
0.00%
2
$2.46
0.00%
00258358710
73
$866.78
0.12%
32
$350.20
0.05%
00364036601
PRIMIDONE
5
$187.68
0.01%
0
$0.00
0.00%
00378156001
PHENYTOIN EX CAP 100MG
540
$15,140.01
0.92%
1,448
$42,560.70
2.16%
00378156010
1,296
$37,804.61
2.22%
1,139
$28,821.52
1.70%
00378191001
18
$203.45
0.03%
13
$56.43
0.02%
00378191010
170
$2,110.69
0.29%
390
$2,505.53
0.58%
00378191201
CLONAZEPAM TAB 1MG
26
$400.98
0.04%
18
$157.48
0.03%
00378191210
CLONAZEPAM TAB 1MG
266
$2,926.54
0.45%
337
$2,006.24
0.50%
00378191401
CLONAZEPAM TAB 2MG
26
$307.95
0.04%
39
$227.04
0.06%
00378191405
CLONAZEPAM TAB 2MG
2
$20.35
0.00%
0
$0.00
0.00%
00472006708
PHENYTOIN SUS 125/5ML
178
$6,909.02
0.30%
303
$10,783.67
0.45%
TAB 250MG
0
Page 257 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
00527123101
PRIMIDONE
00527123110
PRIMIDONE
00527130101
PRIMIDONE
00591074601
$
Market Share*
00472021016
# of Scripts
7
$203.42
0.01%
0
$0.00
0.00%
TAB 250MG
116
$5,903.91
0.20%
125
$6,130.90
0.19%
TAB 250MG
3
$177.00
0.01%
3
$157.49
0.00%
TAB 50MG
55
$2,136.35
0.09%
51
$1,663.64
0.08%
113
$895.70
0.19%
120
$679.70
0.18%
00591074605
371
$4,292.21
0.63%
2
$7.80
0.00%
00591074701
CLONAZEPAM TAB 1MG
28
$371.53
0.05%
44
$304.64
0.07%
00591074705
CLONAZEPAM TAB 1MG
302
$3,912.97
0.52%
13
$86.37
0.02%
00591074801
CLONAZEPAM TAB 2MG
82
$1,252.50
0.14%
44
$413.00
0.07%
00591074805
CLONAZEPAM TAB 2MG
26
$349.79
0.04%
13
$91.57
0.02%
00591401201
37
$997.68
0.06%
26
$1,161.79
0.04%
00591532101
PRIMIDONE
TAB 250MG
172
$8,186.61
0.29%
55
$2,568.12
0.08%
00591532110
PRIMIDONE
TAB 250MG
56
$2,910.71
0.10%
14
$583.67
0.02%
00603184058
6
$349.44
0.01%
5
$158.89
0.01%
00603536921
PRIMIDONE
TAB 50MG
48
$1,376.41
0.08%
10
$264.88
0.01%
00603537021
PRIMIDONE
TAB 250MG
31
$1,301.07
0.05%
9
$453.15
0.01%
00603633421
1
$13.55
0.00%
1
$9.55
0.00%
00615045653
172
$1,907.12
0.29%
0
$0.00
0.00%
00615045663
68
$664.02
0.12%
0
$0.00
0.00%
00615045753
CLONAZEPAM TAB 1MG
65
$930.52
0.11%
0
$0.00
0.00%
00615045763
CLONAZEPAM TAB 1MG
39
$506.89
0.07%
0
$0.00
0.00%
00615132553
6
$236.17
0.01%
0
$0.00
0.00%
00615132563
81
$2,404.58
0.14%
0
$0.00
0.00%
00615134353
76
$1,631.64
0.13%
0
$0.00
0.00%
00615134363
311
$7,006.00
0.53%
0
$0.00
0.00%
00615350553
162
$2,079.45
0.28%
0
$0.00
0.00%
00615350563
24
$353.30
0.04%
0
$0.00
0.00%
Page 258 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00615451553
60
$879.75
0.10%
0
00615451563
16
$206.05
0.03%
00641049325
PHENYTOIN INJ 50MG/ML
2
$41.04
0.00%
00677035401
PRIMIDONE
3
$177.00
00677107901
8
00677115533
00677176101
00781670116
00832100700
$0.00
0.00%
0
$0.00
0.00%
1
$30.83
0.00%
0.01%
1
$58.50
0.00%
$258.37
0.01%
16
$1,093.98
0.02%
4
$116.75
0.01%
0
$0.00
0.00%
58
$841.00
0.10%
0
$0.00
0.00%
10
$318.60
0.02%
0
$0.00
0.00%
8
$172.40
0.01%
26
$677.26
0.04%
00832100800
10
$334.06
0.02%
44
$2,794.92
0.07%
00904056080
PRIMIDONE
0
$0.00
0.00%
1
$7.50
0.00%
00904210316
0
$0.00
0.00%
1
$19.98
0.00%
00904385460
0
$0.00
0.00%
9
$135.89
0.01%
00904385560
1
$4.35
0.00%
10
$92.50
0.01%
00904385580
10
$149.64
0.02%
1
$12.85
0.00%
00904534240
0
$0.00
0.00%
7
$55.25
0.01%
00904534260
0
$0.00
0.00%
28
$168.30
0.04%
00904534280
0
$0.00
0.00%
139
$785.40
0.21%
00904534340
CLONAZEPAM TAB 1MG
0
$0.00
0.00%
54
$461.59
0.08%
00904534360
CLONAZEPAM TAB 1MG
0
$0.00
0.00%
4
$35.40
0.01%
00904534380
CLONAZEPAM TAB 1MG
0
$0.00
0.00%
66
$482.31
0.10%
00904534440
CLONAZEPAM TAB 2MG
0
$0.00
0.00%
13
$132.35
0.02%
00904555940
PRIMIDONE
1
$44.11
0.00%
5
$179.80
0.01%
50111085201
53
$1,531.65
0.09%
74
$3,187.74
0.11%
50111090101
ETHOSUXIMIDE CAP 250MG
0
$0.00
0.00%
39
$2,298.28
0.06%
50383079216
10
$281.18
0.02%
4
$182.80
0.01%
50474000148
KEPPRA
0
$0.00
0.00%
19
$2,089.56
0.03%
TAB 250MG
TAB 250MG
TAB 50MG
SOL 100MG/ML
Page 259 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
50474059140
KEPPRA
TAB 250MG
97
$11,249.68
0.17%
114
$15,053.86
0.17%
50474059240
KEPPRA
TAB 500MG
473
$93,197.71
0.81%
668
$135,287.28
1.00%
50474059340
KEPPRA
TAB 750MG
41
$7,943.67
0.07%
119
$24,087.12
0.18%
51079038520
3
$18.00
0.01%
0
$0.00
0.00%
51079087020
7
$64.35
0.01%
0
$0.00
0.00%
51079088120
2
$17.26
0.00%
5
$17.87
0.01%
51079088220
CLONAZEPAM TAB 1MG
2
$19.84
0.00%
0
$0.00
0.00%
51079088221
CLONAZEPAM TAB 1MG
1
$12.43
0.00%
0
$0.00
0.00%
51672400501
112
$1,364.30
0.19%
499
$6,188.05
0.75%
51672400502
208
$2,482.64
0.36%
300
$3,597.75
0.45%
51672400503
401
$5,617.53
0.69%
413
$5,218.32
0.62%
51672404101
37
$834.38
0.06%
123
$2,011.80
0.18%
51672404102
79
$1,285.25
0.14%
121
$2,230.37
0.18%
51672404709
CARBAMAZEPIN SUS 100/5ML
185
$6,336.74
0.32%
165
$6,323.28
0.25%
52544074601
19
$227.51
0.03%
1
$10.15
0.00%
52544074605
46
$550.61
0.08%
0
$0.00
0.00%
52544074701
CLONAZEPAM TAB 1MG
34
$275.48
0.06%
0
$0.00
0.00%
52544074705
CLONAZEPAM TAB 1MG
21
$275.23
0.04%
0
$0.00
0.00%
52544074801
CLONAZEPAM TAB 2MG
5
$90.75
0.01%
0
$0.00
0.00%
52544074805
CLONAZEPAM TAB 2MG
23
$225.65
0.04%
0
$0.00
0.00%
54092017212
CARBATROL
CAP 200MG
86
$4,130.31
0.15%
533
$42,225.15
0.80%
54092017312
CARBATROL
CAP 300MG
50
$2,764.93
0.09%
421
$28,738.50
0.63%
57664027308
0
$0.00
0.00%
12
$98.60
0.02%
57664027313
16
$209.85
0.03%
82
$496.07
0.12%
57664027318
199
$2,025.44
0.34%
419
$2,635.45
0.63%
57664027408
CLONAZEPAM TAB 1MG
6
$122.10
0.01%
23
$179.00
0.03%
57664027413
CLONAZEPAM TAB 1MG
123
$1,638.74
0.21%
477
$3,491.13
0.71%
Page 260 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
57664027418
CLONAZEPAM TAB 1MG
97
$1,565.51
0.17%
81
$582.90
0.12%
57664027508
CLONAZEPAM TAB 2MG
3
$26.55
0.01%
32
$269.42
0.05%
57664027513
CLONAZEPAM TAB 2MG
2
$17.70
0.00%
14
$96.84
0.02%
57664027518
CLONAZEPAM TAB 2MG
2
$35.30
0.00%
85
$910.91
0.13%
57664034213
18
$331.51
0.03%
0
$0.00
0.00%
57664034288
34
$671.19
0.06%
9
$172.76
0.01%
58521017212
CARBATROL
CAP 200MG
522
$26,163.26
0.89%
127
$6,155.54
0.19%
58521017312
CARBATROL
CAP 300MG
393
$23,962.38
0.67%
87
$5,236.71
0.13%
59075065020
DIASTAT PED MIS 2.5M GEL
12
$3,159.21
0.02%
1
$187.53
0.00%
59075065120
DIASTAT PED MIS 5MG GEL
27
$7,322.67
0.05%
9
$2,813.16
0.01%
59075065220
DIASTAT UNIV MIS 10MG GEL
45
$8,945.41
0.08%
29
$6,117.32
0.04%
59075065420
DIASTAT
MIS 15MG GEL
14
$2,744.67
0.02%
3
$562.59
0.00%
59075065520
DIASTAT
MIS 20MG GEL
1
$177.10
0.00%
0
$0.00
0.00%
59075067112
CARBATROL
59075068010
ZONEGRAN
59075069010
MYSOLINE
59075069050
CAP 200MG
2
$15.18
0.00%
0
$0.00
0.00%
383
$60,919.31
0.66%
445
$79,635.20
0.66%
TAB 50MG
97
$4,329.59
0.17%
36
$1,377.36
0.05%
MYSOLINE
TAB 50MG
0
$0.00
0.00%
4
$286.53
0.01%
59075069110
MYSOLINE
TAB 250MG
51
$6,469.85
0.09%
73
$8,455.11
0.11%
59075069111
MYSOLINE
TAB 250MG
0
$0.00
0.00%
2
$214.19
0.00%
60432012916
CARBAMAZEPIN SUS 100/5ML
0
$0.00
0.00%
8
$202.31
0.01%
60432013108
PHENYTOIN SUS 125/5ML
287
$9,841.73
0.49%
269
$9,912.80
0.40%
60432062116
360
$13,160.21
0.62%
443
$16,113.95
0.66%
60505018300
7
$88.95
0.01%
65
$706.00
0.10%
62037095201
3
$38.85
0.01%
0
$0.00
0.00%
62037095205
150
$1,755.95
0.26%
51
$376.75
0.08%
62037095301
CLONAZEPAM TAB 1MG
19
$273.25
0.03%
5
$28.55
0.01%
62037095305
CLONAZEPAM TAB 1MG
46
$560.66
0.08%
13
$122.25
0.02%
CAP 100MG
Page 261 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
62037095401
CLONAZEPAM TAB 2MG
10
$152.50
0.02%
0
$0.00
0.00%
62037095405
CLONAZEPAM TAB 2MG
88
$1,085.10
0.15%
21
$172.13
0.03%
62269035324
2
$16.30
0.00%
0
$0.00
0.00%
62269035424
CLONAZEPAM TAB 1MG
5
$90.05
0.01%
3
$18.75
0.00%
62794067001
PHENYTEK
CAP 200MG
5
$126.53
0.01%
17
$444.26
0.03%
62794067093
PHENYTEK
CAP 200MG
8
$260.64
0.01%
25
$587.05
0.04%
62794075001
PHENYTEK
CAP 300MG
1
$44.50
0.00%
12
$318.25
0.02%
62794075093
PHENYTEK
CAP 300MG
14
$410.11
0.02%
10
$343.58
0.01%
63459040201
GABITRIL
TAB 2MG
112
$8,628.12
0.19%
46
$4,523.94
0.07%
63459040401
GABITRIL
TAB 4MG
210
$20,212.98
0.36%
160
$17,115.09
0.24%
63459041201
GABITRIL
TAB 12MG
25
$3,038.22
0.04%
30
$2,515.65
0.04%
63459041601
GABITRIL
TAB 16MG
19
$2,390.53
0.03%
32
$3,437.75
0.05%
63739004501
9
$144.00
0.02%
0
$0.00
0.00%
63739026301
0
$0.00
0.00%
3
$31.65
0.00%
63739026401
CLONAZEPAM TAB 1MG
0
$0.00
0.00%
3
$18.15
0.00%
66490065020
DIASTAT PED MIS 2.5M GEL
0
$0.00
0.00%
5
$253.41
0.01%
66490065120
DIASTAT PED MIS 5MG GEL
0
$0.00
0.00%
23
$4,851.09
0.03%
66490065220
DIASTAT UNIV MIS 10MG GEL
0
$0.00
0.00%
31
$9,057.97
0.05%
66490065420
DIASTAT
0
$0.00
0.00%
11
$4,202.33
0.02%
66490065520
DIASTAT ADUL MIS 20MG GEL
5
$1,002.55
0.01%
7
$2,366.62
0.01%
66490069010
MYSOLINE
TAB 50MG
3
$149.34
0.01%
103
$4,668.22
0.15%
66490069050
MYSOLINE
TAB 50MG
0
$0.00
0.00%
5
$420.74
0.01%
66490069110
MYSOLINE
TAB 250MG
6
$718.73
0.01%
186
$22,294.89
0.28%
66490069111
MYSOLINE
TAB 250MG
0
$0.00
0.00%
12
$1,472.17
0.02%
66490069181
MYSOLINE
TAB 250MG
0
$0.00
0.00%
1
$182.96
0.00%
MIS 15MG GEL
MISC - ANTIDEPRESSANTS--Join with SSRI class
Page 262 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
PROZAC WEEKL CAP 90MG
00002321045
SARAFEM
00002322045
SARAFEM
00002400602
PROZAC
00002400630
$
Market Share*
00002300475
# of Scripts
399
$30,342.14
0.38%
CAP 10MG
38
$1,766.55
0.04%
CAP 20MG
133
$9,517.51
0.13%
TAB 10MG
17
$1,635.32
0.02%
PROZAC
TAB 10MG
44
$3,470.39
00008070101
EFFEXOR
TAB 25MG
92
00008070102
EFFEXOR
TAB 25MG
1
00008070301
EFFEXOR
TAB 50MG
00008070302
EFFEXOR
00008070401
00008070402
$3,793.76
0.03%
4
$288.65
0.00%
21
$1,463.39
0.02%
2
$130.15
0.00%
0.04%
10
$817.67
0.01%
$5,371.68
0.09%
100
$7,552.39
0.07%
$20.00
0.00%
0
$0.00
0.00%
43
$3,204.70
0.04%
59
$5,572.48
0.04%
TAB 50MG
2
$18.06
0.00%
1
$97.81
0.00%
EFFEXOR
TAB 75MG
476
$36,191.45
0.46%
461
$41,421.22
0.34%
EFFEXOR
TAB 75MG
0
$0.00
0.00%
2
$165.85
0.00%
00008070501
EFFEXOR
TAB 100MG
77
$5,765.83
0.07%
86
$7,160.75
0.06%
00008078101
EFFEXOR
TAB 37.5MG
251
$15,276.35
0.24%
284
$21,369.75
0.21%
00008083301
EFFEXOR XR CAP 75MG
4,347
$359,066.48
4.17%
4,972
$417,192.27
3.70%
00008083303
EFFEXOR XR CAP 75MG
202
$16,968.57
0.19%
63
$5,283.99
0.05%
00008083601
EFFEXOR XR CAP 150MG
4,905
$455,863.72
4.71%
7,015
$760,045.24
5.22%
00008083603
EFFEXOR XR CAP 150MG
11
$960.10
0.01%
2
$185.34
0.00%
00008083701
EFFEXOR XR CAP 37.5MG
1,162
$67,705.68
1.12%
1,194
$85,492.33
0.89%
00008083703
EFFEXOR XR CAP 37.5MG
1
$30.76
0.00%
2
$153.60
0.00%
00029320613
PAXIL CR
TAB 12.5MG
676
$47,217.25
0.65%
1,569
$111,252.07
1.17%
00029320713
PAXIL CR
TAB 25MG
1,361
$112,509.63
1.31%
3,429
$306,554.33
2.55%
00029320813
PAXIL CR
TAB 37.5MG
247
$18,372.47
0.24%
838
$71,316.67
0.62%
00029321013
PAXIL
TAB 10MG
2,388
$157,850.78
2.29%
1,648
$117,201.79
1.23%
00029321113
PAXIL
TAB 20MG
529
$37,284.37
0.51%
404
$30,732.67
0.30%
00029321120
PAXIL
TAB 20MG
5,713
$408,742.03
5.48%
3,932
$295,731.20
2.92%
00029321213
PAXIL
TAB 30MG
2,453
$210,531.16
2.35%
1,741
$159,077.61
1.29%
00029321313
PAXIL
TAB 40MG
3,571
$286,466.64
3.43%
2,621
$227,755.20
1.95%
46
Page 263 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
PAXIL
00032420201
LUVOX
00032420501
LUVOX
00032421001
SUS 10MG/5ML
$
Market Share*
00029321548
# of Scripts
99
$8,890.36
0.10%
127
$13,619.63
0.09%
TAB 25MG
3
$311.90
0.00%
0
$0.00
0.00%
TAB 50MG
5
$643.43
0.00%
0
$0.00
0.00%
LUVOX
TAB 100MG
18
$2,368.34
0.02%
0
$0.00
0.00%
00049490041
ZOLOFT
TAB 50MG
10
$663.00
0.01%
7
$300.23
0.01%
00049490066
ZOLOFT
TAB 50MG
5,940
$398,719.06
5.70%
4,466
$264,716.78
3.32%
00049490073
ZOLOFT
TAB 50MG
2,902
$185,182.24
2.79%
2,405
$138,272.58
1.79%
00049491041
ZOLOFT
TAB 100MG
12
$1,074.53
0.01%
45
$3,624.08
0.03%
00049491066
ZOLOFT
TAB 100MG
6,415
$529,135.43
6.16%
11,246
$848,823.72
8.36%
00049491073
ZOLOFT
TAB 100MG
2,362
$178,191.02
2.27%
4,506
$315,328.55
3.35%
00049494023
ZOLOFT
CON 20MG/ML
62
$3,173.83
0.06%
113
$7,573.72
0.08%
00049496050
ZOLOFT
TAB 25MG
2,378
$147,530.83
2.28%
1,441
$85,258.55
1.07%
00052010530
REMERON
1,716
$113,235.92
1.65%
23
$1,346.12
0.02%
00052010630
REMERON SLTB TAB 15MG
459
$27,106.69
0.44%
102
$5,271.47
0.08%
00052010693
10
$654.24
0.01%
5
$176.38
0.00%
00052010730
REMERON
TAB 30MG
1,438
$113,573.49
1.38%
12
$926.21
0.01%
00052010790
REMERON
TAB 30MG
8
$645.97
0.01%
0
$0.00
0.00%
00052010830
351
$24,908.87
0.34%
84
$4,758.37
0.06%
00052010893
12
$1,008.92
0.01%
1
$73.91
0.00%
00052010930
REMERON
602
$43,447.73
0.58%
25
$1,938.85
0.02%
00052011030
127
$7,912.09
0.12%
28
$1,850.00
0.02%
00054467221
NEFAZODONE TAB 100MG
0
$0.00
0.00%
14
$685.04
0.01%
00054467321
0
$0.00
0.00%
14
$1,259.65
0.01%
00054467421
0
$0.00
0.00%
6
$511.13
0.00%
00054467713
MIRTAZAPINE TAB 30MG
0
$0.00
0.00%
16
$389.64
0.01%
00054467813
0
$0.00
0.00%
1
$75.26
0.00%
00087003147
SERZONE
77
$4,990.85
0.07%
56
$3,390.90
0.04%
TAB 15MG
TAB 45MG
TAB 50MG
Page 264 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00087003231
SERZONE
TAB 100MG
448
$39,191.04
0.43%
172
$17,524.95
0.13%
00087003331
SERZONE
TAB 200MG
388
$33,547.22
0.37%
179
$16,392.55
0.13%
00087003931
SERZONE
TAB 150MG
385
$36,842.50
0.37%
144
$14,974.94
0.11%
00087004131
SERZONE
TAB 250MG
51
$3,494.44
0.05%
24
$1,965.19
0.02%
00087077541
DESYREL
TAB 50MG
9
$475.80
0.01%
1
$62.18
0.00%
00087077641
DESYREL
TAB 100MG
0
$0.00
0.00%
3
$310.98
0.00%
00087077843
DESYREL
TAB 150MG
28
$4,730.56
0.03%
15
$1,557.45
0.01%
00087079641
DESYREL
TAB 300MG
10
$2,085.36
0.01%
4
$619.39
0.00%
00093028001
BUPROPION
TAB 75MG
297
$7,368.16
0.29%
372
$8,031.64
0.28%
00093029001
BUPROPION
TAB 100MG
218
$7,229.39
0.21%
306
$8,257.94
0.23%
00093063701
TRAZODONE
TAB 50MG
1,841
$9,116.27
1.77%
2,740
$9,072.78
2.04%
00093063710
TRAZODONE
TAB 50MG
99
$530.00
0.10%
38
$130.00
0.03%
00093063801
TRAZODONE
TAB 100MG
1,196
$7,952.52
1.15%
1,649
$8,317.37
1.23%
00093102406
0
$0.00
0.00%
123
$11,459.30
0.09%
00093102506
0
$0.00
0.00%
118
$10,011.20
0.09%
00093102606
0
$0.00
0.00%
16
$1,128.22
0.01%
00093104201
FLUOXETINE CAP 10MG
67
$592.05
0.06%
110
$817.96
0.08%
00093104301
FLUOXETINE CAP 20MG
133
$1,417.56
0.13%
68
$822.41
0.05%
00093610812
FLUOXETINE LIQ 20MG/5ML
155
$17,123.59
0.15%
83
$2,188.09
0.06%
00093711306
0
$0.00
0.00%
96
$8,973.80
0.07%
00093717801
NEFAZODONE TAB 50MG
0
$0.00
0.00%
18
$1,106.95
0.01%
00093718856
FLUOXETINE TAB 10MG
48
$389.30
0.05%
74
$495.33
0.06%
00093719856
FLUOXETINE CAP 40MG
29
$3,175.44
0.03%
50
$525.81
0.04%
00093720656
0
$0.00
0.00%
679
$12,480.78
0.50%
00093720756
0
$0.00
0.00%
638
$14,094.64
0.47%
00093720856
0
$0.00
0.00%
120
$8,422.83
0.09%
00121072104
3
$314.11
0.00%
67
$1,105.05
0.05%
Page 265 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00172433260
0
$0.00
0.00%
00172433310
0
$0.00
0.00%
00172433360
0
$0.00
0.00%
00172433410
0
$0.00
0.00%
00172433460
0
$0.00
00172433560
0
00172434360
NEFAZODONE TAB 50MG
0
00172435660
FLUOXETINE CAP 20MG
00172435670
FLUOXETINE CAP 20MG
00172435680
FLUOXETINE CAP 20MG
00172436360
FLUOXETINE CAP 10MG
00172436370
FLUOXETINE CAP 10MG
00172436380
FLUOXETINE CAP 10MG
00172438960
FLUVOXAMINE TAB 25MG
00172439160
00172439260
00172451060
$3,342.03
0.04%
2
$105.64
0.00%
41
$3,562.74
0.03%
4
$307.29
0.00%
0.00%
32
$2,828.38
0.02%
$0.00
0.00%
10
$532.20
0.01%
$0.00
0.00%
28
$1,517.20
0.02%
33
$368.35
0.03%
214
$2,266.28
0.16%
108
$1,331.44
0.10%
258
$2,700.84
0.19%
0
$0.00
0.00%
150
$1,608.64
0.11%
20
$168.35
0.02%
119
$960.75
0.09%
0
$0.00
0.00%
2
$16.30
0.00%
12
$95.55
0.01%
26
$171.55
0.02%
8
$384.40
0.01%
33
$542.74
0.02%
29
$1,331.50
0.03%
88
$1,976.90
0.07%
99
$9,100.82
0.10%
161
$6,160.55
0.12%
FLUOXETINE TAB 10MG
98
$856.65
0.09%
13
$116.11
0.01%
00172451070
FLUOXETINE TAB 10MG
0
$0.00
0.00%
4
$33.52
0.00%
00172451080
FLUOXETINE TAB 10MG
1
$14.35
0.00%
6
$75.20
0.00%
00173013555
WELLBUTRIN TAB 150MG SR
7,479
$658,290.04
7.18%
8,910
$836,570.10
6.63%
00173017755
WELLBUTRIN TAB 75MG
23
$1,292.56
0.02%
10
$1,198.53
0.01%
00173017855
WELLBUTRIN TAB 100MG
22
$1,033.98
0.02%
5
$353.72
0.00%
00173072200
418
$60,940.93
0.40%
1,246
$196,017.25
0.93%
00173073001
WELLBUTRIN TAB XL 150MG
0
$0.00
0.00%
525
$43,025.37
0.39%
00173073101
WELLBUTRIN TAB XL 300MG
0
$0.00
0.00%
934
$86,588.71
0.69%
00173094755
2,643
$239,894.15
2.54%
2,464
$211,345.17
1.83%
00182129801
TRAZODONE
2
$37.30
0.00%
0
$0.00
0.00%
TAB 150MG
50
Page 266 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00185001701
69
$3,443.62
0.07%
00185002010
0
$0.00
00185002030
0
$0.00
00185002701
202
00185008001
FLUOXETINE CAP 10MG
00185008010
00185008501
35
$992.10
0.03%
0.00%
6
$107.70
0.00%
0.00%
24
$448.68
0.02%
$14,717.02
0.19%
184
$3,928.37
0.14%
3
$26.55
0.00%
0
$0.00
0.00%
FLUOXETINE CAP 10MG
2
$14.70
0.00%
0
$0.00
0.00%
FLUOXETINE CAP 20MG
5
$67.25
0.00%
0
$0.00
0.00%
00185008510
FLUOXETINE CAP 20MG
58
$779.70
0.06%
16
$158.60
0.01%
00185015701
282
$32,846.02
0.27%
314
$12,224.97
0.23%
00185015705
0
$0.00
0.00%
3
$56.85
0.00%
00185021210
0
$0.00
0.00%
76
$1,943.37
0.06%
00185021230
0
$0.00
0.00%
3
$76.95
0.00%
00185022230
0
$0.00
0.00%
12
$868.68
0.01%
00228243910
TRAZODONE
TAB 50MG
0
$0.00
0.00%
3
$10.20
0.00%
00228243950
TRAZODONE
TAB 50MG
35
$157.13
0.03%
24
$97.71
0.02%
00228244110
TRAZODONE
TAB 100MG
0
$0.00
0.00%
1
$3.25
0.00%
00228265511
53
$2,615.20
0.05%
0
$0.00
0.00%
00228265611
58
$4,899.12
0.06%
5
$77.25
0.00%
00228270211
FLUOXETINE CAP 10MG
141
$1,222.24
0.14%
57
$404.52
0.04%
00228270311
FLUOXETINE CAP 20MG
718
$8,967.51
0.69%
41
$562.02
0.03%
00228270411
3
$144.15
0.00%
0
$0.00
0.00%
00364210901
TRAZODONE
TAB 50MG
53
$272.98
0.05%
13
$48.45
0.01%
00364210902
TRAZODONE
TAB 50MG
13
$59.17
0.01%
9
$27.77
0.01%
00364211001
TRAZODONE
TAB 100MG
88
$587.58
0.08%
57
$302.35
0.04%
00364211002
TRAZODONE
TAB 100MG
5
$32.55
0.00%
11
$56.45
0.01%
00364230001
TRAZODONE
TAB 150MG
16
$204.80
0.02%
0
$0.00
0.00%
00378006001
MAPROTILINE TAB 25MG
0
$0.00
0.00%
1
$13.03
0.00%
Page 267 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
00378009201
00378040701
$
Market Share*
00378008701
# of Scripts
5
$201.48
0.00%
6
$236.22
0.01%
19
$912.60
0.02%
00378041201
58
$2,595.28
0.06%
00378041401
171
$16,122.05
00378043301
BUPROPION
TAB 75MG
86
00378043501
BUPROPION
TAB 100MG
70
00378205291
00378205391
$109.06
0.00%
3
$45.12
0.00%
12
$259.10
0.01%
105
$2,374.41
0.08%
0.16%
214
$8,489.35
0.16%
$2,505.87
0.08%
96
$1,944.39
0.07%
$2,549.98
0.07%
46
$1,192.75
0.03%
0
$0.00
0.00%
3
$234.78
0.00%
0
$0.00
0.00%
1
$79.68
0.00%
00378205491
0
$0.00
0.00%
1
$86.65
0.00%
00378351593
0
$0.00
0.00%
910
$15,818.78
0.68%
00378353093
0
$0.00
0.00%
851
$18,544.01
0.63%
00378354593
0
$0.00
0.00%
350
$24,989.87
0.26%
00378422001
FLUOXETINE CAP 20MG
33
$336.45
0.03%
79
$903.80
0.06%
00406066101
FLUOXETINE CAP 10MG
10
$88.60
0.01%
54
$386.35
0.04%
00406066301
FLUOXETINE CAP 20MG
40
$479.94
0.04%
260
$2,660.61
0.19%
00406066303
FLUOXETINE CAP 20MG
0
$0.00
0.00%
3
$27.15
0.00%
00406066305
FLUOXETINE CAP 20MG
166
$1,923.69
0.16%
140
$1,394.81
0.10%
00406066701
49
$3,799.76
0.05%
47
$804.75
0.03%
00456201001
LEXAPRO
TAB 10MG
1,919
$114,258.02
1.84%
7,245
$455,972.27
5.39%
00456201063
LEXAPRO
TAB 10MG
1
$59.55
0.00%
2
$104.32
0.00%
00456202001
LEXAPRO
TAB 20MG
374
$23,411.63
0.36%
3,909
$259,448.02
2.91%
00456202063
LEXAPRO
TAB 20MG
2
$133.47
0.00%
8
$528.22
0.01%
00456210108
LEXAPRO
SOL 5MG/5ML
0
$0.00
0.00%
17
$1,639.41
0.01%
00456401001
CELEXA
TAB 10MG
762
$49,039.52
0.73%
1,176
$81,275.22
0.87%
00456402001
CELEXA
TAB 20MG
5,821
$361,780.60
5.59%
5,522
$371,264.90
4.11%
00456402063
CELEXA
TAB 20MG
18
$1,147.97
0.02%
6
$320.57
0.00%
4
Page 268 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00456404001
CELEXA
TAB 40MG
4,180
$295,539.14
4.01%
4,310
$326,075.99
3.20%
00456404063
CELEXA
TAB 40MG
13
$877.11
0.01%
2
$90.79
0.00%
00456413004
CELEXA
SOL 10MG/5ML
17
$996.67
0.02%
0
$0.00
0.00%
00456413008
CELEXA
SOL 10MG/5ML
37
$3,733.32
0.04%
71
$5,390.78
0.05%
00555048902
TRAZODONE
TAB 50MG
96
$457.51
0.09%
188
$631.80
0.14%
00555048904
TRAZODONE
TAB 50MG
24
$120.88
0.02%
28
$88.99
0.02%
00555049002
TRAZODONE
TAB 100MG
141
$910.81
0.14%
203
$1,029.23
0.15%
00555049004
TRAZODONE
TAB 100MG
0
$0.00
0.00%
2
$6.50
0.00%
00555073202
TRAZODONE
TAB 150MG
378
$5,025.18
0.36%
582
$7,821.62
0.43%
00555073204
TRAZODONE
TAB 150MG
0
$0.00
0.00%
1
$17.65
0.00%
00555073302
TRAZODONE
TAB 300MG
24
$2,814.81
0.02%
13
$1,414.44
0.01%
00555087602
FLUOXETINE CAP 10MG
246
$2,120.83
0.24%
309
$2,308.65
0.23%
00555087702
FLUOXETINE CAP 20MG
2,645
$33,615.53
2.54%
3,645
$40,724.45
2.71%
00555096702
15
$972.70
0.01%
8
$206.35
0.01%
00555096802
23
$1,729.58
0.02%
25
$689.28
0.02%
00555096902
45
$4,739.63
0.04%
34
$1,218.44
0.03%
00591082601
FLUOXETINE CAP 10MG
1
$8.85
0.00%
0
$0.00
0.00%
00591082701
FLUOXETINE CAP 20MG
0
$0.00
0.00%
192
$2,130.20
0.14%
00591082710
FLUOXETINE CAP 20MG
0
$0.00
0.00%
23
$237.73
0.02%
00591082730
FLUOXETINE CAP 20MG
0
$0.00
0.00%
29
$224.34
0.02%
00591111730
0
$0.00
0.00%
827
$14,421.27
0.61%
00591111830
0
$0.00
0.00%
434
$9,512.25
0.32%
00591111930
0
$0.00
0.00%
186
$12,468.80
0.14%
00591230001
TRAZODONE
TAB 150MG
0
$0.00
0.00%
1
$5.31
0.00%
00591559901
TRAZODONE
TAB 100MG
451
$3,013.40
0.43%
588
$3,252.11
0.44%
00591559910
TRAZODONE
TAB 100MG
160
$1,092.68
0.15%
301
$1,586.49
0.22%
00591560001
TRAZODONE
TAB 50MG
478
$2,380.02
0.46%
675
$2,361.04
0.50%
Page 269 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
TRAZODONE
TAB 50MG
00603614528
TRAZODONE
TAB 100MG
00615257863
TRAZODONE
TAB 50MG
00615257953
TRAZODONE
TAB 100MG
00615257963
TRAZODONE
TAB 100MG
00615550253
00615550263
00677113301
TRAZODONE
00677113305
$
Market Share*
00591560010
# of Scripts
$2,927.86
0.59%
638
$2,436.64
0.47%
14
$99.20
0.01%
0
$0.00
0.00%
468
$2,043.29
0.45%
0
$0.00
0.00%
130
$760.49
0.12%
0
$0.00
0.00%
41
$273.99
0.04%
0
$0.00
0.00%
FLUOXETINE TAB 20MG
144
$17,727.44
0.14%
0
$0.00
0.00%
FLUOXETINE TAB 20MG
25
$2,212.15
0.02%
0
$0.00
0.00%
TAB 50MG
7
$33.77
0.01%
17
$67.05
0.01%
TRAZODONE
TAB 50MG
63
$310.43
0.06%
45
$176.41
0.03%
00677113401
TRAZODONE
TAB 100MG
106
$727.94
0.10%
137
$702.99
0.10%
00677113405
TRAZODONE
TAB 100MG
45
$306.09
0.04%
65
$349.21
0.05%
00677130201
TRAZODONE
TAB 150MG
34
$380.60
0.03%
36
$375.71
0.03%
00677130205
TRAZODONE
TAB 150MG
0
$0.00
0.00%
1
$17.65
0.00%
00777310402
PROZAC
CAP 10MG
74
$6,221.58
0.07%
24
$1,912.46
0.02%
00777310502
PROZAC
CAP 20MG
444
$66,417.18
0.43%
200
$35,889.79
0.15%
00777310507
PROZAC
CAP 20MG
7
$319.19
0.01%
0
$0.00
0.00%
00777310530
PROZAC
CAP 20MG
94
$14,068.28
0.09%
51
$10,307.94
0.04%
00777310730
PROZAC
CAP 40MG
55
$9,592.26
0.05%
66
$14,206.69
0.05%
00777512058
PROZAC
LIQ 20MG/5ML
57
$5,608.43
0.05%
17
$1,369.44
0.01%
00781105301
BUPROPION
TAB 75MG
171
$4,564.60
0.16%
154
$2,982.27
0.11%
00781105310
BUPROPION
TAB 75MG
41
$1,197.10
0.04%
4
$35.90
0.00%
00781106401
BUPROPION
TAB 100MG
123
$4,416.82
0.12%
118
$2,967.65
0.09%
00781106410
BUPROPION
TAB 100MG
41
$1,164.85
0.04%
3
$92.85
0.00%
00781180701
TRAZODONE
TAB 50MG
17
$81.29
0.02%
12
$42.75
0.01%
00781180705
TRAZODONE
TAB 50MG
6
$28.88
0.01%
0
$0.00
0.00%
00781180710
TRAZODONE
TAB 50MG
55
$301.92
0.05%
2
$12.50
0.00%
00781180801
TRAZODONE
TAB 100MG
24
$147.35
0.02%
10
$44.70
0.01%
611
Page 270 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
TRAZODONE
00781282201
00781282301
TAB 150MG
$
Market Share*
00781182601
# of Scripts
5
$51.45
0.00%
0
$0.00
0.00%
FLUOXETINE CAP 20MG
2,343
$30,442.83
2.25%
3,100
$34,838.92
2.31%
FLUOXETINE CAP 10MG
584
$5,052.92
0.56%
583
$4,101.26
0.43%
00781282401
FLUOXETINE CAP 40MG
137
$20,807.60
0.13%
77
$1,068.86
0.06%
00781504001
7
$295.10
0.01%
6
$133.50
0.00%
00781504010
4
$186.24
0.00%
3
$66.75
0.00%
00781504101
53
$3,062.98
0.05%
28
$1,047.37
0.02%
00781504110
7
$340.69
0.01%
0
$0.00
0.00%
00781504201
80
$6,470.08
0.08%
54
$2,099.20
0.04%
00904399260
TRAZODONE
TAB 150MG
3
$85.65
0.00%
0
$0.00
0.00%
00904521940
TRAZODONE
TAB 50MG
0
$0.00
0.00%
89
$320.49
0.07%
00904521980
TRAZODONE
TAB 50MG
0
$0.00
0.00%
51
$190.11
0.04%
00904522040
TRAZODONE
TAB 100MG
1
$5.25
0.00%
128
$646.35
0.10%
00904522060
TRAZODONE
TAB 100MG
0
$0.00
0.00%
2
$11.50
0.00%
17236080810
FLUOXETINE CAP 20MG
0
$0.00
0.00%
16
$199.60
0.01%
49884073201
FLUOXETINE CAP 10MG
83
$772.00
0.08%
146
$1,168.60
0.11%
49884073210
FLUOXETINE CAP 10MG
16
$131.50
0.02%
87
$577.34
0.06%
49884073301
FLUOXETINE CAP 20MG
283
$3,579.95
0.27%
282
$2,916.90
0.21%
49884073310
FLUOXETINE CAP 20MG
407
$4,832.20
0.39%
533
$6,185.39
0.40%
49884073401
FLUOXETINE TAB 10MG
273
$2,341.91
0.26%
305
$2,122.93
0.23%
49884073410
FLUOXETINE TAB 10MG
16
$113.70
0.02%
149
$1,176.29
0.11%
49884073411
FLUOXETINE TAB 10MG
173
$1,451.83
0.17%
151
$1,137.68
0.11%
49884073501
FLUOXETINE TAB 20MG
340
$34,033.44
0.33%
202
$2,428.24
0.15%
49884073510
FLUOXETINE TAB 20MG
195
$16,326.68
0.19%
427
$5,657.97
0.32%
49884073511
FLUOXETINE TAB 20MG
55
$4,326.27
0.05%
38
$421.07
0.03%
49884074301
FLUOXETINE CAP 40MG
32
$4,965.78
0.03%
21
$178.05
0.02%
49884074305
FLUOXETINE CAP 40MG
1
$14.95
0.00%
0
$0.00
0.00%
Page 271 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
49884074311
FLUOXETINE CAP 40MG
132
$13,916.89
0.13%
49884075101
FLUOXETINE CAP 20MG
0
$0.00
0.00%
49884075110
FLUOXETINE CAP 20MG
0
$0.00
0.00%
49884087311
0
$0.00
0.00%
49884087611
PAROXETINE TAB 10MG
0
$0.00
49884087701
PAROXETINE TAB 20MG
0
49884087711
PAROXETINE TAB 20MG
0
49884087811
PAROXETINE TAB 30MG
49884087911
PAROXETINE TAB 40MG
49884091802
50111043301
TRAZODONE
TAB 50MG
50111043302
TRAZODONE
TAB 50MG
50111043303
TRAZODONE
TAB 50MG
50111043401
TRAZODONE
TAB 100MG
50111043402
TRAZODONE
TAB 100MG
50111043403
TRAZODONE
TAB 100MG
50111044101
TRAZODONE
50111044102
TRAZODONE
50111064701
FLUOXETINE CAP 10MG
50111064702
$1,072.16
0.08%
26
$622.34
0.02%
156
$5,432.82
0.12%
1
$75.25
0.00%
0.00%
57
$2,723.26
0.04%
$0.00
0.00%
87
$4,469.18
0.06%
$0.00
0.00%
17
$1,074.31
0.01%
0
$0.00
0.00%
51
$3,382.23
0.04%
0
$0.00
0.00%
78
$4,671.27
0.06%
0
$0.00
0.00%
1
$82.69
0.00%
86
$420.17
0.08%
1,452
$4,832.84
1.08%
193
$823.69
0.19%
342
$1,123.72
0.25%
1,064
$4,833.15
1.02%
2,400
$9,590.94
1.78%
82
$500.35
0.08%
1,044
$5,409.49
0.78%
285
$1,763.19
0.27%
460
$2,362.44
0.34%
146
$999.64
0.14%
344
$1,985.13
0.26%
TAB 150MG
181
$2,151.41
0.17%
291
$3,324.30
0.22%
TAB 150MG
158
$1,695.93
0.15%
232
$2,436.65
0.17%
3
$26.55
0.00%
5
$33.20
0.00%
FLUOXETINE CAP 10MG
58
$465.60
0.06%
46
$313.07
0.03%
50111064801
FLUOXETINE CAP 20MG
64
$619.55
0.06%
113
$1,315.16
0.08%
50111064802
FLUOXETINE CAP 20MG
0
$0.00
0.00%
36
$305.07
0.03%
50111064803
FLUOXETINE CAP 20MG
159
$1,850.74
0.15%
295
$3,210.31
0.22%
50111064844
FLUOXETINE CAP 20MG
13
$161.20
0.01%
111
$1,293.05
0.08%
51079042720
TRAZODONE
TAB 50MG
2
$6.98
0.00%
4
$14.99
0.00%
51079042820
TRAZODONE
TAB 100MG
5
$21.60
0.00%
0
$0.00
0.00%
51079097120
FLUOXETINE CAP 20MG
1
$20.35
0.00%
12
$91.12
0.01%
101
Page 272 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
52152022630
0
$0.00
0.00%
52152022730
0
$0.00
52152022830
0
$0.00
52544037401
3
53489037410
FLUOXETINE CAP 20MG
53489051001
TRAZODONE
53489051005
TRAZODONE
53489051010
146
$2,687.67
0.11%
0.00%
88
$1,927.33
0.07%
0.00%
128
$8,843.41
0.10%
$30.00
0.00%
0
$0.00
0.00%
5
$70.25
0.00%
0
$0.00
0.00%
TAB 50MG
792
$3,886.07
0.76%
26
$77.00
0.02%
TAB 50MG
16
$86.72
0.02%
6
$17.25
0.00%
TRAZODONE
TAB 50MG
32
$177.41
0.03%
93
$371.91
0.07%
53489051101
TRAZODONE
TAB 100MG
538
$3,436.45
0.52%
23
$111.47
0.02%
53489051105
TRAZODONE
TAB 100MG
39
$242.43
0.04%
45
$197.02
0.03%
53489051110
TRAZODONE
TAB 100MG
98
$518.09
0.09%
117
$532.07
0.09%
53489051701
TRAZODONE
TAB 150MG
9
$128.21
0.01%
23
$281.63
0.02%
53489051705
TRAZODONE
TAB 150MG
22
$316.30
0.02%
46
$670.54
0.03%
59772317101
TRAZODONE
TAB 150MG
755
$9,926.37
0.72%
791
$9,595.18
0.59%
59772317102
TRAZODONE
TAB 150MG
34
$420.63
0.03%
47
$581.79
0.03%
60505008301
PAROXETINE TAB 20MG
0
$0.00
0.00%
1,280
$85,242.92
0.95%
60505008304
PAROXETINE TAB 20MG
0
$0.00
0.00%
44
$2,662.94
0.03%
60505008401
PAROXETINE TAB 30MG
0
$0.00
0.00%
545
$47,468.68
0.41%
60505009701
PAROXETINE TAB 10MG
0
$0.00
0.00%
422
$25,308.67
0.31%
60505010101
PAROXETINE TAB 40MG
0
$0.00
0.00%
959
$69,904.24
0.71%
60505016401
4
$145.50
0.00%
5
$125.15
0.00%
60505016501
36
$2,474.99
0.03%
50
$1,188.85
0.04%
60505016601
51
$3,720.14
0.05%
90
$3,345.35
0.07%
60505035201
10
$1,286.34
0.01%
30
$850.75
0.02%
62037053801
FLUOXETINE CAP 10MG
56
$494.23
0.05%
53
$317.34
0.04%
62037053805
FLUOXETINE CAP 10MG
1
$9.15
0.00%
1
$1.97
0.00%
62037053810
FLUOXETINE CAP 10MG
3
$26.35
0.00%
45
$321.70
0.03%
Page 273 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
FLUOXETINE CAP 20MG
62037053905
FLUOXETINE CAP 20MG
62037053910
FLUOXETINE CAP 20MG
$
Market Share*
62037053901
# of Scripts
6
$93.10
0.01%
0
$0.00
0.00%
122
$1,637.10
0.12%
3
$33.90
0.00%
3
$55.05
0.00%
404
$4,599.43
0.30%
MISC - ANXIOLYTICS
00049560066
ATARAX
TAB 10MG
0
$0.00
0.00%
1
$19.04
0.01%
00069541066
VISTARIL
CAP 25MG
3
$161.07
0.04%
0
$0.00
0.00%
00069542066
VISTARIL
CAP 50MG
6
$613.19
0.09%
5
$595.05
0.06%
00069544093
VISTARIL
SUS 25MG/5ML
56
$1,045.21
0.80%
64
$732.76
0.83%
00069544097
VISTARIL
SUS 25MG/5ML
32
$873.43
0.46%
18
$270.65
0.23%
00074118701
DROPERIDOL INJ 2.5MG/ML
3
$368.45
0.04%
0
$0.00
0.00%
00074226932
DROPERIDOL INJ 2.5MG/ML
1
$65.05
0.01%
0
$0.00
0.00%
00087081841
BUSPAR
TAB 5MG
7
$373.06
0.10%
0
$0.00
0.00%
00087081844
BUSPAR
TAB 5MG
1
$39.95
0.01%
0
$0.00
0.00%
00087081941
BUSPAR
TAB 10MG
25
$3,130.43
0.36%
13
$2,321.71
0.17%
00087081944
BUSPAR
TAB 10MG
0
$0.00
0.00%
1
$81.12
0.01%
00087082232
BUSPAR
TAB 15MG
13
$2,469.69
0.19%
6
$1,241.26
0.08%
00087082233
BUSPAR
TAB 15MG
4
$730.96
0.06%
0
$0.00
0.00%
00087082481
BUSPAR
TAB 30MG
11
$1,897.53
0.16%
1
$225.43
0.01%
00093005301
BUSPIRONE
TAB 5MG
16
$461.06
0.23%
13
$247.87
0.17%
00093005401
BUSPIRONE
TAB 10MG
42
$1,678.57
0.60%
51
$1,266.39
0.66%
00093005405
BUSPIRONE
TAB 10MG
2
$162.70
0.03%
12
$330.44
0.16%
00093100301
BUSPIRONE
TAB 15MG
78
$2,107.43
1.12%
97
$2,434.47
1.26%
00093100305
BUSPIRONE
TAB 15MG
4
$142.50
0.06%
45
$1,075.83
0.58%
00172290960
HYDROXYZ PAM CAP 50MG
18
$136.51
0.26%
60
$388.49
0.78%
00172290970
1
$13.04
0.01%
5
$29.76
0.06%
00172291160
16
$96.70
0.23%
78
$481.44
1.01%
Page 274 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC - ANXIOLYTICS
00172291170
00172566360
BUSPIRONE
TAB 5MG
00172566370
BUSPIRONE
TAB 5MG
00172566460
BUSPIRONE
TAB 10MG
00172566470
BUSPIRONE
00172566560
00172566565
$47.22
0.10%
30
$169.51
0.39%
3
$79.02
0.04%
50
$1,839.12
0.72%
12
$226.25
0.16%
64
$1,229.19
0.83%
0
$0.00
0.00%
40
$1,056.40
0.52%
TAB 10MG
67
$5,022.47
0.96%
112
$3,035.65
1.46%
BUSPIRONE
TAB 15MG
BUSPIRONE
TAB 15MG
7
$186.41
0.10%
70
$1,950.13
0.91%
3
$176.61
0.04%
0
$0.00
0.00%
00172566570
BUSPIRONE
TAB 15MG
0
$0.00
0.00%
8
$339.34
0.10%
00182109989
0
$0.00
0.00%
1
$7.81
0.01%
00182137640
HYDROXYZ HCL SYP 10MG/5ML
0
$0.00
0.00%
5
$67.32
0.06%
00182149201
HYDROXYZ HCL TAB 10MG
1
$5.18
0.01%
0
$0.00
0.00%
00182149401
1
$23.69
0.01%
0
$0.00
0.00%
00185061301
96
$656.67
1.38%
247
$1,304.64
3.21%
00185061305
53
$392.02
0.76%
63
$435.31
0.82%
00185061501
58
$412.98
0.83%
91
$653.98
1.18%
00185061505
38
$254.86
0.55%
13
$121.61
0.17%
00185071701
MEPROBAMATE TAB 400MG
1
$20.04
0.01%
0
$0.00
0.00%
00364016001
3
$51.24
0.04%
0
$0.00
0.00%
00364016101
10
$176.50
0.14%
3
$79.40
0.04%
00364048301
6
$37.32
0.09%
0
$0.00
0.00%
00364048305
3
$21.27
0.04%
2
$6.90
0.03%
00364048401
12
$100.26
0.17%
7
$39.14
0.09%
00364049405
4
$89.09
0.06%
0
$0.00
0.00%
00364049501
3
$130.25
0.04%
0
$0.00
0.00%
00364049502
9
$131.03
0.13%
2
$10.08
0.03%
00364049505
3
$38.00
0.04%
1
$11.45
0.01%
00378114001
BUSPIRONE
9
$132.50
0.13%
102
$1,973.13
1.33%
TAB 5MG
7
Page 275 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC - ANXIOLYTICS
00378115001
BUSPIRONE
TAB 10MG
00378115005
BUSPIRONE
TAB 10MG
00378116580
BUSPIRONE
TAB 15MG
00378116591
BUSPIRONE
TAB 15MG
00378117591
BUSPIRONE
TAB 30MG
00472077116
00517560125
HYDROXYZ HCL INJ 50MG/ML
00555030202
$599.71
0.20%
$5,094.21
2.53%
3
$225.53
0.04%
96
$8,115.22
1.38%
0
$0.00
0.00%
113
$3,172.82
1.47%
591
$49,854.14
8.48%
484
$14,501.29
6.29%
186
$34,055.08
2.67%
422
$18,747.57
5.48%
37
1
$377.92
0.53%
5
$38.66
0.06%
$6.71
0.01%
1
$7.21
0.01%
310
$2,570.32
4.45%
315
$2,285.92
4.09%
00555030204
71
$578.20
1.02%
147
$1,168.71
1.91%
00555032302
319
$2,097.56
4.58%
582
$3,406.11
7.56%
00555032304
48
$329.77
0.69%
161
$1,018.65
2.09%
00555032402
28
$450.80
0.40%
8
$321.70
0.10%
00591065701
BUSPIRONE
TAB 5MG
232
$9,458.03
3.33%
184
$2,697.20
2.39%
00591065705
BUSPIRONE
TAB 5MG
18
$763.78
0.26%
8
$133.92
0.10%
00591065801
BUSPIRONE
TAB 10MG
387
$25,887.92
5.55%
452
$10,585.63
5.87%
00591065805
BUSPIRONE
TAB 10MG
73
$5,201.41
1.05%
25
$797.05
0.32%
00591065810
BUSPIRONE
TAB 10MG
18
$1,833.51
0.26%
0
$0.00
0.00%
00591071805
BUSPIRONE
TAB 15MG
38
$2,613.93
0.55%
19
$559.05
0.25%
00591071818
BUSPIRONE
TAB 15MG
50
$4,552.77
0.72%
11
$268.05
0.14%
00591071860
BUSPIRONE
TAB 15MG
498
$36,601.03
7.15%
439
$12,842.77
5.71%
00591080101
2
$21.59
0.03%
256
$1,870.70
3.33%
00591523801
33
$709.00
0.47%
31
$2,713.04
0.40%
00591523810
3
$53.55
0.04%
5
$197.02
0.06%
00591523901
9
$275.06
0.13%
17
$1,224.72
0.22%
00591523910
4
$62.58
0.06%
3
$244.98
0.04%
00591552201
50
$1,480.02
0.72%
24
$455.28
0.31%
00591552205
14
$299.03
0.20%
18
$291.99
0.23%
14
195
Page 276 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC - ANXIOLYTICS
00591552301
00591552305
00591552310
157
$3,677.69
2.25%
46
$837.52
0.60%
48
$1,135.67
0.69%
238
$7,519.25
3.42%
10
$117.41
0.13%
86
$1,557.21
1.12%
00591556501
2
$24.36
0.03%
0
$0.00
0.00%
00591556505
3
$32.16
0.04%
0
$0.00
0.00%
00591572601
00591572605
35
$241.21
0.50%
474
$2,576.10
6.16%
10
$67.50
0.14%
124
$763.08
1.61%
00603397021
15
$81.58
0.22%
0
$0.00
0.00%
00615033153
1
$9.41
0.01%
0
$0.00
0.00%
00615033163
7
$55.77
0.10%
0
$0.00
0.00%
00615033263
5
$46.59
0.07%
0
$0.00
0.00%
00615152653
42
$470.66
0.60%
0
$0.00
0.00%
00615152663
34
$530.42
0.49%
0
$0.00
0.00%
00615457553
BUSPIRONE
TAB 10MG
54
$3,867.95
0.77%
0
$0.00
0.00%
00615457563
BUSPIRONE
TAB 10MG
12
$922.23
0.17%
0
$0.00
0.00%
00615459553
BUSPIRONE
TAB 5MG
36
$1,070.02
0.52%
0
$0.00
0.00%
00615459563
BUSPIRONE
TAB 5MG
13
$481.67
0.19%
0
$0.00
0.00%
00615459653
BUSPIRONE
TAB 15MG
3
$241.12
0.04%
0
$0.00
0.00%
00677059601
5
$27.02
0.07%
2
$10.18
0.03%
00677060401
2
$16.58
0.03%
0
$0.00
0.00%
00677060501
43
$1,941.22
0.62%
8
$198.79
0.10%
00677060505
11
$404.06
0.16%
0
$0.00
0.00%
00677060510
29
$1,639.33
0.42%
0
$0.00
0.00%
00677060601
17
$581.38
0.24%
10
$469.11
0.13%
00677060605
7
$209.44
0.10%
2
$74.56
0.03%
00677060610
2
$109.56
0.03%
1
$9.49
0.01%
00677142133
0
$0.00
0.00%
8
$113.75
0.10%
Page 277 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC - ANXIOLYTICS
00781133401
1
$5.95
0.01%
0
$0.00
0.00%
00781133410
1
$9.30
0.01%
0
$0.00
0.00%
00781133601
0
$0.00
0.00%
1
$4.48
0.01%
00781225401
1
$5.52
0.01%
0
$0.00
0.00%
00904035760
1
$8.92
0.01%
0
$0.00
0.00%
00904036360
1
$6.59
0.01%
0
$0.00
0.00%
00904037916
1
$10.72
0.01%
0
$0.00
0.00%
00904558740
BUSPIRONE
TAB 5MG
0
$0.00
0.00%
12
$234.80
0.16%
00904558840
BUSPIRONE
TAB 10MG
0
$0.00
0.00%
7
$160.71
0.09%
00904558860
BUSPIRONE
TAB 10MG
0
$0.00
0.00%
1
$26.05
0.01%
00904558960
BUSPIRONE
TAB 15MG
0
$0.00
0.00%
1
$51.25
0.01%
11098001001
INAPSINE
INJ 2.5MG/ML
1
$359.75
0.01%
0
$0.00
0.00%
49884070701
BUSPIRONE
TAB 5MG
62
$2,176.95
0.89%
21
$383.27
0.27%
49884070705
BUSPIRONE
TAB 5MG
0
$0.00
0.00%
3
$42.15
0.04%
49884070801
BUSPIRONE
TAB 10MG
90
$7,563.54
1.29%
37
$976.60
0.48%
49884070805
BUSPIRONE
TAB 10MG
17
$1,115.65
0.24%
31
$686.71
0.40%
49884072101
BUSPIRONE
TAB 15MG
81
$6,101.59
1.16%
30
$774.89
0.39%
49884072102
BUSPIRONE
TAB 15MG
57
$4,230.33
0.82%
42
$1,217.30
0.55%
49884072105
BUSPIRONE
TAB 15MG
3
$547.25
0.04%
91
$2,927.44
1.18%
49884072113
BUSPIRONE
TAB 15MG
4
$134.11
0.06%
17
$518.35
0.22%
49884072501
BUSPIRONE
TAB 7.5MG
18
$1,069.01
0.26%
45
$2,673.01
0.58%
49884072505
BUSPIRONE
TAB 7.5MG
29
$4,085.87
0.42%
30
$2,778.84
0.39%
50111030701
264
$6,337.42
3.79%
195
$3,971.16
2.53%
50111030702
3
$89.78
0.04%
4
$97.41
0.05%
50111030703
47
$1,357.28
0.67%
15
$624.87
0.19%
50111030801
575
$16,058.26
8.25%
291
$7,161.08
3.78%
50111030802
90
$3,485.79
1.29%
42
$1,181.78
0.55%
Page 278 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC - ANXIOLYTICS
50111030803
69
$2,736.22
0.99%
33
$665.06
0.43%
50111030901
193
$7,583.30
2.77%
98
$2,785.89
1.27%
50111030902
3
$64.17
0.04%
4
$96.67
0.05%
50111030903
8
$219.46
0.11%
0
$0.00
0.00%
50383079616
45
$483.83
0.65%
110
$1,195.68
1.43%
52152022302
BUSPIRONE
TAB 10MG
0
$0.00
0.00%
28
$685.66
0.36%
52152022304
BUSPIRONE
TAB 10MG
0
$0.00
0.00%
40
$1,193.59
0.52%
52152022402
BUSPIRONE
TAB 15MG
0
$0.00
0.00%
12
$373.00
0.16%
52152022403
BUSPIRONE
TAB 15MG
0
$0.00
0.00%
14
$496.92
0.18%
52152022422
BUSPIRONE
TAB 15MG
0
$0.00
0.00%
19
$556.76
0.25%
52544065701
BUSPIRONE
TAB 5MG
89
$3,401.42
1.28%
17
$359.91
0.22%
52544065705
BUSPIRONE
TAB 5MG
6
$222.26
0.09%
0
$0.00
0.00%
52544065801
BUSPIRONE
TAB 10MG
178
$13,610.99
2.55%
28
$704.71
0.36%
52544065805
BUSPIRONE
TAB 10MG
10
$907.90
0.14%
3
$86.55
0.04%
52544069905
5
$42.86
0.07%
0
$0.00
0.00%
52544069910
1
$4.97
0.01%
2
$12.33
0.03%
52544070005
1
$4.49
0.01%
0
$0.00
0.00%
52544070010
1
$5.53
0.01%
0
$0.00
0.00%
52544070401
9
$82.41
0.13%
0
$0.00
0.00%
52544070405
11
$236.19
0.16%
0
$0.00
0.00%
52544080105
2
$10.68
0.03%
0
$0.00
0.00%
52544080110
1
$6.91
0.01%
0
$0.00
0.00%
52544080401
3
$86.46
0.04%
0
$0.00
0.00%
53489012701
3
$69.05
0.04%
7
$259.14
0.09%
53489012705
46
$818.54
0.66%
9
$128.74
0.12%
53489012710
19
$884.68
0.27%
2
$92.48
0.03%
53489012801
7
$550.71
0.10%
4
$158.22
0.05%
Page 279 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC - ANXIOLYTICS
58177026404
BUSPIRONE
TAB 5MG
2
$20.00
0.03%
17
$312.97
0.22%
58177026408
BUSPIRONE
TAB 5MG
7
$248.23
0.10%
11
$103.03
0.14%
58177026422
BUSPIRONE
TAB 5MG
0
$0.00
0.00%
1
$20.65
0.01%
58177026504
BUSPIRONE
TAB 10MG
10
$596.46
0.14%
12
$286.33
0.16%
58177026508
BUSPIRONE
TAB 10MG
34
$2,136.27
0.49%
44
$1,072.85
0.57%
58177030904
BUSPIRONE
TAB 15MG
3
$303.25
0.04%
26
$737.25
0.34%
58177030908
BUSPIRONE
TAB 15MG
57
$6,494.77
0.82%
40
$1,165.00
0.52%
60432015004
5
$5.00
0.07%
9
$44.19
0.12%
60432015016
43
$451.41
0.62%
149
$1,846.26
1.94%
63323005101
HYDROXYZ HCL INJ 50MG/ML
0
$0.00
0.00%
1
$18.85
0.01%
211
$19,465.89
0.79%
MISC - STIMULANTS
00002322730
STRATTERA
CAP 10MG
0
$0.00
0.00%
00002322830
STRATTERA
CAP 25MG
0
$0.00
0.00%
723
$60,056.22
2.70%
00002322930
STRATTERA
CAP 40MG
0
$0.00
0.00%
1,572
$160,084.62
5.87%
00002323830
STRATTERA
CAP 18MG
0
$0.00
0.00%
271
$23,313.08
1.01%
00002323930
STRATTERA
CAP 60MG
0
$0.00
0.00%
674
$53,153.00
2.52%
00007351220
DEXEDRINE
CAP 5MG CR
38
$1,614.54
0.20%
11
$792.25
0.04%
00007351320
DEXEDRINE
CAP 10MG
97
$5,345.89
0.52%
50
$2,634.06
0.19%
00007351420
DEXEDRINE
CAP 15MG CR
86
$4,793.11
0.46%
42
$3,116.61
0.16%
00007351920
DEXEDRINE
TAB 5MG
4
$109.08
0.02%
9
$410.84
0.03%
00074337704
DESOXYN
TAB 5MG
13
$2,007.33
0.07%
7
$1,852.34
0.03%
00074602513
CYLERT
TAB 18.75MG
0
$0.00
0.00%
15
$719.35
0.06%
00074605713
CYLERT
TAB 37.5MG
15
$1,053.43
0.08%
25
$2,829.14
0.09%
00074607313
CYLERT
TAB 75MG
3
$249.84
0.02%
15
$1,831.58
0.06%
00074608813
CYLERT
CHW 37.5MG
7
$573.15
0.04%
7
$607.73
0.03%
00078037005
RITALIN LA CAP 20MG
104
$6,701.31
0.56%
254
$18,399.82
0.95%
Page 280 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC - STIMULANTS
00078037105
RITALIN LA CAP 30MG
25
$1,482.05
0.13%
169
$13,172.28
0.63%
00078037205
RITALIN LA CAP 40MG
30
$1,906.07
0.16%
111
$7,242.20
0.41%
00078038005
FOCALIN
TAB 2.5MG
29
$631.84
0.16%
27
$759.23
0.10%
00078038105
FOCALIN
TAB 5MG
59
$1,659.57
0.32%
43
$1,409.11
0.16%
00078038205
FOCALIN
TAB 10MG
12
$491.77
0.06%
22
$1,414.83
0.08%
00083000330
RITALIN
TAB 10MG
136
$6,165.24
0.73%
53
$2,821.72
0.20%
00083000730
RITALIN
TAB 5MG
98
$2,848.66
0.53%
42
$1,247.87
0.16%
00083001630
RITALIN SR TAB 20MG
72
$6,389.32
0.39%
44
$3,687.60
0.16%
00083003430
RITALIN
63
$4,157.48
0.34%
40
$2,966.15
0.15%
00093952401
PEMOLINE
TAB 37.5MG
3
$715.23
0.02%
3
$45.42
0.01%
00093954101
PEMOLINE
TAB 18.75MG
5
$324.11
0.03%
0
$0.00
0.00%
00093957701
PEMOLINE
CHW 37.5MG
3
$131.58
0.02%
7
$469.07
0.03%
00185008401
AMPHETAMINE TAB 5MG
22
$1,160.37
0.12%
177
$10,077.23
0.66%
00185011101
AMPHETAMINE TAB 10MG
137
$908.23
0.74%
248
$1,335.26
0.93%
00185040101
84
$5,284.63
0.45%
170
$11,947.75
0.63%
00185040401
32
$1,529.39
0.17%
57
$2,975.50
0.21%
00254493028
PEMOLINE
5
$401.33
0.03%
0
$0.00
0.00%
00364047901
METHYLPHENID TAB 10MG
0
$0.00
0.00%
1
$51.63
0.00%
00364047902
2
$31.90
0.01%
9
$251.84
0.03%
00364056101
0
$0.00
0.00%
1
$7.55
0.00%
00364056102
2
$16.90
0.01%
0
$0.00
0.00%
00364056201
1
$21.95
0.01%
0
$0.00
0.00%
00406112101
METHYLIN
TAB 5MG
512
$5,867.91
2.76%
585
$6,280.65
2.19%
00406112201
METHYLIN
TAB 10MG
608
$10,792.29
3.28%
824
$23,368.51
3.08%
00406112210
METHYLIN
TAB 10MG
0
$0.00
0.00%
4
$63.75
0.01%
00406112401
METHYLIN
TAB 20MG
221
$5,484.92
1.19%
373
$14,811.60
1.39%
00406112410
METHYLIN
TAB 20MG
0
$0.00
0.00%
6
$272.46
0.02%
TAB 20MG
TAB 37.5MG
Page 281 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC - STIMULANTS
00406142301
METHYLIN ER TAB 10MG
5
$289.66
0.03%
30
$1,015.26
0.11%
00406145101
METHYLIN ER TAB 20MG
52
$1,422.86
0.28%
82
$4,210.78
0.31%
00406155201
PEMOLINE
TAB 18.75MG
3
$82.38
0.02%
0
$0.00
0.00%
00406155401
PEMOLINE
TAB 37.5MG
1
$20.00
0.01%
0
$0.00
0.00%
00406155801
PEMOLINE
TAB 75MG
3
$198.66
0.02%
0
$0.00
0.00%
00406885401
PEMOLINE
CHW 37.5MG
1
$86.33
0.01%
0
$0.00
0.00%
00406896001
DEXTROAMPHET CAP 5MG CR
0
$0.00
0.00%
1
$65.02
0.00%
00406896101
0
$0.00
0.00%
4
$301.91
0.01%
00406896201
0
$0.00
0.00%
6
$477.27
0.02%
00555077502
AMPHETAMINE TAB 7.5MG
0
$0.00
0.00%
22
$1,003.28
0.08%
00555077602
AMPHETAMINE TAB 12.5MG
0
$0.00
0.00%
4
$181.17
0.01%
00555077702
0
$0.00
0.00%
43
$2,109.67
0.16%
00555095202
DEXTROAMPHET TAB 5MG
193
$2,850.93
1.04%
183
$3,179.92
0.68%
00555095302
188
$8,332.03
1.01%
203
$9,626.29
0.76%
00555095402
54
$2,035.52
0.29%
53
$1,944.22
0.20%
00555095502
192
$9,963.42
1.03%
179
$9,349.64
0.67%
00555095602
155
$8,353.40
0.84%
155
$8,685.75
0.58%
00555097102
AMPHETAMINE TAB 5MG
494
$29,717.13
2.66%
359
$19,743.75
1.34%
00555097202
470
$26,033.63
2.53%
471
$28,897.91
1.76%
00555097302
253
$14,975.11
1.36%
277
$18,179.31
1.03%
00555097402
106
$5,252.99
0.57%
99
$4,918.58
0.37%
00591311101
METHYLPHENID TAB 20MG ER
10
$278.91
0.05%
11
$519.07
0.04%
00591588201
199
$2,402.23
1.07%
220
$2,578.03
0.82%
00591588210
4
$73.15
0.02%
10
$116.50
0.04%
00591588301
179
$3,407.66
0.96%
211
$6,289.43
0.79%
00591588310
28
$440.39
0.15%
25
$761.90
0.09%
00591588401
67
$1,670.87
0.36%
131
$6,224.58
0.49%
Page 282 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC - STIMULANTS
00591588410
3
$75.15
0.02%
1
00597006111
CAFCIT
1
$559.74
0.01%
00603505521
PEMOLINE
TAB 18.75MG
5
$155.98
0.03%
00603505621
PEMOLINE
TAB 37.5MG
11
$841.76
00603505721
PEMOLINE
TAB 75MG
22
00781174101
PEMOLINE
TAB 37.5MG
00781174801
00781174810
00781174901
00781174910
00781175101
PEMOLINE
00781175301
SOL 20MG/ML
$21.01
0.00%
0
$0.00
0.00%
2
$17.50
0.01%
0.06%
4
$268.00
0.01%
$1,937.76
0.12%
14
$1,489.31
0.05%
19
$1,232.41
0.10%
3
$99.35
0.01%
118
$1,245.24
0.64%
117
$1,505.30
0.44%
6
$151.35
0.03%
6
$104.55
0.02%
186
$3,898.06
1.00%
167
$5,420.23
0.62%
3
$123.45
0.02%
0
$0.00
0.00%
14
$1,287.91
0.08%
8
$551.20
0.03%
98
$2,424.89
0.53%
82
$3,602.84
0.31%
00781175310
3
$87.75
0.02%
5
$174.94
0.02%
00781175401
METHYLPHENID TAB 20MG SR
147
$5,376.03
0.79%
9
$482.55
0.03%
00781884001
140
$1,820.34
0.75%
175
$2,292.20
0.65%
00781884010
11
$182.35
0.06%
23
$206.19
0.09%
00781884101
217
$4,264.46
1.17%
397
$12,659.12
1.48%
00781884110
7
$102.35
0.04%
22
$778.28
0.08%
00781884201
84
$2,339.68
0.45%
179
$8,965.73
0.67%
00781884210
0
$0.00
0.00%
21
$1,443.68
0.08%
00781884301
METHYLPHENID TAB 20MG CR
431
$14,873.59
2.32%
504
$28,602.28
1.88%
17314585002
CONCERTA
TAB 18MG
1,737
$114,690.93
9.36%
2,215
$158,493.29
8.27%
17314585102
CONCERTA
TAB 36MG
2,527
$176,623.16
13.62%
2,925
$218,099.21
10.93%
17314585202
CONCERTA
TAB 54MG
2,057
$151,304.47
11.08%
3,038
$244,202.93
11.35%
17314585302
CONCERTA
TAB 27MG
352
$24,060.57
1.90%
966
$71,026.91
3.61%
52152016102
PEMOLINE
TAB 37.5MG
17
$1,329.40
0.09%
2
$118.78
0.01%
53014053007
52
$934.58
0.28%
34
$1,038.95
0.13%
TAB 75MG
Page 283 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC - STIMULANTS
53014053107
9
$82.73
0.05%
2
53014053207
12
$183.09
0.06%
53014057407
METADATE CD CAP 10MG
0
$0.00
0.00%
53014057507
0
$0.00
53014057530
252
53014057572
53014057607
53014059307
METADATE
53014059407
METADATE
53265025310
53265025410
$33.70
0.01%
17
$698.08
0.06%
21
$1,206.94
0.08%
0.00%
203
$13,462.69
0.76%
$14,777.50
1.36%
44
$2,928.15
0.16%
2
$142.19
0.01%
5
$383.46
0.02%
0
$0.00
0.00%
10
$519.63
0.04%
TAB 10MG ER
58
$2,436.87
0.31%
57
$2,420.28
0.21%
TAB 20MG ER
41
$1,217.54
0.22%
39
$1,928.04
0.15%
0
$0.00
0.00%
12
$72.85
0.04%
0
$0.00
0.00%
4
$90.79
0.01%
53265025510
0
$0.00
0.00%
7
$288.48
0.03%
54092037101
ADDERALL
TAB 5MG
0
$0.00
0.00%
8
$489.63
0.03%
54092037201
ADDERALL
TAB 7.5MG
0
$0.00
0.00%
8
$424.78
0.03%
54092037301
ADDERALL
TAB 10MG
0
$0.00
0.00%
27
$2,967.46
0.10%
54092037501
ADDERALL
TAB 15MG
0
$0.00
0.00%
30
$2,314.39
0.11%
54092037601
ADDERALL
TAB 20MG
0
$0.00
0.00%
5
$381.30
0.02%
54092037701
ADDERALL
TAB 30MG
0
$0.00
0.00%
15
$1,049.98
0.06%
54092038101
ADDERALL XR CAP 5MG
92
$6,277.06
0.50%
230
$18,015.94
0.86%
54092038301
ADDERALL XR CAP 10MG
773
$52,209.41
4.17%
1,059
$83,980.17
3.96%
54092038501
189
$11,836.66
1.02%
486
$33,331.85
1.82%
54092038701
1,249
$99,173.61
6.73%
1,632
$143,958.41
6.10%
54092038901
43
$3,153.63
0.23%
224
$18,542.31
0.84%
54092039101
880
$63,798.20
4.74%
1,330
$106,559.80
4.97%
54092044801
DEXTROSTAT TAB 5MG
0
$0.00
0.00%
55
$1,078.55
0.21%
54092045201
DEXTROSTAT TAB 10MG
0
$0.00
0.00%
40
$1,706.06
0.15%
58177031204
0
$0.00
0.00%
10
$369.00
0.04%
Page 284 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC - STIMULANTS
58521003101
ADDERALL
TAB 5MG
102
$7,251.25
0.55%
48
$2,760.96
0.18%
58521003201
ADDERALL
TAB 10MG
138
$9,439.25
0.74%
79
$5,770.99
0.30%
58521003301
ADDERALL
TAB 20MG
77
$4,988.83
0.41%
27
$2,294.04
0.10%
58521003401
ADDERALL
TAB 30MG
25
$1,651.18
0.13%
18
$1,206.29
0.07%
58521007501
ADDERALL
TAB 7.5MG
64
$3,238.08
0.34%
19
$1,308.43
0.07%
58521012501
ADDERALL
TAB 12.5MG
11
$708.11
0.06%
11
$536.30
0.04%
58521015001
ADDERALL
TAB 15MG
103
$5,495.00
0.56%
18
$1,071.13
0.07%
58521045101
DEXTROSTAT TAB 5MG
217
$3,552.97
1.17%
24
$407.80
0.09%
58521045201
DEXTROSTAT TAB 10MG
130
$6,743.48
0.70%
33
$2,250.83
0.12%
59772884001
54
$784.48
0.29%
12
$226.76
0.04%
59772884101
51
$903.34
0.27%
0
$0.00
0.00%
59772884201
9
$258.03
0.05%
6
$199.05
0.02%
59772884203
24
$883.10
0.13%
3
$77.67
0.01%
59772884301
METHYLPHENID TAB 20MG ER
19
$761.50
0.10%
0
$0.00
0.00%
62269039324
PEMOLINE
2
$72.94
0.01%
0
$0.00
0.00%
63304090801
AMPHETAMINE TAB 5MG
0
$0.00
0.00%
2
$81.28
0.01%
63304090901
0
$0.00
0.00%
1
$77.92
0.00%
63459010001
PROVIGIL
TAB 100MG
105
$18,042.39
0.57%
41
$6,378.91
0.15%
63459020001
PROVIGIL
TAB 200MG
373
$78,046.01
2.01%
250
$46,756.91
0.93%
TAB 75MG
MISC.
00002803101
GLUCAGON
KIT 1MG
154
$14,532.82
1.19%
179
$15,321.15
0.83%
00002808501
GLUCAGON
KIT 1MG
9
$1,434.82
0.07%
11
$839.95
0.05%
00003083050
HYDREA
CAP 500MG
1
$62.09
0.01%
0
$0.00
0.00%
00003633717
DROXIA
CAP 400MG
0
$0.00
0.00%
1
$34.40
0.00%
00004025001
VESANOID
CAP 10 MG
1
$1,244.40
0.01%
0
$0.00
0.00%
00004110051
XELODA
TAB 150MG
0
$0.00
0.00%
10
$1,646.90
0.05%
Page 285 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
00004110116
XELODA
00005450723
00006007131
TAB 500MG
16
$14,686.78
0.12%
45
$33,168.25
0.21%
METHOTREXATE TAB 2.5MG
4
$118.36
0.03%
PROPECIA
TAB 1MG
0
$0.00
0.00%
5
$43.00
0.02%
3
$139.97
0.01%
00006007161
PROPECIA
TAB PRO-PAK
0
$0.00
0.00%
1
$45.33
0.00%
00006069068
DEMSER
CAP 250MG
0
$0.00
0.00%
1
$20.00
0.00%
00006468100
M-M-R II
00006470900
ATTENUVAX INJ LIVE
6
$230.74
0.05%
6
$190.02
0.03%
1
$19.78
0.01%
0
$0.00
0.00%
00006473900
PNEUMOVAX 23 INJ 25MCG/.5
3
$54.50
0.02%
4
$333.85
0.02%
00006474900
M-M-R II
4
$167.57
0.03%
14
$613.74
0.07%
00006477300
RECOMBIVA-HB INJ 10MCG/ML
1
$194.47
0.01%
1
$194.97
0.00%
00006477500
12
$919.85
0.09%
4
$267.44
0.02%
00006483100
VAQTA
INJ 25U/.5ML
0
$0.00
0.00%
1
$37.48
0.00%
00006484100
VAQTA
INJ 50U/ML
1
$68.67
0.01%
0
$0.00
0.00%
00006487200
1
$64.45
0.01%
0
$0.00
0.00%
00006489400
9
$189.18
0.07%
0
$0.00
0.00%
00006494300
21
$375.94
0.16%
53
$1,217.33
0.25%
00006499500
5
$328.55
0.04%
21
$1,519.84
0.10%
00006499541
0
$0.00
0.00%
3
$194.85
0.01%
00008034101
TET/DIP ADLT INJ 5-1.5LF
0
$0.00
0.00%
1
$4.65
0.00%
00008098701
INFLUENZA
21
$303.72
0.16%
0
$0.00
0.00%
00008914501
TUBEX INJECT MIS
0
$0.00
0.00%
1
$4.79
0.00%
00008914901
SYNVISC
INJ 8MG/ML
0
$0.00
0.00%
2
$1,282.74
0.01%
00008914902
SYNVISC
INJ 8MG/ML
6
$4,485.74
0.05%
5
$3,206.87
0.02%
00009062601
DEPO-PROVERA INJ 400/ML
2
$192.70
0.02%
0
$0.00
0.00%
00009766304
AROMASIN
27
$5,721.47
0.21%
21
$4,472.52
0.10%
00013013202
EMCYT
1
$133.44
0.01%
4
$1,336.78
0.02%
00013103691
ADRUCIL
3
$27.80
0.02%
0
$0.00
0.00%
INJ LIVE
INJ LIVE
INJ SPLIT
TAB 25MG
CAP 140MG
INJ 50MG/ML
Page 286 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
00013105694
ADRUCIL
INJ 50MG/ML
0
$0.00
0.00%
2
$2.00
0.01%
00013700112
DOSTINEX
TAB 0.5MG
30
$6,113.67
0.23%
47
$7,047.74
0.22%
00013872589
ZINECARD
INJ 500MG
6
$2,504.22
0.05%
3
$2,687.97
0.01%
00015050301
CYTOXAN
TAB 50MG
12
$1,911.37
0.09%
19
$2,515.39
0.09%
00015050302
CYTOXAN
TAB 50MG
0
$0.00
0.00%
1
$206.88
0.00%
00015050401
CYTOXAN
TAB 25MG
00015050842
MEGACE ORAL SUS 40MG/ML
00015059501
MEGACE
00015303020
CEENU
00015303220
00015309145
5
$296.40
0.04%
5
$516.52
0.02%
16
$3,157.02
0.12%
4
$709.05
0.02%
0
$0.00
0.00%
1
$38.77
0.00%
CAP 10MG
0
$0.00
0.00%
1
$29.75
0.00%
CEENU
CAP 100MG
0
$0.00
0.00%
2
$84.42
0.01%
VEPESID
CAP 50MG
3
$3,157.11
0.02%
3
$1,445.09
0.01%
00015356512
MESNEX
TAB 400MG
0
$0.00
0.00%
1
$914.35
0.00%
00024033301
CHEMET
CAP 100MG
7
$1,139.26
0.05%
2
$237.51
0.01%
00024061030
ELIGARD
KIT 30MG
0
$0.00
0.00%
1
$2,099.12
0.00%
00026063101
BAYRHO-D
2
$194.62
0.02%
0
$0.00
0.00%
00026063504
BAYGAM
INJ
1
$27.45
0.01%
0
$0.00
0.00%
00026063605
BAYHEP B
INJ
1
$621.23
0.01%
4
$2,482.92
0.02%
00026064520
GAMUNEX
INJ 10%
0
$0.00
0.00%
1
$443.79
0.00%
00026064571
GAMUNEX
INJ 10%
0
$0.00
0.00%
1
$1,765.09
0.00%
00026064815
GAMIMUNE N INJ 10%
6
$1,274.76
0.05%
3
$890.94
0.01%
00026064820
GAMIMUNE N INJ 10%
1
$453.35
0.01%
14
$8,949.26
0.07%
00026064824
GAMIMUNE N INJ 10%
0
$0.00
0.00%
2
$5,238.22
0.01%
00026064871
GAMIMUNE N INJ 10%
8
$10,197.18
0.06%
3
$3,807.57
0.01%
00043011908
TAVIST-1
TAB 1.34MG
0
$0.00
0.00%
1
$17.58
0.00%
00043011916
TAVIST-1
TAB 1.34MG
0
$0.00
0.00%
1
$19.72
0.00%
00052060202
TICE BCG
INJ
0
$0.00
0.00%
1
$460.60
0.00%
00054224725
HYDROXYUREA CAP 500MG
22
$585.40
0.17%
26
$599.10
0.12%
TAB 20MG
INJ 300MCG
Page 287 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
00054302502
ACETYLCYST SOL 10%
0
00054302602
ACETYLCYST SOL 20%
00054302702
ACETYLCYST SOL 10%
00054302802
ACETYLCYST SOL 20%
00054354258
MEGESTROL AC SUS 40MG/ML
00054449613
00054449625
$0.00
0.00%
1
$48.34
0.01%
6
$195.48
0.05%
0
$0.00
0.00%
40
$7,544.23
LEUCOVOR CA TAB 5MG
0
LEUCOVOR CA TAB 5MG
1
00054449710
LEUCOVOR CA TAB 10MG
00054449911
$132.10
0.01%
1
$12.29
0.00%
10
$1,058.36
0.05%
1
$10.14
0.00%
0.31%
28
$5,108.28
0.13%
$0.00
0.00%
3
$30.23
0.01%
$8.39
0.01%
2
$36.96
0.01%
3
$90.00
0.02%
0
$0.00
0.00%
2
$623.70
0.02%
0
$0.00
0.00%
00054455015
0
$0.00
0.00%
4
$29.90
0.02%
00054455025
8
$170.96
0.06%
15
$101.00
0.07%
00054460425
MEGESTROL AC TAB 40MG
1
$55.35
0.01%
0
$0.00
0.00%
00054483121
TAMOXIFEN TAB 10MG
0
$0.00
0.00%
1
$27.85
0.00%
00054483413
TAMOXIFEN TAB 20MG
0
$0.00
0.00%
1
$48.85
0.00%
00054880925
SOD CHLORIDE NEB 0.9%
2
$48.39
0.02%
0
$0.00
0.00%
00062330300
ORTHO FLEX DPR KIT 65
5
$139.45
0.04%
5
$151.30
0.02%
00062330400
10
$263.39
0.08%
10
$297.60
0.05%
00062330500
11
$299.59
0.08%
6
$174.46
0.03%
00062330600
4
$92.07
0.03%
0
$0.00
0.00%
00062330700
1
$28.69
0.01%
0
$0.00
0.00%
00066006306
ZETAR
0
$0.00
0.00%
2
$29.60
0.01%
00071084013
BENADRYL
CAP 25MG
2
$22.08
0.02%
0
$0.00
0.00%
00071233317
BENADRYL
ELX ALLERGY
1
$4.88
0.01%
1
$4.88
0.00%
00071425945
BENADRYL
INJ 50MG/ML
2
$13.79
0.02%
3
$16.53
0.01%
00072150030
VANIQA
CRE
0
$0.00
0.00%
9
$462.50
0.04%
00072230001
LOWILA
BAR
1
$16.30
0.01%
1
$16.30
0.00%
00074196604
SOD CHLORIDE INJ .9% BACT
2
$13.41
0.02%
16
$188.63
0.07%
SHA 1%
2
Page 288 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
00074196605
3
$3.00
0.02%
0
$0.00
0.00%
00074196607
103
$544.69
0.79%
39
$325.62
0.18%
00074196614
3
$9.72
0.02%
0
$0.00
0.00%
00074330703
ACETYLCYST SOL 10%
2
$221.58
0.02%
5
$179.06
0.02%
00074330803
ACETYLCYST SOL 20%
1
$9.04
0.01%
1
$8.66
0.00%
00074397703
BACTER WATER INJ
5
$19.12
0.04%
1
$4.28
0.00%
00074450810
VANISHPOINT MIS 29GX1/2"
0
$0.00
0.00%
2
$23.02
0.01%
00074454102
LEUCOVOR CA INJ 10MG/ML
0
$0.00
0.00%
5
$33.50
0.02%
00074472901
DOBUTAMINE INJ 12.5/ML
0
$0.00
0.00%
1
$125.85
0.00%
00074488710
STERIL WATER INJ
15
$67.88
0.12%
4
$46.24
0.02%
00074488750
STERIL WATER INJ
0
$0.00
0.00%
1
$5.37
0.00%
00074613922
STERIL WATER SOL IRRIG
5
$68.59
0.04%
0
$0.00
0.00%
00074683801
ENDURONYL
10
$475.82
0.08%
1
$47.46
0.00%
00074713909
19
$185.25
0.15%
19
$185.25
0.09%
00074724101
EPINEPHRINE INJ 1MG/ML
0
$0.00
0.00%
5
$16.43
0.02%
00074790209
KCL/D5W/NACL INJ .15/.45%
1
$9.15
0.01%
7
$260.85
0.03%
00074795309
LACTATED RIN INJ
0
$0.00
0.00%
3
$18.91
0.01%
00078005405
METHERGINE TAB 0.2MG
40
$340.89
0.31%
47
$803.52
0.22%
00078014923
MIACALCIN INJ 200IU/ML
45
$3,380.92
0.35%
27
$2,478.36
0.13%
00078024915
FEMARA
TAB 2.5MG
49
$9,532.44
0.38%
61
$11,983.90
0.28%
00078037366
GLEEVEC
CAP 100MG
1
$1,027.81
0.01%
10
$11,868.36
0.05%
00078040105
GLEEVEC
TAB 100MG
0
$0.00
0.00%
8
$3,585.60
0.04%
00078040215
GLEEVEC
TAB 400MG
0
$0.00
0.00%
6
$120.00
0.03%
00085028203
OPTIMINE
TAB 1MG
4
$302.76
0.03%
0
$0.00
0.00%
00085052506
EULEXIN
CAP 125MG
6
$972.96
0.05%
11
$3,294.66
0.05%
00085053901
INTRON-A
INJ 50MU
2
$7,881.76
0.02%
3
$6,389.01
0.01%
00085057102
INTRON-A
INJ 10MU
0
$0.00
0.00%
1
$284.64
0.00%
TAB
Page 289 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
00085111001
INTRON-A
INJ 18MU
1
00085113301
INTRON-A
INJ 25MU
00085116801
INTRON-A
INJ 18MU
00085117902
INTRON-A
KIT 10MU/ML
00085124401
TEMODAR
00085124402
00085124801
$1,418.89
0.01%
2
$3,066.98
0.01%
0
$0.00
0.00%
3
$2,374.27
0.02%
1
$33.94
0.00%
3
$3,836.66
0.01%
1
$1,579.58
0.01%
0
$0.00
0.00%
CAP 20MG
2
$525.45
0.02%
4
$3,655.42
0.02%
TEMODAR
CAP 20MG
TEMODAR
CAP 5MG
3
$3,246.88
0.02%
5
$5,481.60
0.02%
2
$394.18
0.02%
1
$424.39
0.00%
00085124802
TEMODAR
CAP 5MG
0
$0.00
0.00%
5
$2,954.44
0.02%
00085125201
TEMODAR
CAP 250MG
8
$22,963.21
0.06%
5
$7,044.90
0.02%
00085125202
00085125401
TEMODAR
CAP 250MG
2
$102.10
0.02%
2
$2.36
0.01%
INTRON-A
INJ 10MIU PN
3
$6,322.62
0.02%
0
$0.00
0.00%
00085125901
TEMODAR
CAP 100MG
8
$12,001.06
0.06%
4
$12,356.50
0.02%
00085125902
TEMODAR
CAP 100MG
6
$10,619.28
0.05%
15
$38,343.99
0.07%
00087057003
MUCOMYST
SOL 20%
1
$15.55
0.01%
2
$31.76
0.01%
00087057007
MUCOMYST
SOL 20%
0
$0.00
0.00%
4
$227.34
0.02%
00087057009
MUCOMYST
SOL 20%
1
$17.15
0.01%
3
$79.20
0.01%
00087057201
MUCOMYST-10 SOL 10%
11
$715.87
0.08%
7
$745.04
0.03%
00087057202
MUCOMYST-10 SOL 10%
15
$876.99
0.12%
0
$0.00
0.00%
00087057203
MUCOMYST-10 SOL 10%
3
$1,645.73
0.02%
1
$434.73
0.00%
00093078201
TAMOXIFEN TAB 20MG
0
$0.00
0.00%
32
$866.10
0.15%
00093078256
TAMOXIFEN TAB 20MG
0
$0.00
0.00%
84
$2,541.60
0.39%
00093078406
TAMOXIFEN TAB 10MG
0
$0.00
0.00%
115
$3,355.75
0.53%
00093078486
TAMOXIFEN TAB 10MG
0
$0.00
0.00%
27
$758.40
0.13%
00093712086
FLUTAMIDE
CAP 125 MG
1
$165.17
0.01%
0
$0.00
0.00%
00168020506
SURGILUBE
GEL
1
$9.29
0.01%
0
$0.00
0.00%
00168020536
SURGILUBE
GEL
2
$11.06
0.02%
2
$12.04
0.01%
00168020543
SURGILUBE
GEL
1
$9.73
0.01%
0
$0.00
0.00%
Page 290 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
00169185250
NOVOFINE 30 MIS DISPOS
245
$6,729.88
1.89%
214
$6,223.06
1.00%
00169185255
NOVOFINE 31 MIS DISPOS
29
$893.75
0.22%
74
$2,395.47
0.34%
00169185258
NOVOPEN JR MIS DEVICE
0
$0.00
0.00%
1
$35.97
0.00%
00169185290
NOVOPEN 3
MIS
5
$149.45
0.04%
32
$971.54
0.15%
00172496058
FLUTAMIDE
CAP 125MG
2
$986.75
0.02%
0
$0.00
0.00%
00172565649
TAMOXIFEN TAB 10MG
0
$0.00
0.00%
5
$112.25
0.02%
00172565658
TAMOXIFEN TAB 10MG
0
$0.00
0.00%
91
$2,396.40
0.42%
00172565760
TAMOXIFEN TAB 20MG
0
$0.00
0.00%
68
$1,798.15
0.32%
00173004535
ALKERAN
11
$268.52
0.08%
8
$150.24
0.04%
00173051800
STERILE DILU SOL FLOLAN
8
$5,036.94
0.06%
2
$1,304.66
0.01%
00173051801
STERILE DILU SOL FLOLAN
0
$0.00
0.00%
4
$2,552.83
0.02%
00173063535
LEUKERAN
11
$885.55
0.08%
20
$2,279.07
0.09%
00173080725
PURINETHOL TAB 50MG
115
$16,674.13
0.89%
121
$16,769.24
0.56%
00173080765
PURINETHOL TAB 50MG
24
$2,915.15
0.18%
20
$3,010.06
0.09%
00182186401
1
$16.85
0.01%
0
$0.00
0.00%
00182512852
CAPSICUM OLE CRE 0.025%
0
$0.00
0.00%
8
$75.12
0.04%
00182512952
0
$0.00
0.00%
2
$21.71
0.01%
00185004301
MIDODRINE
TAB 5MG
0
$0.00
0.00%
6
$2,564.09
0.03%
00185099801
YOHIMBINE
TAB 5.4MG
3
$40.80
0.02%
0
$0.00
0.00%
00185112518
FLUTAMIDE
CAP 125 MG
5
$1,650.95
0.04%
0
$0.00
0.00%
00185515601
PAPAVERINE CAP 150MG CR
5
$25.40
0.04%
3
$15.84
0.01%
00193225050
GLUCOMETER TES ENCORE
1
$17.00
0.01%
0
$0.00
0.00%
00193284450
CLINISTIX
3
$43.29
0.02%
5
$74.32
0.02%
00193288221
KETO-DIASTIX TES
0
$0.00
0.00%
6
$116.78
0.03%
00193288250
KETO-DIASTIX TES
0
$0.00
0.00%
3
$30.29
0.01%
00193361050
ASCENSIA
TES AUTODISC
43
$2,778.05
0.33%
142
$7,216.48
0.66%
00193362250
GLUCO DEX TES SENSORS
0
$0.00
0.00%
5
$257.81
0.02%
TAB 2MG
TAB 2MG
TES STRIPS
Page 291 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
00193362350
GLUCO DEX TES SENSORS
00193362721
ASCENSIA
00193387050
GLUCO ELITE TES
00193387150
0
$0.00
0.00%
3
$218.05
0.01%
35
$2,315.59
0.27%
174
$13,101.84
0.81%
0
$0.00
0.00%
5
$465.81
0.02%
GLUCO ELITE TES
0
$0.00
0.00%
6
$160.37
0.03%
00193388501
GLUCOMETER KIT CLASSIC
0
$0.00
0.00%
8
$318.78
0.04%
00193390101
ASCENSIA
KIT DIAB XL
0
$0.00
0.00%
14
$611.09
0.07%
00193391125
ASCENSIA
TES ELITE
13
$554.89
0.10%
10
$509.03
0.05%
00193391850
ASCENSIA
TES ELITE
78
$3,966.67
0.60%
262
$14,065.96
1.22%
00193394221
ASCENSIA
TES ELITE
102
$6,693.22
0.79%
283
$19,946.45
1.32%
00193395201
ASCENSIA DEX KIT SYS
0
$0.00
0.00%
3
$192.70
0.01%
00193550921
AMES GLU SYS MIS
0
$0.00
0.00%
7
$35.55
0.03%
00193611701
ASCENSIA
KIT BREEZE
0
$0.00
0.00%
12
$576.51
0.06%
00193654621
MICROLET
MIS
0
$0.00
0.00%
131
$792.16
0.61%
00264210100
2
$182.21
0.02%
2
$30.81
0.01%
00264210110
0
$0.00
0.00%
1
$19.98
0.00%
00264761200
DEXTROSE 5% INJ NACL.45%
2
$30.70
0.02%
0
$0.00
0.00%
00300210801
LUPR DEP-PED INJ 7.5MG
5
$1,802.65
0.04%
2
$82.51
0.01%
00300228201
LUPR DEP-PED INJ 11.25MG
7
$7,142.52
0.05%
4
$4,324.60
0.02%
00300244001
LUPR DEP-PED INJ 15MG
0
$0.00
0.00%
3
$3,571.29
0.01%
00300334601
LUPRON DEPOT INJ 22.5MG
8
$13,465.32
0.06%
3
$5,350.55
0.01%
00300364101
102
$45,348.55
0.79%
150
$70,943.28
0.70%
00300364201
10
$5,618.05
0.08%
11
$4,341.66
0.05%
00300366301
20
$25,203.10
0.15%
28
$38,595.68
0.13%
00300368301
LUPRON DEPOT INJ 30MG
1
$2,240.60
0.01%
2
$4,755.19
0.01%
00310020130
ARIMIDEX
TAB 1MG
176
$32,741.94
1.35%
261
$53,836.31
1.21%
00310048230
IRESSA
TAB 250MG
0
$0.00
0.00%
14
$23,766.20
0.07%
00310060018
NOLVADEX
56
$5,162.72
0.43%
0
$0.00
0.00%
TES AUTODISC
TAB 10MG
Page 292 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
00310060060
NOLVADEX
TAB 10MG
26
$2,423.90
0.20%
00310060430
NOLVADEX
00310070510
CASODEX
TAB 50MG
TAB 20MG
16
$1,813.13
0.12%
1
$366.63
0.01%
00310070530
CASODEX
TAB 50MG
60
$21,077.77
0.46%
00310073060
TAMOXIFEN TAB 10MG
8
$686.50
00310073130
TAMOXIFEN TAB 20MG
36
00310095036
ZOLADEX
IMP 3.6MG
0
00310095130
ZOLADEX
IMP 10.8MG
00310096036
ZOLADEX
00310096130
ZOLADEX
00338000402
00338000403
$66.14
0.01%
1
$114.57
0.00%
11
$4,185.37
0.05%
51
$19,598.80
0.24%
0.06%
43
$3,110.92
0.20%
$3,906.68
0.28%
9
$306.04
0.04%
$0.00
0.00%
3
$1,229.22
0.01%
0
$0.00
0.00%
6
$6,210.15
0.03%
IMP 3.6MG
2
$818.48
0.02%
4
$1,638.96
0.02%
IMP 10.8MG
3
$3,687.09
0.02%
4
$4,878.18
0.02%
1
$81.15
0.01%
0
$0.00
0.00%
0
$0.00
0.00%
1
$59.05
0.00%
00338000404
3
$560.05
0.02%
7
$823.58
0.03%
00338008504
D5W/NACL
INJ 0.45%
11
$90.80
0.08%
24
$289.70
0.11%
00338008904
D5W/NACL
INJ 0.9%
2
$21.90
0.02%
12
$110.50
0.06%
00338011104
D5W/RINGER'S INJ
7
$1,008.65
0.05%
0
$0.00
0.00%
00338011704
LACTATED RIN INJ
0
$0.00
0.00%
6
$427.00
0.03%
00338066104
KCL/D5W/NACL INJ .075-.2%
1
$32.55
0.01%
2
$240.30
0.01%
00338067104
KCL/D5W/NACL INJ .15/.45%
3
$51.85
0.02%
2
$50.50
0.01%
00378001401
113
$2,228.47
0.87%
123
$1,200.23
0.57%
00378014405
TAMOXIFEN TAB 10MG
0
$0.00
0.00%
6
$167.10
0.03%
00378014491
TAMOXIFEN TAB 10MG
0
$0.00
0.00%
68
$2,002.10
0.32%
00378027401
TAMOXIFEN TAB 20MG
0
$0.00
0.00%
19
$522.65
0.09%
00378027493
TAMOXIFEN TAB 20MG
0
$0.00
0.00%
30
$818.79
0.14%
00378190101
MIDODRINE
TAB 2.5MG
0
$0.00
0.00%
10
$336.96
0.05%
00378190201
MIDODRINE
TAB 5MG
0
$0.00
0.00%
12
$2,141.88
0.06%
00378326694
ETOPOSIDE
CAP 50MG
3
$2,242.05
0.02%
6
$4,237.44
0.03%
2
Page 293 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
00406292434
TRICHLOROACE CRY ACID
00456052321
BANALG
00472075516
CYPROHEPTAD SYP 2MG/5ML
00501200024
BENADRYL
CAP 25MG
00501200048
BENADRYL
CAP 25MG
00501201024
BENADRYL
00501205004
00501205008
$0.00
0.00%
$15.16
0.00%
0
$0.00
0.00%
58
$1,307.57
0.45%
2
$47.50
0.01%
57
$1,290.11
0.27%
13
$91.48
0.10%
3
$20.22
0.01%
3
$44.05
0.02%
1
$17.36
0.00%
CHW ALLERGY
15
$231.41
BENADRYL ALL SYP 12.5/5ML
6
$31.98
0.12%
6
$70.77
0.03%
0.05%
10
$65.09
0.05%
BENADRYL ALL SYP 12.5/5ML
0
$0.00
0.00%
2
$11.01
0.01%
00501205304
BENADRYL ALL LIQ 12.5/5ML
6
$31.95
0.05%
1
$7.61
0.00%
00517064825
00517066225
3
$14.92
0.02%
1
$5.85
0.00%
BACTER WATER INJ BENZ ALC
0
$0.00
0.00%
1
$4.71
0.00%
00517300525
STERIL WATER INJ
254
$1,078.55
1.96%
189
$836.71
0.88%
00517301025
STERIL WATER INJ
0
$0.00
0.00%
11
$129.93
0.05%
00517302025
STERIL WATER INJ
15
$127.75
0.12%
0
$0.00
0.00%
00517305025
STERIL WATER INJ
1
$30.26
0.01%
0
$0.00
0.00%
00517401001
PAPAVERINE SOL 30MG/ML
1
$17.03
0.01%
0
$0.00
0.00%
00517750412
ACETYLCYST SOL 10%
4
$86.22
0.03%
3
$149.53
0.01%
00517751003
ACETYLCYST SOL 10%
6
$294.90
0.05%
14
$409.88
0.07%
00517753003
ACETYLCYST SOL 10%
1
$22.90
0.01%
0
$0.00
0.00%
00517761003
ACETYLCYST SOL 20%
7
$40.65
0.05%
3
$25.31
0.01%
00517763003
ACETYLCYST SOL 20%
0
$0.00
0.00%
7
$215.24
0.03%
00555044603
TAMOXIFEN TAB 10MG
4
$369.77
0.03%
0
$0.00
0.00%
00555044609
TAMOXIFEN TAB 10MG
340
$34,759.11
2.62%
131
$4,471.89
0.61%
00555044663
TAMOXIFEN TAB 10MG
106
$10,006.12
0.82%
31
$740.37
0.14%
00555048401
LEUCOVOR CA TAB 5MG
19
$568.85
0.15%
32
$1,182.56
0.15%
00555048402
LEUCOVOR CA TAB 5MG
7
$59.61
0.05%
16
$159.69
0.07%
00555048527
3
$935.55
0.02%
2
$2.00
0.01%
LIQ
0
1
Page 294 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
00555057202
542
$13,968.82
4.17%
00555057235
12
$231.72
0.09%
00555060602
17
$257.61
0.13%
00555060702
41
$1,856.65
0.32%
00555060703
4
$146.40
00555060704
0
00555087063
FLUTAMIDE
1
00555088202
56
00555090401
TAMOXIFEN TAB 20MG
00555090414
TAMOXIFEN TAB 20MG
00555092801
TREXALL
TAB 7.5MG
00555092901
TREXALL
00555094501
TREXALL
00562780706
00562780806
00574006930
GLUTOSE
00575620030
PROGLYCEM
$6,036.85
3.19%
9
$59.70
0.04%
22
$189.62
0.10%
61
$1,225.44
0.28%
0.03%
6
$86.32
0.03%
$0.00
0.00%
1
$19.45
0.00%
$220.54
0.01%
2
$656.22
0.01%
$1,808.95
0.43%
53
$1,740.30
0.25%
217
$23,118.44
1.67%
100
$3,139.50
0.47%
58
$6,493.38
0.45%
18
$594.17
0.08%
2
$159.94
0.02%
0
$0.00
0.00%
TAB 10MG
0
$0.00
0.00%
3
$328.53
0.01%
TAB 15MG
7
$562.79
0.05%
0
$0.00
0.00%
RHOGAM HUMAN INJ 300MCG
1
$107.23
0.01%
1
$113.09
0.00%
MICRHOGAM
1
$33.35
0.01%
4
$190.96
0.02%
0
$0.00
0.00%
10
$65.68
0.05%
SUS 50MG/ML
0
$0.00
0.00%
2
$133.82
0.01%
00603504321
PAPAVERINE CAP 150MG CR
3
$16.35
0.02%
0
$0.00
0.00%
00603699721
ACCUSURE
MIS .5CC/29G
0
$0.00
0.00%
3
$57.10
0.01%
00603699921
ACCUSURE
MIS .5CC/30G
23
$510.89
0.18%
5
$105.30
0.02%
00603700021
INSULIN SYRG MIS 1CC/30G
4
$87.24
0.03%
7
$142.92
0.03%
00615357053
20
$977.05
0.15%
0
$0.00
0.00%
00615357063
16
$948.20
0.12%
0
$0.00
0.00%
00677141701
YOHIMBINE
1
$26.34
0.01%
0
$0.00
0.00%
00703401418
LEUPROLIDE INJ 1MG/.2ML
0
$0.00
0.00%
1
$322.67
0.00%
00904174960
0
$0.00
0.00%
6
$48.10
0.03%
00904357160
1
$55.35
0.01%
0
$0.00
0.00%
CAP 125MG
INJ 50MCG RH
GEL 40%
TAB 5.4MG
686
Page 295 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
00904437525
MAJOR COMFOR MIS LANCETS
1
$1.00
0.01%
0
00904765151
MAPAP PM
1
$6.44
0.01%
00944262003
GAMMAGARD SD INJ 5GM HU
0
$0.00
0.00%
00944262004
GAMMAGARD SD INJ 10GM HU
6
$13,511.10
08189609600
E-Z JECT
0
08189610000
E-Z JECT JR MIS
08189610001
E-Z JECT
MIS
08189610010
E-Z JECT
08189610601
E-Z JECT
08189850320
08214053501
$0.00
0.00%
0
$0.00
0.00%
2
$3,660.37
0.01%
0.05%
0
$0.00
0.00%
$0.00
0.00%
3
$11.17
0.01%
0
$0.00
0.00%
5
$29.01
0.02%
0
$0.00
0.00%
10
$49.75
0.05%
MIS
0
$0.00
0.00%
3
$8.85
0.01%
MIS THIN 26G
0
$0.00
0.00%
23
$108.32
0.11%
RELI ON THIN MIS LANCETS
0
$0.00
0.00%
1
$6.55
0.00%
UNILET EX II MIS 28G
0
$0.00
0.00%
6
$23.45
0.03%
08214070201
UNISTIK 2
0
$0.00
0.00%
1
$17.71
0.00%
08271036100
VITALET 26 MIS LANCETS
0
$0.00
0.00%
11
$33.57
0.05%
08287126107
3CC LUER-LOK MIS 21GX1.5"
1
$4.29
0.01%
0
$0.00
0.00%
08287126111
3CC LUER-LOK MIS 25GX1"
0
$0.00
0.00%
2
$2.58
0.01%
08290005500
B-D SYRINGES MIS ALLERGY
6
$32.65
0.05%
3
$27.32
0.01%
08290006893
B-D SWABS
1
$2.99
0.01%
1
$0.49
0.00%
08290008410
B-D MF SYRG MIS 1CC/28G
2
$39.42
0.02%
2
$42.48
0.01%
08290301603
5CC SYRINGE MIS SLIP TIP
3
$53.91
0.02%
0
$0.00
0.00%
08290301604
2
$38.26
0.02%
0
$0.00
0.00%
08290301625
20CC SYRINGE MIS LUER SLP
3
$114.99
0.02%
0
$0.00
0.00%
08290305106
YALE NEEDLES MIS 30GX1/2"
4
$101.20
0.03%
7
$267.85
0.03%
08290305109
8
$55.97
0.06%
2
$7.84
0.01%
08290305122
2
$13.82
0.02%
0
$0.00
0.00%
08290305125
HYPO NEEDLE MIS 25GX1"
0
$0.00
0.00%
2
$6.41
0.01%
08290305145
PRECISION MIS GLIDE
5
$31.66
0.04%
0
$0.00
0.00%
08290305155
YALE NEEDLES MIS 22GX1"
0
$0.00
0.00%
4
$42.66
0.02%
TAB 25-500
MIS THIN 26G
MIS 2.4MM
PAD BUTTRFLY
Page 296 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
08290305156
YALE NEEDLES MIS 22GX1.5"
0
$0.00
0.00%
4
08290305167
YALE NEEDLES MIS 21X1.5"
0
$0.00
0.00%
08290305175
0
$0.00
0.00%
08290305195
0
$0.00
08290305196
4
08290305198
08290305200
B-D FIL NEED MIS 5 MICRON
08290305500
$9.32
0.02%
1
$0.25
0.00%
2
$20.50
0.01%
0.00%
2
$24.21
0.01%
$38.00
0.03%
1
$10.25
0.00%
0
$0.00
0.00%
1
$7.26
0.00%
5
$24.03
0.04%
0
$0.00
0.00%
1CC ALLERGY MIS 28GX1/2"
2
$16.42
0.02%
2
$13.51
0.01%
08290305520
1CC ALLERGIS MIS 27GX1/2"
0
$0.00
0.00%
2
$7.62
0.01%
08290305540
ALLERGIST
1
$10.65
0.01%
3
$16.47
0.01%
08290305553
1CC TB SYRNG MIS 27GX1/2"
0
$0.00
0.00%
1
$5.35
0.00%
08290305554
SAFETY SYRNG MIS 25GX5/8"
1
$6.69
0.01%
3
$20.74
0.01%
08290305592
3CC SYRINGE MIS 25GX5/8"
1
$7.62
0.01%
0
$0.00
0.00%
08290305595
3CC SYRINGE MIS 23GX1"
1
$4.76
0.01%
1
$2.76
0.00%
08290305605
MEDSAVER SYR MIS /NDL 1ML
1
$4.23
0.01%
0
$0.00
0.00%
08290305903
B-D 1CC SYRN MIS 25GX5/8"
0
$0.00
0.00%
1
$4.49
0.00%
08290305930
SAFETY-GLIDE MIS 28GX1/2"
7
$293.32
0.05%
2
$83.80
0.01%
08290305932
31
$1,332.28
0.24%
124
$5,244.81
0.58%
08290305935
0
$0.00
0.00%
3
$94.61
0.01%
08290309540
1CC SYR/NEED MIS 25GX5/8"
1
$12.70
0.01%
0
$0.00
0.00%
08290309570
3CC LUER-LOK MIS 25GX5/8"
59
$315.06
0.45%
60
$265.08
0.28%
08290309571
9
$78.17
0.07%
2
$3.85
0.01%
08290309572
11
$81.64
0.08%
4
$8.91
0.02%
08290309573
3CC LL SYRNG MIS 22GX1.25
0
$0.00
0.00%
1
$1.19
0.00%
08290309574
49
$168.60
0.38%
39
$134.16
0.18%
08290309575
15
$88.49
0.12%
5
$15.71
0.02%
08290309577
10
$48.33
0.08%
5
$18.91
0.02%
KIT 27GX1/2"
Page 297 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
08290309578
3CC LL SYRNG MIS 20GX1"
4
$15.56
0.03%
3
$5.00
0.01%
08290309579
3CC LL SYRNG MIS 20GX1.5"
5
$24.99
0.04%
6
$17.34
0.03%
08290309580
0
$0.00
0.00%
1
$1.19
0.00%
08290309581
19
$100.01
0.15%
13
$73.84
0.06%
08290309582
3CC LUER-LOK MIS 25GX1.5
5
$22.25
0.04%
9
$50.94
0.04%
08290309585
3CC SYRINGE MIS LUER-LOK
21
$127.47
0.16%
7
$65.06
0.03%
08290309586
2
$28.74
0.02%
0
$0.00
0.00%
08290309587
3CC LL SYRNG MIS 26GX5/8"
5
$27.48
0.04%
0
$0.00
0.00%
08290309588
0
$0.00
0.00%
1
$1.19
0.00%
08290309589
B-D LL SYRNG MIS 23GX1.5"
1
$4.72
0.01%
3
$9.29
0.01%
08290309592
3CC LL SYRNG MIS 25GX5/8"
8
$93.61
0.06%
4
$54.88
0.02%
08290309594
2
$10.10
0.02%
3
$15.90
0.01%
08290309595
1
$3.54
0.01%
0
$0.00
0.00%
08290309602
1CC TB SYRNG MIS SLIP TIP
9
$52.00
0.07%
6
$30.74
0.03%
08290309603
3
$32.42
0.02%
2
$23.07
0.01%
08290309604
15
$225.43
0.12%
2
$24.72
0.01%
08290309623
71
$427.54
0.55%
53
$258.22
0.25%
08290309625
21
$127.63
0.16%
16
$65.21
0.07%
08290309626
52
$314.48
0.40%
65
$387.83
0.30%
08290309628
4
$106.83
0.03%
0
$0.00
0.00%
08290309634
2
$7.48
0.02%
2
$3.48
0.01%
08290309637
0
$0.00
0.00%
1
$19.66
0.00%
08290309650
3
$120.72
0.02%
1
$53.95
0.00%
08290309653
B-D 60CC SYR MIS LUER-LOK
0
$0.00
0.00%
2
$44.13
0.01%
08290309661
0
$0.00
0.00%
1
$20.84
0.00%
08290309663
50-60CC SYR MIS LUER-LOK
1
$4.25
0.01%
3
$40.96
0.01%
08290309664
2 OZ SYRINGE MIS CATH TIP
2
$42.72
0.02%
1
$35.37
0.00%
Page 298 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
08290320096
B-D SYRINGE MIS INSULIN
08290320109
B-D UF SHORT MIS PENNEEDL
08290320119
B-D UF MINI MIS PENNEEDL
08290321951
0
$0.00
0.00%
2
$14.98
0.01%
326
$9,222.55
2.51%
278
$8,017.70
1.29%
9
$315.26
0.07%
59
$1,895.20
0.27%
B-D PEN MINI MIS
3
$149.25
0.02%
1
$72.95
0.00%
08290322053
B-D TEST
0
$0.00
0.00%
8
$1,262.89
0.04%
08290322057
B-D ULTRA FI MIS 33G
0
$0.00
0.00%
5
$31.89
0.02%
08290325772
B-D ULT FINE MIS LANCETS
2
$13.85
0.02%
7
$56.45
0.03%
08290325773
B-D ULT FINE MIS LANCETS
4
$29.63
0.03%
64
$393.61
0.30%
08290325775
B-D LANCET MIS DEVICE
0
$0.00
0.00%
7
$74.30
0.03%
08290326895
B-D SWABS
08290328203
B-D UF ORIG MIS PENNEEDL
08290328230
TES
PAD REG
0
$0.00
0.00%
24
$76.48
0.11%
155
$3,907.50
1.19%
118
$2,863.94
0.55%
B-D GLUCOSE CHW 5GM
1
$14.63
0.01%
5
$22.41
0.02%
08290328233
B-D MAGNI- MIS GUIDE
0
$0.00
0.00%
1
$5.30
0.00%
08290328410
56
$1,256.63
0.43%
65
$1,423.91
0.30%
08290328411
481
$11,501.44
3.70%
621
$15,242.11
2.89%
08290328412
2
$33.90
0.02%
0
$0.00
0.00%
08290328418
147
$3,358.07
1.13%
300
$6,982.36
1.40%
08290328430
INSULIN SYRG MIS 0.3/28G
14
$357.65
0.11%
23
$559.25
0.11%
08290328431
INSULIN SYRG MIS .3CC/30G
196
$4,696.05
1.51%
272
$6,283.24
1.27%
08290328438
250
$6,764.54
1.92%
379
$9,266.43
1.76%
08290328440
5
$210.99
0.04%
17
$538.48
0.08%
08290328465
B-D MF SYRG MIS .5CC/28G
108
$2,332.10
0.83%
114
$2,401.12
0.53%
08290328466
B-D INS SYRG MIS 30GX1/2"
704
$16,668.94
5.42%
903
$21,519.06
4.20%
08290328468
B-D INS SYRG MIS 31GX5/16
459
$10,941.41
3.53%
712
$17,671.01
3.31%
08290329411
B-D UF SYRG MIS 1CC/29G
2
$51.06
0.02%
0
$0.00
0.00%
08290329424
0
$0.00
0.00%
2
$51.16
0.01%
08290329431
INSULIN SYRG MIS 0.3/29G
6
$125.25
0.05%
0
$0.00
0.00%
Page 299 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
08290329461
1
$25.58
0.01%
0
$0.00
0.00%
08290329464
INSULIN SYRG MIS 29GX1/2"
57
$1,871.65
0.44%
71
$2,373.50
0.33%
08290329465
2
$46.32
0.02%
0
$0.00
0.00%
08290329466
B-D UF SYRG MIS .5CC/29G
4
$102.12
0.03%
6
$172.85
0.03%
08290329622
B-D INS SYRG MIS 1CC/25G
2
$8.44
0.02%
0
$0.00
0.00%
08290329651
B-D INS SYRG MIS 1CC/25G
0
$0.00
0.00%
1
$5.00
0.00%
08290366579
B-D GENIE LA MIS NCETS
0
$0.00
0.00%
2
$18.70
0.01%
08290550002
B-D ALLERGY MIS SYR 1CC
4
$13.16
0.03%
4
$15.52
0.02%
08290550003
B-D ALLERGY MIS SYR 1CC
2
$14.07
0.02%
6
$91.96
0.03%
08290823000
B-D GLUCOSE TAB
2
$15.47
0.02%
1
$3.66
0.00%
08290841003
17
$398.47
0.13%
12
$226.47
0.06%
08290841101
0
$0.00
0.00%
4
$90.95
0.02%
08290841103
155
$3,751.04
1.19%
184
$4,541.98
0.86%
08290841203
0
$0.00
0.00%
1
$18.97
0.00%
08290841801
B-D UFII SYR MIS 1CC/30G
0
$0.00
0.00%
1
$23.23
0.00%
08290841803
B-D ULT FINE MIS 1CC/30G
33
$901.74
0.25%
35
$851.23
0.16%
08290843003
2
$48.26
0.02%
1
$9.73
0.00%
08290843101
B-D UF SYRG MIS .3CCX29G
0
$0.00
0.00%
3
$77.19
0.01%
08290843103
38
$951.35
0.29%
32
$839.47
0.15%
08290843801
B-D UFII SYR MIS .3CCX30G
0
$0.00
0.00%
1
$7.56
0.00%
08290843803
INSULIN SYRG MIS 30GX5/16
46
$1,352.19
0.35%
41
$1,169.72
0.19%
08290846503
10
$225.40
0.08%
7
$145.63
0.03%
08290846601
0
$0.00
0.00%
2
$48.96
0.01%
08290846603
152
$3,744.22
1.17%
152
$3,753.36
0.71%
08290846803
B-D ULTRA-FI MIS 1/2CC
95
$2,381.29
0.73%
92
$2,245.88
0.43%
08317880100
TECHLITE
0
$0.00
0.00%
5
$21.75
0.02%
08329290110
MAJOR INS SY MIS 1ML/29G
2
$46.46
0.02%
0
$0.00
0.00%
MIS LANCETS
Page 300 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
08329290150
MAJOR INS SY MIS .5ML/29G
3
$60.45
0.02%
1
$11.49
0.00%
08329300210
MAJOR INS SY MIS 1ML/30G
1
$24.40
0.01%
0
$0.00
0.00%
08329300230
1
$24.40
0.01%
0
$0.00
0.00%
08329300250
3
$61.79
0.02%
0
$0.00
0.00%
08347100010
LANCETS
0
$0.00
0.00%
1
$6.35
0.00%
08385086701
PRECISION MIS 28G
0
$0.00
0.00%
1
$6.85
0.00%
08418992001
INSULIN SYR MIS .5CC/29G
7
$97.93
0.05%
0
$0.00
0.00%
08418992101
INSULIN SYR MIS 1CC/29G
3
$31.53
0.02%
6
$79.64
0.03%
08881501608
1CC TB SYRNG MIS 28GX1/2
0
$0.00
0.00%
1
$8.40
0.00%
08881511110
14
$556.98
0.11%
17
$663.55
0.08%
08881511136
INSULIN SYR MIS .5CC/29G
8
$275.20
0.06%
12
$515.94
0.06%
08881513207
PHARMACY TRA MIS 3CC LL
0
$0.00
0.00%
1
$1.41
0.00%
08881600004
30
$595.28
0.23%
28
$554.95
0.13%
08881600145
1
$24.14
0.01%
0
$0.00
0.00%
08881600228
4
$92.56
0.03%
2
$45.78
0.01%
08881600251
5
$113.55
0.04%
0
$0.00
0.00%
08881600350
28
$604.87
0.22%
27
$516.35
0.13%
08881600392
0
$0.00
0.00%
1
$13.28
0.00%
08881600700
INS SYRINGE MIS 1/2CC30G
3
$56.85
0.02%
1
$9.59
0.00%
08881600947
2
$46.28
0.02%
0
$0.00
0.00%
08881601044
1
$23.14
0.01%
3
$76.93
0.01%
08881601101
12
$225.58
0.09%
31
$606.45
0.14%
08881601135
2
$14.00
0.02%
0
$0.00
0.00%
08881601358
36
$700.18
0.28%
34
$696.57
0.16%
08881601390
1
$23.14
0.01%
0
$0.00
0.00%
08881602018
MONOLET
MIS LANCETS
0
$0.00
0.00%
10
$77.70
0.05%
08881602034
MONOLET
MIS LANCETS
1
$1.10
0.01%
30
$128.85
0.14%
MIS
Page 301 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
08881602075
MONOLET
08881602125
08881602190
MIS LANCETS
0
$0.00
0.00%
12
$50.84
0.06%
MONOLET THIN MIS LANCETS
0
$0.00
0.00%
2
$9.34
0.01%
0
$0.00
0.00%
1
$6.85
0.00%
08881602208
0
$0.00
0.00%
3
$28.74
0.01%
08881602216
0
$0.00
0.00%
2
$14.25
0.01%
08881608020
ULTRA COMFOR MIS 1ML/28G
1
$11.58
0.01%
0
$0.00
0.00%
08881608022
ULTRA COMFOR MIS .3ML/29G
3
$34.72
0.02%
0
$0.00
0.00%
08881608031
ULTRA COMFOR MIS .5ML/30G
1
$11.58
0.01%
0
$0.00
0.00%
08881609004
MONO INS SYR MIS .5ML/28G
1
$23.14
0.01%
0
$0.00
0.00%
08881609101
1CC INS SYRG MIS 28GX1/2"
10
$233.40
0.08%
0
$0.00
0.00%
08881609350
ULTRA COMFRT MIS SYRINGE
11
$242.43
0.08%
16
$394.88
0.07%
08881609358
ULT COM SYR MIS 1CC/29G
7
$143.56
0.05%
17
$382.64
0.08%
08881609700
INS SYRINGE MIS 1/2CC30G
0
$0.00
0.00%
1
$21.64
0.00%
08881713153
3CC SYRINGE MIS 21GX1.5"
0
$0.00
0.00%
1
$5.01
0.00%
08970200521
1
$13.56
0.01%
0
$0.00
0.00%
08970200531
3
$47.65
0.02%
0
$0.00
0.00%
08970201031
1
$15.80
0.01%
1
$14.30
0.00%
08970501021
ALLERGY SYRN MIS 1CC/27G
1
$4.99
0.01%
0
$0.00
0.00%
11822399280
RA LANCETS MIS
0
$0.00
0.00%
170
$718.32
0.79%
11822801460
RA GLUCOSE MIS MONITOR
0
$0.00
0.00%
1
$9.89
0.00%
11822801870
RA TEST STRI TES
0
$0.00
0.00%
1
$40.84
0.00%
11822871860
LANCETS
0
$0.00
0.00%
5
$31.80
0.02%
11822989400
RA LANCET
MIS THIN
0
$0.00
0.00%
8
$41.78
0.04%
17205062601
INVERSINE
TAB 2.5MG
2
$277.83
0.02%
0
$0.00
0.00%
18270010030
INJEX 30 AMP MIS
0
$0.00
0.00%
1
$44.35
0.00%
24385006576
ALCOHOL PREP PAD SWABS
0
$0.00
0.00%
1
$2.14
0.00%
30142009682
THIN LANCETS MIS
0
$0.00
0.00%
1
$6.85
0.00%
MIS COLORED
Page 302 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
36652030108
THIN LANCETS MIS
0
$0.00
0.00%
7
36652030112
LANCETS
0
$0.00
0.00%
36652030208
THIN LANCETS MIS
0
$0.00
0.00%
36652030508
SUPER THIN MIS LANCET
0
$0.00
36652040412
1
36652400003
36652402602
36652402703
36652402805
$31.59
0.03%
1
$3.85
0.00%
3
$16.89
0.01%
0.00%
6
$23.10
0.03%
$14.78
0.01%
0
$0.00
0.00%
0
$0.00
0.00%
3
$48.62
0.01%
14
$161.82
0.11%
1
$10.08
0.00%
55
$671.14
0.42%
3
$32.74
0.01%
43
$506.93
0.33%
2
$20.16
0.01%
36652403608
22
$281.75
0.17%
1
$10.08
0.00%
36652403707
33
$426.75
0.25%
0
$0.00
0.00%
36652403806
25
$292.92
0.19%
4
$40.32
0.02%
36652404901
RELION THIN MIS LANCETS
0
$0.00
0.00%
8
$13.92
0.04%
37205011882
LANCETS
0
$0.00
0.00%
1
$6.35
0.00%
37205014278
LANCETS THIN MIS
0
$0.00
0.00%
24
$124.62
0.11%
37205014282
LANCETS THIN MIS
0
$0.00
0.00%
4
$24.40
0.02%
37205022873
ALLERHIST-1 TAB 1.34MG
4
$68.71
0.03%
12
$163.47
0.06%
38396044902
0
$0.00
0.00%
4
$9.46
0.02%
38396045002
RELION
0
$0.00
0.00%
3
$16.41
0.01%
38396045102
0
$0.00
0.00%
9
$23.16
0.04%
38396045202
0
$0.00
0.00%
5
$29.85
0.02%
49281025010
IMOVAX RABIE INJ 2.5IU/ML
0
$0.00
0.00%
3
$978.97
0.01%
49281037211
FLUZONE SPLT INJ 2003-04
0
$0.00
0.00%
3
$43.94
0.01%
49281037215
FLUZONE SPLT INJ 2003-04
0
$0.00
0.00%
14
$275.30
0.07%
49281048901
MENOMUNE
INJ A/C/Y/W
2
$133.85
0.02%
1
$73.24
0.00%
49281048905
MENOMUNE
INJ A/C/Y/W
0
$0.00
0.00%
1
$64.46
0.00%
49281068030
JE-VAX
1
$266.47
0.01%
0
$0.00
0.00%
MIS THIN
MIS
MIS LANCETS
INJ
Page 303 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
49281075221
TUBERSOL
INJ 5U/0.1ML
3
$76.10
0.02%
1
49281079001
TYPHIM VI
INJ
2
$131.17
0.02%
49281080083
TETANUS TOX INJ 5LF ADS
0
$0.00
0.00%
49348024110
THIN LANCETS MIS
0
$0.00
49348036810
INS SYR ULTR MIS .3CC/30G
0
49348037010
INS SYR ULTR MIS .5CC/30G
49348056322
SM LANCETS MIS
49348068603
$27.40
0.00%
0
$0.00
0.00%
1
$88.61
0.00%
0.00%
1
$3.85
0.00%
$0.00
0.00%
2
$26.56
0.01%
1
$16.25
0.01%
0
$0.00
0.00%
0
$0.00
0.00%
1
$6.35
0.00%
V-R DAILYHST TAB 1.34MG
0
$0.00
0.00%
3
$48.27
0.01%
49348090910
0
$0.00
0.00%
1
$16.08
0.00%
49348091010
1
$16.26
0.01%
2
$32.16
0.01%
49502018130
ACETYLCYST SOL 10%
15
$176.40
0.12%
0
$0.00
0.00%
49502018204
ACETYLCYST SOL 20%
21
$226.38
0.16%
0
$0.00
0.00%
49502018230
ACETYLCYST SOL 20%
1
$32.33
0.01%
0
$0.00
0.00%
49502083003
74
$1,058.92
0.57%
47
$734.24
0.22%
49502083005
2
$31.90
0.02%
0
$0.00
0.00%
49884014301
HYDRAL/HCTZ CAP 25/25
0
$0.00
0.00%
2
$47.70
0.01%
49884028901
24
$604.08
0.18%
42
$518.96
0.20%
49884029001
12
$268.95
0.09%
59
$1,379.97
0.27%
49884029004
0
$0.00
0.00%
8
$324.40
0.04%
49884029005
18
$856.80
0.14%
62
$1,397.39
0.29%
49884072401
5
$200.25
0.04%
6
$228.60
0.03%
49884090738
MEGESTROL AC SUS 40MG/ML
286
$39,689.18
2.20%
304
$38,674.37
1.41%
50428001771
CVS LANCETS MIS THIN
0
$0.00
0.00%
3
$11.55
0.01%
50428001773
CVS LANCETS MIS ORIGINAL
0
$0.00
0.00%
1
$6.85
0.00%
50428235157
ULTRA THIN MIS LANCETS
0
$0.00
0.00%
3
$9.34
0.01%
50486007822
BRONCHO SAL AER 0.9%
2
$15.78
0.02%
1
$6.74
0.00%
50486007823
136
$1,210.03
1.05%
140
$1,203.01
0.65%
Page 304 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
50924001901
ACCU-CHEK KIT COMPACT
0
$0.00
0.00%
50924010401
ACCU-CHEK KIT ADVANTAG
0
$0.00
0.00%
50924012850
ACCU-CHEK TES COMFORT
0
$0.00
0.00%
50924012910
ACCU-CHECK TES COMFORT
2
$130.12
0.02%
50924027650
ACCU-CHEK TES SIMPLICI
11
$535.98
50924030202
ACCU-CHEK LIQ CPT/GLUC
0
50924031410
ACCU-CHEK TES SIMPLICI
2
50924036550
2
50924037350
50924038110
50924047550
ACCU-CHEK TES ACTIVE
50924047701
$1,636.45
0.08%
1
$44.35
0.00%
10
$835.39
0.05%
4
$281.11
0.02%
0.08%
8
$440.62
0.04%
$0.00
0.00%
1
$7.22
0.00%
$126.84
0.02%
4
$274.27
0.02%
$110.58
0.02%
1
$36.35
0.00%
121
$7,540.59
0.93%
258
$14,194.65
1.20%
347
$24,425.93
2.67%
700
$54,122.09
3.26%
27
$1,194.25
0.21%
115
$5,340.99
0.53%
ACCU-CHEK KIT ACTIVE
0
$0.00
0.00%
9
$158.22
0.04%
50924050125
CHEMSTRIP BG TES VISL STR
0
$0.00
0.00%
1
$71.85
0.00%
50924051501
ACCU-CHEK KIT COMPLETE
0
$0.00
0.00%
10
$1,042.31
0.05%
50924055201
GLUCOSE CONT SOL ADVANTAG
0
$0.00
0.00%
3
$16.06
0.01%
50924055350
ACCU-CHEK TES ADVANTAG
21
$1,292.11
0.16%
43
$2,105.39
0.20%
50924058001
SOFT TOUCH MIS LAN DEVC
0
$0.00
0.00%
1
$12.81
0.00%
50924058510
SOFT TOUCH MIS LANCETS
0
$0.00
0.00%
15
$83.36
0.07%
50924084810
0
$0.00
0.00%
3
$211.44
0.01%
50924086001
ACCU-CHEK KIT ADVANTAG
0
$0.00
0.00%
54
$3,131.95
0.25%
50924087710
ACCU-CHEK TES INST GLC
7
$293.56
0.05%
0
$0.00
0.00%
50924088401
ACCU-CHEK TES TEST DRU
0
$0.00
0.00%
48
$3,817.26
0.22%
50924091350
ACCU-CHEK TES INST GLC
9
$323.54
0.07%
27
$1,256.90
0.13%
50924091901
ACCU-CHEK IN LIQ CONTROL
0
$0.00
0.00%
2
$7.26
0.01%
50924093720
SOFT TOUCH MIS LANCETS
0
$0.00
0.00%
1
$0.96
0.00%
50924095120
SAFE-T-PRO MIS LANCETS
0
$0.00
0.00%
1
$6.85
0.00%
50924095701
SOFTCLIX LAN MIS DEVICE
0
$0.00
0.00%
2
$49.81
0.01%
17
Page 305 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
50924096610
ACCU-CHEK TES ADVANTAG
50924097110
SOFTCLIX
50924098820
SOFTCLIX
50924098850
ACCU-CHEK TES COMPACT
51079058205
51285005866
SEASONALE
51285050902
51285054802
51552020199
30
$1,859.72
0.23%
103
$7,106.23
0.48%
MIS LANCETS
0
$0.00
0.00%
354
$2,274.33
1.65%
MIS LANCETS
0
$0.00
0.00%
34
$341.26
0.16%
53
$4,352.94
0.41%
185
$12,454.22
0.86%
0
$0.00
0.00%
1
$311.35
0.00%
0
$0.00
0.00%
5
$541.25
0.02%
11
$215.62
0.08%
6
$29.35
0.03%
1
$28.35
0.01%
0
$0.00
0.00%
ACETYLCYST POW
1
$4.83
0.01%
0
$0.00
0.00%
51552053312
DHEA
2
$42.28
0.02%
0
$0.00
0.00%
51552064625
COENZYME Q10 POW
2
$29.98
0.02%
0
$0.00
0.00%
52735089301
FP LANCETS MIS THIN
0
$0.00
0.00%
2
$6.98
0.01%
52769047180
POLYGAM S/D SOL 10GM
7
$34,270.05
0.05%
9
$48,749.24
0.04%
53885004610
LIFESCAN FIN MIS LANCETS
0
$0.00
0.00%
80
$534.84
0.37%
53885004810
FASTTAKE
TES STRIPS
11
$678.40
0.08%
22
$1,511.00
0.10%
53885005210
SURESTEP
TES STRIPS
70
$4,632.06
0.54%
140
$10,408.46
0.65%
53885010207
ONE TOUCH MIS LANCETS
0
$0.00
0.00%
5
$37.35
0.02%
53885019725
ONE TOUCH TES STRIPS
53885019850
ONE TOUCH TES
53885020701
LANCETS
53885024450
TAB
POW
9
$507.04
0.07%
11
$386.69
0.05%
146
$8,261.20
1.12%
292
$15,154.13
1.36%
0
$0.00
0.00%
1
$3.85
0.00%
ONE TOUCH UL TES STRIPS
137
$8,798.20
1.05%
465
$29,411.70
2.16%
53885024510
410
$32,826.73
3.16%
1,457
$125,789.69
6.78%
53885024701
ONE TOUCH KIT ULTRA
0
$0.00
0.00%
139
$7,802.36
0.65%
53885027202
ONE TOUCH SOL NORM CON
0
$0.00
0.00%
4
$19.89
0.02%
53885028425
ONE TOUCH SOL NORM CON
0
$0.00
0.00%
1
$2.25
0.00%
53885028550
6
$181.32
0.05%
25
$1,314.21
0.12%
53885032501
ONE TOUCH KIT BASIC
0
$0.00
0.00%
67
$2,796.87
0.31%
MIS
Page 306 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
53885034101
SURESTEP
KIT W/METER
53885035601
PENLET II
53885035950
SURESTEP
53885037201
ONE TOUCH KIT PROFILE
53885037410
53885039310
ONE TOUCH US MIS LANCETS
53885044450
FASTTAKE
53885045802
KIT BLOOD
TES STRIPS
0
$0.00
0.00%
8
$424.40
0.04%
0
$0.00
0.00%
5
$85.05
0.02%
36
$2,027.48
0.28%
65
$3,585.63
0.30%
0
$0.00
0.00%
1
$100.03
0.00%
336
$22,641.66
2.59%
670
$46,722.75
3.12%
0
$0.00
0.00%
478
$3,069.57
2.22%
23
$1,544.39
0.18%
32
$1,883.65
0.15%
OT ULT/FAST SOL CONTROL
0
$0.00
0.00%
4
$26.52
0.02%
53885052401
ONE TOUCH UL KIT
0
$0.00
0.00%
26
$1,909.73
0.12%
53885053810
ONE TOUCH UL KIT BONUS
0
$0.00
0.00%
1
$67.87
0.00%
53885063610
UNISTIK II MIS LANCETS
0
$0.00
0.00%
2
$7.35
0.01%
53885099425
0
$0.00
0.00%
12
$816.45
0.06%
53905050101
RABAVERT
0
$0.00
0.00%
3
$762.04
0.01%
54092000301
PROAMATINE TAB 2.5MG
3
$297.30
0.02%
6
$376.16
0.03%
54092000401
PROAMATINE TAB 5MG
48
$9,761.58
0.37%
35
$5,915.45
0.16%
54092000701
PROAMATINE TAB 10MG
0
$0.00
0.00%
4
$1,384.55
0.02%
54092017030
FARESTON
5
$534.15
0.04%
6
$643.98
0.03%
54482005301
MATULANE
CAP 50MG
3
$65.59
0.02%
6
$157.71
0.03%
54482014407
CARNITOR
TAB 330MG
79
$4,467.98
0.61%
89
$6,887.89
0.41%
54482014508
CARNITOR
SOL 10%
259
$15,134.60
1.99%
214
$13,175.36
1.00%
54569263000
0
$0.00
0.00%
2
$131.22
0.01%
54569279000
ENGERIX-B
1
$54.46
0.01%
4
$222.34
0.02%
54569403700
0
$0.00
0.00%
4
$36.94
0.02%
54569477100
SYNVISC
1
$1,281.42
0.01%
0
$0.00
0.00%
54569519000
ONE TOUCH MIS LANCETS
0
$0.00
0.00%
2
$7.70
0.01%
54569526800
TWINRIX
INJ
2
$171.54
0.02%
0
$0.00
0.00%
54569537100
HAVRIX
INJ
0
$0.00
0.00%
2
$118.18
0.01%
TES STRIPS
INJ
TAB 60MG
INJ 20MCG/ML
INJ 8MG/ML
Page 307 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
54868073400
ENGERIX-B
55283086501
55390000401
55390003110
INJ 20MCG/ML
1
$66.65
0.01%
0
$0.00
0.00%
THIN GP LANC MIS 26 GAUGE
0
$0.00
0.00%
GLUCAGEN
0
$0.00
0.00%
1
$6.35
0.00%
6
$430.73
0.03%
METHOTREXATE INJ 25MG/ML
10
$77.69
0.08%
13
$79.90
0.06%
55390003410
1
$7.81
0.01%
9
$54.79
0.04%
55390005210
LEUCOVOR CA INJ 100MG
55390023510
ADRIAMYCIN INJ 2MG/ML
1
$6.26
0.01%
0
$0.00
0.00%
6
$79.52
0.05%
0
$0.00
0.00%
55390023701
ADRIAMYCIN INJ 2MG/ML
4
$145.52
0.03%
3
$208.23
0.01%
55390029201
ETOPOSIDE
0
$0.00
0.00%
2
$163.74
0.01%
56151014260
PRES SMART MIS LANCETS
0
$0.00
0.00%
5
$22.75
0.02%
56151020201
BLOOD GLUCOS KIT SYSTEM
0
$0.00
0.00%
1
$13.49
0.00%
56151030201
BLOOD GLUCOS TES STRIPS
9
$364.22
0.07%
6
$327.07
0.03%
56151030250
BLOOD GLUCOS TES STRIPS
8
$283.76
0.06%
9
$425.43
0.04%
56151055001
PRESTIGE
TES STRIPS
1
$58.85
0.01%
3
$153.08
0.01%
56151055050
PRESTIGE
TES STRIPS
16
$971.56
0.12%
12
$468.26
0.06%
56151083003
TRUETRACK
0
$0.00
0.00%
1
$45.99
0.00%
56151091001
PRESTIG SMRT TES STRIPS
1
$41.36
0.01%
7
$303.96
0.03%
56151095050
PRESTIG SMRT TES STRIPS
1
$48.57
0.01%
0
$0.00
0.00%
56151099902
PRESTIGE SMT KIT SYS/METR
0
$0.00
0.00%
1
$44.34
0.00%
57565006100
E-Z JECT
MIS LANCETS
0
$0.00
0.00%
2
$9.31
0.01%
57565006101
E-Z JECT
MIS LANCETS
0
$0.00
0.00%
1
$3.85
0.00%
57599710302
EXACTECH
TES
3
$254.19
0.02%
0
$0.00
0.00%
57599717402
EXACTECH
TES
1
$179.05
0.01%
0
$0.00
0.00%
57599740004
PRECISION TES QID
21
$1,155.45
0.16%
25
$1,213.98
0.12%
57599740105
PRECISION TES QID
36
$2,360.51
0.28%
72
$4,635.92
0.33%
57599740201
PRECISION MIS QID TEST
0
$0.00
0.00%
3
$88.49
0.01%
57599754204
EXACTECH RSG TES STRIPS
2
$99.80
0.02%
0
$0.00
0.00%
INJ 1MG
INJ 20MG/ML
TES
Page 308 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
57599754305
EXACTECH RSG TES STRIPS
2
57599833501
PRECISION TES QID
57599854701
SURE-DOSE
57599854801
$180.78
0.02%
0
$0.00
0.00%
0
$0.00
0.00%
3
$116.55
0.01%
1
$11.81
0.01%
0
$0.00
0.00%
SUREDOSE PLS MIS 1CCX29G
18
$339.22
0.14%
33
$590.57
0.15%
57599854901
SUREDOSE SYR MIS .5CCX29G
17
$321.43
0.13%
21
$380.59
0.10%
57599855001
SUREDOSE PLS MIS .3CC/29G
3
$55.34
0.02%
3
$48.71
0.01%
57599868105
THIN LANCETS MIS
0
$0.00
0.00%
5
$25.92
0.02%
57599868206
THIN LANCETS MIS
0
$0.00
0.00%
2
$14.37
0.01%
57599881401
PRECISION MIS XTRA
0
$0.00
0.00%
1
$65.94
0.00%
57599881508
PRECISN XTRA TES KETONE
0
$0.00
0.00%
22
$612.54
0.10%
57599889401
SURE-DOSE SY MIS .3CC/30G
2
$43.96
0.02%
4
$87.93
0.02%
57599889501
SURE-DOSE SY MIS 1/2CC/30
3
$76.74
0.02%
2
$57.59
0.01%
57599895601
PRECISION XT TES STRIPS
16
$1,049.65
0.12%
28
$2,807.59
0.13%
57599958604
PRECISION TES SOF-TACT
6
$386.84
0.05%
2
$217.20
0.01%
57599969405
0
$0.00
0.00%
3
$215.55
0.01%
57599969504
1
$66.74
0.01%
2
$143.70
0.01%
57599972804
6
$398.54
0.05%
44
$3,124.35
0.20%
57599987705
23
$1,406.85
0.18%
67
$5,651.66
0.31%
57599987805
1
$64.39
0.01%
1
$14.49
0.00%
57844052207
PURINETHOL TAB 50MG
0
$0.00
0.00%
47
$5,915.03
0.22%
57844052252
PURINETHOL TAB 50MG
0
$0.00
0.00%
1
$209.04
0.00%
58160083501
HAVRIX
INJ 1440 U
27
$1,613.39
0.21%
35
$2,136.38
0.16%
58160083532
HAVRIX
INJ 1440 U
5
$396.41
0.04%
0
$0.00
0.00%
58160083535
HAVRIX
INJ 1440 U
1
$57.34
0.01%
0
$0.00
0.00%
58160083541
HAVRIX
INJ 1440 U
4
$229.36
0.03%
7
$407.38
0.03%
58160083546
HAVRIX
INJ 1440 U
0
$0.00
0.00%
1
$57.84
0.00%
58160083701
HAVRIX
INJ 720U/0.5
13
$544.79
0.10%
3
$99.21
0.01%
MIS .5CCX28G
Page 309 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
58160083705
HAVRIX
INJ 720U/0.5
58160085601
ENGERIX-B
INJ 10MCG/.5
58160085701
ENGERIX-B
INJ 20MCG/ML
58160085716
ENGERIX-B
INJ 20MCG/ML
58160085746
ENGERIX-B
58160085750
58160086001
58337000301
VIVOTIF BERN CAP EC
58406068114
$0.00
0.00%
$29.22
0.00%
1
$26.42
0.01%
118
$7,387.85
0.91%
1
$47.00
0.00%
165
$9,067.95
0.77%
0
$0.00
0.00%
1
$53.59
0.00%
INJ 20MCG/ML
2
$106.76
0.02%
2
$107.76
0.01%
ENGERIX-B
INJ 20MCG/ML
0
ENGERIX-B
INJ 20MCG/ML
3
$0.00
0.00%
1
$56.38
0.00%
$147.87
0.02%
5
$246.44
0.02%
4
$143.36
0.03%
6
$233.78
0.03%
45
$455.96
0.35%
0
$0.00
0.00%
58406068117
58406068315
13
$262.09
0.10%
0
$0.00
0.00%
2
$18.87
0.02%
0
$0.00
0.00%
58406068316
4
$32.62
0.03%
0
$0.00
0.00%
58468004001
FABRAZYME
0
$0.00
0.00%
3
$97,552.50
0.01%
58468184904
THYROGEN
59366269306
59779032301
INJ 35MG
INJ 1.1MG
0
1
0
$0.00
0.00%
1
$1,202.54
0.00%
17
$210.82
0.13%
28
$325.11
0.13%
CVS LANCETS MIS THIN
0
$0.00
0.00%
9
$47.21
0.04%
59779032304
CVS LANCETS MIS ORIGINAL
0
$0.00
0.00%
2
$14.78
0.01%
59779114599
CVS INS SYR MIS .3CC/29G
1
$12.49
0.01%
0
$0.00
0.00%
59779114796
6
$91.94
0.05%
7
$87.43
0.03%
59779114799
CVS INS SYR MIS 1CC/29G
7
$78.57
0.05%
7
$88.43
0.03%
59779114803
3
$39.97
0.02%
0
$0.00
0.00%
59779114811
1
$13.99
0.01%
7
$76.95
0.03%
59911587401
0
$0.00
0.00%
1
$10.85
0.00%
59930160901
56
$1,172.89
0.43%
56
$1,232.70
0.26%
59930160902
5
$141.39
0.04%
2
$91.10
0.01%
60492002301
WINRHO SDF INJ 1500IU
1
$135.85
0.01%
11
$4,409.46
0.05%
60598000101
NIASPAN
274
$10,922.09
2.11%
382
$17,718.72
1.78%
TAB 500MG ER
Page 310 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
60598000201
NIASPAN
TAB 750MG ER
60598000301
NIASPAN
TAB 1000 ER
61570030141
ADRENALIN IN NEB 1:100
61570041881
ADRENALIN
61703020304
ACETYLCYST SOL 10%
61703030906
VINCRISTINE INJ 1MG/ML
61703030916
VINCRISTINE INJ 1MG/ML
61703040707
62107006701
20
$1,187.12
0.15%
16
$1,228.68
0.07%
111
$6,292.13
0.85%
169
$11,024.98
0.79%
1
$36.84
0.01%
0
$0.00
0.00%
0
$0.00
0.00%
1
$22.67
0.00%
1
$9.46
0.01%
0
$0.00
0.00%
9
$68.12
0.07%
16
$113.92
0.07%
19
$179.57
0.15%
23
$229.08
0.11%
1
$5.00
0.01%
0
$0.00
0.00%
GENTLE TOUCH MIS SYRINGE
0
$0.00
0.00%
3
$65.04
0.01%
62107006801
GENTLE TOUCH MIS SYRINGE
0
$0.00
0.00%
3
$46.71
0.01%
62161000420
CYSTADANE
1
$443.72
0.01%
4
$894.14
0.02%
62161000820
XYREM
3
$1,930.62
0.02%
3
$1,585.95
0.01%
63004773101
ACTHAR HP
5
$4,272.15
0.04%
0
$0.00
0.00%
63323011710
FLUOROURACIL INJ 50MG/ML
6
$102.37
0.05%
15
$150.30
0.07%
63323011720
FLUOROURACIL INJ 50MG/ML
4
$51.77
0.03%
11
$113.15
0.05%
63323012102
4
$53.82
0.03%
8
$95.75
0.04%
63323012110
0
$0.00
0.00%
1
$11.19
0.00%
63323012302
33
$288.03
0.25%
8
$70.20
0.04%
63323012310
7
$73.38
0.05%
5
$71.28
0.02%
63323018510
STERIL WATER INJ
9
$236.19
0.07%
10
$45.42
0.05%
63323025930
5
$115.55
0.04%
1
$5.50
0.00%
63323027810
VINBLASTINE INJ 1MG/ML
1
$12.85
0.01%
0
$0.00
0.00%
64116001101
ACTIMMUNE
INJ 2MMIU/.5
3
$4,959.45
0.02%
0
$0.00
0.00%
64116001112
ACTIMMUNE
INJ 2MMIU/.5
3
$13,499.19
0.02%
8
$25,698.71
0.04%
64894082550
HECTOROL
CAP 2.5MCG
6
$382.72
0.05%
7
$519.50
0.03%
66004953904
RELION TEST TES STRIPS
5
$121.64
0.04%
4
$195.90
0.02%
66004969105
RELION TEST TES STRIPS
14
$736.64
0.11%
22
$1,186.92
0.10%
INJ 1MG/ML
POW
SOL 500MG/ML
INJ GEL 80U
Page 311 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
66479013501
21
$340.25
0.16%
107
$1,188.20
0.50%
66479013509
12
$240.23
0.09%
23
$427.21
0.11%
66479013611
2
$17.90
0.02%
10
$128.80
0.05%
66479013619
0
$0.00
0.00%
3
$54.57
0.01%
66521010501
FLUVIRIN
INJ 2002-03
0
$0.00
0.00%
6
$71.50
0.03%
66521010510
FLUVIRIN
INJ 2002-03
2
$12.60
0.02%
0
$0.00
0.00%
66607100206
ORFADIN
CAP 2MG
3
$3,857.70
0.02%
3
$4,312.68
0.01%
66607101006
ORFADIN
CAP 10MG
9
$56,123.46
0.07%
13
$21,929.23
0.06%
72058004075
DIAFOODS
POW THICK-IT
53
$1,428.79
0.41%
47
$1,467.55
0.22%
72058004076
DIAFOODS
POW THICK-IT
21
$535.50
0.16%
34
$773.89
0.16%
72058004080
DIAFOODS #2 POW THICK-IT
17
$273.29
0.13%
12
$183.49
0.06%
72058004081
DIAFOODS #2 POW THICK-IT
2
$36.92
0.02%
1
$17.54
0.00%
75537030381
ACCU-CK COMF TES CURVE
10
$873.04
0.08%
36
$2,519.14
0.17%
81306051413
3
$35.74
0.02%
11
$118.38
0.05%
81306051423
INSULIN SYRG MIS 0.3CC/30
6
$71.48
0.05%
29
$350.50
0.13%
81306051513
12
$139.96
0.09%
71
$808.40
0.33%
81306051523
17
$225.02
0.13%
95
$1,134.59
0.44%
81306051613
RELI-ON INS MIS 1CC/29G
17
$248.18
0.13%
47
$525.24
0.22%
81306051623
1
$11.58
0.01%
43
$479.00
0.20%
86227070105
2
$49.59
0.02%
0
$0.00
0.00%
93815097137
ULTRA TLC
MIS LANCETS
0
$0.00
0.00%
1
$1.00
0.00%
93815097138
ULTRA TLC
MIS LANCETS
0
$0.00
0.00%
5
$20.54
0.02%
94542051150
SURELITE
0
$0.00
0.00%
1
$3.85
0.00%
99073011001
FS SYSTEM KT KIT
0
$0.00
0.00%
32
$2,095.71
0.15%
99073011003
FS SYSTEM KT KIT
0
$0.00
0.00%
3
$198.30
0.01%
99073011004
FS SYSTEM KT KIT
0
$0.00
0.00%
5
$335.50
0.02%
99073012001
FREESTYLE
75
$5,701.17
0.58%
231
$18,869.62
1.07%
MIS LANCETS
TES STRIPS
Page 312 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC.
99073012050
FREESTYLE
TES STRIPS
99073012051
FREESTYLE
KIT SIDEKICK
99073012101
FREESTYLE
TES STRIPS
99073012301
FREESTYLE
99073012401
32
$2,385.18
0.25%
0
$0.00
0.00%
9
$592.82
0.07%
TES STRIPS
0
$0.00
0.00%
FREESTYLE
TES STRIPS
0
$0.00
0.00%
99073012450
FREESTYLE
TES STRIPS
0
$0.00
99073013001
FREESTYLE
MIS LANCETS
0
$0.00
99073014001
FREESTYLE
LIQ CONTROL
0
99073017001
FREESTYLE
KIT FLASH
190
$12,435.48
0.88%
1
$61.80
0.00%
245
$19,320.12
1.14%
1
$47.50
0.00%
13
$805.45
0.06%
0.00%
17
$1,352.90
0.08%
0.00%
211
$1,371.09
0.98%
$0.00
0.00%
3
$36.11
0.01%
0
$0.00
0.00%
7
$457.57
0.03%
MISC. ANTI INFECTIVE COMBOS
00004011704
BACTRIM DS TAB 800-160
2
$10.18
0.04%
0
$0.00
0.00%
00006355259
PRIMAXIN IV INJ 500MG
0
$0.00
0.00%
5
$3,502.45
0.09%
00006358275
PRIMAXIN IM INJ 500MG
0
$0.00
0.00%
1
$856.56
0.02%
00074715613
EES/SULFISOX SUS 200-600
5
$87.05
0.10%
5
$102.24
0.09%
00074715643
14
$248.07
0.27%
8
$142.33
0.14%
00074715653
3
$94.18
0.06%
8
$198.20
0.14%
00093008801
SMZ-TMP
TAB 400-80MG
203
$1,416.33
3.97%
261
$1,651.41
4.54%
00093008805
SMZ-TMP
TAB 400-80MG
78
$465.31
1.52%
106
$632.77
1.84%
00093008901
SMZ/TMP DS TAB 800-160
565
$3,289.62
11.05%
682
$2,600.14
11.86%
00093008905
1,971
$11,732.56
38.53%
2,753
$11,309.71
47.89%
00093056216
SMZ-TMP PED SUS 200-40/5
10
$73.71
0.20%
1
$19.14
0.02%
00173054700
MEPRON
SUS
3
$1,520.49
0.06%
0
$0.00
0.00%
00173066518
MEPRON
SUS
18
$11,472.83
0.35%
32
$17,980.18
0.56%
00185011201
3
$14.14
0.06%
0
$0.00
0.00%
00364206801
SMZ-TMP
15
$122.34
0.29%
0
$0.00
0.00%
00364206901
23
$123.98
0.45%
0
$0.00
0.00%
TAB 400-80MG
Page 313 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
00364206990
00472128416
SULFATRIM
SUS 200-40/5
00472128516
SULFATRIM
SUS 200-40/5
00472128533
SULFATRIM
$
Market Share*
00364206905
# of Scripts
$404.96
1.21%
$0.00
0.00%
2
$11.61
0.04%
18
$193.46
0.35%
1
$3.47
0.02%
10
$158.45
0.17%
309
$2,796.36
6.04%
194
$2,667.60
3.38%
SUS 200-40/5
2
$17.02
0.04%
2
$20.80
0.03%
00555044521
11
00555044522
16
$210.57
0.22%
20
$425.24
0.35%
$240.78
0.31%
6
$141.54
0.10%
00555044523
17
$482.21
0.33%
13
$327.06
0.23%
00591554601
SMZ-TMP
2
$10.15
0.04%
0
$0.00
0.00%
00591554705
00603168758
162
$964.50
3.17%
3
$11.90
0.05%
3
$32.11
0.06%
2
$22.49
0.03%
00615017053
11
$72.47
0.22%
0
$0.00
0.00%
00615017063
266
$1,323.88
5.20%
0
$0.00
0.00%
00641276543
SMZ-TMP
INJ 400-80/5
2
$157.15
0.04%
0
$0.00
0.00%
00677078301
SMZ-TMP
TAB 400-80MG
6
$39.34
0.12%
0
$0.00
0.00%
00677078401
21
$113.22
0.41%
21
$79.78
0.37%
00677078405
41
$240.32
0.80%
10
$39.70
0.17%
00781606216
12
$99.61
0.23%
0
$0.00
0.00%
00904040616
5
$34.86
0.10%
0
$0.00
0.00%
00904272540
2
$12.70
0.04%
62
$255.77
1.08%
00904272560
0
$0.00
0.00%
8
$34.66
0.14%
00904272561
8
$6.85
0.16%
6
$15.12
0.10%
50111034101
SMZ-TMP
TAB 400-80MG
10
$48.89
0.20%
0
$0.00
0.00%
50383082316
SMZ-TMP
SUS 200-40/5
342
$2,951.13
6.69%
393
$5,084.03
6.84%
50383082416
SMZ-TMP
SUS 200-40/5
128
$1,190.53
2.50%
212
$2,688.96
3.69%
53489014501
SMZ-TMP
TAB 400-80MG
38
$285.33
0.74%
34
$240.82
0.59%
53489014505
SMZ-TMP
TAB 400-80MG
17
$123.57
0.33%
7
$49.98
0.12%
TAB 400-80MG
62
0
Page 314 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
53489014601
257
$1,421.72
5.02%
272
$1,111.14
4.73%
53489014605
342
$1,980.30
6.69%
522
$2,088.82
9.08%
61570005116
SEPTRA
SUS 200-40/5
4
$4.00
0.08%
0
$0.00
0.00%
61570005201
SEPTRA
TAB 400-80MG
1
$5.50
0.02%
3
$49.35
0.05%
61570005301
SEPTRA DS
TAB 800-160
13
$74.03
0.25%
21
$691.32
0.37%
61570005305
SEPTRA DS
TAB 800-160
71
$458.45
1.39%
60
$1,175.65
1.04%
64248011710
BACTRIM DS TAB 800-160
1
$43.50
0.02%
4
$112.16
0.07%
MISC. ANTI-BIOTICS
00002312542
VANCOCIN HCL CAP 125MG
10
$1,593.05
0.50%
21
$4,953.09
0.86%
00002312642
VANCOCIN HCL CAP 250MG
11
$3,234.49
0.55%
40
$20,398.32
1.64%
00002317002
LORABID
CAP 200MG
4
$299.44
0.20%
0
$0.00
0.00%
00002317030
LORABID
CAP 200MG
12
$1,211.88
0.60%
2
$230.51
0.08%
00002317102
LORABID
CAP 400MG
7
$543.89
0.35%
0
$0.00
0.00%
00002317130
LORABID
CAP 400MG
5
$521.60
0.25%
0
$0.00
0.00%
00002510516
VANCOCIN HCL SOL 250/5ML
2
$342.14
0.10%
0
$0.00
0.00%
00002513548
LORABID
SUS 100/5ML
3
$134.10
0.15%
0
$0.00
0.00%
00002513648
LORABID
SUS 200/5ML
6
$408.94
0.30%
0
$0.00
0.00%
00002729801
VANCOCIN HCL INJ 1GM
6
$215.96
0.30%
0
$0.00
0.00%
00002732101
VANCOCIN HCL INJ 1GM
0
$0.00
0.00%
5
$82.10
0.21%
00004100328
GANTRIS PED SUS 500/5ML
47
$792.94
2.34%
53
$912.07
2.18%
00025182150
FLAGYL
TAB 500MG
1
$49.18
0.05%
1
$54.02
0.04%
00025194250
FLAGYL
CAP 375MG
8
$502.63
0.40%
13
$785.26
0.53%
00025196130
FLAGYL ER
48
$2,763.39
2.39%
22
$1,825.84
0.90%
00074433201
VANCOMYCIN INJ 500MG
1
$32.13
0.05%
2
$100.65
0.08%
00074454801
PENTAMIDINE INJ 300MG
5
$212.05
0.25%
0
$0.00
0.00%
00074650901
VANCOMYCIN INJ 5GM
2
$207.50
0.10%
2
$75.88
0.08%
TAB 750MG
Page 315 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC. ANTI-BIOTICS
00074653301
10
$156.94
0.50%
13
00074653349
20
$1,046.21
1.00%
00074653401
10
$126.35
0.50%
00074653501
4
$114.33
00074781124
METRON/NACL INJ 500MG
2
00074781137
METRON/NACL INJ 500MG
00093085101
METRONIDAZOL TAB 250MG
00093085105
00093085152
00093085205
60
00093085253
359
00093215801
TRIMETHOPRIM TAB 100MG
21
00093215901
00172221860
00172297160
$512.05
0.53%
0
$0.00
0.00%
7
$52.50
0.29%
0.20%
11
$2,565.48
0.45%
$16.95
0.10%
2
$7.44
0.08%
2
$10.96
0.10%
0
$0.00
0.00%
101
$471.72
5.03%
78
$286.63
3.21%
6
$28.80
0.30%
5
$15.32
0.21%
9
$52.01
0.45%
17
$66.08
0.70%
$276.17
2.99%
122
$453.37
5.02%
$1,689.76
17.89%
231
$865.10
9.50%
$171.37
1.05%
21
$148.86
0.86%
0
$0.00
0.00%
1
$5.58
0.04%
SULFISOXAZOL TAB 0.5GM
7
$146.61
0.35%
7
$97.92
0.29%
0
$0.00
0.00%
1
$10.11
0.04%
00172300760
5
$24.35
0.25%
6
$20.30
0.25%
00185075701
SULFADIAZINE TAB 500MG
3
$615.10
0.15%
3
$906.18
0.12%
00185075710
SULFADIAZINE TAB 500MG
10
$197.48
0.50%
0
$0.00
0.00%
00338355148
VANCOCIN/DEX INJ 500MG
0
$0.00
0.00%
3
$54.90
0.12%
00338355248
VANCOCIN HCL INJ
30
$10,806.51
1.49%
86
$22,050.14
3.54%
00364059501
4
$17.64
0.20%
1
$6.50
0.04%
00364059504
1
$3.46
0.05%
0
$0.00
0.00%
00364059590
5
$17.43
0.25%
15
$56.68
0.62%
00364064901
3
$43.34
0.15%
1
$10.35
0.04%
00364068750
2
$11.70
0.10%
0
$0.00
0.00%
00574020001
BACITRACIN INJ 50000U
0
$0.00
0.00%
1
$244.45
0.04%
00591554001
25
$115.87
1.25%
72
$250.95
2.96%
Page 316 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC. ANTI-BIOTICS
00591554025
12
00591555250
00591557101
00603464121
$65.27
0.60%
50
$235.09
2.06%
142
$719.61
7.08%
449
$1,764.36
18.46%
92
$1,678.05
4.58%
136
$2,896.23
5.59%
1
$4.95
0.05%
0
$0.00
0.00%
00677069001
3
$11.65
0.15%
2
$20.58
0.08%
00677069003
0
$0.00
0.00%
1
$1.53
0.04%
00677081601
56
$273.70
2.79%
18
$76.00
0.74%
00904145360
1
$11.80
0.05%
0
$0.00
0.00%
00904221860
SULFISOXAZOL TAB 0.5GM
1
$6.48
0.05%
0
$0.00
0.00%
39822061501
COLISTIMETH INJ 150MG
2
$2,981.07
0.10%
4
$5,562.48
0.16%
50111033301
131
$601.81
6.53%
107
$370.66
4.40%
50111033302
10
$45.47
0.50%
6
$23.77
0.25%
50111033306
2
$9.18
0.10%
3
$7.51
0.12%
50111033401
541
$2,562.62
26.96%
648
$2,244.49
26.64%
50111033402
6
$31.25
0.30%
25
$78.45
1.03%
51079012220
3
$1.61
0.15%
0
$0.00
0.00%
51479004115
AZACTAM
1
$716.88
0.05%
0
$0.00
0.00%
53265035203
0
$0.00
0.00%
13
$799.83
0.53%
53489013601
63
$329.55
3.14%
63
$232.40
2.59%
54092043016
FUROXONE
LIQ 50/15ML
0
$0.00
0.00%
1
$17.22
0.04%
59439047802
PRIMSOL
SOL 50MG/5ML
3
$54.97
0.15%
4
$150.17
0.16%
61570005701
PROLOPRIM
TAB 100MG
23
$925.28
1.15%
1
$29.88
0.04%
61570013610
LORABID
SUS 200/5ML
25
$2,075.24
1.25%
11
$758.39
0.45%
61570017001
LORABID
CAP 200MG
1
$32.00
0.05%
4
$560.33
0.16%
61570017101
LORABID
CAP 400MG
3
$188.04
0.15%
1
$111.84
0.04%
61570041451
COLY-MYCIN-M INJ 150MG
4
$2,931.03
0.20%
1
$897.99
0.04%
63323022110
0
$0.00
0.00%
1
$25.21
0.04%
INJ 1GM
Page 317 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC. ANTI-BIOTICS
63323028420
0
63323029561
VANCOMYCIN INJ 5GM
63323031461
VANCOMYCIN INJ 10GM
63323087715
NEBUPENT
INH 300MG
$0.00
0.00%
1
$46.09
0.04%
0
$0.00
0.00%
5
$327.80
0.21%
3
$321.82
0.15%
0
$0.00
0.00%
1
$35.75
0.05%
12
$409.46
0.49%
20
$197.66
0.99%
6
$81.52
0.23%
MISC. ANTI-DIARRHEAL / ANTACID
00002202902
SODIUM BICAR TAB 650MG
00009360502
KAOPECT CHLD SUS 600/15ML
1
$7.08
0.05%
0
$0.00
0.00%
00009378501
KAOPECTATE LIQ REGULAR
1
$6.57
0.05%
2
$13.98
0.08%
00009521301
KAOPECTATE SUS 262/15
0
$0.00
0.00%
1
$3.59
0.04%
00009521402
KAOPECTATE SUS 262/15
0
$0.00
0.00%
1
$4.72
0.04%
00045029412
IMODIUM ADV CHW 2-125MG
0
$0.00
0.00%
1
$13.56
0.04%
00045029418
IMODIUM ADV CHW 2-125MG
1
$26.41
0.05%
0
$0.00
0.00%
00054472125
PROPANTHELIN TAB 15MG
9
$356.83
0.44%
12
$548.06
0.46%
00054472131
PROPANTHELIN TAB 15MG
4
$101.48
0.20%
0
$0.00
0.00%
00067033044
MAALOX
SUS
1
$7.42
0.05%
1
$6.46
0.04%
00067033071
MAALOX
SUS
0
$0.00
0.00%
14
$136.64
0.54%
00067033171
MAALOX
SUS
0
$0.00
0.00%
1
$4.61
0.04%
00067037085
MAALOX QUICK CHW DISSOLVE
2
$13.76
0.10%
0
$0.00
0.00%
00068012361
BENTYL
TAB 20MG
4
$244.44
0.20%
1
$39.96
0.04%
00068012516
BENTYL
SYP 10MG/5ML
2
$27.38
0.10%
5
$132.95
0.19%
00088117112
GAVISCON
00089010510
ALU-CAP
00091311101
SUS
4
$51.57
0.20%
0
$0.00
0.00%
CAP 400MG
2
$64.12
0.10%
4
$133.06
0.15%
NULEV
TAB 0.125MG
16
$691.29
0.79%
13
$597.89
0.50%
00091353101
LEVSIN
TAB 0.125MG
7
$439.72
0.35%
2
$229.70
0.08%
00091353201
LEVSIN/SL
4
$340.10
0.20%
4
$388.05
0.15%
00091353801
LEVBID
4
$327.09
0.20%
4
$74.00
0.15%
SUB 0.125MG
TAB 0.375 ER
Page 318 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00091453216
LEVSIN
ELX .125/5ML
3
$380.40
0.15%
0
$0.00
0.00%
00091453815
LEVSIN
DRO 0.125/ML
0
$0.00
0.00%
1
$34.31
0.04%
00121073312
ALUM HYDROX SUS 320/5ML
0
$0.00
0.00%
2
$46.74
0.08%
00143122710
DICYCLOMINE TAB 20MG
0
$0.00
0.00%
5
$73.74
0.19%
00143312601
DICYCLOMINE CAP 10MG
1
$13.75
0.05%
1
$9.40
0.04%
00143312610
6
$79.95
0.30%
35
$316.66
1.36%
00165002210
MAG-OX 400 TAB 400MG
2
$10.76
0.10%
3
$8.00
0.12%
00165002212
MAG-OX 400 TAB 400MG
34
$322.12
1.68%
45
$302.90
1.74%
00165005441
URO-MAG
2
$43.16
0.10%
3
$65.73
0.12%
00182113694
X-S ANTACID CHW 750MG
23
$132.25
1.14%
26
$149.50
1.01%
00182113920
ANTACID
52
$359.40
2.57%
6
$33.86
0.23%
00182181144
PINK BISMUTH SUS 527/30ML
3
$16.74
0.15%
13
$64.92
0.50%
00182199301
HYOSCYAMINE CAP 0.375 TR
0
$0.00
0.00%
2
$49.34
0.08%
00378161001
170
$1,606.86
8.40%
214
$1,652.26
8.29%
00378161005
4
$25.08
0.20%
15
$136.56
0.58%
00378162001
229
$1,848.15
11.32%
348
$2,886.42
13.48%
00378162005
4
$35.18
0.20%
21
$292.59
0.81%
00482006101
PAMINE
7
$435.72
0.35%
4
$209.20
0.15%
00517101025
ATROPINE SUL INJ 1MG/ML
2
$27.90
0.10%
3
$21.49
0.12%
00517460125
GLYCOPYRROL INJ 0.2MG/ML
0
$0.00
0.00%
1
$3.83
0.04%
00527058601
3
$20.45
0.15%
64
$515.39
2.48%
00527058610
5
$37.74
0.25%
4
$24.19
0.15%
00527128201
13
$127.18
0.64%
66
$749.30
2.56%
00527128210
1
$4.27
0.05%
1
$6.89
0.04%
00536009185
ALUM HYDROX SUS 320/5ML
0
$0.00
0.00%
1
$11.03
0.04%
00536341410
CALCIUM CARB TAB 650MG
39
$121.57
1.93%
20
$60.52
0.77%
00536454010
0
$0.00
0.00%
3
$7.95
0.12%
CAP 140MG
CHW 500MG
TAB 2.5MG
Page 319 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
00536474297
CAL-GEST
00536688908
CALCIUM CARB CHW 500MG
00574704012
$
Market Share*
00536454410
# of Scripts
2
$4.58
0.10%
3
$6.48
0.12%
40
$268.91
1.98%
103
$628.22
3.99%
42
$214.71
2.08%
50
$231.89
1.94%
BELLA/OPIUM SUP
2
$84.16
0.10%
0
$0.00
0.00%
00574704512
BELLADONNA & SUP OPIUM
0
$0.00
0.00%
3
$93.24
0.12%
00591079401
135
$1,234.19
6.67%
148
$1,336.56
5.73%
00591079410
6
$103.35
0.30%
32
$231.54
1.24%
00591079501
109
$1,369.89
5.39%
144
$1,412.92
5.58%
00591079510
15
$195.20
0.74%
10
$95.20
0.39%
00603009727
CAL ANTACID CHW 750MG XS
4
$15.16
0.20%
0
$0.00
0.00%
00603020922
MAG OXIDE
0
$0.00
0.00%
1
$4.91
0.04%
00603131473
HYOSCYAMINE DRO 0.125/ML
0
$0.00
0.00%
1
$14.98
0.04%
00603326521
1
$12.46
0.05%
0
$0.00
0.00%
00603400421
HYOSCYAMINE CAP 0.375 CR
0
$0.00
0.00%
2
$58.36
0.08%
00677013110
20
$90.69
0.99%
15
$42.64
0.58%
00677166201
10
$199.45
0.49%
4
$125.48
0.15%
00677168510
HAPONAL
4
$22.82
0.20%
2
$14.55
0.08%
00677171701
HYOSCYAMINE TAB 0.375 TR
1
$58.88
0.05%
1
$58.38
0.04%
00766073923
TUMS E-X
CHW 750MG
0
$0.00
0.00%
6
$28.32
0.23%
00766073966
TUMS E-X
CHW 750MG
14
$87.70
0.69%
19
$110.71
0.74%
00766074051
TUMS
CHW 500MG
1
$4.73
0.05%
0
$0.00
0.00%
00766074052
TUMS
CHW 500MG
31
$175.89
1.53%
33
$159.64
1.28%
00766074151
TUMS
CHW 500MG
6
$29.25
0.30%
17
$92.02
0.66%
00766074152
TUMS
CHW 500MG
22
$152.46
1.09%
11
$70.73
0.43%
00766074565
TUMS ULTRA CHW 1000MG
4
$19.96
0.20%
10
$62.84
0.39%
00766074575
0
$0.00
0.00%
8
$55.33
0.31%
00766074585
3
$15.45
0.15%
2
$24.81
0.08%
CHW 500MG
TAB 400MG
TAB
Page 320 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00766074610
TUMS ULTRA CHW ASST FRT
6
$48.90
0.30%
1
$6.79
0.04%
00766074625
TUMS ULTRA CHW TRP FRUT
1
$7.35
0.05%
2
$17.16
0.08%
00766074655
TUMS ULTRA CHW ASST BRY
0
$0.00
0.00%
6
$58.80
0.23%
00766074730
TUMS CAL/LIF CHW 750MG
31
$178.71
1.53%
30
$237.69
1.16%
00766738896
TUMS E-X
5
$31.05
0.25%
8
$77.79
0.31%
00766738996
TUMS E-X S/F CHW 750MG
6
$37.56
0.30%
1
$4.55
0.04%
00766739196
TUMS E-X
CHW 750MG
0
$0.00
0.00%
2
$13.66
0.08%
00766739466
TUMS E-X
CHW 750MG
11
$55.71
0.54%
10
$54.15
0.39%
00904019560
1
$7.13
0.05%
1
$7.12
0.04%
00904019580
5
$86.11
0.25%
0
$0.00
0.00%
00904125792
CALC ANTACID CHW 500MG
2
$12.50
0.10%
1
$2.96
0.04%
00904125892
CALC ANTACID CHW 500MG
30
$127.04
1.48%
19
$82.09
0.74%
00904131309
BISMATROL
SUS 524/30ML
2
$19.75
0.10%
0
$0.00
0.00%
00904131546
BISMATROL
CHW 262MG
1
$6.49
0.05%
1
$15.52
0.04%
00904249660
0
$0.00
0.00%
1
$13.48
0.04%
00904531118
MAG-OXIDE
3
$35.32
0.15%
0
$0.00
0.00%
00904769591
CAL ANTACID CHW 750MG XS
2
$11.50
0.10%
0
$0.00
0.00%
00904789660
0
$0.00
0.00%
3
$60.15
0.12%
00904789680
2
$15.65
0.10%
1
$9.05
0.04%
01490003908
PEPTO-BISMOL SUS 262/15ML
0
$0.00
0.00%
1
$5.25
0.04%
16837081024
MYLANTA
1
$5.44
0.05%
0
$0.00
0.00%
24385001758
PINK BISMUTH TAB 262MG
1
$20.81
0.05%
0
$0.00
0.00%
24385047847
ANTACID
CHW 500MG
0
$0.00
0.00%
2
$9.18
0.08%
37205020047
ANTACID
CHW 500MG
24
$136.72
1.19%
15
$78.97
0.58%
37205020580
ANTACID X-ST CHW 750MG
8
$45.28
0.40%
9
$41.25
0.35%
37205021047
ANTACID
8
$47.80
0.40%
23
$113.70
0.89%
37205030234
12
$67.92
0.59%
7
$77.19
0.27%
CHW 750MG
TAB 400MG
CHW 400MG
CHW 500MG
Page 321 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
37205030240
0
37205033734
37205070680
ANTACID XTRA CHW 750MG
37205072065
$0.00
0.00%
1
$5.25
0.04%
0
$0.00
0.00%
2
$8.58
0.08%
4
$15.96
0.20%
3
$9.75
0.12%
PINK BISMUTH CHW 262MG
0
$0.00
0.00%
2
$17.11
0.08%
49348017021
SM ANTACID CHW 500MG
0
$0.00
0.00%
11
$69.84
0.43%
49348019237
SM STOMACH SUS 527/30ML
1
$5.48
0.05%
0
$0.00
0.00%
49348036234
SM ANTACID CHW 750MG XS
0
$0.00
0.00%
7
$25.25
0.27%
49614046965
MEDI-BISMUTH CHW 262MG
0
$0.00
0.00%
1
$0.48
0.04%
50428642686
CVS BISMUTH CHW 262MG
0
$0.00
0.00%
1
$3.99
0.04%
51285093702
HYOSCYAMINE TAB 0.375 SR
1
$29.68
0.05%
3
$45.06
0.12%
52152014302
9
$130.22
0.44%
10
$226.53
0.39%
52152015502
HYOSCYAMINE SUB 0.125MG
11
$173.83
0.54%
15
$331.39
0.58%
52152015602
HYOSCYAMINE TAB 0.375 SR
0
$0.00
0.00%
1
$8.22
0.04%
52152016302
HYOSCYAMINE CAP 0.375 SR
0
$0.00
0.00%
8
$292.25
0.31%
52544079401
2
$11.40
0.10%
6
$46.90
0.23%
52544079410
3
$33.23
0.15%
4
$28.61
0.15%
52544079501
13
$163.64
0.64%
4
$40.82
0.15%
52735051915
ANTACID
CHW 500MG
17
$101.86
0.84%
16
$96.12
0.62%
54569381700
BISMUTH
CHW 262MG
0
$0.00
0.00%
1
$11.63
0.04%
55053031001
HYOSCYAMINE CAP 0.375 TR
1
$29.51
0.05%
0
$0.00
0.00%
55370087907
1
$5.21
0.05%
1
$5.57
0.04%
58177001704
HYOSCYAMINE CAP 0.375 ER
48
$1,452.03
2.37%
60
$1,643.66
2.32%
58177023704
HYOSCYAMINE TAB 0.375 ER
17
$397.52
0.84%
23
$710.28
0.89%
58177025504
31
$624.55
1.53%
40
$773.06
1.55%
58177027404
54
$1,328.93
2.67%
60
$1,468.77
2.32%
58177042304
0
$0.00
0.00%
4
$127.80
0.15%
59630020010
ROBINUL
72
$3,148.22
3.56%
112
$5,162.60
4.34%
TAB 1MG
Page 322 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
59630020510
ROBINUL FORT TAB 2MG
41
$2,216.33
2.03%
40
$2,459.87
1.55%
60258017101
MAG OXIDE
43
$288.45
2.13%
44
$354.44
1.70%
60258080116
HYOSCYAMINE ELX .125/5ML
0
$0.00
0.00%
1
$23.41
0.04%
60258080215
6
$82.11
0.30%
11
$187.45
0.43%
60267074230
SAL-TROPINE TAB 0.4MG
26
$499.10
1.29%
44
$850.06
1.70%
60432010315
3
$48.15
0.15%
5
$80.25
0.19%
60951061570
12
$129.26
0.59%
0
$0.00
0.00%
60951061670
6
$58.32
0.30%
0
$0.00
0.00%
61451501507
B & O 15-A SUP SUPPRETT
9
$303.62
0.44%
0
$0.00
0.00%
61451501607
B & O 16-A SUP SUPPRETT
2
$67.01
0.10%
1
$59.04
0.04%
62175010101
96
$1,909.29
4.75%
110
$2,251.20
4.26%
62175010201
67
$1,381.67
3.31%
81
$2,137.28
3.14%
62175010301
HYOSCYAMINE CAP 0.375 ER
66
$1,640.97
3.26%
40
$1,228.32
1.55%
62175010416
HYOSCYAMINE ELX .125/5ML
2
$47.86
0.10%
6
$242.07
0.23%
62175010801
HYOSCYAMINE TAB 0.375 ER
38
$1,032.41
1.88%
44
$1,404.32
1.70%
63323023401
ATROPINE SUL INJ 0.4MG/ML
1
$4.05
0.05%
3
$46.07
0.12%
63323024601
ATROPINE SUL INJ 1MG/ML
0
$0.00
0.00%
4
$20.28
0.15%
63323026801
SCOPOLAMINE INJ 0.4MG/ML
0
$0.00
0.00%
3
$15.34
0.12%
64731030501
1
$23.20
0.05%
0
$0.00
0.00%
TAB 400MG
MISC. ELECTROLYTES/NUTRITIONALS
00065901470
PEPTAMEN
4
$2,094.02
0.45%
8
$4,625.38
0.55%
00065902470
NUTREN 1.0 LIQ VANILLA
2
$252.35
0.23%
0
$0.00
0.00%
00065902570
NUTREN 1.0 LIQ /FIB VAN
5
$872.68
0.56%
4
$297.70
0.28%
00065903170
NUTREN 1.0 LIQ /FIB UNF
11
$3,153.23
1.24%
4
$177.08
0.28%
00065903270
5
$941.73
0.56%
0
$0.00
0.00%
00065903870
NUTREN 1.5 LIQ UNFLAV
6
$183.20
0.68%
3
$138.38
0.21%
LIQ UNFLAVOR
Page 323 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
00065906770
PEPTAMEN
00065906970
PEPTAMEN JR LIQ UNFLAVRD
00065907070
PEPTAMEN JR LIQ VANILLA
00065907170
$
Market Share*
00065904070
# of Scripts
0
$0.00
0.00%
3
$592.95
0.21%
15
$9,689.49
1.69%
15
$7,458.37
1.04%
8
$4,747.76
0.90%
8
$3,850.51
0.55%
18
$14,038.01
2.03%
26
$21,633.04
1.79%
PEPTAMEN VHP LIQ VANILLA
0
$0.00
0.00%
1
$2,311.85
0.07%
00065908070
NUTRIVENT
4
$66.59
0.45%
2
$2.00
0.14%
00065908491
MODULEN IBD POW
2
$345.52
0.23%
0
$0.00
0.00%
00065908770
PEPTAMEN 1.5 LIQ VANILLA
0
$0.00
0.00%
1
$1,374.35
0.07%
00065908870
PEPTAMEN 1.5 LIQ UNFLAVOR
2
$1,651.90
0.23%
4
$3,533.33
0.28%
00065916270
PROBALANCE LIQ VANILLA
1
$91.19
0.11%
7
$965.73
0.48%
00074024001
PEDIALYTE
SOL GRAPE
1
$7.76
0.11%
1
$12.63
0.07%
00074490234
DEXTROSE
INJ 50%
1
$3.58
0.11%
0
$0.00
0.00%
00074647008
PEDIALYTE
SOL UNFLAVOR
8
$740.31
0.90%
6
$572.70
0.41%
00074647032
PEDIALYTE
SOL UNFLAVOR
0
$0.00
0.00%
2
$192.32
0.14%
00074647132
PEDIALYTE
SOL FRUIT
1
$7.76
0.11%
0
$0.00
0.00%
00074792202
DEXTROSE
INJ 5%
5
$59.47
0.56%
0
$0.00
0.00%
00074792209
DEXTROSE
INJ 5%
0
$0.00
0.00%
1
$8.42
0.07%
00074792261
DEXTROSE
INJ 5%
2
$36.59
0.23%
0
$0.00
0.00%
00074792337
DEXTROSE
INJ 5%
9
$101.79
1.01%
0
$0.00
0.00%
00087001943
ENFAMIL ENFA POW LIPIL
1
$196.89
0.11%
4
$134.98
0.28%
00087001944
ENFAMIL ENFA POW LIPIL
0
$0.00
0.00%
4
$386.11
0.28%
00087004042
MAGNACAL
0
$0.00
0.00%
1
$66.38
0.07%
00087008041
PHENYL-FREE POW 2
6
$1,546.28
0.68%
2
$1,020.02
0.14%
00087008141
PHENYL-FREE POW 2HP
10
$3,501.84
1.13%
11
$3,893.62
0.76%
00087008742
MICROLIPID EMU 50%
0
$0.00
0.00%
3
$77.58
0.21%
00087020373
ENFAMIL A.R. LIQ LIPIL
0
$0.00
0.00%
1
$9.87
0.07%
00087030501
ENFAMIL/FE LIQ RTU
1
$43.88
0.11%
0
$0.00
0.00%
LIQ VANILLA
LIQ 1.5 VAN
LIQ RENAL
Page 324 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
PROSOBEE
CON
00087030974
ENFA PROSOBE LIQ LIPIL
00087033042
ENFAMIL
00087033178
$
Market Share*
00087030801
# of Scripts
$556.73
0.56%
4
$454.35
0.28%
0
$0.00
0.00%
5
$1,072.67
0.35%
4
$623.70
0.45%
0
$0.00
0.00%
ENFAMIL/IRON POW
0
$0.00
0.00%
3
$49.83
0.21%
00087033801
NUTRAMIGEN POW
8
$1,339.21
0.90%
3
$633.03
0.21%
00087035501
ISOCAL
1
$163.07
0.11%
3
$495.27
0.21%
00087036503
MCT
3
$111.16
0.34%
3
$111.09
0.21%
00087036701
PREGESTIMIL POW
7
$1,285.60
0.79%
20
$2,789.74
1.38%
00087036842
PHENYL-FREE POW
1
$309.39
0.11%
2
$628.86
0.14%
00087037943
PREGESTIMIL LIQ 24CAL
0
$0.00
0.00%
3
$1,073.78
0.21%
00087039040
CASEC
2
$65.35
0.23%
6
$170.46
0.41%
00087046242
DELIVER 2.0 LIQ
8
$397.28
0.90%
0
$0.00
0.00%
00087047142
LIPISORB
6
$1,588.19
0.68%
8
$2,748.98
0.55%
00087049801
NUTRAMIGEN CON
0
$0.00
0.00%
1
$86.14
0.07%
00087049901
NUTRAMIGEN LIQ
0
$0.00
0.00%
4
$977.33
0.28%
00087060741
KINDERCAL TF LIQ VANILLA
2
$268.34
0.23%
3
$402.51
0.21%
00087061647
ENFAMIL LACT POW LIPIL
0
$0.00
0.00%
3
$125.01
0.21%
00087064645
BOOST ENERGY BAR STRAWBER
1
$93.81
0.11%
0
$0.00
0.00%
00087066045
CHOICE DM
LIQ CHOCOLAT
0
$0.00
0.00%
1
$42.03
0.07%
00087066046
CHOICE DM
LIQ CHOCOLAT
2
$281.42
0.23%
0
$0.00
0.00%
00087067342
BOOST
LIQ STRW/BAN
5
$220.48
0.56%
0
$0.00
0.00%
00087067442
BOOST
LIQ VANILLA
8
$724.23
0.90%
1
$153.49
0.07%
00087067445
BOOST
LIQ VANILLA
67
$4,726.01
7.55%
42
$2,441.45
2.90%
00087067457
BOOST
LIQ VANILLA
1
$101.92
0.11%
11
$892.96
0.76%
00087067466
BOOST
LIQ VANILLA
0
$0.00
0.00%
11
$780.81
0.76%
00087067542
BOOST
LIQ CHOCOLAT
0
$0.00
0.00%
2
$275.52
0.14%
00087067545
BOOST
LIQ CHOCOLAT
13
$873.64
1.46%
23
$1,700.35
1.59%
POW LOW IRON
LIQ
OIL
POW
LIQ
5
Page 325 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00087067566
BOOST
LIQ CHOCOLAT
0
$0.00
0.00%
6
$284.24
0.41%
00087067645
BOOST
LIQ STRWBRRY
2
$267.40
0.23%
5
$791.35
0.35%
00087067666
BOOST
LIQ STRWBRRY
0
$0.00
0.00%
1
$68.76
0.07%
00087067745
BOOST
LIQ MOCHA
1
$361.05
0.11%
6
$1,275.84
0.41%
00087069446
KINDERCAL TF LIQ FIBER
2
$235.53
0.23%
1
$98.62
0.07%
00087069541
CHOICE DM
LIQ VANILLA
0
$0.00
0.00%
2
$295.65
0.14%
00087069546
CHOICE DM
LIQ VANILLA
3
$94.06
0.34%
0
$0.00
0.00%
00087093145
BOOST PLUS LIQ VANILLA
9
$1,354.75
1.01%
8
$893.26
0.55%
00087093151
1
$50.84
0.11%
0
$0.00
0.00%
00087093166
0
$0.00
0.00%
3
$388.76
0.21%
00087093245
BOOST PLUS LIQ CHOCOLAT
5
$548.96
0.56%
4
$432.83
0.28%
00087093266
BOOST PLUS LIQ CHOCOLAT
0
$0.00
0.00%
5
$354.68
0.35%
00087093345
BOOST PLUS LIQ STRAWBER
6
$231.48
0.68%
0
$0.00
0.00%
00087094045
BOOST HIGH LIQ PROTEIN
1
$37.85
0.11%
0
$0.00
0.00%
00087094046
4
$577.88
0.45%
1
$83.99
0.07%
00087094047
0
$0.00
0.00%
3
$475.46
0.21%
00087094145
1
$123.21
0.11%
0
$0.00
0.00%
00087094447
6
$820.00
0.68%
4
$773.64
0.28%
00087094543
BOOST PUDDIN MIS VANILLA
3
$493.24
0.34%
1
$120.74
0.07%
00087095144
BOOST/FIBER LIQ VANILLA
0
$0.00
0.00%
3
$187.62
0.21%
00087098743
BOOST
3
$359.40
0.34%
0
$0.00
0.00%
00087127341
ENFAMIL LIP POW W/IRON
0
$0.00
0.00%
4
$1,431.24
0.28%
00087140941
NEXT STEP
3
$198.54
0.34%
2
$132.37
0.14%
00087201343
ENFAMIL 24 LIQ
0
$0.00
0.00%
2
$148.54
0.14%
00087201448
ENFAMIL HUMA POW FORTIFIE
1
$227.37
0.11%
0
$0.00
0.00%
00087270242
BOOST BREEZE LIQ BERRY
0
$0.00
0.00%
1
$84.49
0.07%
00087270342
BOOST BREEZE LIQ
3
$169.22
0.34%
0
$0.00
0.00%
LIQ BUT PECN
POW SOY
Page 326 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
BOOST BREEZE LIQ
00087310121
PROSOBEE
00087405741
PKU 3
00087406541
HOM 1
00212140151
COMPLEAT
POW
$
Market Share*
00087270343
# of Scripts
0
$0.00
0.00%
3
$291.21
0.21%
3
$82.21
0.34%
0
$0.00
0.00%
13
$5,570.30
1.46%
12
$5,415.81
0.83%
0
$0.00
0.00%
3
$1,984.82
0.21%
LIQ
0
$0.00
0.00%
3
$226.69
0.21%
00212175762
RESOURCE SUP LIQ STRAWBER
0
$0.00
0.00%
1
$281.06
0.07%
00212337162
RESOURCE
3
$155.67
0.34%
2
$199.98
0.14%
00212458072
TOLEREX
POW
0
$0.00
0.00%
2
$3,460.64
0.14%
00212598475
RESOURCE ARG PAK CHERRY
0
$0.00
0.00%
1
$11.86
0.07%
00212712774
VIVONEX
POW ORG-PINE
1
$47.20
0.11%
0
$0.00
0.00%
00212713176
VIVONEX
POW PEDIATRI
3
$1,356.06
0.34%
0
$0.00
0.00%
00212727873
VIVONEX
POW T.E.N.
5
$258.67
0.56%
1
$124.31
0.07%
00212729818
VIVONEX PLUS POW
4
$3,921.11
0.45%
2
$2,522.04
0.14%
00264151032
DEXTROSE
INJ 5%
2
$9.36
0.23%
1
$4.75
0.07%
00264751020
DEXTROSE
INJ 5%
2
$9.51
0.23%
0
$0.00
0.00%
00338001702
DEXTROSE
INJ 5%
15
$101.05
1.69%
7
$32.55
0.48%
00338001704
DEXTROSE
INJ 5%
1
$2.85
0.11%
3
$19.05
0.21%
00338001718
DEXTROSE
INJ 5%
0
$0.00
0.00%
2
$9.38
0.14%
00338002304
DEXTROSE
INJ 10%
1
$24.93
0.11%
0
$0.00
0.00%
00338049103
INTRALIPID INJ 20%
30
$813.15
3.38%
0
$0.00
0.00%
00338050206
CLINISOL SF INJ 15%
0
$0.00
0.00%
3
$5,140.35
0.21%
00338064404
TRAVASOL
0
$0.00
0.00%
2
$209.76
0.14%
00847095222
PHENYLADE
POW VANILLA
00847095960
PHENYLADE
POW MTE
00904404360
FISH OIL
24385015134
37205022008
POW
POW
LIQ VANILLA
INJ 10%
2
$230.78
0.23%
0
$0.00
0.00%
14
$3,716.31
1.58%
13
$4,474.33
0.90%
1
$8.98
0.11%
7
$74.89
0.48%
NUTR SUPPLE LIQ PL CHOC
1
$79.11
0.11%
2
$157.22
0.14%
PED ELCTRLYT SOL FRUIT
0
$0.00
0.00%
3
$380.55
0.21%
CAP 1000MG
Page 327 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
49348016162
PED ELCTRLYT SOL GRAPE
0
49735010077
PHLEXY-10
BAR
49735010136
PHLEXY-10
CAP
49735010280
DUOCAL
$0.00
0.00%
1
$25.69
0.07%
0
$0.00
0.00%
2
$185.04
0.14%
1
$745.11
0.11%
0
$0.00
0.00%
POW
9
$750.87
1.01%
18
$1,008.56
1.24%
49735010375
XP MAXAMAID POW ORANGE
3
$857.76
0.34%
3
$877.38
0.21%
49735010504
XPHEN-TYR
49735010804
NEOCATE FORM POW INFANT
49735011047
POW MAXAMAID
2
$511.12
0.23%
0
$0.00
0.00%
26
$4,128.07
2.93%
39
$6,118.29
2.69%
NEOCATE ONE POW
3
$2,037.00
0.34%
6
$2,954.16
0.41%
49735011050
PEDIATRIC
2
$1,532.22
0.23%
2
$1,093.82
0.14%
49735011452
XP MAXAMUM POW ORANGE
2
$1,077.55
0.23%
0
$0.00
0.00%
49735011467
PHLEXY-10
POW
1
$110.50
0.11%
1
$1,016.75
0.07%
49735011910
PHLEXY-10
POW
0
$0.00
0.00%
1
$103.40
0.07%
54391005009
L-CARNITINE CAP 250MG
5
$227.08
0.56%
13
$923.43
0.90%
58914080044
SCANDISHAKE POW VANILLA
4
$446.16
0.45%
4
$280.54
0.28%
58914082118
SCANDISHAKE POW CHOC
0
$0.00
0.00%
1
$94.13
0.07%
59781022550
JUVEN
2
$126.08
0.23%
0
$0.00
0.00%
59781022551
JUVEN/HMB
0
$0.00
0.00%
1
$62.91
0.07%
70074011105
ENSURE
0
$0.00
0.00%
10
$1,009.02
0.69%
70074011107
ENSURE PLUS LIQ CHOCOLAT
4
$577.44
0.45%
10
$1,857.91
0.69%
70074011108
ENSURE PLUS LIQ VANILLA
4
$663.22
0.45%
9
$1,432.61
0.62%
70074011111
ENSURE PLUS LIQ STRWBERY
0
$0.00
0.00%
2
$458.28
0.14%
70074011116
ENSURE LIGHT LIQ FREN VAN
0
$0.00
0.00%
4
$265.38
0.28%
70074020107
ISOMIL/IRON POW
0
$0.00
0.00%
4
$57.60
0.28%
70074040143
JEVITY 1 CAL LIQ
30
$3,553.02
3.38%
60
$21,280.39
4.14%
70074040373
PEDIASURE
60
$9,293.34
6.76%
72
$11,259.11
4.97%
70074040699
PULMOCARE
1
$214.23
0.11%
0
$0.00
0.00%
70074040701
ENSURE
31
$2,883.09
3.49%
58
$7,003.70
4.00%
LIQ EO28
POW ORANGE
POW
LIQ VANILLA
LIQ PEDIATRI
LIQ VANILLA
LIQ CHOCOLAT
Page 328 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
70074040703
ENSURE
LIQ BLK WALN
70074040704
ENSURE
LIQ COFFEE
70074040705
ENSURE
LIQ STRWBERY
70074040707
70074040709
OSMOLITE
70074040710
ENSURE
LIQ EGGNOG
70074040711
ENSURE
LIQ VANILLA
70074040717
$
Market Share*
70074040702
# of Scripts
$2,459.70
2.93%
24
$2,879.45
1.66%
0
$0.00
0.00%
2
$404.88
0.14%
3
$114.42
0.34%
6
$230.22
0.41%
8
$430.64
0.90%
34
$2,698.09
2.35%
11
$1,214.80
1.24%
55
$5,933.29
3.80%
0
$0.00
0.00%
4
$1,029.14
0.28%
0
$0.00
0.00%
5
$1,400.53
0.35%
34
$3,225.10
3.83%
110
$9,606.27
7.59%
ENSURE PLUS LIQ COFFEE
0
$0.00
0.00%
1
$155.22
0.07%
70074040718
3
$383.56
0.34%
16
$1,039.07
1.10%
70074040721
ENSURE PLUS LIQ HN VANIL
1
$120.37
0.11%
5
$880.89
0.35%
70074040729
TWOCAL HN LIQ
5
$627.45
0.56%
12
$2,727.62
0.83%
70074040735
OSMOLITE 1 LIQ CAL
1
$46.85
0.11%
9
$2,499.09
0.62%
70074040756
ENSURE/FIBER LIQ CHOCOLAT
1
$15.98
0.11%
0
$0.00
0.00%
70074040759
ENSURE/FIBER LIQ VANILLA
2
$253.20
0.23%
2
$258.70
0.14%
70074040766
VITAL HN
0
$0.00
0.00%
1
$1,044.48
0.07%
70074050241
GLUCERNA
0
$0.00
0.00%
12
$2,207.15
0.83%
70074050461
ENSURE
LIQ VANILLA
9
$1,013.08
1.01%
16
$1,569.40
1.10%
70074050463
ENSURE
LIQ CHOCOLAT
1
$43.79
0.11%
9
$781.67
0.62%
70074050465
0
$0.00
0.00%
14
$1,853.03
0.97%
70074050467
0
$0.00
0.00%
1
$181.25
0.07%
70074050541
ALIMENTUM
12
$892.03
1.35%
0
$0.00
0.00%
70074050629
PERATIVE
5
$2,768.76
0.56%
1
$236.87
0.07%
70074050633
NEPRO
2
$841.66
0.23%
12
$2,206.92
0.83%
70074050647
0
$0.00
0.00%
2
$226.96
0.14%
70074050649
ENSURE
LIQ STRWBERY
2
$82.34
0.23%
0
$0.00
0.00%
70074050653
PEDIASURE
LIQ W/FIBER
12
$1,874.74
1.35%
21
$4,787.32
1.45%
LIQ
POW
LIQ VANILLA
LIQ RTF
LIQ
LIQ
26
Page 329 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
PROMOTE
70074050789
70074050793
LIQ -RTU
$
Market Share*
70074050775
# of Scripts
3
$331.68
0.34%
1
$177.97
0.07%
0
$0.00
0.00%
1
$37.37
0.07%
ENSURE
LIQ CHOCOLAT
0
$0.00
0.00%
1
$80.05
0.07%
70074050795
ENSURE
LIQ VANILLA
2
$358.78
0.23%
3
$362.42
0.21%
70074051122
PHENEX-2
POW
2
$191.64
0.23%
3
$303.66
0.21%
70074051137
I-VALEX-1
POW
4
$576.65
0.45%
3
$753.09
0.21%
70074051138
I-VALEX-2
POW
0
$0.00
0.00%
2
$923.50
0.14%
70074051741
ENSURE PLUS LIQ RTU COFF
1
$111.27
0.11%
1
$112.19
0.07%
70074051785
ENSURE
2
$406.18
0.23%
9
$1,157.30
0.62%
70074051805
PEDIASURE
LIQ RTU VANI
18
$1,686.96
2.03%
54
$12,599.48
3.73%
70074051807
PEDIASURE
LIQ W/FIBER
2
$766.05
0.23%
30
$6,234.78
2.07%
70074051809
PEDIASURE
LIQ BAN CREA
2
$205.80
0.23%
2
$360.82
0.14%
70074051811
PEDIASURE
LIQ STRWBERY
9
$499.81
1.01%
23
$1,564.24
1.59%
70074051813
PEDIASURE
LIQ CHOCOLAT
8
$1,020.08
0.90%
30
$3,197.86
2.07%
70074051873
PROMOTE W/FB LIQ VANILLA
11
$2,004.18
1.24%
11
$2,559.83
0.76%
70074051881
PEDIASURE
LIQ STRWBERY
2
$398.14
0.23%
0
$0.00
0.00%
70074051883
PEDIASURE
LIQ CHOCOLAT
0
$0.00
0.00%
4
$302.31
0.28%
70074051885
PEDIASURE
LIQ BAN CREM
8
$1,396.61
0.90%
0
$0.00
0.00%
70074051895
ENSURE PLUS LIQ BUT PECN
0
$0.00
0.00%
1
$173.85
0.07%
70074052069
ENSURE HP
LIQ CHOCOLAT
0
$0.00
0.00%
1
$255.76
0.07%
70074052071
ENSURE HP
LIQ VANILLA
4
$194.38
0.45%
1
$202.77
0.07%
70074052073
ENSURE HP
LIQ WLD BERY
0
$0.00
0.00%
2
$83.50
0.14%
70074052637
ENSURE
LIQ VANILLA
0
$0.00
0.00%
10
$577.70
0.69%
70074052639
ENSURE
LIQ CHOCOLAT
0
$0.00
0.00%
6
$647.48
0.41%
70074052771
ENSURE LIGHT LIQ FREN VAN
2
$279.26
0.23%
0
$0.00
0.00%
70074053119
JEVITY 1.2 LIQ CAL
1
$296.28
0.11%
20
$4,477.33
1.38%
70074054107
NEPRO
1
$168.54
0.11%
3
$195.58
0.21%
LIQ BUT PECN
LIQ CHERRY
Page 330 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
GLUCERNA
LIQ VANILLA
70074054327
GLUCERNA SHK LIQ BUT PECN
70074054545
GLUCERNA SHK LIQ CHOC
70074054556
$
Market Share*
70074054325
# of Scripts
0
$0.00
0.00%
1
$156.07
0.07%
12
$765.14
1.35%
12
$901.38
0.83%
1
$37.91
0.11%
0
$0.00
0.00%
GLUCERNA SHK LIQ CHOC
0
$0.00
0.00%
2
$308.42
0.14%
70074054568
SIMILAC ALIM POW IRON
0
$0.00
0.00%
3
$282.45
0.21%
70074054569
GLUCERNA SHK LIQ VANILLA
8
$354.34
0.90%
6
$1,227.99
0.41%
70074054666
ELECARE
0
$0.00
0.00%
11
$3,584.69
0.76%
70074054777
ENSURE ENLIV LIQ APPLE
2
$97.06
0.23%
3
$80.04
0.21%
70074054845
ENSURE PUDD MIS VANILLA
0
$0.00
0.00%
1
$199.19
0.07%
70074054847
ENSURE PUDDI MIS CHOCOLAT
4
$516.38
0.45%
1
$157.52
0.07%
70074055756
PHENEX-2
POW
0
$0.00
0.00%
2
$869.12
0.14%
70074055775
PROSURE
LIQ VANILLA
0
$0.00
0.00%
5
$355.88
0.35%
70074055898
PEDIASURE
0
$0.00
0.00%
3
$324.32
0.21%
70074055904
GLUCERNA SHK LIQ STRAWBER
0
$0.00
0.00%
2
$83.16
0.14%
70074055905
GLUCERNA
0
$0.00
0.00%
2
$456.20
0.14%
70074055962
SIMILAC ADVA LIQ IRON
0
$0.00
0.00%
8
$552.32
0.55%
70074056003
ENSURE
BAR CHO MAPL
1
$36.49
0.11%
0
$0.00
0.00%
70074056012
ENSURE
BAR CK/CREAM
3
$129.12
0.34%
3
$266.04
0.21%
70074056017
ENSURE
LIQ COF-LATT
0
$0.00
0.00%
1
$13.45
0.07%
70074057226
PROSURE
LIQ VANILLA
0
$0.00
0.00%
6
$565.92
0.41%
70074057646
GLUCERNA SHK LIQ CHOCOLAT
0
$0.00
0.00%
1
$1.14
0.07%
70074060237
ALIMENTUM
LIQ RTF
3
$130.59
0.34%
4
$205.43
0.28%
70074060733
ENSURE
LIQ VANILLA
0
$0.00
0.00%
1
$71.49
0.07%
70074060746
POLYCOSE
2
$33.16
0.23%
8
$240.63
0.55%
70074060775
PROMOD
3
$83.79
0.34%
9
$330.32
0.62%
70074060799
ENSURE
5
$174.55
0.56%
1
$30.15
0.07%
70074060850
SIMILAC PM POW 60/40
3
$389.79
0.34%
5
$795.43
0.35%
POW PED
LIQ VANILLA
LIQ STRAWBER
POW
POW
LIQ CHOCOLAT
Page 331 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
PEDIALYTE
70074080365
70074080431
$
Market Share*
70074080336
# of Scripts
SOL UNFLAVOR
0
PEDIALYTE
SOL FRUIT
POLYCOSE
LIQ UNFLAVOR
70074080792
82028000080
$0.00
0.00%
2
$120.70
0.14%
1
$5.19
0.11%
1
$21.35
0.07%
3
$234.01
0.34%
0
$0.00
0.00%
ENSURE PUDD MIS VANILLA
0
$0.00
0.00%
5
$289.35
0.35%
PROCEL
0
$0.00
0.00%
4
$55.80
0.28%
POW
MISC. MULTI-VITAMINS
00005417719
CENTRUM
TAB SILVER
2
$18.70
0.08%
5
$26.76
0.15%
00005423419
CENTRUM JR CHW /IRON
2
$7.58
0.08%
6
$23.20
0.19%
00005423918
CENTRUM-LUTE TAB
3
$14.93
0.12%
9
$30.99
0.28%
00005423919
CENTRUM
TAB
14
$90.17
0.56%
8
$56.25
0.25%
00005423930
CENTRUM
TAB
13
$72.73
0.52%
7
$25.92
0.22%
00005423936
CENTRUM-LUTE TAB
0
$0.00
0.00%
6
$19.24
0.19%
00005424919
CENTRUM JR/ CHW EXTRA C
00005434361
CENTRUM
00005443019
2
$6.58
0.08%
6
$22.74
0.19%
15
$137.09
0.60%
11
$115.73
0.34%
CENTRUM PERF TAB
4
$28.80
0.16%
0
$0.00
0.00%
00005558611
MATERNA
7
$185.01
0.28%
0
$0.00
0.00%
00074712530
IBERET-FOLIC TAB 500 CR
4
$19.50
0.16%
3
$91.98
0.09%
00074723530
IBERET-500 TAB
3
$77.53
0.12%
3
$78.87
0.09%
00087040203
POLY-VI-SOL DRO
9
$79.23
0.36%
3
$25.96
0.09%
00087040303
TRI-VI-SOL DRO
1
$9.39
0.04%
1
$7.03
0.03%
00087040501
POLY-VI-SOL DRO /IRON
6
$55.47
0.24%
6
$58.15
0.19%
00087045141
POLY-VI-FLOR DRO 0.25MG
1
$14.95
0.04%
7
$104.65
0.22%
00087045303
TRI-VI-SOL DRO /IRON
2
$18.78
0.08%
1
$9.46
0.03%
00087047841
TRI-VI-FLOR DRO /FE 0.25
0
$0.00
0.00%
1
$13.90
0.03%
00093722193
PRENATAL OPT TAB ADVANCE
10
$275.99
0.40%
0
$0.00
0.00%
00093911101
PRENATAL
583
$8,992.86
23.29%
1,161
$24,100.32
35.80%
LIQ
TAB
TAB PLUS
Page 332 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00093911105
PRENATAL
TAB PLUS
00093915201
B-COMPLEX
00093915801
MULTIVIT/FL CHW 0.5MG
00093915901
$1,130.40
2.56%
$1,481.02
2.62%
0
$0.00
0.00%
9
$40.00
0.36%
1
$2.97
0.03%
25
$111.00
0.77%
MULTIVITAMIN CHW FL1/FE12
5
$14.06
0.20%
3
$11.76
0.09%
00093916554
PRENATAL RX TAB BETA-CAR
11
$88.22
0.44%
51
$449.97
1.57%
00093916601
MULTIVIT/FL CHW 1MG
4
00093916610
MULTIVIT/FL CHW 1MG
2
$13.13
0.16%
12
$48.42
0.37%
$7.84
0.08%
0
$0.00
0.00%
00093919701
MULTIVIT/FL CHW 0.5/FE12
1
$5.25
0.04%
3
$13.09
0.09%
00131230909
NIFEREX-PN TAB FORTE
21
$584.50
0.84%
1
$10.44
0.03%
00131433086
NIFEREX-150 CAP FORTE
13
$139.06
0.52%
9
$107.26
0.28%
00178085201
CITRACAL
0
$0.00
0.00%
2
$16.87
0.06%
00182441326
OPTI-GEN
0
$0.00
0.00%
5
$30.00
0.15%
00182442801
ONE-TAB-DAIL TAB
2
$7.92
0.08%
10
$37.61
0.31%
00182443601
ONE-TAB-DAIL TAB W/MIN
1
$7.54
0.04%
1
$5.54
0.03%
00182443610
ONE-TAB-DAIL TAB W/MIN
0
$0.00
0.00%
13
$54.65
0.40%
00182448726
STRESS NF
1
$8.56
0.04%
0
$0.00
0.00%
00182451906
THERAPEUTIC TAB -M
1
$5.10
0.04%
1
$5.60
0.03%
00182451910
THERAPEUTIC TAB -M
0
$0.00
0.00%
2
$5.41
0.06%
00182610737
THERAVITE
8
$56.44
0.32%
5
$41.55
0.15%
00185538088
FOLTRIN
0
$0.00
0.00%
2
$34.44
0.06%
00186119938
M.V.I. -12 INJ
2
$461.10
0.08%
0
$0.00
0.00%
00245001611
FOLGARD RX TAB 2.2
0
$0.00
0.00%
23
$312.58
0.71%
00256018501
NEPHROCAPS CAP
255
$2,317.67
10.19%
184
$1,538.07
5.67%
00281025918
CHROMAGEN
CAP FA
2
$59.86
0.08%
0
$0.00
0.00%
00281026218
CHROMAGEN
CAP FORTE
7
$258.06
0.28%
4
$134.29
0.12%
00281428518
CHROMAGEN
CAP
8
$228.30
0.32%
2
$79.30
0.06%
00421131701
NESTABS RX TAB
1
$38.91
0.04%
0
$0.00
0.00%
TAB VIT PLUS
TAB PREN RX
TAB
TAB
LIQ
CAP
64
85
Page 333 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00430022640
NATAFORT
TAB
00430022723
NATACHEW
00525085560
FOLTX
TAB
00525085590
FOLTX
TAB
00536344238
17
$457.97
0.68%
5
$58.94
0.15%
63
$1,839.32
2.52%
125
$3,794.54
3.85%
1
$13.18
0.04%
2
$20.98
0.06%
0
$0.00
0.00%
26
$390.24
0.80%
CEROVITE ADV TAB FORMULA
2
$8.18
0.08%
0
$0.00
0.00%
00536344901
BRONTO-VITE CHW /IRON
0
$0.00
0.00%
4
$6.36
0.12%
00536404610
MULTIVITAMIN TAB
2
$3.93
0.08%
9
$22.43
0.28%
00536478701
VITAMIN B CO CAP
1
$3.49
0.04%
0
$0.00
0.00%
00536509008
I-VITE
0
$0.00
0.00%
3
$22.14
0.09%
00536558806
ANTIOXIDANT CAP
0
$0.00
0.00%
4
$9.34
0.12%
00536638401
COD LIVER OI CAP
3
$10.98
0.12%
0
$0.00
0.00%
00536845080
POLY-VITAMIN DRO
0
$0.00
0.00%
1
$7.91
0.03%
00536853080
POLY-VITAMIN DRO /IRON
2
$13.41
0.08%
4
$20.56
0.12%
00603144947
MULTI-VIT/FL DRO 0.25MG
1
$8.79
0.04%
0
$0.00
0.00%
00603145047
MULTI-VIT/FL DRO 0.5MG/ML
0
$0.00
0.00%
2
$18.80
0.06%
00603178547
TRIVIT/FLUOR DRO 0.25MG
0
$0.00
0.00%
1
$10.75
0.03%
00603471021
MULTI VIT/FL CHW 0.25MG
0
$0.00
0.00%
2
$9.17
0.06%
00603536121
PRENATAL
5
$69.22
0.20%
82
$1,255.71
2.53%
00642007912
VITAFOL-OB TAB 65-1MG
0
$0.00
0.00%
1
$4.37
0.03%
00677099006
MULTI FERRO TAB 500
0
$0.00
0.00%
1
$2.75
0.03%
00677168901
PRENATAL NF TAB PLUS
1
$8.86
0.04%
51
$817.85
1.57%
00781202513
CONTRIN
1
$28.00
0.04%
0
$0.00
0.00%
00904067860
FERRO-CAPS CAP
0
$0.00
0.00%
5
$12.25
0.15%
00904418160
B-COMP/B-12 TAB
0
$0.00
0.00%
4
$16.12
0.12%
00904527560
MULTIVITE/FL CHW 1MG
0
$0.00
0.00%
3
$11.76
0.09%
00904531346
PRENATAL
TAB
1
$8.96
0.04%
0
$0.00
0.00%
00904531360
PRENATAL
TAB
0
$0.00
0.00%
2
$14.10
0.06%
CHW
TAB
TAB PLUS
CAP
Page 334 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00904533960
PRENATAL
TAB PLUS/FE
2
$37.90
0.08%
2
$26.98
0.06%
10267206901
PRENATAL
TAB LOW IRON
0
$0.00
0.00%
3
$52.96
0.09%
10267206905
PRENATAL
TAB LOW IRON
0
$0.00
0.00%
6
$88.04
0.19%
17236066801
PRENATAL 1 TAB PLUS 1
0
$0.00
0.00%
14
$198.30
0.43%
17236066805
PRENATAL 1 TAB PLUS 1
0
$0.00
0.00%
1
$5.29
0.03%
24208038760
OCUVITE
1
$10.51
0.04%
4
$42.04
0.12%
24208043262
OCUVITE PRES TAB
0
$0.00
0.00%
20
$120.88
0.62%
36652026768
FERRO-SEQUEL TAB
5
$46.18
0.20%
3
$42.50
0.09%
36652037718
PROTEGRA
CAP
2
$6.96
0.08%
1
$8.87
0.03%
37205008078
ONE DAILY
TAB
2
$7.73
0.08%
0
$0.00
0.00%
49348010110
SM ONE DAILY TAB MULT-VIT
0
$0.00
0.00%
1
$3.71
0.03%
49348010210
SM ONE DAILY TAB /IRON
0
$0.00
0.00%
3
$3.18
0.09%
50383062408
DALYVITE
2
$14.00
0.08%
3
$21.00
0.09%
50383062550
POLY-VITAMIN DRO
3
$22.05
0.12%
2
$14.70
0.06%
50383062850
TRI-VIT/FE DRO FL 0.25
0
$0.00
0.00%
2
$16.56
0.06%
50383063250
POLY-VITAMIN DRO /IRON
0
$0.00
0.00%
2
$14.70
0.06%
50383063450
POLY-VIT/FE DRO /FL 0.25
3
$25.71
0.12%
14
$119.98
0.43%
50383063550
TRI-VITAMIN DRO
0
$0.00
0.00%
1
$7.35
0.03%
50383063750
TRI-VIT/FLUO DRO 0.25MG
2
$20.50
0.08%
5
$48.23
0.15%
50383064150
POLY-VITAMIN DRO 0.5MG
0
$0.00
0.00%
1
$8.14
0.03%
50383064250
POLY-VIT/FL DRO 0.25MG
6
$45.52
0.24%
6
$42.26
0.19%
50383068304
THERA-PLUS LIQ
0
$0.00
0.00%
7
$45.78
0.22%
50474031622
VICON FORTE CAP
51991015391
VINATE
51991015501
VINATE M
51991015791
VINATAL
51991015991
VINATE GT
TAB
LIQ
6
$154.46
0.24%
3
$62.31
0.09%
27
$686.76
1.08%
1
$10.00
0.03%
TAB
1
$21.57
0.04%
0
$0.00
0.00%
TAB FORTE
9
$131.21
0.36%
2
$11.74
0.06%
9
$246.06
0.36%
2
$17.40
0.06%
TAB ADVANCED
TAB
Page 335 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
51991019811
FERREX 150 CAP FORTE
0
$0.00
0.00%
6
$66.94
0.19%
51991063511
FEROCON
1
$37.76
0.04%
2
$47.76
0.06%
52152000102
MULT VIT-BET CHW /FL 1MG
0
$0.00
0.00%
4
$20.62
0.12%
52152003102
MULT VIT-BET CHW /FL .5MG
0
$0.00
0.00%
8
$36.30
0.25%
52152004814
MULT FOL 500 TAB CR
8
$39.50
0.32%
5
$13.75
0.15%
52152007702
VITAPLEX
5
$21.08
0.20%
8
$14.98
0.25%
52152015002
MULT VIT-BET CHW /FL.25MG
0
$0.00
0.00%
8
$37.82
0.25%
52152017802
PRENATAL PLS TAB /IRON
19
$250.27
0.76%
291
$2,477.74
8.97%
52152017804
PRENATAL PLS TAB /IRON
6
$74.71
0.24%
54
$762.76
1.67%
52152024802
PRENATAL FOR TAB 28-1MG
1
$12.36
0.04%
1
$28.17
0.03%
54391000201
NEPHRO-VITE TAB
15
$65.35
0.60%
46
$295.68
1.42%
54391100201
NEPHRO-VITE TAB RX
61
$871.44
2.44%
95
$1,448.10
2.93%
54979070201
FEROCON
CAP
1
$9.33
0.04%
0
$0.00
0.00%
57896050410
ONE DAILY
TAB
58177002511
FE-TINIC 150 CAP FORTE
58177004211
ANEMAGEN
58177004311
ANEMAGEN FA CAP
58177021211
PRENATAL MR TAB 90
58177021611
PRENATAL RX TAB
58177022504
NATALCARE
TAB PLUS
58177025711
NATALCARE
58177025811
NATALCARE
58177029211
ULTRA NATAL TAB CARE
58177031604
PRENATAL MTR TAB SELENIUM
58177031705
NATALCARE RX TAB
58177032220
NATALCARE
58177035020
ADV NATALCAR TAB
CAP
TAB PLUS
CAP
1
$3.53
0.04%
0
$0.00
0.00%
11
$166.97
0.44%
12
$127.01
0.37%
0
$0.00
0.00%
3
$55.24
0.09%
3
$56.78
0.12%
3
$44.94
0.09%
6
$93.38
0.24%
1
$10.44
0.03%
20
$432.41
0.80%
4
$36.06
0.12%
157
$2,559.64
6.27%
11
$80.15
0.34%
TAB PIC
3
$71.41
0.12%
0
$0.00
0.00%
TAB PICFORTE
5
$128.91
0.20%
0
$0.00
0.00%
75
$1,772.22
3.00%
6
$46.56
0.19%
5
$113.44
0.20%
1
$7.76
0.03%
3
$15.51
0.12%
24
$175.35
0.74%
39
$826.87
1.56%
3
$26.34
0.09%
127
$3,140.82
5.07%
6
$68.18
0.19%
TAB CFE 60
Page 336 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
58177035126
NUTRINATE
CHW
58177037504
NATALCARE
TAB 27-1MG
58177037626
NATATAB RX TAB 29-1MG
58177041504
NATALCARE
58177041820
NATALCARE
58177042004
NATALFIRST TAB
58914001006
ADEKS
58914021260
60
$1,557.95
2.40%
10
$124.64
0.31%
1
$26.36
0.04%
0
$0.00
0.00%
4
$136.70
0.16%
0
$0.00
0.00%
TAB THREE
1
$27.94
0.04%
0
$0.00
0.00%
TAB GLOSS
26
$699.21
1.04%
1
$9.45
0.03%
2
$70.05
0.08%
0
$0.00
0.00%
97
$1,634.11
3.88%
107
$1,737.33
3.30%
ADEKS PEDIAT DRO
3
$35.55
0.12%
1
$11.85
0.03%
59528031701
NEPHPLEX RX TAB
54
$400.18
2.16%
69
$450.31
2.13%
59630041090
PRENATE GT TAB
128
$3,539.63
5.11%
25
$320.60
0.77%
59630042090
PRENATE
TAB ADVANCE
32
$993.05
1.28%
3
$44.56
0.09%
59630047590
PRENATE
TAB ADVANCE
0
$0.00
0.00%
4
$96.07
0.12%
59879012301
ULTRA-NATAL TAB
1
$24.84
0.04%
0
$0.00
0.00%
60258010250
POLY-VIT/FL DRO 0.5MG
0
$0.00
0.00%
1
$9.43
0.03%
60258016101
RENA-VITE RX TAB
9
$84.43
0.36%
12
$97.82
0.37%
60258016201
RENAL
18
$163.21
0.72%
84
$697.45
2.59%
60258018601
POLY/IRON
CAP 150 FORT
0
$0.00
0.00%
1
$17.96
0.03%
60258018901
FERROGELS FO CAP FORTE
0
$0.00
0.00%
1
$4.07
0.03%
60258019101
PRENATAB CBF TAB
1
$26.69
0.04%
0
$0.00
0.00%
60258019201
TRINATE
0
$0.00
0.00%
1
$11.51
0.03%
60258019701
PRENATAL 19 CHW TAB
1
$41.84
0.04%
0
$0.00
0.00%
62022002601
EMBREX 600 MIS
5
$97.84
0.20%
0
$0.00
0.00%
62107004506
COMPLETE
2
$16.30
0.08%
0
$0.00
0.00%
63044063119
HEMATOGEN CAP
0
$0.00
0.00%
1
$12.09
0.03%
64011001411
PRECARE
2
$26.27
0.08%
0
$0.00
0.00%
64011001531
PRIMACARE
1
$42.28
0.04%
5
$69.50
0.15%
64011001904
PREMESIS RX TAB
24
$611.75
0.96%
6
$87.74
0.19%
CHW
CAP SOFTGEL
TAB
TAB SENIOR
TAB CONCEIVE
MIS COMBO PA
Page 337 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
64011002411
PRECARE
CHW
22
$765.07
0.88%
64011002511
PRECARE
TAB
40
$1,224.24
1.60%
64011011811
PRECARE
TAB PRENATAL
52
$1,798.44
2.08%
64011012911
CHROMAGEN
0
$0.00
0.00%
64011013411
NIFEREX
0
$0.00
64011013511
NIFEREX-150 CAP
0
64011013611
NIFEREX-150 CAP FORTE
0
64731058001
PRENATAL PLS TAB
64731059001
$13.13
0.03%
1
$13.58
0.03%
11
$178.07
0.34%
3
$82.01
0.09%
0.00%
2
$24.18
0.06%
$0.00
0.00%
4
$64.49
0.12%
$0.00
0.00%
6
$108.00
0.19%
4
$71.88
0.16%
9
$100.07
0.28%
PRENATAL PC TAB 40
1
$32.06
0.04%
0
$0.00
0.00%
64731079501
STUART PREN TAB
0
$0.00
0.00%
1
$7.81
0.03%
64731081401
STUARTNATAL TAB PLUS 3
4
$108.13
0.16%
2
$24.82
0.06%
64731082001
DUET
TAB
0
$0.00
0.00%
14
$448.27
0.43%
64731082801
DUET
TAB
0
$0.00
0.00%
1
$14.04
0.03%
64731083090
DUET
CHW
0
$0.00
0.00%
1
$15.72
0.03%
64980010901
FEOGEN FORTE CAP
1
$10.81
0.04%
1
$17.02
0.03%
64980011401
RENAPHRO
56
$492.62
2.24%
96
$742.59
2.96%
64980011501
FEOGEN
0
$0.00
0.00%
1
$29.64
0.03%
65779041046
MULTI-VITAMN TAB /MINERAL
0
$0.00
0.00%
1
$9.00
0.03%
74312001570
MULTI-DAY TAB
0
$0.00
0.00%
20
$71.51
0.62%
CAP
CAP
CAP
CAP
1
MISC. NEUROLOGICS
00187301030
MESTINON
TAB 60MG
45
$2,432.42
37.50%
29
$1,686.50
25.00%
00187301330
MESTINON
TAB TIMESPAN
10
$434.43
8.33%
11
$455.65
9.48%
00187310010
PROSTIGMIN TAB 15MG
2
$97.58
1.67%
1
$26.16
0.86%
00591319101
PYRIDOSTIGM TAB 60MG
0
$0.00
0.00%
4
$240.84
3.45%
00781501501
PYRIDOSTIGM TAB 60MG
0
$0.00
0.00%
10
$239.89
8.62%
57844015101
ORAP
9
$372.68
7.50%
6
$193.13
5.17%
TAB 1MG
Page 338 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
ORAP
$
Market Share*
MISC. NEUROLOGICS
57844018701
# of Scripts
TAB 2MG
54
$3,038.88
45.00%
55
$4,320.08
47.41%
28
$25,344.35
87.50%
22
$26,456.83
88.00%
4
$70.28
12.50%
3
$58.35
12.00%
4
$248.64
0.36%
1
$43.23
0.08%
MISC. OPHTHALMICS OF INTEREST
00023114501
BOTOX
00065008315
ENUCLENE
INJ 100U
SOL OP
MISC. PLATELET AGGR. INHIBITORS / COMBOS
00039007810
TRENTAL
TAB 400MG CR
00093511601
PENTOXIFYLLI TAB 400MG ER
204
$4,037.40
18.50%
207
$2,596.24
16.51%
00093511605
0
$0.00
0.00%
9
$119.96
0.72%
00228261150
5
$83.35
0.45%
0
$0.00
0.00%
00228261196
29
$604.15
2.63%
37
$492.66
2.95%
00228274711
9
$192.15
0.82%
8
$109.09
0.64%
00228274750
4
$85.40
0.36%
17
$210.76
1.36%
00228276950
0
$0.00
0.00%
25
$321.11
1.99%
00228276996
0
$0.00
0.00%
5
$66.80
0.40%
00378035701
68
$1,365.80
6.17%
47
$633.48
3.75%
00597000160
AGGRENOX
347
$31,525.40
31.46%
428
$43,234.39
34.13%
00615452353
22
$424.30
1.99%
0
$0.00
0.00%
00904544840
0
$0.00
0.00%
4
$50.20
0.32%
17236086201
PENTOXIFYLLI TAB 400MG CR
0
$0.00
0.00%
2
$17.30
0.16%
50111060901
6
$103.14
0.54%
2
$30.10
0.16%
54092006301
AGRYLIN
CAP 0.5MG
5
$2,271.90
0.45%
8
$4,802.66
0.64%
54092006401
AGRYLIN
CAP 1MG
3
$3,554.37
0.27%
5
$3,962.97
0.40%
59148000216
PLETAL
TAB 100MG
255
$21,037.11
23.12%
295
$27,887.27
23.52%
59148000235
PLETAL
TAB 100MG
2
$186.13
0.18%
2
$200.88
0.16%
59148000316
PLETAL
TAB 50MG
31
$2,666.84
2.81%
64
$5,561.10
5.10%
CAP 25-200MG
Page 339 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC. PLATELET AGGR. INHIBITORS / COMBOS
60505003306
52
$1,014.60
4.71%
35
$464.87
2.79%
60505003307
57
$1,213.00
5.17%
53
$669.70
4.23%
MISC. UROLOGICAL
00068027761
HIPREX
89
$5,538.25
2.19%
86
$5,522.89
1.77%
00074613802
SODIUM CHLOR SOL 0.9% IRR
TAB 1GM
0
$0.00
0.00%
1
$76.55
0.02%
00074613803
8
$34.60
0.20%
18
$635.90
0.37%
00074613822
15
$247.55
0.37%
13
$132.35
0.27%
00074614309
ACETIC ACID SOL .25% IRR
7
$24.54
0.17%
7
$80.97
0.14%
00074614322
9
$286.65
0.22%
9
$201.15
0.18%
00074713809
41
$180.66
1.01%
36
$165.46
0.74%
00074797208
1
$9.82
0.02%
0
$0.00
0.00%
00076010803
PROSED/DS
13
$660.96
0.32%
5
$391.56
0.10%
00121059516
CITRIC ACID/ SOL SOD CITR
1
$9.19
0.02%
1
$7.28
0.02%
00149000705
MACRODANTIN CAP 25MG
16
$439.32
0.39%
25
$700.96
0.51%
00149000805
152
$5,088.99
3.74%
753
$29,007.33
15.47%
00149000866
4
$104.60
0.10%
0
$0.00
0.00%
00149000905
48
$2,383.61
1.18%
423
$25,643.05
8.69%
00149000967
0
$0.00
0.00%
2
$114.85
0.04%
00149071001
MACROBID
1,205
$38,552.52
29.69%
948
$28,430.77
19.48%
00172213060
NITROFUR MAC CAP 50MG
271
$7,760.44
6.68%
119
$2,604.58
2.45%
00172213070
11
$47.73
0.27%
1
$4.71
0.02%
00172213080
43
$1,031.73
1.06%
9
$225.64
0.18%
00172213160
228
$9,334.01
5.62%
158
$4,183.29
3.25%
00172213170
3
$94.65
0.07%
0
$0.00
0.00%
00178060001
UROCIT-K 5 TAB 540MG
6
$143.62
0.15%
0
$0.00
0.00%
00178061001
UROCIT-K 10 TAB 1080MG
33
$1,443.94
0.81%
52
$1,514.46
1.07%
TAB
CAP 100MG
Page 340 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC. UROLOGICAL
00182013801
PHENAZOPYRID TAB 100MG
0
$0.00
0.00%
1
$5.90
0.02%
00182090401
6
$33.89
0.15%
3
$8.06
0.06%
00182194489
5
$97.41
0.12%
0
$0.00
0.00%
00254497128
4
$12.79
0.10%
3
$9.47
0.06%
00254497138
3
$12.78
0.07%
0
$0.00
0.00%
00254497228
3
$4.73
0.07%
7
$8.71
0.14%
00264220100
25
$1,513.07
0.62%
34
$1,123.33
0.70%
00264220110
4
$413.59
0.10%
15
$3,147.42
0.31%
00264220150
2
$25.51
0.05%
0
$0.00
0.00%
00264230400
2
$321.90
0.05%
0
$0.00
0.00%
00264230410
1
$20.20
0.02%
0
$0.00
0.00%
00327001105
RENACIDIN
32
$1,507.32
0.79%
48
$2,923.29
0.99%
00338004802
8
$287.00
0.20%
17
$2,171.30
0.35%
00338004803
21
$1,168.14
0.52%
11
$777.74
0.23%
00338004804
41
$4,932.37
1.01%
44
$703.48
0.90%
00338004805
7
$165.05
0.17%
12
$165.86
0.25%
00338028604
IRRIGATING SOL -G
1
$16.85
0.02%
0
$0.00
0.00%
00338065604
7
$455.45
0.17%
20
$617.75
0.41%
00364028601
1
$4.52
0.02%
1
$1.87
0.02%
00378165001
23
$557.56
0.57%
1
$20.79
0.02%
00378165005
3
$110.44
0.07%
0
$0.00
0.00%
00378170001
16
$510.87
0.39%
2
$35.80
0.04%
00378904005
CYSTAGON
CAP 50MG
0
$0.00
0.00%
3
$125.71
0.06%
00378904505
CYSTAGON
CAP 150MG
0
$0.00
0.00%
3
$1,359.04
0.06%
00430016624
MANDELAMINE TAB 0.5GM
2
$93.20
0.05%
0
$0.00
0.00%
00430016724
MANDELAMINE TAB 1GM
4
$166.18
0.10%
3
$58.75
0.06%
00430018124
PYRIDIUM
1
$3.23
0.02%
0
$0.00
0.00%
SOL IRR
TAB 200MG
Page 341 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC. UROLOGICAL
00430018215
PYRIDIUM
TAB PLUS
40
00430018224
PYRIDIUM
TAB PLUS
00456430008
MONUROL
00486111401
UROQID #2
00486113501
K-PHOS
$1,318.61
0.99%
32
$1,364.80
0.66%
0
$0.00
0.00%
1
$33.78
0.02%
2
$67.76
0.05%
1
$36.42
0.02%
TAB
8
$189.17
0.20%
11
$404.27
0.23%
TAB MF
1
$12.05
0.02%
0
$0.00
0.00%
00575022101
POLYCITRA-K POW CRYSTALS
2
$90.16
0.05%
0
$0.00
0.00%
00575022501
BICITRA
SOL
0
$0.00
0.00%
3
$209.00
0.06%
00603514121
30
$142.33
0.74%
30
$242.79
0.62%
00603514221
45
$159.82
1.11%
13
$29.49
0.27%
00677057501
22
$108.50
0.54%
9
$54.91
0.18%
00677080401
57
$223.45
1.40%
40
$140.85
0.82%
00677168101
METHENAM MAN TAB 0.5GM
0
$0.00
0.00%
2
$60.12
0.04%
00677168201
METHENAM MAN TAB 1GM
16
$530.72
0.39%
28
$679.94
0.58%
00781151001
0
$0.00
0.00%
4
$17.05
0.08%
00781151201
8
$29.26
0.20%
4
$5.17
0.08%
00781250201
26
$613.03
0.64%
1
$19.45
0.02%
00781250205
2
$11.85
0.05%
0
$0.00
0.00%
00781250210
22
$531.81
0.54%
1
$17.91
0.02%
00781250301
1
$26.08
0.02%
1
$5.40
0.02%
00904792260
0
$0.00
0.00%
5
$19.28
0.10%
10267086001
0
$0.00
0.00%
6
$8.85
0.12%
17314930001
ELMIRON
119
$22,449.78
2.93%
165
$31,408.04
3.39%
17314932001
POLYCITRA-K POW CRYSTALS
0
$0.00
0.00%
1
$97.95
0.02%
17314932101
POLYCITRA-K SOL
3
$252.52
0.07%
5
$298.82
0.10%
17314932201
POLYCITRA
14
$543.27
0.34%
10
$235.06
0.21%
17314932301
POLYCITRA-LC SOL
2
$61.38
0.05%
5
$349.43
0.10%
17314933001
BICITRA
61
$1,853.92
1.50%
78
$2,619.37
1.60%
PAK GRANULES
CAP 100MG
SYP
SOL
Page 342 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISC. UROLOGICAL
51079058420
51479002906
FURADANTIN SUS 25MG/5ML
51479002947
FURADANTIN SUS 25MG/5ML
51991052001
52152000302
$0.00
0.00%
$4.82
0.02%
4
$369.78
0.10%
56
$3,045.08
1.38%
0
$0.00
0.00%
82
$4,971.77
1.68%
2
$8.76
0.05%
0
$0.00
0.00%
25
$161.01
0.62%
42
$197.33
0.86%
52152000402
136
52152000405
8
$481.79
3.35%
135
$307.29
2.77%
$29.12
0.20%
0
$0.00
0.00%
52152011102
METHENAM MAN TAB 0.5GM
6
$139.20
0.15%
6
$139.20
0.12%
52152011202
41
$1,042.32
1.01%
52
$1,246.86
1.07%
52152011205
52268020001
PHOSLO
TAB 667MG
5
$87.22
0.12%
0
$0.00
0.00%
141
$3,622.92
3.47%
138
$4,509.10
2.84%
52268021001
PHOSLO
CAP 667MG
29
$891.68
0.71%
34
$1,322.63
0.70%
53265019610
105
$545.56
2.59%
186
$802.29
3.82%
53265019710
380
$1,408.99
9.36%
543
$1,335.96
11.16%
55515005502
CINOBAC
CAP 250MG
3
$120.72
0.07%
0
$0.00
0.00%
55515005604
CINOBAC
CAP 500MG
4
$375.86
0.10%
2
$109.36
0.04%
58468002001
RENAGEL
TAB 400MG
28
$3,296.51
0.69%
17
$2,278.35
0.35%
58468002101
RENAGEL
TAB 800MG
131
$33,496.70
3.23%
151
$39,294.23
3.10%
58468470901
RENAGEL
CAP 403MG
26
$3,584.98
0.64%
15
$2,635.58
0.31%
59730640101
PHOSLO
TAB 667MG
0
$0.00
0.00%
43
$1,782.93
0.88%
59730640201
PHOSLO
CAP 667MG
0
$0.00
0.00%
39
$1,406.71
0.80%
60258000116
CYTRA-2
SOL
11
$225.58
0.27%
8
$162.05
0.16%
60258051601
URITACT DS TAB
0
$0.00
0.00%
1
$45.18
0.02%
61451218301
URISED
2
$28.00
0.05%
6
$279.73
0.12%
61570004710
NEOSPORIN GU SOL 40/ML IR
3
$100.28
0.07%
7
$103.13
0.14%
61570004820
NEOSPORIN GU SOL 40/ML IR
1
$125.98
0.02%
1
$136.51
0.02%
64980011901
METHENAM HIP TAB 1GM
0
$0.00
0.00%
7
$308.05
0.14%
TAB
0
1
Page 343 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
UREX
$
Market Share*
MISC. UROLOGICAL
65199120101
# of Scripts
TAB 1GM
5
$199.35
0.12%
1
$72.35
0.02%
MISCELLANEOUS ANALGESICS
00006067561
DOLOBID
TAB 250MG
0
$0.00
0.00%
1
$62.96
0.02%
00006069761
DOLOBID
TAB 500MG
3
$234.03
0.08%
0
$0.00
0.00%
00008009102
EQUAGESIC
1
$10.84
0.03%
0
$0.00
0.00%
00034050080
TRILISATE
TAB 500MG
3
$271.53
0.08%
0
$0.00
0.00%
00034050580
TRILISATE
TAB 750MG
1
$168.22
0.03%
1
$175.65
0.02%
00034052080
TRILISATE
LIQ 500/5ML
4
$227.55
0.10%
0
$0.00
0.00%
00045012304
TYLENOL CHLD SUS 160/5ML
0
$0.00
0.00%
2
$10.64
0.04%
00045012410
TYLENOL
0
$0.00
0.00%
2
$17.22
0.04%
00045018716
TYLENOL CHLD ELX 160/5ML
0
$0.00
0.00%
1
$10.98
0.02%
00045044909
TYLENOL
TAB 500MG
6
$59.02
0.15%
1
$8.61
0.02%
00045045270
TYLENOL
TAB 325MG
0
$0.00
0.00%
3
$27.51
0.05%
00045049660
TYLENOL
TAB 325MG
0
$0.00
0.00%
1
$9.57
0.02%
00045049960
TYLENOL
TAB 500MG
2
$20.66
0.05%
1
$10.83
0.02%
00045050008
TYLENOL
LIQ 167MG/5
1
$7.89
0.03%
0
$0.00
0.00%
00045083810
TYLENOL
TAB ARTHRITI
1
$11.11
0.03%
0
$0.00
0.00%
00045083850
TYLENOL
TAB ARTHRITI
7
$56.77
0.18%
12
$112.17
0.21%
00054301050
ACETAMIN
ELX 160/5ML
1
$6.45
0.03%
0
$0.00
0.00%
00078008405
FIORICET
TAB
105
$5,262.44
2.70%
13
$806.81
0.23%
00078008408
FIORICET
TAB
0
$0.00
0.00%
1
$25.81
0.02%
00078010305
FIORINAL
CAP
4
$114.01
0.10%
2
$58.96
0.04%
00086005010
PHRENILIN TAB 50-325
5
$143.83
0.13%
0
$0.00
0.00%
00086005610
PHRENILIN CAP FORTE
3
$86.22
0.08%
0
$0.00
0.00%
00093075501
DIFLUNISAL TAB 500MG
7
$366.49
0.18%
20
$1,371.22
0.36%
00093075505
0
$0.00
0.00%
3
$144.85
0.05%
TAB 200-325
TAB 500MG
Page 344 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00093075506
186
$8,483.27
4.79%
223
$12,123.92
3.99%
00093085401
BUT/APAP/CAF TAB
113
$1,239.47
2.91%
11
$143.82
0.20%
00113013026
APAP
0
$0.00
0.00%
1
$2.63
0.02%
00113025968
ASPIRIN
TAB 81MG EC
0
$0.00
0.00%
1
$1.38
0.02%
00113040378
ACETAMIN
TAB 325MG
0
$0.00
0.00%
4
$16.23
0.07%
00113042978
ASPIRIN
0
$0.00
0.00%
3
$11.80
0.05%
00113048462
ACETAMIN
TAB 500MG
0
$0.00
0.00%
1
$4.60
0.02%
00113048471
ACETAMIN
TAB 500MG
1
$0.79
0.03%
0
$0.00
0.00%
00113048490
ACETAMIN
TAB 500MG
0
$0.00
0.00%
1
$3.33
0.02%
00113053576
ASPIRIN
TAB 81MG EC
0
$0.00
0.00%
7
$35.81
0.13%
00113097571
APAP
1
$4.12
0.03%
0
$0.00
0.00%
00143111501
BUT/APAP/CAF TAB
26
$1,582.45
0.67%
15
$1,134.33
0.27%
00143178501
BUT/ASA/CAFF TAB
317
$6,338.27
8.16%
377
$7,500.54
6.74%
00143178510
BUT/ASA/CAFF TAB
40
$1,006.76
1.03%
38
$642.27
0.68%
00143178701
BUT/APAP/CAF TAB
69
$647.38
1.78%
121
$1,172.15
2.16%
00143178705
BUT/APAP/CAF TAB
1
$14.35
0.03%
15
$227.75
0.27%
00182014101
GENEBS
TAB 325MG
33
$167.58
0.85%
22
$101.19
0.39%
00182014110
GENEBS
TAB 325MG
0
$0.00
0.00%
24
$56.91
0.43%
00182044401
ASPIRIN
TAB 325MG
2
$7.76
0.05%
7
$8.40
0.13%
00182044801
ASPIRIN
TAB 325MG EC
0
$0.00
0.00%
8
$8.67
0.14%
00182044810
ASPIRIN
TAB 325MG EC
1
$13.25
0.03%
3
$3.54
0.05%
00182044889
ASPIRIN
TAB 325MG EC
0
$0.00
0.00%
1
$3.68
0.02%
00182100010
ACETAMIN
TAB 325MG
3
$11.31
0.08%
22
$68.03
0.39%
00182100019
ACETAMIN
TAB 325MG
0
$0.00
0.00%
3
$13.39
0.05%
00182106105
ASPIRIN
TAB 81MG EC
3
$10.15
0.08%
100
$283.35
1.79%
00182106107
ASPIRIN
TAB 81MG EC
16
$58.30
0.41%
80
$210.10
1.43%
00182109511
ACETAMIN
SUP 650MG
2
$13.68
0.05%
7
$40.35
0.13%
SUS CHILD
TAB 325MG EC
TAB 500MG
Page 345 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00182142095
CHILD ASA CHW 81MG
9
$39.74
0.23%
102
$246.74
1.82%
00182145301
GENEBS
TAB 500MG
0
$0.00
0.00%
23
$136.85
0.41%
00182145310
GENEBS
TAB 500MG
0
$0.00
0.00%
10
$16.23
0.18%
00182145701
GENAPAP
15
$93.40
0.39%
2
$8.61
0.04%
00182147337
ACETAMIN
ELX 160/5ML
2
$7.20
0.05%
2
$10.42
0.04%
00182147340
ACETAMIN
00182147764
GENAPAP
00182166211
ACETAMIN
00182183201
GENEBS
TAB 500MG
00182183210
GENEBS
TAB 500MG
00182215401
GENAPAP
00182600964
TAB 500MG
ELX 160/5ML
0
$0.00
0.00%
2
$7.79
0.04%
DRO 80/0.8ML
4
$14.64
0.10%
0
$0.00
0.00%
SUP 120MG
4
$33.33
0.10%
3
$21.13
0.05%
0
$0.00
0.00%
16
$89.53
0.29%
1
$3.01
0.03%
0
$0.00
0.00%
17
$134.23
0.44%
32
$235.43
0.57%
INFANTS APAP DRO 80/0.8ML
3
$16.71
0.08%
0
$0.00
0.00%
00182700111
ACETAMIN
1
$12.57
0.03%
4
$39.52
0.07%
00182821789
ASPIRIN EC TAB 81MG
0
$0.00
0.00%
1
$4.49
0.02%
00182844789
ACETAMIN
2
$11.27
0.05%
4
$21.82
0.07%
00228202310
BUT/ASA/CAFF TAB
44
$1,237.23
1.13%
19
$322.12
0.34%
00258365701
BUT/APAP/CAF TAB
53
$2,633.68
1.36%
7
$239.57
0.13%
00281019817
AXOCET
8
$342.37
0.21%
0
$0.00
0.00%
00364067701
BUTALBITAL TAB CPD
1
$6.14
0.03%
0
$0.00
0.00%
00364067702
BUTALBITAL TAB CPD
7
$30.26
0.18%
0
$0.00
0.00%
00364229701
BUT/APAP/CAF TAB
3
$28.05
0.08%
0
$0.00
0.00%
00364229705
BUT/APAP/CAF TAB
4
$33.40
0.10%
0
$0.00
0.00%
00406097001
BUT/APAP/CAF TAB
0
$0.00
0.00%
13
$207.45
0.23%
00406097005
BUT/APAP/CAF TAB
5
$48.72
0.13%
62
$533.17
1.11%
00456067801
ESGIC-PLUS TAB
5
$904.73
0.13%
3
$901.62
0.05%
00456067901
ESGIC-PLUS CAP
8
$728.75
0.21%
1
$38.18
0.02%
00472120006
FEVERALL INF SUP 80MG
0
$0.00
0.00%
1
$11.72
0.02%
TAB 500MG
SUP 325MG
TAB 325MG
CAP
Page 346 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
FEVERALL
SUP 120MG
00472141004
APAP
00472141016
APAP
00472141799
APAP
00527155201
BUT/ASA/CAFF CAP
00536012285
ACETAMIN
00536308610
ASPIRIN
TAB 81MG EC
00536308641
ASPIRIN
00536322201
$
Market Share*
00472120106
# of Scripts
2
$29.02
0.05%
2
$27.62
0.04%
ELX 160/5ML
3
$16.35
0.08%
0
$0.00
0.00%
ELX 160/5ML
6
$43.58
0.15%
0
$0.00
0.00%
DRO 80/0.8ML
12
$64.32
0.31%
6
$35.76
0.11%
154
$4,002.22
3.97%
266
$8,617.77
4.75%
0
$0.00
0.00%
7
$100.41
0.13%
2
$8.23
0.05%
7
$37.66
0.13%
TAB 81MG EC
0
$0.00
0.00%
4
$17.16
0.07%
ACETAMIN
TAB 325MG
4
$26.00
0.10%
7
$39.01
0.13%
00536322210
ACETAMIN
TAB 325MG
3
$43.15
0.08%
2
$11.22
0.04%
00536323101
ACETAMIN
TAB 500MG
17
$110.28
0.44%
23
$156.59
0.41%
00536323110
ACETAMIN
TAB 500MG
7
$29.59
0.18%
9
$64.85
0.16%
00536323307
ACETAMIN
CHW 80MG
0
$0.00
0.00%
1
$10.21
0.02%
00536323407
ACETAMIN
CHW 80MG GRP
1
$5.64
0.03%
0
$0.00
0.00%
00536329736
ASPIRIN
CHW 81MG
3
$7.44
0.08%
20
$59.41
0.36%
00536330501
ASPIRIN
TAB 325MG
0
$0.00
0.00%
2
$7.02
0.04%
00536331301
ASPIRIN EC TAB 325MG
1
$3.79
0.03%
19
$48.68
0.34%
00536331310
1
$2.49
0.03%
17
$16.52
0.30%
00536331810
0
$0.00
0.00%
2
$2.36
0.04%
00574000211
ASPIRIN
0
$0.00
0.00%
1
$1.18
0.02%
00574000701
ACETAMIN
5
$50.55
0.13%
2
$4.28
0.04%
00591048501
BUT/APAP/CAF TAB
0
$0.00
0.00%
1
$6.85
0.02%
00591048505
BUT/APAP/CAF TAB
1
$14.35
0.03%
0
$0.00
0.00%
00603002436
ASPIRIN CHLD CHW 81MG
0
$0.00
0.00%
3
$11.08
0.05%
00603002522
ASA LOW DOSE TAB 81MG EC
0
$0.00
0.00%
38
$144.90
0.68%
00603002532
10
$47.50
0.26%
0
$0.00
0.00%
00603003121
ASPIRIN
0
$0.00
0.00%
7
$12.71
0.13%
ELX 160/5ML
TAB 325MG EC
TAB 325MG
TAB 325MG
Page 347 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
ASPIRIN
TAB 325MG EC
00603016721
EC ASPIRIN TAB 325MG
00603026321
Q-NOL
00603026821
$
Market Share*
00603016621
# of Scripts
$0.00
0.00%
1
0
$0.00
0.00%
2
$11.63
0.05%
Q-PAP EX STR TAB 500MG
0
$0.00
00603254021
BUTAL/APAP TAB 50-325
36
$640.95
00603254621
BUT/APAP/CAF CAP
1
$7.00
0.03%
2
$20.00
0.04%
00603254721
BUT/APAP/CAF TAB
434
$4,703.51
11.18%
611
$5,794.38
10.92%
00603254728
BUT/APAP/CAF TAB
49
$623.85
1.26%
4
$83.90
0.07%
00603254821
BUTALBITAL TAB CPD
0
$0.00
0.00%
2
$38.93
0.04%
00603255021
BUTALBITAL CAP CPD
1
$18.39
0.03%
2
$27.07
0.04%
00603255121
BUT/APAP/CAF TAB
13
$471.77
0.33%
3
$73.78
0.05%
00603575421
SALSALATE
TAB 500MG
10
$208.65
0.26%
6
$97.08
0.11%
00603575521
SALSALATE
TAB 750MG
37
$1,113.99
0.95%
54
$1,697.18
0.97%
00642016610
REPAN-CF
TAB 650-50MG
0
$0.00
0.00%
1
$65.25
0.02%
00642713210
QUALA-CET
TAB
0
$0.00
0.00%
3
$48.31
0.05%
00677000101
ACETAMIN
TAB 325MG
18
$108.98
0.46%
2
$20.76
0.04%
00677000110
ACETAMIN
TAB 325MG
1
$17.55
0.03%
0
$0.00
0.00%
00677067801
ACETAMIN
CAP 500MG
10
$76.68
0.26%
7
$55.27
0.13%
00677067810
ACETAMIN
CAP 500MG
1
$7.99
0.03%
1
$1.64
0.02%
00677070012
ACETAMIN
SUP 120MG
0
$0.00
0.00%
2
$27.43
0.04%
00677077101
ASPIRIN
TAB 325MG EC
1
$2.48
0.03%
5
$11.02
0.09%
00677077110
ASPIRIN
TAB 325MG EC
0
$0.00
0.00%
53
$176.72
0.95%
00677082701
FORTABS
19
$1,001.10
0.49%
3
$58.95
0.05%
00677101612
ACETAMIN
SUP 650MG
1
$29.26
0.03%
0
$0.00
0.00%
00677102401
SALSALATE
TAB 500MG
3
$64.50
0.08%
2
$44.58
0.04%
00677102501
SALSALATE
TAB 750MG
4
$123.40
0.10%
3
$91.05
0.05%
00677134701
ASPIRIN
TAB 975MG EC
0
$0.00
0.00%
5
$36.83
0.09%
TAB 325MG
TAB
0
$1.94
0.02%
7
$8.47
0.13%
8
$51.46
0.14%
0.00%
10
$63.24
0.18%
0.93%
56
$1,416.01
1.00%
Page 348 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
BUT/ASA/CAFF CAP
00677173801
BUTAL/APA/CA TAB
00677174801
BUT/APAP/CAF TAB
00677178101
ACETAMIN
TAB 325MG
00677178110
ACETAMIN
TAB 325MG
00677178201
ACETAMIN
TAB 500MG
00677178401
ACETAMIN
TAB 500MG
00677178410
ACETAMIN
TAB 500MG
00677183933
ACETAMIN
LIQ 160/5ML
00677185510
ASPIRIN
00713011812
ACEPHEN
SUP 120MG
00713016412
ACEPHEN
SUP 325MG
00713016501
ACEPHEN
00713016512
ACEPHEN
00781110801
SALSALATE
TAB 500MG
00781129410
ACETAMIN
TAB 325MG
00781160310
ASPIRIN
00781212001
FIORTAL
00781637704
ACETAMIN
00904197446
MAPAP
00904198280
$
Market Share*
00677143901
# of Scripts
$1,733.57
1.70%
87
$2,631.50
1.55%
3
$83.26
0.08%
1
$31.47
0.02%
12
$114.70
0.31%
3
$32.55
0.05%
16
$96.55
0.41%
24
$136.62
0.43%
27
$99.82
0.70%
22
$71.51
0.39%
4
$21.48
0.10%
1
$4.99
0.02%
24
$128.50
0.62%
13
$55.56
0.23%
4
$18.83
0.10%
1
$5.34
0.02%
2
$8.52
0.05%
9
$46.60
0.16%
0
$0.00
0.00%
14
$22.71
0.25%
10
$67.50
0.26%
14
$124.29
0.25%
4
$27.51
0.10%
4
$31.71
0.07%
SUP 650MG
0
$0.00
0.00%
1
$9.63
0.02%
SUP 650MG
4
$37.88
0.10%
1
$7.79
0.02%
1
$10.17
0.03%
0
$0.00
0.00%
17
$69.93
0.44%
62
$269.54
1.11%
0
$0.00
0.00%
1
$1.18
0.02%
4
$50.00
0.10%
0
$0.00
0.00%
1
$2.98
0.03%
0
$0.00
0.00%
CHW 80MG
7
$37.17
0.18%
4
$17.76
0.07%
MAPAP
TAB 325MG
14
$65.97
0.36%
17
$115.49
0.30%
00904198340
MAPAP
TAB 500MG
0
$0.00
0.00%
4
$25.34
0.07%
00904198359
MAPAP
TAB 500MG
26
$200.85
0.67%
4
$10.57
0.07%
00904198500
MAPAP
ELX 160/5ML
1
$5.82
0.03%
0
$0.00
0.00%
00904198516
MAPAP
ELX 160/5ML
3
$30.21
0.08%
2
$5.96
0.04%
00904198760
MAPAP
CAP 500MG
0
$0.00
0.00%
2
$7.78
0.04%
00904198880
MAPAP
TAB 500MG
1
$5.60
0.03%
19
$86.60
0.34%
TAB 81MG
TAB 325MG EC
CAP
LIQ 160/5ML
66
Page 349 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00904200960
ASPIRIN
TAB 325MG
0
$0.00
0.00%
11
$36.11
0.20%
00904201360
ASPIRIN
TAB 325MG EC
0
$0.00
0.00%
2
$8.12
0.04%
00904201372
ASPIRIN
TAB 325MG EC
0
$0.00
0.00%
2
$5.98
0.04%
00904201380
ASPIRIN
TAB 325MG EC
0
$0.00
0.00%
1
$1.18
0.02%
00904328040
BUT/APAP/CAF TAB
85
$688.41
2.19%
35
$401.13
0.63%
00904328060
BUT/APAP/CAF TAB
8
$59.17
0.21%
4
$23.97
0.07%
00904389260
BUTALBITAL TAB CPD
7
$119.53
0.18%
2
$25.66
0.04%
00904389280
BUTALBITAL TAB CPD
0
$0.00
0.00%
5
$38.93
0.09%
00904393460
BUTALBITAL CAP CPD
0
$0.00
0.00%
2
$41.34
0.04%
00904404073
ASPIRIN
0
$0.00
0.00%
2
$10.48
0.04%
00904525530
INF MAPAP
0
$0.00
0.00%
2
$13.22
0.04%
00904525646
MAPAP
0
$0.00
0.00%
5
$26.55
0.09%
00904770418
ASPIR-LOW
TAB 81MG EC
2
$10.58
0.05%
6
$34.48
0.11%
00904770470
ASPIR-LOW
TAB 81MG EC
0
$0.00
0.00%
1
$2.85
0.02%
00904770480
ASPIR-LOW
TAB 81MG EC
4
$15.59
0.10%
32
$99.59
0.57%
10135012310
ACETAMIN
TAB 325MG
16
$62.49
0.41%
6
$25.72
0.11%
10135014401
ACETAMIN
TAB 500MG
4
$7.96
0.10%
0
$0.00
0.00%
10135015201
ACETAMIN
TAB 500MG
2
$12.18
0.05%
1
$4.65
0.02%
10135015210
ACETAMIN
TAB 500MG
12
$50.29
0.31%
3
$12.54
0.05%
10135015213
ACETAMIN
TAB 500MG
1
$2.15
0.03%
0
$0.00
0.00%
10135017310
ASPIRIN
TAB 81MG EC
0
$0.00
0.00%
15
$48.14
0.27%
10135017362
ASPIRIN
TAB 81MG EC
0
$0.00
0.00%
9
$33.95
0.16%
11822300240
RA ASPIRIN TAB 325MG EC
0
$0.00
0.00%
1
$1.18
0.02%
11822317520
RA ASPIRIN CHW 81MG
0
$0.00
0.00%
2
$3.30
0.04%
11822330410
RA ARTHRITIS TAB RELIEF
0
$0.00
0.00%
3
$24.14
0.05%
11822989540
RA NON-ASIRI SUS 160MG/5M
1
$4.56
0.03%
0
$0.00
0.00%
11845079904
MASOPHEN
2
$9.38
0.05%
0
$0.00
0.00%
CHW 81MG
DRO 80/0.8ML
CHW 80MG
TAB 500MG
Page 350 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
ACETAMIN
11845099316
ASPIRIN
12333905201
CHILD PN REL ELX 160/5ML
12843010117
BAYER ASA
12843010349
$
Market Share*
11845090701
# of Scripts
TAB 500MG
1
TAB 81MG EC
$5.92
0.03%
1
$6.42
0.02%
0
$0.00
0.00%
1
$1.29
0.02%
2
$13.64
0.05%
0
$0.00
0.00%
0
$0.00
0.00%
1
$1.01
0.02%
THERAP BAYER TAB 325MG EC
0
$0.00
0.00%
2
$5.72
0.04%
12843010605
BAYER LOW
3
$22.78
0.08%
7
$34.96
0.13%
12843013105
BAYER CHILD CHW ASA 81MG
0
$0.00
0.00%
4
$14.58
0.07%
17236035010
ACETAMIN
0
$0.00
0.00%
3
$6.66
0.05%
17236038210
ASPIRIN
0
$0.00
0.00%
3
$3.85
0.05%
17236060701
APAP
0
$0.00
0.00%
4
$14.06
0.07%
17236070510
ASPIRIN
TAB 81MG EC
0
$0.00
0.00%
22
$41.47
0.39%
17236070566
ASPIRIN
TAB 81MG EC
0
$0.00
0.00%
4
$11.95
0.07%
37205000805
ACETAMIN
2
$13.14
0.05%
4
$77.76
0.07%
37205002071
PAIN RELIEVE TAB 500MG
0
$0.00
0.00%
3
$16.96
0.05%
37205002078
24
$197.79
0.62%
11
$104.19
0.20%
37205002090
11
$48.67
0.28%
9
$36.21
0.16%
37205002571
0
$0.00
0.00%
7
$55.02
0.13%
37205002578
11
$95.59
0.28%
1
$6.11
0.02%
37205003178
15
$112.89
0.39%
45
$311.53
0.80%
37205003572
31
$329.48
0.80%
19
$141.75
0.34%
37205003578
30
$234.00
0.77%
45
$322.57
0.80%
37205004565
PAIN RELIEVE CHW 80MG
2
$9.32
0.05%
0
$0.00
0.00%
37205005565
PAIN RELIEVE CHW 80MG
3
$25.71
0.08%
3
$23.10
0.05%
37205014578
ASPIRIN
TAB 325MG
0
$0.00
0.00%
7
$23.58
0.13%
37205014587
ASPIRIN
TAB 325MG
0
$0.00
0.00%
20
$67.29
0.36%
37205015078
BUFFERED ASA TAB 325MG
3
$14.55
0.08%
4
$21.28
0.07%
37205018778
10
$75.86
0.26%
2
$17.82
0.04%
TAB 325MG
TAB 81MG EC
TAB 325MG
TAB 325MG EC
TAB 500MG
DRO 100MG/ML
Page 351 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
37205031905
INF PAIN REL DRO 80/0.8ML
0
$0.00
0.00%
1
$16.23
0.02%
37205042978
ASPIRIN
TAB 325MG EC
0
$0.00
0.00%
11
$24.85
0.20%
37205042990
ASPIRIN
TAB 325MG EC
0
$0.00
0.00%
21
$48.41
0.38%
37205046768
CHILD ASA CHW 81MG
0
$0.00
0.00%
19
$57.11
0.34%
37205050526
CHILD PAIN LIQ RELIEVER
4
$31.49
0.10%
3
$19.82
0.05%
37205050826
CHILD PAIN SUS 160/5ML
0
$0.00
0.00%
3
$21.56
0.05%
37205051076
ASA LO-DOSE TAB 81MG EC
0
$0.00
0.00%
31
$104.07
0.55%
37205051087
ASA LO-DOSE TAB 81MG EC
0
$0.00
0.00%
2
$2.98
0.04%
37205051172
ASPIRIN
0
$0.00
0.00%
6
$25.86
0.11%
37205051805
INF PAIN REL DRO 80/0.8ML
3
$19.71
0.08%
0
$0.00
0.00%
37205070378
HEADACHE FOR TAB ADDED ST
1
$2.49
0.03%
1
$4.99
0.02%
37205070868
CHILD ASA CHW 81MG
0
$0.00
0.00%
19
$95.79
0.34%
37205071726
PAIN RELIEV SUS 160/5ML
3
$18.72
0.08%
0
$0.00
0.00%
41250017526
CHLD ASAFREE SUS 80/2.5ML
1
$5.03
0.03%
0
$0.00
0.00%
45802073030
ACETAMIN
SUP 650MG
6
$42.29
0.15%
3
$25.37
0.05%
45802073032
ACETAMIN
SUP 650MG
1
$7.72
0.03%
1
$7.72
0.02%
45802073230
ACETAMIN
SUP 120MG
1
$7.39
0.03%
5
$29.66
0.09%
46672005310
BUT/APAP/CAF TAB
210
$2,254.67
5.41%
211
$1,892.96
3.77%
46672005350
BUT/APAP/CAF TAB
288
$3,735.62
7.42%
93
$1,044.10
1.66%
49348000910
NON-ASPIRIN TAB 325MG
1
$7.53
0.03%
12
$104.62
0.21%
49348003410
SM ASPIRIN TAB 325MG EC
0
$0.00
0.00%
8
$19.53
0.14%
49348004209
3
$20.46
0.08%
0
$0.00
0.00%
49348019107
SM ASA CHLD CHW 81MG
2
$2.94
0.05%
0
$0.00
0.00%
49348028609
9
$68.70
0.23%
3
$25.87
0.05%
49348028610
0
$0.00
0.00%
18
$123.69
0.32%
49348075653
SM ASPIRIN TAB 81MG EC
0
$0.00
0.00%
7
$33.70
0.13%
49348088834
V-R NON-ASA SUS CHILDREN
0
$0.00
0.00%
2
$13.98
0.04%
TAB 500MG EC
Page 352 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
MEDI-TABS
49614053576
49692090120
TAB 500MG
$
Market Share*
49614012278
# of Scripts
0
$0.00
0.00%
5
$35.95
0.09%
ADLT ASA LOW TAB 81MG EC
0
$0.00
0.00%
3
$11.97
0.05%
ECOTRIN
TAB 325MG EC
1
$3.94
0.03%
6
$8.41
0.11%
49692090236
ECOTRIN
TAB 81MG EC
3
$12.99
0.08%
2
$4.56
0.04%
49692091236
ECOTRIN
TAB 81MG EC
2
$8.54
0.05%
1
$4.90
0.02%
49884065701
ZORPRIN
TAB 800MG CR
5
$782.11
0.13%
1
$23.91
0.02%
50111039001
SALSALATE
TAB 500MG
29
$631.74
0.75%
93
$1,490.73
1.66%
50111039002
SALSALATE
TAB 500MG
9
$123.66
0.23%
12
$161.55
0.21%
50111039101
SALSALATE
TAB 750MG
39
$925.87
1.00%
81
$1,425.34
1.45%
50111039102
SALSALATE
TAB 750MG
9
$176.55
0.23%
26
$532.38
0.46%
50111052801
CHO MAG TRIS TAB 500MG
29
$1,408.90
0.75%
52
$2,343.56
0.93%
50111052901
43
$1,982.77
1.11%
60
$2,823.06
1.07%
50111053001
10
$776.08
0.26%
9
$670.26
0.16%
50428193588
ARTHRTS PAIN TAB 650MG
0
$0.00
0.00%
1
$6.99
0.02%
50428230268
CVS ASPIRIN TAB EC 81MG
0
$0.00
0.00%
5
$11.66
0.09%
50428371914
0
$0.00
0.00%
1
$5.29
0.02%
50428547802
ASPIRIN CHIL CHW 81MG
0
$0.00
0.00%
1
$0.49
0.02%
50428606384
0
$0.00
0.00%
1
$2.29
0.02%
50428862623
CVS NON-ASA DRO
0
$0.00
0.00%
1
$6.49
0.02%
50580010124
TYLENOL JR CHW 160MG
0
$0.00
0.00%
1
$7.07
0.02%
50580010324
TYLENOL JR CHW 160MG
0
$0.00
0.00%
1
$18.68
0.02%
50580011108
TYLENOL
6
$53.51
0.15%
9
$69.95
0.16%
50580011210
TYLENOL ARTH TAB 650MG
2
$23.36
0.05%
9
$97.63
0.16%
50580011215
0
$0.00
0.00%
1
$13.16
0.02%
50580011225
0
$0.00
0.00%
1
$17.19
0.02%
50580011250
0
$0.00
0.00%
3
$32.05
0.05%
50580012201
TYLENOL INF DRO 80/0.8ML
1
$9.16
0.03%
1
$9.60
0.02%
LIQ 167/5ML
Page 353 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
50580012215
TYLENOL INF DRO 80/0.8ML
0
$0.00
0.00%
8
$63.26
0.14%
50580012304
0
$0.00
0.00%
6
$49.22
0.11%
50580012342
0
$0.00
0.00%
1
$8.26
0.02%
50580012410
TYLENOL
TAB 500MG
1
$23.47
0.03%
9
$62.72
0.16%
50580012610
ST JOSEPH AS TAB 81MG
0
$0.00
0.00%
2
$0.48
0.04%
50580012618
0
$0.00
0.00%
9
$9.70
0.16%
50580012636
0
$0.00
0.00%
5
$16.38
0.09%
50580017308
ST JOSEPH AS CHW 81MG
0
$0.00
0.00%
1
$5.70
0.02%
50580017336
ST JOSEPH AS CHW 81MG
0
$0.00
0.00%
1
$4.77
0.02%
50580018615
TYLENOL
DRO INFANTS
0
$0.00
0.00%
6
$40.62
0.11%
50580018630
TYLENOL
DRO INFANTS
0
$0.00
0.00%
1
$9.60
0.02%
50580029604
0
$0.00
0.00%
3
$24.93
0.05%
50580029710
TYLENOL 8 HR TAB 650MG
0
$0.00
0.00%
1
$12.03
0.02%
50580040704
0
$0.00
0.00%
5
$37.30
0.09%
50580044900
TYLENOL
TAB 500MG
0
$0.00
0.00%
1
$6.59
0.02%
50580044909
TYLENOL
TAB 500MG
0
$0.00
0.00%
3
$18.57
0.05%
50580044930
TYLENOL
TAB 500MG
0
$0.00
0.00%
1
$10.47
0.02%
50580044980
TYLENOL
TAB 500MG
0
$0.00
0.00%
1
$2.33
0.02%
50580049660
TYLENOL
TAB 325MG
0
$0.00
0.00%
16
$130.61
0.29%
50580049932
TYLENOL
TAB 500MG
0
$0.00
0.00%
1
$4.07
0.02%
50580049960
TYLENOL
TAB 500MG
0
$0.00
0.00%
7
$69.43
0.13%
50580049968
TYLENOL
TAB 500MG
0
$0.00
0.00%
2
$19.04
0.04%
50580049970
TYLENOL
TAB 500MG
0
$0.00
0.00%
2
$22.70
0.04%
50580050008
TYLENOL
LIQ 167MG/5
7
$54.90
0.18%
17
$130.18
0.30%
50844022216
ASPIRIN
TAB 81MG
0
$0.00
0.00%
3
$10.38
0.05%
50844022712
ASPIRIN
TAB 325MG EC
0
$0.00
0.00%
3
$3.94
0.05%
51079000222
ACETAMIN
2
$2.19
0.05%
0
$0.00
0.00%
TAB 325MG
Page 354 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
ACETAMIN
51079000260
ACETAMIN
51079000540
ASPIRIN
51111048878
ACETAMIN
51111048893
$
Market Share*
51079000240
# of Scripts
TAB 325MG
0
$0.00
0.00%
1
$2.47
0.02%
TAB 325MG
14
$52.50
0.36%
10
$40.84
0.18%
0
$0.00
0.00%
1
$1.01
0.02%
TAB 325MG
10
$39.67
0.26%
6
$23.46
0.11%
ACETAMIN
TAB 325MG
26
$91.68
0.67%
30
$93.79
0.54%
51111048978
ACETAMIN
TAB 500MG
0
$0.00
0.00%
1
$0.86
0.02%
51111048993
ACETAMIN
TAB 500MG
0
$0.00
0.00%
2
$5.19
0.04%
51672250108
ELIXSURE
GEL F/P CHRY
0
$0.00
0.00%
1
$7.57
0.02%
52152008402
0
$0.00
0.00%
2
$127.18
0.04%
52152008502
4
$189.94
0.10%
4
$208.10
0.07%
52544048501
BUT/APAP/CAF TAB
42
$388.70
1.08%
53
$461.40
0.95%
52544048505
BUT/APAP/CAF TAB
18
$191.98
0.46%
18
$248.80
0.32%
52735070901
ACETAMIN
TAB 325MG
2
$7.54
0.05%
0
$0.00
0.00%
52735071125
ACETAMIN
DRO 100MG/ML
1
$12.51
0.03%
0
$0.00
0.00%
52735074614
ASPIRIN LS TAB 81MG
0
$0.00
0.00%
18
$50.90
0.32%
52735075405
ACETAMIN JR CHW 160MG FR
3
$15.54
0.08%
2
$10.90
0.04%
52735075941
NON-ASA PAIN SUS 160/5ML
0
$0.00
0.00%
7
$111.32
0.13%
52735076025
NON-ASA INF DRO 80/0.8ML
0
$0.00
0.00%
1
$6.24
0.02%
53265023510
BUT/APAP/CAF TAB
30
$1,805.89
0.77%
96
$4,130.98
1.72%
53265023610
BUT/APAP/CAF TAB
199
$2,067.42
5.12%
486
$4,882.29
8.69%
53265023650
BUT/APAP/CAF TAB
0
$0.00
0.00%
198
$2,125.12
3.54%
53489010301
ACETAMIN
TAB 500MG
3
$17.01
0.08%
0
$0.00
0.00%
53489046601
SALSALATE
TAB 750MG
0
$0.00
0.00%
2
$52.19
0.04%
54499022601
ASPIRIN
TAB 325MG EC
0
$0.00
0.00%
3
$12.04
0.05%
54499022894
0
$0.00
0.00%
1
$2.98
0.02%
57664010308
SALSALATE
TAB 500MG
30
$473.49
0.77%
9
$243.65
0.16%
57664010313
SALSALATE
TAB 500MG
10
$157.50
0.26%
0
$0.00
0.00%
TAB 325MG
Page 355 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
57664010508
SALSALATE
TAB 750MG
40
$956.24
1.03%
45
57664010513
SALSALATE
TAB 750MG
17
$367.18
0.44%
57664021908
8
$257.39
0.21%
57664022008
9
$503.54
57896020010
ACETAMIN
TAB 500MG
14
57896022101
ACETAMIN
TAB 500MG
57896022110
ACETAMIN
TAB 500MG
57896090101
ASPIRIN
57896090110
$1,076.84
0.80%
4
$73.66
0.07%
3
$111.06
0.05%
0.23%
7
$374.03
0.13%
$36.95
0.36%
18
$51.65
0.32%
1
$4.13
0.03%
3
$4.58
0.05%
4
$11.62
0.10%
2
$6.03
0.04%
TAB 325MG
0
$0.00
0.00%
2
$1.58
0.04%
ASPIRIN
TAB 325MG
0
$0.00
0.00%
1
$1.74
0.02%
57896091136
ASPIRIN
CHW 81MG
0
$0.00
0.00%
1
$1.17
0.02%
57896092101
ASPIRIN
TAB 325MG EC
1
$3.74
0.03%
30
$106.72
0.54%
57896092110
ASPIRIN
TAB 325MG EC
0
$0.00
0.00%
24
$54.54
0.43%
58659311004
ASPIRIN EC TAB 81MG
0
$0.00
0.00%
2
$2.58
0.04%
59390000113
INFANTAIRE DRO 80/0.8ML
0
$0.00
0.00%
3
$9.21
0.05%
59417097571
EASPRIN
TAB 975MG EC
4
$199.22
0.10%
0
$0.00
0.00%
59439012250
APAP UNISERT SUP 650MG
1
$9.95
0.03%
0
$0.00
0.00%
59606003020
PAIN RELIEF TAB 325MG
1
$2.98
0.03%
3
$13.07
0.05%
59630017010
ZEBUTAL
9
$1,159.51
0.23%
1
$30.69
0.02%
60242011501
EC ASPIRIN TAB 325MG EC
0
$0.00
0.00%
1
$1.94
0.02%
60258009008
CHO MAG TRIS LIQ 500/5ML
19
$675.31
0.49%
11
$452.68
0.20%
60951076860
2
$100.69
0.05%
0
$0.00
0.00%
60951076960
12
$432.44
0.31%
2
$55.05
0.04%
60951076985
1
$177.42
0.03%
0
$0.00
0.00%
62107002726
ASPIR-81
TAB 81MG EC
1
$1.33
0.03%
17
$35.15
0.30%
62107005101
TACTINAL
TAB 500MG
5
$29.48
0.13%
9
$46.36
0.16%
64248009110
EQUAGESIC
3
$169.14
0.08%
1
$62.49
0.02%
65234005010
PHRENILIN TAB 325-50MG
23
$622.68
0.59%
5
$41.49
0.09%
CAP
TAB 200-325
Page 356 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
PHRENILIN FO CAP 650-50MG
$
Market Share*
65234005610
# of Scripts
5
$162.49
0.13%
7
$143.36
0.13%
1
$136.26
0.21%
0
$0.00
0.00%
95
$4,144.04
20.00%
72
$3,336.06
15.42%
6
$668.93
1.26%
2
$235.78
0.43%
9
$303.05
1.89%
1
$32.95
0.21%
11
$1,120.07
2.32%
9
$1,180.59
1.93%
MISCELLANEOUS ANARECTAL
00032190482
CORTENEMA
ENE 100MG
00091069010
PROCTOFOAM AER -HC 1%
00091069520
CORTIFOAM
00091464024
PROCTOCREAM CRE HC 2.5%
00093916871
HYDROCORT
00472051112
HEMORRHOIDAL SUP -HC 25MG
0
$0.00
0.00%
2
$38.46
0.43%
00472051124
HEMORRHOIDAL SUP -HC 25MG
9
$144.83
1.89%
7
$92.75
1.50%
00482480014
ANAMANTLE HC CRE
0
$0.00
0.00%
1
$58.60
0.21%
00496077804
ANALPRAM-HC CRE 1%
19
$644.52
4.00%
17
$659.33
3.64%
00496080004
ANALPRAM-HC CRE 2.5%
12
$403.70
2.53%
31
$1,225.78
6.64%
00496082415
ELA-MAX 5
CRE 5%
1
$27.54
0.21%
0
$0.00
0.00%
00496082430
ELA-MAX 5
CRE 5%
2
$89.74
0.42%
7
$335.43
1.50%
00501420224
ANUSOL
SUP 51%
1
$10.87
0.21%
0
$0.00
0.00%
00574202007
COLOCORT
6
$608.94
1.26%
5
$807.40
1.07%
00603813611
PROCTOSERT H SUP 30 MG
0
$0.00
0.00%
6
$477.45
1.28%
58634002501
PROCTOSOL HC CRE 2.5%
6
$150.18
1.26%
0
$0.00
0.00%
61570031311
ANUSOL-HC
CRE 2.5%
4
$134.60
0.84%
7
$245.91
1.50%
63304040601
PROCTO-KIT CRE 2.5%
16
$372.58
3.37%
9
$278.01
1.93%
63304040701
PROCTOSOL HC CRE 2.5%
104
$2,114.25
21.89%
46
$1,061.26
9.85%
64980030130
PROCTOZONE CRE -HC 2.5%
173
$3,127.32
36.42%
245
$4,908.92
52.46%
AER 90MG
ENE 100MG
ENE 100MG
MISCELLANEOUS ARTHRITIS
00025141134
ARTHROTEC 50 TAB
2
$216.28
0.38%
0
$0.00
0.00%
00025141160
ARTHROTEC 50 TAB
152
$15,835.56
29.17%
45
$3,912.24
35.71%
Page 357 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISCELLANEOUS ARTHRITIS
00025141190
ARTHROTEC 50 TAB
32
$3,129.96
6.14%
9
$1,177.87
7.14%
00025142160
ARTHROTEC 75 TAB
330
$30,391.21
63.34%
62
$4,866.13
49.21%
63032001160
RIDAURA
CAP 3MG
1
$168.22
0.19%
1
$148.98
0.79%
65483009306
RIDAURA
CAP 3MG
4
$472.44
0.77%
9
$1,472.55
7.14%
1
$18.41
0.05%
1
$19.41
0.04%
MISCELLANEOUS EAR
00026431202
DOMEBORO
SOL 2% OTIC
00034549006
CERUMENEX
SOL OTIC
48
$1,317.95
2.18%
8
$224.49
0.31%
00034549012
CERUMENEX
SOL OTIC
12
$496.48
0.54%
3
$125.89
0.11%
00046100010
AURALGAN
00065853110
CIPRO HC
00065853302
CIPRODEX
00088102105
DEBROX
00182117533
ALLERGEN
00254901043
A/B OTIC
00472001699
AUROTO
00472088099
ACETASOL
00472088282
ACETASOL HC SOL OTIC
00603702073
A/B OTIC
SOL
00603703541
ACETIC ACID SOL 2% OTIC
00603723873
OTICAINE
SOL 20% OTIC
00603724073
EAR-GESIC
DRO OTIC
00603749639
ZOTANE HC
00677140630
SOL OTIC
2
$38.83
0.09%
0
$0.00
0.00%
319
$20,695.29
14.46%
276
$19,427.76
10.56%
0
$0.00
0.00%
141
$10,066.18
5.40%
SOL 6.5% OT
1
$4.58
0.05%
0
$0.00
0.00%
SOL OTIC
21
$113.01
0.95%
12
$69.51
0.46%
2
$12.06
0.09%
1
$6.03
0.04%
55
$267.29
2.49%
175
$914.20
6.70%
9
$50.25
0.41%
0
$0.00
0.00%
102
$2,536.44
4.62%
137
$3,248.04
5.24%
33
$186.58
1.50%
48
$271.80
1.84%
4
$21.69
0.18%
4
$22.19
0.15%
12
$158.27
0.54%
12
$162.04
0.46%
1
$14.02
0.05%
0
$0.00
0.00%
2
$32.98
0.09%
2
$29.27
0.08%
ANTIPY/BENZO SOL OTIC
1
$6.55
0.05%
0
$0.00
0.00%
00677167621
ANTIBIOT EAR SOL 1% OTIC
2
$86.00
0.09%
0
$0.00
0.00%
00677167721
ANTIBIOT EAR SUS 1% OTIC
1
$20.35
0.05%
0
$0.00
0.00%
00904079335
AURODEX
17
$80.46
0.77%
7
$33.79
0.27%
SUS OTIC
SUS 0.3-0.1%
DRO
SOL OTIC
SOL 2% OTIC
DRO AQUEOUS
SOL OTIC
Page 358 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISCELLANEOUS EAR
00904301710
CORTOMYCIN SUS 1% OTIC
25
$639.33
1.13%
26
$675.97
1.00%
00904314110
CORTOMYCIN SOL 1% OTIC
7
$168.49
0.32%
12
$282.68
0.46%
00904322035
CARBAMIDE
0
$0.00
0.00%
1
$5.26
0.04%
24208042015
10
$59.84
0.45%
1
$3.78
0.04%
24208056162
251
$1,531.70
11.38%
298
$1,688.95
11.40%
24208061577
ACE ACD/ALUM SOL 2% OTIC
15
$139.29
0.68%
14
$108.96
0.54%
24208063110
NEO/POLY/HC SOL 1% OTIC
185
$4,568.39
8.39%
197
$5,048.90
7.54%
24208063562
NEO/POLY/HC SUS 1% OTIC
596
$15,556.76
27.02%
613
$16,577.65
23.46%
37205045705
EAR WAX DROP SOL 6.5% OT
4
$24.12
0.18%
39
$224.15
1.49%
45802031156
A/B OTIC
30
$149.50
1.36%
2
$9.34
0.08%
49158017830
EAR DROPS RX SOL OTIC
18
$81.70
0.82%
5
$29.03
0.19%
49158017843
EAR DROPS RX SOL OTIC
1
$0.95
0.05%
0
$0.00
0.00%
49158019542
2
$9.22
0.09%
0
$0.00
0.00%
49158019743
ACETIC ACID SOL /HC OTIC
59630013501
ZOTO-HC
60258045110
CYOTIC
60432074115
SOL 6.5% OT
SOL
2
$51.32
0.09%
1
$24.16
0.04%
SOL OTIC
18
$385.27
0.82%
6
$131.34
0.23%
DRO DROPS
0
$0.00
0.00%
2
$29.04
0.08%
22
$103.34
1.00%
27
$104.51
1.03%
61314063810
63
$1,710.97
2.86%
81
$2,084.45
3.10%
61314063910
17
$464.51
0.77%
17
$454.19
0.65%
61314064510
0
$0.00
0.00%
82
$2,136.66
3.14%
61314064610
0
$0.00
0.00%
14
$342.26
0.54%
61570003310
CORTISPORIN SUS 1% OTIC
4
$208.28
0.18%
2
$101.64
0.08%
61570003410
CORTISPORIN SOL 1% OTIC
61570003875
PEDIOTIC
61570009010
1
$52.07
0.05%
1
$49.57
0.04%
17
$786.53
0.77%
10
$434.01
0.38%
CORTISPORIN SUS -TC
15
$729.40
0.68%
12
$631.34
0.46%
63395010105
FLOXIN OTIC SOL 0.3%
183
$7,491.19
8.30%
195
$8,149.74
7.46%
63395010110
FLOXIN OTIC SOL 0.3%
70
$4,007.46
3.17%
117
$7,918.56
4.48%
SUS 1% OTIC
Page 359 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISCELLANEOUS EAR
64029314101
COLY-MYCIN-S SUS OTIC
3
66424052035
AUROGUARD
SOL
66440376701
AERO OTIC HC SOL
$80.00
0.14%
5
$219.64
0.19%
1
$5.87
0.05%
6
$35.22
0.23%
1
$17.52
0.05%
0
$0.00
0.00%
MISCELLANEOUS EYE
00023074501
LENS PLUS
SOL REWET DR
5
$150.90
3.70%
5
$168.40
3.47%
00023082512
LENS PLUS
SOL SALINE
0
$0.00
0.00%
1
$7.61
0.69%
00023916332
RESTASIS
0
$0.00
0.00%
35
$3,179.00
24.31%
00024135801
NEO-SYNEPHRI SOL 2.5% OP
1
$27.16
0.74%
1
$30.70
0.69%
00182702464
SOD CHLORIDE SOL 5% OP
1
$14.51
0.74%
1
$13.01
0.69%
00904531435
1
$10.12
0.74%
1
$10.12
0.69%
00904531538
SOD CHLORIDE OIN 5% OP
0
$0.00
0.00%
2
$15.24
1.39%
00904537720
EYE WASH
SOL
2
$11.50
1.48%
0
$0.00
0.00%
17478020510
AK-DILATE
SOL 10% OP
1
$8.68
0.74%
0
$0.00
0.00%
17478062235
9
$115.71
6.67%
34
$426.31
23.61%
17478062312
3
$41.64
2.22%
22
$281.80
15.28%
24208027615
MURO 128
SOL 2% OP
8
$121.00
5.93%
1
$12.76
0.69%
24208027715
MURO 128
SOL 5% OP
20
$304.97
14.81%
4
$45.17
2.78%
24208027730
MURO 128
SOL 5% OP
1
$19.49
0.74%
1
$19.98
0.69%
24208038555
MURO 128
OIN 5% OP
80
$1,273.90
59.26%
22
$322.00
15.28%
24208038556
MURO 128
OIN 5% OP
1
$11.78
0.74%
2
$82.42
1.39%
24208041105
BRIMONIDINE SOL 0.2% OP
0
$0.00
0.00%
1
$28.96
0.69%
24208041110
BRIMONIDINE SOL 0.2% OP
0
$0.00
0.00%
1
$48.79
0.69%
24208072506
NAPHAZOLINE SOL 0.1% OP
1
$7.03
0.74%
2
$9.06
1.39%
24208074002
PHENYLEPHRIN SOL 2.5% OP
0
$0.00
0.00%
1
$6.95
0.69%
24208074059
0
$0.00
0.00%
1
$6.15
0.69%
37205052505
0
$0.00
0.00%
1
$10.38
0.69%
EMU 0.05%
Page 360 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISCELLANEOUS EYE
37205052683
0
$0.00
0.00%
5
$49.51
3.47%
61314034201
1
$21.18
0.74%
0
$0.00
0.00%
MISCELLANEOUS GI
00005250002
FIBERCON
TAB 625MG
3
$28.02
0.06%
0
$0.00
0.00%
00005250033
FIBERCON
TAB 625MG
6
$89.61
0.13%
10
$121.97
0.14%
00005250086
FIBERCON
TAB 625MG
8
$121.58
0.17%
10
$131.24
0.14%
00034110020
SENOKOT
GRA 326/TSP
5
$50.31
0.11%
0
$0.00
0.00%
00034120020
SENOKOT
TAB 8.6MG
10
$122.31
0.21%
1
$11.01
0.01%
00034120050
SENOKOT
TAB 8.6MG
29
$310.64
0.61%
4
$47.09
0.06%
00034120080
SENOKOT
TAB 8.6MG
28
$409.32
0.59%
16
$304.11
0.23%
00034120081
SENOKOT
TAB 8.6MG
7
$117.19
0.15%
2
$40.26
0.03%
00034120112
SENOKOT XTRA TAB 374MG
6
$46.01
0.13%
1
$25.04
0.01%
00034120163
SENOKOT XTRA TAB 374MG
0
$0.00
0.00%
1
$11.67
0.01%
00034121030
SENOKOT S
TAB
3
$138.46
0.06%
0
$0.00
0.00%
00034121060
SENOKOT S
TAB
4
$138.44
0.08%
0
$0.00
0.00%
00034180020
SENOKOT
SYP 8.8MG/5M
1
$11.14
0.02%
2
$24.92
0.03%
00034180080
SENOKOT
SYP 8.8MG/5M
36
$879.48
0.76%
3
$61.05
0.04%
00034181025
SENOKOT
SYP CHILDREN
11
$125.24
0.23%
3
$36.90
0.04%
00037905112
MALTSUPEX
LIQ 16GM/15
4
$217.12
0.08%
0
$0.00
0.00%
00037910112
MALTSUPEX
POW
5
$284.24
0.11%
0
$0.00
0.00%
00054809919
BISACODYL
SUP 10MG
3
$15.26
0.06%
0
$0.00
0.00%
00067004114
BENEFIBER
PAK
2
$31.58
0.04%
0
$0.00
0.00%
00067004216
BENEFIBER
POW
2
$28.78
0.04%
5
$89.03
0.07%
00067602560
PERDIEM OVER TAB 15MG
0
$0.00
0.00%
7
$57.95
0.10%
00067610050
DULCOLAX
SUP 10MG
2
$67.10
0.04%
4
$132.20
0.06%
00067610051
DULCOLAX
SUP 10MG
2
$73.16
0.04%
0
$0.00
0.00%
Page 361 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISCELLANEOUS GI
00068041816
CITRUCEL
POW ORANGE
1
$9.46
0.02%
0
$0.00
0.00%
00068041830
CITRUCEL
POW ORANGE
7
$235.56
0.15%
7
$184.61
0.10%
00068042017
CITRUCEL
POW SF ORANG
2
$28.22
0.04%
0
$0.00
0.00%
00078031905
ACTIGALL
CAP 300MG
23
$4,327.29
0.49%
1
$249.89
0.01%
00088170015
CARAFATE
SUS 1GM/10ML
323
$16,080.41
6.83%
107
$4,435.94
1.54%
00088171247
CARAFATE
TAB 1GM
15
$1,412.92
0.32%
6
$516.70
0.09%
00088171253
CARAFATE
TAB 1GM
0
$0.00
0.00%
3
$30.00
0.04%
00093221001
SUCRALFATE TAB 1GM
99
$2,867.29
2.09%
239
$6,808.49
3.44%
00093221005
SUCRALFATE TAB 1GM
95
$2,897.84
2.01%
240
$6,854.22
3.45%
00093938001
URSODIOL
89
$13,295.81
1.88%
129
$19,602.15
1.85%
00113033240
MILK OF MAGN SUS MINT
0
$0.00
0.00%
1
$5.10
0.01%
00121043416
DOCUSATE SOD SYP 60/15ML
6
$42.94
0.13%
1
$7.47
0.01%
00121045816
DOC SOD/CAS SYP 60-30/15
0
$0.00
0.00%
2
$6.30
0.03%
00121054416
DOCUSATE SOD LIQ 50MG/5ML
26
$364.67
0.55%
59
$901.10
0.85%
00121065916
SORBITOL
2
$24.31
0.04%
0
$0.00
0.00%
00121074316
DOCUSATE SOD SYP 20MG/5ML
0
$0.00
0.00%
12
$72.78
0.17%
00132010803
FL PHOSPHO SOL SODA-REG
7
$48.04
0.15%
2
$566.28
0.03%
00132010915
FL PHOSPHO SOL SODA-FLV
1
$3.48
0.02%
0
$0.00
0.00%
00132020140
FLEET
ENE
13
$149.66
0.27%
11
$101.03
0.16%
00132020142
FLEET
ENE
5
$94.95
0.11%
2
$24.78
0.03%
00132020220
FLEET
ENE PED
1
$6.32
0.02%
0
$0.00
0.00%
00132030140
FLEET OIL
ENE
1
$4.99
0.02%
0
$0.00
0.00%
00132070402
FLEET LAXATI TAB 5MG EC
3
$11.12
0.06%
0
$0.00
0.00%
00182028701
D.O.S.
CAP 100MG
16
$75.07
0.34%
128
$649.69
1.84%
00182028710
D.O.S.
CAP 100MG
205
$944.46
4.34%
357
$894.40
5.13%
00182083339
MILK OF MAGN SUS
0
$0.00
0.00%
3
$10.57
0.04%
00182083340
MILK OF MAGN SUS
0
$0.00
0.00%
4
$23.56
0.06%
CAP 300MG
SOL 70%
Page 362 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISCELLANEOUS GI
00182109301
SENNA-GEN
TAB 8.6MG
110
$616.89
2.33%
205
$1,012.20
2.95%
00182109310
SENNA-GEN
TAB 8.6MG
39
$185.53
0.82%
136
$389.57
1.95%
00182111301
SENNA S
TAB 8.6-50MG
2
$16.94
0.04%
19
$174.17
0.27%
00182111310
SENNA S
TAB 8.6-50MG
2
$12.82
0.04%
0
$0.00
0.00%
00182138026
FIBER-LAX TAB 625MG
0
$0.00
0.00%
14
$102.14
0.20%
00182151376
GENFIBER
POW 50%
7
$51.86
0.15%
15
$100.58
0.22%
00182151476
GENFIBER
POW ORANGE
0
$0.00
0.00%
2
$15.20
0.03%
00182177440
DIOCTO
5
$48.20
0.11%
12
$98.10
0.17%
00182199201
RELIABLE GEN TAB 5MG EC
0
$0.00
0.00%
5
$15.33
0.07%
00182199210
RELIABLE GEN TAB 5MG EC
0
$0.00
0.00%
6
$12.08
0.09%
00182861689
DOC SOD/CAS CAP 100-30
3
$18.78
0.06%
0
$0.00
0.00%
00185210001
SUCRALFATE TAB 1GM
1
$30.85
0.02%
0
$0.00
0.00%
00245002016
SORBITOL
5
$91.68
0.11%
19
$313.05
0.27%
00245010405
BISACODYL
SUP 10MG
0
$0.00
0.00%
6
$16.02
0.09%
00245010412
BISACODYL
SUP 10MG
0
$0.00
0.00%
1
$3.95
0.01%
00245010450
BISACODYL
SUP 10MG
16
$61.96
0.34%
6
$26.32
0.09%
00364011301
DOCUSATE SOD CAP 100MG
1
$2.98
0.02%
0
$0.00
0.00%
00364011302
1
$3.55
0.02%
0
$0.00
0.00%
00364011501
1
$5.06
0.02%
0
$0.00
0.00%
00395060010
MAGN CITRATE SOL
0
$0.00
0.00%
3
$35.12
0.04%
00395265510
SENNA
0
$0.00
0.00%
1
$16.33
0.01%
00395421110
MAG CITRATE SOL CHERRY
0
$0.00
0.00%
3
$8.34
0.04%
00472092416
DIOCTO
00472093016
DIOCTO-C
00472093616
DIOCTO
00472510012
BISACODYL
00536059085
DIOCTO
LIQ 150/15ML
SOL 70%
POW
SYP 60/15ML
22
$231.41
0.47%
11
$67.52
0.16%
SYP 60-30/15
5
$93.26
0.11%
0
$0.00
0.00%
LIQ 150/15ML
4
$49.46
0.08%
20
$327.78
0.29%
6
$27.30
0.13%
0
$0.00
0.00%
5
$55.22
0.11%
7
$63.22
0.10%
SUP 10MG
LIQ 150/15ML
Page 363 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISCELLANEOUS GI
00536060085
DIOCTO
SYP 60/15ML
00536061085
DIOCTO-C
00536112701
00536135501
BISACODYL
00536135512
BISACODYL
00536247083
MILK OF MAGN SUS
00536297085
K-PEK
00536338101
BISACODYL
00536375101
00536375110
00536375601
00536375610
00536375701
2
$10.72
0.04%
9
$81.85
0.13%
SYP 60-30/15
1
$13.19
0.02%
SUCRALFATE TAB 1GM
3
$63.15
0.06%
0
$0.00
0.00%
3
$63.15
0.04%
SUP 10MG
5
$46.67
0.11%
6
$28.13
0.09%
SUP 10MG
2
$5.88
0.04%
4
$17.57
0.06%
5
$21.30
0.11%
4
$13.73
0.06%
10
$72.95
0.21%
0
$0.00
0.00%
1
$4.01
0.02%
0
$0.00
0.00%
2
$7.32
0.04%
0
$0.00
0.00%
0
$0.00
0.00%
2
$10.17
0.03%
94
$395.13
1.99%
155
$488.48
2.23%
20
$58.61
0.42%
50
$172.35
0.72%
0
$0.00
0.00%
2
$5.78
0.03%
00536430605
FIBER-LAX TAB 500MG
0
$0.00
0.00%
1
$8.01
0.01%
00536430611
FIBER-LAX TAB 500MG
1
$13.13
0.02%
2
$16.48
0.03%
00536590401
SENEXON
8
$39.19
0.17%
16
$72.83
0.23%
00536741551
ENEMA DISPOS ENE
0
$0.00
0.00%
4
$45.48
0.06%
00574000401
BISACODYL
TAB 5MG EC
13
$48.77
0.27%
15
$56.26
0.22%
00574000411
BISACODYL
TAB 5MG EC
0
$0.00
0.00%
1
$2.01
0.01%
00574001816
MILK OF MAGN SUS
0
$0.00
0.00%
3
$12.90
0.04%
00574016816
SORBITOL
29
$331.25
0.61%
11
$143.52
0.16%
00574705012
BISACODYL
SUP 10MG
0
$0.00
0.00%
2
$5.50
0.03%
00574705050
BISACODYL
SUP 10MG
3
$10.70
0.06%
4
$28.42
0.06%
00591078001
SUCRALFATE TAB 1GM
61
$1,719.36
1.29%
41
$1,263.94
0.59%
00591078005
SUCRALFATE TAB 1GM
24
$790.51
0.51%
117
$3,433.60
1.68%
00591315901
URSODIOL
0
$0.00
0.00%
11
$2,839.77
0.16%
00603014621
DOC-Q-LACE CAP 100MG
10
$29.26
0.21%
122
$318.36
1.75%
SUS 750/15ML
TAB 5MG EC
TAB 8.6MG
SOL 70%
CAP 300MG
Page 364 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISCELLANEOUS GI
00603014632
DOC-Q-LACE CAP 100MG
00603014732
DOC-Q-LAX
CAP 100-30
00603028021
SENNA LAX
TAB 8.6MG
00603028032
SENNA LAX
TAB 8.6MG
00603030621
SUR-Q-LAX
CAP 240MG
00603074758
00603078757
$916.44
5.03%
$432.24
1.91%
1
$11.02
0.02%
31
$170.23
0.66%
0
$0.00
0.00%
126
$510.13
1.81%
9
$67.42
0.19%
63
$305.02
0.91%
0
$0.00
0.00%
2
$13.16
0.03%
DOC-Q-LACE SYP 60/15ML
0
MILK OF MAGN SUS 400/5ML
0
$0.00
0.00%
16
$162.01
0.23%
$0.00
0.00%
2
$8.11
0.03%
00603090058
SORBITOL
0
$0.00
0.00%
6
$278.01
0.09%
00603248121
BISACODYL
TAB 5MG EC
9
$35.18
0.19%
31
$65.55
0.45%
00603248132
00603808611
BISACODYL
TAB 5MG EC
4
$14.30
0.08%
0
$0.00
0.00%
BISACODYL
SUP 10MG
0
$0.00
0.00%
1
$2.14
0.01%
00615058553
20
$79.68
0.42%
0
$0.00
0.00%
00615058563
12
$55.17
0.25%
0
$0.00
0.00%
00615451753
SUCRALFATE TAB 1GM
15
$423.45
0.32%
0
$0.00
0.00%
00615451763
SUCRALFATE TAB 1GM
75
$1,998.80
1.59%
0
$0.00
0.00%
00677019101
202
$1,031.10
4.27%
171
$627.88
2.46%
00677019110
713
$3,051.71
15.08%
1,011
$3,815.96
14.53%
00677057801
BISACODYL
TAB 5MG EC
38
$170.72
0.80%
50
$132.13
0.72%
00677057810
BISACODYL
TAB 5MG EC
2
$3.52
0.04%
8
$20.73
0.11%
00677062801
11
$49.26
0.23%
3
$10.22
0.04%
00677062810
19
$73.61
0.40%
0
$0.00
0.00%
00677078001
BISACODYL
SUP 10MG
8
$36.64
0.17%
5
$26.42
0.07%
00677078012
BISACODYL
SUP 10MG
35
$178.83
0.74%
24
$116.84
0.34%
00677081832
MILK OF MAGN SUS
0
$0.00
0.00%
8
$37.54
0.11%
00677092406
UNI-EASE
CAP 100MG
1
$4.30
0.02%
0
$0.00
0.00%
00677092506
UNI-EASE
CAP PLUS
5
$22.75
0.11%
0
$0.00
0.00%
00677171901
UNI-CENNA
5
$24.33
0.11%
11
$50.17
0.16%
SOL 70%
TAB 8.6MG
238
133
Page 365 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISCELLANEOUS GI
00713010901
BISAC-EVAC SUP 10MG
8
$35.62
0.17%
23
$96.41
0.33%
00713010912
BISAC-EVAC SUP 10MG
2
$8.24
0.04%
3
$11.31
0.04%
00713010950
BISAC-EVAC SUP 10MG
1
$3.11
0.02%
0
$0.00
0.00%
00713041601
BISAC-EVAC TAB 5MG EC
0
$0.00
0.00%
1
$2.78
0.01%
00766042520
CITRUCEL
2
$33.00
0.04%
8
$153.00
0.11%
00766739260
TUMS PLUS
0
$0.00
0.00%
1
$12.63
0.01%
00781240801
35
$148.53
0.74%
16
$55.84
0.23%
00781240810
32
$85.68
0.68%
6
$7.32
0.09%
00781258501
DOCUSATE CAL CAP 240MG
1
$8.01
0.02%
1
$6.01
0.01%
00781265301
1
$5.69
0.02%
0
$0.00
0.00%
00904078814
MILK OF MAGN SUS
0
$0.00
0.00%
5
$6.43
0.07%
00904091916
DOK PLUS
2
$18.02
0.04%
0
$0.00
0.00%
00904093616
DOCUSATE SOD SYP 60/15ML
0
$0.00
0.00%
1
$5.52
0.01%
00904312860
SENNA CONC TAB 187MG
5
$29.76
0.11%
0
$0.00
0.00%
00904312880
2
$12.12
0.04%
0
$0.00
0.00%
00904505812
BISCOLAX
SUP 10MG
1
$4.92
0.02%
3
$8.83
0.04%
00904505860
BISCOLAX
SUP 10MG
1
$6.72
0.02%
3
$11.69
0.04%
00904516559
SENNA
TAB 8.6MG
45
$240.45
0.95%
106
$506.97
1.52%
00904516580
SENNA
TAB 8.6MG
54
$239.13
1.14%
106
$378.13
1.52%
00904524909
KAO-TIN
0
$0.00
0.00%
6
$34.86
0.09%
00904543840
SUCRALFATE TAB 1GM
0
$0.00
0.00%
10
$317.07
0.14%
00904543860
SUCRALFATE TAB 1GM
0
$0.00
0.00%
5
$159.06
0.07%
00904545209
SENNA
0
$0.00
0.00%
60
$1,231.10
0.86%
00904551252
SENNA PLUS TAB
0
$0.00
0.00%
1
$9.43
0.01%
00904788959
DOK
CAP 100MG
0
$0.00
0.00%
2
$4.58
0.03%
00904788960
DOK
CAP 100MG
8
$41.68
0.17%
6
$23.80
0.09%
00904788980
DOK
CAP 100MG
16
$66.71
0.34%
50
$159.50
0.72%
TAB 500MG
CHW
SYP 60-30/15
LIQ ADV FORM
SYP
Page 366 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISCELLANEOUS GI
00904789080
DOK PLUS
CAP 100-30
00904792717
BISACODYL
TAB 5MG EC
00904792760
BISACODYL
TAB 5MG EC
00904792780
BISACODYL
TAB 5MG EC
10135011101
4
$22.08
0.08%
3
$9.99
0.06%
12
$47.88
0.25%
3
$12.80
0.06%
35
$109.62
10135011110
110
10135011160
1
10135015450
BISACODYL
TAB 5MG EC
10135031401
SENNA LAXATI TAB 8.6MG
10742003201
FLETCHER'S C LIQ 135MG/ML
11822323960
RA COL-RITE CAP 100MG
11822323990
11822331100
RA SENNA-LAX TAB 217MG
11822331780
11822331790
9
$38.50
0.13%
3
$6.49
0.04%
14
$37.32
0.20%
12
$32.97
0.17%
0.74%
9
$26.31
0.13%
$438.16
2.33%
246
$811.31
3.54%
$3.57
0.02%
0
$0.00
0.00%
1
$2.93
0.02%
0
$0.00
0.00%
1
$3.70
0.02%
0
$0.00
0.00%
0
$0.00
0.00%
2
$12.58
0.03%
22
$49.28
0.47%
50
$88.20
0.72%
17
$31.07
0.36%
23
$82.90
0.33%
4
$9.45
0.08%
52
$176.48
0.75%
32
$114.93
0.68%
34
$84.15
0.49%
4
$19.68
0.08%
20
$61.55
0.29%
11822334070
RA BISACODYL TAB 5MG EC
2
$4.51
0.04%
4
$8.22
0.06%
12333903301
DSS
CAP 100MG
1
$4.14
0.02%
1
$4.80
0.01%
12843035302
PH MILK MAGN SUS
0
$0.00
0.00%
3
$19.46
0.04%
12843036305
PH MILK MAGN SUS MINT
0
$0.00
0.00%
2
$11.10
0.03%
12843039324
PH MILK MAGN SUS CHERRY
0
$0.00
0.00%
4
$20.01
0.06%
17236012110
BISACODYL
TAB 5MG EC
0
$0.00
0.00%
1
$4.30
0.01%
17236044001
2
$11.60
0.04%
0
$0.00
0.00%
17236044010
17236061410
DIOCTYN
24385040478
SENNA
24385048672
24385048678
0
$0.00
0.00%
7
$15.35
0.10%
22
$28.64
0.47%
48
$94.12
0.69%
0
$0.00
0.00%
5
$24.60
0.07%
STOOL SOFTEN CAP 100MG
0
$0.00
0.00%
2
$4.60
0.03%
0
$0.00
0.00%
10
$30.49
0.14%
CAP 100MG
TAB 187MG
Page 367 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISCELLANEOUS GI
37000001008
METAMUCIL
POW 48.57%
6
$33.86
0.13%
5
$85.07
0.07%
37000001009
METAMUCIL
POW 48.57%
3
$24.70
0.06%
0
$0.00
0.00%
37000001308
METAMUCIL
POW 30.9%
5
$48.40
0.11%
0
$0.00
0.00%
37000002306
METAMUCIL
POW 28%
0
$0.00
0.00%
2
$22.38
0.03%
37000002307
METAMUCIL
POW 28%
0
$0.00
0.00%
1
$7.35
0.01%
37000002402
METAMUCIL
POW 58.6% OR
3
$20.16
0.06%
1
$9.16
0.01%
37000002406
METAMUCIL
POW 58.6% OR
1
$9.99
0.02%
2
$16.98
0.03%
37000003001
METAMUCIL
WAF 1.7GM
0
$0.00
0.00%
4
$15.14
0.06%
37000004805
METAMUCIL
POW 58.6%
0
$0.00
0.00%
1
$10.05
0.01%
37000040514
METAMUCIL
CAP 0.52GM
0
$0.00
0.00%
2
$10.47
0.03%
37000074009
METAMUCIL
POW
0
$0.00
0.00%
1
$7.59
0.01%
37000074012
METAMUCIL
POW 30.9%
0
$0.00
0.00%
1
$5.43
0.01%
37000074078
METAMUCIL
POW 28.3%ORG
1
$9.02
0.02%
2
$19.36
0.03%
37000074087
METAMUCIL
POW 28% ORNG
0
$0.00
0.00%
1
$29.00
0.01%
37205003011
READY-TO-USE ENE COMPLETE
2
$14.40
0.04%
0
$0.00
0.00%
37205010253
BISACODYL
17
$79.57
0.36%
50
$231.04
0.72%
37205011038
MAGN CITRATE SOL
1
$5.39
0.02%
14
$49.46
0.20%
37205012863
BISACODYL
TAB 5MG EC
2
$7.75
0.04%
4
$13.00
0.06%
37205021375
FIBER LAXATI TAB 625MG
3
$41.61
0.06%
14
$114.86
0.20%
37205024178
SENNA
169
$901.03
3.57%
348
$1,668.55
5.00%
37205025172
SENNA-PLUS TAB
1
$7.03
0.02%
9
$54.62
0.13%
37205026501
39
$177.44
0.82%
73
$236.60
1.05%
37205030127
NATURAL VEG POW 33%
1
$10.86
0.02%
9
$64.90
0.13%
37205030327
NATURAL VEG POW ORANGE
0
$0.00
0.00%
4
$30.48
0.06%
37205034727
NAT VEGETABL POW 33% ORAN
0
$0.00
0.00%
2
$14.72
0.03%
37205036238
MAGN CITRATE SOL LEMON
1
$8.57
0.02%
1
$9.65
0.01%
37205036638
NATURAL VEG POW 58.6%
0
$0.00
0.00%
2
$17.68
0.03%
SUP 10MG
TAB 187MG
Page 368 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISCELLANEOUS GI
37205048778
STOOL SOFTEN CAP STIM LAX
37205053040
ANTACID/
37205053540
ANTACID
37205083143
MINERAL
12
$60.40
0.25%
1
$8.52
0.01%
SUS SIMETH
0
$0.00
0.00%
2
$10.50
0.03%
SUS ANTI-GAS
0
$0.00
0.00%
3
$17.82
0.04%
OIL
2
$6.36
0.04%
1
$5.80
0.01%
37205083340
MILK OF MAGN SUS 400/5ML
0
$0.00
0.00%
26
$144.07
0.37%
37205083440
MILK OF MAGN SUS MINT
0
$0.00
0.00%
2
$11.25
0.03%
41100007300
CORRECTOL
1
$4.19
0.02%
0
$0.00
0.00%
41163039635
MILK OF MAG SUS REGULAR
0
$0.00
0.00%
1
$10.28
0.01%
41163039640
MILK OF MAG SUS 400/5ML
0
$0.00
0.00%
1
$4.92
0.01%
45802071030
BISACODYL
SUP 10MG
10
$62.17
0.21%
20
$82.71
0.29%
45802071032
BISACODYL
SUP 10MG
4
$22.78
0.08%
2
$9.98
0.03%
45802071033
BISACODYL
SUP 10MG
11
$52.57
0.23%
12
$61.70
0.17%
46287050001
SORBITOL
46
$516.10
0.97%
24
$304.80
0.34%
49348026210
NAT SENNA LX TAB 8.6MG
13
$46.28
0.27%
0
$0.00
0.00%
49348059867
SM LAXATIVE SUP 10MG
0
$0.00
0.00%
7
$35.60
0.10%
49348061610
0
$0.00
0.00%
4
$15.08
0.06%
49348080438
SM MINERAL OIL
0
$0.00
0.00%
1
$5.39
0.01%
50383013112
K-PEC
LIQ 750MG/15
1
$0.13
0.02%
0
$0.00
0.00%
50383013116
K-PEC
LIQ 750MG/15
4
$26.64
0.08%
0
$0.00
0.00%
50383077116
DOCU
LIQ 150/15ML
0
$0.00
0.00%
3
$20.14
0.04%
50428166363
BISACODYL
0
$0.00
0.00%
1
$2.78
0.01%
50428214916
MILK OF MAGN SUS 400MG/5M
0
$0.00
0.00%
5
$15.45
0.07%
50428218420
CVS SENNA-C TAB 8.6MG
0
$0.00
0.00%
9
$40.92
0.13%
50428310425
CVS STL SOFT CAP 100MG
10
$35.85
0.21%
4
$6.36
0.06%
50428606624
CVS STOOL SF CAP 100MG
3
$13.76
0.06%
4
$2.56
0.06%
50962087560
CARAFATE
1
$95.95
0.02%
0
$0.00
0.00%
51079001920
3
$2.16
0.06%
0
$0.00
0.00%
TAB 5MG EC
SOL 70%
TAB 5MG EC
SUS 1GM/10ML
Page 369 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISCELLANEOUS GI
51079001940
49
$172.79
1.04%
70
$243.34
1.01%
51079001960
35
$85.36
0.74%
5
$2.70
0.07%
51079003940
1
$1.51
0.02%
0
$0.00
0.00%
51079052120
17
$112.49
0.36%
60
$338.59
0.86%
52152006002
URSODIOL
21
$2,889.74
0.44%
12
$1,924.17
0.17%
52297048672
HM STOOL SOF CAP 100MG
0
$0.00
0.00%
3
$6.90
0.04%
52544078001
SUCRALFATE TAB 1GM
9
$324.05
0.19%
7
$175.25
0.10%
52544078005
SUCRALFATE TAB 1GM
55
$1,646.69
1.16%
47
$1,090.65
0.68%
52544093001
ACTIGALL
CAP 300MG
5
$210.75
0.11%
4
$733.88
0.06%
52555005701
SUCRALFATE TAB 1GM
12
$468.52
0.25%
23
$633.13
0.33%
52555005705
SUCRALFATE TAB 1GM
52
$1,776.06
1.10%
138
$4,031.92
1.98%
52735051401
0
$0.00
0.00%
4
$15.80
0.06%
53807012501
MILK OF MAGN SUS
0
$0.00
0.00%
1
$4.91
0.01%
54092005310
COLACE
CAP 100MG
0
$0.00
0.00%
1
$11.64
0.01%
54092005330
COLACE
CAP 100MG
15
$299.21
0.32%
4
$109.68
0.06%
54092005360
COLACE
CAP 100MG
2
$24.35
0.04%
3
$41.70
0.04%
54092041706
MINERAL
1
$4.97
0.02%
0
$0.00
0.00%
54429002701
1
$5.76
0.02%
0
$0.00
0.00%
54569238502
0
$0.00
0.00%
1
$2.30
0.01%
55175068401
1
$1.39
0.02%
0
$0.00
0.00%
55966010228
BISACODYL
0
$0.00
0.00%
3
$3.10
0.04%
57480011001
SENNA CONCEN TAB 8.6MG
1
$3.18
0.02%
0
$0.00
0.00%
57648000201
MAGIC BULLET SUP 10MG
1
$15.26
0.02%
1
$13.76
0.01%
57648000212
MAGIC BULLET SUP 10MG
5
$31.78
0.11%
11
$83.37
0.16%
57896040101
26
$73.54
0.55%
49
$118.99
0.70%
57896040110
188
$650.56
3.98%
393
$1,141.59
5.65%
58298013001
BISACODYL
0
$0.00
0.00%
1
$1.82
0.01%
CAP 300MG
OIL
TAB 5MG EC
SUP 10MG
Page 370 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MISCELLANEOUS GI
58914078510
URSO
TAB 250MG
59016009016
UNIFIBER
59606028821
EQUATE STOOL CAP SOFTENER
59606040514
27
$5,730.79
0.57%
3
$51.14
5
$13.29
NAT VEG LAX TAB 8.6MG
7
59606040520
NAT VEG LAX TAB 8.6MG
0
59741030640
BISACODYL
SUP 10MG
59930153201
SUCRALFATE TAB 1GM
59930153202
SUCRALFATE TAB 1GM
61073001101
SENNA
62107003310
DOCUSIL
65779050170
MAG CITRATE SOL
67618010130
COLACE
POW
TAB 187MG
CAP 100MG
CAP 100MG
35
$8,232.48
0.50%
0.06%
6
$103.66
0.09%
0.11%
14
$20.23
0.20%
$58.12
0.15%
12
$45.13
0.17%
$0.00
0.00%
1
$6.04
0.01%
0
$0.00
0.00%
1
$7.99
0.01%
184
$5,331.44
3.89%
113
$3,504.99
1.62%
24
$835.14
0.51%
31
$815.89
0.45%
2
$20.34
0.04%
9
$48.28
0.13%
12
$53.39
0.25%
72
$331.68
1.03%
0
$0.00
0.00%
1
$2.75
0.01%
0
$0.00
0.00%
21
$363.02
0.30%
2
$18.25
0.01%
0
$0.00
0.00%
MISCELLANEOUS MINERALS
00002202402
SOD CHLORIDE TAB 1GM
00005550919
CALTRATE 600 TAB PLUS-D
109
$858.59
0.59%
139
$872.50
0.65%
00005550924
CALTRATE 600 TAB PLUS-D
46
$391.45
0.25%
80
$554.77
0.37%
00005551019
CALTRATE 600 TAB
69
$364.06
0.38%
72
$253.49
0.34%
00005555619
CALTRATE PLS TAB
3
$21.04
0.02%
4
$33.48
0.02%
00005556719
CALTRATE
0
$0.00
0.00%
4
$31.02
0.02%
00024101510
FERGON
TAB 240MG
1
$3.25
0.01%
11
$40.15
0.05%
00045010203
VIACTIV
CHW MILK CHO
0
$0.00
0.00%
6
$52.76
0.03%
00045043760
VIACTIV
CHW CHOC MNT
0
$0.00
0.00%
1
$9.21
0.00%
00047078430
POT CHLORIDE TAB 10MEQ CR
4
$53.78
0.02%
0
$0.00
0.00%
00054311763
CALCIUM CARB SUS 1250/5ML
100
$1,091.35
0.54%
89
$1,286.19
0.42%
00054371663
POT CHLORIDE LIQ 10%
1
$5.80
0.01%
2
$7.36
0.01%
00054412025
6
$40.20
0.03%
6
$21.30
0.03%
CHW PLUS
Page 371 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00054412125
CALCIUM GLUC TAB 500MG
6
$22.87
0.03%
14
00054812125
3
$10.76
0.02%
00067012547
SLOW FE
TAB 160MG CR
7
$67.09
0.04%
00067012574
SLOW FE
TAB 160MG CR
6
$92.41
00067012575
SLOW FE
TAB 160MG CR
3
00074113002
SOD CHLORIDE INJ 23.4%
00074114101
00074181225
$29.65
0.07%
0
$0.00
0.00%
7
$93.92
0.03%
0.03%
1
$12.79
0.00%
$54.80
0.02%
0
$0.00
0.00%
0
$0.00
0.00%
5
$28.64
0.02%
0
$0.00
0.00%
2
$11.62
0.01%
3
$65.08
0.02%
0
$0.00
0.00%
00074191835
2
$11.56
0.01%
0
$0.00
0.00%
00074210202
1
$3.81
0.01%
0
$0.00
0.00%
00074210205
1
$34.00
0.01%
0
$0.00
0.00%
00074488810
18
$1,014.08
0.10%
13
$524.64
0.06%
00074488812
5
$65.90
0.03%
10
$100.94
0.05%
00074488850
4
$31.95
0.02%
1
$4.38
0.00%
00074662502
SOD BICARB INJ 8.4%
1
$50.35
0.01%
3
$10.14
0.01%
00074663722
SOD BICARB INJ 8.4%
3
$23.88
0.02%
0
$0.00
0.00%
00074665106
POT CHLORIDE INJ 2MEQ/ML
0
$0.00
0.00%
4
$55.10
0.02%
00074665305
POT CHLORIDE INJ 2MEQ/ML
0
$0.00
0.00%
1
$1.73
0.00%
00074710102
7
$66.65
0.04%
2
$64.30
0.01%
00074710113
1
$13.50
0.01%
0
$0.00
0.00%
00074710123
1
$23.64
0.01%
0
$0.00
0.00%
00074710166
6
$307.23
0.03%
2
$24.40
0.01%
00074710167
1
$36.75
0.01%
9
$322.20
0.04%
00074729601
POT PHOSPHAT INJ 3MM/ML
0
$0.00
0.00%
1
$7.05
0.00%
00074780413
K-TABS
TAB 10MEQ CR
0
$0.00
0.00%
7
$56.45
0.03%
00074780419
K-TABS
TAB 10MEQ CR
6
$70.53
0.03%
20
$258.83
0.09%
00074798302
18
$264.27
0.10%
0
$0.00
0.00%
Page 372 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
00074798436
00083012575
SLOW FE
00085026301
K-DUR
00085078701
$
Market Share*
00074798309
# of Scripts
2
$24.04
0.01%
3
$17.30
0.01%
6
$75.88
0.03%
0
$0.00
0.00%
11
$109.12
0.06%
2
$12.04
0.01%
TAB 10MEQ CR
9
$235.95
0.05%
0
$0.00
0.00%
K-DUR
TAB 20MEQ CR
116
$3,080.30
0.63%
10
$279.98
0.05%
00085078706
K-DUR
TAB 20MEQ CR
34
$609.11
0.19%
0
$0.00
0.00%
00085078710
K-DUR
TAB 20MEQ CR
6
$110.36
0.03%
0
$0.00
0.00%
00085078781
K-DUR
TAB 20MEQ CR
6
$157.93
0.03%
0
$0.00
0.00%
00087010243
VIACTIV
CHW MILK CHO
6
$45.32
0.03%
3
$27.00
0.01%
00087010343
VIACTIV
CHW CARAMEL
8
$58.89
0.04%
3
$18.27
0.01%
00087010443
VIACTIV
CHW MOCHACIN
3
$21.27
0.02%
3
$27.00
0.01%
00087074002
FER-IN-SOL DRO 15/0.6ML
8
$93.90
0.04%
10
$126.22
0.05%
00087076101
K-LYTE-ORANG TAB 25MEQ EF
5
$196.10
0.03%
0
$0.00
0.00%
00087077141
K-LYTE DS
TAB 50MEQ OR
1
$135.22
0.01%
1
$135.72
0.00%
00087077142
K-LYTE DS
TAB 50MEQ OR
3
$365.16
0.02%
0
$0.00
0.00%
00088165047
OS-CAL
3
$22.62
0.02%
0
$0.00
0.00%
00088165141
OS-CAL 500 TAB
0
$0.00
0.00%
4
$83.91
0.02%
00088165175
OS-CAL 500 TAB
9
$87.70
0.05%
5
$45.37
0.02%
00088165441
OS-CAL
TAB 500 + D
8
$76.25
0.04%
15
$130.14
0.07%
00088165453
OS-CAL
TAB 500 + D
2
$16.84
0.01%
2
$12.84
0.01%
00088165475
OS-CAL
TAB 500 + D
9
$67.68
0.05%
20
$110.41
0.09%
00093913110
FLUORIDE
CHW 1MG
533
$3,404.24
2.90%
458
$3,012.05
2.15%
00093922501
10
$94.70
0.05%
29
$161.08
0.14%
00093922510
2
$17.98
0.01%
8
$57.27
0.04%
00093965457
SOD FLUORIDE DRO 0.5MG/ML
279
$2,796.98
1.52%
227
$2,919.02
1.06%
00121053005
FERROUS SULF SYP 300/5ML
0
$0.00
0.00%
1
$35.12
0.00%
00126000262
LURIDE
0
$0.00
0.00%
1
$11.23
0.00%
TAB 160MG CR
TAB 250+D
DRO 0.5MG/ML
Page 373 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
LURIDE
CHW 1MG
00126001421
LURIDE
CHW 0.5MG
00126018621
LURIDE
CHW 0.25MG
00131220086
NIFEREX
TAB 50MG
00131422009
$
Market Share*
00126000621
# of Scripts
$19.36
0.02%
$0.00
0.00%
6
$32.10
0.03%
258
$1,213.50
1.40%
2
$9.92
0.01%
252
$1,263.19
1.18%
12
$140.30
0.07%
6
$57.92
0.03%
NIFEREX-150 CAP 150MG
19
$410.64
0.10%
16
$352.12
0.07%
00131506668
NIFEREX
ELX 100/5ML
10
00178080001
CITRACAL
TAB 200 MG
6
$184.78
0.05%
6
$124.25
0.03%
$32.61
0.03%
6
$52.51
0.03%
00178080020
CITRACAL
TAB 200 MG
0
$0.00
0.00%
21
$135.26
0.10%
00178081512
CITRACAL + D TAB
4
$40.52
0.02%
5
$43.91
0.02%
00178081560
CITRACAL + D TAB
13
$132.20
0.07%
12
$99.63
0.06%
00178082515
CITRACAL PLS TAB
3
$11.04
0.02%
1
$5.87
0.00%
00178083715
CITRACAL + D TAB
2
$13.16
0.01%
3
$19.34
0.01%
00178390360
CALCIUM/D TAB 600MG
0
$0.00
0.00%
1
$0.48
0.00%
00182036201
CALCIUM LACT TAB 650MG
3
$11.40
0.02%
3
$11.40
0.01%
00182041801
OYST-CAL D TAB 250MG
3
$10.98
0.02%
17
$55.13
0.08%
00182041809
0
$0.00
0.00%
1
$4.92
0.00%
00182041810
0
$0.00
0.00%
9
$22.88
0.04%
00182113801
SELENIUM
2
$9.34
0.01%
3
$16.81
0.01%
00182120140
FERROUS SULF ELX 220/5ML
0
$0.00
0.00%
5
$33.92
0.02%
00182138167
FER-GEN-SOL DRO 15/0.6ML
10
$56.08
0.05%
20
$108.95
0.09%
00182149717
POT BICARBON TAB 25MEQ EF
3
$33.93
0.02%
2
$22.62
0.01%
00182157607
OYST-CAL
TAB 500MG
2
$27.22
0.01%
5
$43.69
0.02%
00182157626
OYST-CAL
TAB 500MG
0
$0.00
0.00%
2
$3.68
0.01%
00182184005
POT CHLORIDE TAB 10MEQ SR
19
$239.19
0.10%
8
$46.81
0.04%
00182402801
FERROUS SULF TAB 325MG
88
$395.21
0.48%
92
$359.01
0.43%
00182402810
374
$1,380.86
2.04%
593
$1,236.15
2.78%
00182402889
5
$33.53
0.03%
7
$40.88
0.03%
TAB 50MCG
4
0
Page 374 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
00182403001
FERROUS SULF TAB 325MG EC
00182403010
00182403101
00182408201
FERROUS GLUC TAB EQ/27MG
00182414005
00182414026
$
Market Share*
00182402901
# of Scripts
$269.70
0.34%
$400.69
0.54%
15
$59.12
0.08%
156
$452.00
0.85%
0
$0.00
0.00%
328
$857.07
1.54%
51
$211.50
0.28%
0
$0.00
0.00%
0
$0.00
0.00%
4
$16.34
0.02%
CALCARB 600 TAB
96
CALCARB 600 TAB
185
$433.38
0.52%
148
$418.41
0.69%
$882.67
1.01%
187
$730.27
0.88%
00182414126
CALCARB/D
305
$1,853.04
1.66%
424
$2,121.08
1.99%
00182415101
CALCIUM CIT TAB 950MG
3
$17.16
0.02%
3
$5.79
0.01%
00182438501
MAGNESIUM
TAB 30MG
00182443910
OYST-CAL-D TAB 500MG
3
$12.30
0.02%
3
$6.30
0.01%
31
$144.52
0.17%
76
$318.78
0.36%
00182443926
OYST-CAL-D TAB 500MG
79
$529.46
0.43%
136
$691.45
0.64%
00245000308
SSKI
SOL 1GM/ML
3
$26.91
0.02%
3
$63.77
0.01%
00245000331
SSKI
SOL 1GM/ML
00245003501
KLOR-CON
POW 20MEQ
6
$67.14
0.03%
6
$62.90
0.03%
16
$329.47
0.09%
16
$213.30
0.07%
00245003530
KLOR-CON
POW 20MEQ
12
$138.63
0.07%
19
$222.42
0.09%
00245003730
KLOR-CON-25 POW 25MEQ
0
$0.00
0.00%
2
$19.58
0.01%
00245003901
KLOR-CON/EF TAB 25MEQ FR
00245003930
KLOR-CON/EF TAB 25MEQ FR
2
$22.74
0.01%
4
$38.53
0.02%
23
$365.24
0.13%
35
$521.01
0.16%
00245004001
KLOR-CON 8 TAB 8MEQ ER
0
$0.00
0.00%
4
$21.92
0.02%
00245004011
32
$219.53
0.17%
51
$293.88
0.24%
00245004015
10
$94.04
0.05%
8
$85.98
0.04%
00245004101
4
$77.80
0.02%
0
$0.00
0.00%
00245004111
216
$2,194.90
1.18%
256
$1,987.17
1.20%
00245004115
587
$6,186.88
3.20%
957
$8,498.65
4.48%
00245005301
FERATAB
2
$8.79
0.01%
0
$0.00
0.00%
00245005710
KLOR-CON M10 TAB 10MEQ ER
159
$2,779.96
0.87%
102
$806.94
0.48%
TAB 600
TAB 300MG
62
116
Page 375 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
00245005801
00245005810
00245005811
00245005815
00245006101
FERROUS GLUC TAB 300MG
00245008011
ZINC SULFATE CAP 220MG
00245010801
$
Market Share*
00245005711
# of Scripts
$6,316.05
2.36%
701
$4,910.79
3.28%
19
$440.47
0.10%
13
$165.69
0.06%
107
$2,461.68
0.58%
32
$438.36
0.15%
1,777
$40,484.58
9.68%
2,140
$36,658.91
10.03%
280
$6,212.21
1.52%
237
$4,058.34
1.11%
11
$40.49
0.06%
12
$42.83
0.06%
19
$148.84
0.10%
33
$223.66
0.15%
1
$6.74
0.01%
3
$14.22
0.01%
00245024210
POT CHLORIDE TAB 8MEQ ER
1
$5.48
0.01%
8
$39.26
0.04%
00254938158
52
$295.24
0.28%
2
$12.36
0.01%
00259029101
NU-IRON 150 CAP 150MG
25
$535.16
0.14%
39
$740.89
0.18%
00281313117
KAON-CL-10 TAB 10MEQ CR
3
$31.65
0.02%
0
$0.00
0.00%
00281320351
KAON
2
$58.72
0.01%
0
$0.00
0.00%
00288551001
FLUORITAB
3
$15.59
0.02%
1
$6.30
0.00%
00338004304
1
$50.35
0.01%
3
$110.95
0.01%
00338004402
2
$22.50
0.01%
1
$9.34
0.00%
00338004902
2
$8.48
0.01%
11
$58.63
0.05%
00338004903
4
$26.90
0.02%
1
$14.15
0.00%
00338004904
21
$206.69
0.11%
47
$450.90
0.22%
00338004918
0
$0.00
0.00%
1
$8.03
0.00%
00338004938
0
$0.00
0.00%
1
$131.99
0.00%
00338004941
1
$4.33
0.01%
0
$0.00
0.00%
00338004948
6
$27.47
0.03%
1
$4.69
0.00%
00338055311
7
$158.55
0.04%
0
$0.00
0.00%
00338802072
132
$12,414.67
0.72%
23
$1,906.88
0.11%
00364301247
INFED
0
$0.00
0.00%
5
$299.45
0.02%
00364737830
POT CHLORIDE POW 20MEQ
0
$0.00
0.00%
3
$28.50
0.01%
ELX 20MEQ/15
CHW CHERRY
INJ 50MG/ML
434
Page 376 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
FEOSTAT
00472100016
00472100028
CHW 100MG
$
Market Share*
00456037263
# of Scripts
7
$93.99
0.04%
5
$49.00
0.02%
POT CHLORIDE LIQ 10% SF
134
$851.70
0.73%
178
$1,140.61
0.83%
5
$36.29
0.03%
2
$12.02
0.01%
00472100116
10
$48.36
0.05%
9
$34.48
0.04%
00472146516
43
$263.04
0.23%
3
$17.76
0.01%
00472146995
FERROUS SULF DRO 75/0.6ML
27
$208.33
0.15%
12
$91.29
0.06%
00486111101
K-PHOS
TAB
2
$22.10
0.01%
2
$19.10
0.01%
00486112501
K-PHOS
TAB NEUTRAL
26
$489.00
0.14%
12
$340.62
0.06%
00517013410
DEXFERRUM
INJ 50MG/ML
1
$36.15
0.01%
4
$306.13
0.02%
00517023410
DEXFERRUM
INJ 50MG/ML
5
$174.75
0.03%
8
$566.93
0.04%
00517261025
MAGNESIUM SU INJ 50%
2
$10.60
0.01%
3
$5.01
0.01%
00517265025
1
$4.97
0.01%
0
$0.00
0.00%
00517281025
10
$74.05
0.05%
0
$0.00
0.00%
00517611025
ZINC SULFATE INJ 1MG/ML
2
$67.04
0.01%
3
$60.00
0.01%
00536065085
4
$20.82
0.02%
9
$53.58
0.04%
00536071080
FER-IRON
DRO 15/0.6ML
3
$21.89
0.02%
0
$0.00
0.00%
00536322301
CIT CALCIUM TAB 950MG
0
$0.00
0.00%
1
$16.64
0.00%
00536322408
CIT CALCIUM TAB 1500 + D
1
$7.28
0.01%
5
$38.90
0.02%
00536341610
5
$15.71
0.03%
3
$5.13
0.01%
00536342201
CALCIUM LACT TAB 650MG
3
$13.95
0.02%
0
$0.00
0.00%
00536342408
CALCIUM 600 TAB -D
105
$624.94
0.57%
168
$989.87
0.79%
00536342608
CALCIUM
TAB 600MG
78
$344.97
0.42%
94
$342.47
0.44%
00536410301
OYSCO D
TAB
2
$8.38
0.01%
0
$0.00
0.00%
00536410602
OYSCO 500
TAB
3
$18.46
0.02%
1
$4.32
0.00%
00536589001
154
$683.85
0.84%
428
$1,821.85
2.01%
00536781708
OYSCO 500/D TAB
10
$86.42
0.05%
13
$79.05
0.06%
00574050801
197
$738.37
1.07%
171
$489.38
0.80%
Page 377 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00574050810
30
$120.93
0.16%
00574050811
38
$157.70
00574060801
88
$354.48
00574060810
47
00574060811
15
00574916701
ZINCATE
00591603501
00591603530
00591737830
77
$217.77
0.36%
0.21%
37
$101.36
0.17%
0.48%
175
$792.84
0.82%
$226.40
0.26%
72
$273.29
0.34%
$105.69
0.08%
28
$163.29
0.13%
0
$0.00
0.00%
3
$19.53
0.01%
3
$29.76
0.02%
0
$0.00
0.00%
8
$114.68
0.04%
14
$181.69
0.07%
16
$171.24
0.09%
15
$233.29
0.07%
00603017929
FERR SULFATE TAB 325MG FC
22
$376.85
0.12%
35
$599.94
0.16%
00603076247
4
$34.81
0.02%
19
$164.57
0.09%
00603076358
6
$30.30
0.03%
11
$44.83
0.05%
00603124447
SOD FLOURIDE DRO 1.1MG/ML
5
$38.95
0.03%
21
$161.28
0.10%
00603153258
23
$138.02
0.13%
19
$117.34
0.09%
00603153458
179
$1,190.81
0.97%
236
$1,459.43
1.11%
00603153460
0
$0.00
0.00%
1
$6.51
0.00%
00603153558
15
$82.89
0.08%
42
$248.01
0.20%
00603153658
8
$39.82
0.04%
18
$97.12
0.08%
00603362232
FLUORIDE
CHW 0.5MG
37
$216.13
0.20%
271
$1,585.89
1.27%
00603362332
FLUORIDE
CHW 1MG
49
$291.32
0.27%
38
$220.31
0.18%
00603417316
K+ POTASSIUM POW 20MEQ
1
$23.87
0.01%
0
$0.00
0.00%
00603523721
19
$134.51
0.10%
1
$7.61
0.00%
00603523728
3
$35.61
0.02%
2
$23.74
0.01%
00603524121
17
$160.05
0.09%
10
$71.20
0.05%
00603524128
42
$477.50
0.23%
55
$529.07
0.26%
00603524132
368
$4,220.44
2.00%
287
$2,710.95
1.34%
00603524321
59
$695.70
0.32%
0
$0.00
0.00%
CAP 220MG
Page 378 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
00603524421
00603524428
00603524432
00615064553
$
Market Share*
00603524332
# of Scripts
$365.74
0.12%
$1,032.62
0.56%
1
$7.25
0.01%
71
$2,018.85
0.39%
0
$0.00
0.00%
29
$443.56
0.14%
117
$2,927.35
0.64%
167
$2,760.84
0.78%
15
$96.19
0.08%
18
$99.80
0.08%
00615064563
305
00615131843
POT CHLORIDE CAP 10MEQ CR
10
$1,855.61
1.66%
115
$676.80
0.54%
$108.89
0.05%
0
$0.00
0.00%
00615131853
508
$6,037.67
2.77%
165
$2,086.77
0.77%
00615131863
151
$1,393.62
0.82%
52
$700.52
0.24%
00615133453
IRON COMPLEX CAP 150MG
00615133463
1
$17.65
0.01%
0
$0.00
0.00%
16
$246.57
0.09%
0
$0.00
0.00%
00615454253
291
$3,388.95
1.58%
0
$0.00
0.00%
00615454263
77
$857.08
0.42%
0
$0.00
0.00%
00677006901
00677007001
29
$124.02
0.16%
28
$79.92
0.13%
129
$556.73
0.70%
128
$412.71
0.60%
00677007010
199
$644.48
1.08%
229
$537.96
1.07%
00677007101
108
$452.17
0.59%
102
$246.88
0.48%
00677007110
659
$2,686.22
3.59%
380
$1,119.65
1.78%
00677013210
SOD FLUORIDE CHW 2.2MG
1
$3.96
0.01%
0
$0.00
0.00%
00677052733
12
$68.80
0.07%
22
$152.68
0.10%
00677054033
8
$52.96
0.04%
5
$23.64
0.02%
00677062201
ZINC SULFATE CAP 220MG
3
$18.15
0.02%
1
$8.41
0.00%
00677081907
POT EFFERVES TAB 25MEQ EF
1
$10.16
0.01%
1
$9.59
0.00%
00677103507
4
$38.60
0.02%
0
$0.00
0.00%
00677109701
5
$40.45
0.03%
7
$52.25
0.03%
00677159701
31
$528.29
0.17%
36
$440.63
0.17%
00677167810
125
$593.32
0.68%
112
$577.70
0.52%
22
120
Page 379 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00761012920
CALCIUM/D TAB 500MG
1
$2.06
0.01%
1
$0.48
0.00%
00761081212
CALCIUM/D TAB 600MG
1
$4.50
0.01%
6
$10.96
0.03%
00766073560
TUMS 500
CHW ASSORTED
0
$0.00
0.00%
1
$11.58
0.00%
00766073660
TUMS 500
CHW PEPPRMNT
10
$66.47
0.05%
9
$60.62
0.04%
00766165160
OS-CAL
TAB 1250MG
3
$13.68
0.02%
1
$15.47
0.00%
00766165460
OS-CAL
TAB 500 + D
61
$404.70
0.33%
78
$427.70
0.37%
00781116113
FERROUS SULF TAB 5GR
1
$6.95
0.01%
0
$0.00
0.00%
00781116213
4
$10.00
0.02%
2
$3.38
0.01%
00781152531
0
$0.00
0.00%
1
$7.79
0.00%
00781152601
35
$413.25
0.19%
37
$379.18
0.17%
00781152610
362
$4,802.93
1.97%
533
$4,974.95
2.50%
00904098950
1
$7.89
0.01%
1
$9.88
0.00%
00904100716
12
$71.26
0.07%
8
$47.20
0.04%
00904112580
2
$4.84
0.01%
0
$0.00
0.00%
00904188352
OYSTER CAL TAB 500MG
0
$0.00
0.00%
2
$8.48
0.01%
00904188372
0
$0.00
0.00%
3
$13.27
0.01%
00904188380
1
$3.07
0.01%
4
$15.26
0.02%
00904188552
OYSTER SHELL TAB /D 500MG
25
$143.45
0.14%
21
$112.01
0.10%
00904188580
2
$7.94
0.01%
3
$5.91
0.01%
00904213761
0
$0.00
0.00%
6
$24.90
0.03%
00904213782
4
$14.62
0.02%
0
$0.00
0.00%
00904216660
1
$1.09
0.01%
0
$0.00
0.00%
00904216680
3
$10.67
0.02%
0
$0.00
0.00%
00904272046
K-VESCENT
TAB 25MEQ EF
3
$33.03
0.02%
5
$50.05
0.02%
00904272060
K-VESCENT
TAB 25MEQ EF
5
$68.63
0.03%
2
$15.92
0.01%
00904316260
SELENIUM
TAB 50MCG
1
$4.57
0.01%
3
$13.71
0.01%
00904323252
30
$126.18
0.16%
22
$47.39
0.10%
Page 380 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
00904323292
00904323352
CALCIUM/D TAB 600MG
00904323392
CALCIUM/D TAB 600MG
00904323852
$
Market Share*
00904323261
# of Scripts
3
$16.80
0.02%
27
$121.15
0.15%
119
$722.77
0.65%
58
$253.53
0.32%
CHEW CALCIUM CHW 500MG
0
$0.00
00904336140
6
00904423960
MAGNESIUM
$27.10
0.03%
44
$150.44
0.21%
214
$1,103.57
1.00%
103
$434.13
0.48%
0.00%
1
$6.70
0.00%
0
$42.63
0.03%
3
$27.12
0.01%
$0.00
0.00%
1
$1.71
0.00%
00904527260
CALCITRATE TAB VIT D
1
$9.94
0.01%
0
$0.00
0.00%
00904534646
K-VESCENT
1
$9.09
0.01%
0
$0.00
0.00%
00904539561
FERREX 150 CAP 150MG
00904540080
0
$0.00
0.00%
5
$52.00
0.02%
207
$956.51
1.13%
102
$526.64
0.48%
00904540180
11
$61.52
0.06%
28
$154.06
0.13%
00904546052
3
$18.21
0.02%
10
$58.20
0.05%
00904546072
20
$97.51
0.11%
37
$132.92
0.17%
00904546080
19
$104.25
0.10%
4
$17.46
0.02%
00904546092
5
$24.75
0.03%
2
$6.42
0.01%
00904759082
28
$225.40
0.15%
32
$167.69
0.15%
00904759161
33
$201.46
0.18%
16
$94.87
0.07%
00904759182
3
$21.56
0.02%
15
$60.78
0.07%
00904759183
18
$63.71
0.10%
31
$81.67
0.15%
08290032003
NORML SALINE INJ FLUSH
3
$169.76
0.02%
0
$0.00
0.00%
08290033005
11
$540.50
0.06%
4
$81.79
0.02%
08290033010
12
$673.60
0.07%
384
$36,784.48
1.80%
10267164004
SOD FLUORIDE TAB 1.1MG
1
$2.05
0.01%
13
$46.62
0.06%
10267164104
SOD FLUORIDE TAB 2.2MG
0
$0.00
0.00%
2
$11.41
0.01%
11822330050
RA CALCIUM+D TAB 600MG
0
$0.00
0.00%
6
$13.66
0.03%
11845013771
CALCIUM 500 TAB /VITMN D
0
$0.00
0.00%
5
$18.31
0.02%
TAB 500MG
POW 20MEQ
6
Page 381 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
11845075505
0
$0.00
0.00%
25
17236038960
CALCIUM/D TAB 600MG
0
$0.00
0.00%
17236043410
OYSTER SHELL TAB 500MG
0
$0.00
0.00%
17314931102
NEUTRA-PHOS POW
16
$450.69
17314931302
NEUTRA-PHOS POW -K
1
24385013778
IRON
TAB 325MG
24385087578
IRON
TAB 325MG
24385088072
CALCIUM/D TAB 600MG
37205008378
$154.91
0.12%
4
$5.06
0.02%
2
$11.84
0.01%
0.09%
21
$830.36
0.10%
$81.96
0.01%
0
$0.00
0.00%
0
$0.00
0.00%
1
$2.26
0.00%
0
$0.00
0.00%
1
$4.52
0.00%
0
$0.00
0.00%
9
$32.19
0.04%
34
$148.63
0.19%
0
$0.00
0.00%
37205039172
CALCIUM
25
$117.75
0.14%
0
$0.00
0.00%
37205039272
CALCIUM/D TAB 600MG
58
$365.91
0.32%
0
$0.00
0.00%
37205041378
9
$46.83
0.05%
0
$0.00
0.00%
38245013120
FLUORIDE
4
$21.53
0.02%
0
$0.00
0.00%
38245022520
4
$28.94
0.02%
0
$0.00
0.00%
43292055585
CALCIUM/D TAB 600MG
3
$13.62
0.02%
0
$0.00
0.00%
43292055643
CALCIUM/D TAB 600MG
1
$5.14
0.01%
7
$22.41
0.03%
44184001602
13
$197.45
0.07%
3
$26.31
0.01%
44184001702
6
$55.86
0.03%
4
$39.44
0.02%
44184001704
0
$0.00
0.00%
1
$11.15
0.00%
44184002502
POT BICAR/CL TAB 25MEQ EF
2
$25.30
0.01%
0
$0.00
0.00%
48107004923
CALCIUM
2
$7.98
0.01%
15
$48.97
0.07%
49348006243
OYSTER SHELL TAB 500MG
1
$7.63
0.01%
0
$0.00
0.00%
49348011012
SM CALCIUM TAB 600 +D
11
$85.39
0.06%
15
$117.64
0.07%
49348018010
0
$0.00
0.00%
1
$3.99
0.00%
49348023312
SM CALCIUM TAB 600
0
$0.00
0.00%
2
$4.70
0.01%
49348026412
SM OYST SHL TAB /D 500MG
2
$13.48
0.01%
1
$2.49
0.00%
49348026443
2
$18.66
0.01%
3
$20.55
0.01%
TAB 600MG
CHW 1MG
TAB
Page 382 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
49348032310
0
$0.00
0.00%
1
$6.59
0.00%
49483000804
1
$4.99
0.01%
0
$0.00
0.00%
49692094113
FEOSOL
TAB 45MG
0
$0.00
0.00%
1
$7.28
0.00%
49692094160
FEOSOL
TAB 45MG
0
$0.00
0.00%
2
$36.00
0.01%
49692094220
FEOSOL
TAB 200MG
0
$0.00
0.00%
2
$9.76
0.01%
50383062930
SOD FLUORIDE DRO 0.275MG
1
$7.92
0.01%
1
$7.92
0.00%
50383063050
5
$30.97
0.03%
5
$37.38
0.02%
50383065650
SOD FLOURIDE DRO 1.1MG/ML
420
$3,819.08
2.29%
486
$4,586.71
2.28%
50383077816
2
$16.69
0.01%
5
$19.93
0.02%
50428145485
CALCIUM + D TAB
0
$0.00
0.00%
1
$6.99
0.00%
50428145625
OYSTER SHELL TAB W/VIT D
0
$0.00
0.00%
9
$45.95
0.04%
50428269530
CALCIUM CARB TAB /VIT D
0
$0.00
0.00%
2
$8.44
0.01%
50428537845
CALCIUM CARB TAB /VIT D
0
$0.00
0.00%
1
$11.10
0.00%
50428901330
CALCIUM/D TAB 600MG
0
$0.00
0.00%
6
$12.72
0.03%
51817060216
FLUOR-A-DAY CHW 0.25MG
85
$406.60
0.46%
56
$368.61
0.26%
51817061116
FLUOR-A-DAY CHW 0.5MG
20
$113.86
0.11%
16
$86.54
0.07%
51817062216
FLUOR-A-DAY CHW 1MG
2
$15.02
0.01%
0
$0.00
0.00%
51817065661
FLUOR-A-DAY DRO 0.125MG
51991020311
FERREX 150 CAP 150MG
51991040516
CALCIQUID
52152012405
52152012705
52152012805
52297055572
52544093102
INFED
52735000613
52735007501
3
$21.09
0.02%
9
$69.52
0.04%
45
$687.77
0.25%
109
$1,777.29
0.51%
1
$48.47
0.01%
0
$0.00
0.00%
1
$3.84
0.01%
0
$0.00
0.00%
568
$3,615.58
3.09%
345
$2,192.24
1.62%
7
$40.83
0.04%
48
$338.24
0.22%
HM CALCIUM TAB 600MG
10
$36.03
0.05%
7
$18.34
0.03%
0
$0.00
0.00%
3
$1,205.25
0.01%
CALCIUM/D TAB 600MG
1
$6.32
0.01%
2
$10.03
0.01%
0
$0.00
0.00%
4
$21.92
0.02%
SYP 1.8GM/5
INJ 50MG/ML
Page 383 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
SLOW-MAG
TAB
54391002703
CALCI-MIX
54838000180
54868484500
$
Market Share*
54092002760
# of Scripts
10
$182.46
0.05%
12
$294.63
0.06%
3
$51.95
0.02%
0
$0.00
0.00%
0
$0.00
0.00%
2
$9.44
0.01%
CALTRATE 600 TAB
0
$0.00
0.00%
1
$37.36
0.00%
55289034701
CALCIUM/D TAB 500MG
0
$0.00
0.00%
4
$43.52
0.02%
55654001402
SOD FLUORIDE DRO 0.275MG
15
$165.08
0.08%
14
$147.86
0.07%
57896070110
10
$16.74
0.05%
16
$29.10
0.07%
57896070301
22
$48.22
0.12%
32
$75.82
0.15%
57896070310
4
$12.45
0.02%
20
$58.60
0.09%
58177000104
POT CHLORIDE CAP 10MEQ ER
288
$3,663.79
1.57%
381
$4,952.95
1.78%
58177000108
230
$2,867.62
1.25%
323
$4,433.81
1.51%
58177000109
1,369
$15,234.15
7.46%
2,112
$28,016.49
9.89%
58177000111
2
$10.42
0.01%
4
$74.06
0.02%
58177002409
FE-TINIC
CAP 150MG
1
$42.29
0.01%
9
$95.36
0.04%
58177002411
FE-TINIC
CAP 150MG
43
$675.20
0.23%
27
$409.92
0.13%
58177020204
34
$860.09
0.19%
21
$345.83
0.10%
58177020208
54
$1,200.18
0.29%
128
$1,968.44
0.60%
58177020209
87
$2,022.25
0.47%
280
$4,319.03
1.31%
58177020211
0
$0.00
0.00%
4
$36.42
0.02%
58177043240
ETHEDENT
CHW 0.25MG
0
$0.00
0.00%
46
$271.84
0.22%
58177043309
ETHEDENT
CHW 0.5MG
0
$0.00
0.00%
192
$1,322.08
0.90%
58177043340
ETHEDENT
CHW 0.5MG
0
$0.00
0.00%
8
$47.15
0.04%
58177043409
ETHEDENT
CHW 1MG
0
$0.00
0.00%
79
$542.99
0.37%
59772691001
37
$398.84
0.20%
13
$111.40
0.06%
59772691002
473
$5,155.77
2.58%
58
$537.98
0.27%
59930171401
266
$6,535.97
1.45%
247
$4,182.59
1.16%
59930171402
115
$2,238.44
0.63%
165
$2,525.03
0.77%
CAP POWDER
Page 384 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
59930171403
125
$2,766.75
0.68%
220
$3,746.14
1.03%
59930171501
5
$57.18
0.03%
38
$267.52
0.18%
60258012006
CALCIUM
1
$5.10
0.01%
0
$0.00
0.00%
60258017201
MAG-G
0
$0.00
0.00%
4
$45.12
0.02%
60258018501
POLY-IRON
3
$68.93
0.02%
7
$121.60
0.03%
60432000516
1
$4.36
0.01%
0
$0.00
0.00%
60432005750
FERROUS SULF DRO 125MG/ML
10
$81.07
0.05%
25
$208.94
0.12%
60432006616
38
$329.25
0.21%
54
$425.31
0.25%
60432009516
14
$87.84
0.08%
0
$0.00
0.00%
62037071001
15
$241.88
0.08%
20
$157.40
0.09%
62037071010
0
$0.00
0.00%
109
$836.03
0.51%
62037072001
42
$952.14
0.23%
37
$611.87
0.17%
62037072005
43
$1,107.83
0.23%
111
$2,065.00
0.52%
62037072010
0
$0.00
0.00%
38
$667.13
0.18%
62107004206
CALCIUM 600 TAB
33
$163.30
0.18%
88
$405.36
0.41%
62107005801
FERRONATE
13
$53.35
0.07%
16
$60.16
0.07%
63323006402
1
$49.56
0.01%
0
$0.00
0.00%
63323014403
P.T.E. -5
63323018610
63739004101
TAB 600MG
TAB 500MG
CAP 150MG
TAB 325MG
INJ
3
$362.40
0.02%
1
$120.80
0.00%
16
$302.63
0.09%
2
$10.72
0.01%
CALCIUM/D TAB 250MG
1
$6.01
0.01%
0
$0.00
0.00%
63807010010
1
$235.35
0.01%
0
$0.00
0.00%
64011000904
MICRO-K
CAP 10MEQ CR
9
$412.80
0.05%
13
$421.56
0.06%
64011001004
MICRO-K
CAP 8MEQ CR
13
$128.19
0.07%
17
$1,632.09
0.08%
64011001008
MICRO-K
CAP 8MEQ CR
6
$34.99
0.03%
0
$0.00
0.00%
64253011130
NORML SALINE INJ IV FLUSH
94
$7,845.91
0.51%
105
$6,098.31
0.49%
64253011133
5
$197.24
0.03%
26
$398.23
0.12%
64253011135
46
$2,640.39
0.25%
101
$5,470.10
0.47%
Page 385 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
64727880101
MAGNESIUM GL TAB 500MG
0
$0.00
0.00%
1
$14.68
0.00%
64980010401
PHOSPHA 250 TAB NEUTRAL
0
$0.00
0.00%
5
$67.59
0.02%
66375010501
CALCIUM + D TAB 600MG
2
$9.88
0.01%
6
$31.50
0.03%
67618010760
SLOW-MAG
0
$0.00
0.00%
1
$42.87
0.00%
74312003900
OYSTERCAL-D TAB 250MG
4
$20.60
0.02%
1
$3.65
0.00%
74312004230
CALCIUM/D TAB 600MG
35
$187.45
0.19%
36
$148.02
0.17%
74312004233
CALCIUM/D TAB 600MG
13
$62.32
0.07%
5
$26.21
0.02%
74312007090
OYSTERCAL
7
$47.91
0.04%
45
$242.99
0.21%
147
$2,789.09
0.23%
42
$672.50
0.05%
TAB
TAB 500 + D
MISCELLANEOUS NARCOTICS
00002035102
DARVOCET-N TAB 50
00002035302
DARVON-N
TAB 100MG
87
$5,451.49
0.14%
30
$1,149.47
0.03%
00002035333
DARVON-N
TAB 100MG
2
$55.48
0.00%
1
$35.52
0.00%
00002036302
DARVOCET-N TAB 100
17
$1,422.58
0.03%
12
$683.49
0.01%
00002036303
DARVOCET-N TAB 100
7
$586.90
0.01%
2
$307.18
0.00%
00002080302
DARVON
CAP 65MG
4
$287.90
0.01%
23
$1,005.95
0.03%
00002311102
DARVON
CAP CPD 65
13
$559.78
0.02%
7
$436.64
0.01%
00024033504
DEMEROL
TAB 50MG
00024193704
TALACEN
TAB
00024195104
TALWIN NX TAB
00034051810
MSIR
00034051910
00034052301
00044072302
4
$196.16
0.01%
0
$0.00
0.00%
15
$942.85
0.02%
0
$0.00
0.00%
1
$22.52
0.00%
2
$74.64
0.00%
TAB 15MG
39
$762.16
0.06%
3
$52.24
0.00%
MSIR
TAB 30MG
36
$579.88
0.06%
6
$80.38
0.01%
MSIR
SOL 20MG/ML
0
$0.00
0.00%
1
$20.60
0.00%
VICOPROFEN TAB
88
$4,011.30
0.14%
0
$0.00
0.00%
00044072341
VICOPROFEN TAB
10
$274.64
0.02%
0
$0.00
0.00%
00044101706
DILAUDID-HP INJ 10MG/ML
20
$11,601.66
0.03%
1
$600.65
0.00%
00044102202
DILAUDID
15
$299.62
0.02%
1
$11.94
0.00%
TAB 2MG
Page 386 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00044102402
DILAUDID
TAB 4MG
27
$1,641.84
0.04%
1
$21.87
0.00%
00044105301
DILAUDID
SUP 3MG
9
$351.22
0.01%
1
$38.12
0.00%
00044108501
DILAUDID-5 LIQ 1MG/ML
1
$4.81
0.00%
2
$57.84
0.00%
00045051360
TYLENOL/COD TAB #3
3
$118.03
0.00%
0
$0.00
0.00%
00045051560
TYLENOL/COD TAB #4
0
$0.00
0.00%
9
$416.98
0.01%
00045052660
TYLOX
00054279525
OXYCOD/APAP CAP 5-500MG
00054300563
CAP 5-500MG
7
$842.88
0.01%
3
$152.74
0.00%
141
$1,796.18
0.22%
63
$808.01
0.07%
APAP/CODEINE ELX 120-12/5
5
$24.59
0.01%
1
$5.27
0.00%
00054316163
CODEINE PHOS SOL 15MG/5ML
9
$97.66
0.01%
9
$91.02
0.01%
00054354563
MEPERIDINE SYP 50MG/5ML
1
$28.15
0.00%
1
$34.17
0.00%
00054368263
ROXICODONE SOL 5MG/5ML
52
$1,350.39
0.08%
36
$811.85
0.04%
00054368344
ROXICODONE CON 20MG/ML
7
$366.33
0.01%
6
$229.95
0.01%
00054368663
ROXICET
88
$1,668.74
0.14%
99
$2,759.48
0.11%
00054375144
ROXANOL
SOL 20MG/ML
3
$63.23
0.00%
7
$142.37
0.01%
00054375150
ROXANOL
SOL 20MG/ML
22
$1,411.21
0.03%
11
$877.47
0.01%
00054375158
ROXANOL
SOL 20MG/ML
0
$0.00
0.00%
2
$43.02
0.00%
00054377450
ROXANOL-T
0
$0.00
0.00%
1
$37.26
0.00%
00054415625
CODEINE SULF TAB 30MG
75
$2,122.48
0.12%
100
$2,835.29
0.12%
00054415725
15
$844.00
0.02%
15
$1,245.16
0.02%
00054437025
HYDROMORPHON TAB 8MG
9
$3,376.05
0.01%
17
$4,774.55
0.02%
00054439225
35
$621.94
0.06%
28
$399.10
0.03%
00054439425
53
$3,431.60
0.08%
40
$3,305.04
0.05%
00054458225
MORPHINE SUL TAB 15MG
217
$3,199.59
0.34%
375
$5,165.02
0.44%
00054458325
123
$3,030.23
0.19%
193
$4,378.90
0.22%
00054459525
MEPERIDINE TAB 50MG
22
$618.13
0.03%
8
$452.33
0.01%
00054465025
ROXICET
TAB 5-325MG
734
$7,070.68
1.16%
1,277
$9,038.65
1.48%
00054465029
ROXICET
TAB 5-325MG
741
$7,678.24
1.17%
229
$1,948.77
0.27%
SOL 5-325/5
SOL 20MG/ML
Page 387 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00054465725
ROXICODONE TAB 5MG
543
00054465825
ROXICODONE TAB 15MG
00054466525
ROXICODONE TAB 30MG
00054478425
ROXICET
$13,894.15
0.86%
168
$5,596.78
0.19%
110
$8,598.19
0.17%
560
$54,281.02
0.65%
189
$28,922.47
0.30%
493
$88,567.85
0.57%
TAB 5-500MG
8
$232.64
0.01%
2
$169.06
0.00%
00054815524
9
$101.93
0.01%
15
$223.74
0.02%
00054815624
0
$0.00
0.00%
1
$9.77
0.00%
00054839224
0
$0.00
0.00%
1
$40.28
0.00%
00054858224
3
$37.69
0.00%
1
$1.09
0.00%
00054858324
1
$28.35
0.00%
0
$0.00
0.00%
00054865024
ROXICET
10
$24.07
0.02%
17
$24.73
0.02%
00054865724
ROXICODONE TAB 5MG
21
$57.50
0.03%
16
$57.26
0.02%
00054866524
ROXICODONE TAB 30MG
4
$766.13
0.01%
2
$97.30
0.00%
00054878424
ROXICET
2
$130.32
0.00%
0
$0.00
0.00%
00074117801
DEMEROL
INJ 50MG/ML
14
$101.89
0.02%
0
$0.00
0.00%
00074117831
DEMEROL
INJ 50MG/ML
7
$84.50
0.01%
0
$0.00
0.00%
00074117901
DEMEROL
INJ 75MG/ML
6
$36.68
0.01%
0
$0.00
0.00%
00074117902
DEMEROL
INJ 75MG/ML
97
$859.66
0.15%
15
$686.07
0.02%
00074118001
DEMEROL
INJ 100MG/ML
1
$8.93
0.00%
0
$0.00
0.00%
00074118002
DEMEROL
INJ 100MG/ML
5
$35.00
0.01%
1
$13.92
0.00%
00074118069
DEMEROL
INJ 100MG/ML
0
$0.00
0.00%
1
$9.82
0.00%
00074118130
DEMEROL
INJ 50MG/ML
3
$50.49
0.00%
1
$21.97
0.00%
00074125301
DEMEROL
INJ 50MG/ML
0
$0.00
0.00%
1
$1.00
0.00%
00074130401
HYDROMORPHON INJ 4MG/ML
4
$46.12
0.01%
1
$29.42
0.00%
00074130431
0
$0.00
0.00%
5
$103.84
0.01%
00074131202
2
$11.00
0.00%
0
$0.00
0.00%
00074131230
0
$0.00
0.00%
1
$14.88
0.00%
00074194914
VICODIN
1
$15.97
0.00%
3
$94.00
0.00%
TAB 5-325MG
TAB 5-500MG
TAB 5-500MG
Page 388 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
VICODIN ES TAB 7.5-750
00074227454
VICODIN HP TAB 10-660
00074227714
VICOPROFEN TAB
00074227754
VICOPROFEN TAB
00074241514
DILAUDID
00074241614
00074242614
$
Market Share*
00074197314
# of Scripts
$0.00
0.00%
$9.46
0.00%
1
$52.06
0.00%
771
$34,678.54
1.21%
0
$0.00
0.00%
36
$1,792.57
0.04%
57
$2,904.03
0.09%
0
$0.00
0.00%
TAB 2MG
4
$64.92
0.01%
4
$75.07
0.00%
DILAUDID
TAB 4MG
0
DILAUDID
TAB 8 MG
0
$0.00
0.00%
1
$21.87
0.00%
$0.00
0.00%
1
$110.48
0.00%
00074245107
DILAUDID
SUP 3MG
0
$0.00
0.00%
1
$86.80
0.00%
00074245202
DILAUDID-5 LIQ 1MG/ML
0
$0.00
0.00%
6
$68.75
0.01%
00074245351
DILAUDID-HP INJ 10MG/ML
0
$0.00
0.00%
4
$3,457.63
0.00%
00074245531
DILAUDID-HP INJ 250MG
0
$0.00
0.00%
1
$710.67
0.00%
00074246024
ACTIQ
LOZ 200MCG
1
$211.85
0.00%
0
$0.00
0.00%
00074246224
ACTIQ
LOZ 600MCG
3
$490.43
0.00%
0
$0.00
0.00%
00074909461
FENTANYL CIT INJ .05MG/ML
1
$329.95
0.00%
0
$0.00
0.00%
00078010705
FIORINAL/COD CAP 30MG
3
$274.86
0.00%
1
$25.00
0.00%
00078024305
FIORICET/COD CAP
29
$2,022.81
0.05%
6
$513.53
0.01%
00086004616
CAPITAL/COD SUS 120-12/5
3
$38.33
0.00%
0
$0.00
0.00%
00093005001
APAP/CODEINE TAB 300-15MG
45
$375.81
0.07%
30
$205.50
0.03%
00093005010
7
$43.07
0.01%
0
$0.00
0.00%
00093015001
171
$1,433.15
0.27%
120
$994.65
0.14%
00093015010
2,426
$20,524.73
3.82%
1,425
$10,488.67
1.65%
00093035001
100
$2,486.87
0.16%
50
$1,031.73
0.06%
00093035005
18
$366.86
0.03%
4
$169.48
0.00%
00093035010
4
$71.26
0.01%
0
$0.00
0.00%
00093049001
PROPO-N/APAP TAB 100-650
28
$359.49
0.04%
55
$623.48
0.06%
00093049005
535
$6,918.75
0.84%
578
$6,304.09
0.67%
00093068601
PROPOXYPHENE CAP CPD 65
1
$6.90
0.00%
0
$0.00
0.00%
0
1
Page 389 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
00093074101
00093074105
$
Market Share*
00093068605
# of Scripts
1
$19.87
0.00%
0
$0.00
0.00%
PROPOXY HCL CAP 65MG
52
$1,053.44
0.08%
45
$1,021.07
0.05%
59
$1,143.01
0.09%
10
$391.74
0.01%
00093074110
0
$0.00
0.00%
5
$268.11
0.01%
00093089001
11
$122.00
0.02%
1
$3.40
0.00%
00093089005
1,143
$14,434.21
1.80%
1,225
$14,069.49
1.42%
00093516101
HYDROCOD/IBU TAB 7.5-200
0
$0.00
0.00%
271
$8,797.72
0.31%
00121050416
1
$1.68
0.00%
42
$231.14
0.05%
00121065504
HYDROCODONE/ ELX APAP
0
$0.00
0.00%
1
$15.52
0.00%
00143300001
BUT/APAP/CAF CAP CODEINE
91
$5,495.15
0.14%
49
$2,163.31
0.06%
00172218660
84
$1,845.04
0.13%
102
$2,334.68
0.12%
00172398460
ASA/CODEINE TAB 325-30MG
4
$15.48
0.01%
2
$6.24
0.00%
00172498060
2
$14.35
0.00%
0
$0.00
0.00%
00172498070
551
$6,050.33
0.87%
854
$7,574.07
0.99%
00172498080
228
$3,143.98
0.36%
632
$7,087.51
0.73%
00172564360
HYDROCO/APAP TAB 5-500MG
15
$72.58
0.02%
0
$0.00
0.00%
00172564370
7
$46.60
0.01%
9
$29.30
0.01%
00182068101
HYDROCO/APAP TAB 7.5-750
1
$6.30
0.00%
0
$0.00
0.00%
00182068105
1
$9.25
0.00%
0
$0.00
0.00%
00182094810
16
$152.68
0.03%
0
$0.00
0.00%
00182107840
1
$4.07
0.00%
1
$4.15
0.00%
00185047401
0
$0.00
0.00%
1
$4.78
0.00%
00228208510
2
$12.50
0.00%
0
$0.00
0.00%
00228208550
47
$667.29
0.07%
17
$202.90
0.02%
00228302010
14
$109.76
0.02%
0
$0.00
0.00%
00228302096
24
$89.96
0.04%
7
$104.11
0.01%
00228302110
3
$62.29
0.00%
0
$0.00
0.00%
Page 390 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00228305696
24
$217.68
0.04%
16
$90.82
0.02%
00228305811
9
$134.66
0.01%
0
$0.00
0.00%
00254359728
3
$41.75
0.00%
0
$0.00
0.00%
00254359735
2
$31.70
0.00%
0
$0.00
0.00%
00254359828
HYDROCO/APAP TAB 10/660MG
1
$18.20
0.00%
0
$0.00
0.00%
00254360128
11
$418.85
0.02%
2
$2.00
0.00%
00254360135
3
$154.27
0.00%
0
$0.00
0.00%
00254511335
18
$300.50
0.03%
17
$176.82
0.02%
00254511435
12
$121.06
0.02%
0
$0.00
0.00%
00258362205
3
$44.85
0.00%
0
$0.00
0.00%
00258365805
34
$388.70
0.05%
7
$70.70
0.01%
00378012901
87
$1,694.03
0.14%
22
$431.37
0.03%
00378012905
68
$1,243.52
0.11%
21
$547.68
0.02%
00378013001
PROPOXY/APAP TAB 65-650MG
37
$347.37
0.06%
27
$268.99
0.03%
00378013005
13
$157.10
0.02%
16
$172.71
0.02%
00378013101
12
$317.91
0.02%
0
$0.00
0.00%
00378015501
71
$856.49
0.11%
10
$221.12
0.01%
00378015505
2,544
$32,453.23
4.01%
2,668
$31,450.25
3.10%
00378115505
84
$1,097.70
0.13%
26
$251.73
0.03%
00406035701
66
$325.06
0.10%
188
$793.91
0.22%
00406035705
10,507
$55,362.45
16.55%
22,200
$87,667.34
25.76%
00406035801
603
$6,095.50
0.95%
1,385
$12,624.22
1.61%
00406035805
276
$2,822.76
0.43%
924
$8,878.31
1.07%
00406035862
0
$0.00
0.00%
1
$2.30
0.00%
00406035901
34
$218.80
0.05%
102
$592.26
0.12%
00406035905
24
$126.38
0.04%
13
$75.63
0.02%
00406036001
323
$2,697.85
0.51%
632
$4,643.17
0.73%
Page 391 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
00406036101
00406036105
$
Market Share*
00406036005
# of Scripts
2,007
$16,517.93
3.16%
3,449
$23,210.85
4.00%
678
$7,944.34
1.07%
1,034
$11,962.34
1.20%
175
$2,235.66
0.28%
414
$5,309.25
0.48%
00406036201
235
$8,727.72
0.37%
468
$9,669.14
0.54%
00406036301
494
$13,634.42
0.78%
870
$14,904.49
1.01%
00406036305
103
$3,492.94
0.16%
143
$2,652.03
0.17%
00406036501
0
$0.00
0.00%
180
$4,086.66
0.21%
00406036601
0
$0.00
0.00%
95
$4,453.69
0.11%
00406036701
250
$13,433.49
0.39%
762
$19,768.11
0.88%
00406036705
25
$1,687.13
0.04%
81
$2,222.45
0.09%
00406036762
0
$0.00
0.00%
2
$30.82
0.00%
00406037516
HYDROCODONE/ SOL APAP
89
$1,853.07
0.14%
189
$5,149.56
0.22%
00406048301
5
$37.25
0.01%
32
$216.60
0.04%
00406048401
18
$172.45
0.03%
44
$294.88
0.05%
00406048410
1,630
$13,993.53
2.57%
2,696
$19,784.28
3.13%
00406048501
40
$782.68
0.06%
91
$1,510.73
0.11%
00406048505
14
$272.91
0.02%
1
$4.22
0.00%
00406051201
OXYCOD/APAP TAB 5-325MG
1,238
$10,916.84
1.95%
1,919
$12,732.10
2.23%
00406051205
125
$1,025.18
0.20%
449
$3,536.51
0.52%
00406051262
0
$0.00
0.00%
4
$17.15
0.00%
00406053201
716
$9,182.15
1.13%
781
$8,608.06
0.91%
00406053205
21
$246.29
0.03%
27
$233.73
0.03%
00406055201
OXYCODONE
TAB 5MG
2,197
$61,535.86
3.46%
4,786
$109,158.55
5.55%
00406055262
OXYCODONE
TAB 5MG
0
$0.00
0.00%
10
$174.82
0.01%
00406055401
OXYCODONE
CAP 5MG
33
$1,058.67
0.05%
85
$2,037.60
0.10%
00406172101
0
$0.00
0.00%
1
$21.25
0.00%
00406172105
162
$1,694.65
0.26%
207
$2,127.10
0.24%
Page 392 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00406177201
2
$17.95
0.00%
0
$0.00
0.00%
00406177205
2,860
$35,804.37
4.51%
3,395
$37,790.65
3.94%
00406177210
0
$0.00
0.00%
9
$83.07
0.01%
00406177260
0
$0.00
0.00%
1
$23.60
0.00%
00406324301
147
$2,905.74
0.23%
219
$4,423.36
0.25%
00406324401
96
$8,857.29
0.15%
167
$13,624.65
0.19%
00406435701
HYDROCO/APAP CAP 5-500MG
5
$70.05
0.01%
9
$103.29
0.01%
00406711301
MEPERIDINE TAB 50MG
13
$326.76
0.02%
35
$711.94
0.04%
00406711501
MEPERIDINE TAB 100MG
2
$25.20
0.00%
9
$233.56
0.01%
00406855550
OXYCODONE
SOL 5MG/5ML
24
$1,060.18
0.04%
36
$1,586.05
0.04%
00406855830
OXYCODONE
CON 20MG/ML
4
$134.85
0.01%
63
$2,085.40
0.07%
00472141904
3
$14.85
0.00%
4
$22.10
0.00%
00472141916
222
$1,166.83
0.35%
443
$2,281.68
0.51%
00527131201
ASA/CAFF/BUT CAP COD 30MG
73
$3,755.72
0.12%
113
$6,398.10
0.13%
00555030302
13
$172.99
0.02%
9
$106.35
0.01%
00555030305
3
$32.05
0.00%
140
$1,214.31
0.16%
00555030402
0
$0.00
0.00%
1
$14.91
0.00%
00555038102
MEPERIDINE TAB 50MG
173
$4,008.87
0.27%
164
$3,683.96
0.19%
00555038202
58
$1,173.78
0.09%
35
$1,946.31
0.04%
00555065802
346
$4,983.84
0.55%
569
$6,232.57
0.66%
00555073602
2
$10.07
0.00%
0
$0.00
0.00%
00555089602
7
$89.26
0.01%
1
$22.41
0.00%
00574711012
25
$379.69
0.04%
29
$464.20
0.03%
00574711612
0
$0.00
0.00%
1
$52.70
0.00%
00574722406
HYDROMORPHON SUP 3MG
4
$326.54
0.01%
17
$793.55
0.02%
00591034901
560
$2,761.43
0.88%
235
$972.19
0.27%
00591034905
5,167
$28,249.41
8.14%
2,911
$12,962.45
3.38%
Page 393 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00591038501
256
$2,792.31
0.40%
00591038505
200
$2,051.49
0.32%
00591038701
469
$3,736.84
0.74%
00591038705
706
$5,682.93
1.11%
00591038801
133
$1,795.90
00591039501
PENTAZOCINE/ TAB NALOXONE
61
00591039601
PENTA/APAP TAB 25-650MG
3
00591042501
BUT/ASA/CAF/ CAP COD 30MG
00591050201
00591050205
00591050301
00591050305
00591054001
$1,590.02
0.16%
94
$954.97
0.11%
268
$1,674.60
0.31%
391
$2,911.70
0.45%
0.21%
149
$1,915.18
0.17%
$3,331.28
0.10%
74
$3,276.54
0.09%
$180.88
0.00%
6
$303.50
0.01%
53
$2,295.86
0.08%
70
$5,775.48
0.08%
53
$405.84
0.08%
55
$360.24
0.06%
55
$590.25
0.09%
17
$118.76
0.02%
241
$3,013.14
0.38%
161
$2,514.90
0.19%
338
$4,719.77
0.53%
330
$4,810.61
0.38%
196
$5,658.48
0.31%
102
$1,894.21
0.12%
00591054005
112
$4,465.44
0.18%
248
$5,009.08
0.29%
00591071401
1
$19.22
0.00%
0
$0.00
0.00%
00591072601
MEPERIDINE TAB 50MG
33
$883.26
0.05%
99
$3,132.85
0.11%
00591072701
14
$746.51
0.02%
15
$1,248.63
0.02%
00591073701
25
$188.13
0.04%
45
$467.47
0.05%
00591073705
22
$217.93
0.03%
1
$5.65
0.00%
00591074901
6
$42.75
0.01%
5
$20.72
0.01%
00591074905
8
$57.80
0.01%
5
$12.53
0.01%
00591082001
OXYCOD/ASA TAB
0
$0.00
0.00%
17
$298.28
0.02%
00591082401
OXYCO/APAP TAB 7.5-500M
293
$16,244.89
0.46%
116
$4,902.71
0.13%
00591082501
OXYCO/APAP TAB 10-650
156
$14,724.31
0.25%
56
$3,514.62
0.06%
00591085101
3
$55.05
0.00%
0
$0.00
0.00%
00591085301
31
$1,678.27
0.05%
107
$3,601.04
0.12%
00591085305
29
$1,537.02
0.05%
143
$3,845.77
0.17%
136
Page 394 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
OXYCOD-APAP TAB 7.5-325
00591322001
00603102058
00603233721
$
Market Share*
00591093301
# of Scripts
0
$0.00
0.00%
39
$2,912.03
0.05%
0
$0.00
0.00%
1
$65.67
0.00%
18
$100.36
0.03%
4
$22.04
0.00%
0
$0.00
0.00%
2
$12.10
0.00%
00603233832
50
$433.74
0.08%
3
$16.25
0.00%
00603236121
0
$0.00
0.00%
4
$10.54
0.00%
00603255221
2
$219.68
0.00%
0
$0.00
0.00%
00603255321
37
$2,003.22
0.06%
22
$1,280.11
0.03%
00603388021
0
$0.00
0.00%
1
$19.17
0.00%
00603388121
4
$19.73
0.01%
0
$0.00
0.00%
00603388128
39
$180.37
0.06%
200
$885.79
0.23%
00603388221
2
$15.56
0.00%
0
$0.00
0.00%
00603388228
8
$62.19
0.01%
0
$0.00
0.00%
00603388232
0
$0.00
0.00%
8
$77.70
0.01%
00603388321
30
$252.85
0.05%
40
$255.84
0.05%
00603388328
8
$45.03
0.01%
0
$0.00
0.00%
00603388428
0
$0.00
0.00%
6
$68.10
0.01%
00603388521
1
$10.75
0.00%
0
$0.00
0.00%
00603388528
0
$0.00
0.00%
4
$57.15
0.00%
00603388621
9
$288.91
0.01%
24
$489.75
0.03%
00603388721
97
$5,448.41
0.15%
34
$1,017.70
0.04%
00603388728
39
$1,870.05
0.06%
30
$811.60
0.03%
00603388732
0
$0.00
0.00%
1
$26.85
0.00%
00603388821
1
$7.65
0.00%
0
$0.00
0.00%
00603388828
0
$0.00
0.00%
3
$78.15
0.00%
00603388832
1
$18.35
0.00%
39
$631.45
0.05%
00603441521
MEPERITAB
0
$0.00
0.00%
7
$447.68
0.01%
TAB 50MG
Page 395 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00603499721
13
00603499821
00603499828
00603545921
$147.55
0.02%
11
$75.73
0.02%
54
$510.17
0.09%
115
$2,437.68
0.18%
00603545928
0
$0.00
00603546521
PROPO-N/APAP TAB 50/325
83
00603546621
4
00603546628
00603546632
$29.85
0.01%
0
$0.00
0.00%
63
$514.59
0.07%
267
$6,025.60
0.31%
0.00%
20
$680.63
0.02%
$1,445.07
0.13%
121
$1,863.25
0.14%
$26.35
0.01%
30
$261.41
0.03%
161
$1,868.38
0.25%
132
$1,482.05
0.15%
46
$564.87
0.07%
12
$147.22
0.01%
00603546728
24
$273.66
0.04%
25
$239.30
0.03%
00603546732
62
$686.09
0.10%
96
$1,153.39
0.11%
00603546821
85
$989.39
0.13%
23
$278.90
0.03%
00603546828
35
$348.71
0.06%
13
$138.30
0.02%
00603546832
20
$158.20
0.03%
88
$803.57
0.10%
00615040053
195
$1,049.39
0.31%
0
$0.00
0.00%
00615040063
254
$1,343.63
0.40%
23
$99.82
0.03%
00615043053
114
$902.29
0.18%
0
$0.00
0.00%
00615043063
30
$237.38
0.05%
0
$0.00
0.00%
00615045553
331
$3,004.22
0.52%
0
$0.00
0.00%
00615045563
264
$2,098.46
0.42%
0
$0.00
0.00%
00641012125
1
$21.40
0.00%
1
$10.09
0.00%
00641014025
MEPERIDINE INJ 50MG/ML
3
$26.65
0.00%
0
$0.00
0.00%
00641113035
MEPERIDINE INJ 50MG/ML
1
$8.29
0.00%
0
$0.00
0.00%
00641234141
1
$12.59
0.00%
0
$0.00
0.00%
00641240341
FENTANYL CIT INJ 2500MCG
5
$1,906.75
0.01%
0
$0.00
0.00%
00677064701
1
$3.87
0.00%
1
$1.87
0.00%
00677099633
0
$0.00
0.00%
2
$11.02
0.00%
5
Page 396 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00677118401
45
00677118405
00677171401
00781160601
$290.90
0.07%
0
$0.00
0.00%
0
$0.00
0.00%
8
$17.24
0.01%
1
$10.99
0.00%
0
$0.00
0.00%
7
$35.23
0.01%
0
$0.00
0.00%
00781222101
FIORTAL/COD CAP 30MG
2
$59.46
0.00%
0
$0.00
0.00%
00785112201
LORCET PLUS TAB 7.5-650
00785635001
LORCET
00904017580
3
$748.35
0.00%
3
$571.03
0.00%
11
$1,001.83
0.02%
2
$183.92
0.00%
1
$6.85
0.00%
0
$0.00
0.00%
00904344040
26
$133.93
0.04%
0
$0.00
0.00%
00904515860
1
$3.90
0.00%
0
$0.00
0.00%
00904528840
4
$30.40
0.01%
0
$0.00
0.00%
00904528860
1
$7.35
0.00%
0
$0.00
0.00%
00904763160
3
$47.65
0.00%
7
$100.53
0.01%
00904770240
90
$905.29
0.14%
42
$358.63
0.05%
00904770280
2
$18.30
0.00%
7
$56.95
0.01%
00904770340
1
$19.35
0.00%
0
$0.00
0.00%
00904777516
1
$7.19
0.00%
0
$0.00
0.00%
12496127802
SUBUTEX
0
$0.00
0.00%
24
$2,414.37
0.03%
12496128302
SUBOXONE
SUB 2MG
0
$0.00
0.00%
487
$47,729.74
0.57%
12496130602
SUBOXONE
SUB 8MG
0
$0.00
0.00%
516
$69,601.72
0.60%
12496131002
SUBUTEX
SUB 8MG
0
$0.00
0.00%
18
$2,247.39
0.02%
50474090201
LORTAB 5
TAB
1
$23.57
0.00%
5
$111.17
0.01%
50474090701
LORTAB 7.5 TAB
3
$296.34
0.00%
0
$0.00
0.00%
50474090916
LORTAB
0
$0.00
0.00%
2
$106.39
0.00%
50474091001
LORTAB 10
TAB
4
$494.84
0.01%
0
$0.00
0.00%
50474092501
LORTAB 2.5 TAB
0
$0.00
0.00%
1
$12.76
0.00%
51079093420
9
$61.43
0.01%
9
$80.30
0.01%
TAB 10/650
SUB 2MG
SOL
Page 397 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
51285030302
51285030305
51285030402
51285065802
51285068404
51991007401
ASCOMP
52152004102
52152016502
OXYCODONE
TAB 5MG
52152016511
OXYCODONE
52152018702
OXYCODONE
52152021102
52152021302
PENTA/APAP TAB 25-650MG
52544034901
52544034905
52544038501
52544038505
$
Market Share*
51285030202
# of Scripts
3
$53.70
0.00%
0
$0.00
0.00%
11
$78.64
0.02%
110
$1,047.19
0.17%
15
$90.79
0.02%
71
$484.34
0.08%
0
$0.00
0.00%
7
$45.30
0.01%
192
$2,840.37
0.30%
58
$813.91
0.07%
2
$172.96
0.00%
0
$0.00
0.00%
103
$4,698.66
0.16%
33
$1,436.44
0.04%
0
$0.00
0.00%
3
$63.03
0.00%
16
$340.21
0.03%
87
$2,939.66
0.10%
TAB 5MG
4
$117.35
0.01%
1
$53.65
0.00%
CAP 5MG
11
$355.46
0.02%
14
$644.30
0.02%
19
$1,122.76
0.03%
21
$837.00
0.02%
0
$0.00
0.00%
1
$41.40
0.00%
68
$347.58
0.11%
2
$8.38
0.00%
538
$2,823.68
0.85%
89
$427.66
0.10%
126
$1,303.35
0.20%
38
$455.44
0.04%
13
$124.82
0.02%
2
$21.31
0.00%
52544038701
79
$655.85
0.12%
26
$184.95
0.03%
52544038705
40
$327.10
0.06%
8
$52.89
0.01%
52544038801
8
$70.06
0.01%
2
$23.06
0.00%
52544039501
10
$347.11
0.02%
0
$0.00
0.00%
52544042501
5
$207.35
0.01%
0
$0.00
0.00%
52544042505
3
$140.25
0.00%
0
$0.00
0.00%
52544050201
13
$128.19
0.02%
18
$128.18
0.02%
52544050301
83
$1,212.50
0.13%
11
$121.95
0.01%
52544050305
2
$17.20
0.00%
1
$11.75
0.00%
52544053901
NORCO
7
$635.97
0.01%
0
$0.00
0.00%
CAP COD 30MG
TAB 10-325MG
Page 398 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
52544054001
13
$359.30
0.02%
0
$0.00
0.00%
52544063401
MAXIDONE
18
$740.69
0.03%
0
$0.00
0.00%
52544072601
MEPERIDINE TAB 50MG
1
$15.78
0.00%
0
$0.00
0.00%
52544072901
NORCO
14
$633.62
0.02%
3
$364.06
0.00%
52544073701
2
$38.75
0.00%
0
$0.00
0.00%
52544077401
OXYCODONE
3
$70.29
0.00%
0
$0.00
0.00%
52544082401
OXYCO/APAP TAB 7.5-500M
29
$1,492.95
0.05%
2
$20.46
0.00%
52544082501
OXYCO/APAP TAB 10-650
41
$2,842.02
0.06%
1
$50.51
0.00%
52544085110
5
$55.15
0.01%
1
$12.95
0.00%
52544085201
0
$0.00
0.00%
20
$316.92
0.02%
52544085301
8
$329.05
0.01%
0
$0.00
0.00%
52544085305
15
$775.35
0.02%
0
$0.00
0.00%
52544091301
NORCO
50
$1,704.29
0.08%
10
$247.26
0.01%
53265025611
983
$13,023.57
1.55%
1,340
$16,548.94
1.55%
53265025650
250
$3,299.94
0.39%
206
$2,671.96
0.24%
53265026110
0
$0.00
0.00%
3
$42.35
0.00%
53265026111
2
$17.25
0.00%
7
$64.50
0.01%
53265026150
13
$201.00
0.02%
47
$551.24
0.05%
53265028511
17
$123.72
0.03%
45
$416.44
0.05%
53265028550
0
$0.00
0.00%
20
$153.34
0.02%
53265028650
0
$0.00
0.00%
4
$59.64
0.00%
53265032810
0
$0.00
0.00%
11
$247.25
0.01%
53265032850
0
$0.00
0.00%
16
$495.34
0.02%
53265032950
0
$0.00
0.00%
229
$923.85
0.27%
53265033350
0
$0.00
0.00%
2
$35.04
0.00%
53265033450
0
$0.00
0.00%
62
$499.18
0.07%
53265033510
0
$0.00
0.00%
40
$1,451.60
0.05%
TAB
TAB 7.5-325
TAB 5MG
TAB 5-325MG
Page 399 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
53265034510
0
$0.00
0.00%
111
$2,762.68
0.13%
53265034550
0
$0.00
0.00%
15
$357.37
0.02%
54569549600
SUBOXONE
0
$0.00
0.00%
3
$443.17
0.00%
58177004104
OXYCODONE
204
$7,021.40
0.32%
256
$6,811.13
0.30%
58177029804
0
$0.00
0.00%
4
$80.58
0.00%
58177029811
0
$0.00
0.00%
6
$124.74
0.01%
58177031304
27
$348.69
0.04%
33
$438.26
0.04%
58177031404
10
$182.00
0.02%
30
$506.35
0.03%
58177031504
OXYCODONE
TAB 5MG
198
$5,717.56
0.31%
725
$13,861.33
0.84%
58177031511
OXYCODONE
TAB 5MG
0
$0.00
0.00%
5
$115.65
0.01%
58177088601
MORPHINE SUL SOL 20MG/ML
20
$625.95
0.03%
125
$2,856.99
0.15%
58177088603
MORPHINE SUL SOL 20MG/ML
7
$439.33
0.01%
28
$2,174.84
0.03%
58177090907
HYDROCO/APAP ELX
83
$2,426.03
0.13%
85
$2,017.32
0.10%
58177091401
OXYDOSE
41
$2,001.34
0.06%
91
$4,972.58
0.11%
59011020110
OXYIR
70
$2,699.72
0.11%
12
$384.43
0.01%
59011022520
OXYFAST
CON 20MG/ML
58
$3,298.67
0.09%
26
$1,991.50
0.03%
60258072016
HYDROCODONE/ ELX APAP
2
$23.95
0.00%
1
$28.70
0.00%
60432024504
1
$5.27
0.00%
0
$0.00
0.00%
60432024516
634
$3,407.69
1.00%
587
$3,065.94
0.68%
60951060270
ENDOCET
TAB 5-325MG
3,252
$29,545.81
5.12%
5,538
$40,138.54
6.43%
60951060275
ENDOCET
TAB 5-325MG
0
$0.00
0.00%
6
$41.10
0.01%
60951060285
ENDOCET
TAB 5-325MG
2,197
$20,180.52
3.46%
3,145
$23,624.17
3.65%
60951061070
ENDODAN
TAB
63
$1,005.65
0.10%
64
$1,768.04
0.07%
60951061085
ENDODAN
TAB
1
$9.85
0.00%
0
$0.00
0.00%
60951067570
1
$170.99
0.00%
12
$866.54
0.01%
60951075270
0
$0.00
0.00%
13
$278.48
0.02%
60951075770
16
$1,471.37
0.03%
14
$813.77
0.02%
SUB 2MG
CAP 5MG
CON 20MG/ML
CAP 5MG
Page 400 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
60951079670
ENDOCET
TAB 7.5-500M
419
$20,651.91
0.66%
184
60951079770
ENDOCET
TAB 10-650MG
409
$29,817.24
0.64%
61703024350
0
$0.00
0.00%
62022056301
ANEXSIA
12
$419.67
62037052210
0
63304050601
63304056101
63304056105
$8,376.94
0.21%
87
$6,107.68
0.10%
12
$12,796.61
0.01%
0.02%
0
$0.00
0.00%
$0.00
0.00%
53
$407.54
0.06%
4
$99.03
0.01%
0
$0.00
0.00%
0
$0.00
0.00%
24
$455.31
0.03%
21
$414.70
0.03%
16
$599.93
0.02%
63304056201
1
$7.65
0.00%
36
$212.01
0.04%
63304056205
29
$190.66
0.05%
4
$18.70
0.00%
63304056210
420
$3,647.45
0.66%
1,357
$9,487.75
1.57%
63304070601
34
$1,255.65
0.05%
21
$831.03
0.02%
63304070801
4
$159.15
0.01%
4
$163.64
0.00%
63304074801
CODEINE PHOS TAB SOL 30MG
0
$0.00
0.00%
1
$20.46
0.00%
63459030224
ACTIQ
LOZ 200MCG
2
$156.65
0.00%
0
$0.00
0.00%
63459030424
ACTIQ
LOZ 400MCG
2
$786.96
0.00%
0
$0.00
0.00%
63459050230
ACTIQ
LOZ 200MCG
0
$0.00
0.00%
5
$916.31
0.01%
63459050430
ACTIQ
LOZ 400MCG
0
$0.00
0.00%
1
$108.64
0.00%
63459051630
ACTIQ
LOZ 1600MCG
0
$0.00
0.00%
7
$8,177.09
0.01%
63481013570
PERCODAN
TAB
3
$1,132.14
0.00%
2
$100.66
0.00%
63481062170
PERCOCET
TAB 7.5-500
6
$967.89
0.01%
0
$0.00
0.00%
63481062270
PERCOCET
TAB 10-650MG
7
$544.91
0.01%
3
$491.23
0.00%
63481062370
PERCOCET
TAB 5-325MG
23
$2,285.24
0.04%
19
$2,818.77
0.02%
63481062770
PERCOCET
TAB 2.5-325
79
$1,713.14
0.12%
26
$542.94
0.03%
63481062870
PERCOCET
TAB 7.5-325M
142
$11,097.19
0.22%
113
$8,100.56
0.13%
63481062970
PERCOCET
TAB 10-325MG
243
$28,902.73
0.38%
126
$12,631.67
0.15%
63481066870
ZYDONE
111
$3,247.39
0.17%
13
$384.65
0.02%
TAB 5-325MG
TAB 5-400MG
Page 401 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
63481066970
ZYDONE
TAB 7.5-400
108
$3,603.72
0.17%
12
$413.01
0.01%
63481069870
ZYDONE
TAB 10-400MG
120
$7,865.53
0.19%
10
$662.69
0.01%
63739014115
0
$0.00
0.00%
1
$17.22
0.00%
64248041910
SYNALGOS DC CAP
9
$1,752.82
0.01%
7
$119.53
0.01%
65234004616
CAPITAL/COD SUS 120-12/5
16
$271.33
0.03%
1
$6.54
0.00%
65234006110
PHRENILIN/ CAP CAFF/COD
17
$929.98
0.03%
3
$124.57
0.00%
$99.00
0.03%
0
$0.00
0.00%
MONOPHASIC COMBINATION O/CS
00008005601
OVRAL
TAB -21
2
00008007501
NORDETTE-21 TAB
0
$0.00
0.00%
2
$71.18
0.02%
00008007801
LO/OVRAL
1
$34.70
0.01%
18
$669.12
0.16%
00008251101
OVRAL
TAB -28
0
$0.00
0.00%
4
$166.86
0.04%
00008251102
OVRAL
TAB -28
28
$1,181.63
0.35%
17
$874.46
0.15%
00008251401
LO/OVRAL
TAB -28
0
$0.00
0.00%
9
$319.05
0.08%
00008251402
LO/OVRAL
TAB -28
127
$3,662.98
1.61%
1,447
$50,867.68
12.96%
00008253301
NORDETTE-28 TAB
0
$0.00
0.00%
1
$35.75
0.01%
00008253302
NORDETTE-28 TAB
28
$830.34
0.35%
9
$296.00
0.08%
00008257601
ALESSE
TAB -28
1
$29.39
0.01%
15
$530.40
0.13%
00008257602
ALESSE
TAB -28
208
$7,035.22
2.63%
1,622
$57,171.70
14.52%
00025008109
DEMULEN
TAB 1/50-28
11
$349.99
0.14%
45
$1,603.35
0.40%
00025015107
DEMULEN
TAB 1/35-21
6
$190.28
0.08%
0
$0.00
0.00%
00025016109
DEMULEN
TAB 1/35-28
37
$1,117.86
0.47%
240
$7,751.77
2.15%
00025016124
DEMULEN
TAB 1/35-28
1
$27.74
0.01%
9
$277.91
0.08%
00052026106
DESOGEN-28 TAB
96
$2,854.08
1.21%
773
$24,479.96
6.92%
00052028106
MIRCETTE
196
$6,369.94
2.48%
83
$2,884.88
0.74%
00062133215
12
$418.60
0.15%
114
$4,380.26
1.02%
00062133220
0
$0.00
0.00%
6
$237.72
0.05%
TAB -21
TAB 28
Page 402 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
MODICON
TAB .5/35-28
00062176115
00062176120
00062179615
ORTHO-CEPT TAB 28
00062190115
ORTHO-CYCLEN TAB 0.25/35
00071091345
LOESTRIN FE TAB 1/20
00071091348
LOESTRIN FE TAB 1/20
00071091548
LOESTRIN
TAB 1/20-21
00071091647
$
Market Share*
00062171415
# of Scripts
4
$136.26
0.05%
47
$1,980.10
0.42%
51
$1,592.83
0.64%
1,228
$48,526.36
10.99%
0
$0.00
0.00%
11
$255.86
0.10%
75
$2,467.49
0.95%
527
$20,305.71
4.72%
705
$23,736.55
8.91%
1,368
$53,873.83
12.25%
0
$0.00
0.00%
4
$138.12
0.04%
67
$1,961.74
0.85%
364
$12,223.34
3.26%
44
$1,436.08
0.56%
19
$623.62
0.17%
LOESTRIN 21 TAB 1.5/30
4
$121.80
0.05%
0
$0.00
0.00%
00071091648
LOESTRIN 21 TAB 1.5/30
25
$838.39
0.32%
8
$277.06
0.07%
00071091745
LOESTRIN FE TAB 1.5/30
3
$87.44
0.04%
3
$104.49
0.03%
00071091747
2
$60.64
0.03%
0
$0.00
0.00%
00071091748
42
$1,230.08
0.53%
365
$12,490.22
3.27%
00087057841
OVCON-35 28 TAB
6
$185.33
0.08%
1
$30.87
0.01%
00430058214
OVCON-35 28 TAB
207
$6,654.06
2.62%
367
$12,810.08
3.29%
00430058514
OVCON 50
39
$1,379.58
0.49%
85
$3,316.32
0.76%
00555900858
NORTREL 28 TAB 0.5/35MC
3
$71.85
0.04%
11
$249.37
0.10%
00555901058
NORTREL (28) TAB 1/35
71
$2,147.50
0.90%
60
$1,422.55
0.54%
00555901458
LESSINA-28 TAB
28
$833.80
0.35%
9
$227.97
0.08%
00555901658
SPRINTEC 28 TAB 28 DAY
425
$12,844.51
5.37%
94
$1,936.07
0.84%
00555902058
PORTIA-28
TAB
2
$50.94
0.03%
21
$471.47
0.19%
00555902658
JUNEL FE
TAB 1/20
0
$0.00
0.00%
10
$273.98
0.09%
00555902858
JUNEL FE
00555904358
APRI
00555904558
AVIANE
00555904958
CRYSELLE-28 TAB 28 TABS
00555905058
KARIVA
TAB 28
TAB 1.5-30
TAB
TAB
TAB 28 DAY
0
$0.00
0.00%
2
$20.00
0.02%
176
$4,345.66
2.22%
180
$3,608.41
1.61%
324
$9,974.42
4.10%
200
$5,115.77
1.79%
0
$0.00
0.00%
48
$781.60
0.43%
570
$15,678.06
7.21%
201
$5,290.04
1.80%
Page 403 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
LEVORA-28
TAB 0.15/30
50419040203
YASMIN 28
50419040803
LEVLITE
50419041128
LEVLEN-28
51285001728
AVIANE
51285054628
CRYSELLE-28 TAB 28 TABS
51285057628
APRI
52544025428
BREVICON
52544025928
TAB 3-0.03MG
$
Market Share*
00905027928
# of Scripts
3
$62.91
0.04%
0
$0.00
0.00%
359
$10,869.83
4.54%
631
$20,591.09
5.65%
TAB -28
17
$563.90
0.21%
3
$102.93
0.03%
TAB
38
$1,039.39
0.48%
238
$7,869.84
2.13%
426
$12,795.91
5.38%
6
$174.90
0.05%
TAB
13
$362.41
0.16%
2
$50.94
0.02%
589
$14,532.41
7.45%
10
$195.92
0.09%
TAB 0.5/35
13
$400.27
0.16%
5
$188.50
0.04%
NORINYL
TAB 1+35-28
6
$226.18
0.08%
3
$109.05
0.03%
52544026528
NORINYL
TAB 1+50-28
2
$54.86
0.03%
0
$0.00
0.00%
52544027721
LEVORA-21
TAB 0.15/30
1
$19.94
0.01%
0
$0.00
0.00%
52544027928
LEVORA-28
TAB 0.15/30
218
$5,925.36
2.76%
58
$1,262.53
0.52%
52544038328
ZOVIA 1/35E TAB
219
$5,707.53
2.77%
46
$1,152.53
0.41%
52544038428
ZOVIA 1/50E TAB
18
$590.65
0.23%
12
$356.99
0.11%
52544050821
NECON
TAB 1/35-21
2
$75.31
0.03%
0
$0.00
0.00%
52544051021
NECON
TAB 1/50-21
8
$171.28
0.10%
0
$0.00
0.00%
52544052628
MONONESSA TAB
0
$0.00
0.00%
38
$1,132.76
0.34%
52544055028
NECON
TAB .5/35-28
24
$671.29
0.30%
6
$179.42
0.05%
52544055228
NECON
TAB 1/35-28
771
$24,169.52
9.75%
156
$4,346.42
1.40%
52544055628
NECON
TAB 1/50-28
93
$2,846.37
1.18%
31
$676.00
0.28%
52544063028
MICROGESTIN TAB FE 1/20
201
$6,181.79
2.54%
41
$989.03
0.37%
52544063128
MICROGESTIN TAB 1.5/30
253
$7,316.49
3.20%
45
$1,060.10
0.40%
52544084728
LOW-OGESTREL TAB
976
$27,748.85
12.34%
158
$3,332.40
1.41%
52544084828
OGESTREL
34
$1,775.16
0.43%
27
$1,074.35
0.24%
52544095021
MICROGESTIN TAB 1/20
0
$0.00
0.00%
6
$131.13
0.05%
TAB
TAB
MOUTH ANTI-FECTIVES
Page 404 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MOUTH ANTI-FECTIVES
00003054320
MYCOSTATIN LOZ 200000U
00005542918
NILSTAT
00054350049
LIDOCAINE
SOL 2% VISC
00364207516
NYSTATIN
SUS 100000U
00472099633
LIDOCAINE
00472132002
00472132016
$544.18
0.94%
$226.20
0.28%
1
$7.95
0.07%
30
$177.20
2.18%
0
$0.00
0.00%
26
$131.59
1.45%
0
$0.00
0.00%
1
$13.60
0.06%
SOL 2% VISC
21
$128.99
1.53%
2
$15.04
0.11%
NYSTATIN
SUS 100000U
101
NYSTATIN
SUS 100000U
115
$1,028.35
7.34%
89
$1,340.05
4.97%
$2,502.50
8.36%
93
$2,904.66
5.19%
00603139264
LIDOCAINE
SOL 2% VISC
4
$23.02
0.29%
0
$0.00
0.00%
00603148058
NYSTATIN
SUS 100000U
6
$78.15
0.44%
2
$36.84
0.11%
00677083625
00677083633
NYSTATIN
SUS 100000U
2
$21.34
0.15%
2
$61.44
0.11%
NYSTATIN
SUS 100000U
5
$82.60
0.36%
10
$317.50
0.56%
00677101527
LIDOCAINE
SOL 2% VISC
6
$61.35
0.44%
3
$18.76
0.17%
00781610561
NYSTATIN
SUS 100000U
4
$69.20
0.29%
1
$22.25
0.06%
00781619046
LIDOCAINE
SOL 2% VISC
9
$55.78
0.65%
0
$0.00
0.00%
00904086304
LIDOCAINE
SOL 2% VISC
1
$5.63
0.07%
1
$8.35
0.06%
00904276116
NYSTATIN
SUS 100000U
2
$98.24
0.15%
3
$83.00
0.17%
17314940001
MYCELEX
TRO 10MG
138
$9,230.02
10.03%
87
$5,995.11
4.85%
17314940002
MYCELEX
TRO 10MG
1
$27.96
0.07%
4
$321.57
0.22%
17314940003
MYCELEX
TRO 10MG
14
$1,226.28
1.02%
19
$2,066.73
1.06%
24208041329
NYSTATIN
SUS 100000U
1
$11.85
0.07%
0
$0.00
0.00%
50383077504
LIDOCAINE
SOL 2% VISC
48
$304.43
3.49%
131
$686.63
7.31%
60432046400
LIDOCAINE
SOL 2% VISC
155
$1,152.24
11.26%
173
$1,154.93
9.65%
60432053716
NYSTATIN
SUS 100000U
532
$10,632.51
38.66%
877
$25,707.06
48.94%
60432053760
NYSTATIN
SUS 100000U
167
$1,691.13
12.14%
263
$3,845.83
14.68%
269
$2,519.85
48.47%
302
$2,359.34
36.25%
SUS 100000U
13
5
MOUTH ANTISEPTICS
00093001416
CHLORHEX GLU SOL 0.12%
Page 405 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
MOUTH ANTISEPTICS
00116200116
00126027116
PERIOGARD
SOL 0.12%
00186035003
XYLOCAINE
OIN 5% DENTL
00186036001
XYLOCAINE
00186036011
XYLOCAINE
$251.70
5.05%
113
$950.78
13.57%
1
$9.03
0.18%
3
$24.59
0.36%
1
$28.61
0.18%
0
$0.00
0.00%
SOL 2% VISC
3
$37.57
0.54%
1
$21.85
0.12%
SOL 2% VISC
0
$0.00
0.00%
1
$65.23
0.12%
00472003616
154
$1,309.34
27.75%
271
$2,215.67
32.53%
00591221826
TRIAM DENTAL PST 0.1%
1
$5.83
0.18%
0
$0.00
0.00%
00603787069
TRIAMCIN/ORA PST 0.1%
2
$14.98
0.36%
2
$14.98
0.24%
00677120036
1
$7.49
0.18%
1
$7.49
0.12%
00904364368
TRIA ORADENT PST 0.1%
1
$7.49
0.18%
0
$0.00
0.00%
00904514516
0
$0.00
0.00%
3
$24.75
0.36%
10158005901
APHTHASOL
10
$210.20
1.80%
6
$126.62
0.72%
51672126705
76
$594.26
13.69%
112
$776.51
13.45%
60505035500
8
$65.83
1.44%
18
$137.41
2.16%
11
$10,636.99
2.13%
1
$964.04
0.14%
PST 5%
28
MULTIPLE SCLEROSIS AGENTS
00088115003
COPAXONE
INJ 20MG
00088115330
COPAXONE
KIT 20MG/ML
158
$146,772.98
30.56%
221
$221,562.15
31.17%
44087002203
REBIF
INJ 22MCG/.5
6
$3,800.50
1.16%
11
$11,501.79
1.55%
44087004403
REBIF
INJ 44MCG/.5
18
$21,020.41
3.48%
53
$64,441.02
7.48%
50419052115
BETASERON INJ 0.3MG
25
$22,624.00
4.84%
1
$982.10
0.14%
50419052315
BETASERON INJ 0.3MG
59627000103
AVONEX
INJ 30MCG
59627000205
AVONEX
KIT
75
$70,377.98
14.51%
111
$117,499.70
15.66%
224
$194,144.40
43.33%
62
$58,140.78
8.74%
0
$0.00
0.00%
249
$241,798.40
35.12%
1
$61.74
1.10%
0
$0.00
0.00%
MUSCLE RELAXANT COMBINATIONS
00089023110
NORGESIC
TAB
Page 406 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
NORGESIC
TAB FORTE
00185071401
ORPHEN CPD TAB DS
00185072401
CARISOPR/ASA TAB 200-325
00185074901
CARISOPRODOL TAB ASA/COD
00378335401
ORPH/ASA/CAF TAB
00378335601
ORPH/ASA/CAF TAB
49884024601
49884047201
$
Market Share*
MUSCLE RELAXANT COMBINATIONS
00089023310
# of Scripts
0
$0.00
0.00%
2
$99.55
5.71%
8
$228.05
8.79%
3
$83.25
8.57%
20
$378.99
21.98%
10
$142.13
28.57%
18
$2,749.83
19.78%
2
$323.27
5.71%
2
$22.00
2.20%
0
$0.00
0.00%
5
$445.35
5.49%
4
$138.50
11.43%
21
$332.50
23.08%
7
$113.00
20.00%
ORPHENGESIC TAB
1
$55.35
1.10%
0
$0.00
0.00%
49884047301
ORPHENGESIC TAB FORTE
7
$505.60
7.69%
7
$380.70
20.00%
52152013702
6
$109.60
6.59%
0
$0.00
0.00%
62269026624
ORPH/ASA/CAF TAB DS
2
$53.70
2.20%
0
$0.00
0.00%
NARCOTIC ANTAGONISTS
00056001130
REVIA
TAB 50MG
9
$778.84
3.38%
2
$271.96
0.75%
00056001170
REVIA
TAB 50MG
4
$423.20
1.50%
1
$135.98
0.38%
00074121201
NALOXONE
0
$0.00
0.00%
2
$10.16
0.75%
00185003901
NALTREXONE TAB 50MG
0
$0.00
0.00%
3
$214.35
1.13%
00406117001
NALTREXONE TAB 50MG
39
$4,394.10
14.66%
18
$743.96
6.77%
00406117003
NALTREXONE TAB 50MG
20
$1,925.85
7.52%
20
$1,464.14
7.52%
00555090201
NALTREXONE TAB 50MG
173
$15,826.45
65.04%
118
$8,678.32
44.36%
00555090202
NALTREXONE TAB 50MG
21
$1,440.99
7.89%
83
$6,105.49
31.20%
52152010502
NALTREXONE TAB 50MG
0
$0.00
0.00%
10
$903.80
3.76%
52152010530
NALTREXONE TAB 50MG
0
$0.00
0.00%
9
$678.45
3.38%
00009770901
NASALCROM
AER 5.2/ACT
2
$31.56
0.39%
83
$923.01
16.47%
00009770902
NASALCROM
AER 5.2/ACT
1
$13.21
0.19%
43
$620.01
8.53%
INJ 0.4MG/ML
NASAL MISC.
Page 407 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NASAL MISC.
00024131501
NASAL
SPR 0.65%
00024131630
NASAL MOIST SPR 0.65%
00029152611
BACTROBAN
00037024110
ASTELIN NASA SPR 137MCG
00054004544
1
$5.08
0.19%
3
$9.16
0.60%
4
$15.56
0.78%
1
$1.89
0.20%
39
$2,315.72
7.59%
37
$2,092.31
7.34%
70
$3,663.52
13.62%
50
$2,533.32
9.92%
IPRATROPIUM SPR 0.03%
0
$0.00
0.00%
36
$1,549.71
7.14%
00054004641
0
$0.00
0.00%
35
$1,221.30
6.94%
00113031213
SALINE NASAL SPR 0.65%
0
$0.00
0.00%
1
$3.99
0.20%
00182613577
NASAL
2
$9.98
0.39%
7
$20.01
1.39%
00225038080
AYR
5
$29.01
0.97%
16
$77.07
3.17%
00225052547
AYR SALINE GEL NASAL
1
$5.68
0.19%
0
$0.00
0.00%
00225055050
BABY AYR
1
$5.38
0.19%
1
$3.86
0.20%
00256015201
OCEAN NASAL SPR 0.65%
1
$3.44
0.19%
1
$4.32
0.20%
00451450050
SALINEX
4
$30.60
0.78%
0
$0.00
0.00%
00536250676
SALINE MIST SPR 0.65%
2
$5.96
0.39%
1
$3.83
0.20%
00597008130
ATROVENT NAS SOL 0.03%
133
$5,845.41
25.88%
35
$1,814.19
6.94%
00597008676
ATROVENT NAS SOL 0.06%
119
$4,577.51
23.15%
22
$854.83
4.37%
00904386575
DEEP SEA
19
$99.29
3.70%
33
$129.51
6.55%
24208039830
0
$0.00
0.00%
6
$280.01
1.19%
24208039915
0
$0.00
0.00%
5
$197.80
0.99%
37205093013
63
$291.90
12.26%
24
$95.61
4.76%
37205093021
1
$5.78
0.19%
4
$17.67
0.79%
41250031213
0
$0.00
0.00%
1
$5.89
0.20%
45802031758
0
$0.00
0.00%
4
$12.30
0.79%
45802035758
SALINE MIST SPR 0.65%
37
$240.58
7.20%
22
$142.36
4.37%
49158020744
SEA MIST SPR SPR 0.65%
3
$7.49
0.58%
5
$7.75
0.99%
49348035625
NASAL SALINE SPR 0.65%
0
$0.00
0.00%
1
$0.70
0.20%
49502078530
0
$0.00
0.00%
4
$114.69
0.79%
OIN NASAL 2%
SPR 0.65%
SPR 0.65%
SPR 0.65%
SPR 0.4%
SPR 0.65%
Page 408 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NASAL MISC.
49502078615
0
$0.00
0.00%
9
50428006205
0
$0.00
0.00%
50486002701
NASAL MOIST SPR 0.65%
0
$0.00
0.00%
52735042528
NASAL SALINE SPR 0.65%
1
$3.72
60505082601
0
60505082701
64899054487
HCA SALINE SPR NASAL
65504013004
87701095182
$282.24
1.79%
1
$4.99
0.20%
3
$14.10
0.60%
0.19%
1
$4.00
0.20%
$0.00
0.00%
3
$101.19
0.60%
0
$0.00
0.00%
5
$182.09
0.99%
0
$0.00
0.00%
1
$3.49
0.20%
1
$5.01
0.19%
0
$0.00
0.00%
BL NASAL
4
$17.14
0.78%
0
$0.00
0.00%
333
$16,557.92
4.56%
14
$705.71
0.15%
775
$41,241.91
10.61%
605
$34,052.34
6.64%
SPR 0.65%
NASAL STEROIDS
00075150543
NASACORT
AER 55MCG/AC
00075150616
NASACORT AQ AER 55MCG/AC
00085064902
VANCENASE NA AER PKTHALER
00085119701
NASONEX
00173033602
BECONASE NA AER INHALER
00173038879
BECONASE AQ SPR 0.042%
00173045301
FLONASE
00173046800
BECONASE NA AER INHALER
00186107006
RHINOCORT
00186107008
RHINOCORT
00186107509
RHINOCORT
00451505015
TRI-NASAL
24208034425
FLUNISOLIDE SPR 0.025%
51479003725
NASAREL
51479003825
59310003725
1
$42.37
0.01%
0
$0.00
0.00%
1,316
$76,398.35
18.02%
2,080
$131,106.84
22.82%
69
$3,472.40
0.94%
1
$50.51
0.01%
262
$14,632.27
3.59%
182
$10,967.78
2.00%
3,352
$188,205.19
45.89%
5,571
$332,333.73
61.13%
3
$91.22
0.04%
0
$0.00
0.00%
SUS AQUA
5
$344.26
0.07%
1
$79.78
0.01%
SUS AQUA
886
$50,583.29
12.13%
631
$37,022.79
6.92%
AER 32MCG
259
$10,611.57
3.55%
0
$0.00
0.00%
1
$40.74
0.01%
0
$0.00
0.00%
14
$590.39
0.19%
20
$776.40
0.22%
SPR 29/.025%
4
$175.76
0.05%
0
$0.00
0.00%
NASALIDE
SPR 0.025%
21
$929.06
0.29%
0
$0.00
0.00%
NASAREL
SPR 29/.025%
4
$177.76
0.05%
9
$393.49
0.10%
SPR 50MCG/AC
SPR 0.05%
SPR
Page 409 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NICARDIPINES
00004018022
CARDENE SR CAP 30MG
15
$638.85
23.08%
1
$17.13
16.67%
00004018091
CARDENE SR CAP 30MG
3
$143.13
4.62%
0
$0.00
0.00%
00004018122
CARDENE SR CAP 45MG
3
$226.83
4.62%
0
$0.00
0.00%
00004018222
CARDENE SR CAP 60MG
0
$0.00
0.00%
1
$101.56
16.67%
00004018301
CARDENE
8
$393.44
12.31%
0
$0.00
0.00%
00093079301
NICARDIPINE CAP 20MG
5
$72.14
7.69%
1
$3.19
16.67%
00172428960
3
$88.25
4.62%
0
$0.00
0.00%
00378102005
3
$45.15
4.62%
0
$0.00
0.00%
00378102077
15
$402.72
23.08%
2
$25.10
33.33%
00378143077
4
$135.40
6.15%
0
$0.00
0.00%
49884049801
5
$103.40
7.69%
0
$0.00
0.00%
49884049805
1
$22.32
1.54%
1
$18.40
16.67%
CAP 20MG
NICOTINE PATCHES / TABLETS
00009519702
NICOTROL
DIS STEP 1
0
$0.00
0.00%
1
$24.20
0.02%
00009519707
NICOTROL
DIS STEP 1
0
$0.00
0.00%
1
$81.17
0.02%
00009527001
NICOTROL
DIS STEP 2
0
$0.00
0.00%
1
$83.67
0.02%
00067021307
NICOTINE
DIS 7MG
4
$139.32
0.10%
0
$0.00
0.00%
00067021407
NICOTINE
DIS 14MG
14
$991.89
0.34%
2
$117.09
0.05%
00067021414
NICOTINE
DIS 14MG
0
$0.00
0.00%
1
$31.96
0.02%
00067021507
NICOTINE
DIS 21MG
31
$1,932.43
0.75%
6
$328.71
0.15%
00067021514
NICOTINE
DIS 21MG
2
$65.11
0.05%
7
$433.21
0.17%
00173055601
ZYBAN
TAB 150MG SR
252
$23,725.08
6.10%
59
$5,975.48
1.47%
00173055602
ZYBAN
TAB 150MG SR
350
$33,716.21
8.48%
86
$8,767.50
2.15%
00364289030
NICOTINE TD DIS 7MG/24
382
$23,367.30
9.25%
41
$2,467.01
1.02%
00364289330
871
$60,938.15
21.10%
93
$6,650.77
2.32%
Page 410 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
00591289030
NICOTINE
00591290130
NICOTINE
00766142020
$
Market Share*
NICOTINE PATCHES / TABLETS
00364290130
# of Scripts
1,696
$135,579.13
41.09%
166
$11,483.00
4.14%
DIS 7MG/24HR
0
$0.00
0.00%
11
$1,224.12
0.27%
DIS 21MG/24
0
$0.00
0.00%
18
$2,207.92
0.45%
NICODERM CQ DIS 21MG/24H
41
$3,098.69
0.99%
364
$25,798.06
9.09%
00766142050
0
$0.00
0.00%
9
$587.03
0.22%
00766143020
39
$2,677.71
0.94%
346
$22,212.83
8.64%
00766144020
NICODERM CQ DIS 7MG/24HR
11
$691.19
0.27%
182
$11,164.10
4.54%
00766145010
NICODERM CQ DIS 21MG/24
34
$2,283.10
0.82%
154
$10,099.72
3.84%
00766145020
235
$16,372.19
5.69%
1,572
$110,265.68
39.24%
00766146010
38
$2,266.22
0.92%
129
$9,266.96
3.22%
00766146020
76
$5,054.73
1.84%
486
$31,146.92
12.13%
00766147010
20
$1,015.81
0.48%
85
$5,893.51
2.12%
00766147012
28
$1,666.02
0.68%
181
$11,518.61
4.52%
37205003774
NICOTINE TD DIS SYSTEM
4
$305.08
0.10%
0
$0.00
0.00%
37205035874
0
$0.00
0.00%
1
$36.69
0.02%
37205036174
0
$0.00
0.00%
1
$44.54
0.02%
37205036374
0
$0.00
0.00%
2
$82.66
0.05%
52735094052
FP NICOTINE DIS 21MG/24
0
$0.00
0.00%
1
$34.13
0.02%
94
$8,305.54
5.82%
18
$928.41
1.78%
NICOTINE REPLACEMENT - OTHER
00009519401
NICOTROL NS SPR 10MG/ML
00009519402
0
$0.00
0.00%
3
$636.29
0.30%
00009519501
NICOTROL
INH
959
$57,059.68
59.38%
349
$21,074.60
34.52%
00009519508
NICOTROL
INH
50
$5,670.43
3.10%
20
$2,184.02
1.98%
00045090101
NICOTROL
INH
23
$1,321.02
1.42%
0
$0.00
0.00%
00135017107
NICORETTE
GUM 4MG MINT
0
$0.00
0.00%
2
$97.02
0.20%
00135019707
NICORETTE
GUM 2MG
0
$0.00
0.00%
2
$166.68
0.20%
Page 411 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00135020801
COMMIT
LOZ 2MG
0
$0.00
0.00%
3
$108.94
0.30%
00135020803
COMMIT
LOZ 2MG
0
$0.00
0.00%
1
$23.52
0.10%
00135020903
COMMIT
LOZ 4MG
0
$0.00
0.00%
1
$20.17
0.10%
00536310618
NICOTINE POL GUM 2MG
5
$185.05
0.31%
94
$4,138.67
9.30%
00536310643
0
$0.00
0.00%
41
$1,926.23
4.06%
00536310718
17
$770.31
1.05%
161
$7,503.84
15.92%
00536310743
0
$0.00
0.00%
34
$1,916.80
3.36%
00766004320
NICORETTE
GUM 2MG MINT
27
$1,764.36
1.67%
10
$465.43
0.99%
00766004330
NICORETTE
GUM 2MG MINT
11
$280.51
0.68%
6
$306.81
0.59%
00766004350
NICORETTE ST GUM 2MG
13
$673.66
0.80%
3
$128.57
0.30%
00766004360
NICORETTE
GUM 2MG/REF
8
$180.60
0.50%
0
$0.00
0.00%
00766004420
NICORETTE
GUM 4MG MINT
62
$3,911.09
3.84%
9
$432.58
0.89%
00766004430
NICORETTE
GUM 4MG MINT
7
$216.59
0.43%
6
$335.84
0.59%
00766004450
NICORETTE ST GUM 4MG
48
$2,581.77
2.97%
4
$194.37
0.40%
00766004460
NICORETTE
GUM 4MG/REF
5
$195.33
0.31%
0
$0.00
0.00%
00766004508
NICORETTE
GUM 2MG
100
$4,826.07
6.19%
41
$2,177.35
4.06%
00766004548
NICORETTE
GUM 2MG REF
18
$630.79
1.11%
11
$394.45
1.09%
00766004560
NICORETTE
GUM 2MG
12
$660.97
0.74%
3
$168.34
0.30%
00766004708
NICORETTE
GUM 4MG
105
$5,556.84
6.50%
30
$1,493.86
2.97%
00766004748
NICORETTE
GUM 4MG REF
16
$658.90
0.99%
14
$584.06
1.38%
00766004760
NICORETTE
GUM 4MG
14
$1,140.25
0.87%
3
$287.58
0.30%
00766150010
COMMIT
LOZ 2MG
0
$0.00
0.00%
10
$396.94
0.99%
00766150020
COMMIT
LOZ 4MG
0
$0.00
0.00%
16
$1,201.08
1.58%
37205020323
NICOTINE
GUM 2MG
0
$0.00
0.00%
32
$1,682.73
3.17%
37205020367
NICOTINE
GUM 2MG
0
$0.00
0.00%
3
$189.59
0.30%
37205020423
NICOTINE
GUM 4MG
0
$0.00
0.00%
40
$2,232.32
3.96%
37205020467
NICOTINE
GUM 4MG
0
$0.00
0.00%
41
$1,784.96
4.06%
Page 412 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
50580090101
NICOTROL
INH
$
Market Share*
50580089901
# of Scripts
3
$120.99
0.19%
0
$0.00
0.00%
18
$937.60
1.11%
0
$0.00
0.00%
NIFEDIPINES
00026884148
ADALAT CC
TAB 30MG ER
0
$0.00
0.00%
1
$44.21
0.03%
00026884151
ADALAT CC
TAB 30MG ER
819
$31,341.59
34.81%
1,199
$51,932.47
40.06%
00026884154
ADALAT CC
TAB 30MG ER
4
$132.60
0.17%
88
$3,686.57
2.94%
00026885148
ADALAT CC
TAB 60MG ER
0
$0.00
0.00%
2
$147.26
0.07%
00026885151
ADALAT CC
TAB 60MG ER
599
$41,191.99
25.46%
823
$62,859.59
27.50%
00026885154
ADALAT CC
TAB 60MG ER
0
$0.00
0.00%
40
$3,045.42
1.34%
00026886148
ADALAT CC
TAB 90MG ER
0
$0.00
0.00%
7
$356.51
0.23%
00026886151
ADALAT CC
TAB 90MG ER
377
$27,473.12
16.02%
539
$45,002.04
18.01%
00069260066
PROCARDIA CAP 10MG
2
$90.96
0.08%
0
$0.00
0.00%
00069265066
PROCARDIA XL TAB 30MG CR
11
$931.69
0.47%
7
$725.68
0.23%
00069265072
4
$168.56
0.17%
7
$270.45
0.23%
00069266066
26
$1,792.63
1.10%
16
$1,199.26
0.53%
00069266072
0
$0.00
0.00%
1
$74.90
0.03%
00069267066
23
$1,340.58
0.98%
16
$1,156.94
0.53%
00093081901
NIFEDICAL XL TAB 30MG
29
$827.24
1.23%
22
$793.34
0.74%
00093102101
NIFEDIPINE TAB 30MG CR
103
$4,198.94
4.38%
13
$457.08
0.43%
00093102201
NIFEDIAC CC TAB 60MG ER
65
$3,392.78
2.76%
7
$585.85
0.23%
00093102301
NIFEDIPINE TAB 90MG ER
50
$3,653.94
2.12%
9
$523.88
0.30%
00093517301
NIFEDICAL XL TAB 60MG
24
$1,093.85
1.02%
9
$510.15
0.30%
00093817101
NIFEDIPINE CAP 10MG
13
$151.84
0.55%
8
$103.88
0.27%
00093817155
NIFEDIPINE CAP 10MG
2
$27.97
0.08%
1
$38.68
0.03%
00228249710
NIFEDIPINE CAP 10MG
35
$513.03
1.49%
31
$580.51
1.04%
00228249730
NIFEDIPINE CAP 10MG
18
$271.81
0.76%
11
$158.82
0.37%
Page 413 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NIFEDIPINES
00228253010
NIFEDIPINE CAP 20MG
00228253030
NIFEDIPINE CAP 20MG
00378347501
00378347530
00378348201
00378348230
00378349501
00591066001
00591066101
00591319301
AFEDITAB
00591319401
AFEDITAB
14
$220.87
0.59%
5
$45.00
0.21%
27
$1,062.13
1.15%
9
$234.54
0.38%
35
$1,913.72
1.49%
3
$290.25
0.13%
20
$1,557.91
0.85%
26
$1,049.12
1.10%
10
$420.86
TAB 30MG CR
0
TAB 60MG CR
0
20
$249.86
0.67%
2
$24.60
0.07%
27
$982.10
0.90%
11
$287.06
0.37%
20
$1,291.94
0.67%
2
$91.70
0.07%
17
$1,027.54
0.57%
5
$133.53
0.17%
0.42%
10
$331.96
0.33%
$0.00
0.00%
14
$411.19
0.47%
$0.00
0.00%
8
$401.70
0.27%
NISOLDIPINE
00310089110
SULAR
TAB 10MG CR
92
$2,917.45
28.31%
145
$5,207.13
33.72%
00310089210
SULAR
TAB 20MG CR
94
$2,991.02
28.92%
131
$4,676.74
30.47%
00310089239
SULAR
TAB 20MG CR
11
$361.89
3.38%
13
$574.00
3.02%
00310089310
SULAR
TAB 30MG CR
68
$2,589.56
20.92%
80
$3,903.08
18.60%
00310089410
SULAR
TAB 40MG CR
60
$1,883.69
18.46%
61
$2,333.96
14.19%
NITRO - OINTMENT/CAP/CR
00168032630
NITROBID
OIN 2%
16
$187.10
6.45%
10
$133.04
3.92%
00168032660
NITROBID
OIN 2%
38
$565.13
15.32%
35
$507.17
13.73%
00182070289
NITROGLYCER CAP 2.5MG TD
2
$19.34
0.81%
2
$16.34
0.78%
00185121701
NITROGLYCER CAP 9MG CR
1
$13.65
0.40%
1
$12.15
0.39%
00185121760
NITROGLYCER CAP 9MG CR
4
$39.91
1.61%
4
$37.30
1.57%
00185123501
NITROGLYCER CAP 6.5MG CR
54
$473.76
21.77%
42
$276.77
16.47%
00185123560
6
$35.65
2.42%
5
$42.49
1.96%
Page 414 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NITRO - OINTMENT/CAP/CR
00185517401
NITROGLYCER CAP 2.5MG SR
33
$227.39
13.31%
17
$101.31
6.67%
00185517460
NITROGLYCER CAP 2.5MG SR
0
$0.00
0.00%
5
$33.65
1.96%
00281003856
NITROL
OIN 2%
0
$0.00
0.00%
1
$7.88
0.39%
00603478221
0
$0.00
0.00%
1
$17.32
0.39%
00677048501
0
$0.00
0.00%
3
$20.85
1.18%
00677048601
9
$68.67
3.63%
10
$75.48
3.92%
00904064360
1
$18.82
0.40%
0
$0.00
0.00%
00904064460
0
$0.00
0.00%
5
$27.95
1.96%
49483022106
NITRO-TIME CAP 2.5MG CR
2
$13.02
0.81%
0
$0.00
0.00%
49483022110
NITRO-TIME CAP 2.5MG CR
7
$52.68
2.82%
0
$0.00
0.00%
49483022210
10
$81.36
4.03%
8
$53.78
3.14%
58177000403
NITROGLYCER CAP 2.5MG ER
0
$0.00
0.00%
7
$51.08
2.75%
58177000404
31
$234.56
12.50%
41
$232.81
16.08%
58177000503
0
$0.00
0.00%
9
$87.00
3.53%
58177000504
30
$270.29
12.10%
43
$333.36
16.86%
58177000603
NITROGLYCER CAP 9MG ER
1
$22.69
0.40%
2
$15.26
0.78%
58177000604
NITROGLYCER CAP 9MG ER
3
$27.39
1.21%
4
$30.52
1.57%
NITRO - PATCHES
00085081930
NITRO-DUR
DIS 0.8MG/HR
148
$10,045.01
3.34%
103
$7,399.85
2.33%
00085081935
NITRO-DUR
DIS 0.8MG/HR
0
$0.00
0.00%
1
$75.31
0.02%
00085330530
NITRO-DUR
DIS 0.1MG/HR
10
$563.11
0.23%
2
$123.36
0.05%
00085331030
NITRO-DUR
DIS 0.2MG/HR
47
$2,666.84
1.06%
7
$378.21
0.16%
00085331530
NITRO-DUR
DIS 0.3MG/HR
82
$4,892.20
1.85%
27
$1,668.61
0.61%
00085331535
NITRO-DUR
DIS 0.3MG/HR
2
$130.72
0.05%
3
$146.68
0.07%
00085332030
NITRO-DUR
DIS 0.4MG/HR
82
$5,135.97
1.85%
24
$1,486.96
0.54%
00085333030
NITRO-DUR
DIS 0.6MG/HR
21
$1,457.07
0.47%
1
$75.31
0.02%
Page 415 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NITRO - PATCHES
00089030102
MINITRAN
DIS 0.1MG/HR
29
00089030202
MINITRAN
DIS 0.2MG/HR
306
00089030302
MINITRAN
DIS 0.4MG/HR
541
00089030402
MINITRAN
DIS 0.6MG/HR
199
00089130130
NITROGLYCER DIS 0.1MG/HR
00089130230
00089130330
$618.71
0.65%
19
$380.95
0.43%
$9,406.77
6.91%
$21,234.23
12.21%
202
$8,897.08
4.58%
325
$17,525.15
7.37%
$7,796.87
4.49%
135
$6,388.32
3.06%
0
$0.00
0.00%
5
$102.75
0.11%
0
$0.00
0.00%
72
$3,034.45
1.63%
0
$0.00
0.00%
123
$2,574.47
2.79%
00089130430
0
$0.00
0.00%
11
$417.05
0.25%
00364250230
3
$125.23
0.07%
0
$0.00
0.00%
00378910293
65
$1,405.15
1.47%
123
$2,573.29
2.79%
00378910493
371
$8,801.95
8.38%
650
$25,748.74
14.73%
00378911293
633
$13,800.96
14.29%
978
$21,823.94
22.17%
00378911693
225
$7,702.98
5.08%
276
$10,261.20
6.26%
00904065446
0
$0.00
0.00%
2
$80.10
0.05%
00904549546
13
$321.35
0.29%
29
$1,166.13
0.66%
00904549646
5
$164.35
0.11%
24
$511.20
0.54%
00904549746
0
$0.00
0.00%
1
$31.25
0.02%
49730011130
NITRO-TRANSD DIS 0.2MG/HR
121
$2,971.15
2.73%
25
$983.16
0.57%
49730011230
NITROGLYCERN DIS 0.4MG/HR
237
$5,331.23
5.35%
199
$4,372.49
4.51%
49730011330
NITROGLYCERI DIS 0.6MG/HR
96
$3,548.55
2.17%
88
$3,351.63
1.99%
62794020293
NITREK
DIS 0.2MG/HR
401
$9,294.12
9.05%
374
$15,957.97
8.48%
62794020493
NITREK
DIS 0.4MG/HR
650
$13,788.06
14.68%
466
$10,157.71
10.56%
62794020693
NITREK
DIS 0.6MG/HR
142
$4,794.92
3.21%
117
$3,902.25
2.65%
NITRO - SUBLINGUAL / SPRAY
00071041724
NITROSTAT
SUB 0.3MG
15
$131.59
0.63%
46
$1,352.39
1.92%
00071041813
NITROSTAT
SUB 0.4MG
180
$1,553.87
7.60%
657
$5,484.70
27.38%
Page 416 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NITRO - SUBLINGUAL / SPRAY
00071041824
NITROSTAT
SUB 0.4MG
140
00071041924
NITROSTAT
SUB 0.6MG
00075085084
NITROLINGUAL AER 0.4/DOSE
53265024910
NITROTAB
53265025004
$1,462.76
5.91%
387
$4,010.70
16.13%
1
$8.35
0.04%
3
$31.96
0.13%
1
$29.39
0.04%
0
$0.00
0.00%
SUB 0.3MG
44
$347.61
1.86%
45
$305.52
1.88%
NITROTAB
SUB 0.4MG
476
$3,540.11
20.11%
630
$3,938.19
26.25%
53265025010
NITROTAB
SUB 0.4MG
195
$1,668.79
8.24%
214
$1,589.66
8.92%
53265025110
NITROTAB
SUB 0.6MG
8
$67.47
0.34%
8
$55.80
0.33%
58177032304
NITROQUICK SUB 0.3MG
63
$519.28
2.66%
20
$144.61
0.83%
58177032404
430
$4,057.70
18.17%
96
$807.23
4.00%
58177032418
684
$5,227.62
28.90%
146
$922.25
6.08%
58177032504
6
$47.48
0.25%
2
$15.20
0.08%
59630030020
NITROLINGUAL SPR PUMPSPRA
124
$4,259.53
5.24%
122
$5,075.43
5.08%
59630030065
NITROLINGUAL SPR PUMPSPRA
0
$0.00
0.00%
5
$208.95
0.21%
60951071862
NITROGLYCER SUB 0.4MG
0
$0.00
0.00%
8
$54.24
0.33%
60951071870
NITROGLYCER SUB 0.4MG
0
$0.00
0.00%
11
$73.47
0.46%
Non-Benzodiazepine - GABA-Receptor Modulators
00008092581
SONATA
CAP 5MG
79
$2,947.52
1.28%
30
$1,166.68
0.60%
00008092681
SONATA
CAP 10MG
377
$20,731.78
6.11%
265
$16,090.79
5.29%
00024540131
AMBIEN
TAB 5MG
966
$34,152.14
15.66%
1,085
$40,777.65
21.67%
00024540134
AMBIEN
TAB 5MG
16
$563.07
0.26%
1
$21.69
0.02%
00024542131
AMBIEN
TAB 10MG
4,022
$195,747.18
65.21%
3,588
$175,807.27
71.67%
00024542134
AMBIEN
TAB 10MG
36
$1,948.59
0.58%
8
$544.48
0.16%
00025540131
AMBIEN
TAB 5MG
303
$10,075.78
4.91%
10
$223.24
0.20%
00025540134
AMBIEN
TAB 5MG
4
$175.48
0.06%
0
$0.00
0.00%
00025542131
AMBIEN
TAB 10MG
363
$18,665.12
5.89%
17
$701.86
0.34%
00025542134
AMBIEN
TAB 10MG
2
$94.99
0.03%
2
$48.34
0.04%
Page 417 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NON-SEDATING ANTIHISTIMINES
00067606330
TAVIST ND
TAB 10MG
00069550066
ZYRTEC
TAB 5MG
00069551066
ZYRTEC
TAB 10MG
00069553047
ZYRTEC
00069553093
ZYRTEC
00085045803
CLARITIN
00085045804
0
$0.00
0.00%
886
$16,536.95
5.82%
248
$13,975.85
1.91%
115
$6,679.54
0.75%
3,928
$204,879.08
30.20%
1,717
$83,401.60
11.27%
SYP 5MG/5ML
946
$32,539.42
7.27%
686
$22,401.28
4.50%
SYP 5MG/5ML
565
$20,605.53
4.34%
397
$13,799.53
2.61%
TAB 10MG
2,168
$172,839.07
16.67%
57
$4,456.37
0.37%
CLARITIN
TAB 10MG
4
$340.55
0.03%
0
$0.00
0.00%
00085045805
CLARITIN
TAB 10MG
192
$15,614.14
1.48%
5
$433.10
0.03%
00085045806
CLARITIN
TAB 10MG
551
$42,666.84
4.24%
8
$729.78
0.05%
00085112802
CLARITIN
TAB REDITAB
892
$83,082.48
6.86%
37
$2,200.73
0.24%
00085122301
CLARITIN
SYP 10/10ML
272
$16,558.75
2.09%
42
$2,354.33
0.28%
00085126401
CLARINEX
TAB 5MG
789
$44,348.15
6.07%
1,067
$62,415.85
7.00%
00085126402
CLARINEX
TAB 5MG
0
$0.00
0.00%
4
$258.78
0.03%
00085126403
CLARINEX
TAB 5MG
8
$476.69
0.06%
3
$192.18
0.02%
00085126404
CLARINEX
TAB 5MG
24
$1,254.50
0.18%
3
$199.68
0.02%
00085128001
CLARINEX
TAB REDITABS
0
$0.00
0.00%
5
$328.63
0.03%
00088110247
ALLEGRA
CAP 60MG
5
$286.76
0.04%
1
$62.63
0.01%
00088110647
ALLEGRA
TAB 30MG
148
$5,188.64
1.14%
77
$2,825.08
0.51%
00088110747
ALLEGRA
TAB 60MG
1,020
$63,828.98
7.84%
409
$24,488.55
2.68%
00088110749
ALLEGRA
TAB 60MG
0
$0.00
0.00%
1
$52.43
0.01%
00088110755
ALLEGRA
TAB 60MG
00088110947
ALLEGRA
TAB 180MG
00573262012
ALAVERT
00573262024
84
$5,113.49
0.65%
31
$1,617.36
0.20%
1,162
$69,290.41
8.93%
694
$39,146.76
4.56%
TAB NON-DROW
0
$0.00
0.00%
1
$38.15
0.01%
ALAVERT
TAB NON-DROW
0
$0.00
0.00%
3
$62.83
0.02%
00573262048
ALAVERT
TAB NON-DROW
0
$0.00
0.00%
7,165
$128,063.65
47.03%
00573264530
ALAVERT
TAB 10MG
0
$0.00
0.00%
1,019
$17,936.72
6.69%
Page 418 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NON-SEDATING ANTIHISTIMINES
11523716002
CLARITIN
TAB 10MG
0
$0.00
0.00%
1
$29.95
0.01%
11523716003
CLARITIN
TAB 10MG
0
$0.00
0.00%
279
$6,739.32
1.83%
11523716301
CLARITIN
SYP 5MG/5ML
0
$0.00
0.00%
520
$7,310.45
3.41%
49348054244
LORATADINE TAB 10MG
0
$0.00
0.00%
1
$13.78
0.01%
NON-SEDATING ANTIHISTIMINES / DECONGESTANTS
00069163066
ZYRTEC-D
TAB 5-120MG
291
$12,889.57
18.50%
2
$7.52
66.67%
00085063501
CLARITIN-D TAB 5-120MG
314
$24,479.52
19.96%
0
$0.00
0.00%
00085063505
4
$384.04
0.25%
0
$0.00
0.00%
00085123301
547
$46,245.39
34.77%
0
$0.00
0.00%
00085123302
4
$375.16
0.25%
0
$0.00
0.00%
00088109047
ALLEGRA-D TAB 60-120ER
382
$21,915.09
24.28%
1
$65.72
33.33%
00088109049
13
$846.06
0.83%
0
$0.00
0.00%
00088109055
18
$1,228.77
1.14%
0
$0.00
0.00%
00004002828
NAPROSYN
16
$597.14
0.08%
6
$289.44
0.02%
00004027301
TORADOL ORAL TAB 10MG
2
$33.98
0.01%
1
$24.20
0.00%
00004620001
ANAPROX DS TAB 550MG
4
$389.03
0.02%
3
$258.78
0.01%
00004620201
ANAPROX
1
$82.64
0.01%
0
$0.00
0.00%
00004631101
NAPROSYN
TAB 375MG
1
$15.71
0.01%
0
$0.00
0.00%
00004631401
NAPROSYN
TAB 375MG
00004641601
EC-NAPROSYN TAB 500MG
00004692709
TORADOL
00005328443
NSAIDS
SUS 125/5ML
TAB 275MG
0
$0.00
0.00%
1
$77.50
0.00%
11
$548.53
0.06%
3
$119.16
0.01%
4
$30.54
0.02%
1
$3.02
0.00%
KETOPROFEN CAP 25MG
2
$46.70
0.01%
1
$26.10
0.00%
00005328643
KETOPROFEN CAP 75MG
4
$32.35
0.02%
0
$0.00
0.00%
00005330031
NAPROXEN
1
$8.15
0.01%
0
$0.00
0.00%
INJ 30MG/ML
TAB 250MG
Page 419 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NSAIDS
00006002568
INDOCIN
CAP 25MG
1
$70.26
0.01%
0
$0.00
0.00%
00006005068
INDOCIN
CAP 50MG
2
$115.68
0.01%
0
$0.00
0.00%
00006069361
INDOCIN SR CAP 75MG
1
$22.94
0.01%
0
$0.00
0.00%
00006094168
CLINORIL
TAB 150MG
3
$98.37
0.02%
0
$0.00
0.00%
00006094268
CLINORIL
TAB 200MG
3
$119.28
0.02%
4
$237.96
0.02%
00008069001
ORUVAIL
CAP 200MG ER
1
$85.33
0.01%
1
$57.50
0.00%
00008082101
ORUVAIL
CAP 100MG ER
7
$875.31
0.04%
3
$196.50
0.01%
00008082201
ORUVAIL
CAP 150MG ER
4
$305.75
0.02%
0
$0.00
0.00%
00009030503
ANSAID
TAB 100MG
5
$469.49
0.03%
0
$0.00
0.00%
00009738501
MOTRIN
TAB 400MG
2
$53.60
0.01%
1
$14.83
0.00%
00009738601
MOTRIN
TAB 600MG
11
$202.04
0.06%
0
$0.00
0.00%
00009738701
MOTRIN
TAB 800MG
13
$245.45
0.07%
2
$45.44
0.01%
00009738702
MOTRIN
TAB 800MG
1
$7.55
0.01%
1
$4.95
0.00%
00009738704
MOTRIN
TAB 800MG
3
$113.04
0.02%
0
$0.00
0.00%
00025138131
DAYPRO
TAB 600MG
30
$2,538.10
0.15%
19
$1,967.27
0.07%
00025138134
DAYPRO
TAB 600MG
2
$220.44
0.01%
0
$0.00
0.00%
00028015101
CATAFLAM
8
$1,085.14
0.04%
2
$211.70
0.01%
00028020501
VOLTAREN-XR TAB 100MG
7
$1,167.32
0.04%
6
$1,484.80
0.02%
00028026401
VOLTAREN
4
$297.02
0.02%
7
$619.38
0.03%
00029485120
RELAFEN
TAB 500MG
27
$2,594.82
0.14%
12
$1,230.25
0.05%
00029485220
RELAFEN
TAB 750MG
27
$2,361.78
0.14%
14
$1,501.16
0.05%
00045041660
TOLECTIN
TAB 600MG
1
$52.83
0.01%
1
$111.83
0.00%
00045043110
MOTRIN
CHW 100MG
3
$36.63
0.02%
0
$0.00
0.00%
00045044804
MOTRIN
SUS 100/5ML
4
$40.09
0.02%
5
$63.90
0.02%
00045044816
MOTRIN
SUS 100/5ML
1
$32.99
0.01%
0
$0.00
0.00%
00045044817
MOTRIN
SUS 100/5ML
2
$33.63
0.01%
0
$0.00
0.00%
00045048102
MOTRIN IB
TAB 200MG
0
$0.00
0.00%
1
$6.89
0.00%
TAB 50MG
TAB 75MG EC
Page 420 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NSAIDS
00046073881
LODINE
00046082981
LODINE XL
00046083181
LODINE XL
00046083981
LODINE XL
00054363063
NAPROXEN
00054422225
00054463929
CAP 200MG
2
$67.90
0.01%
0
$0.00
0.00%
TAB 400MG
16
$1,430.92
0.08%
0
$0.00
0.00%
TAB 600MG
1
$163.22
0.01%
0
$0.00
0.00%
TAB 500MG
6
$539.23
0.03%
1
$93.87
0.00%
26
$792.76
0.13%
52
$2,121.75
0.20%
DICLOFENAC TAB 75MG EC
1
$8.10
0.01%
0
$0.00
0.00%
NAPROXEN SOD TAB 550MG
1
$8.66
0.01%
1
$12.22
0.00%
00069322066
FELDENE
CAP 10MG
2
$97.30
0.01%
2
$104.78
0.01%
00071054024
PONSTEL
CAP 250MG
4
$135.97
0.02%
0
$0.00
0.00%
00074228702
KETOROLAC
INJ 30MG/ML
1
$337.91
0.01%
1
$9.03
0.00%
00074228731
KETOROLAC
INJ 30MG/ML
0
$0.00
0.00%
3
$121.15
0.01%
00074379301
KETOROLAC
INJ 15MG/ML
1
$49.03
0.01%
0
$0.00
0.00%
00074379501
KETOROLAC
INJ 30MG/ML
0
$0.00
0.00%
3
$79.55
0.01%
00074379601
KETOROLAC
INJ 30MG/ML
2
$36.03
0.01%
1
$115.85
0.00%
00086009010
NAPRELAN
TAB 375MG CR
13
$790.89
0.07%
1
$38.41
0.00%
00086009175
NAPRELAN
TAB 500MG CR
35
$2,866.38
0.18%
1
$12.25
0.00%
00093014701
NAPROXEN
TAB 250MG
154
$1,186.58
0.79%
171
$1,038.21
0.67%
00093014705
NAPROXEN
TAB 250MG
15
$108.05
0.08%
31
$217.21
0.12%
00093014710
NAPROXEN
TAB 250MG
0
$0.00
0.00%
2
$16.30
0.01%
00093014801
NAPROXEN
TAB 375MG
268
$2,217.12
1.38%
421
$2,960.31
1.64%
00093014805
NAPROXEN
TAB 375MG
12
$109.60
0.06%
10
$68.93
0.04%
00093014810
NAPROXEN
TAB 375MG
4
$27.55
0.02%
8
$59.35
0.03%
00093014901
NAPROXEN
TAB 500MG
1,166
$12,770.38
5.99%
1,767
$16,694.90
6.89%
00093014905
NAPROXEN
TAB 500MG
202
$2,239.49
1.04%
205
$1,872.15
0.80%
00093014910
NAPROXEN
TAB 500MG
273
$3,073.65
1.40%
407
$3,995.13
1.59%
00093031401
KETOROLAC
TAB 10MG
112
$2,034.37
0.58%
123
$1,469.63
0.48%
00093053601
75
$2,526.56
0.39%
47
$828.35
0.18%
SUS 125/5ML
Page 421 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NSAIDS
00093053605
6
$264.32
0.03%
5
$85.90
0.02%
00093053701
516
$19,903.47
2.65%
541
$9,439.17
2.11%
00093053705
73
$2,337.34
0.38%
43
$803.53
0.17%
00093053710
0
$0.00
0.00%
1
$8.45
0.00%
00093071101
FLURBIPROFEN TAB 100MG
48
$1,067.90
0.25%
55
$1,242.55
0.21%
00093071105
31
$524.75
0.16%
90
$1,731.86
0.35%
00093075601
PIROXICAM
CAP 10MG
45
$303.03
0.23%
105
$577.69
0.41%
00093075701
PIROXICAM
CAP 20MG
333
$1,849.95
1.71%
485
$1,861.89
1.89%
00093075705
PIROXICAM
CAP 20MG
30
$164.50
0.15%
50
$192.24
0.19%
00093089201
ETODOLAC
TAB 400MG
37
$640.41
0.19%
61
$1,022.73
0.24%
00093094801
DICLOFEN POT TAB 50MG
20
$849.21
0.10%
9
$206.69
0.04%
00093094805
3
$181.55
0.02%
6
$151.20
0.02%
00093100501
NAPROXEN DR TAB 375MG
15
$474.80
0.08%
6
$168.25
0.02%
00093100601
70
$2,630.39
0.36%
67
$2,468.35
0.26%
00093100605
11
$390.45
0.06%
0
$0.00
0.00%
00093101501
NABUMETONE TAB 500MG
196
$12,660.50
1.01%
411
$13,508.27
1.60%
00093101601
172
$12,712.36
0.88%
360
$13,065.03
1.40%
00093104101
DICLOFENAC TAB 100MG ER
21
$1,212.04
0.11%
24
$1,308.50
0.09%
00093111801
ETODOLAC ER TAB 600MG
14
$1,340.08
0.07%
13
$995.48
0.05%
00093112201
ETODOLAC ER TAB 400
42
$2,826.50
0.22%
110
$4,693.27
0.43%
00093319301
KETOPROFEN CAP 50MG
33
$604.15
0.17%
40
$892.63
0.16%
00093319501
KETOPROFEN CAP 75MG
38
$314.39
0.20%
91
$644.11
0.35%
00093319505
KETOPROFEN CAP 75MG
2
$23.10
0.01%
0
$0.00
0.00%
00093717201
77
$4,589.60
0.40%
88
$4,438.82
0.34%
00093839701
ETODOLAC
14
$441.70
0.07%
54
$1,430.16
0.21%
00093881501
TOLMETIN SOD CAP 400MG
7
$615.42
0.04%
7
$594.28
0.03%
00113036871
0
$0.00
0.00%
1
$4.01
0.00%
CAP 300MG
Page 422 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NSAIDS
00113060471
IBUPROFEN TAB 200MG
0
$0.00
0.00%
1
$5.18
0.00%
00113060478
IBUPROFEN TAB 200MG
0
$0.00
0.00%
1
$5.13
0.00%
00113064752
IBUPROFEN TAB 200MG
1
$4.79
0.01%
0
$0.00
0.00%
00113064778
IBUPROFEN TAB 200MG
0
$0.00
0.00%
1
$1.85
0.00%
00143990801
122
$3,906.54
0.63%
276
$4,850.45
1.08%
00143990805
141
$4,538.51
0.72%
174
$3,083.05
0.68%
00143991601
1
$42.45
0.01%
19
$441.30
0.07%
00172402960
INDOMETHACIN CAP 25MG
236
$3,988.22
1.21%
361
$6,207.87
1.41%
00172402970
0
$0.00
0.00%
1
$8.84
0.00%
00172402980
42
$813.72
0.22%
31
$707.53
0.12%
00172403060
229
$5,605.43
1.18%
271
$7,123.09
1.06%
00172403070
2
$21.26
0.01%
16
$381.78
0.06%
00172414160
FENOPROFEN TAB 600MG
8
$129.28
0.04%
2
$20.90
0.01%
00172417460
ETODOLAC
TAB 500MG
20
$823.10
0.10%
4
$120.35
0.02%
00172417560
ETODOLAC
TAB 400MG
44
$790.47
0.23%
0
$0.00
0.00%
00172417570
ETODOLAC
TAB 400MG
3
$65.65
0.02%
0
$0.00
0.00%
00172434860
OXAPROZIN
TAB 600MG
0
$0.00
0.00%
2
$81.95
0.01%
00172436160
1
$11.35
0.01%
0
$0.00
0.00%
00172436260
41
$879.40
0.21%
0
$0.00
0.00%
00182103901
IBUPROFEN TAB 200MG
11
$52.82
0.06%
17
$86.71
0.07%
00182103910
IBUPROFEN TAB 200MG
1
$3.93
0.01%
2
$6.77
0.01%
00182109719
0
$0.00
0.00%
1
$3.69
0.00%
00182110616
0
$0.00
0.00%
1
$1.00
0.00%
00185013901
ETODOLAC
TAB 500MG
12
$577.80
0.06%
23
$1,027.22
0.09%
00185014001
ETODOLAC
TAB 400MG
6
$169.70
0.03%
9
$288.42
0.04%
00185014101
OXAPROZIN
TAB 600MG
41
$2,663.35
0.21%
65
$2,360.25
0.25%
00185014105
OXAPROZIN
TAB 600MG
4
$332.65
0.02%
4
$165.60
0.02%
Page 423 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NSAIDS
00185014501
00185014505
00185014601
00185072001
INDOMETHACIN CAP 75MG ER
00185072060
00228248010
00228252010
$981.35
0.07%
$1,886.86
0.23%
3
$213.15
0.02%
17
$1,358.50
0.09%
0
$0.00
0.00%
41
$1,571.95
0.16%
77
$3,165.62
0.40%
20
$942.19
0.08%
34
$1,391.85
0.17%
28
$1,505.27
0.11%
TOLMETIN SOD TAB 600MG
2
1
$67.98
0.01%
0
$0.00
0.00%
$67.46
0.01%
0
$0.00
0.00%
00228255011
3
$39.45
0.02%
3
$51.15
0.01%
00228259911
ETODOLAC
TAB 400MG
143
$2,385.27
0.74%
230
$4,490.33
0.90%
00228259950
00228261411
ETODOLAC
TAB 400MG
2
$43.10
0.01%
14
$396.30
0.05%
OXAPROZIN
TAB 600MG
1
$86.64
0.01%
0
$0.00
0.00%
00228261450
OXAPROZIN
TAB 600MG
0
$0.00
0.00%
1
$21.12
0.00%
00228263211
ETODOLAC
TAB 500MG
87
$4,027.32
0.45%
96
$4,161.01
0.37%
00228267111
ETODOLAC CR TAB 400MG
33
$1,996.82
0.17%
13
$584.35
0.05%
00228274311
2
$28.45
0.01%
12
$284.40
0.05%
00228274406
0
$0.00
0.00%
7
$79.40
0.03%
00228274411
8
$83.05
0.04%
28
$343.13
0.11%
00228274496
1
$6.90
0.01%
12
$162.21
0.05%
00228274511
1
$22.60
0.01%
0
$0.00
0.00%
00228274610
5
$130.75
0.03%
1
$36.85
0.00%
00258360701
5
$222.01
0.03%
0
$0.00
0.00%
00364076501
IBUPROFEN TAB 400MG
8
$53.39
0.04%
0
$0.00
0.00%
00364076505
IBUPROFEN TAB 400MG
7
$43.23
0.04%
0
$0.00
0.00%
00364076601
IBUPROFEN TAB 600MG
16
$101.37
0.08%
10
$59.14
0.04%
00364076605
IBUPROFEN TAB 600MG
44
$299.39
0.23%
6
$25.99
0.02%
00364213705
IBUPROFEN TAB 800MG
15
$116.53
0.08%
0
$0.00
0.00%
00364214501
IBUPROFEN TAB 200MG
1
$1.29
0.01%
0
$0.00
0.00%
14
60
Page 424 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NSAIDS
00364244101
SULINDAC
TAB 150MG
22
$387.94
0.11%
17
$299.70
0.07%
00364244201
SULINDAC
TAB 200MG
4
$93.24
0.02%
3
$66.54
0.01%
00364244205
SULINDAC
TAB 200MG
3
$29.62
0.02%
0
$0.00
0.00%
00364256401
NAPROXEN
19
$221.55
0.10%
2
$16.30
0.01%
00364266701
KETOPROFEN CAP 200MG ER
9
$835.36
0.05%
6
$397.54
0.02%
00378007601
3
$48.69
0.02%
0
$0.00
0.00%
00378009301
12
$186.80
0.06%
12
$220.60
0.05%
00378014301
143
$2,784.76
0.74%
153
$2,591.56
0.60%
00378014310
15
$267.56
0.08%
22
$428.63
0.09%
00378014701
92
$2,138.47
0.47%
120
$2,736.16
0.47%
00378014705
21
$619.74
0.11%
3
$85.65
0.01%
00378023701
ETODOLAC
10
$139.50
0.05%
2
$26.60
0.01%
00378031301
16
$1,052.84
0.08%
15
$1,670.76
0.06%
00378037701
NAPROXEN
TAB 250MG
51
$373.46
0.26%
49
$345.22
0.19%
00378037705
NAPROXEN
TAB 250MG
7
$54.55
0.04%
5
$28.35
0.02%
00378042701
SULINDAC
44
$755.93
0.23%
45
$727.15
0.18%
00378045101
NAPROXEN
TAB 500MG
70
$710.32
0.36%
94
$913.32
0.37%
00378045105
NAPROXEN
TAB 500MG
94
$1,000.11
0.48%
136
$1,357.64
0.53%
00378047101
FENOPROFEN TAB 600MG
20
$319.80
0.10%
31
$612.45
0.12%
00378053101
SULINDAC
61
$1,356.12
0.31%
98
$2,196.27
0.38%
00378053701
3
$42.02
0.02%
1
$15.85
0.00%
00378053705
5
$112.70
0.03%
4
$39.65
0.02%
00378055501
NAPROXEN
TAB 375MG
14
$126.23
0.07%
23
$156.05
0.09%
00378055505
NAPROXEN
TAB 375MG
13
$101.91
0.07%
8
$62.45
0.03%
00378101001
PIROXICAM
CAP 10MG
38
$272.78
0.20%
119
$625.10
0.46%
00378113401
KETOROLAC
TAB 10MG
168
$3,006.71
0.86%
184
$2,816.36
0.72%
00378117701
OXAPROZIN
TAB 600MG
0
$0.00
0.00%
1
$41.40
0.00%
TAB 500MG
TAB 400MG
TAB 150MG
TAB 200MG
Page 425 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NSAIDS
00378124201
ETODOLAC
TAB 500MG
00378160105
IBUPROFEN TAB 600MG
00378202001
PIROXICAM
CAP 20MG
00378202005
PIROXICAM
CAP 20MG
00378215001
$560.40
0.06%
$29.00
0.01%
0
$0.00
0.00%
181
$967.40
0.93%
1
$6.79
0.00%
245
$952.11
0.95%
24
$134.02
0.12%
66
$245.12
0.26%
MECLOFEN SOD CAP 50MG
5
$329.79
0.03%
2
$263.39
0.01%
00378247401
12
00378300001
MECLOFEN SOD CAP 100MG
11
$440.45
0.06%
16
$425.56
0.06%
$573.87
0.06%
10
$941.38
0.04%
00378407001
KETOPROFEN CAP 50MG
7
$113.05
0.04%
7
$91.25
0.03%
00378520001
7
$564.93
0.04%
7
$499.71
0.03%
00378575001
KETOPROFEN CAP 75MG
00378720001
ETODOLAC
CAP 200MG
24
$199.16
0.12%
46
$527.58
0.18%
7
$207.65
0.04%
5
$120.47
0.02%
00378723301
ETODOLAC
CAP 300MG
49
$1,266.20
0.25%
12
$257.55
0.05%
00378820001
0
$0.00
0.00%
1
$74.00
0.00%
00472127016
00472127094
IBUPROFEN SUS 100/5ML
219
$4,145.38
1.13%
200
$4,723.38
0.78%
IBUPROFEN SUS 100/5ML
6
$66.44
0.03%
6
$64.27
0.02%
00536393902
IBUPROFEN TAB 200MG
2
$4.42
0.01%
0
$0.00
0.00%
00536393910
IBUPROFEN TAB 200MG
5
$3.55
0.03%
1
$1.09
0.00%
00573015040
ADVIL
TAB 200MG
0
$0.00
0.00%
2
$17.55
0.01%
00573016030
ADVIL
TAB 200MG
1
$2.87
0.01%
0
$0.00
0.00%
00573017030
CHILD ADVIL SUS 100/5ML
1
$10.95
0.01%
3
$36.87
0.01%
00573017910
ADVIL JR STR CHW 100MG
0
$0.00
0.00%
1
$8.79
0.00%
00591033801
DICLOFENAC TAB 50MG
0
$0.00
0.00%
59
$1,449.14
0.23%
00591033860
DICLOFENAC TAB 50MG
0
$0.00
0.00%
15
$242.05
0.06%
00591033901
DICLOFENAC TAB 75MG DR
5
$47.54
0.03%
111
$1,401.39
0.43%
00591033910
0
$0.00
0.00%
3
$56.14
0.01%
00591033960
0
$0.00
0.00%
24
$563.92
0.09%
00591079101
NAPROXEN
0
$0.00
0.00%
2
$38.50
0.01%
TAB 500MG
12
2
Page 426 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NSAIDS
00591079105
NAPROXEN
00591079201
00591079205
TAB 500MG
0
$0.00
0.00%
1
$8.15
0.00%
16
$157.69
0.08%
14
$211.60
0.05%
0
$0.00
0.00%
5
$101.75
0.02%
00591079301
101
$2,486.16
0.52%
129
$2,502.94
0.50%
00591079305
7
$387.58
0.04%
18
$282.22
0.07%
00591213701
IBUPROFEN TAB 800MG
3
$20.45
0.02%
0
$0.00
0.00%
00591213705
IBUPROFEN TAB 800MG
101
$710.32
0.52%
162
$1,039.97
0.63%
00591401001
IBUPROFEN TAB 400MG
2
$9.17
0.01%
4
$23.02
0.02%
00591401005
IBUPROFEN TAB 400MG
49
$281.45
0.25%
64
$347.64
0.25%
00591401101
IBUPROFEN TAB 600MG
10
$66.28
0.05%
13
$88.17
0.05%
00591401105
IBUPROFEN TAB 600MG
105
$677.84
0.54%
118
$690.95
0.46%
00591566001
SULINDAC
TAB 200MG
115
$2,428.33
0.59%
224
$4,665.32
0.87%
00591566005
SULINDAC
TAB 200MG
33
$679.04
0.17%
21
$503.70
0.08%
00591566101
SULINDAC
TAB 150MG
32
$533.56
0.16%
122
$1,946.38
0.48%
00591566105
SULINDAC
TAB 150MG
11
$190.36
0.06%
18
$306.27
0.07%
00597002901
MOBIC
TAB 7.5
246
$18,751.08
1.26%
231
$20,075.53
0.90%
00597003001
MOBIC
TAB 15MG
121
$8,500.46
0.62%
143
$13,459.08
0.56%
00603401821
IBUPROFEN TAB 400MG
2
$15.56
0.01%
1
$2.92
0.00%
00603401828
IBUPROFEN TAB 400MG
1
$4.83
0.01%
5
$26.35
0.02%
00603401921
IBUPROFEN TAB 600MG
1
$1.20
0.01%
0
$0.00
0.00%
00603401928
IBUPROFEN TAB 600MG
2
$11.36
0.01%
0
$0.00
0.00%
00603402028
IBUPROFEN TAB 800MG
2
$13.67
0.01%
12
$79.86
0.05%
00603587221
SULINDAC
TAB 150MG
1
$8.10
0.01%
0
$0.00
0.00%
00615252553
IBUPROFEN TAB 400MG
11
$63.17
0.06%
0
$0.00
0.00%
00615252563
IBUPROFEN TAB 400MG
20
$125.06
0.10%
0
$0.00
0.00%
00615252653
IBUPROFEN TAB 600MG
17
$111.49
0.09%
0
$0.00
0.00%
00615252663
IBUPROFEN TAB 600MG
24
$166.69
0.12%
0
$0.00
0.00%
Page 427 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NSAIDS
00615252853
IBUPROFEN TAB 800MG
12
$100.89
0.06%
0
$0.00
0.00%
00615252863
IBUPROFEN TAB 800MG
5
$43.98
0.03%
0
$0.00
0.00%
00615356353
NAPROXEN
TAB 500MG
8
$83.98
0.04%
0
$0.00
0.00%
00615356363
NAPROXEN
TAB 500MG
17
$156.96
0.09%
0
$0.00
0.00%
00677087301
2
$24.36
0.01%
0
$0.00
0.00%
00677103205
IBUPROFEN TAB 600MG
24
$126.78
0.12%
16
$98.64
0.06%
00677109001
IBUPROFEN TAB 200MG
0
$0.00
0.00%
1
$3.69
0.00%
00677117301
SULINDAC
TAB 150MG
0
$0.00
0.00%
12
$209.08
0.05%
00677117306
SULINDAC
TAB 150MG
0
$0.00
0.00%
5
$83.00
0.02%
00677117401
SULINDAC
TAB 200MG
4
$105.23
0.02%
4
$72.40
0.02%
00677142501
2
$142.42
0.01%
2
$123.70
0.01%
00781116301
NAPROXEN
TAB 250MG
4
$45.68
0.02%
1
$4.85
0.00%
00781116401
NAPROXEN
TAB 375MG
19
$170.90
0.10%
19
$139.10
0.07%
00781116405
NAPROXEN
TAB 375MG
1
$5.55
0.01%
1
$6.65
0.00%
00781116410
NAPROXEN
TAB 375MG
7
$53.89
0.04%
6
$43.70
0.02%
00781116501
NAPROXEN
TAB 500MG
22
$238.04
0.11%
12
$143.70
0.05%
00781116505
NAPROXEN
TAB 500MG
23
$260.77
0.12%
4
$44.50
0.02%
00781116510
NAPROXEN
TAB 500MG
6
$66.10
0.03%
0
$0.00
0.00%
00781118801
5
$369.55
0.03%
7
$157.95
0.03%
00781118810
3
$80.19
0.02%
0
$0.00
0.00%
00781129701
8
$274.59
0.04%
0
$0.00
0.00%
00781130601
136
$8,641.40
0.70%
57
$1,949.27
0.22%
00781130801
148
$10,423.89
0.76%
38
$1,428.22
0.15%
00781134901
IBUPROFEN TAB 200MG
2
$1.58
0.01%
1
$5.63
0.00%
00781136201
IBUPROFEN TAB 600MG
5
$46.42
0.03%
4
$26.54
0.02%
00781136301
IBUPROFEN TAB 800MG
1
$9.15
0.01%
0
$0.00
0.00%
00781138101
DICLOFENAC TAB 100MG XR
11
$584.29
0.06%
12
$675.72
0.05%
Page 428 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NSAIDS
00781164601
13
$499.70
0.07%
8
$265.80
0.03%
00781165301
138
$4,513.64
0.71%
117
$3,718.14
0.46%
00781178501
0
$0.00
0.00%
4
$76.30
0.02%
00781178560
0
$0.00
0.00%
1
$27.85
0.00%
00781178701
34
$956.62
0.17%
131
$2,947.53
0.51%
00781178760
0
$0.00
0.00%
14
$251.88
0.05%
00781178901
49
$518.40
0.25%
164
$1,865.15
0.64%
00781178910
0
$0.00
0.00%
1
$1.00
0.00%
00781178960
0
$0.00
0.00%
11
$147.63
0.04%
00781501701
47
$1,747.05
0.24%
97
$2,611.32
0.38%
00904174751
IBU-200
TAB 200MG
5
$23.30
0.03%
0
$0.00
0.00%
00904174760
IBU-200
TAB 200MG
1
$11.01
0.01%
1
$5.48
0.00%
00904174840
IBUPROFEN TAB 400MG
6
$48.68
0.03%
24
$176.13
0.09%
00904174860
IBUPROFEN TAB 400MG
1
$5.81
0.01%
4
$29.11
0.02%
00904175840
IBUPROFEN TAB 600MG
1
$5.26
0.01%
0
$0.00
0.00%
00904337960
SULINDAC
TAB 200MG
0
$0.00
0.00%
10
$143.70
0.04%
00904518640
IBUPROFEN TAB 600MG
1
$5.07
0.01%
59
$355.97
0.23%
00904518660
IBUPROFEN TAB 600MG
1
$4.57
0.01%
0
$0.00
0.00%
00904518661
IBUPROFEN TAB 600MG
2
$2.40
0.01%
3
$4.63
0.01%
00904518740
IBUPROFEN TAB 800MG
0
$0.00
0.00%
38
$237.78
0.15%
00904518760
IBUPROFEN TAB 800MG
0
$0.00
0.00%
9
$48.95
0.04%
00904522959
5
$38.67
0.03%
1
$5.91
0.00%
00904523051
ALL DAY RELI TAB 220MG
3
$25.32
0.02%
1
$7.60
0.00%
00904523059
ALL DAY RELI TAB 220MG
1
$4.35
0.01%
1
$6.94
0.00%
00904530920
CHLD IBUPROF SUS 100/5ML
36
$443.33
0.19%
57
$703.44
0.22%
00904558460
INDOMETHACIN CAP 75MG CR
0
$0.00
0.00%
3
$104.47
0.01%
00904559040
NAPROXEN
0
$0.00
0.00%
3
$16.21
0.01%
TAB 375MG
Page 429 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NSAIDS
00904780260
1
00904791259
IBUPROFEN TAB 200MG
00904791459
IBUPROFEN TAB 200MG
00904791524
$32.43
0.01%
1
$8.12
0.01%
2
$15.22
0.01%
IBUPROFEN TAB 200MG
17
$97.10
0.09%
00904791540
IBUPROFEN TAB 200MG
2
$14.71
00904791559
IBUPROFEN TAB 200MG
1
10019002209
KETOROLAC
INJ 30MG/ML
1
10019002232
KETOROLAC
INJ 30MG/ML
15127033501
$0.00
0.00%
9
$57.69
0.04%
30
$212.71
0.12%
0
$0.00
0.00%
0.01%
2
$7.42
0.01%
$8.12
0.01%
1
$1.89
0.00%
$6.37
0.01%
1
$12.21
0.00%
2
$77.96
0.01%
9
$139.31
0.04%
SB IBUPROFEN TAB 200MG
1
$4.25
0.01%
2
$9.37
0.01%
17236007610
NAPROXEN
TAB 250MG
6
$50.10
0.03%
0
$0.00
0.00%
17236007801
NAPROXEN
TAB 500MG
1
$11.95
0.01%
1
$10.45
0.00%
17236007805
NAPROXEN
TAB 500MG
10
$126.75
0.05%
0
$0.00
0.00%
17236056510
IBUPROFEN TAB 200MG
8
$42.80
0.04%
0
$0.00
0.00%
24385060478
IBUPROFEN TAB 200MG
0
$0.00
0.00%
2
$17.12
0.01%
24385064778
IBUPROFEN TAB 200MG
0
$0.00
0.00%
1
$4.65
0.00%
37205026171
6
$29.59
0.03%
7
$40.85
0.03%
37205026178
1
$9.01
0.01%
12
$72.80
0.05%
37205028226
3
$11.47
0.02%
5
$78.52
0.02%
37205034178
IBUPROFEN TAB 200MG
8
$44.02
0.04%
13
$55.57
0.05%
37205035071
IBUPROFEN TAB 200MG
3
$18.13
0.02%
1
$6.47
0.00%
37205035078
IBUPROFEN TAB 200MG
4
$26.54
0.02%
11
$54.97
0.04%
37205035085
IBUPROFEN TAB 200MG
2
$10.17
0.01%
12
$53.52
0.05%
37205064326
6
$89.67
0.03%
12
$151.53
0.05%
37205064426
1
$4.99
0.01%
2
$18.15
0.01%
37205064605
IBU-DROPS
DRO 40MG/ML
1
$7.39
0.01%
3
$22.17
0.01%
38245014610
NAPROXEN
TAB 250MG
2
$14.10
0.01%
0
$0.00
0.00%
49348019609
IBUPROFEN TAB 200MG
1
$6.32
0.01%
0
$0.00
0.00%
0
Page 430 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NSAIDS
49348022934
0
$0.00
0.00%
1
49348080810
IBUPROFEN TAB 200MG
1
$7.80
0.01%
49884016305
IBUPROFEN TAB 600MG
0
$0.00
0.00%
49884021601
IBUPROFEN TAB 800MG
1
$4.75
49884021605
IBUPROFEN TAB 800MG
31
49884046701
IBU
TAB 400MG
49884046705
IBU
TAB 400MG
49884046801
IBU
49884046805
$17.13
0.00%
0
$0.00
0.00%
5
$26.50
0.02%
0.01%
0
$0.00
0.00%
$268.16
0.16%
1
$2.50
0.00%
17
$114.43
0.09%
24
$149.02
0.09%
90
$549.67
0.46%
23
$134.00
0.09%
TAB 600MG
13
$85.65
0.07%
0
$0.00
0.00%
IBU
TAB 600MG
412
$2,738.46
2.12%
216
$1,178.31
0.84%
49884046901
IBU
TAB 800MG
17
$119.96
0.09%
10
$82.44
0.04%
49884046905
IBU
TAB 800MG
535
$3,791.78
2.75%
77
$485.85
0.30%
49884072301
OXAPROZIN
TAB 600MG
5
$392.91
0.03%
2
$85.30
0.01%
49884072305
OXAPROZIN
TAB 600MG
0
$0.00
0.00%
1
$43.90
0.00%
49884077701
IBUPROFEN TAB 400MG
13
$70.16
0.07%
19
$113.69
0.07%
49884077705
IBUPROFEN TAB 400MG
174
$1,135.75
0.89%
326
$1,697.78
1.27%
49884077801
IBUPROFEN TAB 600MG
3
$19.37
0.02%
10
$47.77
0.04%
49884077805
IBUPROFEN TAB 600MG
1,418
$8,940.04
7.29%
2,243
$11,262.44
8.74%
49884077901
IBUPROFEN TAB 800MG
17
$119.08
0.09%
14
$90.70
0.05%
49884077905
IBUPROFEN TAB 800MG
2,599
$18,981.53
13.36%
4,692
$28,020.12
18.28%
50111040601
4
$64.77
0.02%
0
$0.00
0.00%
50111040603
13
$149.96
0.07%
3
$23.43
0.01%
50111040701
1
$10.23
0.01%
0
$0.00
0.00%
50111060801
KETOROLAC
0
$0.00
0.00%
1
$9.65
0.00%
50428232565
IBUPROFEN IB TAB 200MG
0
$0.00
0.00%
1
$0.29
0.00%
50580010015
CHLRNS MOTRN DRO BERRY
1
$7.67
0.01%
0
$0.00
0.00%
50580048100
MOTRIN IB
0
$0.00
0.00%
1
$7.96
0.00%
50580060104
CHILD MOTRIN SUS 100/5ML
0
$0.00
0.00%
1
$8.50
0.00%
TAB 10MG
TAB 200MG
Page 431 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NSAIDS
51079019020
0
51079028124
IBUPROFEN TAB 400MG
51672401601
ETODOLAC
CAP 200MG
51672401701
ETODOLAC
51672401801
$0.00
0.00%
1
$0.44
0.01%
1
$35.75
0.01%
CAP 300MG
4
$110.60
0.02%
ETODOLAC
TAB 400MG
30
$559.96
51672403601
ETODOLAC
TAB 500MG
6
51672405204
0
51991073005
IBUPROFEN TAB 600MG
52544033801
$10.48
0.00%
0
$0.00
0.00%
41
$908.45
0.16%
40
$1,104.23
0.16%
0.15%
141
$2,533.86
0.55%
$262.69
0.03%
37
$1,600.73
0.14%
$0.00
0.00%
2
$120.50
0.01%
4
$27.16
0.02%
0
$0.00
0.00%
3
$69.13
0.02%
0
$0.00
0.00%
52544033810
5
$110.25
0.03%
6
$89.34
0.02%
52544033860
5
$119.75
0.03%
0
$0.00
0.00%
52544033901
14
$149.49
0.07%
25
$324.34
0.10%
52544033960
7
$48.84
0.04%
0
$0.00
0.00%
52544071201
PIROXICAM
CAP 10MG
9
$65.27
0.05%
3
$28.93
0.01%
52544071301
PIROXICAM
CAP 20MG
35
$188.49
0.18%
16
$61.34
0.06%
52544071305
PIROXICAM
CAP 20MG
22
$102.61
0.11%
0
$0.00
0.00%
52544079101
NAPROXEN
TAB 500MG
15
$175.00
0.08%
0
$0.00
0.00%
52544079105
NAPROXEN
TAB 500MG
6
$56.56
0.03%
0
$0.00
0.00%
52544079301
6
$107.92
0.03%
0
$0.00
0.00%
52555020501
3
$43.50
0.02%
0
$0.00
0.00%
52555097201
PIROXICAM
CAP 10MG
1
$8.20
0.01%
3
$16.64
0.01%
52555097301
PIROXICAM
CAP 20MG
74
$408.88
0.38%
108
$445.03
0.42%
52555097305
PIROXICAM
CAP 20MG
48
$270.26
0.25%
49
$202.37
0.19%
52735057741
13
$89.09
0.07%
13
$89.05
0.05%
53265026910
33
$2,110.84
0.17%
105
$6,056.93
0.41%
53265026960
0
$0.00
0.00%
7
$361.84
0.03%
53489047801
SULINDAC
165
$2,837.66
0.85%
196
$3,087.17
0.76%
TAB 150MG
1
Page 432 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NSAIDS
53489047805
SULINDAC
TAB 150MG
1
$18.10
0.01%
1
$19.10
0.00%
53489047901
SULINDAC
TAB 200MG
273
$5,782.20
1.40%
327
$6,722.84
1.27%
53489047905
SULINDAC
TAB 200MG
14
$308.38
0.07%
0
$0.00
0.00%
53489050601
0
$0.00
0.00%
2
$162.70
0.01%
53746013101
IBUPROFEN TAB 400MG
4
$26.69
0.02%
0
$0.00
0.00%
53746013105
IBUPROFEN TAB 400MG
10
$55.12
0.05%
39
$220.53
0.15%
53746013201
IBUPROFEN TAB 600MG
1
$5.07
0.01%
9
$48.69
0.04%
53746013205
IBUPROFEN TAB 600MG
35
$232.77
0.18%
59
$326.84
0.23%
53746013501
IBUPROFEN TAB 200MG
3
$7.95
0.02%
9
$57.41
0.04%
53746013510
IBUPROFEN TAB 200MG
0
$0.00
0.00%
1
$0.69
0.00%
53746013701
IBUPROFEN TAB 800MG
0
$0.00
0.00%
27
$164.67
0.11%
53746013705
IBUPROFEN TAB 800MG
163
$1,221.31
0.84%
208
$1,258.33
0.81%
53746018801
NAPROXEN
TAB 250MG
0
$0.00
0.00%
6
$41.40
0.02%
53746018901
NAPROXEN
TAB 375MG
0
$0.00
0.00%
5
$57.05
0.02%
53746018905
NAPROXEN
TAB 375MG
0
$0.00
0.00%
2
$14.90
0.01%
53746019001
NAPROXEN
TAB 500MG
4
$47.80
0.02%
0
$0.00
0.00%
53746019005
NAPROXEN
TAB 500MG
7
$80.56
0.04%
12
$122.78
0.05%
54569200500
IBUPROFEN TAB 200MG
0
$0.00
0.00%
1
$5.30
0.00%
55111010101
IBUPROFEN TAB 400MG
0
$0.00
0.00%
40
$175.81
0.16%
55111010105
IBUPROFEN TAB 400MG
0
$0.00
0.00%
1
$3.81
0.00%
55111010205
IBUPROFEN TAB 600MG
0
$0.00
0.00%
256
$1,271.54
1.00%
55111010301
IBUPROFEN TAB 800MG
0
$0.00
0.00%
2
$12.60
0.01%
55111010305
IBUPROFEN TAB 800MG
0
$0.00
0.00%
394
$2,267.90
1.54%
55111017001
OXAPROZIN
TAB 600MG
0
$0.00
0.00%
81
$3,156.12
0.32%
55370013907
NAPROXEN
TAB 250MG
52
$368.74
0.27%
52
$312.33
0.20%
55370013909
NAPROXEN
TAB 250MG
0
$0.00
0.00%
1
$15.25
0.00%
55370014007
NAPROXEN
TAB 375MG
140
$1,212.99
0.72%
135
$942.94
0.53%
Page 433 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NSAIDS
55370014009
NAPROXEN
TAB 375MG
15
$124.65
0.08%
3
$21.55
0.01%
55370014107
NAPROXEN
TAB 500MG
128
$1,468.69
0.66%
129
$1,289.43
0.50%
55370014108
NAPROXEN
TAB 500MG
808
$8,900.43
4.15%
370
$3,677.18
1.44%
55390048101
KETOROLAC
INJ 30MG/ML
5
$98.88
0.03%
2
$7.38
0.01%
57664016508
0
$0.00
0.00%
10
$193.40
0.04%
57664039108
OXAPROZIN
TAB 600MG
7
$288.87
0.04%
45
$1,797.46
0.18%
57896054001
IBUPROFEN TAB 200MG
0
$0.00
0.00%
2
$11.24
0.01%
58177030104
KETOROLAC
95
$1,369.55
0.49%
94
$1,157.84
0.37%
58177030204
12
$458.62
0.06%
10
$374.50
0.04%
58177030304
157
$5,466.21
0.81%
200
$6,753.43
0.78%
59630040010
PONSTEL
50
$2,089.43
0.26%
35
$1,625.02
0.14%
59762372401
8
$111.80
0.04%
16
$382.00
0.06%
59762372403
0
$0.00
0.00%
1
$9.85
0.00%
59762500201
OXAPROZIN
TAB 600MG
35
$1,954.65
0.18%
26
$948.28
0.10%
59762500202
OXAPROZIN
TAB 600MG
0
$0.00
0.00%
2
$82.80
0.01%
59762737801
IBUPROFEN TAB 400MG
31
$188.48
0.16%
0
$0.00
0.00%
59762737802
IBUPROFEN TAB 400MG
176
$1,156.08
0.90%
81
$468.67
0.32%
59762737901
IBUPROFEN TAB 600MG
11
$67.24
0.06%
2
$11.00
0.01%
59762737902
IBUPROFEN TAB 600MG
598
$3,941.00
3.07%
144
$806.75
0.56%
59762738001
IBUPROFEN TAB 800MG
13
$88.42
0.07%
11
$88.17
0.04%
59762738002
IBUPROFEN TAB 800MG
913
$6,854.33
4.69%
419
$2,583.41
1.63%
59911360601
ETODOLAC
CAP 200MG
1
$14.15
0.01%
1
$24.23
0.00%
59911360701
ETODOLAC
CAP 300MG
3
$39.83
0.02%
6
$138.90
0.02%
59911360801
ETODOLAC
TAB 400MG
2
$40.12
0.01%
0
$0.00
0.00%
59911588701
3
$282.69
0.02%
0
$0.00
0.00%
59911588801
4
$320.93
0.02%
0
$0.00
0.00%
59911588901
2
$117.46
0.01%
0
$0.00
0.00%
TAB 10MG
CAP 250MG
Page 434 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
NSAIDS
59930150801
OXAPROZIN
TAB 600MG
73
$4,819.78
0.38%
24
59930150802
OXAPROZIN
60951078070
SULINDAC
TAB 150MG
TAB 600MG
1
$56.18
0.01%
2
$36.20
0.01%
60951078085
SULINDAC
TAB 150MG
15
$254.78
60951078170
SULINDAC
TAB 200MG
3
62037052001
62037082675
NAPROXEN SOD TAB 500MG CR
62269028724
$1,001.01
0.09%
0
$0.00
0.00%
7
$123.70
0.03%
0.08%
0
$0.00
0.00%
$49.97
0.02%
7
$155.17
0.03%
78
$6,460.79
0.40%
109
$8,806.62
0.42%
8
$626.56
0.04%
10
$623.15
0.04%
1
$48.60
0.01%
0
$0.00
0.00%
62269028924
5
$183.25
0.03%
0
$0.00
0.00%
62269029024
6
$281.10
0.03%
0
$0.00
0.00%
63304068101
NALFON
CAP 200MG
1
$10.58
0.01%
0
$0.00
0.00%
63304068201
NALFON
CAP 300MG
4
$260.60
0.02%
1
$28.84
0.00%
63304069001
PIROXICAM
CAP 10MG
5
$28.60
0.03%
17
$86.28
0.07%
63304069101
PIROXICAM
CAP 20MG
145
$807.43
0.75%
288
$1,116.74
1.12%
63304069105
PIROXICAM
CAP 20MG
6
$31.50
0.03%
33
$131.49
0.13%
64899000950
IBUPROFEN M TAB 200MG
0
$0.00
0.00%
1
$7.93
0.00%
67253062010
NAPROXEN
TAB 250MG
0
$0.00
0.00%
19
$185.01
0.07%
67253062110
NAPROXEN
TAB 375MG
0
$0.00
0.00%
18
$165.68
0.07%
67253062111
NAPROXEN
TAB 375MG
0
$0.00
0.00%
13
$120.12
0.05%
67253062210
NAPROXEN
TAB 500MG
0
$0.00
0.00%
165
$1,613.51
0.64%
67253062250
NAPROXEN
TAB 500MG
0
$0.00
0.00%
860
$8,439.06
3.35%
87701088535
1
$7.00
0.01%
2
$22.44
0.01%
SOL OP
7
$149.36
0.21%
1
$30.91
0.03%
DRO 0.3%
0
$0.00
0.00%
151
$6,436.13
4.19%
2
$22.34
0.06%
1
$10.25
0.03%
OPHTHALMIC ANTIBIOTICS
00023782410
POLYTRIM
00023921805
ZYMAR
00049080108
TERRAMYCIN OIN POLYM OP
Page 435 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
TOBREX
OIN 0.3% OP
00168002638
BACITRACIN OIN OP
00168002738
BAC/NEO/POLY OIN OP
00168007038
$
Market Share*
00065064435
# of Scripts
43
$1,799.53
1.28%
35
$1,515.97
0.97%
70
$450.50
2.09%
77
$416.62
2.13%
7
$67.12
0.21%
10
$84.45
0.28%
ERYTHROMYCIN OIN OP
631
$4,604.19
18.82%
701
$4,882.26
19.43%
00168007039
ERYTHROMYCIN OIN OP
1
$6.25
0.03%
1
$5.38
0.03%
00168007938
SULFACET SOD OIN 10% OP
51
$488.15
1.52%
40
$339.03
1.11%
00168022015
SOD SULFACET SOL 10% OP
31
$168.42
0.92%
9
$50.85
0.25%
00168027338
BACIT/POLYMY OIN OP
6
$62.10
0.18%
0
$0.00
0.00%
00364713672
1
$5.65
0.03%
0
$0.00
0.00%
00603713770
ERYTHROMYCIN OIN OP
0
$0.00
0.00%
1
$7.18
0.03%
00603728041
29
$130.31
0.86%
2
$11.30
0.06%
00603734537
TOBRAMYCIN SOL 0.3% OP
0
$0.00
0.00%
1
$6.75
0.03%
00677090621
OCUTRICIN SOL OP
4
$95.70
0.12%
1
$23.04
0.03%
00677091730
6
$33.90
0.18%
1
$5.65
0.03%
00777186317
ILOTYCIN
1
$8.20
0.03%
0
$0.00
0.00%
00904190705
GENTAMICIN SOL 0.3% OP
1
$6.62
0.03%
0
$0.00
0.00%
00904272835
6
$31.70
0.18%
13
$65.95
0.36%
00904296838
BACIT/POLYMY OIN OP
2
$20.70
0.06%
0
$0.00
0.00%
00904297005
0
$0.00
0.00%
1
$4.25
0.03%
00904301610
NEOCIDIN
0
$0.00
0.00%
1
$25.54
0.03%
00904792638
ERYTHROMYCIN OIN OP
3
$23.88
0.09%
1
$7.66
0.03%
11980001105
BLEPH-10
2
$8.24
0.06%
0
$0.00
0.00%
11980010908
CHLOROPTIC SOL 0.5% OP
1
$22.58
0.03%
0
$0.00
0.00%
17478007035
ERYTHROMYCIN OIN OP
3
$21.83
0.09%
2
$7.53
0.06%
17478022112
SULFACET SOD SOL 10% OP
68
$370.68
2.03%
2
$10.53
0.06%
17478022735
AK-SULF
3
$18.90
0.09%
1
$6.30
0.03%
17478023035
TERAK
1
$16.01
0.03%
0
$0.00
0.00%
OIN OP
SOL OP
SOL 10% OP
OIN 10% OP
OIN OPHTH
Page 436 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
AK-SPORE
OIN OP
17478023835
AK-POLY-BAC OIN OP
17478028310
GENTAK
SOL 0.3% OP
17478028435
GENTAK
OIN 0.3% OP
17478029010
AK-TOB
SOL 0.3% OP
17478070311
TRIMETHOPRIM SOL POLYMYXN
24208029005
24208031510
24208041905
24208041915
24208055555
BACIT/POLYMY OIN OP
24208058060
$
Market Share*
17478023535
# of Scripts
2
$16.96
0.06%
3
$21.66
0.08%
3
$30.05
16
$104.07
0.09%
9
$86.40
0.25%
0.48%
18
$86.62
0.50%
59
$1,114.46
1.76%
89
$1,631.37
2.47%
4
$24.75
0.12%
7
$47.25
0.19%
1
$15.71
0.03%
3
$44.63
0.08%
91
$592.61
2.71%
103
$617.32
2.85%
303
$4,576.97
9.04%
334
$4,973.58
9.26%
1
$6.62
0.03%
0
$0.00
0.00%
2
$25.32
0.06%
0
$0.00
0.00%
76
$757.24
2.27%
52
$459.43
1.44%
325
$2,135.96
9.69%
318
$1,418.53
8.81%
24208058064
25
$307.06
0.75%
12
$88.86
0.33%
24208067004
369
$1,984.48
11.01%
434
$2,178.16
12.03%
24208078055
NEO/BAC/POLY OIN OP
10
$160.28
0.30%
7
$106.92
0.19%
24208079062
NEO/POLY/GRA SOL OP
97
$2,415.76
2.89%
74
$1,863.68
2.05%
24208091055
ERYTHROMYCIN OIN OP
419
$3,399.31
12.50%
491
$3,626.92
13.61%
52238065015
OCUSULF-10 SOL 10% OP
18
$96.50
0.54%
2
$11.30
0.06%
58768025136
GENTAMICIN OIN 0.3% OP
3
$52.92
0.09%
0
$0.00
0.00%
58768036505
GENTACIDIN SOL 0.3% OP
0
$0.00
0.00%
1
$5.00
0.03%
60758018805
1
$6.12
0.03%
16
$74.15
0.44%
60758090810
15
$222.99
0.45%
6
$94.26
0.17%
61314004475
TRIFLURIDINE SOL 1% OP
61314062810
POLYMYXIN B/ SOL TRIMETHP
61314063305
7
$481.98
0.21%
6
$474.01
0.17%
94
$1,400.19
2.80%
119
$1,779.63
3.30%
314
$2,051.24
9.36%
240
$1,079.35
6.65%
61314064305
105
$659.03
3.13%
108
$634.85
2.99%
61314070101
SULFACET SOD SOL 10% OP
0
$0.00
0.00%
94
$455.44
2.61%
Page 437 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
VIROPTIC
61570004510
61570004635
61570004935
SOL 1% OP
$
Market Share*
61570003775
# of Scripts
8
$617.11
0.24%
6
$460.64
0.17%
NEOSPORIN SOL OP
1
$25.54
0.03%
NEOSPORIN OIN OP
3
$95.24
0.09%
0
$0.00
0.00%
1
$30.47
0.03%
POLYSPORIN OIN OP
1
$9.35
0.03%
2
$61.10
0.06%
OPHTHALMIC NSAIAS
00023218103
ACULAR
SOL 0.5% OP
1
$30.70
0.46%
0
$0.00
0.00%
00023218105
ACULAR
SOL 0.5% OP
132
$6,684.27
60.55%
53
$3,167.41
32.92%
00023218110
ACULAR
SOL 0.5% OP
25
$2,326.96
11.47%
10
$1,083.10
6.21%
00023927705
ACULAR LS
SOL 0.4%
0
$0.00
0.00%
2
$110.92
1.24%
11980080103
OCUFEN
SOL 0.03% OP
2
$27.04
0.92%
0
$0.00
0.00%
24208031425
FLURBIPROFEN SOL 0.03% OP
3
$60.43
1.38%
4
$44.42
2.48%
58768010002
VOLTAREN
SOL 0.1% OP
12
$415.02
5.50%
16
$539.60
9.94%
58768010005
VOLTAREN
SOL 0.1% OP
42
$1,846.48
19.27%
75
$3,918.00
46.58%
60758091003
FLURBIPROFEN SOL 0.03% OP
1
$12.83
0.46%
1
$12.83
0.62%
OPHTHALMIC QUINOLONES
00065065435
CILOXAN
OIN 0.3% OP
42
$1,893.04
4.48%
28
$1,617.06
3.32%
00065065605
CILOXAN
SOL 0.3% OP
505
$19,781.47
53.84%
332
$14,585.19
39.38%
00065065610
CILOXAN
SOL 0.3% OP
8
$556.43
0.85%
2
$174.18
0.24%
00065065625
CILOXAN
SOL 0.3% OP
37
$822.12
3.94%
40
$928.49
4.74%
00065401303
VIGAMOX
DRO 0.5%
0
$0.00
0.00%
294
$13,293.17
34.88%
11980077905
OCUFLOX
SOL 0.3% OP
318
$11,591.77
33.90%
119
$4,930.76
14.12%
11980077910
OCUFLOX
SOL 0.3% OP
13
$888.17
1.39%
16
$1,158.97
1.90%
65086013505
QUIXIN
15
$521.08
1.60%
12
$442.74
1.42%
SOL 0.5%
OSTEOPOROSIS
Page 438 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
OSTEOPOROSIS
00002416502
EVISTA
TAB 60MG
729
$46,723.45
7.71%
420
$27,386.68
3.81%
00002416530
EVISTA
TAB 60MG
872
$55,757.93
9.22%
375
$25,226.79
3.40%
00002897101
FORTEO
0
$0.00
0.00%
24
$13,016.35
0.22%
00006003121
FOSAMAX
TAB 70MG
165
$9,214.19
1.74%
318
$19,000.04
2.88%
00006003144
FOSAMAX
TAB 70MG
3,249
$193,591.76
34.34%
4,472
$286,359.27
40.53%
00006007721
FOSAMAX
TAB 35MG
6
$360.12
0.06%
10
$652.55
0.09%
00006007744
FOSAMAX
TAB 35MG
162
$10,132.95
1.71%
289
$18,487.60
2.62%
00006092531
FOSAMAX
TAB 5MG
51
$3,241.43
0.54%
43
$2,910.36
0.39%
00006092558
FOSAMAX
TAB 5MG
34
$2,160.84
0.36%
15
$1,172.83
0.14%
00006093631
FOSAMAX
TAB 10MG
205
$13,217.58
2.17%
143
$9,112.75
1.30%
00006093658
FOSAMAX
TAB 10MG
181
$11,682.76
1.91%
155
$9,996.46
1.40%
00078031190
MIACALCIN SPR 200IU/AC
2,286
$117,751.31
24.16%
1,240
$71,689.96
11.24%
00083260104
AREDIA
2
$1,221.09
0.02%
1
$490.31
0.01%
00149040560
DIDRONEL
TAB 200MG
13
$970.91
0.14%
17
$2,032.32
0.15%
00149040660
DIDRONEL
TAB 400MG
41
$3,303.27
0.43%
28
$2,285.65
0.25%
00149047001
ACTONEL
TAB 30MG
471
$29,764.43
4.98%
369
$25,415.09
3.34%
00149047101
ACTONEL
TAB 5MG
182
$10,579.14
1.92%
152
$10,424.19
1.38%
00149047201
ACTONEL
TAB 35MG
811
$45,155.64
8.57%
2,963
$180,819.70
26.85%
SOL 750/3ML
INJ 30MG
OTHER ANTI-HYPERTENSIVES - CENTRAL
00005318023
CLONIDINE
TAB 0.1MG
24
$166.18
0.29%
2
$16.60
0.02%
00005318034
CLONIDINE
TAB 0.1MG
100
$683.58
1.22%
20
$143.90
0.21%
00005318123
CLONIDINE
TAB 0.2MG
21
$207.01
0.26%
17
$142.69
0.18%
00005318134
CLONIDINE
TAB 0.2MG
46
$426.27
0.56%
10
$74.00
0.10%
00005318223
CLONIDINE
TAB 0.3MG
8
$70.72
0.10%
2
$21.14
0.02%
00005347443
PRAZOSIN HCL CAP 2MG
1
$14.95
0.01%
0
$0.00
0.00%
00031890163
TENEX
115
$7,485.73
1.40%
12
$1,332.69
0.12%
TAB 1MG
Page 439 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00031890170
TENEX
TAB 1MG
1
$42.15
0.01%
0
$0.00
0.00%
00031890363
TENEX
TAB 2MG
5
$271.45
0.06%
2
$506.58
0.02%
00069437071
MINIPRESS
2
$76.80
0.02%
0
$0.00
0.00%
00172293160
METHYLDOPA TAB 250MG
54
$1,237.95
0.66%
83
$1,625.70
0.86%
00172293180
3
$45.20
0.04%
5
$58.32
0.05%
00172293260
14
$509.74
0.17%
23
$637.43
0.24%
00172293270
13
$309.46
0.16%
9
$156.90
0.09%
00172406760
35
$337.19
0.43%
53
$393.40
0.55%
00172406780
4
$30.85
0.05%
0
$0.00
0.00%
00172406860
21
$509.05
0.26%
16
$340.11
0.17%
00172406865
2
$42.50
0.02%
0
$0.00
0.00%
00172406880
1
$5.87
0.01%
2
$82.30
0.02%
00172406960
6
$201.90
0.07%
16
$451.82
0.17%
00172406965
3
$101.85
0.04%
0
$0.00
0.00%
00172406970
2
$33.56
0.02%
0
$0.00
0.00%
00172422660
GUANABENZ
0
$0.00
0.00%
3
$52.22
0.03%
00182055489
HYDRALAZINE TAB 25MG
0
$0.00
0.00%
2
$21.92
0.02%
00185003201
RESERPINE
TAB 0.1MG
23
$211.59
0.28%
18
$157.78
0.19%
00185013401
RESERPINE
TAB 0.25MG
33
$756.02
0.40%
21
$431.46
0.22%
00228212710
CLONIDINE
TAB 0.1MG
481
$3,148.05
5.87%
517
$3,193.41
5.37%
00228212750
CLONIDINE
TAB 0.1MG
1,496
$10,334.36
18.27%
1,897
$12,152.09
19.69%
00228212810
CLONIDINE
TAB 0.2MG
110
$957.02
1.34%
171
$1,429.35
1.78%
00228212850
CLONIDINE
TAB 0.2MG
290
$2,545.96
3.54%
387
$3,567.77
4.02%
00228212910
CLONIDINE
TAB 0.3MG
100
$887.98
1.22%
157
$1,375.38
1.63%
00364217201
MINOXIDIL
TAB 2.5MG
3
$27.75
0.04%
0
$0.00
0.00%
00364217301
MINOXIDIL
TAB 10MG
3
$30.45
0.04%
3
$25.95
0.03%
00378015201
CLONIDINE
TAB 0.1MG
559
$3,662.32
6.83%
1,409
$9,096.84
14.63%
CAP 2MG
TAB 4MG
Page 440 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00378015210
CLONIDINE
TAB 0.1MG
1,806
$12,314.24
22.05%
1,691
$11,044.56
17.56%
00378018601
CLONIDINE
TAB 0.2MG
339
$3,113.66
4.14%
450
$4,053.61
4.67%
00378018610
CLONIDINE
TAB 0.2MG
67
$669.07
0.82%
105
$862.95
1.09%
00378019901
CLONIDINE
TAB 0.3MG
66
$659.43
0.81%
136
$1,235.94
1.41%
00378042101
35
$1,118.22
0.43%
39
$1,243.36
0.40%
00378042105
2
$68.78
0.02%
0
$0.00
0.00%
00378061101
29
$441.77
0.35%
38
$729.75
0.39%
00378061110
8
$165.10
0.10%
9
$221.57
0.09%
00378110101
17
$176.48
0.21%
38
$269.33
0.39%
00378116001
GUANFACINE TAB 1MG
297
$5,262.26
3.63%
352
$4,187.57
3.65%
00378119001
GUANFACINE TAB 2MG
57
$1,218.95
0.70%
48
$975.90
0.50%
00378230201
30
$614.37
0.37%
45
$603.90
0.47%
00378320501
4
$130.80
0.05%
9
$227.01
0.09%
00378320525
10
$270.30
0.12%
5
$75.65
0.05%
00591044401
GUANFACINE TAB 1MG
322
$4,897.60
3.93%
359
$3,835.73
3.73%
00591045301
GUANFACINE TAB 2MG
36
$796.35
0.44%
31
$639.10
0.32%
00591564201
MINOXIDIL
TAB 2.5MG
7
$125.60
0.09%
9
$277.61
0.09%
00591564205
MINOXIDIL
TAB 2.5MG
0
$0.00
0.00%
4
$122.42
0.04%
00591564301
MINOXIDIL
TAB 10MG
4
$116.58
0.05%
11
$179.47
0.11%
00597000601
CATAPRES
TAB 0.1MG
29
$1,663.07
0.35%
17
$1,069.21
0.18%
00597000701
CATAPRES
TAB 0.2MG
9
$589.76
0.11%
0
$0.00
0.00%
00597001101
CATAPRES
TAB 0.3MG
5
$235.69
0.06%
1
$50.37
0.01%
00597003112
CATAPRES-TTS DIS 0.1/24HR
254
$10,857.19
3.10%
264
$12,527.59
2.74%
00597003212
188
$13,010.39
2.30%
181
$15,596.06
1.88%
00597003334
172
$18,316.45
2.10%
224
$27,284.55
2.33%
00603377421
GUANFACINE TAB 1MG
4
$51.79
0.05%
1
$12.95
0.01%
00603383121
0
$0.00
0.00%
2
$2.00
0.02%
Page 441 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00615257253
CLONIDINE
TAB 0.1MG
7
$45.70
0.09%
0
$0.00
0.00%
00615257263
CLONIDINE
TAB 0.1MG
164
$1,024.86
2.00%
0
$0.00
0.00%
00615257353
CLONIDINE
TAB 0.2MG
9
$64.25
0.11%
0
$0.00
0.00%
00615257363
CLONIDINE
TAB 0.2MG
18
$149.10
0.22%
0
$0.00
0.00%
00904557960
GUANFACINE TAB 1MG
0
$0.00
0.00%
29
$319.55
0.30%
49884002701
21
$99.09
0.26%
5
$35.30
0.05%
49884002710
10
$70.42
0.12%
3
$22.38
0.03%
49884002801
13
$115.36
0.16%
7
$50.68
0.07%
49884002810
2
$17.00
0.02%
0
$0.00
0.00%
49884002901
3
$17.12
0.04%
13
$94.78
0.13%
49884002910
4
$28.56
0.05%
0
$0.00
0.00%
49884012101
6
$68.04
0.07%
5
$48.73
0.05%
49884012110
3
$33.33
0.04%
0
$0.00
0.00%
49884025601
MINOXIDIL
TAB 2.5MG
37
$764.05
0.45%
35
$844.63
0.36%
49884025701
MINOXIDIL
TAB 10MG
6
$125.29
0.07%
13
$411.05
0.13%
49884025705
MINOXIDIL
TAB 10MG
3
$103.65
0.04%
0
$0.00
0.00%
49884057201
GUANFACINE TAB 1MG
13
$156.91
0.16%
19
$179.86
0.20%
49884057301
GUANFACINE TAB 2MG
0
$0.00
0.00%
2
$36.85
0.02%
50111032701
89
$664.02
1.09%
106
$684.74
1.10%
50111032703
72
$509.70
0.88%
55
$354.14
0.57%
50111032801
58
$497.38
0.71%
117
$876.57
1.21%
50111032803
29
$226.41
0.35%
51
$372.18
0.53%
50111039701
15
$172.78
0.18%
31
$337.33
0.32%
50111039801
81
$635.10
0.99%
78
$477.12
0.81%
50111039803
50
$358.57
0.61%
66
$434.36
0.69%
51079030120
CLONIDINE
TAB 0.3MG
2
$12.02
0.02%
0
$0.00
0.00%
52152011802
GUANFACINE TAB 1MG
56
$1,023.45
0.68%
30
$366.60
0.31%
Page 442 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
52152011902
GUANFACINE TAB 2MG
7
$109.25
0.09%
4
$168.40
0.04%
52544044401
GUANFACINE TAB 1MG
20
$282.50
0.24%
20
$133.20
0.21%
52544045301
GUANFACINE TAB 2MG
5
$192.25
0.06%
0
$0.00
0.00%
53489038601
MINOXIDIL
TAB 2.5MG
2
$45.10
0.02%
5
$100.85
0.05%
53489038701
MINOXIDIL
TAB 10MG
9
$419.75
0.11%
12
$467.18
0.12%
Other Antihistamines
00054819004
DIPHENHYDRAM ELX 12.5/5ML
0
$0.00
0.00%
2
$9.98
0.05%
00074229001
DIPHENHYDRAM INJ 50MG/ML
4
$45.28
0.11%
0
$0.00
0.00%
00085000902
CHLOR-TRIMET TAB 12MG CR
2
$25.28
0.05%
1
$19.53
0.02%
00085000903
4
$59.05
0.11%
8
$135.35
0.19%
00085000909
1
$25.47
0.03%
5
$79.11
0.12%
00085008001
CHLOR-TRIMET TAB 4MG
0
$0.00
0.00%
1
$8.37
0.02%
00085008002
CHLOR-TRIMET TAB 4MG
0
$0.00
0.00%
1
$6.53
0.02%
00085037402
6
$83.36
0.16%
0
$0.00
0.00%
00085037409
18
$257.91
0.48%
10
$177.07
0.23%
00093030801
CLEMASTINE TAB 2.68MG
247
$3,956.28
6.55%
244
$3,723.40
5.72%
00093030912
CLEMASTINE SYP 0.67/5ML
20
$653.18
0.53%
39
$1,173.83
0.91%
00121048905
0
$0.00
0.00%
2
$9.98
0.05%
00172292960
CYPROHEPTAD TAB 4MG
172
$2,679.23
4.56%
177
$2,631.28
4.15%
00172292980
CYPROHEPTAD TAB 4MG
28
$331.23
0.74%
16
$174.78
0.37%
00182047101
CHLORPHENIR TAB 4MG
46
$172.08
1.22%
41
$130.23
0.96%
00182047110
CHLORPHENIR TAB 4MG
41
$122.22
1.09%
32
$71.07
0.75%
00182049210
DIPHENHYDRAM CAP 25MG
370
$1,546.39
9.81%
407
$1,467.85
9.54%
00182101501
DEXCHLORPHEN TAB 6MG TR
1
$12.10
0.03%
0
$0.00
0.00%
00182113289
CYPROHEPTAD TAB 4MG
3
$46.97
0.08%
4
$25.72
0.09%
00182200137
GENAHIST
0
$0.00
0.00%
10
$49.90
0.23%
ELX 12.5/5ML
Page 443 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00182616837
HYDRAMINE
ELX 12.5/5ML
00182616840
HYDRAMINE
ELX 12.5/5ML
00185064801
00185064810
00185064901
$0.00
0.00%
$4.97
0.02%
17
$88.89
0.45%
236
$1,509.92
6.25%
14
$86.76
0.33%
250
$1,351.89
5.86%
217
$1,099.76
5.75%
143
$627.12
3.35%
66
$357.50
1.75%
75
$353.36
1.76%
00185064910
76
00247082814
0
$417.71
2.01%
84
$409.35
1.97%
$0.00
0.00%
1
$29.18
0.02%
00472122394
HYDRAMINE
ELX 12.5/5ML
5
$43.16
0.13%
0
$0.00
0.00%
00472123216
HYDRAMINE
SYP 12.5/5ML
3
$12.08
0.08%
1
$1.59
0.02%
00536037097
00536063297
ALLER-CHLOR SYP 2MG/5ML
6
$47.14
0.16%
6
$47.09
0.14%
DIPHENHYDRAM SYP 12.5/5ML
1
$4.58
0.03%
0
$0.00
0.00%
00536077085
DIPHENHIST ELX 12.5/5ML
31
$159.52
0.82%
36
$229.88
0.84%
00536077097
DIPHENHIST ELX 12.5/5ML
23
$129.26
0.61%
12
$62.18
0.28%
00536359401
DIPHENHIST CAP 25MG
53
$337.27
1.40%
28
$144.30
0.66%
00555005902
399
$2,253.57
10.58%
621
$2,502.77
14.55%
00555005905
88
$413.74
2.33%
120
$513.19
2.81%
00591400901
DEXCHLOR
0
$0.00
0.00%
1
$30.10
0.02%
00603024018
Q-DRYL
CAP 25MG
2
$16.92
0.05%
0
$0.00
0.00%
00603082358
Q-DRYL
ELX 12.5/5ML
0
$0.00
0.00%
1
$4.51
0.02%
00603082394
Q-DRYL
ELX 12.5/5ML
1
$4.97
0.03%
5
$17.41
0.12%
00603109654
1
$10.53
0.03%
1
$39.23
0.02%
00603278421
CHLORPHENIR CAP 8MG TR
40
$325.36
1.06%
33
$246.04
0.77%
00603278432
5
$58.99
0.13%
5
$39.80
0.12%
00603278521
36
$283.83
0.95%
39
$217.85
0.91%
00603278532
14
$114.80
0.37%
9
$55.90
0.21%
00603333721
0
$0.00
0.00%
132
$773.21
3.09%
00603333732
0
$0.00
0.00%
17
$63.03
0.40%
TAB 6MG CR
0
1
Page 444 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00603333821
0
$0.00
0.00%
1
$0.91
0.02%
00603333832
124
$582.82
3.29%
173
$829.50
4.05%
00615036953
5
$25.57
0.13%
0
$0.00
0.00%
00615036963
33
$167.22
0.87%
0
$0.00
0.00%
00641037625
31
$320.64
0.82%
25
$294.16
0.59%
00677168701
CHLORPHENIR TAB 4MG
31
$88.45
0.82%
36
$96.75
0.84%
00677168710
CHLORPHENIR TAB 4MG
56
$191.97
1.48%
40
$61.24
0.94%
00677185801
DIPHENHYDRAM TAB 25MG
0
$0.00
0.00%
1
$0.59
0.02%
00781114801
CHLORPHENIR TAB 4MG
37
$161.22
0.98%
2
$3.04
0.05%
00781135801
345
$6,705.62
9.14%
384
$6,931.46
9.00%
00781135901
280
$4,421.94
7.42%
312
$4,765.86
7.31%
00904001259
ALLERGY
TAB 4MG
5
$22.58
0.13%
6
$28.32
0.14%
00904001280
ALLERGY
TAB 4MG
4
$14.04
0.11%
6
$16.56
0.14%
00904114580
CYPROHEPTAD TAB 4MG
3
$39.13
0.08%
0
$0.00
0.00%
00904114616
CYPROHEPTAD SYP 2MG/5ML
1
$8.72
0.03%
0
$0.00
0.00%
00904122716
1
$3.47
0.03%
0
$0.00
0.00%
00904122800
BANOPHEN
ELX 12.5/5ML
0
$0.00
0.00%
5
$24.95
0.12%
00904203060
BANOPHEN
TAB 25MG
3
$23.88
0.08%
0
$0.00
0.00%
00904203524
1
$7.14
0.03%
0
$0.00
0.00%
00904203559
2
$10.34
0.05%
3
$15.27
0.07%
00904205560
0
$0.00
0.00%
1
$2.98
0.02%
00904517416
BANOPHEN
1
$5.59
0.03%
4
$25.83
0.09%
00904530660
88
$402.96
2.33%
93
$327.29
2.18%
00904530661
0
$0.00
0.00%
5
$19.69
0.12%
00904530680
59
$195.29
1.56%
46
$161.72
1.08%
00904530760
4
$17.03
0.11%
12
$50.28
0.28%
00904530780
7
$37.77
0.19%
12
$42.13
0.28%
LIQ 12.5/5
Page 445 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
10135013301
CHLORPHENIR TAB 4MG
1
$3.48
0.03%
0
$0.00
0.00%
10135013310
CHLORPHENIR TAB 4MG
0
$0.00
0.00%
2
$3.26
0.05%
10135013324
CHLORPHENIR TAB 4MG
0
$0.00
0.00%
4
$8.80
0.09%
10135014901
7
$32.34
0.19%
0
$0.00
0.00%
10267083501
2
$10.44
0.05%
0
$0.00
0.00%
10267083601
3
$14.85
0.08%
4
$22.00
0.09%
10267099701
CHLORPHENIR TAB 4MG
1
$3.75
0.03%
0
$0.00
0.00%
11822304090
RA ALLERGY CAP 25MG
1
$3.24
0.03%
4
$16.13
0.09%
11845086001
CHLORPHENIR TAB 4MG
1
$3.88
0.03%
0
$0.00
0.00%
17236051601
2
$9.84
0.05%
19
$77.16
0.45%
17236051610
6
$31.63
0.16%
32
$125.51
0.75%
17236051801
10
$62.70
0.27%
3
$21.55
0.07%
17236051810
9
$40.17
0.24%
1
$0.90
0.02%
17714001601
C.P.M.
TAB 4MG
3
$5.29
0.08%
1
$3.72
0.02%
17714002001
2
$4.74
0.05%
0
$0.00
0.00%
17714002010
3
$9.90
0.08%
4
$9.46
0.09%
17714002101
0
$0.00
0.00%
1
$3.44
0.02%
17714002110
51
$178.36
1.35%
27
$82.89
0.63%
24385037926
DIPHEDRYL
0
$0.00
0.00%
1
$5.41
0.02%
37205021562
ALLERGY
TAB 4MG
1
$3.79
0.03%
4
$15.01
0.09%
37205021578
ALLERGY
TAB 4MG
3
$14.97
0.08%
13
$44.61
0.30%
37205027062
COMPLETE ALL TAB 25MG
5
$29.87
0.13%
2
$10.25
0.05%
37205027078
COMPLETE ALL TAB 25MG
0
$0.00
0.00%
4
$8.14
0.09%
37205027762
COMPLETE ALL CAP 25MG
3
$16.88
0.08%
5
$21.32
0.12%
37205027778
COMPLETE ALL CAP 25MG
13
$63.50
0.34%
13
$48.67
0.30%
37205056526
COMPLETE ALG ELX 12.5/5ML
23
$102.85
0.61%
15
$60.50
0.35%
37205056534
COMPLETE ALG ELX 12.5/5ML
1
$6.37
0.03%
3
$15.66
0.07%
ELX 12.5/5ML
Page 446 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
49483004101
CHLORPHENIR CAP 8MG ER
0
$0.00
0.00%
42
49483004110
2
$13.98
0.05%
49483004301
4
$30.10
0.11%
49884004301
CYPROHEPTAD TAB 4MG
38
$462.00
49884004310
CYPROHEPTAD TAB 4MG
4
50111031401
CYPROHEPTAD TAB 4MG
50111031403
CYPROHEPTAD TAB 4MG
50428215046
$247.58
0.98%
0
$0.00
0.00%
3
$17.85
0.07%
1.01%
24
$236.39
0.56%
$43.72
0.11%
2
$32.90
0.05%
82
$1,329.11
2.17%
167
$2,259.45
3.91%
11
$201.45
0.29%
14
$239.57
0.33%
CVS ALLERGY TAB 4MG
0
$0.00
0.00%
1
$1.19
0.02%
50844010716
1
$3.43
0.03%
0
$0.00
0.00%
50844019012
1
$3.38
0.03%
0
$0.00
0.00%
50844019016
0
$0.00
0.00%
1
$1.45
0.02%
51079006620
0
$0.00
0.00%
1
$1.65
0.02%
51079016320
CHLORPHENIR TAB 4MG
6
$20.82
0.16%
4
$9.48
0.09%
51079096720
DIPHENHYDRAM TAB 25MG
3
$15.58
0.08%
1
$6.67
0.02%
52297046262
HM DIPHEDRYL CAP 25MG
1
$2.67
0.03%
0
$0.00
0.00%
52735040101
ALLERGY
0
$0.00
0.00%
3
$7.68
0.07%
53746003701
CHLORPHENIR TAB 4MG
11
$29.88
0.29%
1
$1.36
0.02%
59390006546
ALTARYL
SYP 12.5/5ML
4
$27.36
0.11%
1
$4.35
0.02%
59606027720
ALLERGY MED CAP 25MG
0
$0.00
0.00%
3
$12.93
0.07%
60432003304
DIPHEN AF
SYP 12.5/5ML
8
$49.80
0.21%
2
$9.98
0.05%
60432003316
DIPHEN AF
SYP 12.5/5ML
27
$164.61
0.72%
24
$128.04
0.56%
60432073204
3
$63.32
0.08%
2
$35.13
0.05%
60505035700
0
$0.00
0.00%
2
$43.32
0.05%
61073002604
DIPHENHYDRAM LIQ 12.5MG/5
0
$0.00
0.00%
1
$4.17
0.02%
61646031101
10
$67.24
0.27%
1
$6.27
0.02%
61646031201
2
$8.24
0.05%
0
$0.00
0.00%
63323066401
0
$0.00
0.00%
1
$541.68
0.02%
TAB 4MG
Page 447 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
66375010601
CHLORPHENIR TAB 4MG
0
$0.00
0.00%
2
$10.80
0.05%
66424002101
0
$0.00
0.00%
1
$7.47
0.02%
1
$4.89
0.04%
0
$0.00
0.00%
5
$220.99
0.19%
8
$358.21
0.22%
OTHER DOPAMINERGICS/CARBII/LEVO
00004007201
LARODOPA
00056051168
LODOSYN
00056052168
SINEMET CR TAB 50/200
25
$3,609.42
0.96%
11
$1,667.92
0.30%
00056060168
SINEMET CR TAB 25/100
17
$1,940.75
0.66%
8
$1,431.23
0.22%
00056065068
SINEMET
9
$569.49
0.35%
7
$627.27
0.19%
00078001705
PARLODEL
TAB 2.5MG
25
$3,572.05
0.96%
2
$164.60
0.06%
00078001715
PARLODEL
TAB 2.5MG
17
$2,133.95
0.66%
2
$328.40
0.06%
00078010205
PARLODEL
CAP 5MG
11
$1,296.80
0.42%
11
$2,333.22
0.30%
00078010215
PARLODEL
CAP 5MG
14
$3,321.42
0.54%
7
$1,991.26
0.19%
00078040905
STALEVO 150 TAB
0
$0.00
0.00%
5
$718.77
0.14%
00093029201
CARB/LEVO TAB 10-100MG
56
$2,007.66
2.16%
65
$1,796.41
1.79%
00093029205
0
$0.00
0.00%
3
$46.27
0.08%
00093029301
179
$7,342.70
6.91%
243
$8,354.00
6.70%
00093029305
104
$3,167.58
4.01%
153
$5,418.40
4.22%
00093029310
34
$1,164.44
1.31%
17
$707.61
0.47%
00093029401
31
$1,117.67
1.20%
56
$2,454.87
1.54%
00093029405
0
$0.00
0.00%
10
$380.00
0.28%
00121064616
AMANTADINE SYP 50MG/5ML
1
$15.16
0.04%
29
$212.28
0.80%
00228253810
13
$342.66
0.50%
87
$2,213.29
2.40%
00228253850
39
$954.59
1.50%
61
$1,852.59
1.68%
00228253910
12
$513.58
0.46%
30
$610.22
0.83%
00228253950
67
$2,802.97
2.58%
144
$5,224.77
3.97%
00228253996
224
$9,063.76
8.64%
487
$18,414.47
13.43%
TAB 100MG
TAB 25MG
TAB 25/100
Page 448 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
00228254050
00228254096
00378008801
CARB/LEVO ER TAB 25/100
00378009401
CARB/LEVO ER TAB 50-200MG
00378201191
00378225291
$
Market Share*
00228254010
# of Scripts
$462.30
0.31%
16
$704.45
0.44%
0
$0.00
0.00%
34
$1,657.69
1.31%
11
$325.87
0.30%
71
$2,949.07
1.96%
161
$8,872.90
6.21%
190
$11,849.03
5.24%
284
$28,876.92
10.96%
347
$35,137.45
9.57%
SELEGILINE TAB 5MG
SELEGILINE CAP 5MG
0
$0.00
0.00%
8
$325.46
0.22%
0
$0.00
0.00%
31
$2,721.80
0.85%
00472083316
5
$107.28
0.19%
4
$102.62
0.11%
00603216321
AMANTADINE CAP 100MG
2
$47.04
0.08%
0
$0.00
0.00%
00615353763
27
$444.43
1.04%
0
$0.00
0.00%
00615356153
231
$8,541.09
8.91%
0
$0.00
0.00%
00615356163
59
$1,836.79
2.28%
0
$0.00
0.00%
00615450453
50
$1,716.25
1.93%
0
$0.00
0.00%
00615450463
4
$173.15
0.15%
0
$0.00
0.00%
00615456853
44
$4,324.72
1.70%
0
$0.00
0.00%
00615456863
7
$483.80
0.27%
0
$0.00
0.00%
00781181701
BROMOCRIPTIN TAB 2.5MG
8
$639.47
0.31%
31
$3,976.21
0.85%
00781181731
5
$378.03
0.19%
4
$127.64
0.11%
00781204801
45
$927.91
1.74%
296
$6,194.07
8.16%
00781204805
1
$14.78
0.04%
2
$69.98
0.06%
00832011100
AMANTADINE TAB 100MG
0
$0.00
0.00%
3
$34.29
0.08%
00832101500
153
$2,882.43
5.90%
545
$9,467.48
15.03%
00832101550
0
$0.00
0.00%
6
$51.72
0.17%
39506002260
ELDEPRYL
CAP 5MG
10
$1,007.46
0.39%
0
$0.00
0.00%
49884061002
SELEGILINE TAB 5MG
9
$337.15
0.35%
6
$228.60
0.17%
50383080716
3
$73.02
0.12%
18
$156.76
0.50%
51079048120
0
$0.00
0.00%
79
$397.80
2.18%
8
Page 449 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
52544013660
SELEGILINE TAB 5MG
52544013760
SELEGILINE CAP 5MG
59075071210
MYOBLOC
59911325401
$
Market Share*
51079075620
# of Scripts
$250.13
0.27%
10
$341.23
0.28%
6
$162.58
0.23%
2
$78.70
0.06%
21
$2,225.72
0.81%
1
$20.27
0.03%
0
$0.00
0.00%
1
$30.00
0.03%
SELEGILINE TAB 5MG
3
$63.75
0.12%
0
$0.00
0.00%
59911588601
SELEGILINE CAP 5MG
8
$860.63
0.31%
0
$0.00
0.00%
60432009316
6
$160.01
0.23%
14
$347.09
0.39%
60505005501
SELEGILINE CAP 5MG
1
$123.49
0.04%
5
$317.10
0.14%
60505343803
SELEGILINE TAB 5MG
6
$232.10
0.23%
12
$459.70
0.33%
60951060368
81
$2,265.21
3.13%
68
$2,404.75
1.87%
60951060568
172
$6,015.50
6.64%
133
$4,901.32
3.67%
60951060585
71
$2,374.86
2.74%
133
$5,056.42
3.67%
60951060768
13
$454.40
0.50%
15
$498.95
0.41%
60951060785
6
$339.00
0.23%
5
$301.15
0.14%
60951062060
SELEGILINE TAB 5MG
4
$119.05
0.15%
4
$214.45
0.11%
60951065616
5
$130.84
0.19%
23
$187.25
0.63%
62269021124
112
$2,013.39
4.32%
48
$708.95
1.32%
62269021129
17
$224.33
0.66%
0
$0.00
0.00%
63481010870
SYMMETREL
2
$139.16
0.08%
0
$0.00
0.00%
66685590500
11
$1,045.70
0.42%
29
$4,149.91
0.80%
66685590503
6
$710.31
0.23%
10
$1,968.93
0.28%
100
$3,785.88
3.88%
116
$4,191.04
7.99%
INJ 10000U/2
TAB 100MG
7
PATCHES/ VAGINAL PRODUCTS
00052027301
NUVARING
00062192001
ORTHO EVRA DIS WEEK
67
$1,253.12
2.60%
28
$650.17
1.93%
00062192015
ORTHO EVRA DIS WEEK
2,413
$79,791.39
93.53%
1,308
$45,583.35
90.08%
MIS
Page 450 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
PLATELET AGGREGATION INHIBITORS
00004001822
TICLID
TAB 250MG
00005379131
DIPYRIDAMOLE TAB 75MG
00093015401
TICLOPIDINE TAB 250MG
00185011560
00228261306
00228261311
00555025202
00555025204
00555025205
1
$129.41
0.04%
1
$6.41
0.04%
13
$626.55
0.46%
3
$114.45
0.11%
10
$375.50
2
11
6
00555028502
00555028504
0
$0.00
0.00%
0
$0.00
0.00%
12
$380.60
0.26%
9
$324.07
0.20%
0.35%
0
$0.00
0.00%
$41.50
0.07%
11
$273.49
0.24%
$296.47
0.39%
11
$246.82
0.24%
$155.90
0.21%
6
$186.90
0.13%
12
$173.75
0.43%
6
$96.43
0.13%
22
$715.74
0.78%
14
$738.39
0.30%
9
$265.96
0.32%
0
$0.00
0.00%
00555028505
5
$136.27
0.18%
13
$176.19
0.28%
00555028602
6
$51.69
0.21%
10
$61.94
0.22%
00555028604
1
$4.63
0.04%
0
$0.00
0.00%
00555028605
3
$31.41
0.11%
0
$0.00
0.00%
49884059902
6
$191.20
0.21%
7
$259.55
0.15%
49884059905
7
$141.79
0.25%
0
$0.00
0.00%
60505002702
1
$105.75
0.04%
1
$105.25
0.02%
60505002704
62
$2,325.60
2.20%
69
$2,670.91
1.50%
60505002707
7
$228.28
0.25%
3
$54.75
0.07%
63653117101
PLAVIX
TAB 75MG
1,506
$147,696.74
53.39%
2,381
$251,944.66
51.59%
63653117103
PLAVIX
TAB 75MG
44
$4,552.76
1.56%
26
$2,937.36
0.56%
63653117105
PLAVIX
TAB 75MG
217
$21,431.65
7.69%
442
$46,404.94
9.58%
63653117106
PLAVIX
TAB 75MG
866
$88,989.46
30.70%
1,594
$173,769.18
34.54%
18
$617.25
2.45%
7
$244.30
0.71%
PROGESTIN ONLY CONTRACEPTIVES
00008006201
OVRETTE 28 TAB 0.075MG
Page 451 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
OVRETTE 28 TAB 0.075MG
00062141101
ORTHO MICRON TAB DIALPAK
00062141116
ORTHO MICRON TAB DIALPAK
00555034458
ERRIN
00555071558
CAMILA
52544023528
NOR-QD
52544062928
NORA-BE
TAB 0.35MG
52544089228
JOLIVETTE
00009005002
$
Market Share*
PROGESTIN ONLY CONTRACEPTIVES
00008006202
# of Scripts
$34.63
0.14%
80
$3,213.77
10.90%
64
$2,520.36
6.48%
270
$10,402.91
36.78%
812
$36,789.68
82.27%
0
$0.00
0.00%
20
$608.79
2.03%
TAB 0.35MG
4
$141.88
0.54%
23
$726.18
2.33%
TAB 0.35MG
268
$9,931.34
36.51%
22
$902.77
2.23%
93
$3,558.81
12.67%
18
$618.88
1.82%
TAB 0.35MG
0
$0.00
0.00%
21
$612.43
2.13%
PROVERA
TAB 10MG
5
$264.03
0.36%
0
$0.00
0.00%
00009006404
PROVERA
TAB 2.5MG
17
$259.76
1.21%
2
$23.89
0.15%
00009028603
PROVERA
TAB 5MG
1
$7.27
0.07%
0
$0.00
0.00%
00032170801
PROMETRIUM CAP 100MG
184
$4,740.98
13.07%
138
$4,240.04
10.07%
00032171101
PROMETRIUM CAP 200MG
105
$3,092.25
7.46%
74
$2,604.78
5.40%
00364668354
PROGESTERONE INJ 50MG/ML
0
$0.00
0.00%
1
$34.56
0.07%
00555021110
NORETHIN ACE TAB 5MG
42
$2,059.88
2.98%
121
$6,264.26
8.83%
00555077902
MEDROXYPR AC TAB 10MG
333
$1,803.00
23.65%
188
$708.74
13.71%
00555077904
33
$369.85
2.34%
39
$256.85
2.84%
00555087202
MEDROXYPR AC TAB 2.5MG
191
$1,706.89
13.57%
96
$539.93
7.00%
00555087204
36
$307.94
2.56%
28
$158.50
2.04%
00555087302
99
$730.80
7.03%
73
$370.81
5.32%
00555087304
1
$7.05
0.07%
2
$11.76
0.15%
00574043000
PROGESTERONE POW MICRONIZ
2
$20.36
0.14%
1
$9.22
0.07%
00574043001
PROGESTERONE POW MICRONIZ
3
$101.25
0.21%
1
$32.41
0.07%
00677080301
8
$67.60
0.57%
5
$35.45
0.36%
00677080302
7
$69.95
0.50%
0
$0.00
0.00%
TAB 0.35MG
1
0
$0.00
0.00%
PROGESTINS
Page 452 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
PROGESTINS
00677080303
1
$3.85
0.07%
0
00832008700
4
$15.80
0.28%
00832008725
1
$3.85
0.07%
00904269070
4
$18.90
51285054002
31
51285054004
51285054102
51285054202
51285054204
$0.00
0.00%
0
$0.00
0.00%
5
$22.75
0.36%
0.28%
0
$0.00
0.00%
$235.86
2.20%
0
$0.00
0.00%
1
$16.30
0.07%
0
$0.00
0.00%
15
$106.66
1.07%
8
$49.26
0.58%
10
$78.50
0.71%
13
$34.25
0.95%
0
$0.00
0.00%
2
$5.70
0.15%
59762374001
101
$832.76
7.17%
145
$884.88
10.58%
59762374004
2
$15.00
0.14%
0
$0.00
0.00%
59762374005
15
$113.50
1.07%
23
$109.37
1.68%
59762374101
39
$247.67
2.77%
70
$373.29
5.11%
59762374104
6
$37.10
0.43%
8
$34.13
0.58%
59762374202
82
$435.11
5.82%
290
$1,274.52
21.15%
59762374208
15
$70.52
1.07%
35
$141.00
2.55%
59911589401
AYGESTIN
14
$419.90
0.99%
1
$41.65
0.07%
63323026110
PROGESTERONE INJ 50MG/ML
0
$0.00
0.00%
2
$196.80
0.15%
TAB 5MG
PROSTAGLANDINS - GI
00025145120
CYTOTEC
TAB 100MCG
13
$703.18
16.46%
0
$0.00
0.00%
00025145160
CYTOTEC
TAB 100MCG
10
$440.66
12.66%
4
$333.17
1.49%
00025146131
CYTOTEC
TAB 200MCG
14
$891.63
17.72%
4
$163.74
1.49%
00025146160
CYTOTEC
TAB 200MCG
6
$518.85
7.59%
2
$162.50
0.74%
00172443049
MISOPROSTOL TAB 100MCG
2
$90.74
2.53%
21
$569.10
7.81%
00172443059
12
$764.32
15.19%
27
$1,124.27
10.04%
00172443149
3
$191.83
3.80%
76
$2,962.98
28.25%
Page 453 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
PROSTAGLANDINS - GI
00172443160
13
$1,450.72
16.46%
76
59762500701
3
$176.13
3.80%
13
$620.85
4.83%
59762500801
3
$132.27
3.80%
45
$1,736.83
16.73%
59762500802
0
$0.00
0.00%
1
$38.05
0.37%
$3,451.24
28.25%
PROSTAGLANDINS - OPHTHALMIC
00013830301
XALATAN
SOL 0.005%
0
$0.00
0.00%
284
$14,429.54
9.16%
00013830304
XALATAN
SOL 0.005%
1,897
$91,025.44
70.60%
1,867
$88,744.69
60.19%
00023918703
LUMIGAN
SOL 0.03%
251
$13,447.99
9.34%
289
$15,177.24
9.32%
00023918705
LUMIGAN
SOL 0.03%
168
$16,276.03
6.25%
202
$21,435.78
6.51%
00065026617
TRAVATAN
SOL 0.004%
8
$636.40
0.30%
7
$642.63
0.23%
00065026625
TRAVATAN
SOL 0.004%
336
$16,266.92
12.50%
426
$22,016.38
13.73%
58768096105
RESCULA
27
$1,190.43
1.00%
27
$1,260.32
0.87%
SOL 0.15%
PROTON PUMP INHIBITOR
00008084181
PROTONIX
TAB 40MG
25,220
$2,372,268.66
62.96%
28,323
$2,957,416.70
52.43%
00008084199
PROTONIX
TAB 40MG
68
$6,741.74
0.17%
82
$8,413.13
0.15%
00008084381
PROTONIX
TAB 20MG
59
$5,738.86
0.15%
128
$14,122.77
0.24%
00186060628
PRILOSEC
CAP 10MG CR
3
$171.24
0.01%
1
$108.74
0.00%
00186060631
PRILOSEC
CAP 10MG CR
28
$3,609.28
0.07%
7
$1,096.05
0.01%
00186060668
PRILOSEC
CAP 10MG CR
7
$1,303.09
0.02%
2
$217.48
0.00%
00186074228
PRILOSEC
CAP 20MG CR
10
$1,232.40
0.02%
0
$0.00
0.00%
00186074231
PRILOSEC
CAP 20MG CR
1,267
$169,174.93
3.16%
91
$12,792.19
0.17%
00186074282
PRILOSEC
CAP 20MG CR
282
$35,156.18
0.70%
7
$1,093.87
0.01%
00186074328
PRILOSEC
CAP 40MG CR
3
$512.36
0.01%
3
$523.54
0.01%
00186074331
PRILOSEC
CAP 40MG CR
453
$77,995.95
1.13%
168
$26,819.94
0.31%
00186074368
PRILOSEC
CAP 40MG CR
28
$4,482.14
0.07%
13
$1,310.40
0.02%
Page 454 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
PROTON PUMP INHIBITOR
00186502031
NEXIUM
CAP 20MG
159
$18,228.23
0.40%
102
$11,356.71
0.19%
00186502054
NEXIUM
CAP 20MG
15
$2,102.35
0.04%
3
$369.42
0.01%
00186502228
NEXIUM
CAP 20MG
1
$58.63
0.00%
0
$0.00
0.00%
00186504031
NEXIUM
CAP 40MG
2,006
$231,326.33
5.01%
1,321
$161,889.66
2.45%
00186504054
NEXIUM
CAP 40MG
119
$13,746.33
0.30%
299
$36,726.19
0.55%
00186504082
NEXIUM
CAP 40MG
2
$234.46
0.00%
0
$0.00
0.00%
00186504228
NEXIUM
CAP 40MG
12
$1,521.21
0.03%
0
$0.00
0.00%
00300154111
PREVACID
CAP 15MG DR
0
$0.00
0.00%
2
$250.94
0.00%
00300154119
PREVACID
CAP 15MG DR
83
$8,973.09
0.21%
125
$14,250.91
0.23%
00300154130
PREVACID
CAP 15MG DR
907
$103,177.20
2.26%
1,529
$182,904.92
2.83%
00300304611
PREVACID
CAP 30MG DR
0
$0.00
0.00%
9
$962.64
0.02%
00300304613
PREVACID
CAP 30MG DR
7,472
$919,331.93
18.65%
15,801
$2,060,833.93
29.25%
00300304619
PREVACID
CAP 30MG DR
1,114
$126,322.99
2.78%
2,368
$300,200.05
4.38%
00300730930
PREVACID
GRA 15MG
36
$4,560.30
0.09%
24
$2,426.32
0.04%
00300731130
PREVACID
GRA 30MG
105
$12,701.03
0.26%
42
$4,052.14
0.08%
00378521193
OMEPRAZOLE CAP 10MG
0
$0.00
0.00%
2
$199.40
0.00%
00378615093
OMEPRAZOLE CAP 20MG
0
$0.00
0.00%
161
$18,662.82
0.30%
37000045502
PRILOSEC OTC TAB 20MG
0
$0.00
0.00%
2
$80.79
0.00%
37000045503
0
$0.00
0.00%
7
$255.30
0.01%
37000045504
0
$0.00
0.00%
1,713
$40,876.23
3.17%
62175011832
OMEPRAZOLE CAP 20MG
72
$8,616.07
0.18%
439
$59,128.65
0.81%
62175011837
OMEPRAZOLE CAP 20MG
1
$105.84
0.00%
0
$0.00
0.00%
62856024330
ACIPHEX
TAB 20MG
460
$56,815.32
1.15%
921
$116,545.48
1.71%
62856024341
ACIPHEX
TAB 20MG
5
$392.19
0.01%
1
$117.12
0.00%
62856024390
ACIPHEX
TAB 20MG
60
$7,137.96
0.15%
300
$39,849.67
0.56%
66685042200
OMEPRAZOLE CAP 20MG
0
$0.00
0.00%
6
$811.32
0.01%
66685042201
OMEPRAZOLE CAP 20MG
0
$0.00
0.00%
15
$2,079.63
0.03%
Page 455 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
PULMONARY ANTI-HYPERTENSIVES
00173051700
FLOLAN
INJ 0.5MG
2
$932.76
7.69%
0
$0.00
0.00%
00173051900
FLOLAN
INJ 1.5MG
6
$19,002.78
23.08%
6
$12,924.27
23.08%
66215010106
TRACLEER
TAB 62.5MG
2
$5,312.87
7.69%
4
$11,351.34
15.38%
66215010206
TRACLEER
TAB 125MG
16
$41,937.48
61.54%
16
$45,385.36
61.54%
$9,355.29
63.26%
PURINE ANALOG
00054408425
AZATHIOPRINE TAB 50MG
351
$9,713.69
76.30%
353
00781105901
80
$2,652.71
17.39%
10
$365.20
1.79%
00781507501
0
$0.00
0.00%
79
$2,448.10
14.16%
60976059755
IMURAN
TAB 50MG
18
$1,235.12
3.91%
0
$0.00
0.00%
65483059010
IMURAN
TAB 50MG
3
$105.00
0.65%
9
$1,471.79
1.61%
66591022141
8
$340.10
1.74%
105
$3,669.81
18.82%
66591024141
AZASAN
0
$0.00
0.00%
2
$220.49
0.36%
TAB 100MG
RHEUMATOID ARTHRITIS
00074379902
HUMIRA
KIT 40MG/0.8
0
$0.00
0.00%
73
$100,406.39
15.90%
00088216030
ARAVA
TAB 10MG
16
$5,298.58
5.06%
27
$8,223.25
5.88%
00088216130
ARAVA
TAB 20MG
114
$28,338.51
36.08%
142
$38,589.95
30.94%
55513017701
KINERET
INJ
1
$1,065.61
0.32%
1
$1,134.56
0.22%
55513017707
KINERET
INJ
33
$28,996.10
10.44%
7
$7,498.58
1.53%
58406042534
ENBREL
INJ 25MG
149
$162,540.17
47.15%
205
$235,953.17
44.66%
58406042541
ENBREL
INJ 25MG
3
$858.27
0.95%
4
$4,773.24
0.87%
RSV PROPHYLAXIS
60574411101
SYNAGIS
INJ 100MG
262
$284,866.37
70.81%
318
$377,165.05
66.11%
60574411201
SYNAGIS
INJ 50MG
108
$49,522.52
29.19%
163
$86,876.05
33.89%
Page 456 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
SCABICIDES AND PEDICULICIDES
00023791560
ELIMITE
CRE 5%
82
$2,217.15
2.88%
37
$1,201.65
1.27%
00072210360
EURAX
CRE 10%
25
$334.32
0.88%
14
$238.54
0.48%
00072220316
EURAX
LOT 10%
1
$41.68
0.04%
3
$119.18
0.10%
00072220360
EURAX
LOT 10%
21
$378.48
0.74%
11
$160.64
0.38%
00472057002
LINDANE
LOT 1%
2
$114.22
0.07%
0
$0.00
0.00%
00472057016
LINDANE
LOT 1%
7
$74.01
0.25%
0
$0.00
0.00%
00472057202
LINDANE
SHA 1%
17
$935.17
0.60%
57
$2,065.93
1.96%
00472057216
LINDANE
SHA 1%
33
$568.67
1.16%
19
$291.92
0.65%
00472158394
PYRINYL
SHA
0
$0.00
0.00%
1
$4.98
0.03%
00472524267
PERMETHRIN LOT 1%
64
$717.85
2.25%
195
$2,024.57
6.71%
00472524269
PERMETHRIN LOT 1%
13
$99.47
0.46%
11
$137.19
0.38%
00501078202
NIX CREME
LIQ RINSE 1%
693
$8,308.96
24.32%
703
$8,299.20
24.19%
00501078214
NIX CREME
LIQ RINSE 1%
265
$3,554.93
9.30%
175
$2,229.34
6.02%
00501378202
NIX CREME
LIQ RINSE 1%
77
$959.75
2.70%
75
$907.80
2.58%
00501378214
NIX CREME
LIQ RINSE 1%
30
$302.42
1.05%
13
$178.03
0.45%
00677080833
LINDANE
LOT 1%
2
$28.73
0.07%
0
$0.00
0.00%
00677080933
LINDANE
SHA 1%
8
$72.65
0.28%
0
$0.00
0.00%
00904069003
LINDANE
LOT 1%
4
$23.85
0.14%
0
$0.00
0.00%
00904069203
LINDANE
SHA 1%
24
$405.55
0.84%
0
$0.00
0.00%
00904069216
LINDANE
SHA 1%
2
$50.38
0.07%
0
$0.00
0.00%
10310022523
PRONTO
KIT COMPLETE
2
$1,174.51
0.07%
0
$0.00
0.00%
10310036502
PRONTO
SHA W/COMB
1
$14.07
0.04%
0
$0.00
0.00%
12810020604
OSCO LICE
0
$0.00
0.00%
1
$13.00
0.03%
24385016006
LICE
0
$0.00
0.00%
2
$23.42
0.07%
37205016526
LICE KILLING SHA
1
$8.82
0.04%
0
$0.00
0.00%
37205028516
LICE TREATMN LIQ CRM RNSE
10
$135.47
0.35%
13
$134.08
0.45%
37205028526
LICE TREATMN LIQ CRM RNSE
0
$0.00
0.00%
6
$91.53
0.21%
SHA ELIMINAT
LIQ TREATMEN
Page 457 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
SCABICIDES AND PEDICULICIDES
45802026937
PERMETHRIN CRE 5%
0
51672527204
OVIDE
54868357300
RID
60432054616
LINDANE
60432054660
$0.00
0.00%
368
$9,630.84
12.66%
0
$0.00
0.00%
97
$4,873.97
3.34%
1
$18.14
0.04%
0
$0.00
0.00%
LOT 1%
83
$1,388.15
2.91%
33
$613.10
1.14%
LINDANE
LOT 1%
48
$1,302.07
1.68%
116
$12,800.07
3.99%
60432054716
LINDANE
SHA 1%
358
$6,301.13
12.57%
81
$1,383.16
2.79%
60432054760
LINDANE
SHA 1%
81
$2,002.74
2.84%
246
$21,394.08
8.47%
62794013106
ACTICIN
684
$17,760.74
24.01%
519
$12,403.94
17.86%
74300000320
RID
LIQ
3
$50.46
0.11%
2
$27.86
0.07%
74300000412
RID
LIQ
17
$213.27
0.60%
28
$280.37
0.96%
74300000414
RID
LIQ
14
$152.81
0.49%
18
$207.75
0.62%
99207065002
OVIDE
176
$7,828.90
6.18%
62
$2,931.38
2.13%
LOT 0.5%
LIQ
CRE 5%
LOT 0.5%
SEDATIVE HYPNOTICS - BENZODIAZEPINES
00009001011
HALCION
TAB 0.125MG
0
$0.00
0.00%
1
$4.39
0.05%
00009001759
HALCION
TAB 0.25MG
4
$734.34
0.27%
0
$0.00
0.00%
00037900201
DORAL
TAB 15MG
4
$256.20
0.27%
21
$832.44
1.14%
00037900202
DORAL
TAB 15MG
3
$111.69
0.20%
0
$0.00
0.00%
00054356699
MIDAZOLAM
SYP 2MG/ML
1
$9.91
0.07%
0
$0.00
0.00%
00054485806
TRIAZOLAM
TAB 0.125MG
0
$0.00
0.00%
2
$12.10
0.11%
00054885825
TRIAZOLAM
TAB 0.125MG
1
$5.95
0.07%
2
$27.18
0.11%
00074373513
PROSOM
TAB 1MG
4
$562.13
0.27%
3
$425.04
0.16%
00074373613
PROSOM
TAB 2MG
2
$81.16
0.13%
0
$0.00
0.00%
00078009905
RESTORIL
CAP 30MG
3
$137.76
0.20%
0
$0.00
0.00%
00078014005
RESTORIL
CAP 7.5MG
23
$793.47
1.54%
11
$360.29
0.60%
00093012901
ESTAZOLAM
1
$9.46
0.07%
0
$0.00
0.00%
00143336701
FLURAZEPAM CAP 15MG
12
$58.69
0.80%
20
$56.55
1.09%
TAB 1MG
Page 458 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
FLURAZEPAM CAP 30MG
00228207610
TEMAZEPAM
00228207650
TEMAZEPAM
00228207710
$
Market Share*
00143337001
# of Scripts
2
$11.24
0.13%
14
$53.15
0.76%
CAP 15MG
100
$410.61
6.69%
173
$444.52
9.41%
CAP 15MG
27
$123.22
1.81%
24
$68.10
1.31%
TEMAZEPAM
CAP 30MG
112
$626.98
7.49%
166
$617.02
9.03%
00228207750
TEMAZEPAM
CAP 30MG
31
$180.98
2.07%
31
$119.10
1.69%
00378401001
TEMAZEPAM
CAP 15MG
310
$1,355.26
20.74%
391
$1,046.01
21.27%
00378401005
TEMAZEPAM
CAP 15MG
39
$166.74
2.61%
115
$417.63
6.26%
00378441501
FLURAZEPAM CAP 15MG
23
$114.15
1.54%
45
$170.49
2.45%
00378441505
FLURAZEPAM CAP 15MG
2
$10.20
0.13%
0
$0.00
0.00%
00378443001
FLURAZEPAM CAP 30MG
139
$566.44
9.30%
84
$328.77
4.57%
00378505001
TEMAZEPAM
CAP 30MG
270
$1,586.07
18.06%
303
$1,210.85
16.49%
00378505005
TEMAZEPAM
CAP 30MG
68
$435.74
4.55%
89
$426.70
4.84%
00406991501
RESTORIL
2
$85.96
0.13%
41
$1,904.86
2.23%
00591074401
ESTAZOLAM
TAB 1MG
0
$0.00
0.00%
17
$193.07
0.92%
00591074501
ESTAZOLAM
TAB 2MG
11
$213.04
0.74%
11
$177.69
0.60%
00781144205
TRIAZOLAM
TAB 0.25MG
2
$12.36
0.13%
5
$27.43
0.27%
00781144283
TRIAZOLAM
TAB 0.25MG
8
$97.90
0.54%
1
$3.65
0.05%
00781220101
TEMAZEPAM
CAP 15MG
1
$5.30
0.07%
5
$19.69
0.27%
00781220105
TEMAZEPAM
CAP 15MG
41
$190.19
2.74%
13
$49.14
0.71%
00781220201
TEMAZEPAM
CAP 30MG
9
$59.85
0.60%
3
$14.30
0.16%
00781220205
TEMAZEPAM
CAP 30MG
17
$113.25
1.14%
3
$6.60
0.16%
00781220901
TEMAZEPAM
CAP 7.5MG
5
$74.10
0.33%
8
$64.55
0.44%
49884019401
FLURAZEPAM CAP 30MG
1
$5.62
0.07%
0
$0.00
0.00%
49884024105
TEMAZEPAM
1
$6.60
0.07%
0
$0.00
0.00%
49884045305
TRIAZOLAM
TAB 0.125MG
11
$100.97
0.74%
6
$59.62
0.33%
49884045312
TRIAZOLAM
TAB 0.125MG
8
$42.12
0.54%
5
$18.55
0.27%
49884045362
TRIAZOLAM
TAB 0.125MG
8
$55.28
0.54%
2
$17.30
0.11%
CAP 7.5MG
CAP 30MG
Page 459 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
Market Share*
49884045405
TRIAZOLAM
TAB 0.25MG
37
$419.95
2.47%
28
49884045412
TRIAZOLAM
TAB 0.25MG
13
$125.85
0.87%
49884045462
TRIAZOLAM
TAB 0.25MG
29
$239.40
1.94%
52544074401
ESTAZOLAM
TAB 1MG
4
$35.12
52544074501
ESTAZOLAM
TAB 2MG
5
59762371704
TRIAZOLAM
TAB 0.125MG
59762371803
TRIAZOLAM
TAB 0.25MG
59762371804
TRIAZOLAM
TAB 0.25MG
63304020518
MIDAZOLAM
SYP 2MG/ML
$
$217.72
1.52%
11
$93.35
0.60%
45
$307.91
2.45%
0.27%
2
$19.48
0.11%
$92.07
0.33%
0
$0.00
0.00%
21
$210.76
1.40%
26
$190.80
1.41%
12
$93.11
0.80%
23
$186.27
1.25%
66
$581.33
4.41%
88
$557.63
4.79%
2
$20.06
0.13%
0
$0.00
0.00%
SELECTED DOPAMIN AGONISTS
00007489020
REQUIP
TAB 0.25MG
44
$3,705.79
5.94%
55
$5,761.77
5.71%
00007489120
REQUIP
TAB 0.5MG
63
$6,437.68
8.50%
74
$7,217.22
7.68%
00007489220
REQUIP
TAB 1MG
58
$7,512.73
7.83%
59
$7,969.50
6.13%
00007489320
REQUIP
TAB 2MG
29
$3,032.49
3.91%
37
$4,030.58
3.84%
00007489420
REQUIP
TAB 5MG
4
$827.16
0.54%
6
$1,297.59
0.62%
00007489520
REQUIP
TAB 3MG
0
$0.00
0.00%
8
$1,200.73
0.83%
00007489620
REQUIP
TAB 4MG
0
$0.00
0.00%
3
$433.38
0.31%
00009000202
MIRAPEX
TAB 0.125MG
137
$8,322.51
18.49%
191
$12,334.49
19.83%
00009000402
MIRAPEX
TAB 0.25MG
118
$9,623.23
15.92%
177
$11,431.85
18.38%
00009000602
MIRAPEX
TAB 1MG
23
$3,920.75
3.10%
33
$5,111.42
3.43%
00009000802
MIRAPEX
TAB 0.5MG
55
$8,370.12
7.42%
122
$16,555.24
12.67%
00009003702
MIRAPEX
TAB 1.5MG
5
$758.05
0.67%
18
$2,359.82
1.87%
00093715901
PERGOLIDE
TAB 0.25MG
0
$0.00
0.00%
60
$9,718.87
6.23%
00093716001
PERGOLIDE
TAB 0.05MG
1
$120.60
0.13%
20
$1,996.34
2.08%
00093716101
PERGOLIDE
TAB 1.0MG
0
$0.00
0.00%
42
$12,570.65
4.36%
00172452060
PERGOLIDE
TAB 0.05MG
0
$0.00
0.00%
3
$315.19
0.31%
Page 460 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
PERGOLIDE
59075061530
59075062510
$
Market Share*
SELECTED DOPAMIN AGONISTS
00172452260
# of Scripts
TAB 1.0MG
0
PERMAX
TAB 0.05MG
50
PERMAX
TAB 0.25MG
96
59075063010
PERMAX
TAB 1MG
42
65234002610
PERMAX
TAB 1MG
$0.00
0.00%
2
$361.62
0.21%
$5,661.89
6.75%
10
$1,135.92
1.04%
$16,716.68
12.96%
25
$3,585.58
2.60%
$8,298.43
5.67%
7
$1,685.35
0.73%
16
$4,525.90
2.16%
11
$2,220.47
1.14%
SELECTED NARCOTICS
00045065010
ULTRACET
TAB 37.5-325
10
$313.60
0.18%
4
$395.68
0.06%
00045065060
ULTRACET
TAB 37.5-325
1,447
$80,820.40
26.18%
549
$23,379.95
7.71%
00045065960
ULTRAM
TAB 50MG
176
$14,372.50
3.18%
12
$1,239.69
0.17%
00045065970
ULTRAM
TAB 50MG
38
$1,724.13
0.69%
5
$105.22
0.07%
00054309036
BUTORPHANOL SOL 10MG/ML
16
$11,532.64
0.29%
9
$568.26
0.13%
00074146401
NALBUPHINE INJ 10MG/ML
3
$620.64
0.05%
0
$0.00
0.00%
00087565041
STADOL NS
SOL 10MG/ML
10
$1,360.74
0.18%
1
$90.12
0.01%
00093005801
TRAMADOL HCL TAB 50MG
398
$22,058.64
7.20%
388
$5,944.35
5.45%
00093005805
101
$4,267.56
1.83%
512
$7,999.49
7.19%
00172651560
91
$5,990.29
1.65%
58
$859.74
0.81%
00172651570
242
$12,388.29
4.38%
373
$4,858.04
5.24%
00185031101
3
$137.34
0.05%
1
$6.25
0.01%
00185031110
7
$92.21
0.13%
0
$0.00
0.00%
00228271411
1,208
$71,416.42
21.86%
4
$58.48
0.06%
00228271450
6
$583.95
0.11%
0
$0.00
0.00%
00378415101
142
$7,859.56
2.57%
70
$1,043.66
0.98%
00378415105
649
$36,759.07
11.74%
368
$5,489.72
5.17%
00378963943
62
$5,123.57
1.12%
8
$479.96
0.11%
00406717101
70
$3,947.94
1.27%
127
$1,447.85
1.78%
00406717105
24
$1,332.63
0.43%
119
$1,921.00
1.67%
Page 461 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
SELECTED NARCOTICS
00591046601
38
$1,397.93
0.69%
00591046610
7
$393.52
0.13%
00904555640
0
$0.00
0.00%
00904555660
0
$0.00
0.00%
12496075701
BUPRENEX
4
$237.04
49884074201
0
50111061601
0
50111061603
53489049901
$346.85
0.25%
2
$39.50
0.03%
149
$2,231.45
2.09%
4
$94.80
0.06%
0.07%
0
$0.00
0.00%
$0.00
0.00%
1,923
$29,482.87
27.00%
$0.00
0.00%
5
$152.57
0.07%
0
$0.00
0.00%
9
$294.85
0.13%
97
$3,237.30
1.76%
136
$2,069.79
1.91%
53489049905
96
$3,648.30
1.74%
274
$4,663.81
3.85%
53489049910
56
$2,444.24
1.01%
1
$4.28
0.01%
57664037708
292
$18,965.54
5.28%
229
$3,561.63
3.22%
57664037713
30
$2,029.41
0.54%
238
$3,921.70
3.34%
57664037718
0
$0.00
0.00%
38
$569.56
0.53%
60505017101
34
$1,130.11
0.62%
131
$1,597.19
1.84%
60505017102
8
$395.52
0.14%
38
$887.95
0.53%
60505081301
0
$0.00
0.00%
4
$284.12
0.06%
63481050805
NUBAIN
4
$94.16
0.07%
7
$1,635.06
0.10%
65162012710
10
$437.86
0.18%
87
$957.36
1.22%
65162012711
1
$9.13
0.02%
199
$2,530.19
2.79%
65162012750
147
$9,573.23
2.66%
1,022
$17,497.98
14.35%
INJ .324/ML
INJ 10MG/ML
18
SELECTIVE ALPHA ADRENERGIC AGONISTS
00023866505
ALPHAGAN
SOL 0.2% OP
14
$547.51
1.23%
1
$34.91
0.08%
00023866510
ALPHAGAN
SOL 0.2% OP
31
$1,975.42
2.72%
1
$66.41
0.08%
00023866515
ALPHAGAN
SOL 0.2% OP
4
$380.00
0.35%
1
$95.50
0.08%
00023917705
ALPHAGAN P SOL 0.15%
513
$18,302.47
45.00%
751
$28,149.65
56.81%
Page 462 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
SELECTIVE ALPHA ADRENERGIC AGONISTS
00023917710
471
$31,478.65
41.32%
470
$33,111.16
35.55%
00023917715
77
$7,512.57
6.75%
92
$9,514.61
6.96%
00065066505
IOPIDINE
SOL 0.5% OP
24
$1,304.37
2.11%
6
$371.60
0.45%
00065066510
IOPIDINE
SOL 0.5% OP
6
$671.31
0.53%
0
$0.00
0.00%
SELECTIVE SEROTONIN AGONISTS (5HT)--Injectables
00173044901
IMITREX
KIT 6MG/.5ML
5
$1,920.31
1.46%
0
$0.00
0.00%
00173044902
IMITREX
INJ 6MG/.5ML
2
$1,818.82
0.58%
1
$265.99
0.30%
00173047800
IMITREX
KIT RF
136
$44,787.42
39.65%
167
$63,073.91
49.70%
00173047900
IMITREX
KIT 6MG/.5ML
74
$14,015.59
21.57%
92
$26,019.81
27.38%
00173052300
IMITREX
SPR 20MG/ACT
94
$13,684.49
27.41%
63
$8,037.84
18.75%
00173052400
IMITREX
SPR 5MG/ACT
32
$4,691.43
9.33%
12
$1,973.73
3.57%
00310020860
ZOMIG
0
$0.00
0.00%
1
$138.29
0.30%
SPR 5MG
SELECTIVE SEROTONIN AGONISTS (5HT)--Tabs
00006026606
MAXALT
TAB 5MG
13
$1,463.16
0.63%
98
$13,082.99
3.42%
00006026706
MAXALT
TAB 10MG
158
$22,674.28
7.64%
340
$49,424.39
11.87%
00006380006
MAXALT-MLT TAB 5MG
28
$3,687.51
1.35%
56
$6,277.46
1.95%
00006380106
MAXALT-MLT TAB 10MG
155
$20,595.20
7.50%
249
$33,547.90
8.69%
00025208006
AXERT
TAB 6.25MG
6
$417.59
0.29%
12
$2,519.76
0.42%
00025208506
AXERT
TAB 12.5MG
98
$8,971.93
4.74%
58
$9,139.41
2.02%
00049233034
RELPAX
TAB 20MG
0
$0.00
0.00%
10
$1,346.04
0.35%
00049234034
RELPAX
TAB 40MG
0
$0.00
0.00%
72
$8,992.99
2.51%
00173045003
IMITREX
TAB 100MG
160
$22,952.48
7.74%
380
$53,224.57
13.26%
00173045900
IMITREX
TAB 50MG
528
$72,616.56
25.54%
853
$124,507.51
29.77%
00173046002
IMITREX
TAB 25MG
234
$36,804.81
11.32%
333
$55,179.64
11.62%
00173056100
AMERGE
TAB 1MG
2
$366.08
0.10%
5
$1,020.08
0.17%
Page 463 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
00173056200
AMERGE
00310020920
ZOMIG ZMT
36
$3,582.95
1.74%
00310021020
ZOMIG
TAB 2.5MG
227
$29,165.22
10.98%
00310021125
ZOMIG
TAB 5MG
242
$37,114.55
11.71%
00310021321
ZOMIG ZMT
24
$3,331.64
59075074089
FROVA
39
TAB 2.5 MG
TAB 5MG
TAB 2.5MG
$
Market Share*
SELECTIVE SEROTONIN AGONISTS (5HT)--Tabs
TAB 2.5MG
# of Scripts
117
$19,665.30
5.66%
67
$13,612.78
2.34%
22
$2,386.72
0.77%
103
$13,433.05
3.60%
165
$26,240.25
5.76%
1.16%
16
$2,645.60
0.56%
$4,645.00
1.89%
26
$2,893.30
0.91%
$1,851.19
7.89%
4
$2,085.96
12.12%
SOMATOSTATIC AGENTS
00078018003
SANDOSTATIN INJ .05MG/ML
3
00078018101
SANDOSTATIN INJ 0.1MG/ML
0
$0.00
0.00%
3
$1,138.29
9.09%
00078018103
9
$1,938.61
23.68%
6
$3,015.85
18.18%
00078018203
3
$4,761.78
7.89%
0
$0.00
0.00%
00078018325
1
$3,470.43
2.63%
4
$7,795.88
12.12%
00078018425
SANDOSTATIN INJ 1MG/ML
15
$85,086.69
39.47%
13
$88,538.63
39.39%
00078034184
SANDOSTATIN KIT LAR 20MG
4
$6,502.24
10.53%
3
$5,095.26
9.09%
00078034284
SANDOSTATIN KIT LAR 30MG
3
$6,549.84
7.89%
0
$0.00
0.00%
SPECIAL ATYPICALS
00078012605
CLOZARIL
TAB 25MG
204
$10,846.45
3.76%
216
$11,214.82
3.95%
00078012606
CLOZARIL
TAB 25MG
52
$1,194.08
0.96%
9
$264.78
0.16%
00078012705
CLOZARIL
TAB 100MG
389
$53,408.82
7.17%
411
$72,781.19
7.52%
00078012706
CLOZARIL
TAB 100MG
79
$4,181.14
1.46%
21
$2,079.25
0.38%
00172430360
CLOZAPINE
TAB 12.5
0
$0.00
0.00%
11
$63.55
0.20%
00172435910
CLOZAPINE
TAB 25MG
7
$314.75
0.13%
8
$109.28
0.15%
00172435960
CLOZAPINE
TAB 25MG
882
$26,662.07
16.26%
886
$18,781.74
16.21%
00172435970
CLOZAPINE
TAB 25MG
245
$7,072.06
4.52%
286
$6,456.95
5.23%
00172436010
CLOZAPINE
TAB 100MG
31
$1,651.92
0.57%
19
$872.95
0.35%
Page 464 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
SPECIAL ATYPICALS
00172436060
CLOZAPINE
TAB 100MG
1,710
$169,131.65
31.53%
1,911
$109,234.18
34.96%
00172436070
CLOZAPINE
TAB 100MG
495
$55,065.72
9.13%
528
$27,876.55
9.66%
00378082501
CLOZAPINE
TAB 25MG
495
$15,551.74
9.13%
359
$8,665.82
6.57%
00378086001
CLOZAPINE
TAB 100MG
357
$34,610.21
6.58%
267
$14,356.25
4.88%
00378086005
CLOZAPINE
TAB 100MG
478
$60,914.48
8.81%
535
$37,321.75
9.79%
1,179
$73,639.98
14.53%
1,233
$83,850.60
14.77%
461
$22,231.33
5.68%
0
$0.00
0.00%
STEROID INHALANTS
00075006037
AZMACORT
AER 100MCG
00085073604
VANCERIL
00089017540
QVAR
AER 40MCG
8
$332.66
0.10%
0
$0.00
0.00%
00089017780
QVAR
AER 80MCG
3
$165.60
0.04%
0
$0.00
0.00%
00173031298
BECLOVENT RF AER 42MCG
0
$0.00
0.00%
1
$35.23
0.01%
00173049100
FLOVENT
AER 44MCG/AC
1,020
$49,977.55
12.57%
1,243
$64,505.86
14.89%
00173049400
FLOVENT
AER 110MCG/A
2,296
$153,574.17
28.30%
2,487
$176,500.37
29.79%
00173049500
FLOVENT
AER 220MCG/A
1,391
$153,072.50
17.15%
1,421
$163,571.14
17.02%
00173049700
FLOVENT
AER 44MCG/AC
0
$0.00
0.00%
1
$79.44
0.01%
00173049800
FLOVENT
AER 110MCG/A
1
$76.10
0.01%
0
$0.00
0.00%
00173049900
FLOVENT
AER 220MCG/A
2
$240.50
0.02%
0
$0.00
0.00%
00173050400
FLOVENT ROTA AER 250MCG
1
$70.90
0.01%
9
$837.34
0.11%
00173050900
17
$746.49
0.21%
33
$1,785.84
0.40%
00173051100
29
$1,204.35
0.36%
38
$1,414.61
0.46%
00186091542
PULMICORT
INH 200MCG
538
$63,828.32
6.63%
455
$56,395.01
5.45%
00186198804
PULMICORT
SUS .25MG/2M
335
$47,804.51
4.13%
349
$53,496.09
4.18%
00186198904
PULMICORT
SUS .5MG/2ML
371
$53,968.50
4.57%
494
$73,335.02
5.92%
00456067099
AEROBID-M
AER 250MCG
107
$8,542.81
1.32%
33
$2,671.55
0.40%
00456067299
AEROBID
334
$24,077.82
4.12%
390
$30,663.81
4.67%
50580017540
QVAR
1
$75.21
0.01%
0
$0.00
0.00%
AER 42MCG
AER 250MCG
AER 40MCG
Page 465 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
STEROID INHALANTS
59310017540
QVAR
AER 40MCG
9
$397.70
0.11%
75
$4,058.65
0.90%
59310017780
QVAR
AER 80MCG
9
$544.18
0.11%
86
$5,026.75
1.03%
STEROID LOCAL ANESTHETICS
00091074010
EPIFOAM
0
$0.00
0.00%
3
$94.97
10.00%
00496071603
PRAMOSONE
AER 1%
CRE 1%
0
$0.00
0.00%
2
$88.24
6.67%
00496071604
PRAMOSONE
CRE 1%
2
$50.72
16.67%
5
$79.62
16.67%
00496071704
PRAMOSONE
CRE 2.5%
2
$64.11
16.67%
0
$0.00
0.00%
00496072604
PRAMOSONE
LOT 2.5%
0
$0.00
0.00%
11
$827.40
36.67%
00496072606
PRAMOSONE
LOT 2.5%
1
$23.00
8.33%
4
$189.00
13.33%
00496072904
PRAMOSONE
LOT 1%
2
$118.78
16.67%
2
$129.90
6.67%
00496076304
PRAMOSONE
OIN 1%
1
$15.00
8.33%
0
$0.00
0.00%
00496077704
PRAMOSONE
OIN 2.5%
0
$0.00
0.00%
2
$52.40
6.67%
00785550202
ZONE-A FORTE LOT
3
$362.07
25.00%
0
$0.00
0.00%
10337071052
LIDAMANTLE CRE HC 3-.5%
1
$26.57
8.33%
0
$0.00
0.00%
60258004101
LIDOCAINE-HC CRE 3-0.5%
0
$0.00
0.00%
1
$32.51
3.33%
TETRACYCLINES
00003060343
SUMYCIN
TAB 500MG
2
$20.60
0.06%
0
$0.00
0.00%
00003065540
SUMYCIN
CAP 250MG
4
$17.60
0.12%
0
$0.00
0.00%
00003065560
SUMYCIN
CAP 250MG
18
$104.39
0.55%
0
$0.00
0.00%
00003066345
SUMYCIN
TAB 250MG
4
$19.56
0.12%
3
$10.14
0.07%
00003076340
SUMYCIN
CAP 500MG
4
$36.30
0.12%
0
$0.00
0.00%
00003081550
SUMYCIN
SYP 125/5ML
9
$506.70
0.27%
9
$585.80
0.20%
00005534323
MINOCIN
CAP 50MG
0
$0.00
0.00%
6
$695.56
0.14%
00005534418
MINOCIN
CAP 100MG
0
$0.00
0.00%
3
$630.93
0.07%
00005921823
DECLOMYCIN TAB 150MG
11
$6,162.14
0.33%
2
$834.41
0.05%
Page 466 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
TETRACYCLINES
00005927029
DECLOMYCIN TAB 300MG
7
00069097065
VIBRAMYCIN SUS 25MG/5ML
00069097193
VIBRAMYCIN SYP 50MG/5ML
00093316501
$1,855.89
0.21%
8
$4,264.37
0.18%
0
$0.00
1
$69.00
0.00%
2
$161.73
0.05%
0.03%
10
$845.17
0.23%
MINOCYCLINE CAP 50MG
92
$1,681.68
2.80%
131
$1,899.85
2.98%
00093316753
192
$6,780.69
5.84%
276
$8,733.14
6.28%
00115140003
00115701701
TETRACYCLINE CAP 250MG
7
$28.59
0.21%
0
$0.00
0.00%
0
$0.00
0.00%
31
$378.68
0.70%
00115701806
0
$0.00
0.00%
38
$1,288.60
0.86%
00115705401
1
$150.95
0.03%
1
$52.55
0.02%
00143211250
DOXYCYCL HYC TAB 100MG
0
$0.00
0.00%
17
$79.65
0.39%
00143314150
DOXYCYCL HYC CAP 50MG
0
$0.00
0.00%
5
$28.30
0.11%
00143314205
21
$110.53
0.64%
139
$517.68
3.16%
00143314250
33
$177.45
1.00%
149
$591.59
3.39%
00172240760
28
$169.82
0.85%
41
$291.24
0.93%
00172240780
37
$262.72
1.13%
48
$341.92
1.09%
00172241660
50
$247.25
1.52%
58
$246.58
1.32%
00172241680
37
$199.40
1.13%
49
$219.21
1.11%
00172298448
12
$72.68
0.37%
4
$17.50
0.09%
00172298548
84
$467.71
2.56%
123
$494.19
2.80%
00172298570
6
$23.36
0.18%
37
$136.95
0.84%
00172362648
82
$481.67
2.50%
213
$1,087.45
4.84%
00172362670
17
$98.72
0.52%
25
$108.01
0.57%
00182011289
0
$0.00
0.00%
2
$7.23
0.05%
00185081001
DOXYCYC MONO CAP 100MG
2
$10.00
0.06%
0
$0.00
0.00%
00185081053
3
$96.92
0.09%
3
$89.93
0.07%
00364203250
3
$10.56
0.09%
2
$7.06
0.05%
00364203290
1
$1.86
0.03%
1
$3.53
0.02%
Page 467 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
TETRACYCLINES
00364203305
00364203350
00364249701
00364249850
00378010110
00378010201
00378010205
00378014589
00378014889
00430083620
DORYX
CAP 75MG EC
00430083819
DORYX
CAP 100MG EC
00555001002
00555001005
00555001102
00555001105
00591049805
00591049850
$31.00
0.14%
0
$0.00
0.00%
4
$37.50
0.09%
0.06%
2
$78.70
0.05%
$0.00
0.00%
2
$7.28
0.05%
3
$36.80
0.09%
1
$8.81
0.02%
15
$100.37
0.46%
8
$70.29
0.18%
0
$0.00
0.00%
1
$8.84
0.02%
1
$4.45
0.03%
2
$5.54
0.05%
2
$207.27
0.06%
0
$0.00
0.00%
21
$1,902.15
0.64%
17
$962.95
0.39%
265
$2,341.19
8.07%
331
$2,617.60
7.53%
54
$401.07
1.64%
42
$277.92
0.95%
14
$70.35
0.43%
82
$340.54
1.86%
311
$1,648.39
9.47%
319
$1,523.04
7.25%
177
$942.26
5.39%
625
$2,354.37
14.21%
7
$29.59
0.21%
64
$266.38
1.46%
00591049905
0
$0.00
0.00%
4
$32.58
0.09%
00591049950
0
$0.00
0.00%
152
$821.77
3.46%
00591050050
0
$0.00
0.00%
33
$256.36
0.75%
00591544005
85
$444.84
2.59%
95
$470.15
2.16%
00591544050
18
$77.38
0.55%
44
$209.73
1.00%
00591553550
6
$38.19
0.18%
34
$151.98
0.77%
00591555305
95
$577.58
2.89%
91
$474.27
2.07%
00591555350
9
$62.13
0.27%
42
$236.29
0.95%
00591569401
66
$1,106.73
2.01%
81
$1,087.35
1.84%
00591569550
247
$7,548.08
7.52%
180
$5,449.43
4.09%
23
$124.43
0.70%
6
1
$4.45
0.03%
21
$373.56
0.64%
2
$107.50
0
Page 468 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
TETRACYCLINES
00603348019
0
$0.00
0.00%
1
$6.34
0.02%
00603348119
1
$4.45
0.03%
0
$0.00
0.00%
00603348128
1
$4.45
0.03%
0
$0.00
0.00%
00603348228
11
$55.08
0.33%
0
$0.00
0.00%
00677056202
14
$66.14
0.43%
7
$25.13
0.16%
00677056205
3
$12.87
0.09%
25
$115.77
0.57%
00677059802
2
$13.76
0.06%
2
$17.93
0.05%
00677079902
2
$11.11
0.06%
0
$0.00
0.00%
00677079905
0
$0.00
0.00%
2
$11.99
0.05%
00904042751
0
$0.00
0.00%
2
$12.68
0.05%
00904042840
0
$0.00
0.00%
1
$2.45
0.02%
00904042851
0
$0.00
0.00%
24
$114.76
0.55%
00904043051
0
$0.00
0.00%
5
$32.26
0.11%
00904240780
1
$10.39
0.03%
4
$26.13
0.09%
00904241680
1
$5.45
0.03%
2
$11.95
0.05%
49884072601
1
$22.69
0.03%
0
$0.00
0.00%
49884072703
5
$428.82
0.15%
6
$202.03
0.14%
49884079701
SUMYCIN
TAB 250MG
0
$0.00
0.00%
2
$6.14
0.05%
49884079933
SUMYCIN
SYP 125/5ML
0
$0.00
0.00%
6
$218.57
0.14%
52544031025
0
$0.00
0.00%
2
$45.77
0.05%
52544031050
1
$102.53
0.03%
0
$0.00
0.00%
52544049805
262
$1,365.29
7.98%
14
$50.82
0.32%
52544049850
120
$626.63
3.65%
27
$122.59
0.61%
52544049905
90
$575.01
2.74%
25
$115.89
0.57%
52544049950
174
$1,191.42
5.30%
13
$89.90
0.30%
52544050050
37
$287.85
1.13%
13
$76.27
0.30%
53489011802
1
$5.87
0.03%
3
$13.93
0.07%
Page 469 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
TETRACYCLINES
53489011902
53489011905
53489012002
18
$67.13
0.55%
24
$104.38
0.55%
45
$213.24
1.37%
129
$850.11
3.93%
10
$38.98
0.23%
93
$413.45
2.11%
53489012005
7
$60.10
0.21%
12
$80.93
0.27%
55515025904
MONODOX
CAP 100MG
5
$345.25
0.15%
1
$75.74
0.02%
59911586901
59911587001
17
$257.47
0.52%
8
$84.40
0.18%
1
$58.05
0.03%
2
$41.50
0.05%
62436072903
ADOXA
0
$0.00
0.00%
1
$47.02
0.02%
63304069401
40
$717.00
1.22%
81
$1,010.30
1.84%
63304069501
63304069650
1
$101.75
0.03%
4
$347.80
0.09%
68
$2,605.40
2.07%
258
$7,593.64
5.87%
64682000802
PERIOSTAT
TAB
16
$758.10
0.49%
14
$422.39
0.32%
99207049250
DYNACIN
TAB 100MG
0
$0.00
0.00%
4
$351.49
0.09%
99207049850
DYNACIN
CAP 100MG
0
$0.00
0.00%
2
$60.70
0.05%
1,225
$13,768.94
5.27%
175
$1,782.56
0.60%
TAB 100MG
THYROID HORMONES
00048102003
SYNTHROID
TAB 25MCG
00048102005
SYNTHROID
TAB 25MCG
107
$1,029.79
0.46%
4
$34.88
0.01%
00048104003
SYNTHROID
TAB 50MCG
1,704
$20,992.77
7.33%
164
$1,843.23
0.56%
00048104005
SYNTHROID
TAB 50MCG
464
$4,855.64
2.00%
104
$1,139.39
0.36%
00048104013
SYNTHROID
TAB 50MCG
21
$241.50
0.09%
19
$191.16
0.07%
00048105003
SYNTHROID
TAB 75MCG
1,543
$20,301.21
6.64%
222
$2,625.83
0.76%
00048105005
SYNTHROID
TAB 75MCG
150
$1,738.08
0.65%
15
$171.34
0.05%
00048105013
SYNTHROID
TAB 75MCG
8
$97.91
0.03%
21
$231.99
0.07%
00048106003
SYNTHROID
TAB 88MCG
557
$7,393.61
2.40%
117
$1,480.54
0.40%
00048106004
SYNTHROID
TAB 88MCG
26
$299.27
0.11%
6
$65.88
0.02%
00048107003
SYNTHROID
TAB 100MCG
1,458
$19,555.37
6.27%
215
$2,673.63
0.74%
Page 470 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
THYROID HORMONES
00048107005
SYNTHROID
TAB 100MCG
00048107013
SYNTHROID
TAB 100MCG
00048108003
SYNTHROID
TAB 112MCG
00048108005
SYNTHROID
TAB 112MCG
00048109003
SYNTHROID
00048109005
00048110003
$6,565.22
2.42%
$1,451.71
0.44%
11
$144.98
0.05%
469
$7,000.36
2.02%
8
$95.29
0.03%
71
$985.47
0.24%
22
$272.92
0.09%
4
$53.30
0.01%
TAB 150MCG
849
$13,029.16
3.65%
146
$2,137.28
0.50%
SYNTHROID
TAB 150MCG
116
SYNTHROID
TAB 175MCG
445
$1,580.15
0.50%
17
$267.84
0.06%
$7,887.58
1.91%
90
$1,541.37
0.31%
00048110004
SYNTHROID
TAB 175MCG
25
$385.41
0.11%
3
$46.41
0.01%
00048113003
SYNTHROID
TAB 125MCG
1,091
$16,991.29
4.69%
186
$2,642.89
0.64%
00048113005
00048114003
SYNTHROID
TAB 125MCG
117
$1,513.28
0.50%
25
$328.50
0.09%
SYNTHROID
TAB 200MCG
524
$9,737.55
2.25%
108
$1,950.12
0.37%
00048114005
SYNTHROID
TAB 200MCG
20
$296.25
0.09%
22
$336.08
0.08%
00048117003
SYNTHROID
TAB 300MCG
85
$1,997.45
0.37%
38
$936.09
0.13%
00048117005
SYNTHROID
TAB 300MCG
3
$62.16
0.01%
0
$0.00
0.00%
00074232701
SYNTHROID
INJ 200MCG
0
$0.00
0.00%
1
$1,612.00
0.00%
00074372713
SYNTHROID
TAB 137MCG
16
$253.84
0.07%
80
$1,304.44
0.28%
00074434113
SYNTHROID
TAB 25MCG
3
$35.64
0.01%
957
$11,091.34
3.29%
00074434119
SYNTHROID
TAB 25MCG
0
$0.00
0.00%
286
$3,102.67
0.98%
00074455211
SYNTHROID
TAB 50MCG
0
$0.00
0.00%
18
$218.78
0.06%
00074455213
SYNTHROID
TAB 50MCG
1
$13.05
0.00%
1,606
$20,628.91
5.52%
00074455219
SYNTHROID
TAB 50MCG
0
$0.00
0.00%
546
$6,170.62
1.88%
00074518211
SYNTHROID
TAB 75MCG
0
$0.00
0.00%
7
$97.27
0.02%
00074518213
SYNTHROID
TAB 75MCG
4
$55.24
0.02%
1,388
$19,126.02
4.77%
00074518219
SYNTHROID
TAB 75MCG
0
$0.00
0.00%
352
$4,270.95
1.21%
00074659413
SYNTHROID
TAB 88MCG
0
$0.00
0.00%
517
$7,330.79
1.78%
00074659419
SYNTHROID
TAB 88MCG
0
$0.00
0.00%
73
$941.49
0.25%
00074662413
SYNTHROID
TAB 100MCG
0
$0.00
0.00%
1,136
$15,865.18
3.91%
562
127
Page 471 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
THYROID HORMONES
00074662419
SYNTHROID
TAB 100MCG
0
$0.00
0.00%
788
$9,909.20
2.71%
00074706813
SYNTHROID
TAB 125MCG
2
$18.82
0.01%
1,156
$19,191.67
3.97%
00074706819
SYNTHROID
TAB 125MCG
0
$0.00
0.00%
201
$2,728.59
0.69%
00074706911
SYNTHROID
TAB 150MCG
0
$0.00
0.00%
3
$52.22
0.01%
00074706913
SYNTHROID
TAB 150MCG
0
$0.00
0.00%
752
$12,581.83
2.59%
00074706919
SYNTHROID
TAB 150MCG
0
$0.00
0.00%
172
$2,539.89
0.59%
00074707013
SYNTHROID
TAB 175MCG
0
$0.00
0.00%
401
$7,684.90
1.38%
00074707019
SYNTHROID
TAB 175MCG
0
$0.00
0.00%
37
$630.67
0.13%
00074714811
SYNTHROID
TAB 200MCG
0
$0.00
0.00%
1
$21.13
0.00%
00074714813
SYNTHROID
TAB 200MCG
1
$18.12
0.00%
514
$10,433.29
1.77%
00074714819
SYNTHROID
TAB 200MCG
0
$0.00
0.00%
23
$389.94
0.08%
00074714913
SYNTHROID
TAB 300MCG
0
$0.00
0.00%
57
$1,508.22
0.20%
00074714919
SYNTHROID
TAB 300MCG
0
$0.00
0.00%
3
$72.48
0.01%
00074929613
SYNTHROID
TAB 112MCG
0
$0.00
0.00%
513
$8,279.91
1.76%
00074929619
SYNTHROID
TAB 112MCG
0
$0.00
0.00%
30
$345.89
0.10%
00254391128
LEVOTHYROXIN TAB 25MCG
1
$8.32
0.00%
2
$16.64
0.01%
00254391338
3
$12.28
0.01%
0
$0.00
0.00%
00254391438
4
$37.68
0.02%
0
$0.00
0.00%
00254391938
2
$10.64
0.01%
0
$0.00
0.00%
00378180001
0
$0.00
0.00%
30
$256.25
0.10%
00378180301
0
$0.00
0.00%
27
$245.34
0.09%
00378180501
0
$0.00
0.00%
6
$74.83
0.02%
00378180701
0
$0.00
0.00%
11
$96.36
0.04%
00378180901
0
$0.00
0.00%
29
$273.02
0.10%
00378181101
0
$0.00
0.00%
6
$64.79
0.02%
00378181301
0
$0.00
0.00%
19
$220.18
0.07%
00378181501
0
$0.00
0.00%
6
$77.43
0.02%
Page 472 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
THYROLAR-1/4 TAB 15MG
00456004501
THYROLAR-1/2 TAB 30MG
00456005001
THYROLAR-1 TAB 60MG
00456032001
LEVOTHROID TAB 25MCG
00456032100
$
Market Share*
THYROID HORMONES
00456004001
# of Scripts
$314.44
0.07%
17
$407.79
0.06%
5
$94.48
12
$317.39
0.02%
6
$109.34
0.02%
0.05%
14
$311.20
0.05%
556
$5,274.79
2.39%
528
$4,435.82
1.82%
74
$812.29
0.32%
201
$1,814.77
0.69%
00456032101
00456032163
960
$9,398.98
4.13%
712
$5,958.17
2.45%
0
$0.00
0.00%
7
$38.60
0.02%
00456032201
837
$8,512.25
3.60%
619
$5,733.72
2.13%
00456032300
1
$23.53
0.00%
50
$441.18
0.17%
00456032301
852
$8,867.34
3.66%
619
$5,995.03
2.13%
00456032401
485
$5,754.76
2.09%
340
$3,860.40
1.17%
00456032463
0
$0.00
0.00%
6
$43.77
0.02%
00456032500
3
$32.34
0.01%
0
$0.00
0.00%
00456032501
316
$3,856.17
1.36%
298
$3,556.90
1.02%
00456032551
0
$0.00
0.00%
2
$14.94
0.01%
00456032563
15
$150.91
0.06%
2
$19.89
0.01%
00456032601
136
$1,796.65
0.58%
172
$2,038.29
0.59%
00456032701
128
$1,799.04
0.55%
147
$1,955.09
0.51%
00456032763
0
$0.00
0.00%
2
$22.23
0.01%
00456032801
8
$194.62
0.03%
19
$334.86
0.07%
00456032901
228
$2,363.86
0.98%
203
$1,913.72
0.70%
00456033001
175
$1,999.15
0.75%
140
$1,458.33
0.48%
00456033101
44
$574.83
0.19%
56
$647.02
0.19%
00456045701
ARMOUR THYRO TAB 15MG
40
$231.74
0.17%
54
$290.15
0.19%
00456045800
5
$43.60
0.02%
0
$0.00
0.00%
00456045801
47
$368.56
0.20%
63
$424.00
0.22%
00456045900
9
$68.26
0.04%
20
$115.23
0.07%
16
Page 473 of 522
Utilization Report
PDL Category
NDC
Q4 2002
Description
# of Scripts
$
Q4 2003
Market Share*
00456045963
00456046001
00456046101
00456046201
00456132001
00456132101
$
Market Share*
THYROID HORMONES
00456045901
# of Scripts
$753.99
0.44%
$593.04
0.35%
6
$59.16
0.03%
69
$569.42
0.30%
9
$93.69
0.03%
72
$592.10
0.25%
39
$373.58
0.17%
46
$406.29
0.16%
16
$211.70
0.07%
18
$202.74
0.06%
0
$0.00
0.00%
0
$0.00
0.00%
9
$75.67
0.03%
21
$170.06
0.07%
00456132201
0
$0.00
0.00%
12
$116.82
0.04%
00456132301
0
$0.00
0.00%
28
$235.66
0.10%
00456132401
0
00456132501
0
$0.00
0.00%
6
$68.01
0.02%
$0.00
0.00%
6
$62.08
0.02%
00456132601
0
$0.00
0.00%
1
$7.58
0.00%
00456132701
0
$0.00
0.00%
1
$11.51
0.00%
00456132801
0
$0.00
0.00%
1
$15.67
0.00%
00456132901
0
$0.00
0.00%
2
$15.96
0.01%
00456133001
0
$0.00
0.00%
4
$49.73
0.01%
00527134101
0
$0.00
0.00%
225
$2,063.10
0.77%
00527134110
0
$0.00
0.00%
93
$812.26
0.32%
00527134201
0
$0.00
0.00%
385
$3,788.77
1.32%
00527134210
0
$0.00
0.00%
87
$817.18
0.30%
00527134301
0
$0.00
0.00%
400
$4,152.10
1.38%
00527134310
0
$0.00
0.00%
18
$167.84
0.06%
00527134401
0
$0.00
0.00%
113
$1,127.53
0.39%
00527134501
0
$0.00
0.00%
319
$3,388.59
1.10%
00527134510
0
$0.00
0.00%
29
$288.49
0.10%
00527134601
0
$0.00
0.00%
100
$1,228.63
0.34%
00527134701
0
$0.00
0.00%
154
$1,846.09
0.53%
103
103
Page 474 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
THYROID HORMONES
00527134901
0
$0.00
0.00%
00527134910
0
$0.00
0.00%
00527135001
0
$0.00
0.00%
00527135101
0
$0.00
0.00%
00527137001
UNITHROID
TAB 25MCG
0
$0.00
00527137101
UNITHROID
TAB 50MCG
0
00527137201
UNITHROID
TAB 75MCG
0
00527137401
UNITHROID
TAB 100MCG
00527137601
UNITHROID
TAB 125MCG
00603419432
00603419632
$1,390.87
0.39%
1
$12.78
0.00%
49
$638.78
0.17%
50
$691.21
0.17%
0.00%
1
$6.49
0.00%
$0.00
0.00%
11
$91.52
0.04%
$0.00
0.00%
1
$6.49
0.00%
0
$0.00
0.00%
3
$48.90
0.01%
0
$0.00
0.00%
4
$29.56
0.01%
8
$70.24
0.03%
0
$0.00
0.00%
1
$16.98
0.00%
0
$0.00
0.00%
00603419721
1
$11.51
0.00%
0
$0.00
0.00%
00603419832
2
$25.86
0.01%
0
$0.00
0.00%
00603420032
7
$77.35
0.03%
0
$0.00
0.00%
00603604632
THYROID
TAB 65MG
3
$10.60
0.01%
0
$0.00
0.00%
00603605232
THYROID
TAB 60MG
0
$0.00
0.00%
6
$30.08
0.02%
00677165710
THYROID
TAB 32.5MG
0
$0.00
0.00%
3
$3.99
0.01%
00677165810
THYROID
TAB 65MG
5
$23.49
0.02%
5
$11.80
0.02%
00677165910
THYROID
TAB 130MG
3
$10.89
0.01%
3
$4.89
0.01%
00689111005
LEVOXYL
TAB 100MCG
3
$29.86
0.01%
0
$0.00
0.00%
00689111010
LEVOXYL
TAB 100MCG
1
$22.23
0.00%
0
$0.00
0.00%
00689111101
LEVOXYL
TAB 150MCG
6
$77.18
0.03%
0
$0.00
0.00%
00689111205
LEVOXYL
TAB 200MCG
5
$104.50
0.02%
1
$21.30
0.00%
00689111705
LEVOXYL
TAB 25MCG
1
$9.49
0.00%
0
$0.00
0.00%
00689111801
LEVOXYL
TAB 50MCG
11
$123.16
0.05%
0
$0.00
0.00%
00689111805
LEVOXYL
TAB 50MCG
2
$16.98
0.01%
0
$0.00
0.00%
00689111810
LEVOXYL
TAB 50MCG
4
$29.01
0.02%
0
$0.00
0.00%
114
Page 475 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
THYROID HORMONES
00689111910
LEVOXYL
TAB 75MCG
00689112005
LEVOXYL
TAB 125MCG
00689112201
LEVOXYL
TAB 175MCG
00689113201
LEVOXYL
TAB 88MCG
00689113501
LEVOXYL
00904076160
00904076180
$112.93
0.03%
0
$0.00
0.00%
3
$23.99
0.01%
0
$0.00
0.00%
16
$252.88
0.07%
0
$0.00
0.00%
23
$278.93
0.10%
0
$0.00
0.00%
TAB 137MCG
2
$24.20
0.01%
0
$0.00
0.00%
THYROID
TAB 65MG
3
$9.06
0.01%
2
$9.80
0.01%
THYROID
TAB 65MG
3
$11.64
0.01%
0
$0.00
0.00%
00904076260
THYROID
TAB 130MG
1
$4.26
0.00%
0
$0.00
0.00%
00904786560
THYROID
TAB 30MG
6
$27.42
0.03%
8
$41.32
0.03%
50564052210
3
$32.49
0.01%
0
$0.00
0.00%
50564056210
2
$20.38
0.01%
0
$0.00
0.00%
52544090201
UNITHROID
TAB 25MCG
32
$295.42
0.14%
16
$141.65
0.06%
52544090301
UNITHROID
TAB 50MCG
11
$125.93
0.05%
5
$45.85
0.02%
52544090401
UNITHROID
TAB 75MCG
11
$162.77
0.05%
15
$196.24
0.05%
52544090501
UNITHROID
TAB 88MCG
3
$43.77
0.01%
4
$38.56
0.01%
52544090601
UNITHROID
TAB 100MCG
10
$118.51
0.04%
0
$0.00
0.00%
52544090701
UNITHROID
TAB 112MCG
7
$87.74
0.03%
8
$92.55
0.03%
52544090801
UNITHROID
TAB 125MCG
2
$42.23
0.01%
6
$58.26
0.02%
52544090901
UNITHROID
TAB 150MCG
6
$83.43
0.03%
11
$132.72
0.04%
52544091001
UNITHROID
TAB 175MCG
3
$63.27
0.01%
0
$0.00
0.00%
52544091101
UNITHROID
TAB 200MCG
1
$29.76
0.00%
0
$0.00
0.00%
52604341401
CYTOMEL
TAB 5MCG
48
$1,288.01
0.21%
60
$2,009.75
0.21%
52604341601
CYTOMEL
TAB 25MCG
78
$1,460.14
0.34%
102
$2,024.33
0.35%
52604341701
CYTOMEL
TAB 50MCG
17
$552.65
0.07%
12
$342.71
0.04%
52604502501
LEVOXYL
TAB 25MCG
484
$5,295.87
2.08%
765
$8,301.48
2.63%
52604502502
LEVOXYL
TAB 25MCG
206
$1,836.51
0.89%
251
$2,597.86
0.86%
52604505001
LEVOXYL
TAB 50MCG
911
$10,651.44
3.92%
1,351
$16,805.60
4.64%
8
Page 476 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
THYROID HORMONES
52604505002
LEVOXYL
TAB 50MCG
373
$3,670.70
1.60%
414
$4,617.22
1.42%
52604507501
LEVOXYL
TAB 75MCG
550
$7,127.05
2.37%
861
$12,188.91
2.96%
52604507502
LEVOXYL
TAB 75MCG
355
$3,866.69
1.53%
399
$4,664.35
1.37%
52604508801
LEVOXYL
TAB 88MCG
268
$3,345.28
1.15%
387
$5,445.71
1.33%
52604508802
LEVOXYL
TAB 88MCG
27
$335.34
0.12%
10
$182.97
0.03%
52604510001
LEVOXYL
TAB 100MCG
545
$7,076.45
2.34%
824
$11,369.08
2.83%
52604510002
LEVOXYL
TAB 100MCG
460
$5,427.05
1.98%
464
$6,167.23
1.60%
52604511201
LEVOXYL
TAB 112MCG
207
$3,090.22
0.89%
340
$5,302.01
1.17%
52604511202
LEVOXYL
TAB 112MCG
16
$237.03
0.07%
12
$170.70
0.04%
52604512501
LEVOXYL
TAB 125MCG
478
$7,160.64
2.06%
637
$10,384.06
2.19%
52604512502
LEVOXYL
TAB 125MCG
117
$1,533.35
0.50%
125
$1,823.19
0.43%
52604513701
LEVOXYL
TAB 137MCG
156
$2,395.28
0.67%
237
$3,830.52
0.81%
52604513702
LEVOXYL
TAB 137MCG
2
$19.99
0.01%
2
$48.18
0.01%
52604515001
LEVOXYL
TAB 150MCG
348
$4,825.53
1.50%
528
$8,140.84
1.82%
52604515002
LEVOXYL
TAB 150MCG
83
$1,184.51
0.36%
74
$1,141.56
0.25%
52604517501
LEVOXYL
TAB 175MCG
206
$3,499.64
0.89%
293
$5,695.91
1.01%
52604517502
LEVOXYL
TAB 175MCG
19
$264.73
0.08%
24
$332.74
0.08%
52604520001
LEVOXYL
TAB 200MCG
199
$3,636.23
0.86%
325
$6,483.47
1.12%
52604520002
LEVOXYL
TAB 200MCG
19
$363.74
0.08%
22
$445.79
0.08%
52604530001
LEVOXYL
TAB 300MCG
33
$554.80
0.14%
20
$519.64
0.07%
52604530002
LEVOXYL
TAB 300MCG
2
$34.30
0.01%
0
$0.00
0.00%
55390088010
LEVOTHYROXIN INJ 200MCG
2
$30.42
0.01%
1
$27.49
0.00%
55390088110
0
$0.00
0.00%
1
$117.54
0.00%
63323024710
3
$1,463.07
0.01%
0
$0.00
0.00%
1
$31.81
0.01%
0
$0.00
0.00%
TOPICAL ANTI-FUNGALS
00003041120
FUNGIZONE
CRE 3%
Page 477 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00003056660
MYCOLOG II CRE
3
00003056665
MYCOLOG II CRE
00003059320
MYCOSTATIN POW 100000U
00003325105
$43.31
0.04%
1
$30.25
0.01%
1
$3.45
0.01%
2
$136.41
0.03%
0
$0.00
0.00%
3
$87.17
0.03%
ALOE VESTA OIN ANTIFUNG
0
$0.00
0.00%
1
$24.08
0.01%
00039000930
LOPROX
CRE 0.77%
1
$21.66
0.01%
0
$0.00
0.00%
00039000990
LOPROX
CRE 1%
00062543401
MONISTAT
CRE DERM 2%
3
$112.81
0.04%
1
$9.17
0.01%
82
$2,800.35
1.08%
33
$1,241.69
0.37%
00062543402
MONISTAT
CRE DERM 2%
31
$702.69
0.41%
22
$485.48
0.25%
00062543403
MONISTAT
CRE DERM 2%
13
$600.01
0.17%
5
$295.15
0.06%
00062546001
00062546002
SPECTAZOLE CRE 1%
140
$4,321.60
1.84%
97
$3,794.21
1.09%
SPECTAZOLE CRE 1%
46
$1,109.61
0.60%
33
$695.62
0.37%
00062546003
SPECTAZOLE CRE 1%
73
$4,056.32
0.96%
40
$2,652.85
0.45%
00066800801
PENLAC
SOL 8%
57
$3,630.22
0.75%
6
$448.64
0.07%
00066800802
PENLAC
SOL 8%
48
$5,056.79
0.63%
48
$5,389.12
0.54%
00067399842
LAMISIL AT CRE 1%
24
$403.98
0.31%
0
$0.00
0.00%
00067399885
LAMISIL AT CRE 1%
3
$39.57
0.04%
3
$50.19
0.03%
00072820015
EXELDERM
CRE 1%
2
$28.56
0.03%
2
$16.42
0.02%
00072820030
EXELDERM
CRE 1%
9
$181.78
0.12%
3
$62.74
0.03%
00072820060
EXELDERM
CRE 1%
1
$33.22
0.01%
0
$0.00
0.00%
00072840030
EXELDERM
SOL 1%
1
$24.88
0.01%
0
$0.00
0.00%
00078032882
LAMISIL
5
$350.97
0.07%
6
$370.50
0.07%
00085018202
LOTRIMIN
SOL 1%
1
$15.78
0.01%
0
$0.00
0.00%
00085025406
TINACTIN
AER POWD 1%
3
$23.10
0.04%
3
$23.10
0.03%
00085061304
LOTRIMIN
CRE 1%
4
$105.29
0.05%
0
$0.00
0.00%
00085061305
LOTRIMIN
CRE 1%
1
$27.30
0.01%
0
$0.00
0.00%
00085070702
LOTRIMIN
LOT 1%
8
$223.79
0.10%
1
$30.37
0.01%
00085071507
TINACTIN
CRE 1%
2
$13.98
0.03%
1
$8.40
0.01%
SPR 1%
Page 478 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00085080901
LOTRISONE
LOT
56
$2,605.59
0.73%
39
00085092402
LOTRISONE
CRE
2
$102.36
0.03%
00093024831
CLOTRIMAZOLE SOL 1%
7
$71.85
0.09%
00093024843
CLOTRIMAZOLE SOL 1%
7
$38.75
00093084015
KETOCONAZOLE CRE 2%
183
00093084030
KETOCONAZOLE CRE 2%
00093084092
KETOCONAZOLE CRE 2%
00168000715
NYSTATIN
00168000730
$1,919.37
0.44%
0
$0.00
0.00%
6
$53.75
0.07%
0.09%
7
$32.75
0.08%
$2,735.26
2.40%
73
$1,213.68
0.82%
374
$8,934.47
4.91%
225
$5,730.45
2.54%
118
$5,141.78
1.55%
71
$2,849.10
0.80%
OIN 100000U
19
$100.14
0.25%
34
$162.46
0.38%
NYSTATIN
OIN 100000U
35
$238.60
0.46%
143
$944.36
1.61%
00168005415
NYSTATIN
CRE 100000U
20
$91.37
0.26%
44
$168.40
0.50%
00168005430
NYSTATIN
CRE 100000U
85
$472.15
1.12%
71
$358.55
0.80%
00168008115
NYSTAT/TRIAM CRE
13
$62.97
0.17%
3
$11.93
0.03%
00168008130
NYSTAT/TRIAM CRE
66
$403.50
0.87%
17
$85.72
0.19%
00168008160
NYSTAT/TRIAM CRE
7
$63.90
0.09%
5
$38.15
0.06%
00168008930
NYSTAT/TRIAM OIN
9
$56.52
0.12%
9
$56.94
0.10%
00168008960
NYSTAT/TRIAM OIN
3
$27.60
0.04%
1
$9.20
0.01%
00168014231
MICONAZOLE CRE 2%
0
$0.00
0.00%
4
$20.05
0.05%
00168025815
CLOTRIM/BETA CRE DIPROP
77
$2,362.38
1.01%
137
$4,374.62
1.55%
00168025846
82
$3,823.25
1.08%
128
$5,870.09
1.44%
00168031215
ECONAZOLE
CRE 1%
0
$0.00
0.00%
8
$164.08
0.09%
00168031230
ECONAZOLE
CRE 1%
0
$0.00
0.00%
46
$1,302.13
0.52%
00168031285
ECONAZOLE
CRE 1%
1
$52.38
0.01%
24
$1,336.22
0.27%
00173042300
OXISTAT
CRE 1%
1
$23.21
0.01%
0
$0.00
0.00%
00173042301
OXISTAT
CRE 1%
19
$663.15
0.25%
8
$317.50
0.09%
00173042304
OXISTAT
CRE 1%
1
$53.98
0.01%
2
$102.96
0.02%
00173044801
OXISTAT
LOT 1%
2
$103.94
0.03%
2
$54.26
0.02%
00259412615
NAFTIN
3
$112.58
0.04%
3
$96.99
0.03%
CRE 1%
Page 479 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
00259412630
NAFTIN
CRE 1%
5
$226.00
0.07%
2
$76.28
0.02%
00259412660
NAFTIN
CRE 1%
2
$107.58
0.03%
1
$58.39
0.01%
00259477040
NAFTIN
GEL 1%
1
$53.04
0.01%
1
$52.02
0.01%
00472015015
NYSTAT/TRIAM CRE
29
$150.16
0.38%
5
$23.88
0.06%
00472015030
NYSTAT/TRIAM CRE
115
$756.06
1.51%
194
$1,273.94
2.19%
00472015060
NYSTAT/TRIAM CRE
41
$363.21
0.54%
44
$388.21
0.50%
00472015515
NYSTAT/TRIAM OIN
7
$38.05
0.09%
7
$29.27
0.08%
00472015530
NYSTAT/TRIAM OIN
19
$137.85
0.25%
16
$135.54
0.18%
00472015560
NYSTAT/TRIAM OIN
2
$18.40
0.03%
1
$9.20
0.01%
00472016315
NYSTATIN
CRE 100000U
35
$173.68
0.46%
15
$65.15
0.17%
00472016330
NYSTATIN
CRE 100000U
219
$1,210.87
2.87%
325
$1,780.59
3.67%
00472016615
NYSTATIN
OIN 100000U
40
$220.96
0.52%
22
$105.57
0.25%
00472016630
NYSTATIN
OIN 100000U
106
$701.64
1.39%
121
$785.44
1.37%
00472073514
MICONAZOLE CRE 2%
1
$3.19
0.01%
0
$0.00
0.00%
00472073542
MICONAZOLE CRE 2%
0
$0.00
0.00%
2
$14.60
0.02%
00472073556
MICONAZOLE CRE 2%
1
$8.97
0.01%
1
$6.16
0.01%
00536299520
CLOTRIMAZOLE CRE 1%
1
$6.95
0.01%
0
$0.00
0.00%
00574200802
NYSTOP
POW 100000U
0
$0.00
0.00%
1
$170.18
0.01%
00574200815
NYSTOP
POW 100000U
939
$26,300.57
12.32%
916
$25,927.72
10.34%
00574200830
NYSTOP
POW 100000U
5
$223.49
0.07%
36
$1,797.94
0.41%
00884039602
PEDI-DRI
POW 100000U
25
$790.99
0.33%
333
$18,768.40
3.76%
00904257431
NYSTAT/TRIAM CRE
3
$18.84
0.04%
3
$13.62
0.03%
00904257436
NYSTAT/TRIAM CRE
0
$0.00
0.00%
1
$4.81
0.01%
00904270631
NYSTATIN
1
$5.62
0.01%
5
$32.63
0.06%
39822090007
NYSTAT-RX POW 1BU
1
$465.55
0.01%
0
$0.00
0.00%
45802002735
NTA
1
$5.78
0.01%
0
$0.00
0.00%
45802004811
NYSTATIN
16
$104.61
0.21%
19
$108.12
0.21%
CRE 100000U
OIN
OIN 100000U
Page 480 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
45802004835
NYSTATIN
OIN 100000U
5
$27.46
0.07%
4
$24.66
0.05%
45802005911
NYSTATIN
CRE 100000U
84
$444.10
1.10%
134
$599.09
1.51%
45802005935
NYSTATIN
CRE 100000U
4
$10.50
0.05%
15
$65.63
0.17%
50458022130
NIZORAL
CRE 2%
5
$121.75
0.07%
0
$0.00
0.00%
50458022160
NIZORAL
CRE 2%
7
$554.75
0.09%
1
$47.48
0.01%
50458022304
NIZORAL
SHA 2%
457
$11,597.87
6.00%
494
$14,175.28
5.57%
51479042300
OXISTAT
CRE 1%
2
$39.12
0.03%
1
$137.05
0.01%
51479042301
OXISTAT
CRE 1%
4
$109.02
0.05%
0
$0.00
0.00%
51479042304
OXISTAT
CRE 1%
4
$254.94
0.05%
2
$91.94
0.02%
51479044801
OXISTAT
LOT 1%
1
$56.59
0.01%
0
$0.00
0.00%
51672126003
CLOTRIMAZOLE SOL 1%
4
$38.20
0.05%
7
$73.85
0.08%
51672126301
NYSTAT/TRIAM CRE
143
$718.64
1.88%
142
$625.53
1.60%
51672126302
NYSTAT/TRIAM CRE
403
$2,548.01
5.29%
424
$2,325.35
4.78%
51672126303
NYSTAT/TRIAM CRE
161
$1,355.78
2.11%
203
$1,582.80
2.29%
51672127201
NYSTAT/TRIAM OIN
37
$185.64
0.49%
43
$179.51
0.49%
51672127202
NYSTAT/TRIAM OIN
39
$250.56
0.51%
45
$235.11
0.51%
51672127203
NYSTAT/TRIAM OIN
27
$232.08
0.35%
21
$170.65
0.24%
51672127501
CLOTRIMAZOLE CRE 1%
161
$1,257.53
2.11%
289
$2,470.75
3.26%
51672127502
CLOTRIMAZOLE CRE 1%
428
$4,419.34
5.61%
613
$6,523.99
6.92%
51672127506
CLOTRIMAZOLE CRE 1%
377
$5,087.72
4.95%
353
$5,083.63
3.98%
51672127507
CLOTRIMAZOLE CRE 1%
69
$1,049.30
0.91%
192
$2,734.40
2.17%
51672128901
NYSTATIN
CRE 100000U
206
$943.47
2.70%
260
$1,148.85
2.93%
51672128902
NYSTATIN
CRE 100000U
631
$3,676.75
8.28%
787
$4,314.62
8.88%
51672129801
KETOCONAZOLE CRE 2%
0
$0.00
0.00%
71
$1,070.00
0.80%
51672129802
KETOCONAZOLE CRE 2%
0
$0.00
0.00%
190
$4,532.14
2.14%
51672129803
KETOCONAZOLE CRE 2%
0
$0.00
0.00%
77
$3,090.82
0.87%
51672130301
ECONAZOLE
0
$0.00
0.00%
5
$121.42
0.06%
CRE 1%
Page 481 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
51672130302
ECONAZOLE
CRE 1%
1
$30.26
0.01%
13
$372.67
0.15%
51672130308
ECONAZOLE
CRE 1%
0
$0.00
0.00%
5
$281.05
0.06%
51672200202
CLOTRIMAZOLE CRE 1%
0
$0.00
0.00%
3
$31.65
0.03%
51672404801
153
$4,125.47
2.01%
238
$6,993.93
2.69%
51672404806
170
$7,066.92
2.23%
365
$15,442.09
4.12%
58177080302
HYDROCORT/ CRE IODOQUIN
2
$90.56
0.03%
4
$155.40
0.05%
59366270601
HYDROCORT/ CRE IODOQUIN
5
$230.31
0.07%
0
$0.00
0.00%
59930150301
0
$0.00
0.00%
4
$105.89
0.05%
59930150302
1
$47.49
0.01%
12
$514.39
0.14%
59930157001
CLOTRIMAZOLE CRE 1%
73
$552.56
0.96%
20
$145.45
0.23%
59930157002
CLOTRIMAZOLE CRE 1%
98
$1,093.67
1.29%
15
$144.78
0.17%
59930157003
CLOTRIMAZOLE CRE 1%
181
$2,451.12
2.37%
119
$1,605.39
1.34%
59930157009
CLOTRIMAZOLE CRE 1%
1
$10.55
0.01%
1
$24.95
0.01%
60258003230
HYDROC IODO CRE 1%
4
$193.72
0.05%
3
$145.79
0.03%
60267053104
VERSICLEAR LOT
0
$0.00
0.00%
1
$17.81
0.01%
62794015102
MENTAX
CRE 1%
19
$856.92
0.25%
6
$184.63
0.07%
62794015103
MENTAX
CRE 1%
75
$4,078.98
0.98%
25
$1,608.90
0.28%
99207000830
LOPROX
LOT 0.77%
4
$383.83
0.05%
0
$0.00
0.00%
99207000860
LOPROX
LOT 0.77%
13
$887.47
0.17%
0
$0.00
0.00%
99207000915
LOPROX
CRE 0.77%
24
$629.13
0.31%
29
$869.35
0.33%
99207000930
LOPROX
CRE 0.77%
93
$4,222.85
1.22%
73
$3,481.39
0.82%
99207000990
LOPROX
CRE 0.77%
13
$1,070.83
0.17%
9
$839.59
0.10%
99207001010
LOPROX
SHA 1%
0
$0.00
0.00%
1
$44.35
0.01%
99207001330
LOPROX
GEL TOPICAL
33
$1,241.01
0.43%
5
$238.29
0.06%
99207001345
LOPROX
GEL TOPICAL
29
$1,495.12
0.38%
19
$1,044.75
0.21%
99207001530
LOPROX
CRE 0.77%
0
$0.00
0.00%
5
$214.79
0.06%
99207001590
LOPROX
CRE 0.77%
0
$0.00
0.00%
1
$102.54
0.01%
Page 482 of 522
Utilization Report
PDL Category
NDC
Q4 2002
# of Scripts
Description
$
Q4 2003
Market Share*
# of Scripts
$
Market Share*
99207002230
LOPROX TS
SOL 0.77%
0
$0.00
0.00%
3
$116.66
0.03%
99207002260
LOPROX TS
SOL 0.77%
2
$138.12
0.03%
20
$1,837.35
0.23%
TOPICAL CORTICOSTEROIDS
00003024815
HALOG
OIN 0.1%
0
$0.00
0.00%
2
$64.41
0.02%
00003024820
HALOG
OIN 0.1%
3
$108.79
0.04%
0
$0.00
0.00%
00003024830
HALOG
OIN 0.1%
1
$57.46
0.01%
0
$0.00
0.00%
00003024915
HALOG
SOL 0.1%
1
$26.09
0.01%
1
$28.09
0.01%
00003024920
HALOG
SOL 0.1%
7
$375.80
0.10%
5
$281.50
0.06%
00003050162
KENALOG
AER SPRAY
14
$496.88
0.19%
8
$266.65
0.10%
00003050649
KENALOG
CRE 0.1%
0
$0.00
0.00%
1
$195.12
0.01%
00003148215
HALOG
CRE 0.1%
3
$80.81
0.04%
2
$43.50
0.02%
00003148220
HALOG
CRE 0.1%
1
$34.93
0.01%
4
$137.72
0.05%
00003148230
HALOG
CRE 0.1%
5
$287.30
0.07%
16
$2,056.71
0.19%
00003149421
HALOG-E
1
$34.93
0.01%
0
$0.00
0.00%
00026556162
TRIDESILON CRE 0.05%
2
$61.90
0.03%
0
$0.00
0.00%
00062035115
DERMATOP
CRE 0.1%
10
$239.05
0.14%
0
$0.00
0.00%
00062035160
DERMATOP
CRE 0.1%
15
$789.65
0.20%
1
$43.64
0.01%
00062035215
DERMATOP
OIN 0.1%
3
$105.33
0.04%
0
$0.00
0.00%
00062035260
DERMATOP
OIN 0.1%
1
$41.64
0.01%
0
$0.00
0.00%
00064221002
NUTRACORT
LOT 2.5%
5
$151.62
0.07%
3
$102.17
0.04%
00064221004
NUTRACORT
LOT 2.5%
0
$0.00
0.00%
1
$81.26
0.01%
00064310015
CLODERM
CRE 0.1%
8
$180.27
0.11%
5
$159.30
0.06%
00064310045
CLODERM
CRE 0.1%
13
$533.24
0.18%
13
$305.83
0.16%
00064310090
CLODERM
CRE 0.1%
0
$0.00
0.00%
1
$69.36
0.01%
00066006960
PSORCON
CRE 0.05%
4
$321.20
0.05%
7
$819.08
0.09%
00066007160
PSORCON
OIN 0.05%
2
$244.56
0.03%
1
$

Utilization Report

Transcription

Similar documents

Supplemental Rebate Utilization Report

Molina Washington Marketplace 1/1/16

2015 Florida - Molina Healthcare

mhccr Formulary

Colorado Health OP Formulary

Drug Formulary